PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ozaki, M; Wada-Katsumata, A; Fujikawa, K; Iwasaki, M; Yokohari, F; Satoji, Y; Nisimura, T; Yamaoka, R				Ozaki, M; Wada-Katsumata, A; Fujikawa, K; Iwasaki, M; Yokohari, F; Satoji, Y; Nisimura, T; Yamaoka, R			Ant nestmate and non-nestmate discrimination by a chemosensory sensillum	SCIENCE			English	Article							KIN RECOGNITION; HYMENOPTERA; INSECTS; ODOR	In animal societies, chemical communication plays an important role in conflict and cooperation. For ants, cuticular hydrocarbon (CHC) blends produced by non-nestmates elicit overt aggression. We describe a sensory sensillum on the antennae of the carpenter ant Camponotus japonicus that functions in nestmate discrimination. This sensillum is multiporous and responds only to non-nestmate CHC blends. This suggests a role for a peripheral recognition mechanism in detecting colony-specific chemical signals.	Kyoto Inst Technol, Fac Text Sci, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; Fukuoka Univ, Fac Sci, Dept Earth Syst Sci, Fukuoka 8140180, Japan	Kyoto Institute of Technology; Fukuoka University	Ozaki, M (corresponding author), Kyoto Inst Technol, Fac Text Sci, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.	mamiko@kit.ac.jp		Wada-Katsumata, Ayako/0000-0002-2895-1102				Breed M.D., 1987, P243; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; GETZ WM, 1987, INT J NEUROSCI, V32, P963, DOI 10.3109/00207458709043353; GETZ WM, 1994, BEHAV NEURAL BIOL, V61, P191, DOI 10.1016/S0163-1047(05)80075-5; GETZ WM, 1982, J THEOR BIOL, V99, P585, DOI 10.1016/0022-5193(82)90212-0; Holldobler B., 1980, Evolution of social behaviour: hypotheses and empirical tests, P35; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Isidoro N, 2001, MICROSC RES TECHNIQ, V55, P350, DOI 10.1002/jemt.1183; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; OBIN MS, 1989, ANIM BEHAV, V38, P430, DOI 10.1016/S0003-3472(89)80036-3; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Vander Meer Robert K., 1998, P79; VANDERMEER RK, 1989, J CHEM ECOL, V15, P2115, DOI 10.1007/BF01207442; Wilson EO., 1971, INSECT SOC; YAMAOKA R, 1990, PHYSL ECOL JPN, V27, P3152	16	306	331	3	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					311	314		10.1126/science.1105244	http://dx.doi.org/10.1126/science.1105244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	15947139				2022-12-24	WOS:000230449800049
J	Hersch, GL; Burton, RE; Bolon, DN; Baker, TA; Sauer, RT				Hersch, GL; Burton, RE; Bolon, DN; Baker, TA; Sauer, RT			Asymmetric interactions of ATP with the AAA+ ClpX(6) unfoldase: Allosteric control of a protein machine	CELL			English	Article							MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; DEPENDENT PROTEOLYSIS; DEGRADATION MACHINE; HYDROLYSIS; BINDING; DNA; MECHANISM; HELICASE; HEXAMER	ATP hydrolysis by AAA+ ClpX hexamers powers protein unfolding and translocation during ClpXP degradation. Although ClpX is a homohexamer, positive and negative allosteric interactions partition six potential nucleotide binding sites into three classes with asymmetric properties. Some sites release ATP rapidly, others release ATP slowly, and at least two sites remain nucleotide free. Recognition of the degradation tag of protein substrates requires ATP binding to one set of sites and ATP or ADP binding to a second set of sites, suggesting a mechanism that allows repeated unfolding attempts without substrate release over multiple ATPase cycles. Our results rule out concerted hydrolysis models involving ClPX6 center dot ATP(6) or ClPX6 center dot ADP(6) and highlight structures of hexameric AAA+ machines with three or four nucleotides as likely functional states. These studies further emphasize commonalities between distant AAA+ family members, including protein and DNA translocases, helicases, motor proteins, clamp loaders, and other ATP-dependent enzymes.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399; Bolon, Daniel/0000-0001-5857-6676	NIAID NIH HHS [AI-15706] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015706, R37AI015706] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bolon DN, 2004, MOL CELL, V16, P343, DOI 10.1016/j.molcel.2004.10.001; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glover JR, 2001, BIOCHEM CELL BIOL, V79, P557, DOI 10.1139/bcb-79-5-557; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Hishida T, 2004, P NATL ACAD SCI USA, V101, P9573, DOI 10.1073/pnas.0403584101; Jeong YJ, 2002, J BIOL CHEM, V277, P43778, DOI 10.1074/jbc.M208634200; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kim DY, 2003, J BIOL CHEM, V278, P50664, DOI 10.1074/jbc.M305882200; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Marrione PE, 1996, BIOCHEMISTRY-US, V35, P11228, DOI 10.1021/bi960316c; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; PATEL SS, 1995, BIOPHYS J, V68, pS186; Piszczek G, 2005, J BIOL CHEM, V280, P12221, DOI 10.1074/jbc.M411733200; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Segel IH, 1976, BIOCH CALCULATIONS; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Stitt BL, 2001, BIOCHEMISTRY-US, V40, P2276, DOI 10.1021/bi002253a; STITT BL, 1988, J BIOL CHEM, V263, P11130; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Wang JM, 1997, CELL, V91, P447, DOI 10.1016/S0092-8674(00)80431-6; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219	44	133	133	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1017	1027		10.1016/j.cell.2005.05.024	http://dx.doi.org/10.1016/j.cell.2005.05.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989952	Bronze			2022-12-24	WOS:000230448000009
J	Jacobson, MZ; Colella, WG; Golden, DM				Jacobson, MZ; Colella, WG; Golden, DM			Cleaning the air and improving health with hydrogen fuel-cell vehicles	SCIENCE			English	Article							GATOR-GCMM; POLLUTION; ECONOMY; US; STRATOSPHERE; TROPOSPHERE; WEATHER; BUDGET; IMPACT; OZONE	Converting all U.S. onroad vehicles to hydrogen fuel-cell vehicles (HFCVs) may improve air quality, health, and climate significantly, whether the hydrogen is produced by steam reforming of natural gas, wind electrolysis, or coal gasification. Most benefits would result from eliminating current vehicle exhaust. Wind and natural gas HFCVs offer the greatest potential health benefits and could save 3700 to 6400 U.S. lives annually. Wind HFCVs should benefit climate most. An all-HFCV fleet would hardly affect tropospheric water vapor concentrations. Conversion to coal HFCVs may improve health but would damage climate more than fossil/electric hybrids. The real cost of hydrogen from wind electrolysis may be below that of U.S. gasoline.	Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Jacobson, MZ (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	jacobson@stanford.edu		Jacobson, Mark/0000-0002-4315-4128				Archer CL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002076; BOLINGER M, SUMMARY POWER AUTHOR; COLELLA WC, IN PRESS J POWER SOU; Delucchi MA, 2000, J TRANSP ECON POLICY, V34, P135; Demirdoven N, 2004, SCIENCE, V305, P974, DOI 10.1126/science.1093965; Derwent RG, 2001, CLIMATIC CHANGE, V49, P463, DOI 10.1023/A:1010648913655; Heywood J.B., 1988, INTERNAL COMBUSTION, V1st ed; Jacobson MZ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004945; Jacobson MZ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018448; Jacobson MZ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD002044; Jacobson MZ, 2001, J GEOPHYS RES-ATMOS, V106, P5385, DOI 10.1029/2000JD900560; Jacobson MZ, 2001, J GEOPHYS RES-ATMOS, V106, P5403, DOI 10.1029/2000JD900559; Jacobson MZ, 2001, SCIENCE, V293, P1438, DOI 10.1126/science.1063376; LEE K, 2004, WORLD REN EN C, V8; McCubbin DR, 1999, J TRANSP ECON POLICY, V33, P253; Myers DB, 2003, HYDROGEN RENEWABLE E; National Academy of Science, 2004, HYDR EC OPP COSTS BA; Novelli PC, 1999, J GEOPHYS RES-ATMOS, V104, P30427, DOI 10.1029/1999JD900788; *NREL, 2004, FS56036705 NREL; Rahn T, 2003, NATURE, V424, P918, DOI 10.1038/nature01917; Schultz MG, 2003, SCIENCE, V302, P624, DOI 10.1126/science.1089527; Service RF, 2004, SCIENCE, V305, P958, DOI 10.1126/science.305.5686.958; Tromp TK, 2003, SCIENCE, V300, P1740, DOI 10.1126/science.1085169; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; *US EPA, 2003, CLEAR INV EM FACT; Warwick NJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019224; 1998, EXTERNE EXTERNALITIE, V7	27	741	753	13	426	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1901	1905		10.1126/science.1109157	http://dx.doi.org/10.1126/science.1109157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976300				2022-12-24	WOS:000230120000038
J	Schriner, SE; Linford, NJ; Martin, GM; Treuting, P; Ogburn, CE; Emond, M; Coskun, PE; Ladiges, W; Wolf, N; Van Remmen, H; Wallace, DC; Rabinovitch, PS				Schriner, SE; Linford, NJ; Martin, GM; Treuting, P; Ogburn, CE; Emond, M; Coskun, PE; Ladiges, W; Wolf, N; Van Remmen, H; Wallace, DC; Rabinovitch, PS			Extension of murine life span by overexpression of catalase targeted to mitochondria	SCIENCE			English	Article							SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; IN-VIVO; THIOREDOXIN; EXPRESSION; LONGEVITY; INCREASE	To determine the, role of reactive oxygen species in mammalian longevity, we generated transgenic mice that overexpress human catalase localized to the peroxisome, the nucleus, or mitochondria (MCAT). Median and maximum life spans were maximally increased (averages of 5 months and 5.5 months, respectively) in MCAT animals. Cardiac pathology and cataract development were delayed, oxidative damage was reduced, H2O2 production and H2O2-induced aconitase inactivation were attenuated, and the development of mitochondria) deletions was reduced. These results support the free radical theory of aging and reinforce the importance of mitochondria as a source of these radicals.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92697 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas Health San Antonio	Rabinovitch, PS (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	petersr@u.washington.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519	NATIONAL INSTITUTE ON AGING [P01AG001751, P30AG013280] Funding Source: NIH RePORTER; NIA NIH HHS [AG001751, AG13280] Funding Source: Medline; NIEHS NIH HHS [ES07033] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BURNS TR, 1990, MODERN PATHOL, V3, P336; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5; Jiang JJ, 2003, J BIOCHEM, V133, P423, DOI 10.1093/jb/mvg055; Keaney M, 2004, FREE RADICAL BIO MED, V37, P239, DOI 10.1016/j.freeradbiomed.2004.04.005; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974; Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Sampayo JN, 2003, AGING CELL, V2, P319, DOI 10.1046/j.1474-9728.2003.00063.x; Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X; Sun JT, 2002, GENETICS, V161, P661	20	1263	1325	2	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1909	1911		10.1126/science.1106653	http://dx.doi.org/10.1126/science.1106653			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15879174				2022-12-24	WOS:000230120000040
J	Baba, D; Maita, N; Jee, JG; Uchimura, Y; Saitoh, H; Sugasawa, K; Hanaoka, F; Tochio, H; Hiroaki, H; Shirakawa, M				Baba, D; Maita, N; Jee, JG; Uchimura, Y; Saitoh, H; Sugasawa, K; Hanaoka, F; Tochio, H; Hiroaki, H; Shirakawa, M			Crystal structure of thymine DNA glycosylase conjugated to SUMO-1	NATURE			English	Article							UBIQUITIN; RECOGNITION; PROTEINS; NUCLEAR; COMPLEX	Members of the small ubiquitin-like modifier ( SUMO) family can be covalently attached to the lysine residue of a target protein through an enzymatic pathway similar to that used in ubiquitin conjugation(1), and are involved in various cellular events that do not rely on degradative signalling via the proteasome or lysosome(2-5). However, little is known about the molecular mechanisms of SUMO-modification-induced protein functional transfer. During DNA mismatch repair, SUMO conjugation of the uracil/ thymine DNA glycosylase TDG promotes the release of TDG from the abasic (AP) site created after base excision, and coordinates its transfer to AP endonuclease 1, which catalyses the next step in the repair pathway(6). Here we report the crystal structure of the central region of human TDG conjugated to SUMO-1 at 2.1 angstrom resolution. The structure reveals a helix protruding from the protein surface, which presumably interferes with the product DNA and thus promotes the dissociation of TDG from the DNA molecule. This helix is formed by covalent and non-covalent contacts between TDG and SUMO-1. The non-covalent contacts are also essential for release from the product DNA, as verified by mutagenesis.	Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 2300045, Japan; Japan Biol Informat Consortium, Tokyo 1040032, Japan; RIKEN Genom Sci Ctr, Kanagawa 2300045, Japan; Kumamoto Univ, Inst Mol Embryol & Genet, Dept Regenerat Med, Kumamoto 8600811, Japan; RIKEN, Discovery Res Inst, Cellular Physiol Lab, Wako, Saitama 3510198, Japan; Japan Sci & Technol Univ, SORST, Kawaguchi, Saitama 3320012, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Yokohama City University; RIKEN; Kumamoto University; RIKEN; Japan Science & Technology Agency (JST); Osaka University; Kyoto University; Japan Science & Technology Agency (JST)	Shirakawa, M (corresponding author), Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 2300045, Japan.	shirakawa@moleng.kyoto-u.ac.jp	Maita, Nobuo/J-1443-2012; HIROAKI, HIDEKAZU/N-1658-2019; Hiroaki, Hidekazu/G-9564-2012; Tochio, Hidehito/F-6109-2011	Maita, Nobuo/0000-0003-2260-5783; HIROAKI, HIDEKAZU/0000-0003-1621-5893; Tochio, Hidehito/0000-0003-3843-3330				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W. L., 2002, PYMOL; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; ROBERTS RJ, 1995, CELL, V82, P9, DOI 10.1016/0092-8674(95)90046-2; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67	25	177	187	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					979	982		10.1038/nature03634	http://dx.doi.org/10.1038/nature03634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959518				2022-12-24	WOS:000229799700054
J	van Es, JH; van Gijn, ME; Riccio, O; van den Born, M; Vooijs, M; Begthel, H; Cozijnsen, M; Robine, S; Winton, DJ; Radtke, F; Clevers, H				van Es, JH; van Gijn, ME; Riccio, O; van den Born, M; Vooijs, M; Begthel, H; Cozijnsen, M; Robine, S; Winton, DJ; Radtke, F; Clevers, H			Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells	NATURE			English	Article							COLORECTAL-CANCER; NOTCH; RECOMBINATION; COMMITMENT; EXPRESSION; ENHANCER; COMPLEX; SPLIT; DELTA; FATE	The self-renewing epithelium of the small intestine is ordered into stem/progenitor crypt compartments and differentiated villus compartments. Recent evidence indicates that the Wnt cascade is the dominant force in controlling cell fate along the crypt-villus axis(1). Here we show a rapid, massive conversion of proliferative crypt cells into post-mitotic goblet cells after conditional removal of the common Notch pathway transcription factor CSL/RBP-J (ref. 2). We obtained a similar phenotype by blocking the Notch cascade with a gamma-secretase inhibitor. The inhibitor also induced goblet cell differentiation in adenomas in mice carrying a mutation of the Apc tumour suppressor gene. Thus, maintenance of undifferentiated, proliferative cells in crypts and adenomas requires the concerted activation of the Notch and Wnt cascades. Our data indicate that gamma-secretase inhibitors, developed for Alzheimer's disease, might be of therapeutic benefit in colorectal neoplastic disease.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; Inst Curie, CNRS, UMR 144, F-75248 Paris, France; Addenbrookes Hosp, Cambridge Inst Med Res, Canc Res UK Dept Oncol, Cambridge CB2 2XY, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Ludwig Institute for Cancer Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Cancer Research UK; University of Cambridge	Clevers, H (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	Vooijs, Marc/K-3522-2019; Radtke, Freddy/Q-3198-2017; van+Es, Johan/ABD-5411-2021	Radtke, Freddy/0000-0003-4315-4045; 				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; DE SB, 1999, NATURE, V398, P518; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Heitzler P, 1996, DEVELOPMENT, V122, P161; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409; Schroeder Natalia, 2002, Gene Expression Patterns, V2, P247, DOI 10.1016/S1567-133X(02)00060-1; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zheng JL, 2000, DEVELOPMENT, V127, P4551	28	1205	1257	5	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					959	963		10.1038/nature03659	http://dx.doi.org/10.1038/nature03659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959515				2022-12-24	WOS:000229799700050
J	Frank, KT; Petrie, B; Choi, JS; Leggett, WC				Frank, KT; Petrie, B; Choi, JS; Leggett, WC			Trophic cascades in a formerly cod-dominated ecosystem	SCIENCE			English	Article							FOOD WEBS; FISHERIES; DYNAMICS	Removal of top predators from ecosystems can result in cascading effects through the trophic levels below, completely restructuring the food Web. Cascades have been observed in small-scale or simple food webs, but not in large, complex, open-ocean ecosystems. Using data spanning many decades from a once cod-dominated northwest Atlantic ecosystem, we demonstrate a trophic cascade in a large marine ecosystem. Several cod stocks in other geographic areas have also collapsed without recovery, suggesting the existence of trophic cascades in these systems.	Fisheries & Oceans Canada, Bedford Inst Oceanog, Ocean Sci Div, Dartmouth, NS B2Y 4A2, Canada; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Queens University - Canada	Frank, KT (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, Ocean Sci Div, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	frankk@mar.dfo-mpo.gc.ca	Leggett, William C/F-6009-2011					Bowen WD, 2003, ICES J MAR SCI, V60, P1265, DOI 10.1016/S1054-3139(03)00147-4; Choi JS, 2005, OCEANOGR MAR BIOL, V43, P47; Choi JS, 2004, CAN J FISH AQUAT SCI, V61, P505, DOI 10.1139/F04-079; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; FANNING LP, 2003, 27 CAN SCI ADV; Frank KT, 2000, ICES J MAR SCI, V57, P1023, DOI 10.1006/jmsc.2000.0587; Frank KT, 2000, CAN J FISH AQUAT SCI, V57, P513, DOI 10.1139/cjfas-57-3-513; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2001, SCI MAR, V65, P273, DOI 10.3989/scimar.2001.65s2273; Micheli F, 1999, SCIENCE, V285, P1396, DOI 10.1126/science.285.5432.1396; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; Reid PC, 2000, ICES J MAR SCI, V57, P495, DOI 10.1006/jmsc.2000.0740; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Steele J. H., 2004, GLOBAL COASTAL OCEAN, V13; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	20	867	908	7	620	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2005	308	5728					1621	1623		10.1126/science.1113075	http://dx.doi.org/10.1126/science.1113075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947186				2022-12-24	WOS:000229827000055
J	Que, LG; Liu, LM; Yan, Y; Whitehead, GS; Gavett, SH; Schwartz, DA; Stamler, JS				Que, LG; Liu, LM; Yan, Y; Whitehead, GS; Gavett, SH; Schwartz, DA; Stamler, JS			Protection from experimental asthma by an endogenous bronchodilator	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN S-NITROSYLATION; AIRWAY HYPERRESPONSIVENESS; CYSTIC-FIBROSIS; NITROGEN-OXIDES; EXHALED AIR; NITROSOTHIOLS; DISEASE; INFLAMMATION; INHIBITION	Mechanisms that protect against asthma remain poorly understood. S-nitrosoglutathione (GSNO), an endogenous bronchodilator, is depleted from asthmatic airways, suggesting a protective role. We report that, following allergen challenge, witd-type mice exhibiting airway hyperresponsivity have increased airway levels of the enzyme GSNO reductase (GSNOR) and are depleted of lung S-nitrosothiols (SNOs). In contrast, mice with genetic deletion of GSNOR exhibit increases in lung SNOs and are protected from airway hyperresponsivity. Our results indicate that endogenous SNOs, governed by GSNOR, are critical regulators of airway responsivity and may provide new therapeutic approaches to asthma.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; US EPA, Expt Toxicol Div, Res Triangle Pk, NC 27711 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; United States Environmental Protection Agency	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	STAML001@mc.duke.edu		Stamler, Jonathan/0000-0002-6866-1572	NHLBI NIH HHS [K08 HL004171-05, K08 HL004171, HL004171] Funding Source: Medline; NIEHS NIH HHS [ES012496, P01 ES012496-010004, P01 ES012496] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES012496, Z01ES101945] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALVING K, 1993, EUR RESPIR J, V6, P1368; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; De Sanctis GT, 1999, J EXP MED, V189, P1621, DOI 10.1084/jem.189.10.1621; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Grasemann H, 1999, J PEDIATR-US, V135, P770, DOI 10.1016/S0022-3476(99)70101-0; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; HAMID Q, 1993, LANCET, V342, P1510, DOI 10.1016/S0140-6736(05)80083-2; Hansel TT, 2003, FASEB J, V17, P1298, DOI 10.1096/fj.02-0633fje; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; KHARITONOV SA, 1994, LANCET, V343, P133, DOI 10.1016/S0140-6736(94)90931-8; Koarai A, 2000, PULM PHARMACOL THER, V13, P267, DOI 10.1006/pupt.2000.0254; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; QUE LG, UNPUB; Saleh D, 1998, FASEB J, V12, P929, DOI 10.1096/fasebj.12.11.929; Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/ajrccm.165.7.2105032; Whalen EJ, 2000, HYPERTENSION, V36, P376, DOI 10.1161/01.HYP.36.3.376; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Xiong YL, 1999, J IMMUNOL, V162, P445	25	246	264	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1618	1621		10.1126/science.1108228	http://dx.doi.org/10.1126/science.1108228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15919956	Green Accepted			2022-12-24	WOS:000229827000054
J	Granich, RM; Oh, P; Lewis, B; Porco, TC; Flood, J				Granich, RM; Oh, P; Lewis, B; Porco, TC; Flood, J			Multidrug resistance among persons with tuberculosis in California, 1994-2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; UNITED-STATES; TRANSMISSION; OUTBREAK; INFECTIONS; OUTCOMES	Context Between 1994 and 2003, tuberculosis (TB) cases in California declined 33% (4834 to 3224). However, in 2003 California reported the largest number of cases in the nation, and over the past decade the proportion of cases with multidrug-resistant tuberculosis (MDR-TB) has not decreased. Objective To describe the magnitude, trends, geographic distribution, clinical characteristics, risk factors, and outcomes of MDR-TB cases reported to the California registry of Reports of Verified Cases of TB. Design, Setting, and Cases Analysis of 38 291 TB cases reported from all 61 local health jurisdictions in California during 1994-2003. Multidrug-resistant TB was defined as resistance to at least isoniazid and rifampin. Main Outcome Measures Results of univariate and multivariable analyses of MDR-TB magnitude, trends, geographic distribution, clinical characteristics, associated factors, and outcomes. Results Of 38 291 reported TB cases, 28 712 (75%) were tested for resistance to at least isoniazid and rifampin; of these, 407 MDR-TB cases (1.4%) were reported from 38 of 61 California health jurisdictions (62%); the proportion of MDR-TB cases did not significantly change over the study period (P=.87). Cases of MDR-TB were twice as likely to have cavitary lesions compared with non-MDR-TB cases (P<.001) and were 7 times more likely to have reported previous treatment for TB (P<.001). Of MDR-TB cases with outcomes, 231 (67%) completed therapy, and those with MDR-TB were significantly less likely to complete therapy than those without MDR-TB (P<.001). Multivariate analysis identified previous TB diagnosis, positive acid-fast bacilli sputum smear results, Asian/Pacific Islander ethnicity, time in the United States less than 5 years at the time of diagnosis, and outcomes of "died" and "moved" as factors associated with MDR-TB. Conclusions Multidrug-resistant TB, an airborne disease with limited, costly treatment options, persists in 1% to 2 % of all cases despite California's control efforts. Local and global TB control efforts are needed to prevent the further development and spread of MDR-TB.	Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA; Calif Dept Hlth Serv, TB Control Branch, Sacramento, CA USA	Centers for Disease Control & Prevention - USA; California Department of Health Care Services	Granich, RM (corresponding author), Off US Global AIDS Coordinator, 2100 Penn Ave NW, Washington, DC 20522 USA.	granichrm@state.gov	Lewis, Bryan/AGI-2140-2022	Lewis, Bryan/0000-0003-0793-6082				Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; BECKSAGUE C, 1992, JAMA-J AM MED ASSOC, V268, P1280, DOI 10.1001/jama.268.10.1280; BLOCH AB, 1994, JAMA-J AM MED ASSOC, V271, P665, DOI 10.1001/jama.271.9.665; *CA DEP HLTH SERV, 2001, REP TUB CAL 2000; *CDCP, 1993, JAMA-J AM MED ASSOC, V269, P978; *CDCP, 1990, JAMA-J AM MED ASSOC, V264, P173; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; CORONADO VG, 1993, J INFECT DIS, V168, P1052, DOI 10.1093/infdis/168.4.1052; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; FRIEDMAN CR, 1995, AM J RESP CRIT CARE, V152, P355, DOI 10.1164/ajrccm.152.1.7599845; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Granich RM, 2001, INT J TUBERC LUNG D, V5, P53; KOO D, 1995, WESTERN J MED, V163, P441; Lobato MN, 1998, PEDIATR INFECT DIS J, V17, P407, DOI 10.1097/00006454-199805000-00012; Lockman S, 2001, CLIN INFECT DIS, V32, P373, DOI 10.1086/318489; MILLER A, 2003, SUBSET SELECTION REG; Moore M, 1997, JAMA-J AM MED ASSOC, V278, P833, DOI 10.1001/jama.278.10.833; NEVILLE K, 1994, CHEST, V105, P45, DOI 10.1378/chest.105.1.45; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Peter CR, 1998, WESTERN J MED, V169, P208; Rajbhandary SS, 2004, INT J TUBERC LUNG D, V8, P1012; Raviglione MC, 2001, ANN NY ACAD SCI, V953, P88, DOI 10.1111/j.1749-6632.2001.tb11364.x; Ridzon R, 1997, J PEDIATR-US, V131, P863, DOI 10.1016/S0022-3476(97)70034-9; RILEY LW, 1989, AM REV RESPIR DIS, V139, P1282, DOI 10.1164/ajrccm/139.5.1282; *STAT CA DEP FIN, 2003, CAL CURR POP SURV RE; *STAT CA DEP FIN, 2002, REV HIST CIT COUNT S; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976.abs; BAYESIAN MODEL AVERI; 1991, MMWR MORB MORTAL WKL, V40, P649	30	59	63	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2732	2739		10.1001/jama.293.22.2732	http://dx.doi.org/10.1001/jama.293.22.2732			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933OV	15941802	Bronze			2022-12-24	WOS:000229643700021
J	Nelson, MR; Liew, D; Bertram, M; Vos, T				Nelson, MR; Liew, D; Bertram, M; Vos, T			Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >= 70	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COST-EFFECTIVENESS; RISK; EVENTS; PANEL	Objective To investigate the routine use of low dose aspirin in people aged ! 70 without overt cardiovascular disease. Design Epidemiological modelling in a hypothetical population. Setting Reference populations of men and women in the year 2000 from the state of Victoria, Australia. Subjects 10 000 men and 10 000 women aged 70-74 with no cardiovascular disease. Main outcome measures First ever myocardial infarction or unstable angina, ischaemic or haemorrhagic stroke, and major gastrointestinal haemorrhage. Health adjusted years of life lived. Results The proportional benefit gained from the use of low dose aspirin by the prevention of myocardial infarctions (- 389 in men, - 321 in women) and ischaemic stroke (- 19 in men and - 35 in women) is offset by excess gastrointestinal (499 in men, 572 in women) and intracranial (76 in men, 54 in women) bleeding. The results in health adjusted years of life lived (which take into account length and quality of life) are equivocal for aspirin causing net harm or net benefit. Conclusion Epidemiological modelling suggests that any benefits of low dose aspirin on risk of cardiovascular disease in people aged ! 70 are offset by adverse events. These findings are tempered by wide confidence intervals, indicating that the overall outcome could be beneficial or adverse.	Univ Tasmania, Sch Med, Discipline Gen Practice, Hobart, Tas 7001, Australia; Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; WHO, CH-1211 Geneva, Switzerland; Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia	University of Tasmania; Florey Institute of Neuroscience & Mental Health; Monash University; World Health Organization; University of Queensland	Nelson, MR (corresponding author), Univ Tasmania, Sch Med, Discipline Gen Practice, Hobart, Tas 7001, Australia.	Mark.Nelson@utas.edu.au	matt, peter/AFR-0434-2022; Vos, Theo/F-3324-2010	matt, peter/0000-0002-6855-3440; Liew, Danny/0000-0002-0131-623X				Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baron JA, 2000, ANNU REV MED, V51, P511, DOI 10.1146/annurev.med.51.1.511; Bonita R, 1997, STROKE, V28, P1898, DOI 10.1161/01.STR.28.10.1898; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; *DEP HUM SERV VICT, 2000, VICT ADM EV DAT; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hart RG, 2000, ARCH NEUROL-CHICAGO, V57, P326, DOI 10.1001/archneur.57.3.326; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Liew D, 2002, MED J AUSTRALIA, V177, P364, DOI 10.5694/j.1326-5377.2002.tb04839.x; Lilford RJ, 1998, BMJ-BRIT MED J, V317, P405; MATHERS C, 1999, 17 AIHW PHE; MCELDUFF P, 2000, 11 AIHW CVD; Meade TW, 1998, LANCET, V351, P233; Nelson MR, 2003, DRUG AGING, V20, P897, DOI 10.2165/00002512-200320120-00004; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; ROSS R, 1999, NEW ENGL J MED, V143, P683; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; *STEER COMM PHYS H, 1980, NEW ENGL J MED, V321, P129; Sturmer T, 1996, AM J EPIDEMIOL, V143, P683; Thrift AG, 2000, STROKE, V31, P2087, DOI 10.1161/01.STR.31.9.2087; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; *VICT DEP HUM SERV, 1999, VICT BURD DIS STUD M; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WEINSTEIN MC, 1996, JAMA-J AM MED ASSOC, V276, P1353	31	44	44	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2005	330	7503					1306	1308A		10.1136/bmj.38456.676806.8F	http://dx.doi.org/10.1136/bmj.38456.676806.8F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15908442	Green Published, Bronze			2022-12-24	WOS:000229655700024
J	Dong, JH; Yang, GY; Mchaourab, HS				Dong, JH; Yang, GY; Mchaourab, HS			Structural basis of energy transduction in the transport cycle of MsbA	SCIENCE			English	Article							RESISTANCE P-GLYCOPROTEIN; BINDING CASSETTE TRANSPORTERS; MULTIDRUG-RESISTANCE; ABC TRANSPORTERS; ATP-BINDING; ESCHERICHIA-COLI; TRANSMEMBRANE DOMAINS; CROSS-LINKING; MECHANISM; CONFORMATION	We used site-directed spin-labeling and electron paramagnetic resonance spectroscopy to characterize the conformational motion that couples energy expenditure to substrate translocation in the multidrug transporter MsbA. In liposomes, ligand-free MsbA samples conformations that depart from the crystal structures, including looser packing and water penetration along the periplasmic side. Adenosine triphosphate (ATP) binding closes the substrate chamber to the cytoplasm while increasing hydration at the periplasmic side, consistent with an alternating access model. Accentuated by ATP hydrolysis, the changes in the chamber dielectric environment and its geometry provide the likely driving force for flipping amphipathic substrates and a potential exit pathway. These results establish the structural dynamic basis of the power stroke in multidrug-resistant ATP-binding cassette (MDR ABC) transporters.	Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Mchaourab, HS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	hassane.mchaourab@vanderbilt.edu		Dong, Jinhui/0000-0003-4542-7756				Buchaklian AH, 2004, BIOCHEMISTRY-US, V43, P8600, DOI 10.1021/bi0497751; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dong J.-K., UNPUB; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cellbio.8.1.67; Higgins CF, 2001, SCIENCE, V293, P1782, DOI 10.1126/science.1065588; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Higgins CF, 1997, SEMIN CANCER BIOL, V8, P135, DOI 10.1006/scbi.1997.0067; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; MITCHELL P, 1990, RES MICROBIOL, V141, P286, DOI 10.1016/0923-2508(90)90002-8; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Nikaido H, 1998, METHOD ENZYMOL, V292, P3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poelarends GJ, 2002, J BIOL CHEM, V277, P42891, DOI 10.1074/jbc.M206508200; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Seigneuret M, 2003, J BIOL CHEM, V278, P30115, DOI 10.1074/jbc.M302443200; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stenham DR, 2003, FASEB J, V17, P2287, DOI 10.1096/fj.03-0107fje; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; van Veen HW, 1998, ADV EXP MED BIOL, V456, P145; van Veen HW, 1998, BBA-BIOENERGETICS, V1365, P31, DOI 10.1016/S0005-2728(98)00039-5; van Veen HW, 2001, RES MICROBIOL, V152, P365, DOI 10.1016/S0923-2508(01)01208-6; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	32	128	133	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1023	1028		10.1126/science.1106592	http://dx.doi.org/10.1126/science.1106592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890883				2022-12-24	WOS:000229190700047
J	Cho, PF; Poulin, F; Cho-Park, YA; Cho-Park, IB; Chicoine, JD; Lasko, P; Sonenberg, N				Cho, PF; Poulin, F; Cho-Park, YA; Cho-Park, IB; Chicoine, JD; Lasko, P; Sonenberg, N			A new paradigm for translational control: Inhibition via 5 '-3 ' mRNA tethering by Bicoid and the eIF4E cognate 4EHP	CELL			English	Article							BINDING-PROTEIN; INITIATION-FACTOR; POLY(A)-BINDING PROTEIN; DROSOPHILA CUP; CAP; REPRESSION; RECOGNITION; RECRUITMENT; OSKAR; MOTIF	Translational control is a key genetic regulatory mechanism implicated in regulation of cell and organismal growth and early embryonic development. Initiation at the mRNA 5' cap structure recognition step is frequently targeted by translational control mechanisms. In the Drosophila embryo, cap-dependent translation of the uniformly distributed caudal (cad) mRNA is inhibited in the anterior by Bicoid (Bcd) to create an asymmetric distribution of Cad protein. Here, we show that d4EHP, an eIF4E-related cap binding protein, specifically interacts with Bcd to suppress cad translation. Translational inhibition depends on the Bcd binding region (BBR) present in the cad 3' untranslated region. Thus, simultaneous interactions of d4EHP with the cap structure and of Bcd with BBR renders cad mRNA translationally inactive. This example of cap-dependent translational control that is not mediated by canonical eIF4E defines a new paradigm for translational inhibition involving tethering of the mRNA 5' and 3' ends.	McGill Univ, Dept Biochem, Mcgill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University	Poulin, F (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	fpoulin@berkeley.edu; nahum.sonenberg@mcgill.ca	Lasko, Paul/C-6761-2014	Lasko, Paul/0000-0002-4037-3501				Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Chan SK, 1997, NATURE, V388, P634, DOI 10.1038/41692; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hodel AE, 1997, NAT STRUCT BIOL, V4, P350, DOI 10.1038/nsb0597-350; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kobayashi S, 1999, ADV MOLEC BIOL, P426; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lynch J, 2003, CURR BIOL, V13, pR557, DOI 10.1016/S0960-9822(03)00472-X; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mazza C, 2001, MOL CELL, V8, P383, DOI 10.1016/S1097-2765(01)00299-4; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Niessing D, 1999, EMBO J, V18, P1966, DOI 10.1093/emboj/18.7.1966; Niessing D, 2002, GENE DEV, V16, P2576, DOI 10.1101/gad.240002; Poulin F, 2003, MOL B INT U, P280; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; STJOHNSTON D, 1992, CELL, V68, P201; Svitkin YV, 2001, RNA, V7, P1743; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; Tee AR, 2004, FEBS LETT, V564, P58, DOI 10.1016/S0014-5793(04)00313-8; Thomson T, 2004, GENESIS, V40, P164, DOI 10.1002/gene.20079; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088	48	177	178	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					411	423		10.1016/j.cell.2005.02.024	http://dx.doi.org/10.1016/j.cell.2005.02.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882623	Bronze, Green Published			2022-12-24	WOS:000229031600011
J	Tsubouchi, T; Roeder, GS				Tsubouchi, T; Roeder, GS			A synaptonemal complex protein promotes homology-independet centromere coupling	SCIENCE			English	Article							MEIOTIC CHROMOSOMES; BUDDING YEAST; PH1 LOCUS; MEIOSIS; RECOMBINATION; INITIATION; SYNAPSIS; LINK	We describe a process in meiotic cells of budding yeast in which chromosomes become joined together in pairs at their centromeres independent of chromosomal homology. These centromeric interactions depend on the synaptonemal complex component Zip1. During meiosis in wild-type diploids, centromere couples are initially nonhomologous and then undergo switching until all couples involve homologs. This transition to homologous coupling depends on Spo11, a protein required for the initiation of meiotic recombination. Regions of synaptonemal complex assembled early in meiosis are often centromere-associated. We propose that centromere coupling facilitates homolog pairing and promotes synapsis initiation.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Roeder, GS (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	shirleen.roeder@yale.edu		Tsubouchi, Tomomi/0000-0001-9960-3888	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Dong HJ, 2000, J CELL BIOL, V148, P417, DOI 10.1083/jcb.148.3.417; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Maestra B, 2002, CHROMOSOME RES, V10, P655, DOI 10.1023/A:1021564327226; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; NAG DK, 1995, GENETICS, V141, P75; Rockmill B, 1998, GENE DEV, V12, P2574, DOI 10.1101/gad.12.16.2574; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Walker MY, 2000, CHROMOSOMA, V109, P3, DOI 10.1007/s004120050407	18	124	129	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					870	873		10.1126/science.1108283	http://dx.doi.org/10.1126/science.1108283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879219				2022-12-24	WOS:000228986500053
J	Rothwell, PM; Giles, MF; Flossmann, E; Lovelock, CE; Redgrave, JNE; Warlow, CP; Mehta, Z				Rothwell, PM; Giles, MF; Flossmann, E; Lovelock, CE; Redgrave, JNE; Warlow, CP; Mehta, Z			A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack	LANCET			English	Article							SYMPTOMATIC CAROTID STENOSIS; ACUTE CORONARY SYNDROMES; PROGNOSIS; OXFORDSHIRE; ENDARTERECTOMY; CLOPIDOGREL; PREVENTION; MANAGEMENT; SUBGROUPS; MORTALITY	Background Effective early management of patients with transient ischaemic attacks (TIA) is undermined by an inability to predict who is at highest early risk of stroke. Methods We derived a score for 7-day risk of stroke in a population-based cohort of patients (n=209) with a probable or definite TIA (Oxfordshire Community Stroke Project; OCSP), and validated the score in a similar population-based cohort (Oxford Vascular Study; OXVASC, n=190). We assessed likely clinical usefulness to front-line health services by using the score to stratify all patients with suspected TIA referred to OXVASC (n=378, outcome: 7-day risk of stroke) and to a hospital-based weekly TIA clinic (n=210; outcome: risk of stroke before appointment) Results A six-point score derived in the OCSP (age [>= 60 years=1], blood pressure [systolic >140 mm Hg and/or diastolic >= 90 mm Hg=1], clinical features [unilateral weakness=2, speech disturbance without weakness=1, other=0], and duration of symptoms in min [>= 60=2,10-59=1, <10=0]; ABCD) was highly predictive of 7-day risk of stroke in OXVASC patients with probable or definite TIA (p<0.0001), in the OXVASC population-based cohort of all referrals with suspected TIA (p<0.0001), and in the hospital-based weekly TIA clinic-referred cohort (p=0.006). In the OXVASC suspected TIA cohort, 19 of 20 (95%) strokes occurred in 101 (27%) patients with a score of 5 or greater: 7-day risk was 0.4% (95% CI 0-1.1) in 274 (73%) patients with a score less than 5, 12.1% (4.2-20.0) in 66 (18%) with a score of 5, and 31.4% (16.0-46.8) in 35 (9%) with a score of 6. In the hospital-referred clinic cohort, 14 (7.5%) patients had a stroke before their scheduled appointment, all with a score of 4 or greater. Conclusions Risk of stroke during the 7 days after TIA seems to be highly predictable. Although further validations and refinements are needed, the ABCD score can be used in routine clinical practice to identify high-risk individuals who need emergency investigation and treatment.	Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England; Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland	Radcliffe Infirmary; University of Oxford; University of Edinburgh	Rothwell, PM (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	Medical Research Council [G0500987] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Bond R, 2003, STROKE, V34, P2290, DOI 10.1161/01.STR.0000087785.01407.CC; Coull AJ, 2004, STROKE, V35, P2041, DOI 10.1161/01.STR.0000137605.48864.2f; Coull AJ, 2004, STROKE, V35, P1925, DOI 10.1161/01.STR.0000133129.58126.67; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; DENNIS M, 1990, STROKE, V21, P848, DOI 10.1161/01.STR.21.6.848; DENNIS MS, 1989, STROKE, V20, P333, DOI 10.1161/01.STR.20.3.333; GILES MF, 2004, CEREBROVASC DIS, V17, P6; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Goldstein LB, 2000, ARCH INTERN MED, V160, P2941, DOI 10.1001/archinte.160.19.2941; Gubitz G, 1999, CEREBROVASC DIS, V9, P210, DOI 10.1159/000015957; Hacke W, 2004, LANCET, V363, P768; HANKEY GJ, 1992, J NEUROL NEUROSUR PS, V55, P640, DOI 10.1136/jnnp.55.8.640; HATANO S, 1976, B WORLD HEALTH ORGAN, V56, P541; Hill MD, 2004, NEUROLOGY, V62, P2015, DOI 10.1212/01.WNL.0000129482.70315.2F; *INT STROK TRIAL C, 1977, LANCET, V349, P1569; Intercollegiate working Party for Stroke, 2004, NAT CLIN GUID STROK; Johnston SC, 2003, NEUROLOGY, V60, P1429, DOI 10.1212/01.WNL.0000063309.41867.0F; Johnston SC, 1999, EUR NEUROL, V42, P105, DOI 10.1159/000069419; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; KENNEDY J, 2003, SEMIN CEREBROVASC DI, V3, P25; Kernan WN, 2000, STROKE, V31, P456, DOI 10.1161/01.STR.31.2.456; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lisabeth LD, 2004, STROKE, V35, P1842, DOI 10.1161/01.STR.0000134416.89389.9d; Lovett JK, 2004, NEUROLOGY, V62, P569, DOI 10.1212/01.WNL.0000110311.09970.83; Lovett JK, 2003, STROKE, V34, pE138, DOI 10.1161/01.STR.0000080935.01264.91; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Ovbiagele B, 2004, STROKE, V35, P2879, DOI 10.1161/01.STR.0000147967.49567.d6; Pearce LA, 2000, AM J MED, V109, P45, DOI 10.1016/S0002-9343(00)00440-X; Purroy F, 2004, STROKE, V35, P2313, DOI 10.1161/01.STR.0000141703.21173.91; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2005, NEUROLOGY, V64, P817, DOI 10.1212/01.WNL.0000152985.32732.EE; Rothwell PM, 2003, CEREBROVASC DIS, V16, P2, DOI 10.1159/000070271; Rothwell PM, 2005, LANCET, V365, P256; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Wolf PA, 1999, STROKE, V30, P1991, DOI 10.1161/01.STR.30.9.1991; Yusuf S, 2001, NEW ENGL J MED, V345, P494	39	436	495	4	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					29	36		10.1016/S0140-6736(05)66702-5	http://dx.doi.org/10.1016/S0140-6736(05)66702-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	15993230				2022-12-24	WOS:000230277600031
J	Gardner, MJ; Bishop, R; Shah, T; de Villiers, EP; Carlton, JM; Hall, N; Ren, QH; Paulsen, IT; Pain, A; Berriman, M; Wilson, RJM; Sato, S; Ralph, SA; Mann, DJ; Xiong, ZK; Shallom, SJ; Weidman, J; Jiang, LX; Lynn, J; Weaver, B; Shoaibi, A; Domingo, AR; Wasawo, D; Crabtree, J; Wortman, JR; Haas, B; Angiuoli, SV; Creasy, TH; Lu, C; Suh, B; Silva, JC; Utterback, TR; Feldblyum, TV; Pertea, M; Allen, J; Nierman, WC; Taracha, ELN; Salzberg, SL; White, OR; Fitzhugh, HA; Morzaria, S; Venter, JC; Fraser, CM; Nene, V				Gardner, MJ; Bishop, R; Shah, T; de Villiers, EP; Carlton, JM; Hall, N; Ren, QH; Paulsen, IT; Pain, A; Berriman, M; Wilson, RJM; Sato, S; Ralph, SA; Mann, DJ; Xiong, ZK; Shallom, SJ; Weidman, J; Jiang, LX; Lynn, J; Weaver, B; Shoaibi, A; Domingo, AR; Wasawo, D; Crabtree, J; Wortman, JR; Haas, B; Angiuoli, SV; Creasy, TH; Lu, C; Suh, B; Silva, JC; Utterback, TR; Feldblyum, TV; Pertea, M; Allen, J; Nierman, WC; Taracha, ELN; Salzberg, SL; White, OR; Fitzhugh, HA; Morzaria, S; Venter, JC; Fraser, CM; Nene, V			Genome sequence of Theileria parva, a bovine pathogen that transforms lymphocytes	SCIENCE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; PYRUVATE-DEHYDROGENASE COMPLEX; OPEN READING FRAMES; ENCODED PROTEINS; MALARIA; GENES; DNA; APICOMPLEXAN; MITOCHONDRIA; TELOMERES	We report the genome sequence of Theileria parva, an apicomplexan pathogen causing economic losses to smallholder farmers in Africa. The parasite chromosomes exhibit limited conservation of gene synteny with Plasmodium falciparum, and its plastid-like genome represents the first example where all apicoplast genes are encoded on one DNA strand. We tentatively identify proteins that facilitate parasite segregation during host cell cytokinesis and contribute to persistent infection of transformed host cells. Several biosynthetic pathways are incomplete or absent, suggesting substantial metabolic dependence on the host cell. One protein family that may generate parasite antigenic diversity is not telomere-associated.	Inst Genom Res TIGR, Rockville, MD 20850 USA; Int Livestock Res Inst, Nairobi, Kenya; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Natl Inst Med Res, London NW7 1AA, England; Inst Pasteur, F-75724 Paris, France; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute; CGIAR; International Livestock Research Institute (ILRI); Wellcome Trust Sanger Institute; MRC National Institute for Medical Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Imperial College London; J. Craig Venter Institute	Gardner, MJ (corresponding author), Inst Genom Res TIGR, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	gardner@tigr.org	Paulsen, Ian T/K-3832-2012; Silva, Joana/GVT-6441-2022; Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011; Angiuoli, Samuel V/H-7340-2014; Berriman, Matthew/A-7618-2011; Pertea, Mihaela/AAT-2705-2021; Pain, Arnab/L-5766-2015; Silva, Joana/GYQ-9526-2022; Hall, Neil/A-8717-2013; Ralph, Stuart/C-8590-2014; Sato, Shigeharu/K-9464-2013	Paulsen, Ian T/0000-0001-9015-9418; Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Berriman, Matthew/0000-0002-9581-0377; Pertea, Mihaela/0000-0003-0762-8637; Pain, Arnab/0000-0002-1755-2819; Hall, Neil/0000-0002-7995-3810; Sato, Shigeharu/0000-0003-2738-430X; Wortman, Jennifer/0000-0002-8713-1227; Nene, Vishvanath/0000-0001-7066-4169; de Villiers, Etienne/0000-0001-9878-1009; Shah, Trushar/0000-0002-0091-7981; Fraser, Claire/0000-0003-1462-2428; Gardner, Malcolm/0000-0003-2180-5089; Hall, Neil/0000-0003-2808-0009; Angiuoli, Samuel/0000-0001-9525-4350; Ralph, Stuart/0000-0003-0114-7808; Allen, Jonathan/0000-0002-4359-8263; Sato, Shigeharu/0000-0001-9559-7580				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; ANDERS RF, 1986, PARASITE IMMUNOL, V8, P529, DOI 10.1111/j.1365-3024.1986.tb00867.x; Barry JD, 2003, INT J PARASITOL, V33, P29, DOI 10.1016/S0020-7519(02)00247-3; BAYLIS HA, 1991, MOL BIOCHEM PARASIT, V49, P133, DOI 10.1016/0166-6851(91)90136-T; Bishop R, 1997, MOL CELL BIOL, V17, P1666, DOI 10.1128/MCB.17.3.1666; Bishop R, 2000, MOL BIOCHEM PARASIT, V110, P359, DOI 10.1016/S0166-6851(00)00291-7; BISHOP R, UNPUB; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Cheeseman IM, 2004, CURR BIOL, V14, pR70, DOI 10.1016/j.cub.2003.12.048; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; GRAHAM SV, UNPUB; GUNDERSON JH, 1987, SCIENCE, V238, P933, DOI 10.1126/science.3672135; KAIRO A, 1994, EMBO J, V13, P898, DOI 10.1002/j.1460-2075.1994.tb06333.x; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; MCCOLM AA, 1984, ANN TROP MED PARASIT, V78, P345, DOI 10.1080/00034983.1984.11811831; Norval R.A.I., 1992, EPIDEMIOLOGY THEILER, P481; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Ralph SA, 2005, MOL MICROBIOL, V55, P1, DOI 10.1111/j.1365-2958.2004.04314.x; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Sohanpal B, 2000, GENE, V255, P401, DOI 10.1016/S0378-1119(00)00284-5; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Walter RF, 2005, CURR ISSUES MOL BIOL, V7, P57, DOI 10.21775/cimb.007.057; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101	29	255	308	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					134	137		10.1126/science.1110439	http://dx.doi.org/10.1126/science.1110439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994558	Bronze			2022-12-24	WOS:000230212800076
J	Maeda, S; Kamata, H; Luo, JL; Leffert, H; Karin, M				Maeda, S; Kamata, H; Luo, JL; Leffert, H; Karin, M			IKK beta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; HEPATOCELLULAR-CARCINOMA; NUCLEAR-FACTOR; TRANSGENIC MICE; LIVER-REGENERATION; JNK ACTIVATION; MOUSE-LIVER; CELL-DEATH; TNF-ALPHA	I kappa B kinase beta (IKK beta), required for NF-kappa B activation, links chronic inflammation with carcinogenesis. We investigated whether IKK beta is involved in chemically induced liver cancer, a model not involving overt inflammation. Surprisingly, mice lacking IKK beta only in hepatocytes (Ikk beta(Delta hep) mice) exhibited a marked increase in hepatocarcinogenesis caused by diethylnitrosamine (DEN). This correlated with enhanced reactive oxygen species (ROS) production, increased JNK activation, and hepatocyte death, giving rise to augmented compensatory proliferation of surviving hepatocytes. Brief oral administration of an antioxidant around the time of DEN exposure blocked prolonged JNK activation and compensatory proliferation and prevented excessive DEN-induced carcinogenesis in Ikk beta(Delta hep) mice. Decreased hepatocarcinogenesis was also found in mice lacking IKKP in both hepatocytes and hematopoietic-derived Kupffer cells. These mice exhibited reduced hepatocyte regeneration and diminished induction of hepatomitogens, which were unaltered in Ikk beta(Delta hep) mice. IKK beta, therefore, orchestrates inflammatory crosstalk between hepatocytes and hematopoietic-derived cells that promotes chemical hepatocarcinogenesis.	Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr,MC 0723, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Kamata, Hideaki/N-3907-2017	Luo, Jun-Li/0000-0002-7625-4766	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337, R01ES006376] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43477] Funding Source: Medline; NIEHS NIH HHS [ES06376, ES010337] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; BERENBLUM I, 1954, ADV CANCER RES, V2, P129, DOI 10.1016/S0065-230X(08)60493-5; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cavin LG, 2004, CANCER RES, V64, P7030, DOI 10.1158/0008-5472.CAN-04-1647; CHISARI FV, 1995, HEPATOLOGY, V22, P1316, DOI 10.1016/0270-9139(95)90645-2; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; DYROFF MC, 1986, CARCINOGENESIS, V7, P241, DOI 10.1093/carcin/7.2.241; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Factor VM, 2000, P NATL ACAD SCI USA, V97, P2196, DOI 10.1073/pnas.040428797; FARBER J L, 1984, Pharmacological Reviews, V36, p71S; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hara A, 2000, BRIT J CANCER, V82, P467; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Horiguchi N, 2002, ONCOGENE, V21, P1791, DOI 10.1038/sj.onc.1205248; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Im YH, 2001, CANCER RES, V61, P6665; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; KORSMEYER SJ, 1992, BLOOD, V80, P879; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; LIAO WSL, 1980, J BIOL CHEM, V255, P36; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006; Pierce RH, 2002, AM J PATHOL, V160, P1555, DOI 10.1016/S0002-9440(10)61101-7; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; SARMA DSR, 1986, CANCER SURV, V5, P781; Satoh K, 2002, CARCINOGENESIS, V23, P457, DOI 10.1093/carcin/23.3.457; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schirmacher P, 1993, EXS, V65, P285; SELL S, 1982, HEPATOLOGY, V2, P77; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; TALBOT D, 1994, NUCLEIC ACIDS RES, V22, P756, DOI 10.1093/nar/22.5.756; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Thorgeirsson SS, 2000, TOXICOL LETT, V112, P553, DOI 10.1016/S0378-4274(99)00224-6; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; WILLIAMS GM, 1993, TOXICOL IND HEALTH, V9, P303, DOI 10.1177/0748233793009001-222; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904; Zhou ZX, 2004, AM J PATHOL, V164, P1547, DOI 10.1016/S0002-9440(10)63713-3	54	914	958	4	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					977	990		10.1016/j.cell.2005.04.014	http://dx.doi.org/10.1016/j.cell.2005.04.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989949	Bronze			2022-12-24	WOS:000230448000006
J	Murata, Y; Iwasaki, H; Sasaki, M; Inaba, K; Okamura, Y				Murata, Y; Iwasaki, H; Sasaki, M; Inaba, K; Okamura, Y			Phosphoinositide phosphatase activity coupled to an intrinsic voltage sensor	NATURE			English	Article							ASCIDIAN CIONA-INTESTINALIS; RECTIFYING K+ CHANNELS; ION CHANNELS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; POTASSIUM CHANNELS; TUMOR-SUPPRESSOR; PTEN; ACTIVATION; IDENTIFICATION; PERSPECTIVE	Changes in membrane potential affect ion channels and transporters, which then alter intracellular chemical conditions. Other signalling pathways coupled to membrane potential have been suggested(1-3) but their underlying mechanisms are unknown. Here we describe a novel protein from the ascidian Ciona intestinalis that has a transmembrane voltage-sensing domain homologous to the S1 - S4 segments of voltage-gated channels and a cytoplasmic domain similar to phosphatase and tensin homologue. This protein, named C. intestinalis voltage-sensor-containing phosphatase (Ci-VSP), displays channel-like 'gating' currents and directly translates changes in membrane potential into the turnover of phosphoinositides. The activity of the phosphoinositide phosphatase in Ci-VSP is tuned within a physiological range of membrane potential. Immunocytochemical studies show that Ci-VSP is expressed in Ciona sperm tail membranes, indicating a possible role in spermfunction or morphology. Our data demonstrate that voltage sensing can function beyond channel proteins and thus more ubiquitously than previously realized.	Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Sect Dev Neurophysiol, Aichi 4448787, Japan; Natl Inst Nat Sci, Natl Inst Physiol Sci, Aichi 4448585, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan; Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST)	Okamura, Y (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Sect Dev Neurophysiol, Higashiyama 5-1,Myodaiji Cho, Aichi 4448787, Japan.	yokamura@nips.ac.jp		Murata, Yoshimichi/0000-0002-2070-7949; Iwasaki, Hirohide/0000-0002-7432-5938				BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dong XY, 2003, BRIT J CANCER, V89, P291, DOI 10.1038/sj.bjc.6601062; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Izumi H, 1999, DEV BIOL, V213, P246, DOI 10.1006/dbio.1999.9367; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Padma P, 2003, MOL BIOL CELL, V14, P774, DOI 10.1091/mbc.02-06-0089; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; SCHULTZ JE, 1992, SCIENCE, V255, P600, DOI 10.1126/science.1371017; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Taylor GS, 2003, METHOD ENZYMOL, V366, P43; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Yoshida M, 2002, P NATL ACAD SCI USA, V99, P14831, DOI 10.1073/pnas.242470599; Zhang C, 2004, NEURON, V42, P225, DOI 10.1016/S0896-6273(04)00189-8; Zhang C, 2002, NAT NEUROSCI, V5, P425, DOI 10.1038/nn845; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	29	523	540	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1239	1243		10.1038/nature03650	http://dx.doi.org/10.1038/nature03650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15902207				2022-12-24	WOS:000230140500045
J	Biswas, T; Aihara, H; Radman-Livaja, M; Filman, D; Landy, A; Ellenberger, T				Biswas, T; Aihara, H; Radman-Livaja, M; Filman, D; Landy, A; Ellenberger, T			A structural basis for allosteric control of DNA recombination by lambda integrase	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; CRYSTAL-STRUCTURE; INT PROTEIN; COMPLEX; ORDER; IHF; ARCHITECTURE; FLEXIBILITY; MUTATIONS; VANADATE	Site-specific DNA recombination is important for basic cellular functions including viral integration, control of gene expression, production of genetic diversity and segregation of newly replicated chromosomes, and is used by bacteriophage lambda to integrate or excise its genome into and out of the host chromosome. lambda recombination is carried out by the bacteriophage-encoded integrase protein (lambda-int) together with accessory DNA sites and associated bending proteins that allow regulation in response to cell physiology. Here we report the crystal structures of lambda-int in higher-order complexes with substrates and regulatory DNAs representing different intermediates along the reaction pathway. The structures show how the simultaneous binding of two separate domains of lambda-int to DNA facilitates synapsis and can specify the order of DNA strand cleavage and exchange. An intertwined layer of amino-terminal domains bound to accessory (arm) DNAs shapes the recombination complex in a way that suggests how arm binding shifts the reaction equilibrium in favour of recombinant products.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Brown Univ, Div Biol & Med, Providence, RI 02912 USA	Harvard University; Harvard Medical School; Brown University	Ellenberger, T (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	tome@hms.harvard.edu		Radman-Livaja, Marta/0000-0003-4987-0608; filman, david/0000-0002-8714-1644	NIGMS NIH HHS [R01 GM062723, R01 GM033928] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062723, R01GM033928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aihara H, 2003, MOL CELL, V12, P187, DOI 10.1016/S1097-2765(03)00268-5; Azaro MA, 1997, EMBO J, V16, P3744, DOI 10.1093/emboj/16.12.3744; Azaro MA., 2002, MOBILE DNA-UK, P118, DOI DOI 10.1128/9781555817954.CH7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bankhead TM, 2003, J BACTERIOL, V185, P2653, DOI 10.1128/JB.185.8.2653-2666.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSHMAN W, 1985, SCIENCE, V230, P906, DOI 10.1126/science.2932798; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chen Y, 2003, ANNU REV BIOPH BIOM, V32, P135, DOI 10.1146/annurev.biophys.32.110601.141732; Crisona NJ, 1999, J MOL BIOL, V289, P747, DOI 10.1006/jmbi.1999.2771; Davies DR, 2003, CHEM BIOL, V10, P139, DOI 10.1016/S1074-5521(03)00021-8; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DEVARGAS LM, 1989, SCIENCE, V244, P1457; FRANZ B, 1995, EMBO J, V14, P397, DOI 10.1002/j.1460-2075.1995.tb07014.x; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kazmierczak RA, 2002, NUCLEIC ACIDS RES, V30, P5193, DOI 10.1093/nar/gkf652; KIM S, 1992, SCIENCE, V256, P198, DOI 10.1126/science.1533056; KITTS PA, 1988, J MOL BIOL, V204, P95, DOI 10.1016/0022-2836(88)90602-X; Kwon HJ, 1997, SCIENCE, V276, P126, DOI 10.1126/science.276.5309.126; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Martin SS, 2003, BIOCHEM BIOPH RES CO, V308, P529, DOI 10.1016/S0006-291X(03)01437-2; MIZUUCHI K, 1978, J MOL BIOL, V121, P375, DOI 10.1016/0022-2836(78)90370-4; NASH HA, 1996, CELLULAR MOL BIOL, P2263; NUMRYCH TE, 1990, NUCLEIC ACIDS RES, V18, P3953, DOI 10.1093/nar/18.13.3953; NUNESDUBY SE, 1987, CELL, V50, P779, DOI 10.1016/0092-8674(87)90336-9; NUNESDUBY SE, 1995, CURR BIOL, V5, P139, DOI 10.1016/S0960-9822(95)00035-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radman-Livaja M, 2005, P NATL ACAD SCI USA, V102, P3913, DOI 10.1073/pnas.0500844102; Radman-Livaja M, 2003, MOL CELL, V11, P783, DOI 10.1016/S1097-2765(03)00111-4; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; RICHET E, 1988, CELL, V52, P9, DOI 10.1016/0092-8674(88)90526-0; ROSS W, 1979, CELL, V18, P297, DOI 10.1016/0092-8674(79)90049-7; ROSS W, 1982, P NATL ACAD SCI-BIOL, V79, P7724, DOI 10.1073/pnas.79.24.7724; Sam MD, 2004, J MOL BIOL, V338, P229, DOI 10.1016/j.jmb.2004.02.053; Sarkar D, 2002, J MOL BIOL, V324, P775, DOI 10.1016/S0022-2836(02)01199-3; Segall AM, 1996, GENES CELLS, V1, P453, DOI 10.1046/j.1365-2443.1996.d01-254.x; Sherratt DJ, 1998, CELL, V93, P149, DOI 10.1016/S0092-8674(00)81566-4; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; THOMPSON JF, 1987, J MOL BIOL, V195, P481, DOI 10.1016/0022-2836(87)90177-X; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; Tirumalai RS, 1998, J MOL BIOL, V279, P513, DOI 10.1006/jmbi.1998.1786; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Warren D, 2005, MOL MICROBIOL, V55, P1104, DOI 10.1111/j.1365-2958.2004.04447.x; Wojciak JM, 2002, P NATL ACAD SCI USA, V99, P3434, DOI 10.1073/pnas.052017999	48	131	137	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1059	1066		10.1038/nature03657	http://dx.doi.org/10.1038/nature03657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973401	Green Accepted			2022-12-24	WOS:000229970400040
J	Reguera, G; McCarthy, KD; Mehta, T; Nicoll, JS; Tuominen, MT; Lovley, DR				Reguera, G; McCarthy, KD; Mehta, T; Nicoll, JS; Tuominen, MT; Lovley, DR			Extracellular electron transfer via microbial nanowires	NATURE			English	Article							INSOLUBLE FE(III) OXIDE; GEOBACTER-METALLIREDUCENS; PSEUDOMONAS-AERUGINOSA; IV PILI; REDUCTION; SULFURREDUCENS; RESPIRATION; BIOGENESIS; METABOLISM; MOTILITY	Microbes that can transfer electrons to extracellular electron acceptors, such as Fe(III) oxides, are important in organic matter degradation and nutrient cycling in soils and sediments(1,2). Previous investigations on electron transfer to Fe(III) have focused on the role of outer-membrane c-type cytochromes(1,3). However, some Fe(III) reducers lack c-cytochromes(4). Geobacter species, which are the predominant Fe(III) reducers in many environments(1), must directly contact Fe(III) oxides to reduce them(5), and produce monolateral pili(6) that were proposed(1,2), on the basis of the role of pili in other organisms(7,8), to aid in establishing contact with the Fe(III) oxides. Here we report that a pilus-deficient mutant of Geobacter sulfurreducens could not reduce Fe(III) oxides but could attach to them. Conducting-probe atomic force microscopy revealed that the pili were highly conductive. These results indicate that the pili of G. sulfurreducens might serve as biological nanowires, transferring electrons from the cell surface to the surface of Fe(III) oxides. Electron transfer through pili indicates possibilities for other unique cell-surface and cell-cell interactions, and for bioengineering of novel conductive materials.	Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	dlovley@microbio.umass.edu	Tuominen, Mark/A-6129-2012; Reguera, Gemma/AAZ-5864-2020	Reguera, Gemma/0000-0003-4317-7933				AHO EL, 1987, INFECT IMMUN, V55, P1009, DOI 10.1128/IAI.55.4.1009-1013.1987; Alm RA, 1997, GENE, V192, P89, DOI 10.1016/S0378-1119(96)00805-0; BUTLER JE, UNPUB J BACTERIOL; Childers SE, 2002, NATURE, V416, P767, DOI 10.1038/416767a; CHILDERS SE, 2003, 103 GEN M, P361; Coppi MV, 2001, APPL ENVIRON MICROB, V67, P3180, DOI 10.1128/AEM.67.7.3180-3187.2001; Davis JJ, 2003, PHILOS T R SOC A, V361, P2807, DOI 10.1098/rsta.2003.1270; DOIG P, 1988, INFECT IMMUN, V56, P1641, DOI 10.1128/IAI.56.6.1641-1646.1988; Holmes DE, 2004, INT J SYST EVOL MICR, V54, P1591, DOI 10.1099/ijs.0.02958-0; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; LOVLEY DR, 1995, APPL ENVIRON MICROB, V61, P2132, DOI 10.1128/AEM.61.6.2132-2138.1995; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; LOVLEY DR, 2004, ADV MICROBIAL PHYSL, V49; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Nassif X, 1997, GENE, V192, P149, DOI 10.1016/S0378-1119(96)00802-5; Nevin KP, 2000, APPL ENVIRON MICROB, V66, P2248, DOI 10.1128/AEM.66.5.2248-2251.2000; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Sahu SN, 2003, MOL CELL BIOCHEM, V253, P167, DOI 10.1023/A:1026028930203; Sayler GS, 2004, CURR OPIN MICROBIOL, V7, P267, DOI 10.1016/j.mib.2004.04.003; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x	25	1705	1847	76	1286	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1098	1101		10.1038/nature03661	http://dx.doi.org/10.1038/nature03661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973408				2022-12-24	WOS:000229970400049
J	Tomita, S; Adesnik, H; Sekiguchi, M; Zhang, W; Wada, K; Howe, JR; Nicoll, RA; Bredt, DS				Tomita, S; Adesnik, H; Sekiguchi, M; Zhang, W; Wada, K; Howe, JR; Nicoll, RA; Bredt, DS			Stargazin modulates AMPA receptor gating and trafficking by distinct domains	NATURE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR GRANULE CELLS; NON-NMDA RECEPTOR; SYNAPTIC PLASTICITY; SUBUNIT STOICHIOMETRY; EXCITATORY SYNAPSES; MOUSE STARGAZER; GAMMA-SUBUNIT; ION CHANNELS; MUTANT MOUSE	AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors mediate fast excitatory synaptic transmission in the brain. These ion channels rapidly deactivate and desensitize, which determine the time course of synaptic transmission. Here, we find that the AMPA receptor interacting protein, stargazin, not only mediates AMPA receptor trafficking but also shapes synaptic responses by slowing channel deactivation and desensitization. The cytoplasmic tail of stargazin determines receptor trafficking, whereas the ectodomain controls channel properties. Stargazin alters AMPA receptor kinetics by increasing the rate of channel opening. Disrupting the interaction of stargazin ectodomain with hippocampal AMPA receptors alters the amplitude and shape of synaptic responses, establishing a crucial function for stargazin in controlling the efficacy of synaptic transmission in the brain.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo 1878502, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; National Center for Neurology & Psychiatry - Japan	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu; bredt@itsa.ucsf.edu	zhang, wei/V-6712-2018	zhang, wei/0000-0001-9825-0371				Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; Chen L, 2003, MOL PHARMACOL, V64, P703, DOI 10.1124/mol.64.3.703; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dingledine R, 1999, PHARMACOL REV, V51, P7; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Goff DC, 2001, J CLIN PSYCHOPHARM, V21, P484, DOI 10.1097/00004714-200110000-00005; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; KOH JY, 1990, J NEUROSCI, V10, P693; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Lynch G, 1997, EXP NEUROL, V145, P89, DOI 10.1006/exnr.1997.6447; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; O'Neill MJ, 2004, EUR J PHARMACOL, V486, P163, DOI 10.1016/j.ejphar.2003.12.023; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Robert A, 2003, J NEUROSCI, V23, P847; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sekiguchi M, 2002, BRIT J PHARMACOL, V136, P1033, DOI 10.1038/sj.bjp.0704804; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Smith TC, 2000, J NEUROSCI, V20, P2073; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; Stein V, 2003, J NEUROSCI, V23, P5503; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; WYLLIE DJA, 1993, J PHYSIOL-LONDON, V463, P193, DOI 10.1113/jphysiol.1993.sp019591; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	43	373	385	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1052	1058		10.1038/nature03624	http://dx.doi.org/10.1038/nature03624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15858532				2022-12-24	WOS:000229970400039
J	Hargreaves, EL; Rao, G; Lee, I; Knierim, JJ				Hargreaves, EL; Rao, G; Lee, I; Knierim, JJ			Major dissociation between medial and lateral entorhinal input to dorsal hippocampus	SCIENCE			English	Article							POSITIONAL FIRING PROPERTIES; FREELY MOVING RATS; HEAD-DIRECTION CELLS; PLACE CELLS; POSTRHINAL CORTEX; PERIRHINAL CORTEX; MEMORY; PARASUBICULUM; NEURONS; PRESUBICULUM	Hippocampal place cells are a model system of how the brain constructs cognitive representations and of how these representations support complex behavior, teaming, and memory. There is, however, a lack of detailed knowledge about the properties of hippocampal afferents. We recorded multiple single units from the hippocampus and the medial and lateral entorhinal areas of behaving rats. Although many medial entorhinal neurons had highly specific place fields, Lateral entorhinal neurons displayed weak spatial specificity. This finding demonstrates a fundamental dissociation between the information conveyed to the hippocampus by its major input streams, with spatial information represented by the medial and nonspatial information represented by the lateral entorhinal cortex.	Univ Texas, Med Sch Houston, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX 77225 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Texas System; University of Texas Health Science Center Houston; New York University	Knierim, JJ (corresponding author), Univ Texas, Med Sch Houston, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	james.j.knierim@uth.tmc.edu	Hargreaves, Eric/H-4891-2011	Hargreaves, Eric/0000-0001-5311-9804	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH063297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039456] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH63297] Funding Source: Medline; NINDS NIH HHS [R01 NS039456] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARNES CA, 1990, PROG BRAIN RES, V83, P287; Burwell RD, 1998, NEUROREPORT, V9, P3013, DOI 10.1097/00001756-199809140-00017; Burwell RD, 2003, NEUROSCIENCE, V119, P577, DOI 10.1016/S0306-4522(03)00160-X; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; CABALLEROBLEDA M, 1993, J COMP NEUROL, V328, P115, DOI 10.1002/cne.903280109; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gaffan D, 1998, EXP BRAIN RES, V123, P201, DOI 10.1007/s002210050562; JUNG MW, 1994, J NEUROSCI, V14, P7347; MIZUMORI SJY, 1992, BRAIN RES, V570, P188, DOI 10.1016/0006-8993(92)90581-S; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; Norman G, 2005, BEHAV NEUROSCI, V119, P557, DOI 10.1037/0735-7044.119.2.557; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; TAUBE JS, 1995, J NEUROSCI, V15, P70; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Witter M. P., 2004, RAT NERVOUS SYSTEM, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	28	447	456	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1792	1794		10.1126/science.1110449	http://dx.doi.org/10.1126/science.1110449			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961670				2022-12-24	WOS:000229926800056
J	Turner, PC; Sylla, A; Gong, YY; Diailo, MS; Sutcliffe, AE; Hall, AJ; Wild, CP				Turner, PC; Sylla, A; Gong, YY; Diailo, MS; Sutcliffe, AE; Hall, AJ; Wild, CP			Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study	LANCET			English	Article							HEPATOCELLULAR-CARCINOMA; PRIMARY PREVENTION; DIETARY AFLATOXIN; YOUNG-CHILDREN; LIVER-CANCER; BENIN; RISK; INFECTION; GROWTH; TOGO	Background Aflatoxins are fungal metabolites that frequently contaminate staple foods in much of sub-Saharan Africa, and are associated with increased risk of liver cancer and impaired growth in young children. We aimed to assess whether postharvest measures to restrict aflatoxin contamination of groundnut crops could reduce exposure in west African villages. Methods We undertook an intervention study at subsistence farms in the lower Kindia region of Guinea. Farms from 20 villages were included, ten of which implemented a package of postharvest measures to restrict aflatoxin contamination of the groundnut crop; ten controls followed usual postharvest practices. We measured the concentrations of blood aflatoxin-albumin adducts from 600 people immediately after harvest and at 3 months and 5 months postharvest to monitor the effectiveness of the intervention. Findings In control villages mean aflatoxin-albumin concentration increased postharvest (from 5.5 pg/mg [95% CI 4.7-6.1] immediately after harvest to 18.7 pg/mg [17.0-20.6] 5 months later). By contrast, mean aflatoxin-albumin concentration in intervention villages after 5 months of groundnut storage was much the same as that immediately postharvest (7.2 pg/mg [6.2-8.4] vs 8.0 pg/mg [7.0-9.2]). At 5 months, mean adduct concentration in intervention villages was less than 50% of that in control villages (8.0 pg/mg [7.2-9.2] vs 18.7 pg/mg [17.0-20.6], p<0.0001). About a third of the number of people had non-detectable aflatoxin-albumin concentrations at harvest. At 5 months, five (2%) people in the control villages had non-detectable adduct concentrations compared with 47 (20%) of those in the intervention group (p<0.0001). Mean concentrations of aflatoxin B1 in groundnuts in household stores in intervention and control villages were consistent with measurements of aflatoxin-albumin adducts. Interpretation Use of low-technology approaches at the subsistence-farm level in sub-Saharan Africa could substantially reduce the disease burden caused by aflatoxin exposure.	Univ Leeds, Ctr Biostat & Epidemiol, Leeds Inst Genet Hlth & Therpaeut, Mol Epidemiol Unit, Leeds LS2 9JT, W Yorkshire, England; Univ London, London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London, England; Inst Pasteur Guinee, Kindia, Guinea	University of Leeds; University of London; London School of Hygiene & Tropical Medicine	Wild, CP (corresponding author), Univ Leeds, Ctr Biostat & Epidemiol, Leeds Inst Genet Hlth & Therpaeut, Mol Epidemiol Unit, Leeds LS2 9JT, W Yorkshire, England.	c.p.wild@leeds.ac.uk	Gong, Yun Yun/L-7094-2016; Turner, Paul C/A-6152-2011; Gong, Yun Yun/C-8412-2018; Turner, Paul C/B-8131-2013; Wild, Christopher/ABC-6260-2020	Gong, Yun Yun/0000-0003-4927-5526; Gong, Yun Yun/0000-0003-4927-5526; Wild, Christopher/0000-0003-0249-8669	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES006052] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES06052] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P426, DOI 10.1016/0035-9203(92)90253-9; *ASS OFF AN CHEM, 1990, OFF METH AN AOAC NAT, P1184; Chapot B., 1991, TECHNIQUES DIAGNOSTI, P135; CROMPTON JAF, 1993, TROP SCI, V33, P283; Diallo Mamadou S., 1995, Natural Toxins, V3, P6, DOI 10.1002/nt.2620030103; Egner PA, 2001, P NATL ACAD SCI USA, V98, P14601, DOI 10.1073/pnas.251536898; Gong YY, 2004, ENVIRON HEALTH PERSP, V112, P1334, DOI 10.1289/ehp.6954; Gong YY, 2003, INT J EPIDEMIOL, V32, P556, DOI 10.1093/ije/dyg109; Gong YY, 2002, BRIT MED J, V325, P20, DOI 10.1136/bmj.325.7354.20; Hall AJ, 2003, BRIT MED J, V326, P994, DOI 10.1136/bmj.326.7397.994; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC Monogr Eval Carcinog Risks Hum, V82, P1; Montesano R, 1997, JNCI-J NATL CANCER I, V89, P1844, DOI 10.1093/jnci/89.24.1844; QIAN GS, 1994, CANCER EPIDEM BIOMAR, V3, P3; RAISUDDIN S, 1993, MYCOPATHOLOGIA, V124, P189, DOI 10.1007/BF01103737; Sylla A, 1999, MUTAT RES-FUND MOL M, V428, P187, DOI 10.1016/S1383-5742(99)00046-0; Turner PC, 2002, J GASTROEN HEPATOL, V17, pS441, DOI 10.1046/j.1440-1746.17.s4.7.x; Turner PC, 2003, ENVIRON HEALTH PERSP, V111, P217, DOI 10.1289/ehp.5753; Wang LY, 1996, INT J CANCER, V67, P620, DOI 10.1002/(SICI)1097-0215(19960904)67:5&lt;620::AID-IJC5&gt;3.0.CO;2-W; *WHO, 1998, FOOD ADDITIVES SERIE, P359; *WHO INT AG RES CA, 2003, IARC SCI PUBL, V153, P299; Wild CP, 2002, MUTAGENESIS, V17, P471, DOI 10.1093/mutage/17.6.471; Wild CP, 2000, MUTAT RES-REV MUTAT, V462, P381, DOI 10.1016/S1383-5742(00)00027-2	22	190	195	2	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2005	365	9475					1950	1956		10.1016/S0140-6736(05)66661-5	http://dx.doi.org/10.1016/S0140-6736(05)66661-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936422				2022-12-24	WOS:000229587800029
J	Kim, MG; da Cunha, L; McFall, AJ; Belkhadir, Y; DebRoy, S; Dangl, JL; Mackey, D				Kim, MG; da Cunha, L; McFall, AJ; Belkhadir, Y; DebRoy, S; Dangl, JL; Mackey, D			Two Pseudomonas syringae type III effectors inhibit RIM-regulated basal defense in Arabidopsis	CELL			English	Article							DISEASE-RESISTANCE; HYPERSENSITIVE RESPONSE; SECRETION SYSTEM; GENOMEWIDE IDENTIFICATION; CALLOSE SYNTHASE; GENE-PRODUCT; BACTERIAL; AVRRPT2; VIRULENCE; PROTEINS	Plant cells have two defense systems that detect bacterial pathogens. One is a basal defense system that recognizes complex pathogen-associated molecular patterns (PAMPs). A second system uses diseaseresistance (R) proteins to recognize type III effector proteins that are delivered into the plant cell by the pathogen's type III secretion system. Here we show that these two pathways are linked. We find that two Pseudomonas syringae type III effectors, AvrRpt2 and AvrRpm1, inhibit PAMP-induced signaling and thus compromise the host's basal defense system. RIN4 is an Arabidopsis protein targeted by AvrRpt2 and AvrRpm1 for degradation and phosphorylation, respectively. We find that RIN4 is itself a regulator of PAMP signaling. The R proteins, RPS2 and RPM1, sense type III effector-induced perturbations of RIN4. Thus, R proteins guard the plant against type III effectors that inhibit PAMP signaling and provide a mechanistic link between the two plant defense systems.	Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; Ohio State Univ, Dept Plant Cellular & Mol Biol, Columbus, OH 43210 USA; Ohio State Univ, Program Plant Mol Biol & Biotechnol, Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; Michigan State Univ, Dept Energy, Plant Res Lab, Cell & Mol Biol Program, E Lansing, MI 48824 USA; Univ N Carolina, Carolina Ctr Genome Sci, Curriculum Genet, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Curriculum Genet, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Michigan State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mackey, D (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Room 306C Kottman Hall, Columbus, OH 43210 USA.	mackey.86@osu.edu	Belkhadir, Youssef/GXM-6743-2022	Belkhadir, Youssef/0000-0001-7149-7139				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Belkhadir Y, 2004, PLANT CELL, V16, P2822, DOI 10.1105/tpc.104.024117; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chang JH, 2004, CURR OPIN MICROBIOL, V7, P11, DOI 10.1016/j.mib.2003.12.006; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Chen ZY, 2004, PLANT J, V37, P494, DOI 10.1111/j.1365-313X.2003.01984.x; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deng WL, 1998, J BACTERIOL, V180, P4523, DOI 10.1128/JB.180.17.4523-4531.1998; Espinosa A, 2004, CELL MICROBIOL, V6, P1027, DOI 10.1111/j.1462-5822.2004.00452.x; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; JAKOBEK JL, 1993, PLANT CELL, V5, P57, DOI 10.1105/tpc.5.1.57; Jin P, 2003, PLANT PHYSIOL, V133, P1072, DOI 10.1104/pp.103.025999; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Keshavarzi M, 2004, MOL PLANT MICROBE IN, V17, P805, DOI 10.1094/MPMI.2004.17.7.805; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lehmann Przemyslaw, 2002, Journal of Applied Genetics, V43, P403; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Newman MA, 2002, PLANT J, V29, P487, DOI 10.1046/j.0960-7412.2001.00233.x; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Qureshi ST, 2003, GENES IMMUN, V4, P87, DOI 10.1038/sj.gene.6363937; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Rohmer L, 2003, MOL MICROBIOL, V47, P1545, DOI 10.1046/j.1365-2958.2003.03402.x; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	54	360	376	3	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					749	759		10.1016/j.cell.2005.03.025	http://dx.doi.org/10.1016/j.cell.2005.03.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935761	Bronze			2022-12-24	WOS:000229658000013
J	Schweitzer, MH; Wittmeyer, JL; Horner, JR				Schweitzer, MH; Wittmeyer, JL; Horner, JR			Gender-specific reproductive tissue in ratites and Tyrannosaurus rex	SCIENCE			English	Article							MALE JAPANESE QUAIL; MEDULLARY BONE; AVIAN BONE; ESTROGEN; EVOLUTION; CALCIUM; BIRDS; OSTEOGENESIS; ORIGIN; MODEL	Unambiguous indicators of gender in dinosaurs are usually lost during fossilization, along with other aspects of soft tissue anatomy. We report the presence of endosteally derived bone tissues lining the interior marrow cavities of portions of Tyrannosaurus rex (Museum of the Rockies specimen number 1125) hindlimb elements, and we hypothesize that these tissues are homologous to specialized avian tissues known as medullary bone. Because medullary bone is unique to female birds, its discovery in extinct dinosaurs solidifies the link between dinosaurs and birds, suggests similar reproductive strategies, and provides an objective means of gender differentiation in dinosaurs.	N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; N Carolina State Museum Nat Sci, Raleigh, NC 27601 USA; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA	University of North Carolina; North Carolina State University; Montana State University System; Montana State University Bozeman	Schweitzer, MH (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA.	schweitzer@ncsu.edu	schweitzer, mary h/A-6756-2010; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; 				Arias JL, 2001, WORLD POULTRY SCI J, V57, P349, DOI 10.1079/WPS20010024; ASCENZI A, 1963, J ULTRA MOL STRUCT R, V8, P491, DOI 10.1016/S0022-5320(63)80051-9; BLOOM MA, 1958, AM J ANAT, V102, P411, DOI 10.1002/aja.1001020304; BONUCCI E, 1975, CELL TISSUE RES, V163, P81; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; CARPENTER K, 1999, EGGS NESTS BAYB DINO; CHIAPPE LM, 1995, NATURE, V378, P349, DOI 10.1038/378349a0; Chinsamy A, 1997, J VERTEBR PALEONTOL, V17, P450, DOI 10.1080/02724634.1997.10010993; Chinsamy A, 1995, PALEOBIOLOGY, V21, P561, DOI 10.1017/S0094837300013543; Cracraft J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P143; DACKE CG, 1993, J EXP BIOL, V184, P63; ELSEY RM, 1986, COMP BIOCHEM PHYS A, V84, P107, DOI 10.1016/0300-9629(86)90050-2; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Knott L, 1999, BRIT POULTRY SCI, V40, P371, DOI 10.1080/00071669987476; Martill DM, 1996, NATURE, V379, P778, DOI 10.1038/379778a0; Mikhailov K.E., 1997, SPEC PAP PALAEONTOL, V56, P1; MILLER SC, 1981, DEV BIOL, V87, P52, DOI 10.1016/0012-1606(81)90060-9; OHASHI T, 1987, BRIT POULTRY SCI, V28, P727, DOI 10.1080/00071668708417008; Padian K, 1998, SCI AM, V278, P38, DOI 10.1038/scientificamerican0298-38; SATO T, SCIENCE, V308, P375; SCHRAER H, 1985, COMP BIOCHEM PHYS A, V82, P13, DOI 10.1016/0300-9629(85)90697-8; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Schweitzer MH, 2001, J EXP ZOOL, V291, P317, DOI 10.1002/jez.1132; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sugiyama T, 2001, ASIAN AUSTRAL J ANIM, V14, P82; Whitehead CC, 2004, POULTRY SCI, V83, P193, DOI 10.1093/ps/83.2.193; Wilson S, 1998, CALCIFIED TISSUE INT, V62, P506, DOI 10.1007/s002239900470; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Yamamoto T, 2001, ANAT REC, V264, P25, DOI 10.1002/ar.1101; [No title captured]	32	107	134	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2005	308	5727					1456	1460		10.1126/science.1112158	http://dx.doi.org/10.1126/science.1112158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933198	Green Submitted			2022-12-24	WOS:000229619300050
J	Hsieh, CH; Glaser, SM; Lucas, AJ; Sugihara, G				Hsieh, CH; Glaser, SM; Lucas, AJ; Sugihara, G			Distinguishing random environmental fluctuations from ecological catastrophes for the North Pacific Ocean	NATURE			English	Article							DETECTING REGIME SHIFTS; TIME-SERIES; STABLE POINTS; CHAOS; VARIABILITY; POPULATIONS; CALIFORNIA; MODELS; ERROR	The prospect of rapid dynamic changes in the environment is a pressing concern that has profound management and public policy implications(1,2). Worries over sudden climate change and irreversible changes in ecosystems are rooted in the potential that nonlinear systems have for complex and 'pathological' behaviours(1,2). Nonlinear behaviours have been shown in model systems(3) and in some natural systems(1,4-8), but their occurrence in large-scale marine environments remains controversial(9,10). Here we show that time series observations of key physical variables(11-14) for the North Pacific Ocean that seem to show these behaviours are not deterministically nonlinear, and are best described as linear stochastic. In contrast, we find that time series for biological variables(5,15-17) having similar properties exhibit a low-dimensional nonlinear signature. To our knowledge, this is the first direct test for nonlinearity in large-scale physical and biological data for the marine environment. These results address a continuing debate over the origin of rapid shifts in certain key marine observations as coming from essentially stochastic processes or from dominant nonlinear mechanisms(1,9,10,18-20). Our measurements suggest that large-scale marine ecosystems are dynamically nonlinear, and as such have the capacity for dramatic change in response to stochastic fluctuations in basin-scale physical states.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Sugihara, G (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu	Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272; Lucas, Andrew/0000-0001-7722-7252				deYoung B, 2004, PROG OCEANOGR, V60, P143, DOI 10.1016/j.pocean.2004.02.017; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Dixon PA, 2001, NONLINEAR DYNAMICS AND STATISTICS, P339; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; Hastings HM, 1993, FRACTALS USERS GUIDE; HSIEH CH, UNPUB PROG OCEANOGR; HURRELL J, 2003, N PACIFIC NP INDEX I; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; Mantua N, 2004, PROG OCEANOGR, V60, P165, DOI 10.1016/j.pocean.2004.02.016; MANTUA NJ, 2004, PACIFIC DECADAL OSCI; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; McGowan JA, 2003, DEEP-SEA RES PT II, V50, P2567, DOI 10.1016/S0967-0645(03)00135-8; *NAT CTR ATM RES, 2004, SO OSC IND; Patil DAS, 2001, MON WEATHER REV, V129, P2116, DOI 10.1175/1520-0493(2001)129<2116:ILDNBI>2.0.CO;2; Rebstock GA, 2002, GLOBAL CHANGE BIOL, V8, P71, DOI 10.1046/j.1365-2486.2002.00456.x; Rudnick DL, 2003, DEEP-SEA RES PT I, V50, P691, DOI 10.1016/S0967-0637(03)00053-0; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; STEELE JH, 1984, SCIENCE, V224, P985, DOI 10.1126/science.224.4652.985; Sugihara G, 1996, P NATL ACAD SCI USA, V93, P2608, DOI 10.1073/pnas.93.6.2608; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Sugihara G, 1999, P NATL ACAD SCI USA, V96, P14210, DOI 10.1073/pnas.96.25.14210; SUGIHARA G, 1990, PHILOS T R SOC B, V330, P235, DOI 10.1098/rstb.1990.0195; SUGIHARA G, 1994, PHILOS T R SOC A, V348, P477, DOI 10.1098/rsta.1994.0106; SUTHERLAND JP, 1974, AM NAT, V108, P859, DOI 10.1086/282961; *WA DEP FISH WILDL, 2004, STAT REP COL RIV FIS; Wunsch C, 1999, B AM METEOROL SOC, V80, P245, DOI 10.1175/1520-0477(1999)080<0245:TIOSCR>2.0.CO;2; [No title captured]	29	245	250	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					336	340		10.1038/nature03553	http://dx.doi.org/10.1038/nature03553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902256				2022-12-24	WOS:000229185000044
J	Shlipak, MG; Sarnak, MJ; Katz, R; Fried, LF; Seliger, SL; Newman, AB; Siscovick, DS; Stehman-Breen, C				Shlipak, MG; Sarnak, MJ; Katz, R; Fried, LF; Seliger, SL; Newman, AB; Siscovick, DS; Stehman-Breen, C			Cystatin C and the risk of death and cardiovascular events among elderly persons	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; RENAL-INSUFFICIENCY; MYOCARDIAL-INFARCTION; OLDER-ADULTS; MORTALITY; OUTCOMES; DYSFUNCTION; HOSPITALIZATION; PREDICTION	BACKGROUND: Cystatin C is a serum measure of renal function that appears to be independent of age, sex, and lean muscle mass. We compared creatinine and cystatin C levels as predictors of mortality from cardiovascular causes and from all causes in the Cardiovascular Health Study, a cohort study of elderly persons living in the community. METHODS: Creatinine and cystatin C were measured in serum samples collected from 4637 participants at the study visit in 1992 or 1993; follow-up continued until June 30, 2001. For each measure, the study population was divided into quintiles, with the fifth quintile subdivided into thirds (designated 5a, 5b, and 5c). RESULTS: Higher cystatin C levels were directly associated, in a dose-response manner, with a higher risk of death from all causes. As compared with the first quintile, the hazard ratios (and 95 percent confidence intervals) for death were as follows: second quintile, 1.08 (0.86 to 1.35); third quintile, 1.23 (1.00 to 1.53); fourth quintile, 1.34 (1.09 to 1.66); quintile 5a, 1.77 (1.34 to 2.26); 5b, 2.18 (1.72 to 2.78); and 5c, 2.58 (2.03 to 3.27). In contrast, the association of creatinine categories with mortality from all causes appeared to be J-shaped. As compared with the two lowest quintiles combined (cystatin C level, lessthan/equal 0.99 mg per liter), the highest quintile of cystatin C (greater/equal 1.29 mg per liter) was associated with a significantly elevated risk of death from cardiovascular causes (hazard ratio, 2.27 [1.73 to 2.97]), myocardial infarction (hazard ratio, 1.48 [1.08 to 2.02]), and stroke (hazard ratio, 1.47 [ 1.09 to 1.96]) after multivariate adjustment. The fifth quintile of creatinine, as compared with the first quintile, was not independently associated with any of these three outcomes. CONCLUSIONS: Cystatin C, a serum measure of renal function, is a stronger predictor of the risk of death and cardiovascular events in elderly persons than is creatinine.	Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Tufts New England Med Ctr, Dept Med, Div Nephrol, Boston, MA USA; Collaborat Hlth Studies Coordinating Ctr, Seattle, WA USA; Vet Affairs Pittsburgh Healthcare Syst, Med Serv, Renal Sect, Pittsburgh, PA USA; Univ Maryland, Sch Med, Div Nephrol, Baltimore, MD 21201 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Div Geriatr Med, Pittsburgh, PA USA; Univ Washington, Dept Med, Seattle, WA USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Amgen Inc, Thousand Oaks, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tufts Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Amgen	Shlipak, MG (corresponding author), Vet Affairs Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.	shlip@itsa.ucsf.edu	Katz, Ronit/ABA-1880-2021; Newman, Anne B./C-6408-2013	Newman, Anne B./0000-0002-0106-1150; Seliger, Stephen/0000-0002-1693-0734	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085081, N01HC085086, N01HC085080, N01HC035129, N01HC015103, N01HC085082, N01HC085083, N01HC085084, N01HC085079, N01HC085085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073208] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-85082, N01-HC-35129, N01-HC-85081, N01-HC-85079, N01-HC-85080, N01-HC-85086, N01-HC-85085, R01 HL073208-01, N01 HC-15103, N01-HC-85084, N01-HC-85083] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; BROWNER WS, 1992, JAMA-J AM MED ASSOC, V268, P228, DOI 10.1001/jama.268.2.228; Chertow GM, 1997, CIRCULATION, V95, P878; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; CUSHMAN M, 1995, CLIN CHEM, V41, P264; Erlandsen EJ, 1999, SCAND J CLIN LAB INV, V59, P1, DOI 10.1080/00365519950185940; Fliser D, 2001, AM J KIDNEY DIS, V37, P79, DOI 10.1053/ajkd.2001.20591; Fricker M, 2003, KIDNEY INT, V63, P1944, DOI 10.1046/j.1523-1755.2003.00925.x; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Garg AX, 2004, KIDNEY INT, V65, P649, DOI 10.1111/j.1523-1755.2004.00412.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Herget-Rosenthal S, 2000, AM J NEPHROL, V20, P97, DOI 10.1159/000013564; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jayagopal V, 2003, CLIN CHEM, V49, P680, DOI 10.1373/49.4.680; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Price T R, 1993, Ann Epidemiol, V3, P504; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2004, J AM SOC NEPHROL, V15, P2195, DOI 10.1097/01.ASN.0000135121.81744.75; Singer MA, 2001, AM J KIDNEY DIS, V37, P164, DOI 10.1016/S0272-6386(01)80073-1; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Wiesli P, 2003, CLIN CHIM ACTA, V338, P87, DOI 10.1016/j.cccn.2003.07.022	28	956	1014	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2005	352	20					2049	2060		10.1056/NEJMoa043161	http://dx.doi.org/10.1056/NEJMoa043161			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GJ	15901858				2022-12-24	WOS:000229180100003
J	Talbot, TR; Hartert, TV; Mitchel, E; Halasa, NB; Arbogast, PG; Poehling, KA; Schaffner, W; Craig, AS; Griffin, MR				Talbot, TR; Hartert, TV; Mitchel, E; Halasa, NB; Arbogast, PG; Poehling, KA; Schaffner, W; Craig, AS; Griffin, MR			Asthma as a risk factor for invasive pneumococcal disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYSACCHARIDE VACCINE; OLDER-ADULTS; INFECTIONS; HEALTH	BACKGROUND: The risk of invasive pneumococcal disease among persons with asthma is unknown. METHODS: We conducted a nested case-control study to examine the association between asthma and invasive pneumococcal disease. The study population included persons 2 to 49 years of age who were enrolled in Tennessee's Medicaid program (TennCare) for more than one year during the study period (1995 through 2002) and who resided in counties participating in a prospective laboratory-based program of surveillance for invasive pneumococcal disease. For each subject with invasive pneumococcal disease, 10 age-matched controls without invasive pneumococcal disease were randomly selected from the same population. TennCare files were queried to identify the presence of coexisting conditions that confer a high risk of pneumococcal disease. For the purpose of our study, asthma was defined by documentation of one or more inpatient or emergency-department diagnoses of asthma, two outpatient diagnoses, or the use of asthma-related medications. High-risk asthma was defined as asthma requiring admission to a hospital or a visit to an emergency department, the use of rescue therapy or long-term use of oral corticosteroids, or the dispensing of three or more prescriptions for (beta)-agonists within the year before enrollment in the study. RESULTS: A total of 635 persons with invasive pneumococcal disease and 6350 controls were identified, of whom 114 (18.0 percent) and 516 (8.1 percent), respectively, had asthma. Persons with asthma had an increased risk of invasive pneumococcal disease (adjusted odds ratio, 2.4; 95 percent confidence interval, 1.9 to 3.1) as compared with controls. Among those without coexisting conditions, the annual incidence of invasive pneumococcal disease was 4.2 episodes per 10,000 persons with high-risk asthma and 2.3 episodes per 10,000 persons with low-risk asthma, as compared with 1.2 episodes per 10,000 persons without asthma. CONCLUSIONS: Asthma is an independent risk factor for invasive pneumococcal disease. The risk among persons with asthma was at least double that among controls.	Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Ctr Educ & Res Therapeut, Nashville, TN 37212 USA; Tennessee Dept Hlth, Nashville, TN USA; Vet Affairs Tennessee Valley Healthcare Syst, Ctr Geriatr Res Educ & Clin, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Tennessee Department Health; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Talbot, TR (corresponding author), A-4103C Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	tom.talbot@vanderbilt.edu		Talbot, Thomas/0000-0002-6139-212X	NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017697, M01RR000095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050884, K08AI001582] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00095, K12 RR-017697] Funding Source: Medline; NHLBI NIH HHS [UO1HL72471] Funding Source: Medline; NIAID NIH HHS [KO8 AI 001582, R01 AI 50884] Funding Source: Medline; ODCDC CDC HHS [U50/CCU416123] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ODCDC CDC HHS		[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; BARDIN PG, 1994, CLIN EXP ALLERGY, V24, P457, DOI 10.1111/j.1365-2222.1994.tb00934.x; BURMAN LA, 1985, REV INFECT DIS, V7, P133; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; *CDCP, 2002, ACT BACT COR SURV EM; Fahy J V, 2000, Curr Opin Pulm Med, V6, P15, DOI 10.1097/00063198-200001000-00004; HART AC, 2002, INT CLASSIFICATION D, V1; HART AC, 2002, INT CLASSIFICATION D, V3; HART AC, 2002, INT CLASSIFICATION D, V2; Hartert T V, 2000, Curr Opin Pulm Med, V6, P4, DOI 10.1097/00063198-200001000-00002; Hartert TV, 2000, J AM GERIATR SOC, V48, P651, DOI 10.1111/j.1532-5415.2000.tb04723.x; Hartert TV, 2002, ANN ALLERG ASTHMA IM, V89, P467, DOI 10.1016/S1081-1206(10)62083-2; Koehler DR, 2004, AM J RESP CELL MOL, V31, P377, DOI 10.1165/rcmb.2004-0124TR; LIPSKY BA, 1986, ARCH INTERN MED, V146, P2179, DOI 10.1001/archinte.146.11.2179; Message SD, 2004, J LEUKOCYTE BIOL, V75, P5, DOI 10.1189/jlb.0703315; MIRVIS DM, 1995, JAMA-J AM MED ASSOC, V274, P1235, DOI 10.1001/jama.274.15.1235; *NAT ASTHM ED PREV, 1997, NIH PUBL; National Asthma Education and Prevention Program, 2003, J ALLERGY CLIN IMMUN, V111, P466, DOI DOI 10.1542/PEDS.2007-3825; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Plouffe JF, 1996, JAMA-J AM MED ASSOC, V275, P194, DOI 10.1001/jama.275.3.194; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Talbot TR, 2004, PEDIATR INFECT DIS J, V23, P726, DOI 10.1097/01.inf.0000133046.60555.de; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; US CENSUS 2000 STAT; 2004, MMWR MORB MORTAL WKL, V53, P145	32	299	313	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2005	352	20					2082	2090		10.1056/NEJMoa044113	http://dx.doi.org/10.1056/NEJMoa044113			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GJ	15901861	Bronze			2022-12-24	WOS:000229180100006
J	Kanaya, AM; Herrington, D; Vittinghoff, E; Lin, F; Bittner, V; Cauley, JA; Hulley, S; Barrett-Connor, E				Kanaya, AM; Herrington, D; Vittinghoff, E; Lin, F; Bittner, V; Cauley, JA; Hulley, S; Barrett-Connor, E			Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease	ANNALS OF INTERNAL MEDICINE			English	Article							HEART-DISEASE; RISK-FACTOR; ESTROGEN/PROGESTIN REPLACEMENT; DIABETES-MELLITUS; HYPERGLYCEMIA; MORTALITY; ASSOCIATION; POPULATION; PREVENTION; INFARCTION	Background: Type 2 diabetes increases risk for cardiovascular disease. Persons with impaired fasting glucose levels may also have increased risk. Objective: To evaluate the association between glucose status and cardiovascular outcomes and the effect of lowering the fasting glucose level criterion for impaired fasting glucose from a lower limit of 6.1 mmol/L (110 mg/dL) to 5.6 mmol/L (100 mg/dL). Design: Prospective cohort study. Setting: 20 U.S. clinical centers. Patients: 2763 postmenopausal women with established coronary heart disease (CHD) who were followed for 6.8 years. Measurements: Any CHD event (nonfatal myocardial infarction or CHD death), stroke or transient ischemic attack (TIA), congestive heart failure (CHF) hospitalization, and any cardiovascular event. Results: During follow-up, 583 women had a CHD event, 329 women had a stroke or TIA, and 348 women were hospitalized for CHF. Women with diabetes were at an approximately 75% increased risk for each outcome compared with normoglycemic women. The 218 women with impaired fasting glucose according to the 1997 definition (fasting glucose level, 6.1 to 6.9 mmol/L [110 to 125 mg/dL]) had increased risk for any CHID event (hazard ratio, 1.37 [95% CI, 1.08 to 1.74]), while the 698 women with impaired fasting glucose according to the 2003 definition (fasting glucose level, 5.6 to 6.9 mmol/L [100 to 125 mg/dL]) were not at increased risk (hazard ratio, 1.09 [CI, 0.90 to 1.34]). Most of the women (n = 480) with fasting glucose levels between 5.6 mmol/L (100 mg/dL) and 6.0 mmol/L (109 mg/dL) had no increased risk for CHD (hazard ratio, 0.90 [CI, 0.73 to 1.12]). Women with impaired fasting glucose according to either definition were not at increased risk for stroke or TIA or CHF. Limitations: These findings may not be generalizable to men or women without existing heart disease. Conclusions: Among postmenopausal women with coronary artery disease, the 2003 definition for impaired fasting glucose was not associated with increased risk for new CHID, stroke or TIA, or CHF.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; Wake Forest University; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego	Kanaya, AM (corresponding author), Womens Hlth Clin Res Ctr, 1635 Divisadero St,Suite 600, San Francisco, CA 94115 USA.	alkak@itsa.ucsf.edu	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408; Bittner, Vera/0000-0001-9456-850X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K12AR047659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG015272] Funding Source: NIH RePORTER; NIAMS NIH HHS [5 K12 AR47659] Funding Source: Medline; NIA NIH HHS [P30-AG15272] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P833; Arcavi L, 2004, AM HEART J, V147, P239, DOI 10.1016/j.ahj.2003.09.013; BELL DSH, 1995, DIABETES CARE, V18, P708, DOI 10.2337/diacare.18.5.708; Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; Borch-Johnsen K, 1999, LANCET, V354, P617; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Davidson MB, 2003, DIABETES CARE, V26, P3329, DOI 10.2337/diacare.26.12.3329; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Fisman EZ, 2001, AM HEART J, V141, P485, DOI 10.1067/mhj.2001.113219; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; Harris MI, 1997, DIABETES CARE, V20, P1859, DOI 10.2337/diacare.20.12.1859; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Lindsberg PJ, 2004, STROKE, V35, P363, DOI 10.1161/01.STR.0000115297.92132.84; PYORALA K, 1987, Diabetes Metabolism Reviews, V3, P463; Qureshi AI, 1998, STROKE, V29, P1329, DOI 10.1161/01.STR.29.7.1329; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Tuomilehto J, 1996, STROKE, V27, P210, DOI 10.1161/01.STR.27.2.210; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x	28	60	67	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2005	142	10					813	820		10.7326/0003-4819-142-10-200505170-00006	http://dx.doi.org/10.7326/0003-4819-142-10-200505170-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926CE	15897531				2022-12-24	WOS:000229099600002
J	Wahlund, JE; Bostrom, R; Gustafsson, G; Gurnett, DA; Kurth, WS; Pedersen, A; Averkamp, TF; Hospodarsky, GB; Persoon, AM; Canu, P; Neubauer, FM; Dougherty, MK; Eriksson, AI; Morooka, MW; Gill, R; Andre, M; Eliasson, L; Muller-Wodarg, I				Wahlund, JE; Bostrom, R; Gustafsson, G; Gurnett, DA; Kurth, WS; Pedersen, A; Averkamp, TF; Hospodarsky, GB; Persoon, AM; Canu, P; Neubauer, FM; Dougherty, MK; Eriksson, AI; Morooka, MW; Gill, R; Andre, M; Eliasson, L; Muller-Wodarg, I			Cassini measurements of cold plasma in the ionosphere of Titan	SCIENCE			English	Article							WAVE OBSERVATIONS; MARS; MAGNETOSPHERE; SATURN; RADIO	The Cassini Radio and Plasma Wave Science (RPWS) Langmuir probe (LP) sensor observed the cold plasma environment around Titan during the first two flybys. The data show that conditions in Saturn's magnetosphere affect the structure and dynamics deep in the ionosphere of Titan. The maximum measured ionospheric electron number density reached 3800 per cubic centimeter near closest approach, and a complex chemistry was indicated. The electron temperature profiles are consistent with electron heat conduction from the hotter Titan wake. The ionospheric escape flux was estimated to be 10(25) ions per second.	Swedish Inst Space Phys, SE-75121 Uppsala, Sweden; Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Univ Oslo, Dept Phys, NO-0316 Oslo, Norway; Inst Pierre Simon Laplace, CNRS, Ctr Etud Environm Terr & Planetaires, F-78140 Velizy Villacoublay, France; Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BW, England; Swedish Inst Space Phys, SE-98128 Kiruna, Sweden	University of Iowa; University of Oslo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Cologne; Imperial College London	Wahlund, JE (corresponding author), Swedish Inst Space Phys, Box 537, SE-75121 Uppsala, Sweden.	jwe@irfu.se	Kurth, William/AAA-7334-2019; Eriksson, Anders I/C-2887-2009; Mueller-Wodarg, Ingo C. F./M-9945-2014; Hospodarsky, George B/A-7996-2015; Wahlund, Jan-Erik/AAL-6439-2021; Morooka, Michiko/AAO-8594-2020	Kurth, William/0000-0002-5471-6202; Eriksson, Anders I/0000-0003-2926-6761; Mueller-Wodarg, Ingo C. F./0000-0001-6308-7826; Hospodarsky, George B/0000-0001-9200-9878; Morooka, Michiko/0000-0001-9958-0241				Backes H, 2005, SCIENCE, V308, P992, DOI 10.1126/science.1109763; BACKES H, 2004, AM GEOPH UN FALL M S; Blanc M, 2002, SPACE SCI REV, V104, P253, DOI 10.1023/A:1023605110711; COATES A, 2004, AM GEOPH UN FALL M S; CRAVENS TE, UNPUB; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; Gurnett DA, 2004, SPACE SCI REV, V114, P395, DOI 10.1007/s11214-004-1434-0; GURNETT DA, 1982, J GEOPHYS RES-SPACE, V87, P1395, DOI 10.1029/JA087iA03p01395; Kallio E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020344; KELLER CN, 1994, J GEOPHYS RES-SPACE, V99, P6527, DOI 10.1029/93JA02681; Ledvina SA, 2004, ADV SPACE RES-SERIES, V33, P2092, DOI 10.1016/j.asr.2003.07.056; Lundin R, 2004, ADV SPACE RES-SERIES, V33, P1945, DOI 10.1016/j.asr.2003.07.054; Nagy AF, 2004, SPACE SCI REV, V111, P33, DOI 10.1023/B:SPAC.0000032718.47512.92; Nagy AF, 2001, J GEOPHYS RES-SPACE, V106, P6151, DOI 10.1029/2000JA000183; ROBOZ A, 1994, J GEOPHYS RES-SPACE, V99, P2087, DOI 10.1029/93JA02286; Vignes D, 2000, GEOPHYS RES LETT, V27, P49, DOI 10.1029/1999GL010703	16	163	163	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					986	989		10.1126/science.1109807	http://dx.doi.org/10.1126/science.1109807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15894529				2022-12-24	WOS:000229190700035
J	Marcus, GM; Gerber, IL; McKeown, BH; Vessey, JC; Jordan, MV; Huddleston, M; McCulloch, CE; Foster, E; Chatterjee, K; Michaels, AD				Marcus, GM; Gerber, IL; McKeown, BH; Vessey, JC; Jordan, MV; Huddleston, M; McCulloch, CE; Foster, E; Chatterjee, K; Michaels, AD			Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							JUGULAR VENOUS-PRESSURE; INTEROBSERVER AGREEMENT; NATRIURETIC PEPTIDE; GALLOP SOUNDS; FAILURE; AUSCULTATION; DISEASE; FLOW	Context The third (S-3) and fourth (S-4) heart sounds detected by phonocardiography are considered to represent the criterion standards of the gallop sounds, but their test characteristics have not been explored. Objective To determine the diagnostic test characteristics of the S-3 and S-4 for prediction of left ventricular dysfunction using a computerized heart sound detection algorithm. Design, Setting, and Participants Prospective study of 90 adult patients undergoing elective left-sided heart catheterization at a single US teaching hospital between August 2003 and June 2004. The mean age was 62 (SD, 13) years (range, 24-90 years) and 61 (68%) were male. Within a 4-hour period, participants underwent computerized heart sound phonocardiographic analysis, cardiac catheterization, transthoracic echocardiography, and blood sampling for assessment of an S-3/S-4, left ventricular end-diastolic pressure (LVEDP), left ventricular ejection fraction (LVEF), and B-type natriuretic peptide (BNP), respectively. Main Outcome Measures Diagnostic test characteristics of the computerized phonocardiographic S-3 and S-4 using markers of left ventricular function as criterion standards. Results Mean (SD) LVEDP was significantly elevated (18.4 [6.9] mm Hg vs 12.1 [7.3] mm Hg; P<.001), mean (SD) LVEF was reduced (49.4% [20.2%] vs 63.6% (14.8%]; P<.001), and median (interquartile range) BNP was elevated (330 [98-1155] pg/mL vs 86 [41-192] pg/mL; P<.001) in those with an S-3, S-4, or both compared with patients without a diastolic heart sound. The sensitivities of these heart sounds to detect an elevated LVEDP, reduced LVEF, or elevated BNP were 41%, 52%, and 32% for an S-3, and 46%, 43 %, and 40% for an S-4, respectively. For abnormal levels of the same markers of ventricular function, the specificities of the S-3 were 92 %, 87%, and 92 %, while the specificities of the S-4 were 80%, 72%, and 78%, respectively. Conclusions Neither the phonocardiographic S-3 nor the S-4 is a sensitive marker of left ventricular dysfunction. The phonocardiographic S-3 is specific for left ventricular dysfunction and appears to be superior to the moderate specificity of the phonocardiographic S-4.	Univ Calif San Francisco, Med Ctr, Div Cardiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Michaels, AD (corresponding author), Univ Calif San Francisco, Med Ctr, Div Cardiol, 505 Parnassus Ave,Box 0124, San Francisco, CA 94143 USA.	andrewm@medicine.ucsf.edu	Marcus, Gregory/AAN-8584-2021	Marcus, Gregory/0000-0001-5197-7696	NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR018319] Funding Source: NIH RePORTER; NCRR NIH HHS [K23 RR018319-01 A1] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AREVALO F, 1964, AM J PHYSIOL, V207, P319, DOI 10.1152/ajplegacy.1964.207.2.319; BAIM DS, 2000, GROSSMANS CARDIAC CA; Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641; Drazner MH, 2003, AM J MED, V114, P431, DOI 10.1016/S0002-9343(03)00058-5; GLOWER DD, 1992, J AM COLL CARDIOL, V19, P450, DOI 10.1016/0735-1097(92)90504-G; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HARLAN WR, 1977, ANN INTERN MED, V86, P133, DOI 10.7326/0003-4819-86-2-133; HOMMA S, 1991, CLIN CARDIOL, V14, P671, DOI 10.1002/clc.4960140809; ISHMAIL AA, 1987, CHEST, V91, P870, DOI 10.1378/chest.91.6.870; KONO T, 1993, J AM COLL CARDIOL, V21, P419, DOI 10.1016/0735-1097(93)90684-S; KUPARI M, 1994, CIRCULATION, V89, P1189, DOI 10.1161/01.CIR.89.3.1189; Lok CE, 1998, CHEST, V114, P1283, DOI 10.1378/chest.114.5.1283; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; MAISEL AS, 1985, J AM COLL CARDIOL, V6, P731, DOI 10.1016/S0735-1097(85)80474-5; Mangione S, 1997, JAMA-J AM MED ASSOC, V278, P717, DOI 10.1001/jama.278.9.717; MANSON AL, 1995, CIRCULATION, V92, P388, DOI 10.1161/01.CIR.92.3.388; Marcus GM, 2004, AM J CARDIOL, V93, P1312, DOI 10.1016/j.amjcard.2004.01.074; OZAWA Y, 1983, CIRCULATION, V67, P399, DOI 10.1161/01.CIR.67.2.399; PATEL R, 1993, WESTERN J MED, V158, P606; Potain P., 1880, GAZ D HOP, V53, P529; RIHAL CS, 1995, AM J CARDIOL, V75, P220, DOI 10.1016/0002-9149(95)80023-L; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SHAH PM, 1968, NEW ENGL J MED, V278, P753, DOI 10.1056/NEJM196804042781402; STEFADOUROS MA, 1980, ARCH INTERN MED, V140, P537, DOI 10.1001/archinte.140.4.537; VANDEWERF F, 1984, J CLIN INVEST, V73, P1400, DOI 10.1172/JCI111344	25	81	99	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2238	2244		10.1001/jama.293.18.2238	http://dx.doi.org/10.1001/jama.293.18.2238			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886379				2022-12-24	WOS:000228981100025
J	Murray, SA; Kendall, M; Boyd, K; Sheikh, A				Murray, SA; Kendall, M; Boyd, K; Sheikh, A			Illness trajectories and palliative care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PROSPECTIVE QUALITATIVE INTERVIEW; LUNG-CANCER; PEOPLE; LIFE; FAILURE; END		Univ Edinburgh, Gen Practice Sect, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Gen Practice Sect, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland.	Scott.Murray@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Boyd, Kirsty/0000-0002-5526-1078				Asbring P, 2004, QUAL HEALTH RES, V14, P226, DOI 10.1177/1049732303260682; BALLAM M, 2001, CUMULATIVE TRIVIA EX; BUCTOW S, 2001, PATIENT EDUC COUNS, V45, P181; Burke S O, 2000, Can J Nurs Res, V32, P19; CASSELL EJ, 1991, NATURE SUFFERING; Ellershaw JE, 2003, CARE DYING PATHWAY E; GLARE PA, 2004, OXFORD TXB PALLIATIV; Hardin SB, 2004, ARCH INTERN MED, V164, P1531, DOI 10.1001/archinte.164.14.1531; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Higgs R, 1999, J ROY COLL PHYS LOND, V33, P110; KITE S, 2001, PALLIATIVE MED, V15, P413; Lehman R, 2004, BRIT J GEN PRACT, V54, P892; Levenson JW, 2000, J AM GERIATR SOC, V48, pS101, DOI 10.1111/j.1532-5415.2000.tb03119.x; LUNNEY JR, 2003, JAMA-J AM MED ASSOC, V298, P2387; Lynn J, 2000, JAMA-J AM MED ASSOC, V284, P2508, DOI 10.1001/jama.284.19.2508; Lynn J, 2003, LIVING WELL END LIFE; McKinley RK, 2004, BRIT J GEN PRACT, V54, P909; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murtagh FEM, 2004, CLIN MED, V4, P39, DOI 10.7861/clinmedicine.4-1-39; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Thomas K., 2003, CARING DYING HOME CO; WILLIAMS R, 1992, SOC SCI MED, V34, P763, DOI 10.1016/0277-9536(92)90363-U; World Health Organization, 2004, PALL CAR SOL FACTS	24	828	836	4	54	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2005	330	7498					1007	1011		10.1136/bmj.330.7498.1007	http://dx.doi.org/10.1136/bmj.330.7498.1007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15860828	Green Published, Green Submitted			2022-12-24	WOS:000228935100024
J	Minamimoto, T; Hori, Y; Kimura, M				Minamimoto, T; Hori, Y; Kimura, M			Complementary process to response bias in the centromedian nucleus of the thalamus	SCIENCE			English	Article							CM-PF COMPLEX; BASAL GANGLIA; ANTERIOR CINGULATE; NEURONAL SIGNALS; DOPAMINE NEURONS; PARIETAL CORTEX; REWARD; PREDICTION; MOTIVATION; DECISION	Activity in several areas of the human brain and the monkey brain increases when a subject anticipates events associated with a reward, implicating a role for bias of decision and action. However, in real life, events do not always appear as expected, and we must choose an undesirable action, More than half of the neurons in the monkey centromedian (CM) thalamus were selectively activated when a small-reward action was required but a Large-reward option was anticipated. Electrical stimulation of the CM after a large-reward action request substituted a brisk performance with a sluggish performance. These results suggest involvement of the CM in a mechanism complementary to decision and action bias.	Kyoto Prefectural Univ Med, Dept Physiol, Kamigyo Ku, Kyoto 6028566, Japan	Kyoto Prefectural University of Medicine	Kimura, M (corresponding author), Kyoto Prefectural Univ Med, Dept Physiol, Kamigyo Ku, Kyoto 6028566, Japan.	mkimura@koto.kpu-m.ac.jp	Minamimoto, Takafumi/AAD-8726-2020; Minamimoto, Takafumi/D-6610-2012	Minamimoto, Takafumi/0000-0003-4305-0174; Minamimoto, Takafumi/0000-0003-4305-0174				Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; Hatanaka N, 2003, J COMP NEUROL, V462, P121, DOI 10.1002/cne.10720; HERMSTEIN RJ, 1961, J EXPT ANAL BEHAV, V4, P267; Kimura M, 2004, NEUROSCI RES, V48, P355, DOI 10.1016/j.neures.2003.12.002; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Minamimoto T, 2002, J NEUROPHYSIOL, V87, P3090, DOI 10.1152/jn.2002.87.6.3090; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shidara M, 1998, J NEUROSCI, V18, P2613; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; STERIADE M, 1997, THALAMUS, V1, P55; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; THORNDIKE EL, 1898, ANIMAL INTELLIGENCE; Watanabe M, 2001, EXP BRAIN RES, V140, P511, DOI 10.1007/s002210100856	24	97	102	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1798	1801		10.1126/science.1109154	http://dx.doi.org/10.1126/science.1109154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961671				2022-12-24	WOS:000229926800058
J	Sipkins, DA; Wei, XB; Wu, JW; Runnels, JM; Cote, D; Means, TK; Luster, AD; Scadden, DT; Lin, CP				Sipkins, DA; Wei, XB; Wu, JW; Runnels, JM; Cote, D; Means, TK; Luster, AD; Scadden, DT; Lin, CP			In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment	NATURE			English	Article							CHEMOKINE RECEPTOR CXCR4; STEM-CELLS; ADHESION MOLECULES; NOD/SCID MICE; CANCER-CELLS; PRECURSOR-B; EXPRESSION; LEUKEMIA; MICROVESSELS; VOLUNTEERS	The organization of cellular niches is known to have a key role in regulating normal stem cell differentiation and regeneration, but relatively little is known about the architecture of microenvironments that support malignant metastasis(1,2). Using dynamic in vivo confocal imaging, here we show that murine bone marrow contains unique anatomic regions defined by specialized endothelium. This vasculature expresses the adhesion molecule E-selectin and the chemoattractant stromal-cell-derived factor 1 (SDF-1) in discrete, discontinuous areas that influence the homing of a variety of tumour cell lines. Disruption of the interactions between SDF-1 and its receptor CXCR4 inhibits the homing of Nalm-6 cells (an acute lymphoblastic leukaemia cell line) to these vessels. Further studies revealed that circulating leukaemic cells can engraft around these vessels, suggesting that this molecularly distinct vasculature demarcates a microenvironment for early metastatic tumour spread in bone marrow. Finally, purified haematopoietic stem/progenitor cells and lymphocytes also localize to the same microdomains, indicating that this vasculature might also function in benign states to demarcate specific portals for the entry of cells into the marrow space. Specialized vascular structures therefore appear to delineate a microenvironment with unique physiology that can be exploited by circulating malignant cells.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med & Technol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Hematol Oncol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp E, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University	Lin, CP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, 55 Fruit St, Boston, MA 02114 USA.	dsipkins1@partners.org; lin@helix.mgh.harvard.edu	Luster, Andrew/ABE-6504-2020; Côté, Daniel/D-5185-2011	Luster, Andrew/0000-0001-9679-7912; 	NCI NIH HHS [T32 CA071345, P50 CA086355] Funding Source: Medline; NEI NIH HHS [R01 EY014106] Funding Source: Medline; NIBIB NIH HHS [R01 EB000664] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000664] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Burger JA, 2002, LEUKEMIA LYMPHOMA, V43, P461, DOI 10.1080/10428190290011921; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; CRISTY M, 1981, PHYS MED BIOL, V26, P389, DOI 10.1088/0031-9155/26/3/003; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; HONN KV, 1992, CANCER METAST REV, V11, P353, DOI 10.1007/BF01307187; Jo DY, 2003, BRIT J HAEMATOL, V121, P649, DOI 10.1046/j.1365-2141.2003.04326.x; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mastro AM, 2003, CLIN EXP METASTAS, V20, P275, DOI 10.1023/A:1022995403081; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Novak J, 2004, OPT LETT, V29, P77, DOI 10.1364/OL.29.000077; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; REUSSBORST MA, 1995, LEUKEMIA, V9, P869; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; Shen W, 2001, EXP HEMATOL, V29, P1439, DOI 10.1016/S0301-472X(01)00741-X; Spano JP, 2004, ANN ONCOL, V15, P613, DOI 10.1093/annonc/mdh136; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693	30	640	679	3	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					969	973		10.1038/nature03703	http://dx.doi.org/10.1038/nature03703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959517	Green Accepted			2022-12-24	WOS:000229799700052
J	Blumberg, HM; Leonard, MK; Jasmer, RM				Blumberg, HM; Leonard, MK; Jasmer, RM			Update on the treatment of tuberculosis and latent tuberculosis infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RIFAMPIN PREVENTIVE THERAPY; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; TREATMENT COMPLETION; PYRAZINAMIDE; HEPATOTOXICITY; TWICE; ACCEPTABILITY; RIFAPENTINE; EXPERIENCE	Tuberculosis (TB) has emerged as a global public health epidemic. Despite decreasing numbers of cases in the United States since 1992, TB remains a serious public health problem among certain patient populations and is highly prevalent in many urban areas. The responsibility for prescribing an appropriate drug regimen and ensuring that treatment is completed is assigned to the public health program or the clinician not to the patient. The initial prescribed regimen for the treatment of TB usually consists of 4 drugs: isoniazid, rifampin, pyrazinamide, and ethambutol. The minimum length for the treatment of drug-susceptible TB with a rifampin-based regimen is 6 to 9 months. Providing medications directly to the patient and watching him/ her swallow the anti-TB drugs, which is termed directly observed therapy, is recommended for all patients diagnosed with TB and can help ensure higher completion rates, prevent the emergence of drug resistant TB, and enhance TB control. There has been renewed interest in the treatment of those with latent TB infection as a TB-control strategy in the United States for eliminating the large reservoir of individuals at risk for progression to TB. The 2 broad categories of persons who should be tested for latent TB infection are those who are likely to have been recently infected (such as contacts to infectious TB cases) and persons who are at increased risk of progression to TB disease following infection with Mycobacterium tuberculosis (eg, human immunodeficiency virus infection and selected medical conditions; recent immigrants to the United States from high TB-burden countries). The preferred regimen for the treatment of latent TB infection is 9 months of isoniazid. There is now renewed interest in and great need for the development of new drugs to treat TB and latent TB infection.	Emory Univ, Sch Med, Div Infect Dis, Dept Med, Atlanta, GA 30303 USA; Grady Mem Hosp, Dept Epidemiol, Atlanta, GA USA; Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA USA	Emory University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Blumberg, HM (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Dept Med, 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	henry.m.blumberg@emory.edu	Blumberg, Henry/W-2156-2019	Blumberg, Henry/0000-0002-3110-2443	FIC NIH HHS [D43TW007124] Funding Source: Medline; NHLBI NIH HHS [K07 HL03078] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K07HL003078] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P245; [Anonymous], 1948, BMJ-BRIT MED J, V2, P769; Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Blumberg HM, 2004, CLIN INFECT DIS, V39, P1772, DOI 10.1086/425620; Bock NN, 2001, CHEST, V119, P833, DOI 10.1378/chest.119.3.833; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Burman WJ, 2005, CLIN CHEST MED, V26, P283, DOI 10.1016/j.ccm.2005.02.002; BYRD RB, 1979, JAMA-J AM MED ASSOC, V241, P1239, DOI 10.1001/jama.241.12.1239; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P37; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P735; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P214; Chaisson RE, 2002, JAMA-J AM MED ASSOC, V288, P165, DOI 10.1001/jama.288.2.165; Chaulk CP, 1998, JAMA-J AM MED ASSOC, V279, P943, DOI 10.1001/jama.279.12.943; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FOX W, 1986, AM REV RESPIR DIS, V133, P779; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Gordin FM, 2004, CLIN INFECT DIS, V39, P561, DOI 10.1086/422724; GROSS PA, 1994, CLIN INFECT DIS, V18, P428, DOI 10.1093/clinids/18.3.428; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; *I MED, 2000, END NEGL EL TUB US; Jasmer RM, 2002, ANN INTERN MED, V137, P640, DOI 10.7326/0003-4819-137-8-200210150-00007; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lee AM, 2002, INT J TUBERC LUNG D, V6, P995; Leung CC, 2003, CHEST, V124, P2112, DOI 10.1378/chest.124.6.2112; Lobato MN, 2005, CHEST, V127, P1296, DOI 10.1378/chest.127.4.1296; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Mazurek Gerald H, 2003, MMWR Recomm Rep, V52, P15; McNeill L, 2003, CHEST, V123, P102, DOI 10.1378/chest.123.1.102; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; Nolan CM, 2003, AM J RESP CRIT CARE, V168, P412, DOI 10.1164/rccm.2306004; O'Brien RJ, 2005, CLIN CHEST MED, V26, P327, DOI 10.1016/j.ccm.2005.02.013; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Polesky A, 1996, AM J RESP CRIT CARE, V154, P1473, DOI 10.1164/ajrccm.154.5.8912767; Priest DH, 2004, CLIN INFECT DIS, V39, P1764, DOI 10.1086/425610; Saiman L, 2004, PEDIATRICS, V114, P1175, DOI 10.1542/peds.2004-0809; Sotir MJ, 1999, CLIN INFECT DIS, V29, P1138, DOI 10.1086/313453; *TB ALL, GLOB ALL TB DRUG DEV; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tortajada C, 2005, INT J TUBERC LUNG D, V9, P276; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; Villarino ME, 1997, AM J RESP CRIT CARE, V155, P1735, DOI 10.1164/ajrccm.155.5.9154885; *WHO, 2004, GLOB TUB CONTR SURV	59	119	127	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2776	2784		10.1001/jama.293.22.2776	http://dx.doi.org/10.1001/jama.293.22.2776			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933OV	15941808				2022-12-24	WOS:000229643700027
J	Butler, D				Butler, D			China rejects Internet claims of human cases	NATURE			English	News Item								Reports that the outbreak of avian influenza among wild birds in Qinghai has resulted in any human cases of the disease are being denied by China. Rumours that people had been infected began when the ProMED-mail Internet alert system relayed a translation of an article from the independent Chinese website BoxunNews, which is based in the United States. ProMED warned that the informationwas unofficial and needed to be confirmed.											0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2005	435	7042					542	543						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15954220				2022-12-24	WOS:000229476200005
J	Choi, MH; Lee, IK; Kim, GW; Kim, BU; Han, YH; Yu, DY; Park, HS; Kim, KY; Lee, JS; Choi, CH; Bae, YS; Lee, BI; Rhee, SG; Kang, SW				Choi, MH; Lee, IK; Kim, GW; Kim, BU; Han, YH; Yu, DY; Park, HS; Kim, KY; Lee, JS; Choi, CH; Bae, YS; Lee, BI; Rhee, SG; Kang, SW			Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II	NATURE			English	Article							CYSTEINE-SULFINIC ACID; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; MAMMALIAN PEROXIREDOXIN; SITE CYSTEINE; ACTIVATION; MECHANISM; REQUIRES; RECEPTOR	Platelet-derived growth factor ( PDGF) is a potent mitogenic and migratory factor that regulates the tyrosine phosphorylation of a variety of signalling proteins via intracellular production of H2O2 (refs 1 - 3). Mammalian 2-Cys peroxiredoxin type II ( Prx II; gene symbol Prdx2) is a cellular peroxidase that eliminates endogenous H2O2 produced in response to growth factors such as PDGF and epidermal growth factor(4); however, its involvement in growth factor signalling is largely unknown. Here we show that Prx II is a negative regulator of PDGF signalling. Prx II deficiency results in increased production of H2O2, enhanced activation of PDGF receptor ( PDGFR) and phospholipase C gamma 1, and subsequently increased cell proliferation and migration in response to PDGF. These responses are suppressed by expression of wild-type Prx II, but not an inactive mutant. Notably, Prx II is recruited to PDGFR upon PDGF stimulation, and suppresses protein tyrosine phosphatase inactivation. Prx II also leads to the suppression of PDGFR activation in primary culture and a murine restenosis model, including PDGF-dependent neointimal thickening of vascular smooth muscle cells. These results demonstrate a localized role for endogenous H2O2 in PDGF signalling, and indicate a biological function of Prx II in cardiovascular disease.	Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; Yonsei Univ, Coll Med, Dept Neurol, Seoul 120752, South Korea; Korea Res Inst Biosci & Biotechnol, Lab Human Genom, Taejon 305333, South Korea; Labfrontier Co Ltd, Inst Life Sci, Suwon 442766, Kyunggi Do, South Korea; NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA; Korea Adv Inst Sci & Technol, Dept Biosyst, Taejon 305701, South Korea	Ewha Womans University; Ewha Womans University; Yonsei University; Yonsei University Health System; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Korea Advanced Institute of Science & Technology (KAIST)	Rhee, SG (corresponding author), Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea.	sgrhee@nih.gov	Choi, Chulhee/C-1642-2011	Choi, Chulhee/0000-0001-5542-9136				Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Baxter RM, 1998, J BIOL CHEM, V273, P17050, DOI 10.1074/jbc.273.27.17050; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kang SW, 2004, J BIOL CHEM, V279, P2535, DOI 10.1074/jbc.M307698200; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Ohmi K, 1997, BIOCHEM BIOPH RES CO, V238, P154, DOI 10.1006/bbrc.1997.7218; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rosado JA, 2004, J BIOL CHEM, V279, P1665, DOI 10.1074/jbc.M307963200; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Saito S, 2002, J BIOL CHEM, V277, P44695, DOI 10.1074/jbc.M208332200; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Sekiya F, 2004, J BIOL CHEM, V279, P32181, DOI 10.1074/jbc.M405116200; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	23	310	326	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					347	353		10.1038/nature03587	http://dx.doi.org/10.1038/nature03587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902258				2022-12-24	WOS:000229185000046
J	Dworkin, MS				Dworkin, MS			Adults are whooping, but are internists listening?	ANNALS OF INTERNAL MEDICINE			English	Article							BORDETELLA-PERTUSSIS INFECTION; UNITED-STATES; PERSISTENT COUGH; ADOLESCENTS; OUTBREAK; EPIDEMIOLOGY; AZITHROMYCIN; PROPHYLAXIS; PREVALENCE; ILLNESS	Although studies have shown that pertussis is responsible for approximately 20% to 30% of cases of cough lasting more than 2 weeks in adults and adolescents, physicians have generally considered pertussis a disease that affects only children. Epidemiologic trends demonstrate that the incidence of pertussis has been rising, especially in adolescents and adults. Consequently, pertussis is not a "zebra" diagnosis but deserves a place among the community-acquired list of adult pathogens. Increased awareness among physicians about pertussis is important because adults may transmit the infection to infants, in whom the disease often leads to hospitalization and may result in death. Reporting this disease to the local health department is critical to its control because both case-patients and their close contacts should receive antimicrobial prophylaxis. A booster vaccine for adolescents and adults is likely to become available in the near future, so this is an important time to ensure that all physicians, not just pediatricians, are knowledgeable about the diagnosis, treatment, and reporting requirements for pertussis.	Illinois Dept Publ Hlth, Chicago, IL 60601 USA		Dworkin, MS (corresponding author), Illinois Dept Publ Hlth, 160 N LaSalle,7th Floor, Chicago, IL 60601 USA.	mdworkin@idph.state.il.us						ADDISS DG, 1991, J INFECT DIS, V164, P704, DOI 10.1093/infdis/164.4.704; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Baughman AL, 2004, CLIN DIAGN LAB IMMUN, V11, P1045, DOI 10.1128/CDLI.11.6.1045-1053.2004; Centers for Disease Control and Prevention (CDC) HIPAA Privacy Rule and Public Health, 2003, MMWR-MORBID MORTAL W, V52, P1; Cherry JD, 2004, CLIN INFECT DIS, V39, P1715, DOI 10.1086/425003; Cherry JD, 1998, ANN INTERN MED, V128, P64, DOI 10.7326/0003-4819-128-1-199801010-00010; Cloud JL, 2002, J CLIN MICROBIOL, V40, P3838, DOI 10.1128/JCM.40.10.3838-3840.2002; Dworkin MS, 1998, ANN INTERN MED, V128, P1047, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00025; DWORKIN MS, 2004, P 42 ANN M INF DIS S; DWORKIN MS, 1997, P 31 ANN NAT IMM C D; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; HERWALDT LA, 1991, ARCH INTERN MED, V151, P1510, DOI 10.1001/archinte.151.8.1510; HODDER SL, 1992, EPIDEMIOL REV, V14, P243, DOI 10.1093/oxfordjournals.epirev.a036089; Klass P, 2004, NEW ENGL J MED, V350, P2023, DOI 10.1056/NEJMp038243; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; Langley JM, 2004, PEDIATRICS, V114, pE96, DOI 10.1542/peds.114.1.e96; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Mannerstedt G, 1934, J PEDIATR-US, V5, P596, DOI 10.1016/S0022-3476(34)80039-X; Marchant CD, 2004, CLIN INFECT DIS, V39, P1581, DOI 10.1086/425012; Martinez SM, 2001, INFECT CONT HOSP EP, V22, P781, DOI 10.1086/501863; MINK CM, 1992, CLIN INFECT DIS, V14, P464, DOI 10.1093/clinids/14.2.464; MORSE SI, 1968, ANN INTERN MED, V68, P953, DOI 10.7326/0003-4819-68-4-953; Nennig ME, 1996, JAMA-J AM MED ASSOC, V275, P1672, DOI 10.1001/jama.275.21.1672; *OKL STAT DEP HLTH, 2004, 2003 ANN SUMM INF DI; POSTELSMULTANI S, 1995, INFECTION, V23, P139, DOI 10.1007/BF01793853; Purdy KW, 2004, CLIN INFECT DIS, V39, P20, DOI 10.1086/421091; ROBERTSON PW, 1987, MED J AUSTRALIA, V146, P522, DOI 10.5694/j.1326-5377.1987.tb120392.x; ROSENTHAL S, 1995, J INFECT DIS, V171, P1650, DOI 10.1093/infdis/171.6.1650; SCHMITTGROHE S, 1995, CLIN INFECT DIS, V21, P860, DOI 10.1093/clinids/21.4.860; Senzilet LD, 2001, CLIN INFECT DIS, V32, P1691, DOI 10.1086/320754; STEKETEE RW, 1988, J INFECT DIS, V157, P434, DOI 10.1093/infdis/157.3.434; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; WRIGHT SW, 1995, JAMA-J AM MED ASSOC, V273, P1044, DOI 10.1001/jama.273.13.1044; 1995, MMWR MORB MORTAL WKL, V44, P74; 1997, MMWR MORB MORTAL WKL, V46, P822; 2004, MMWR MORB MORTAL WKL, V53, P131; 2002, MMWR MORB MORTAL WKL, V51, P616; 2002, MMWR MORB MORTAL WKL, V51, P73	38	22	22	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2005	142	10					832	835		10.7326/0003-4819-142-10-200505170-00008	http://dx.doi.org/10.7326/0003-4819-142-10-200505170-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926CE	15897533				2022-12-24	WOS:000229099600004
J	Seynaeve, C; Brekelmans, CTM				Seynaeve, C; Brekelmans, CTM			Tailoring breast cancer therapy to genetic status	LANCET			English	Editorial Material							20-YEAR FOLLOW-UP; CONSERVING TREATMENT; GERMLINE MUTATIONS; LUMPECTOMY; MASTECTOMY; BRCA2; WOMEN		Dr Daniel den Hoed Canc Ctr, Erasmus MC, Dept Med Oncol, NL-3075 AE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Seynaeve, C (corresponding author), Dr Daniel den Hoed Canc Ctr, Erasmus MC, Dept Med Oncol, NL-3075 AE Rotterdam, Netherlands.	c.seynaeve@erasmusmc.nl						Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Haffty BG, 2002, LANCET, V359, P1471, DOI 10.1016/S0140-6736(02)08434-9; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Pierce LJ, 2000, J CLIN ONCOL, V18, P3360, DOI 10.1200/JCO.2000.18.19.3360; Robson M, 2005, CANCER, V103, P44, DOI 10.1002/cncr.20728; Seynaeve C, 2004, EUR J CANCER, V40, P1150, DOI 10.1016/j.ejca.2004.01.017; SEYNAEVE C, 2002, P ASCO, V21, pA426; Turner BC, 1999, J CLIN ONCOL, V17, P3017, DOI 10.1200/JCO.1999.17.10.3017; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989	9	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1672	1673		10.1016/S0140-6736(05)66528-2	http://dx.doi.org/10.1016/S0140-6736(05)66528-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894086				2022-12-24	WOS:000229082300008
J	Flasar, FM; Achterberg, RK; Conrath, BJ; Gierasch, PJ; Kunde, VG; Nixon, CA; Bjoraker, GL; Jennings, DE; Romani, PN; Simon-Miller, AA; Bezard, B; Coustenis, A; Irwin, PGJ; Teanby, NA; Brasunas, J; Pearl, JC; Segura, ME; Carlson, RC; Mamoutkine, A; Schinder, PJ; Barucci, A; Courtin, R; Fouchet, T; Gautier, D; Lellouch, E; Marten, A; Prange, R; Vinatier, S; Strobel, DF; Calcutt, SB; Read, PL; Taylor, FW; Bowles, N; Samuelson, RE; Orton, GS; Spilker, LJ; Owen, TC; Spencer, JR; Showalter, MR; Ferrari, C; Abbas, MM; Raulin, F; Edgington, S; Ade, P; Wishnow, EH				Flasar, FM; Achterberg, RK; Conrath, BJ; Gierasch, PJ; Kunde, VG; Nixon, CA; Bjoraker, GL; Jennings, DE; Romani, PN; Simon-Miller, AA; Bezard, B; Coustenis, A; Irwin, PGJ; Teanby, NA; Brasunas, J; Pearl, JC; Segura, ME; Carlson, RC; Mamoutkine, A; Schinder, PJ; Barucci, A; Courtin, R; Fouchet, T; Gautier, D; Lellouch, E; Marten, A; Prange, R; Vinatier, S; Strobel, DF; Calcutt, SB; Read, PL; Taylor, FW; Bowles, N; Samuelson, RE; Orton, GS; Spilker, LJ; Owen, TC; Spencer, JR; Showalter, MR; Ferrari, C; Abbas, MM; Raulin, F; Edgington, S; Ade, P; Wishnow, EH			Titan's atmospheric temperatures, winds, and composition	SCIENCE			English	Article							HETERODYNE OBSERVATIONS; VERTICAL PROFILE; POLAR VORTEX; PHOTOCHEMISTRY; OCCULTATION; STRATOSPHERE; MILLIMETER; CHEMISTRY; DYNAMICS; SYSTEM	Temperatures obtained from early Cassini infrared observations of Titan show a stratopause at an altitude of 310 kilometers (and 186 kelvin at 15 degrees S). Stratospheric temperatures are coldest in the winter northern hemisphere, with zonal winds reaching 160 meters per second. The concentrations of several stratospheric organic compounds are enhanced at mid- and high northern latitudes, and the strong zonal winds may, inhibit mixing between these latitudes and the rest of Titan. Above the south pole, temperatures in the stratosphere are 4 to 5 kelvin cooler than at the equator. The stratospheric mole fractions of methane and carbon monoxide are (1.6 +/- 0.5) x 10(-2) and (4.5 +/- 1.5) x 10(-5), respectively.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Sci Syst & Applicat, Lanham, MD 20706 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Observ Paris, LESIA, CNRS, UMR 8109, F-91925 Meudon, France; Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; QSS Grp, Lanham, MD 20706 USA; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Search Extraterr Intelligence Inst, Mountain View, CA 94043 USA; CEA, Serv Astrophys, F-91191 Gif Sur Yvette, France; NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; Univ Paris 07, Lab Interuniv Syst Atmospher, CNRS, UMR 7583, F-94010 Creteil, France; Univ Paris 12, Lab Interuniv Syst Atmospher, CNRS, UMR 7583, F-94010 Creteil, France; Univ Cardiff, Dept Phys & Astron, Cardiff CF24 3YB, S Glam, Wales; Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; Univ Calif Berkeley, Space Sci Lab, Livermore, CA 94551 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Cornell University; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Oxford; Johns Hopkins University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hawaii System; CEA; UDICE-French Research Universities; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Cardiff University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley	Flasar, FM (corresponding author), NASA, Goddard Space Flight Ctr, Code 693, Greenbelt, MD 20771 USA.	f.m.flasar@nasa.gov	Ferrari, Cécile/P-9735-2016; Vinatier, Sandrine/AAB-8763-2019; Simon, Amy/C-8020-2012; Fouchet, Thierry/C-6374-2017; brasunas, john/I-2798-2013; Strobel, Darrell5/AAO-6643-2021; Jennings, Donald/D-7978-2012; Flasar, F Michael/C-8509-2012; Romani, Paul N/D-2729-2012; Bjoraker, Gordon L/D-5032-2012; Nixon, Conor A/A-8531-2009; Orton, Glenn/AAD-9862-2020	Ferrari, Cécile/0000-0001-5962-7439; Vinatier, Sandrine/0000-0001-5541-2502; Simon, Amy/0000-0003-4641-6186; Fouchet, Thierry/0000-0001-9040-8285; Strobel, Darrell5/0000-0002-0944-8675; Nixon, Conor A/0000-0001-9540-9121; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Calcutt, Simon/0000-0002-0102-3170; Achterberg, Richard/0000-0002-7643-7626; Bezard, Bruno/0000-0002-5433-5661; Taylor, Fred/0000-0002-0675-9769; Teanby, Nicholas/0000-0003-3108-5775; Ade, Peter/0000-0002-5127-0401				BACMEISTER JT, 1995, J GEOPHYS RES-ATMOS, V100, P11669, DOI 10.1029/94JD02958; BEZARD B, 1995, ICARUS, V113, P267, DOI 10.1006/icar.1995.1023; BOUCHEZ AH, 2004, THESIS CALTECH; COUSTENIS A, 1995, ICARUS, V115, P126, DOI 10.1006/icar.1995.1084; Coustenis A, 2003, ICARUS, V161, P383, DOI 10.1016/S0019-1035(02)00028-3; COUSTENIS A, 1993, ICARUS, V102, P240, DOI 10.1006/icar.1993.1047; Flasar FM, 2005, SCIENCE, V307, P1247, DOI 10.1126/science.1105806; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; FLASAR FM, 1990, ICARUS, V85, P346, DOI 10.1016/0019-1035(90)90122-P; FLASAR FM, 1981, NATURE, V292, P693, DOI 10.1038/292693a0; Flasar FM, 1998, PLANET SPACE SCI, V46, P1125, DOI 10.1016/S0032-0633(97)00223-7; GURWELL MA, 1995, ICARUS, V117, P375, DOI 10.1006/icar.1995.1163; Hidayat T, 1998, ICARUS, V133, P109, DOI 10.1006/icar.1998.5908; Hourdin F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002282; HOURDIN F, 1995, ICARUS, V117, P358, DOI 10.1006/icar.1995.1162; HUBBARD WB, 1993, ASTRON ASTROPHYS, V269, P541; Hunten D.M, 1984, SATURN, P671; KUNDE V, 1996, SPIE P, P162; Lebonnois S, 2001, ICARUS, V152, P384, DOI 10.1006/icar.2001.6632; Lellouch E, 2003, ICARUS, V162, P125, DOI 10.1016/S0019-1035(02)00079-9; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; Marten A, 2002, ICARUS, V158, P532, DOI 10.1006/icar.2002.6897; Moses JI, 2000, ICARUS, V143, P244, DOI 10.1006/icar.1999.6270; Roe HG, 2004, ICARUS, V169, P440, DOI 10.1016/j.icarus.2004.01.002; Samuelson RE, 1997, PLANET SPACE SCI, V45, P959, DOI 10.1016/S0032-0633(97)00090-1; SCHOEBERL MR, 1991, SCIENCE, V251, P46, DOI 10.1126/science.251.4989.46; Sicardy B, 1999, ICARUS, V142, P357, DOI 10.1006/icar.1999.6219; STROBEL DF, 1982, PLANET SPACE SCI, V30, P839, DOI 10.1016/0032-0633(82)90116-7; TOUBLANC D, 1995, ICARUS, V113, P2, DOI 10.1006/icar.1995.1002; Wilson EH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002181; YELLE RV, 1991, ASTROPHYS J, V383, P380, DOI 10.1086/170796; YUNG YL, 1987, ICARUS, V72, P468, DOI 10.1016/0019-1035(87)90186-2; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	33	277	278	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					975	978		10.1126/science.1111150	http://dx.doi.org/10.1126/science.1111150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15894528				2022-12-24	WOS:000229190700032
J	Moore, P				Moore, P			Hot from the vent	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					235	235		10.1038/435235b	http://dx.doi.org/10.1038/435235b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889099	Bronze			2022-12-24	WOS:000229021100049
J	Wienholds, E; Kloosterman, WP; Miska, E; Alvarez-Saavedra, E; Berezikov, E; de Bruijn, E; Horvitz, HR; Kauppinen, S; Plasterk, RHA				Wienholds, E; Kloosterman, WP; Miska, E; Alvarez-Saavedra, E; Berezikov, E; de Bruijn, E; Horvitz, HR; Kauppinen, S; Plasterk, RHA			MicroRNA expression in zebrafish embryonic development	SCIENCE			English	Article								MicroRNAs (miRNAs) are small noncoding RNAs, about 21 nucleotides in length, that can regulate gene expression by base-pairing to partially complementary mRNAs. Regulation by miRNAs can play essential roles in embryonic development. We determined the temporal and spatial expression patterns of 115 conserved vertebrate miRNAs in zebrafish embryos by microarrays and by in situ hybridizations, using locked-nucleic acid-modified oligonucleotide probes. Most miRNAs were expressed in a highly tissue-specific manner during segmentation and later stages, but not early in development, which suggests that their role is not in tissue fate establishment but in differentiation or maintenance of tissue identity.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Univ Cambridge, Canc Res UK, Gurdon Inst, Wellcome Trust, Cambridge CB2 1QN, England; Univ Copenhagen, Inst Med Biochem & Genet, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen, Denmark	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Copenhagen	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	Berezikov, Eugene/D-3363-2013	Berezikov, Eugene/0000-0002-1145-2884; Miska, Eric/0000-0002-4450-576X				Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	8	1243	1367	3	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					310	311		10.1126/science.1114519	http://dx.doi.org/10.1126/science.1114519			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	15919954				2022-12-24	WOS:000230449800048
J	Theise, ND				Theise, ND			Now you see it, now you don't	NATURE			English	Editorial Material									Beth Israel Med Ctr, Div Digest Dis, New York, NY 10003 USA	Harvard University; Beth Israel Deaconess Medical Center	Theise, ND (corresponding author), Beth Israel Med Ctr, Div Digest Dis, 1st Ave & 16th St, New York, NY 10003 USA.							Kurakin A, 2005, DEV GENES EVOL, V215, P46, DOI 10.1007/s00427-004-0448-7; Theise ND, 2004, BLOOD CELL MOL DIS, V32, P17, DOI 10.1016/j.bcmd.2003.09.010; Theise ND, 2002, LEUKEMIA, V16, P542, DOI 10.1038/sj.leu.2402445	3	14	14	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2005	435	7046					1165	1165		10.1038/4351165a	http://dx.doi.org/10.1038/4351165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988502				2022-12-24	WOS:000230140500021
J	Thomas, DSG; Knight, M; Wiggs, GFS				Thomas, DSG; Knight, M; Wiggs, GFS			Remobilization of southern African desert dune systems by twenty-first century global warming	NATURE			English	Article							SOUTHWEST KALAHARI DESERT; DUNEFIELD ACTIVITY; MOBILITY; VARIABILITY; RAINFALL	Although desert dunes cover 5 per cent of the global land surface and 30 per cent of Africa, the potential impacts of twenty-first century global warming on desert dune systems are not well understood(1). The inactive Sahel and southern African dune systems, which developed in multiple arid phases since the last interglacial period(2), are used today by pastoral and agricultural systems(3,4) that could be disrupted if climate change alters twenty-first century dune dynamics. Empirical data and model simulations have established that the interplay between dune surface erodibility ( determined by vegetation cover and moisture availability) and atmospheric erosivity ( determined by wind energy) is critical for dunefield dynamics(5). This relationship between erodibility and erosivity is susceptible to climate-change impacts. Here we use simulations with three global climate models and a range of emission scenarios to assess the potential future activity of three Kalahari dunefields. We determine monthly values of dune activity by modifying and improving an established dune mobility index(6) so that it can account for global climate model data outputs. We find that, regardless of the emission scenario used, significantly enhanced dune activity is simulated in the southern dunefield by 2039, and in the eastern and northern dunefields by 2069. By 2099 all dunefields are highly dynamic, from northern South Africa to Angola and Zambia. Our results suggest that dunefields are likely to be reactivated ( the sand will become significantly exposed and move) as a consequence of twenty-first century climate warming.	Univ Oxford, Ctr Environm, Sch Geog & Environm, Oxford OX1 3QY, England; Univ Salford, Dept Earth & Life Sci, Manchester M5 4WT, Lancs, England	University of Oxford; University of Salford	Thomas, DSG (corresponding author), Univ Oxford, Ctr Environm, Sch Geog & Environm, S Parks Rd, Oxford OX1 3QY, England.	david.thomas@ouce.ox.ac.uk		Thomas, David/0000-0001-6867-5504; Wiggs, Giles/0000-0002-2131-0724				Bauer BO, 1998, J ARID ENVIRON, V39, P345, DOI 10.1006/jare.1998.0380; Bullard JE, 1997, EARTH SURF PROC LAND, V22, P165, DOI 10.1002/(SICI)1096-9837(199702)22:2&lt;165::AID-ESP687&gt;3.0.CO;2-9; CHEPIL W. S., 1963, ADVAN AGRON, V15, P211, DOI 10.1016/S0065-2113(08)60400-9; Hulme M., 1996, CLIMATE CHANGE SO AF; IPCC, 2001, CLIM CHANG 2001; KAR A, 1993, J ARID ENVIRON, V25, P83, DOI 10.1006/jare.1993.1044; Knight M, 2004, GEOMORPHOLOGY, V59, P197, DOI 10.1016/j.geomorph.2003.07.017; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; LANCASTER N, 1988, J ARID ENVIRON, V14, P233; Lancaster N, 2000, EARTH SURF PROC LAND, V25, P197, DOI [10.1002/(SICI)1096-9837(200002)25:2&lt;197::AID-ESP82&gt;3.0.CO;2-H, 10.1002/(SICI)1096-9837(200002)25:2<197::AID-ESP82>3.0.CO;2-H]; Livingstone I., 1993, GEOLOGICAL SOC SPECI, V720, P91; Muhs D.R., 1993, J ARID ENVIRON, V25, P905; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Nicholson SE, 1997, INT J CLIMATOL, V17, P117, DOI 10.1002/(SICI)1097-0088(199702)17:2<117::AID-JOC84>3.0.CO;2-O; RINGROSE S, 1991, INT J REMOTE SENS, V12, P1023, DOI 10.1080/01431169108929708; SCANLON TM, 2002, REMOTE SENS ENVIRON, V13, P419; Sporton D., 2002, SUSTAINABLE LIVELIHO; Stokes S, 1997, NATURE, V388, P154, DOI 10.1038/40596; SUMMER G, 2001, INT J CLIMATOL, V21, P211; TALBOT MR, 1984, PALAEOECOL AFR, V16, P203; Thomas DSG, 2005, GEOMORPHOLOGY, V64, P117, DOI 10.1016/j.geomorph.2004.06.004; Thomas DSG, 2002, QUATERNARY SCI REV, V21, P783, DOI 10.1016/S0277-3791(01)00127-5; THOMAS DSG, 1998, ARID ZONE GEOMORPHOL, P373; Tsoar H., 2020, AEOLIAN GEOMORPHOLOG, P75; Turner MD, 1999, J ARID ENVIRON, V41, P277, DOI 10.1006/jare.1998.0485; WASSON RJ, 1986, EARTH SURF PROCESSES, V11, P505, DOI 10.1002/esp.3290110505; WIGGS GFS, 1995, EARTH SURF PROC LAND, V20, P515, DOI 10.1002/esp.3290200604; WOODRUFF WP, 1968, J SOIL WATER CONSERV, V23, P103	28	219	234	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2005	435	7046					1218	1221		10.1038/nature03717	http://dx.doi.org/10.1038/nature03717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988522				2022-12-24	WOS:000230140500040
J	Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM				Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM			Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIPHOSPHOLIPID SYNDROME; PHOSPHOLIPIDS; EPITOPE; ANTICARDIOLIPIN; AUTOANTIBODIES; LA	The design of a human immunodeficiency virus-1 (HIV-1) immunogen that can induce broadly reactive neutralizing antibodies is a major goal of HIV-1 vaccine development. Although rare human monoclonal antibodies (mAbs) exist that broadly neutralize HIV-1, HIV-1 envelope immunogens do not induce these antibody specificities. Here we demonstrate that the two most broadly reactive HIV-1 envelope gp41 human mAbs, 2175 and 4E10, are polyspecific autoantibodies reactive with the phospholipid cardiolipin. Thus, current HIV-1 vaccines may not induce these types of antibodies because of autoantigen mimicry of the conserved membrane-proximal epitopes of the virus. These results may have important implications for generating effective neutralizing, antibody responses by using HIV-1 vaccines.	Duke Univ, Sch Med, Durham, NC 27710 USA; Univ Agr Vienna, Inst Appl Microbiol, Vienna, Austria; Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Duke University; University of Natural Resources & Life Sciences, Vienna; Tulane University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Durham, NC 27710 USA.	hayne002@mc.duke.edu	Alam, S. Munir/AAC-6711-2019; Kunert, Renate E/B-9185-2018	Kunert, Renate E/0000-0002-3397-3621; Staats, Herman/0000-0003-1039-1087	NIAID NIH HHS [P0-1 AI52816, AI51445] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI052816, P30AI051445] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abuaf N, 1997, THROMB HAEMOSTASIS, V77, P856; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; BEVERS EM, 1991, THROMB HAEMOSTASIS, V66, P629; Bouvet JP, 1998, INFECT IMMUN, V66, P1; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; DELGADO AJ, 2002, ARTHRITIS RHEUM, V46, P2686, DOI DOI 10.1371/JOURNAL.PONE.0186513; Douvas A, 1996, AIDS RES HUM RETROV, V12, P1509, DOI 10.1089/aid.1996.12.1509; Fenger M, 2004, CLIN CHEM, V50, P2141, DOI 10.1373/clinchem.2004.038422; Fox RA, 1997, ARTHRITIS RHEUM-US, V40, P1168, DOI 10.1002/art.1780400623; Guerin J, 1998, BRIT J HAEMATOL, V102, P896, DOI 10.1046/j.1365-2141.1998.00876.x; HAYNES BF, UNPUB; Kessler JA, 1997, AIDS RES HUM RETROV, V13, P575, DOI 10.1089/aid.1997.13.575; Kunert RE, 2002, AIDS, V16, P667, DOI 10.1097/00002030-200203080-00020; Loizou S, 2003, ANN RHEUM DIS, V62, P1106, DOI 10.1136/ard.62.11.1106; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI13051; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Opalka D, 2004, J IMMUNOL METHODS, V287, P49, DOI 10.1016/j.jim.2004.01.016; Palacios R, 2004, INT J STD AIDS, V15, P277, DOI 10.1258/095646204773557857; Petrovas C, 1999, J AUTOIMMUN, V13, P347, DOI 10.1006/jaut.1999.0324; Radway-Bright EL, 2000, RHEUMATOLOGY, V39, P427, DOI 10.1093/rheumatology/39.4.427; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Shaw Gerald Sinclair, COMMUNICATION; Stiegler G, 2003, J ANTIMICROB CHEMOTH, V51, P757, DOI 10.1093/jac/dkg172; WEISS L, 1995, CLIN IMMUNOL IMMUNOP, V77, P69, DOI 10.1016/0090-1229(95)90138-8; Zhu M, 1999, BRIT J HAEMATOL, V105, P102, DOI 10.1111/j.1365-2141.1999.01292.x	29	609	650	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1906	1908		10.1126/science.1111781	http://dx.doi.org/10.1126/science.1111781			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15860590				2022-12-24	WOS:000230120000039
J	Sun, T; Patoine, C; Abu-Khalil, A; Visvader, J; Sum, E; Cherry, TJ; Orkin, SH; Geschwind, DH; Walsh, CA				Sun, T; Patoine, C; Abu-Khalil, A; Visvader, J; Sum, E; Cherry, TJ; Orkin, SH; Geschwind, DH; Walsh, CA			Early asymmetry of gene transcription in embryonic human left and right cerebral cortex	SCIENCE			English	Article							HUMAN-BRAIN; HANDEDNESS; SPEECH; LATERALITY; EVOLUTION; MICE	The human left and right cerebral hemispheres are anatomically and functionally asymmetric. To test whether human cortical asymmetry has a molecular basis, we studied gene expression levels between the left and right embryonic hemispheres using serial analysis of gene expression (SAGE). We identified and verified 27 differentialty expressed genes, which suggests that human cortical asymmetry is accompanied by early, marked transcriptional asymmetries. LMO4 is consistently more highly expressed in the right perisylvian human cerebral cortex than in the left and is essential for cortical development in mice, suggesting that human left-right specialization reflects asymmetric cortical development at early stages.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Univ Calif Los Angeles, Dept Neurol, Program Neurogenet, Sch Med, Los Angeles, CA 90095 USA; Walter & Eliza Hall Inst Med Res, Victorian Breast Canc Res Consortium Lab, Melbourne, Vic 3050, Australia; Boston Childrens Hosp, Howard Hughes Med Inst, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Walter & Eliza Hall Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, New Res Bldg Room 0266,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu		Walsh, Christopher/0000-0002-0156-2238	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R37 MH060233, MH60233, R01 MH060233, R56 MH060233] Funding Source: Medline; NINDS NIH HHS [R01 R37 NS35129, R01 NS035129-03, R37 NS035129-05, R37 NS035129, R01 NS035129] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH060233, R37MH060233, R01MH060233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035129, R01NS035129] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; BARNEOUD P, 1993, P NATL ACAD SCI USA, V90, P3246, DOI 10.1073/pnas.90.8.3246; BIDDLE FG, 1993, GENOME, V36, P935, DOI 10.1139/g93-123; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; CHI JG, 1977, ARCH NEUROL-CHICAGO, V34, P346, DOI 10.1001/archneur.1977.00500180040008; COLLINS RL, 1991, BRAIN RES, V564, P194, DOI 10.1016/0006-8993(91)91455-A; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; FALKAI P, 1992, SCHIZOPHR RES, V7, P23, DOI 10.1016/0920-9964(92)90070-L; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; GALABURDA AM, 1994, P NATL ACAD SCI USA, V91, P8010, DOI 10.1073/pnas.91.17.8010; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Geschwind DH, 2001, AM J MED GENET, V101, P370; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Hugdahl K, 1998, SCAND AUDIOL, V27, P26, DOI 10.1080/010503998420621; Kennedy DN, 1999, NEUROLOGY, V53, P1260, DOI 10.1212/WNL.53.6.1260; LEMAY M, 1972, NEW ENGL J MED, V287, P168, DOI 10.1056/NEJM197207272870404; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; RIDDLE DR, 1995, J NEUROSCI, V15, P4184; Sidman RL, 1982, HISTOLOGY HISTOPATHO; SIGNORE P, 1991, PHYSIOL BEHAV, V49, P701, DOI 10.1016/0031-9384(91)90305-8; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009	23	268	272	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1794	1798		10.1126/science.1110324	http://dx.doi.org/10.1126/science.1110324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15894532	Green Accepted			2022-12-24	WOS:000229926800057
J	Manasse, HR				Manasse, HR			Conscientious objection and the pharmacist	SCIENCE			English	Editorial Material									Amer Soc Hlth Syst Pharmacists, Bethesda, MD 20814 USA		Manasse, HR (corresponding author), Amer Soc Hlth Syst Pharmacists, Bethesda, MD 20814 USA.	evp@ashp.org						BEAUCHAMP TL, 1989, PRINCIPLES BIOMEDICA, P389; Davey Monica, 2005, N Y Times Web, pA16	2	7	8	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1558	1559		10.1126/science.1114371	http://dx.doi.org/10.1126/science.1114371			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947160				2022-12-24	WOS:000229827000027
J	Ogata, J; Kanno, Y; Itoh, Y; Tsugawa, H; Suzuki, M				Ogata, J; Kanno, Y; Itoh, Y; Tsugawa, H; Suzuki, M			Anthocyanin biosynthesis in roses	NATURE			English	Editorial Material									Aomori Green BioCtr, Nogi Yamaguchi, Aomori 0300142, Japan; Tokyo Univ Agr & Technol, Fac Technol, Dept Biotechnol, Tokyo 1848588, Japan	Tokyo University of Agriculture & Technology	Ogata, J (corresponding author), Aomori Green BioCtr, Nogi Yamaguchi, Aomori 0300142, Japan.	masahiko_suzuki@ags.pref.aomori.jp						CAIRNS T, 2000, MODERN ROSES, V11; GUDIN S, 2003, ENCY ROSE SCI, V1, P25; Heller W., 1993, FLAVONOIDS ADV RES 1, P499; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Jay M., 2003, ENCY ROSE SCI, V1, P248; Ogata J., 2004, PLANT BIOTECHNOL, V21, P367, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.21.367; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; STRACK D, 1993, FLAVONOIDS ADV RES 1, P1; Tanaka Y, 2005, PLANT CELL TISS ORG, V80, P1, DOI 10.1007/s11240-004-0739-8; Yamazaki M, 1999, J BIOL CHEM, V274, P7405, DOI 10.1074/jbc.274.11.7405	10	90	120	9	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					757	758		10.1038/nature435757a	http://dx.doi.org/10.1038/nature435757a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944692				2022-12-24	WOS:000229638700038
J	Draper, G; Vincent, T; Kroll, ME; Swanson, J				Draper, G; Vincent, T; Kroll, ME; Swanson, J			Childhood cancer in relation to distance from high voltage power lines in England and Wales: a case-control study	BRITISH MEDICAL JOURNAL			English	Article							MAGNETIC-FIELDS; POOLED ANALYSIS; LEUKEMIA; CHILDREN; RISK	Objective To determine whether there is an association between distance of home address at birth from high voltage power lines and the incidence of leukaemia and other cancers in children in England and Wales. Design Case-control study. Setting Cancer registry and National Grid records. Subjects Records of 29 081 children with cancer, including 9700 with leukaemia. Children were aged 0-14 years and born in England and Wales, 1962-95. Controls were individually matched for sex, approximate date of birth, and birth registration district. No active participation was required. Main outcome measures Distance from home address at birth to the nearest high voltage overhead power line in existence at the time. Results Compared with those who lived > 600 m from a line at birth, children who lived within 200 m had a relative risk of leukaemia of 1.69 (95% confidence interval 1.13 to 2.53); those born between 200 and 600 m had a relative risk of 1.23 (1.02 to 1.49). There was a significant (P < 0.01) trend in risk in relation to the reciprocal of distance from the line. No excess risk in relation to proximity to lines was found for other childhood cancers. Conclusions There is an association between childhood leukaemia and proximity of home address at birth to high voltage power lines, and the apparent risk extends to a greater distance than would have been expected from previous studies. About 4% of children in England and Wales live within 600 in of high voltage lines at birth. If the association is causal, about 1% of childhood leukaemia in England and Wales would be attributable to these lines, though this estimate has considerable statistical uncertainty. There is no accepted biological mechanism to explain the epidemiological results; indeed, the relation may be due to chance or confounding.	Univ Oxford, Childhood Canc Res Grp, Oxford OX2 6HJ, England; Natl Grid Transco Plc, London WC2N 5EH, England	University of Oxford	Draper, G (corresponding author), Univ Oxford, Childhood Canc Res Grp, Oxford OX2 6HJ, England.	gerald.draper@ccrg.ox.ac.uk						Ahlbom A, 2000, BRIT J CANCER, V83, P692, DOI 10.1054/bjoc.2000.1376; Cheng KK, 2000, BRIT J CANCER, V83, P1573, DOI 10.1054/bjoc.2000.1550; Dockerty JD, 2001, INT J EPIDEMIOL, V30, P1428, DOI 10.1093/ije/30.6.1428; DRAPER GJ, OPCS STUDIES MED POP, V53; Fews AP, 1999, INT J RADIAT BIOL, V75, P1523, DOI 10.1080/095530099139124; FEYCHTING M, 1993, AM J EPIDEMIOL, V138, P467, DOI 10.1093/oxfordjournals.aje.a116881; Greenland S, 2000, EPIDEMIOLOGY, V11, P624, DOI 10.1097/00001648-200011000-00003; Kinlen L, 2004, BRIT J CANCER, V91, P1, DOI 10.1038/sj.bjc.6601982; Kleinerman RA, 2000, AM J EPIDEMIOL, V151, P512, DOI 10.1093/oxfordjournals.aje.a010237; MADDOCK BJ, 1992, POWER ENG        SEP, P217; McBride ML, 1999, AM J EPIDEMIOL, V149, P831, DOI 10.1093/oxfordjournals.aje.a009899; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; OLSEN JH, 1993, BRIT MED J, V307, P891, DOI 10.1136/bmj.307.6909.891; Tynes T, 1997, AM J EPIDEMIOL, V145, P219, DOI 10.1093/oxfordjournals.aje.a009094; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681	15	206	218	0	45	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 4	2005	330	7503					1290	1292A		10.1136/bmj.330.7503.1290	http://dx.doi.org/10.1136/bmj.330.7503.1290			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15933351	Green Published, Bronze			2022-12-24	WOS:000229655700014
J	Peggs, KS; Hunter, A; Chopra, R; Parker, A; Mahendra, P; Milligan, D; Craddock, C; Pettengell, R; Dogan, A; Thomson, KJ; Morris, EC; Hale, G; Waldmann, H; Goldstone, AH; Linch, DC; Mackinnon, S				Peggs, KS; Hunter, A; Chopra, R; Parker, A; Mahendra, P; Milligan, D; Craddock, C; Pettengell, R; Dogan, A; Thomson, KJ; Morris, EC; Hale, G; Waldmann, H; Goldstone, AH; Linch, DC; Mackinnon, S			Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation	LANCET			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW TRANSPLANTS; POSITRON-EMISSION-TOMOGRAPHY; DONOR LEUKOCYTE INFUSIONS; HIGH-DOSE CHEMOTHERAPY; ADOPTIVE IMMUNOTHERAPY; STATISTICAL-METHODS; DISEASE; THERAPY; BLOOD	Background In patients with multiply relapsed Hodgkin's lymphoma allogeneic stem-cell transplantation has been limited by prohibitive non-relapse-related mortality rates and by a lack of definitive evidence for a therapeutic graft-versus-tumour effect. Therefore, we aimed to assess the graft-versus-tumour effect of reduced-intensity allogeneic transplantation. Methods We undertook reduced-intensity transplantation in 49 patients with multiply relapsed Hodgkin's lymphoma, 44 (90%) of whom had progression of disease after previous autologous transplantation (median age 32 years [range 18-51], number of previous treatment courses was five [range 3-8], and time from diagnosis 4.8 years [range 0.6-4.8]). 31 patients had HLA-matched donors who were related and 18 had donors who were unrelated. Median follow-up was 967 days (range 102-2232). The primary endpoints were engraftment, toxic effects, non-relapse-related mortality, incidence of graft-versus-host disease (GVHD), and the toxic effects of adjuvant donor-lymphocyte infusion. Findings All patients engrafted. Eight of 49 (16%) had grade II-IV acute GVHD and seven (14%) had chronic GVHD before donor-lymphocyte infusion. 16 (33%) patients received donor-lymphocyte infusion from 3 months after transplantation for residual disease or progression. Six (38%) of the 16 developed grade II-IV acute GVHD and five developed chronic GVHD. Nine (56%) showed disease responses after infusion (eight complete, one partial). Non-relapse-related mortality was 16.3% at 730 days (7.2% for patients who had related donors vs 34.1% for those with unrelated donors, p=0.0206). Projected 4-year overall and progression-free survival were 55.7% and 39.0%, respectively (62.0% and 41.5% for related donors). Interpretation These data show the potential for durable responses in patients who have previously had substantial treatment for Hodgkin's lymphoma. The low non-relapse-related mortality suggests the procedure could be undertaken earlier in the course of the disease.	Royal Free & UCL, Dept Haematol, London WC1E 6HX, England; Leicester Royal Infirm, Dept Haematol, Leicester, Leics, England; Christie Hosp, Dept Haematol, Manchester, Lancs, England; Glasgow Royal Infirm, Dept Haematol, Glasgow, Lanark, Scotland; Queen Elizabeth Hosp, Dept Haematol, Birmingham, W Midlands, England; Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9 5ST, W Midlands, England; UCL Hosp, Dept Haematol, London, England; UCL Hosp, Dept Histopathol, London, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 2JD, England	University of London; University College London; University of Leicester; Christie NHS Foundation Trust; Christie Hospital; University of Glasgow; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Oxford	Peggs, KS (corresponding author), Royal Free & UCL, Dept Haematol, London WC1E 6HX, England.	kpeggs@hotmail.com	PEGGS, Karl/B-3869-2009; waldmann, herman/F-7412-2011; waldmann, herman/W-8051-2019; Mackinnon, Stephen/C-5559-2008	Parker, Anne/0000-0002-4905-6860; Waldmann, Herman/0000-0001-7519-6720; Morris, Emma/0000-0003-4834-1130; Craddock, Charles/0000-0001-5041-6678; Hale, Geoff/0000-0001-9473-423X				Akpek G, 2001, J CLIN ONCOL, V19, P4314, DOI 10.1200/JCO.2001.19.23.4314; Anderlini P, 2000, BONE MARROW TRANSPL, V26, P615, DOI 10.1038/sj.bmt.1702580; Anderlini P, 2004, BONE MARROW TRANSPL, V34, P511, DOI 10.1038/sj.bmt.1704621; ANDERSON JE, 1993, J CLIN ONCOL, V11, P2342, DOI 10.1200/JCO.1993.11.12.2342; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Branson K, 2002, J CLIN ONCOL, V20, P4022, DOI 10.1200/JCO.2002.11.088; Carella AM, 2001, HAEMATOLOGICA, V86, P1121; CHOPRA R, 1993, BLOOD, V81, P1137; Claviez A, 2004, ANN HEMATOL, V83, P237, DOI 10.1007/s00277-003-0814-y; Gajewski JL, 1996, J CLIN ONCOL, V14, P572, DOI 10.1200/JCO.1996.14.2.572; Hiddemann W, 1994, Drugs, V47 Suppl 6, P50; Johnston LJ, 2000, BIOL BLOOD MARROW TR, V6, P289, DOI 10.1016/S1083-8791(00)70054-1; JONES RJ, 1991, BLOOD, V77, P649; Josting A, 2000, BLOOD, V96, P1280, DOI 10.1182/blood.V96.4.1280.h8001280_1280_1286; Klein JP, 2001, BONE MARROW TRANSPL, V28, P909, DOI 10.1038/sj.bmt.1703260; Klein JP, 2001, BONE MARROW TRANSPL, V28, P1001, DOI 10.1038/sj.bmt.1703271; KOLB HJ, 1990, BLOOD, V76, P2462, DOI 10.1182/blood.V76.12.2462.2462; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Milpied N, 1996, J CLIN ONCOL, V14, P1291, DOI 10.1200/JCO.1996.14.4.1291; Morris EC, 2003, BLOOD, V102, P404, DOI 10.1182/blood-2002-09-2687; Porter DL, 1999, J CLIN ONCOL, V17, P1234, DOI 10.1200/JCO.1999.17.4.1234; Porter DL, 2003, BONE MARROW TRANSPL, V31, P739, DOI 10.1038/sj.bmt.1703895; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; SALISBURY JR, 1994, J CLIN PATHOL, V47, P313, DOI 10.1136/jcp.47.4.313; Schmitz N, 2002, LANCET, V359, P2065, DOI 10.1016/S0140-6736(02)08938-9; Spaepen K, 2003, BLOOD, V102, P53, DOI 10.1182/blood-2002-12-3842; Spaepen K, 2001, BRIT J HAEMATOL, V115, P272, DOI 10.1046/j.1365-2141.2001.03169.x; Sureda A, 2002, ANN ONCOL, V13, P128, DOI 10.1093/annonc/13.S1.128; Tarella C, 2003, CANCER-AM CANCER SOC, V97, P2748, DOI 10.1002/cncr.11414	29	210	220	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1934	1941		10.1016/S0140-6736(05)66659-7	http://dx.doi.org/10.1016/S0140-6736(05)66659-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936420				2022-12-24	WOS:000229587800027
J	Oltersdorf, T; Elmore, SW; Shoemaker, AR; Armstrong, RC; Augeri, DJ; Belli, BA; Bruncko, M; Deckwerth, TL; Dinges, J; Hajduk, PJ; Joseph, MK; Kitada, S; Korsmeyer, SJ; Kunzer, AR; Letai, A; Li, C; Mitten, MJ; Nettesheim, DG; Ng, S; Nimmer, PM; O'Connor, JM; Oleksijew, A; Petros, AM; Reed, JC; Shen, W; Tahir, SK; Thompson, CB; Tomaselli, KJ; Wang, BL; Wendt, MD; Zhang, HC; Fesik, SW; Rosenberg, SH				Oltersdorf, T; Elmore, SW; Shoemaker, AR; Armstrong, RC; Augeri, DJ; Belli, BA; Bruncko, M; Deckwerth, TL; Dinges, J; Hajduk, PJ; Joseph, MK; Kitada, S; Korsmeyer, SJ; Kunzer, AR; Letai, A; Li, C; Mitten, MJ; Nettesheim, DG; Ng, S; Nimmer, PM; O'Connor, JM; Oleksijew, A; Petros, AM; Reed, JC; Shen, W; Tahir, SK; Thompson, CB; Tomaselli, KJ; Wang, BL; Wendt, MD; Zhang, HC; Fesik, SW; Rosenberg, SH			An inhibitor of Bcl-2 family proteins induces regression of solid tumours	NATURE			English	Article							SMALL-MOLECULE INHIBITORS; CELL-DEATH; RATIONAL DESIGN; BH3 DOMAIN; APOPTOSIS; DISCOVERY; BCL-X(L); EXPRESSION; ANTISENSE; COMPOUND	Proteins in the Bcl-2 family are central regulators of programmed cell death(1), and members that inhibit apoptosis, such as Bcl-X-L and Bcl-2, are overexpressed in many cancers and contribute to tumour initiation, progression and resistance to therapy(2). Bcl-X-L expression correlates with chemo-resistance of tumour cell lines(3), and reductions in Bcl-2 increase sensitivity to anticancer drugs(4) and enhance in vivo survival(5). The development of inhibitors of these proteins as potential anti-cancer therapeutics has been previously explored(6-15), but obtaining potent small-molecule inhibitors has proved difficult owing to the necessity of targeting a protein - protein interaction. Here, using nuclear magnetic resonance (NMR)-based screening, parallel synthesis and structure-based design, we have discovered ABT-737, a small-molecule inhibitor of the anti-apoptotic proteins Bcl-2, Bcl-X-L and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compounds(7-15). Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation. ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumours, and produces cures in a high percentage of the mice.	Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA; Idun Pharmaceut, San Diego, CA 92121 USA; Burnham Inst, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Abbott Laboratories; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine	Rosenberg, SH (corresponding author), Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA.	stephen.fesik@abbott.com; saul.rosenberg@abbott.com						Amundson SA, 2000, CANCER RES, V60, P6101; Baell JB, 2002, BIOCHEM PHARMACOL, V64, P851, DOI 10.1016/S0006-2952(02)01148-6; Becattini B, 2004, CHEM BIOL, V11, P389, DOI 10.1016/j.chembiol.2004.02.020; BRUNGER AT, 1992, XPLOR VERSION 3 1; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f; FEARON ER, 1992, P NATL ACAD SCI USA, V89, P7958, DOI 10.1073/pnas.89.17.7958; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Klasa RJ, 2002, ANTISENSE NUCLEIC A, V12, P193, DOI 10.1089/108729002760220798; Kutzki O, 2002, J AM CHEM SOC, V124, P11838, DOI 10.1021/ja026861k; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Mao HY, 2000, PROTEIN EXPRES PURIF, V20, P492, DOI 10.1006/prep.2000.1330; Mao HY, 2001, J AM CHEM SOC, V123, P10429, DOI 10.1021/ja015955b; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Reed JC, 1997, J NATL CANCER I, V89, P988, DOI 10.1093/jnci/89.14.988; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zhang HC, 2002, ANAL BIOCHEM, V307, P70, DOI 10.1016/S0003-2697(02)00028-3	30	2760	2920	6	509	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					677	681		10.1038/nature03579	http://dx.doi.org/10.1038/nature03579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15902208				2022-12-24	WOS:000229476200051
J	Rieder, MJ; Reiner, AP; Gage, BF; Nickerson, DA; Eby, CS; McLeod, HL; Blough, DK; Thummel, KE; Veenstra, DL; Rettie, AE				Rieder, MJ; Reiner, AP; Gage, BF; Nickerson, DA; Eby, CS; McLeod, HL; Blough, DK; Thummel, KE; Veenstra, DL; Rettie, AE			Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METABOLISM; PHARMACOGENETICS; ASSOCIATION; POPULATION; REDUCTASE; PREDICT; GENE	BACKGROUND: The management of warfarin therapy is complicated by a wide variation among patients in drug response. Variants in the gene encoding vitamin K epoxide reductase complex 1 (VKORC1) may affect the response to warfarin. METHODS: We conducted a retrospective study of European-American patients receiving long-term warfarin maintenance therapy. Multiple linear-regression analysis was used to determine the effect of VKORC1 haplotypes on the warfarin dose. We determined VKORC1 haplotype frequencies in African-American, European-American, and Asian-American populations and VKORC1 messenger RNA (mRNA) expression in human liver samples. RESULTS: We identified 10 common noncoding VKORC1 single-nucleotide polymorphisms and inferred five major haplotypes. We identified a low-dose haplotype group (A) and a high-dose haplotype group (B). The mean (+/-SE) maintenance dose of warfarin differed significantly among the three haplotype group combinations, at 2.7+/-0.2 mg per day for A/A, 4.9+/-0.2 mg per day for A/B, and 6.2+/-0.3 mg per day for B/B (P<0.001). VKORC1 haplotype groups A and B explained approximately 25 percent of the variance in dose. Asian Americans had a higher proportion of group A haplotypes and African Americans a higher proportion of group B haplotypes. VKORC1 mRNA levels varied according to the haplotype combination. CONCLUSIONS: VKORC1 haplotypes can be used to stratify patients into low-, intermediate-, and high-dose warfarin groups and may explain differences in dose requirements among patients of different ancestries. The molecular mechanism of this warfarin dose response appears to be regulated at the transcriptional level.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Pharm, Seattle, WA 98195 USA; Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; Washington Univ, Dept Med, St Louis, MO USA; Washington Univ, Dept Pathol & Immunol, St Louis, MO USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL)	Rieder, MJ (corresponding author), Univ Washington, Dept Genome Sci, Box 357730, Seattle, WA 98195 USA.	mrieder@u.washington.edu	Rieder, Michael J/L-2397-2013; McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232; Gage, Brian/0000-0002-4727-8742	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074724, U01HL066682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068797, P01GM032165, U01GM063340] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL074724, U01 HL66682] Funding Source: Medline; NIEHS NIH HHS [P30ES07033] Funding Source: Medline; NIGMS NIH HHS [GM32165, GM63340, GM068797] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Absher RK, 2002, ANN PHARMACOTHER, V36, P1512, DOI 10.1345/aph.1C025; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Ansell J, 2005, CHEST, V127, P415; Chenhsu RY, 2000, ANN PHARMACOTHER, V34, P1395; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; FASCO MJ, 1983, BIOCHEMISTRY-US, V22, P5655, DOI 10.1021/bi00293a031; Gage BF, 2004, THROMB HAEMOSTASIS, V91, P87, DOI 10.1160/TH03-06-0379; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Lesko LJ, 2004, NAT REV DRUG DISCOV, V3, P763, DOI 10.1038/nrd1499; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Lin YS, 2002, MOL PHARMACOL, V62, P162, DOI 10.1124/mol.62.1.162; MARKETOS M, 2004, DRUG TOPICS, V148, P76; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; RETTIE AE, 1992, CHEM RES TOXICOL, V5, P54, DOI 10.1021/tx00025a009; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Voora D, 2005, THROMB HAEMOSTASIS, V93, P700, DOI 10.1160/TH04-08-0542; Yu HCM, 1996, QJM-MON J ASSOC PHYS, V89, P127	22	1066	1170	1	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2005	352	22					2285	2293		10.1056/NEJMoa044503	http://dx.doi.org/10.1056/NEJMoa044503			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930VY	15930419				2022-12-24	WOS:000229446400005
J	McElwain, JC; Wade-Murphy, J; Hesselbo, SP				McElwain, JC; Wade-Murphy, J; Hesselbo, SP			Changes in carbon dioxide during an oceanic anoxic event linked to intrusion into Gondwana coals	NATURE			English	Article							CENOMANIAN-TURONIAN BOUNDARY; ATMOSPHERIC CO2; MASS EXTINCTION; GAS-HYDRATE; TOARCIAN; DISSOCIATION; ANTARCTICA; METHANE	The marine sedimentary record exhibits evidence for episodes of enhanced organic carbon burial known as 'oceanic anoxic events' (OAEs)(1,2). They are characterized by carbon-isotope excursions in marine(3) and terrestrial(4) reservoirs and mass extinction of marine faunas(5). Causal mechanisms for the enhancement of organic carbon burial during OAEs are still debated(6,7), but it is thought that such events should draw down significant quantities of atmospheric carbon dioxide(7). In the case of the Toarcian OAE (similar to 183 million years ago), a short-lived negative carbon-isotope excursion in oceanic and terrestrial reservoirs has been interpreted to indicate raised atmospheric carbon dioxide(4) caused by oxidation of methane catastrophically released from either marine gas hydrates(4) or magma-intruded organic-rich rocks(8). Here we test these two leading hypotheses(4,8) for a negative carbon isotopic excursion marking the initiation of the Toarcian OAE using a high-resolution atmospheric carbon dioxide record obtained from fossil leaf stomatal frequency(9,10). We find that coincident with the negative carbon-isotope excursion carbon dioxide is first drawn down by 350 +/- 100 p. p. m. v. and then abruptly elevated by 1,200 6 400 p. p. m. v, and infer a global cooling and greenhouse warming of 2.5 +/- 0.1 degrees C and 6.5 +/- 1 degrees C, respectively. The pattern and magnitude of carbon dioxide change are difficult to reconcile with catastrophic input of isotopically light methane from hydrates(5) as the cause of the negative isotopic signal. Our carbon dioxide record better supports a magma-intrusion hypothesis(8), and suggests that injection of isotopically light carbon from the release of thermogenic methane occurred owing to the intrusion of Gondwana coals by Toarcian-aged Karoo-Ferrar dolerites.	Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	Field Museum of Natural History (Chicago); University of Chicago; University of Oxford	McElwain, JC (corresponding author), Field Museum Nat Hist, Dept Geol, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	jmcelwain@fieldmuseum.org	McElwain, Jennifer/B-1735-2009; McElwain, Jennifer/AAX-1605-2020	McElwain, Jennifer/0000-0002-1729-6755; 				ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; Bailey TR, 2003, EARTH PLANET SC LETT, V212, P307, DOI 10.1016/S0012-821X(03)00278-4; Ballance PF, 2002, NEW ZEAL J GEOL GEOP, V45, P71, DOI 10.1080/00288306.2002.9514960; Beerling DJ, 2002, AM J SCI, V302, P28, DOI 10.2475/ajs.302.1.28; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cohen AS, 2004, GEOLOGY, V32, P157, DOI 10.1130/G20158.1; Elliot DH, 2004, GONDWANA RES, V7, P223, DOI 10.1016/S1342-937X(05)70322-1; Harries PJ, 1999, PALAEOGEOGR PALAEOCL, V154, P39, DOI 10.1016/S0031-0182(99)00086-3; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; JENKYNS HC, 1988, AM J SCI, V288, P101, DOI 10.2475/ajs.288.2.101; Jenkyns HC, 2002, J GEOL SOC LONDON, V159, P351, DOI 10.1144/0016-764901-130; Jenkyns HC, 2003, PHILOS T R SOC A, V361, P1885, DOI 10.1098/rsta.2003.1240; Kerr AC, 1998, J GEOL SOC LONDON, V155, P619, DOI 10.1144/gsjgs.155.4.0619; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; Koppelhus Eva Bundgaard, 1994, Palynology, V18, P139; Kothavala Z, 1999, GEOPHYS RES LETT, V26, P209, DOI 10.1029/1998GL900275; Kump LR, 1999, CHEM GEOL, V161, P181, DOI 10.1016/S0009-2541(99)00086-8; Kurschner WM, 1997, REV PALAEOBOT PALYNO, V96, P1, DOI 10.1016/S0034-6667(96)00051-6; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; McElwain JC, 1998, PHILOS T R SOC B, V353, P83, DOI 10.1098/rstb.1998.0193; McElwain JC, 2002, J QUATERNARY SCI, V17, P21, DOI 10.1002/jqs.664.abs; MICHELSON O, 2003, JURASSIC DENMARK GRE, P147; Milkov AV, 2004, EARTH-SCI REV, V66, P183, DOI 10.1016/j.earscirev.2003.11.002; Palfy J, 2000, GEOLOGY, V28, P747, DOI 10.1130/0091-7613(2000)28<747:SBEJEO>2.0.CO;2; Royer DL, 2001, SCIENCE, V292, P2310, DOI 10.1126/science.292.5525.2310; Royer DL, 2001, EARTH-SCI REV, V54, P349, DOI 10.1016/S0012-8252(00)00042-8; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Vakhrameev V.A., 1991, JURASSIC CRETACEOUS; Veevers J. J., 1994, PERMIAN TRIASSIC PAN, P331	30	367	381	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					479	482		10.1038/nature03618	http://dx.doi.org/10.1038/nature03618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917805				2022-12-24	WOS:000229337800051
J	Ndayimirije, N; Kindhauser, MK				Ndayimirije, N; Kindhauser, MK			Marburg hemorrhagic fever in Angola - Fighting fear and a lethal pathogen.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									WHO, Brazzaville, Rep Congo; WHO, Geneva, Switzerland	World Health Organization; World Health Organization	Ndayimirije, N (corresponding author), WHO, Brazzaville, Rep Congo.								0	25	25	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2005	352	21					2155	2157		10.1056/NEJMp058115	http://dx.doi.org/10.1056/NEJMp058115			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929HS	15917379	Bronze			2022-12-24	WOS:000229333300001
J	Nilsson, DE; Gislen, L; Coates, MM; Skogh, C; Garm, A				Nilsson, DE; Gislen, L; Coates, MM; Skogh, C; Garm, A			Advanced optics in a jellyfish eye	NATURE			English	Article							PRIMARY VISUAL-CORTEX; TRIPEDALIA-CYSTOPHORA; CRYSTALLINE LENS; PHOTORECEPTORS; CUBOZOA; BRAIN; MODEL	Cubozoans, or box jellyfish, differ from all other cnidarians by an active fish-like behaviour and an elaborate sensory apparatus(1,2). Each of the four sides of the animal carries a conspicuous sensory club ( the rhopalium), which has evolved into a bizarre cluster of different eyes(3). Two of the eyes on each rhopalium have long been known to resemble eyes of higher animals, but the function and performance of these eyes have remained unknown(4). Here we show that box-jellyfish lenses contain a finely tuned refractive index gradient producing nearly aberration-free imaging. This demonstrates that even simple animals have been able to evolve the sophisticated visual optics previously known only from a few advanced bilaterian phyla. However, the position of the retina does not coincide with the sharp image, leading to very wide and complex receptive fields in individual photoreceptors. We argue that this may be useful in eyes serving a single visual task. The findings indicate that tailoring of complex receptive fields might have been one of the original driving forces in the evolution of animal lenses.	Lund Univ, Dept Cell & Organism Biol, S-22362 Lund, Sweden; Lund Univ, Dept Theoret Phys, SE-22362 Lund, Sweden	Lund University; Lund University	Nilsson, DE (corresponding author), Lund Univ, Dept Cell & Organism Biol, Zool Bldg,Helgonavagen 3, S-22362 Lund, Sweden.	dan-e.nilsson@cob.lu.se	Garm, Anders/K-4362-2014	Garm, Anders/0000-0002-2080-735X				Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Bartels A, 1998, P ROY SOC B-BIOL SCI, V265, P2327, DOI 10.1098/rspb.1998.0579; Berger E. W., 1898, J COMP NEUROL, V8, P223; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; FLETCHER A, 1954, PROC R SOC LON SER-A, V223, P216, DOI 10.1098/rspa.1954.0110; Jagger WS, 1999, VISION RES, V39, P2841, DOI 10.1016/S0042-6989(99)00012-7; KROGER RHH, 1994, VISION RES, V34, P1815, DOI 10.1016/0042-6989(94)90306-9; Land MF, 2002, ANIMAL EYES; LASKA G, 1984, ZOOMORPHOLOGY, V104, P163, DOI 10.1007/BF00312135; Laska G., 1982, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V108, P107; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; NILSSON DE, 1983, J MICROSC-OXFORD, V132, P21, DOI 10.1111/j.1365-2818.1983.tb04705.x; Nilsson DE, 2004, CURR OPIN NEUROBIOL, V14, P407, DOI 10.1016/j.conb.2004.07.004; Piatigorsky J, 2004, INT J DEV BIOL, V48, P719, DOI 10.1387/ijdb.041851jp; Piatigorsky J, 2001, P NATL ACAD SCI USA, V98, P12362, DOI 10.1073/pnas.231310698; PIATIGORSKY J, 1993, J BIOL CHEM, V268, P11894; Schweigart G, 2002, EUR J NEUROSCI, V15, P1585, DOI 10.1046/j.1460-9568.2002.01996.x; STANGE G, 1981, J COMP PHYSIOL, V141, P335, DOI 10.1007/BF00609936; Stewart SE, 1996, MAR FRESHW BEHAV PHY, V27, P175, DOI 10.1080/10236249609378963; Suder K, 2002, EXP BRAIN RES, V144, P430, DOI 10.1007/s00221-002-1061-5; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0	24	164	167	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					201	205		10.1038/nature03484	http://dx.doi.org/10.1038/nature03484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889091				2022-12-24	WOS:000229021100039
J	Hochedlinger, K; Yamada, Y; Beard, C; Jaenisch, R				Hochedlinger, K; Yamada, Y; Beard, C; Jaenisch, R			Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues	CELL			English	Article							EMBRYONIC STEM-CELLS; BREAST-CANCER CELLS; GENE-EXPRESSION; SOMATIC-CELLS; BETA-CATENIN; HAIR FOLLICLE; SELF-RENEWAL; ES CELLS; INTESTINAL EPITHELIUM; TRANSCRIPTION FACTOR	The POU-domain transcription factor Oct-4 is normally expressed in pluripotent cells of the mammalian embryo. In addition, germ-cell tumors and a few somatic tumors show detectable expression of Oct-4. While Oct-4's role during preimplantation development is to maintain embryonic cells in a pluripotent state, little is known about its potential oncogenic properties. Here we investigate the effect of ectopic Oct-4 expression on somatic tissues of adult mice using a doxycycline-dependent expression system. Activation of Oct-4 results in dysplastic growths in epithelial tissues that are dependent on continuous Oct-4 expression. Dysplastic lesions show an expansion of progenitor cells and increased beta-catenin transcriptional activity. In the intestine, Oct-4 expression causes dysplasia by inhibiting cellular differentiation in a manner similar to that in embryonic cells. These data show that certain adult progenitors remain competent to interpret key embryonic signals and support the notion that progenitor cells are a driving force in tumorigenesis.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02141 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NCI NIH HHS [R01 CA 87869, R37 CA 84198] Funding Source: Medline; NICHD NIH HHS [R01 HD 445022] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087869, R37CA084198] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adamson ED, 2002, J CELL PHYSIOL, V190, P267, DOI 10.1002/jcp.10072; Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Belting HG, 2001, DEVELOPMENT, V128, P4165; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Brickman JM, 2002, NAT GENET, V32, P557, DOI 10.1038/ng1202-557; Burgess S, 2002, DEVELOPMENT, V129, P905; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cheng L, 2004, CANCER-AM CANCER SOC, V101, P2006, DOI 10.1002/cncr.20566; Cheng L, 2004, AM J SURG PATHOL, V28, P1341, DOI 10.1097/01.pas.0000135528.03942.1f; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CIARDIELLO F, 1991, CANCER RES, V51, P1051; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Honecker F, 2004, WORLD J UROL, V22, P15, DOI 10.1007/s00345-004-0399-7; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones TD, 2004, AM J SURG PATHOL, V28, P935, DOI 10.1097/00000478-200407000-00014; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Looijenga LHJ, 2003, APMIS, V111, P161, DOI 10.1034/j.1600-0463.2003.11101201.x; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OGUIN WM, 1992, J INVEST DERMATOL, V98, P24, DOI 10.1111/1523-1747.ep12494172; Okuda T, 2004, MOL BRAIN RES, V132, P18, DOI 10.1016/j.molbrainres.2004.08.021; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Ramos-Mejia V, 2005, DEV DYNAM, V232, P180, DOI 10.1002/dvdy.20211; Reim G, 2002, DEVELOPMENT, V129, P917; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; SHIMAZAKI T, 1993, EMBO J, V12, P4489, DOI 10.1002/j.1460-2075.1993.tb06138.x; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Steingart RA, 2002, LIFE SCI, V71, P2543, DOI 10.1016/S0024-3205(02)02082-9; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Wang PX, 2003, BIOCHEM J, V375, P199, DOI 10.1042/BJ20030579; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Yamaguchi S, 2005, GENE CHROMOSOME CANC, V43, P217, DOI 10.1002/gcc.20171; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	83	649	699	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					465	477		10.1016/j.cell.2005.02.018	http://dx.doi.org/10.1016/j.cell.2005.02.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882627	Bronze			2022-12-24	WOS:000229031600015
J	Fung, E; Wong, WW; Suen, JK; Bulter, T; Lee, SG; Liao, JC				Fung, E; Wong, WW; Suen, JK; Bulter, T; Lee, SG; Liao, JC			A synthetic gene-metabolic oscillator	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; CELL-CELL COMMUNICATION; ESCHERICHIA-COLI; GLYCOLYTIC OSCILLATIONS; TOGGLE SWITCH; NETWORKS; EXPRESSION; REGULATORS; CLOCK; YEAST	Autonomous oscillations found in gene expression and metabolic, cardiac and neuronal systems(1-4) have attracted significant attention both because of their obvious biological roles and their intriguing dynamics. In addition, de novo designed(5-12) oscillators(13,14) have been demonstrated, using components that are not part of the natural oscillators. Such oscillators are useful in testing the design principles and in exploring potential applications not limited by natural cellular behaviour(15). To achieve transcriptional and metabolic integration characteristic of natural oscillators, here we designed and constructed a synthetic circuit in Escherichia coli K12, using glycolytic flux to generate oscillation through the signalling metabolite acetyl phosphate. If two metabolite pools are interconverted by two enzymes that are placed under the transcriptional control of acetyl phosphate, the system oscillates when the glycolytic rate exceeds a critical value. We used bifurcation analysis to identify the boundaries of oscillation, and verified these experimentally. This work demonstrates the possibility of using metabolic flux as a control factor in system-wide oscillation, as well as the predictability of a de novo gene - metabolic circuit designed using nonlinear dynamic analysis.	Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90095 USA.	liaoj@ucla.edu		Liao, James/0000-0002-4580-7276; Bulter, Thomas/0000-0002-7968-5844				Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bier M, 2000, BIOPHYS J, V78, P1087, DOI 10.1016/S0006-3495(00)76667-7; Bier M, 1996, BIOPHYS CHEM, V62, P15, DOI 10.1016/S0301-4622(96)02195-3; BROSIUS J, 1984, P NATL ACAD SCI-BIOL, V81, P6929, DOI 10.1073/pnas.81.22.6929; Bulter T, 2004, P NATL ACAD SCI USA, V101, P2299, DOI 10.1073/pnas.0306484101; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; FENG JL, 1992, J BACTERIOL, V174, P6061, DOI 10.1128/JB.174.19.6061-6070.1992; Ferry G, 2000, J BIOL CHEM, V275, P8794, DOI 10.1074/jbc.275.12.8794; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hess B, 2000, NATURWISSENSCHAFTEN, V87, P199, DOI 10.1007/s001140050704; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Joseph D., 1989, ELEMENTARY STABILITY; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Rines DR, 2002, METHOD ENZYMOL, V351, P16; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	29	294	312	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					118	122		10.1038/nature03508	http://dx.doi.org/10.1038/nature03508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875027				2022-12-24	WOS:000228864600050
J	Chendrimada, TP; Gregory, RI; Kumaraswamy, E; Norman, J; Cooch, N; Nishikura, K; Shiekhattar, R				Chendrimada, TP; Gregory, RI; Kumaraswamy, E; Norman, J; Cooch, N; Nishikura, K; Shiekhattar, R			TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing	NATURE			English	Article							RNA-BINDING-PROTEIN; MICROPROCESSOR COMPLEX; C-ELEGANS; INTERFERENCE; INITIATION; ARGONAUTE2; CELLS	MicroRNAs ( miRNAs) are generated by a two-step processing pathway to yield RNA molecules of approximately 22 nucleotides that negatively regulate target gene expression at the post-transcriptional level(1). Primary miRNAs are processed to precursor miRNAs (pre-miRNAs) by the Microprocessor complex(2-4). These pre-miRNAs are cleaved by the RNase III Dicer(5-8) to generate mature miRNAs that direct the RNA-induced silencing complex ( RISC) to messenger RNAs with complementary sequence(9). Here we show that TRBP ( the human immunodeficiency virus transactivating response RNA-binding protein(10)), which contains three double-stranded, RNA-binding domains, is an integral component of a Dicer-containing complex. Biochemical analysis of TRBP-containing complexes revealed the association of Dicer - TRBP with Argonaute 2 (Ago2)(11,12), the catalytic engine of RISC. The physical association of Dicer - TRBP and Ago2 was confirmed after the isolation of the ternary complex using Flag-tagged Ago2 cell lines. In vitro reconstitution assays demonstrated that TRBP is required for the recruitment of Ago2 to the small interfering RNA ( siRNA) bound by Dicer. Knockdown of TRBP results in destabilization of Dicer and a consequent loss of miRNA biogenesis. Finally, depletion of the Dicer - TRBP complex via exogenously introduced siRNAs diminished RISC-mediated reporter gene silencing. These results support a role of the Dicer - TRBP complex not only in miRNA processing but also as a platform for RISC assembly.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.org	Chan, Edward K. L./B-5671-2009	Chan, Edward K. L./0000-0003-3938-9503	NATIONAL CANCER INSTITUTE [P01CA072765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA072765-050002, P01 CA072765] Funding Source: Medline; NHLBI NIH HHS [R01 HL070045-03, R01 HL070045] Funding Source: Medline; NIGMS NIH HHS [R01 GM040536-15, R01 GM040536] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684	19	1458	1557	1	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					740	744		10.1038/nature03868	http://dx.doi.org/10.1038/nature03868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	15973356	Green Accepted			2022-12-24	WOS:000230964500052
J	Kato, H; Goto, DB; Martienssen, RA; Urano, T; Furukawa, K; Murakami, Y				Kato, H; Goto, DB; Martienssen, RA; Urano, T; Furukawa, K; Murakami, Y			RNA polymerase II is required for RNAi-dependent heterochromatin assembly	SCIENCE			English	Article							FISSION YEAST; LYSINE-9 METHYLATION; EPIGENETIC CONTROL; NUCLEAR-RNA; TRANSCRIPTION; RITS; DNA	In Schizosaccharomyces pombe, the RNA interference (RNAi) machinery con. verts pericentromeric transcripts into small interfering RNAs (siRNAs) and is, required for the assembly of pericentromeric heterochromatin. Here we describe a. mutation in the second largest subunit of RNA polymerase II (RNAPII). Both wild-type and mutant RNAPII localized to the pericentromere. However, the mutation resulted in the loss of heterochromatic histone modifications and in the accumulation of pericentromeric transcripts, accompanied by the loss of siRNAs. This phenotype resembles mutants in RNAi and suggests that RNAPII couples pericentromeric transcription with siRNA processing and heterochromatin assembly.	Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4668550, Japan	Kyoto University; Cold Spring Harbor Laboratory; Nagoya University	Murakami, Y (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan.	yota@virus.kyoto-u.ac.jp	Murakami, Yota/F-8850-2012; Kato, Hiroaki/B-2799-2008; Goto, Derek B/B-7053-2009; Kato, Hiroaki/T-1674-2017	Kato, Hiroaki/0000-0001-9591-1875; Urano, Takeshi/0000-0003-3383-3554	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM067014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Hamada M, 2000, J BIOL CHEM, V275, P29076, DOI 10.1074/jbc.M003980200; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; KAWAGISHIKOBAYASHI, 1996, MOL GEN GENET, V250, P1; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; TANI T, 1989, NATURE, V337, P87, DOI 10.1038/337087a0; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	19	230	240	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					467	469		10.1126/science.1114955	http://dx.doi.org/10.1126/science.1114955			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	15947136				2022-12-24	WOS:000230574900047
J	Zhao, Y; Samal, E; Srivastava, D				Zhao, Y; Samal, E; Srivastava, D			Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis	NATURE			English	Article							BHLH TRANSCRIPTION FACTOR; C-ELEGANS; CAENORHABDITIS-ELEGANS; POSTTRANSCRIPTIONAL REGULATION; CARDIAC DEVELOPMENT; GENE-EXPRESSION; SMALL RNAS; HEART; PREDICTION; MYOCARDIN	Gradients of signalling and transcription factors govern many aspects of embryogenesis, highlighting the need for spatiotemporal control of regulatory protein levels. MicroRNAs are phylogenetically conserved small RNAs that regulate the translation of target messenger RNAs, providing a mechanism for protein dose regulation. Here we show that microRNA-1-1 (miR-1-1) and miR-1-2 are specifically expressed in cardiac and skeletal muscle precursor cells. We found that the miR-1 genes are direct transcriptional targets of muscle differentiation regulators including serum response factor, MyoD and Mef2. Correspondingly, excess miR-1 in the developing heart leads to a decreased pool of proliferating ventricular cardiomyocytes. Using a new algorithm for microRNA target identification that incorporates features of RNA structure and target accessibility, we show that Hand2, a transcription factor that promotes ventricular cardiomyocyte expansion, is a target of miR-1. This work suggests that miR-1 genes titrate the effects of critical cardiac regulatory proteins to control the balance between differentiation and proliferation during cardiogenesis.	Univ Texas, SW Med Ctr, Dept Pediat Cardiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Childrens Med Ctr Dallas, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu						Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yelon D, 2000, DEVELOPMENT, V127, P2573; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	1276	1438	5	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					214	220		10.1038/nature03817	http://dx.doi.org/10.1038/nature03817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	15951802				2022-12-24	WOS:000230459500031
J	de Ruiter, PC; Wolters, V; Moore, JC; Winemiller, KO				de Ruiter, PC; Wolters, V; Moore, JC; Winemiller, KO			Food web ecology: Playing Jenga and beyond	SCIENCE			English	Editorial Material							COMMUNITY DESCRIPTION; SPECIES ABUNDANCE; BODY-SIZE; STABILITY; BIODIVERSITY; DYNAMICS		Univ Utrecht, Dept Environm Sci, Copernicus Res Inst Sustainable Dev & Innovat, NL-3508 TC Utrecht, Netherlands; Univ Giessen, Dept Anim Ecol, D-35392 Giessen, Germany; Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA; Texas A&M Univ, Dept Wildlife & Fisheries Sci, Sect Ecol & Evolutionary Biol, College Stn, TX 77843 USA	Utrecht University; Justus Liebig University Giessen; University of Northern Colorado; Texas A&M University System; Texas A&M University College Station	de Ruiter, PC (corresponding author), Univ Utrecht, Dept Environm Sci, Copernicus Res Inst Sustainable Dev & Innovat, NL-3508 TC Utrecht, Netherlands.	p.deruiter@geo.uu.nl; Volkmar.Wolters@allzool.bio.uni-giessen.de; john.moore@unco.edu; k-winemiller@tamu.edu	Wolters, Volkmar/B-4635-2010; Moore, John/E-9802-2011	Wolters, Volkmar/0000-0002-7556-4578; Winemiller, Kirk/0000-0003-0236-5129				Brose U, 2004, NATURE, V428, P167, DOI 10.1038/nature02297; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; DEANGELIS DL, 1992, DYNAMICS FOOD WEBS N; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Elton C., 1927, ANIMAL ECOLOGY; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; May R. M., 1973, STABILITY COMPLEXITY; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Odum H.T., 1983, SYSTEMS ECOLOGY INTR; PAINE RT, 1980, J ANIM ECOL, V49, P667; Polis G.A., 1996, FOOD WEBS INTEGRATIO; Thebault E, 2003, P NATL ACAD SCI USA, V100, P14949, DOI 10.1073/pnas.2434847100; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	20	96	103	0	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2005	309	5731					68	+		10.1126/science.1096112	http://dx.doi.org/10.1126/science.1096112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994518				2022-12-24	WOS:000230212800035
J	Sun, F; Huo, X; Zhai, YJ; Wang, AJ; Xu, JX; Su, D; Bartlam, M; Rao, ZH				Sun, F; Huo, X; Zhai, YJ; Wang, AJ; Xu, JX; Su, D; Bartlam, M; Rao, ZH			Crystal structure of mitochondrial respiratory membrane protein complex II	CELL			English	Article							SUCCINATE-UBIQUINONE REDUCTASE; CYTOCHROME BC(1) COMPLEX; BOVINE HEART-MITOCHONDRIA; COLI FUMARATE REDUCTASE; ANCHORING SUBUNIT QPS3; QUINONE-BINDING-SITES; ESCHERICHIA-COLI; FAMILIAL PHEOCHROMOCYTOMA; NECK PARAGANGLIOMAS; FLAVOPROTEIN GENE	The mitochondrial respiratory Complex II or succinate: ubiquinone oxidoreductase (SQR) is an integral membrane protein complex in both the tricarboxylic acid cycle and aerobic respiration. Here we report the first crystal structure of Complex II from porcine heart at 2.4 angstrom resolution and its complex structure with inhibitors 3-nitropropionate and 2-thenoyltrifluoroacetone (TTFA) at 3.5 angstrom resolution. Complex II is comprised of two hydrophilic proteins, flavoprotein (Fp) and ironsulfur protein (Ip), and two transmembrane proteins (CybL and CybS), as well as prosthetic groups required for electron transfer from succinate to ubiquinone. The structure correlates the protein environments around prosthetic groups with their unique midpoint redox potentials. Two ubiquinone binding sites are discussed and elucidated by TTFA binding. The Complex II structure provides a bona fide model for study of the mitochondrial respiratory system and human mitochondrial diseases related to mutations in this complex.	Tsinghua Univ, Tsing Hua IBP Joint Res Grp Struct Biol, Beijing 100084, Peoples R China; Chinese Acad Sci, Inst Biophys IBP, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Rao, ZH (corresponding author), Tsinghua Univ, Tsing Hua IBP Joint Res Grp Struct Biol, Beijing 100084, Peoples R China.	raozh@xtal.tsinghua.edu.cn	Su, Dan/F-8177-2010; Rao, Zihe/HCH-6944-2022; Sun, Fei/C-4190-2015; Sun, Fei/AAR-3186-2020	Sun, Fei/0000-0002-0351-5144; Sun, Fei/0000-0002-0351-5144; Bartlam, Mark/0000-0001-5173-5080				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ackrell BAC, 2002, MOL ASPECTS MED, V23, P369, DOI 10.1016/S0098-2997(02)00012-2; Astuti D, 2001, LANCET, V357, P1181, DOI 10.1016/S0140-6736(00)04378-6; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Bauters C, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.6.e75; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dekker PBD, 2003, J PATHOL, V201, P480, DOI 10.1002/path.1461; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; INGLEDEW WJ, 1976, ARCH BIOCHEM BIOPHYS, V177, P176, DOI 10.1016/0003-9861(76)90427-6; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE GY, 1995, J BIOL CHEM, V270, P6193, DOI 10.1074/jbc.270.11.6193; Lemos RS, 2002, BBA-BIOENERGETICS, V1553, P158, DOI 10.1016/S0005-2728(01)00239-0; Lu GG, 2000, J APPL CRYSTALLOGR, V33, P176, DOI 10.1107/S0021889899012339; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; MIKI T, 1992, ARCH BIOCHEM BIOPHYS, V293, P61, DOI 10.1016/0003-9861(92)90365-4; Milunsky JM, 2001, AM J MED GENET, V100, P311, DOI 10.1002/ajmg.1270; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyedotun KS, 2001, J BIOL CHEM, V276, P16936, DOI 10.1074/jbc.M100184200; Oyedotun KS, 1999, J BIOL CHEM, V274, P23956, DOI 10.1074/jbc.274.34.23956; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033; Rustin P, 2002, BBA-BIOENERGETICS, V1553, P117, DOI 10.1016/S0005-2728(01)00228-6; RUZICKA FJ, 1975, P NATL ACAD SCI USA, V72, P2886, DOI 10.1073/pnas.72.8.2886; SALERNO JC, 1977, FEBS LETT, V82, P179, DOI 10.1016/0014-5793(77)80579-6; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shenoy SK, 1999, J BIOL CHEM, V274, P8717, DOI 10.1074/jbc.274.13.8717; Shenoy SK, 1997, J BIOL CHEM, V272, P17867, DOI 10.1074/jbc.272.28.17867; Taschner PEM, 2001, GENE CHROMOSOME CANC, V31, P274, DOI 10.1002/gcc.1144; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Van Coster R, 2003, AM J MED GENET A, V120A, P13, DOI 10.1002/ajmg.a.10202; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; XU Y, 1987, BIOCHEM BIOPH RES CO, V144, P315, DOI 10.1016/S0006-291X(87)80512-0; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yankovskaya V, 1996, J BIOL CHEM, V271, P21020, DOI 10.1074/jbc.271.35.21020; YU L, 1987, J BIOL CHEM, V262, P1137; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	57	554	581	16	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1043	1057		10.1016/j.cell.2005.05.025	http://dx.doi.org/10.1016/j.cell.2005.05.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989954	Bronze			2022-12-24	WOS:000230448000011
J	Becks, L; Hilker, FM; Malchow, H; Jurgens, K; Arndt, H				Becks, L; Hilker, FM; Malchow, H; Jurgens, K; Arndt, H			Experimental demonstration of chaos in a microbial food web	NATURE			English	Article							PREDATOR-PREY SYSTEM; LYAPUNOV EXPONENTS; DYNAMICS; CYCLES; POPULATIONS; BIFURCATION; DIVERSITY; BACTERIA	Discovering why natural population densities change over time and vary with location is a central goal of ecological and evolutional disciplines. The recognition that even simple ecological systems can undergo chaotic behaviour has made chaos a topic of considerable interest among theoretical ecologists(1-4). However, there is still a lack of experimental evidence that chaotic behaviour occurs in the real world of coexisting populations in multi-species systems. Here we study the dynamics of a defined predator - prey system consisting of a bacterivorous ciliate and two bacterial prey species. The bacterial species preferred by the ciliate was the superior competitor. Experimental conditions were kept constant with continuous cultivation in a one-stage chemostat. We show that the dynamic behaviour of such a two-prey, one-predator system includes chaotic behaviour, as well as stable limit cycles and coexistence at equilibrium. Changes in the population dynamics were triggered by changes in the dilution rates of the chemostat. The observed dynamics were verified by estimating the corresponding Lyapunov exponents. Such a defined microbial food web offers a new possibility for the experimental study of deterministic chaos in real biological systems.	Univ Cologne, Inst Zool, Dept Gen Ecol & Limnol, D-50923 Cologne, Germany; Univ Osnabruck, Inst Environm Syst Res, Dept Math & Comp Sci, D-49069 Osnabruck, Germany; Max Planck Inst Limnol, D-24302 Plon, Germany; Balt Sea Res Inst, D-18119 Rostock, Germany	University of Cologne; University Osnabruck; Max Planck Society	Arndt, H (corresponding author), Univ Cologne, Inst Zool, Dept Gen Ecol & Limnol, D-50923 Cologne, Germany.	hartmut.arndt@uni-koeln.de	Hilker, Frank/B-8624-2008; Arndt, Hartmut/K-9364-2017; Becks, Lutz/I-8256-2012	Hilker, Frank/0000-0001-5470-8889; Arndt, Hartmut/0000-0003-2811-3595; Jurgens, Klaus/0000-0002-7999-9368				Arndt H., 2000, FLAGELLATES, P240; BEGON M, 2002, ECOLOGY; CARON DA, 1982, SCIENCE, V218, P795, DOI 10.1126/science.218.4574.795; Christoffersen K, 1997, AQUAT MICROB ECOL, V13, P127, DOI 10.3354/ame013127; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; Dennis B, 1997, J ANIM ECOL, V66, P704, DOI 10.2307/5923; Eisenmann H, 1998, APPL ENVIRON MICROB, V64, P1264; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; GILPIN ME, 1979, AM NAT, V113, P306, DOI 10.1086/283389; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; HEERKLOSS R, 1993, VERH INT VEREIN LIMN, V25, P995; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; JOST JL, 1973, J BACTERIOL, V113, P834, DOI 10.1128/JB.113.2.834-840.1973; KANTZ H, 1994, PHYS LETT A, V185, P77, DOI 10.1016/0375-9601(94)90991-1; Kooi BW, 2003, DYNAM CONT DIS SER B, V10, P259; LUCKINBILL LS, 1978, ECOLOGY, V59, P1271, DOI 10.2307/1938241; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; Nelson WA, 2005, NATURE, V433, P413, DOI 10.1038/nature03212; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; TAKEUCHI Y, 1983, B MATH BIOL, V45, P877, DOI 10.1007/BF02458820; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Vayenas DV, 1999, MATH BIOSCI, V162, P69, DOI 10.1016/S0025-5564(99)00044-9; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	30	161	167	2	76	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1226	1229		10.1038/nature03627	http://dx.doi.org/10.1038/nature03627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988524				2022-12-24	WOS:000230140500042
J	Kurz, T; Ozlu, N; Rudolf, F; O'Rourke, SM; Luke, B; Hofmann, K; Hyman, AA; Bowerman, B; Peter, M				Kurz, T; Ozlu, N; Rudolf, F; O'Rourke, SM; Luke, B; Hofmann, K; Hyman, AA; Bowerman, B; Peter, M			The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C-elegans and S-cerevisiae	NATURE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; MODIFICATION PATHWAY; UBIQUITIN LIGASES; NEDD8; CUL1; DEGRADATION; COMPLEX; SCF; DESTRUCTION; CLEAVAGE	SCF-type E3 ubiquitin ligases are multi-protein complexes required for polyubiquitination and subsequent degradation of target proteins by the 26S proteasome(1). Cullins, together with the RING-finger protein Rbx1, form the catalytic core of the ligase, and recruit the substrate-recognition module(1-4). Cycles of covalent modification of cullins by the ubiquitin-like molecule Nedd8 (neddylation)(5) and removal of Nedd8 by the COP9 signalosome (deneddylation) positively regulate E3 ligase activity(6,7). Here we report the identification and analysis of a widely conserved protein that is required for cullin neddylation in the nematode Caenorhabditis elegans and the yeast Saccharomyces cerevisiae. C. elegans DCN-1 and S. cerevisiae Dcn1p ( defective in cullin neddylation) are characterized by a novel UBA-like ubiquitin-binding domain and a DUF298 domain of unknown function. Consistent with their requirements for neddylation, DCN-1 and Dcn1p directly bind Nedd8 and physically associate with cullins in both species. Moreover, overexpression of Dcn1p in yeast results in the accumulation of Nedd8-modified cullin Cdc53p. Both in vivo and in vitro experiments indicate that Dcn1p does not inhibit deneddylation of Cdc53p by the COP9 signalosome, but greatly increases the kinetics of the neddylation reaction.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Memorec Biotec GmbH, D-50829 Cologne, Germany	University of Oregon; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Peter, M (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	matthias.peter@bc.biol.ethz.ch	Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Kurz, Thimo/E-4116-2012; Hofmann, Kay/D-6714-2011	Hyman, Anthony A/0000-0003-3664-154X; Hofmann, Kay/0000-0002-2289-9083; Kurz, Thimo/0000-0003-0700-6993; Peter, Matthias/0000-0002-2160-6824; Luke, Brian/0000-0002-1648-5511				Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Dow MR, 1998, GENETICS, V150, P119; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Guthrie C, 1991, GUIDE YEAST GENETICS; Hofmann K, 2000, Brief Bioinform, V1, P167, DOI 10.1093/bib/1.2.167; Jaquenoud M, 1998, EMBO J, V17, P5360, DOI 10.1093/emboj/17.18.5360; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Srayko M, 2000, GENE DEV, V14, P1072; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Verma R, 1997, METHOD ENZYMOL, V283, P366; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	29	146	159	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1257	1261		10.1038/nature03662	http://dx.doi.org/10.1038/nature03662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988528				2022-12-24	WOS:000230140500048
J	Liu, JG; Diamond, J				Liu, JG; Diamond, J			China's environment in a globalizing world	NATURE			English	Article							ACID DEPOSITION; TRADE		Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China; Fudan Univ, Shanghai 200433, Peoples R China; Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	Michigan State University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Fudan University; University of California System; University of California Los Angeles	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	jliu@panda.msu.edu; jdiamond@geog.ucla.edu	liang, jiwang/A-5334-2009; Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039789] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD39789] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS M, 2001, ITTO NEWSLETTER; Brown L.R., 1995, WHO WILL FEED CHINA; Chai JCH, 2002, SUSTAIN DEV, V10, P25, DOI 10.1002/sd.174; DAI Q, 1998, RIVER DRAGON HAS COM, P3; Dean JM, 2002, CAN J ECON, V35, P819, DOI 10.1111/0008-4085.00155; *ED BOARD, 2000, ENV PROT CHIN; *ED BOARD, 2001, ATL POP ENV SUST DEV; Feng ZW, 2002, J ENVIRON SCI-CHINA, V14, P227; GUO X, 2004, CHINA ENV DEV REV, V2, P53; Holden C, 2001, SCIENCE, V294, P2457; Johnson Todd M., 1997, CLEAR WATER BLUE SKI; Liu JG, 2003, SCIENCE, V300, P1240, DOI 10.1126/science.1078868; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; *NAT BUR STAT CHIN, 2000, CHIN STAT YB 2000; National Bureau of Statistics of China, 2004, CHIN STAT YB 2003; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; QU G, 2000, DREAM EXPECTATION PA; *SEPA, 1999, REP CHIN EC ISS; United Nations Center for Human Settlement (HABITAT), 2001, CIT GLOB WORLD GLOB; World Bank, 2001, CHIN AIR LAND WAT; Xie Y, 2001, BIODIVERS CONSERV, V10, P1317, DOI 10.1023/A:1016695609745; XIE Z, 1997, GREENING STRATEGY, P44; Xu XP, 1998, ECOSYST HEALTH, V4, P199, DOI 10.1046/j.1526-0992.1998.98096.x; Yang L, 2002, PHYTON-ANN REI BOT A, V42, P255; YE R, 2001, ENV TRADE; ZHANG P, INTRO NATURAL FOREST, P99	26	1203	1323	28	650	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1179	1186		10.1038/4351179a	http://dx.doi.org/10.1038/4351179a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988514	Bronze			2022-12-24	WOS:000230140500032
J	Bhandawat, V; Reisert, J; Yau, KW				Bhandawat, V; Reisert, J; Yau, KW			Elementary response of olfactory receptor neurons to odorants	SCIENCE			English	Article							RETINAL RODS; CELLS; CALCIUM; DESENSITIZATION; TRANSDUCTION; PHOTOTRANSDUCTION; ADAPTATION; SALAMANDER; MECHANISM; MAGNESIUM	Signaling by heterotrimeric GTP-binding proteins (G proteins) drives numerous cellular processes. The number of G protein molecules activated by a single membrane receptor is a determinant of signal amplification, although in most cases this parameter remains unknown. In retinal rod photoreceptors, a long-lived photoisomerized rhodopsin molecule activates many G protein molecules (transducins), yielding substantial amplification and a large elementary (single-photon) response, before rhodopsin activity is terminated. Here we report that the elementary response in olfactory transduction is extremely small. A ligand-bound odorant receptor has a low probability of activating even one G protein molecule because the odorant dwell-time is very brief. Thus, signal amplification in olfactory transduction appears fundamentally different from that of phototransduction.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Bhandawat, V (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Room 907,Preclin Teaching Bldg,725 N Wolfe St, Baltimore, MD 21205 USA.	vbhanda@mail.jhmi.edu; kwyau@mail.jhmi.edu			NEI NIH HHS [R01 EY006837-18, R01 EY014596, R01 EY014596-03, R37 EY006837-15S1, R01 EY014596-01, R01 EY006837-17, R01 EY006837, R37 EY006837, R01 EY006837-16A1, R01 EY014596-02, R37 EY006837-15] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904, DC06904, R01 DC006904-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006837, R01EY014596, R37EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; GOLD GH, 1995, NATURE, V376, P27, DOI 10.1038/376027a0; KLEENE SJ, 1995, NEUROSCIENCE, V66, P1001, DOI 10.1016/0306-4522(94)00634-H; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; LOWE G, 1995, P NATL ACAD SCI USA, V92, P7864, DOI 10.1073/pnas.92.17.7864; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; MENINI A, 1995, NATURE, V373, P435, DOI 10.1038/373435a0; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9	24	110	114	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1931	1934		10.1126/science.1109886	http://dx.doi.org/10.1126/science.1109886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976304	Green Accepted			2022-12-24	WOS:000230120000046
J	Escher, P; Lacazette, E; Courtet, M; Blindenbacher, A; Landmann, L; Bezakova, G; Lloyd, KC; Mueller, U; Brenner, HR				Escher, P; Lacazette, E; Courtet, M; Blindenbacher, A; Landmann, L; Bezakova, G; Lloyd, KC; Mueller, U; Brenner, HR			Synapses form in skeletal muscles lacking neuregulin receptors	SCIENCE			English	Article							ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; IN-VIVO; DIFFERENTIATION; SUBUNIT; ERBB4; MICE; PROTEIN	The formation of the neuromuscular junction (NMJ) is directed by reciprocal interactions between motor neurons and muscle fibers. Neuregulin (NRG) and Agrin from motor nerve terminals are both implicated. Here, we demonstrate that NMJs can form in the absence of the NRG receptors ErbB2 and ErbB4 in mouse muscle. Postsynaptic differentiation is, however, induced by Agrin. We therefore conclude that NRG signaling to muscle is not required for NMJ formation. The effects of NRG signaling to muscle may be mediated indirectly through Schwann cells.	Univ Basel, Inst Physiol, CH-4056 Basel, Switzerland; Univ Basel, Inst Anat, Dept Clin Biol Sci, CH-4056 Basel, Switzerland; Univ Basel, Div Pharmacol, Biozentrum, CH-4056 Basel, Switzerland; Univ Calif Davis, Ctr Comparat Med, Sch Vet Med, Davis, CA 95616 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	University of Basel; University of Basel; University of Basel; University of California System; University of California Davis; Scripps Research Institute; Scripps Research Institute	Escher, P (corresponding author), Univ Basel, Inst Physiol, CH-4056 Basel, Switzerland.	Hans-Rudolf.Brenner@unibas.ch	Lacazette, eric/M-7168-2014	lacazette, eric/0000-0003-1234-5260				BEZAKOVA G, UNPUB; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9; Cossins J, 2004, HUM MOL GENET, V13, P2947, DOI 10.1093/hmg/ddh320; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; ESCHER P, UNPUB; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Hashemolhosseini S, 2000, MOL CELL NEUROSCI, V16, P697, DOI 10.1006/mcne.2000.0911; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; Leu M, 2003, DEVELOPMENT, V130, P2291, DOI 10.1242/dev.00447; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Meier T, 1997, J NEUROSCI, V17, P6534; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Rimer M, 2004, MOL CELL NEUROSCI, V26, P271, DOI 10.1016/j.mcn.2004.02.002; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Witzemann V, 1996, P NATL ACAD SCI USA, V93, P13286, DOI 10.1073/pnas.93.23.13286; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	28	93	95	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1920	1923		10.1126/science.1108258	http://dx.doi.org/10.1126/science.1108258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976301				2022-12-24	WOS:000230120000043
J	Solomon, SD; Zelenkofske, S; McMurray, JJV; Finn, PV; Velazquez, E; Ertl, G; Harsanyi, A; Rouleau, JL; Maggioni, A; Kober, L; White, H; Van de Werf, F; Pieper, K; Califf, RM; Pfeffer, MA				Solomon, SD; Zelenkofske, S; McMurray, JJV; Finn, PV; Velazquez, E; Ertl, G; Harsanyi, A; Rouleau, JL; Maggioni, A; Kober, L; White, H; Van de Werf, F; Pieper, K; Califf, RM; Pfeffer, MA		VALIANT Investigators	Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; CARDIAC DEATH; RISK STRATIFICATION	Background The risk of sudden death from cardiac causes is increased among survivors of acute myocardial infarction with reduced left ventricular systolic function. We assessed the risk and time course of sudden death in high-risk patients after myocardial infarction. Methods We studied 14,609 patients with left ventricular dysfunction, heart failure, or both after myocardial infarction to assess the incidence and timing of sudden unexpected death or cardiac arrest with resuscitation in relation to the left ventricular ejection fraction. Results Of 14,609 patients, 1067 (7 percent) had an event a median of 180 days after myocardial infarction: 903 died suddenly, and 164 were resuscitated after cardiac arrest. The risk was highest in the first 30 days after myocardial infarction -- 1.4 percent per month (95 percent confidence interval, 1.2 to 1.6 percent) -- and decreased to 0.14 percent per month (95 percent confidence interval, 0.11 to 0.18 percent) after 2 years. Patients with a left ventricular ejection fraction of 30 percent or less were at highest risk in this early period (rate, 2.3 percent per month; 95 percent confidence interval, 1.8 to 2.8 percent). Nineteen percent of all sudden deaths or episodes of cardiac arrest with resuscitation occurred within the first 30 days after myocardial infarction, and 83 percent of all patients who died suddenly did so in the first 30 days after hospital discharge. Each decrease of 5 percentage points in the left ventricular ejection fraction was associated with a 21 percent adjusted increase in the risk of sudden death or cardiac arrest with resuscitation in the first 30 days. Conclusions The risk of sudden death is highest in the first 30 days after myocardial infarction among patients with left ventricular dysfunction, heart failure, or both. Thus, earlier implementation of strategies for preventing sudden death may be warranted in selected patients.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Novartis Pharmaceut, E Hanover, NJ USA; Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland; Duke Univ, Med Ctr, Durham, NC USA; Univ Wurzburg, Wurzburg, Germany; Natl Ctr Hlth Serv, Budapest, Hungary; Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; Assoc Nazl Med Cardiol Osped Res Ctr, Florence, Italy; Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; Green Lane Hosp, Dept Cardiol, Auckland 3, New Zealand; Leuven Coordinating Ctr, Louvain, Belgium	Harvard University; Brigham & Women's Hospital; Novartis; University of Glasgow; Duke University; University of Wurzburg; Universite de Montreal; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Rigshospitalet; University of Copenhagen; KU Leuven	Solomon, SD (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	ssolomon@rics.bwh.harvard.edu	mcmurray, John/B-2467-2013; Solomon, Scott/I-5789-2013; Maggioni, Aldo Pietro/AAL-5334-2020	mcmurray, John/0000-0002-6317-3975; Maggioni, Aldo Pietro/0000-0003-2764-6779; Kober, Lars/0000-0002-6635-1466; Van de Werf, Frans/0000-0001-9479-7767; Patt, Mitchell/0000-0001-9696-4477				ALKHATIB SM, IN PRESS AM HEART J; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Buxton AE, 2000, NEW ENGL J MED, V343, P1813; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; CALIFF RM, 1982, AM J CARDIOL, V50, P23, DOI 10.1016/0002-9149(82)90004-2; Every N, 2002, AM HEART J, V144, P390, DOI 10.1067/mhj.2002.125495; Hohnloser SH, 2000, AM HEART J, V140, P735, DOI 10.1067/mhj.2000.110088; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; MYERBURG RJ, 1993, ANN INTERN MED, V119, P1187, DOI 10.7326/0003-4819-119-12-199312150-00006; Naccarella F, 2000, CURR OPIN CARDIOL, V15, P1, DOI 10.1097/00001573-200001000-00001; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Savard P, 1997, CIRCULATION, V96, P202; STEINBERG JS, 1992, AM J CARDIOL, V69, P13, DOI 10.1016/0002-9149(92)90669-P; Uretsky BF, 2000, CIRCULATION, V102, P611, DOI 10.1161/01.CIR.102.6.611; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	23	548	568	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2581	2588		10.1056/NEJMoa043938	http://dx.doi.org/10.1056/NEJMoa043938			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972864				2022-12-24	WOS:000229953700005
J	Waxman, HA				Waxman, HA			The lessons of Vioxx - Drug safety and sales	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Dai CL, 2005, ARCH INTERN MED, V165, P171, DOI 10.1001/archinte.165.2.171; *FDA ADV COMM, 2001, 21042S007 NDA FDA AD; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; ROSE JL, 2002, PHYS EXPECTATIONS IN; *US HOUS REPR COMM, MERCK DOC SHOW AGGR	5	80	83	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2576	2578		10.1056/NEJMp058136	http://dx.doi.org/10.1056/NEJMp058136			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972862				2022-12-24	WOS:000229953700003
J	Obermann, K				Obermann, K			When the patient comes back	LANCET			English	Editorial Material									CHD Eastern Visayas, GTZ Hlth Sector Philippines, Palo 6501, Leyte, Philippines		Obermann, K (corresponding author), CHD Eastern Visayas, GTZ Hlth Sector Philippines, Palo 6501, Leyte, Philippines.	obermannk@gmx.de							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 18	2005	365	9477					2149	2149		10.1016/S0140-6736(05)66741-4	http://dx.doi.org/10.1016/S0140-6736(05)66741-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936LZ	15964454				2022-12-24	WOS:000229858800035
J	Kuzuyama, T; Noel, JP; Richard, SB				Kuzuyama, T; Noel, JP; Richard, SB			Structural basis for the promiscuous biosynthetic prenylation of aromatic natural products	NATURE			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; PROTEIN FARNESYLTRANSFERASE; POLYKETIDE SYNTHASE; BINDING PROTEIN; RESOLUTION; PRENYLTRANSFERASE; IDENTIFICATION; MECHANISM; ENZYMES	The anti-oxidant naphterpin is a natural product containing a polyketide-based aromatic core with an attached 10-carbon geranyl group derived from isoprenoid ( terpene) metabolism(1-3). Hybrid natural products such as naphterpin that contain 5-carbon ( dimethylallyl), 10-carbon ( geranyl) or 15-carbon ( farnesyl) isoprenoid chains possess biological activities distinct from their non-prenylated aromatic precursors(4). These hybrid natural products represent new anti-microbial, anti-oxidant, anti-inflammatory, anti-viral and anti-cancer compounds. A small number of aromatic prenyltransferases (PTases) responsible for prenyl group attachment have only recently been isolated and characterized(5,6). Here we report the gene identification, biochemical characterization and high-resolution X-ray crystal structures of an architecturally novel aromatic PTase, Orf2 from Streptomyces sp. strain CL190, with substrates and substrate analogues bound. In vivo, Orf2 attaches a geranyl group to a 1,3,6,8-tetrahydroxynaphthalene-derived polyketide during naphterpin biosynthesis. In vitro, Orf2 catalyses carbon-carbon-based and carbon-oxygen-based prenylation of a diverse collection of hydroxyl-containing aromatic acceptors of synthetic, microbial and plant origin. These crystal structures, coupled with in vitro assays, provide a basis for understanding and potentially manipulating the regio-specific prenylation of aromatic small molecules using this structurally unique family of aromatic PTases.	Salk Inst Biol Studies, Jack Skirball Chem Biol & Proteom Lab, La Jolla, CA 92037 USA; Univ Tokyo, Biotechnol Res Ctr, Lab Cell Biotechnol, Tokyo 1138657, Japan	Salk Institute; University of Tokyo	Richard, SB (corresponding author), Salk Inst Biol Studies, Jack Skirball Chem Biol & Proteom Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	richard@salk.edu	Noel, Joseph P/A-9459-2009	Kuzuyama, Tomohisa/0000-0002-7221-5858	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241; Branden C., 1999, INTRO PROTEIN STRUCT; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNO M, 1985, HETEROCYCLES, V23, P1147, DOI 10.3987/R-1985-05-1147; CANE DE, 1998, ISOPRENOIDS INCLUDIN; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Izumikawa M, 2003, J IND MICROBIOL BIOT, V30, P510, DOI 10.1007/s10295-003-0075-8; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kharel Y, 2003, NAT PROD REP, V20, P111, DOI 10.1039/b108934j; Koyama T, 1996, BIOCHEMISTRY-US, V35, P9533, DOI 10.1021/bi960137v; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SCHUTZ BA, 1995, PHYTOCHEMISTRY, V40, P1273, DOI 10.1016/0031-9422(95)00508-5; Seto H, 1996, TETRAHEDRON LETT, V37, P7979, DOI 10.1016/0040-4039(96)01787-X; SHIN-YA K, 1990, Tetrahedron Letters, V31, P6025, DOI 10.1016/S0040-4039(00)98019-5; SHINYA K, 1990, J ANTIBIOT, V43, P444, DOI 10.7164/antibiotics.43.444; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Taura F, 1996, J BIOL CHEM, V271, P17411, DOI 10.1074/jbc.271.29.17411; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; XU ZH, 1993, J BIOL CHEM, V268, P7874	29	238	252	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					983	987		10.1038/nature03668	http://dx.doi.org/10.1038/nature03668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959519	Green Accepted, Green Submitted			2022-12-24	WOS:000229799700055
J	Flewelling, LJ; Naar, JP; Abbott, JP; Baden, DG; Barros, NB; Bossart, GD; Bottein, MYD; Hammond, DG; Haubold, EM; Heil, CA; Henry, MS; Jacocks, HM; Leighfield, TA; Pierce, RH; Pitchford, TD; Rommel, SA; Scott, PS; Steidinger, KA; Truby, EW; Van Dolah, FM; Landsberg, JH				Flewelling, LJ; Naar, JP; Abbott, JP; Baden, DG; Barros, NB; Bossart, GD; Bottein, MYD; Hammond, DG; Haubold, EM; Heil, CA; Henry, MS; Jacocks, HM; Leighfield, TA; Pierce, RH; Pitchford, TD; Rommel, SA; Scott, PS; Steidinger, KA; Truby, EW; Van Dolah, FM; Landsberg, JH			Brevetoxicosis: Red tides and marine mammal mortalities	NATURE			English	Editorial Material							DINOFLAGELLATE		Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA; Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28409 USA; Mote Marine Lab, Sarasota, FL 34236 USA; Harbor Branch Oceanog Inst Inc, Ft Pierce, FL 34946 USA; NOAA, NOS, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC 29412 USA	Florida Fish & Wildlife Conservation Commission; University of North Carolina; University of North Carolina Wilmington; Mote Marine Laboratory & Aquarium; Harbor Branch Oceanographic Institute Foundation; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Flewelling, LJ (corresponding author), Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA.	naarj@uncw.edu	Bottein, Marie-Yasmine Dechraoui/J-8851-2018	Dechraoui Bottein, Marie-Yasmine/0000-0002-6468-7222	NIEHS NIH HHS [P01 ES010594-05, P01 ES010594] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES010594] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], HARMFUL ALGAL BLOOMS; BADEN DG, 1982, TOXICON, V20, P457, DOI 10.1016/0041-0101(82)90009-5; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; GERACI J, 1989, CLIN INVESTIGATION 1; OSHEA TJ, 1991, MAR MAMMAL SCI, V7, P165, DOI 10.1111/j.1748-7692.1991.tb00563.x; Ross PS, 2000, HUM ECOL RISK ASSESS, V6, P29, DOI 10.1080/10807030091124437; Steidinger Karen A., 1993, P1; Van Dolah FM, 2003, N P TOX ENV, P247; *WORK GROUP MAR MA, 2004, BOTTL DOLPH TURS TRU	9	297	308	3	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					755	756		10.1038/nature435755a	http://dx.doi.org/10.1038/nature435755a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944690	Green Accepted			2022-12-24	WOS:000229638700036
J	Drobniewski, F; Balabanova, Y; Nikolayevsky, V; Ruddy, M; Kuznetzov, S; Zakharova, S; Melemyev, A; Fedorin, I				Drobniewski, F; Balabanova, Y; Nikolayevsky, V; Ruddy, M; Kuznetzov, S; Zakharova, S; Melemyev, A; Fedorin, I			Drug-resistant, tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; TREATMENT FAILURE; IMMUNE-RESPONSE; GENOTYPE; EPIDEMIOLOGY; VIETNAM; SPREAD; RISK	Context Tuberculosis and multidrug-resistant tuberculosis is a serious public health problem in Russia. Objective To address the extent of "Beijing strain" transmission in the prison/civil sectors and the association of drug resistance, clinical, and social factors with the Beijing genotype. Design and Setting Cross-sectional population-based molecular epidemiological study of all civilian and penitentiary tuberculosis facilities in the Samara region, Russia. Patients Consecutively recruited patients with bacteriologically proven tuberculosis (n = 880). Main Outcome Measure Proportion of Beijing strains and association with drug resistance, human immunodeficiency virus infection, imprisonment, radiological, clinical, and other social factors. Results Beijing-family strains (identified by spoligotyping and composed of 2 main types by mycobacterial interspersed repetitive unit analysis) were predominant: 586/880 (66.6%; 95% confidence interval ICU, 63.4%-69.7%) with a significantly higher prevalence in the prison population (rate ratio [RR], 1.3; 95% Cl, 1.2-1.5) and those aged younger than 35 years (RR, 1.2; 95% Cl, 1.0-1.3). Comparable proportions were coinfected with the human immunodeficiency virus ( 10%), concurrent hepatitis B and C (21.6%), drank alcohol (approximate to 90%), smoked (approximate to 90%), and had a similar sexual history. Drug resistance was nearly 2-fold higher in patients infected with Beijing strains compared with non-Beijing strains: multidrug resistance (RR, 2.4; 95% Cl, 1.9-3.0), for isoniazid (RR, 1.8; 95% Cl, 1.5-2.1), for rifampicin (RR, 2.2; 95% Cl, 1.7-2.7), for streptomycin (RR, 1.9; 95% Cl, 1.5-2.3), and for ethambutol (RR, 2.2; 95% Cl, 1.63.2). Univariate analysis demonstrated that male sex (odds ratio [OR], 1.5; 95% Cl, 1.1-1.9), advanced radiological abnormalities (OR, 3.3; 95% Cl, 1.3-8.4), homelessness (OR, 5.6; 95% Cl, 1.1-6.3), and previous imprisonment (OR, 2.0; 95% Cl, 1.52.7) were strongly associated with Beijing-strain family disease. Multivariate analysis supported previous imprisonment to be a risk factor (OR, 2.0; 95% Cl, 1.4-3.3) and night sweats to be less associated (OR 0.7; 95% Cl, 0.5-1.0) with Beijing-strain disease. Conclusions Drug resistance and previous imprisonment but not human immunodeficiency virus co-infection were significantly associated with Beijing-strain infection. There was evidence that Beijing isolates caused radiologically more advanced disease.	Guys & St Thomas Med Sch, Dept Microbiol & Infect, HPA Mycobacterium Reference Unit, London, England; Samara Reg TB Serv, Samara Oblast Dispensary, Samara, Russia; Samara City TB Serv, Samara, Russia; Samara Reg Minist Hlth, Samara, Russia; Samara Prison TB Serv, Samara, Russia	University of London; King's College London	Drobniewski, F (corresponding author), Queen Marys Sch Med, Inst Cell & Mol Sci, Ctr Clin Sci, Newark St, London E1, England.	francis.drobniewski@kcl.ac.uk	Nikolayevskyy, Vladyslav/HFZ-7738-2022	Nikolayevskyy, Vladyslav/0000-0002-9502-0332				ABRAMSON JH, 2001, COMPUTER PROGRAMS EP; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Borydorff MW, 2004, TUBERCULOSIS, V84, P337, DOI 10.1016/j.tube.2003.10.002; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Coker RJ, 2003, INT J TUBERC LUNG D, V7, P920; Drobniewski F, 2004, CURR OPIN PULM MED, V10, P211, DOI 10.1097/00063198-200405000-00011; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Kimerling ME, 2003, INT J TUBERC LUNG D, V7, P866; Kruuner A, 2002, CLIN INFECT DIS, V35, P146, DOI 10.1086/340980; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; Lillebaek T, 2003, EMERG INFECT DIS, V9, P1553, DOI 10.3201/eid0912.030276; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; NARVSKAIA OV, 2002, PROBL TUBERK, V3, P50; Narvskaya O, 2002, EUR J CLIN MICROBIOL, V21, P596, DOI 10.1007/s10096-002-0775-4; Pfyffer GE, 2001, EMERG INFECT DIS, V7, P855, DOI 10.3201/eid0705.017514; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Toungoussova OS, 2002, INT J TUBERC LUNG D, V6, P406; Tracevska T, 2003, INT J TUBERC LUNG D, V7, P1097; Van Soolingen D, 2001, J MED MICROBIOL, V50, P749, DOI 10.1099/0022-1317-50-9-749; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1995, EUR RESPIR J, V8, pS649	26	193	204	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2726	2731		10.1001/jama.293.22.2726	http://dx.doi.org/10.1001/jama.293.22.2726			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933OV	15941801	Bronze			2022-12-24	WOS:000229643700020
J	Dharmasiri, N; Dharmasiri, S; Estelle, M				Dharmasiri, N; Dharmasiri, S; Estelle, M			The F-box protein TIR1 is an auxin receptor	NATURE			English	Article							SCF UBIQUITIN-LIGASE; AUX/IAA PROTEINS; DEGRADATION; COMPLEX; MECHANISMS; EXPRESSION; BINDING; GROWTH; DOMAIN; GENES	The plant hormone auxin regulates diverse aspects of plant growth and development. Recent studies indicate that auxin acts by promoting the degradation of the Aux/IAA transcriptional repressors through the action of the ubiquitin protein ligase SCFTIR1. The nature of the signalling cascade that leads to this effect is not known. However, recent studies indicate that the auxin receptor and other signalling components involved in this response are soluble factors. Using an in vitro pull-down assay, we demonstrate that the interaction between transport inhibitor response 1 (TIR1) and Aux/IAA proteins does not require stable modification of either protein. Instead auxin promotes the Aux/IAA-SCFTIR1 interaction by binding directly to SCFTIR1. We further show that the loss of TIR1 and three related F-box proteins eliminates saturable auxin binding in plant extracts. Finally, TIR1 synthesized in insect cells binds Aux/IAA proteins in an auxin-dependent manner. Together, these results indicate that TIR1 is an auxin receptor that mediates Aux/IAA degradation and auxin-regulated transcription.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Estelle, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	maestell@indiana.edu	Estelle, Mark/ABD-6742-2021					BLATT MR, 1994, PLANT J, V5, P55, DOI 10.1046/j.1365-313X.1994.5010055.x; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Davies Peter J., 1995, P1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Frias I, 1996, PLANT CELL, V8, P1533; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Luthen H, 1999, PROG BOT, V60, P315; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Philippar K, 1999, P NATL ACAD SCI USA, V96, P12186, DOI 10.1073/pnas.96.21.12186; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Tian Q, 2003, PLANT J, V36, P643, DOI 10.1046/j.1365-313X.2003.01909.x; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Weijers D, 2005, CURR OPIN PLANT BIOL, V8, P32, DOI 10.1016/j.pbi.2004.11.001; WENT F. W., 1928, REC TRAV BOT NEERL, V25, P1; Willemsen V, 2004, ANNU REV GENET, V38, P587, DOI 10.1146/annurev.genet.38.072902.092231; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yang XQ, 2004, PLANT J, V40, P772, DOI 10.1111/j.1365-313X.2004.02254.x; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	30	1431	1590	20	386	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					441	445		10.1038/nature03543	http://dx.doi.org/10.1038/nature03543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917797				2022-12-24	WOS:000229337800043
J	Holmes, MD; Chen, WY; Feskanich, D; Kroenke, CH; Colditz, GA				Holmes, MD; Chen, WY; Feskanich, D; Kroenke, CH; Colditz, GA			Physical activity and survival after breast cancer diagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; ADJUVANT CHEMOTHERAPY; WEIGHT-GAIN; RISK; EXERCISE; VALIDITY; DISEASE; OBESITY	Context Physical activity has been shown to decrease the incidence of breast cancer, but the effect on recurrence or survival after a breast cancer diagnosis is not known. Objective To determine whether physical activity among women with breast cancer decreases their risk of death from breast cancer compared with more sedentary women. Design, Setting, and Participants Prospective observational study based on responses from 2987 female registered nurses in the Nurses' Health Study who were diagnosed with stage I, II, or III breast cancer between 1984 and 1998 and who were followed up until death or June 2002, whichever came first. Main Outcome Measure Breast cancer mortality risk according to physical activity category (<3, 3-8.9, 9-14.9,15-23.9, or >= 24 metabolic equivalenttask [MET] hours per week). Results Compared with women who engaged in less than 3 MET-hours per week of physical activity, the adjusted relative risk (RR) of death from breast cancer was 0.80 (95% confidence interval [CI], 0.60-1.06) for 3 to 8.9 MET-hours per week; 0.50 (95% Cl, 0.31-0.82) for 9 to 14.9 MET-hours per week; 0.56 (95% Cl, 0.38-0.84) for 15 to 23.9 MET-hours per week; and 0.60 (95% Cl, 0.40-0.89) for 24 or more MET-hours per week (P for trend =.004). Three MET-hours is equivalent to walking at average pace of 2 to 2.9 mph for 1 hour. The benefit of physical activity was particularly apparent among women with hormone-responsive tumors. The RR of breast cancer death for women with hormone-responsive tumors who engaged in 9 or more MET-hours per week of activity compared with women with hormone-responsive tumors who engaged in less than 9 MET-hours per week was 0.50 (95% Cl, 0.34-0.74). Compared with women who engaged in less than 3 MET-hours per week of activity, the absolute unadjusted mortality risk reduction was 6% at 10 years for women who engaged in 9 or more MET-hours per week. Conclusions Physical activity after a breast cancer diagnosis may reduce the risk of death from this disease. The greatest benefit occurred in women who performed the equivalent of walking 3 to 5 hours per week at an average pace, with little evidence of a correlation between increased benefit and greater energy expenditure. Women with breast cancer who follow US physical activity recommendations may improve their survival.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Holmes, MD (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.	michelle.holmes@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Holmes, Michelle/0000-0002-8664-2172	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Bartelink H, 2001, NEW ENGL J MED, V345, P1378, DOI 10.1056/NEJMoa010874; BASTARRACHEA J, 1994, ANN INTERN MED, V120, P18, DOI 10.7326/0003-4819-120-1-199401010-00004; Bean JF, 2004, ARCH PHYS MED REHAB, V85, pS31, DOI 10.1016/j.apmr.2004.03.010; Bianchini Franca, 2002, Obes Rev, V3, P5, DOI 10.1046/j.1467-789X.2002.00046.x; Blair SN, 2004, AM J CLIN NUTR, V79, P913; BROOCKS A, 1990, J APPL PHYSIOL, V68, P2083, DOI 10.1152/jappl.1990.68.5.2083; BULLEN BA, 1985, NEW ENGL J MED, V312, P1349, DOI 10.1056/NEJM198505233122103; CAMORIANO JK, 1990, J CLIN ONCOL, V8, P1327, DOI 10.1200/JCO.1990.8.8.1327; *CDCP, ACT DO AD NEED BE GA; Chang VT, 1998, CANCER, V83, P173, DOI 10.1002/(SICI)1097-0142(19980701)83:1<173::AID-CNCR23>3.0.CO;2-T; Chlebowski RT, 2002, J CLIN ONCOL, V20, P1128, DOI 10.1200/JCO.20.4.1128; Daling JR, 2001, CANCER, V92, P720, DOI 10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T; Demark-Wahnefried W, 2001, J CLIN ONCOL, V19, P2381, DOI 10.1200/JCO.2001.19.9.2381; DEMARKWAHNEFRIED W, 1993, J CLIN ONCOL, V11, P1418, DOI 10.1200/JCO.1993.11.7.1418; DemarkWahnefried W, 1997, AM J CLIN NUTR, V65, P1495, DOI 10.1093/ajcn/65.5.1495; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.2300; Galanis DJ, 1998, CANCER CAUSE CONTROL, V9, P217, DOI 10.1023/A:1008842613331; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goodwin PJ, 1999, J CLIN ONCOL, V17, P120, DOI 10.1200/JCO.1999.17.1.120; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Holmberg L, 2001, EUR J SURG ONCOL, V27, P152, DOI 10.1053/ejso.2000.1084; Holmes MD, 1999, CANCER, V86, P826, DOI 10.1002/(SICI)1097-0142(19990901)86:5&lt;826::AID-CNCR19&gt;3.0.CO;2-0; Hu FB, 2000, JAMA-J AM MED ASSOC, V283, P2961, DOI 10.1001/jama.283.22.2961; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hu FB, 2001, ANN INTERN MED, V134, P96, DOI 10.7326/0003-4819-134-2-200101160-00009; Irwin ML, 2004, MED SCI SPORT EXER, V36, P1484, DOI 10.1249/01.MSS.0000074670.03001.98; Irwin ML, 2003, CANCER-AM CANCER SOC, V97, P1746, DOI 10.1002/cncr.11227; Jebb SA, 1999, MED SCI SPORT EXER, V31, pS534, DOI 10.1097/00005768-199911001-00008; Kramer JA, 2000, EUR J CANCER, V36, P1498, DOI 10.1016/S0959-8049(00)00144-1; Kroenke CH, 2005, J CLIN ONCOL, V23, P1370, DOI 10.1200/JCO.2005.01.079; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Lonning PE, 1996, BREAST CANCER RES TR, V39, P335, DOI 10.1007/BF01806162; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Martinez ME, 1997, J NATL CANCER I, V89, P948, DOI 10.1093/jnci/89.13.948; McTiernan A, 2003, J CLIN ONCOL, V21, P1961, DOI 10.1200/JCO.2003.07.057; McTiernan A, 2004, CANCER RES, V64, P2923, DOI 10.1158/0008-5472.CAN-03-3393; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Newman SC, 1997, INT J EPIDEMIOL, V26, P484, DOI 10.1093/ije/26.3.484; NIEMAN DC, 1994, MED SCI SPORT EXER, V26, P128, DOI 10.1249/00005768-199402000-00002; Obermair A, 1995, ANTICANCER RES, V15, P2265; Pinto BM, 1999, PSYCHO-ONCOL, V8, P191, DOI 10.1002/(SICI)1099-1611(199905/06)8:3<191::AID-PON355>3.3.CO;2-K; Reeves GK, 2000, INT J CANCER, V89, P293, DOI 10.1002/1097-0215(20000520)89:3<293::AID-IJC13>3.0.CO;2-R; Rich-Edwards JW, 2002, EPIDEMIOLOGY, V13, P184, DOI 10.1097/00001648-200203000-00013; Rockhill B, 1999, ARCH INTERN MED, V159, P2290, DOI 10.1001/archinte.159.19.2290; Rockhill B, 2001, AM J PUBLIC HEALTH, V91, P578, DOI 10.2105/AJPH.91.4.578; ROHAN TE, 1995, EUR J CANCER PREV, V4, P419, DOI 10.1097/00008469-199510000-00010; RUTQVIST LE, 1985, ACTA RADIOL ONCOL, V24, P385, DOI 10.3109/02841868509134405; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Sesso HD, 1998, CANCER CAUSE CONTROL, V9, P433, DOI 10.1023/A:1008827903302; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Steindorf K, 2003, AM J EPIDEMIOL, V157, P121, DOI 10.1093/aje/kwf181; Taylor AH, 2004, J SPORT SCI, V22, P703, DOI 10.1080/02640410410001712421; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; ZHANG SM, 1995, CANCER, V76, P275, DOI 10.1002/1097-0142(19950715)76:2<275::AID-CNCR2820760218>3.0.CO;2-6	57	1172	1194	5	109	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2005	293	20					2479	2486		10.1001/jama.293.20.2479	http://dx.doi.org/10.1001/jama.293.20.2479			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929BX	15914748	Bronze			2022-12-24	WOS:000229318200022
J	Patel, V; Kirkwood, B; Weiss, H; Pednekar, S; Fernandes, J; Pereira, B; Upadhye, M; Mabey, D				Patel, V; Kirkwood, B; Weiss, H; Pednekar, S; Fernandes, J; Pereira, B; Upadhye, M; Mabey, D			Chronic fatigue in developing countries: population based survey of women in India	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; PSYCHIATRIC-DISORDER; SOMATIC SYMPTOMS; DEPRESSION; EPIDEMIOLOGY; COMMUNITY; MORBIDITY; POVERTY; WORLD; GOA	Objectives To describe the prevalence of and risk factors for chronic fatigue in a developing country; in particular, to determine the association of anaemia, mental health, and gender disadvantage factors with chronic fatigue. Design Community survey. Setting Primary health centre catchment area in Goa, India. Participants 3000 randomly sampled women aged 18 to 50 years. Main outcome measures Data on the primary outcome (reporting of fatigue for at least six months) and psychosocial exposures elicited by structured interview; presence of anaemia determined from a blood sample. Results 2494 (83%) women consented to participate; 12.1% (95% confidence interval 10.8 to 13.4%) complained of chronic fatigue. In multivariate analyses, older women (P=0.03) and those experiencing socioeconomic deprivation-less education (P < 0.001), families in debt (P=0.09), hunger in the past three months(P=0.03)-were more likely to report chronic fatigue. After adjustment for these factors, factors indicating gender disadvantage (notably sexual violence by the husband; P < 0.001) and poor mental health (P < 0.001) were strongly associated with chronic fatigue. Although women with a high body mass index had a reduced risk, suggesting an influence of poor nutrition, no association was found between chronic fatigue and haemoglobin concentrations. Conclusions Chronic fatigue was commonly reported by women in this community study from India. The strongest associations with chronic fatigue were for psychosocial factors indicative of poor mental health and gender disadvantage.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Sangath, Porvorim, Goa, India	University of London; London School of Hygiene & Tropical Medicine	Patel, V (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Vikram.patel@lshtm.ac.uk	Pednekar, Sulochana/GVS-0184-2022; weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Pednekar, Sulochana/0000-0002-4538-4795; Mabey, David/0000-0002-0031-8276; Kirkwood, Betty/0000-0001-5274-6072; Patel, Vikram/0000-0003-1066-8584				Araya R, 2001, BRIT J PSYCHIAT, V178, P228, DOI 10.1192/bjp.178.3.228; Astbury J., 2001, MENTAL HLTH CALL ACT, P73; BHATIA JC, 1995, STUD FAMILY PLANN, V26, P203, DOI 10.2307/2137846; Chaturvedi S K, 1987, Indian J Psychiatry, V29, P337; DINESHKUMAR B, 1995, PHARMACOECONOMICS, V7, P332, DOI 10.2165/00019053-199507040-00007; GUREJE O, 1992, ACTA PSYCHIAT SCAND, V86, P223, DOI 10.1111/j.1600-0447.1992.tb03256.x; *INT I POP SCI, 2001, NAT FAM HLTH SURV, V2; ISAAC M, 1995, PSYCHOTHER PSYCHOSOM, V64, P88, DOI 10.1159/000288996; *IUSSP COMM REPR H, 1997, GEND REPR HLTH WEAKN; Krenzischek D A, 1996, Am J Crit Care, V5, P427; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Patel V, 1998, BRIT J PSYCHIAT, V172, P533, DOI 10.1192/bjp.172.6.533; Patel V, 2004, TROP MED INT HEALTH, V9, P539, DOI 10.1111/j.1365-3156.2004.01243.x; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Patel V, 1998, PSYCHOL MED, V28, P135, DOI 10.1017/S0033291797005941; SHIVA M, 1992, STATE INDIAS HLTH, P265; Skapinakis P, 2003, INT REV PSYCHIATR, V15, P57, DOI 10.1080/0954026021000045958; Skapinakis P, 2003, BRIT J PSYCHIAT, V182, P205, DOI 10.1192/bjp.182.3.205; Sumathipala A, 2000, PSYCHOL MED, V30, P747, DOI 10.1017/S0033291799002160; USTUN TB, 1995, MENTAL ILLNESS GEN H, P347; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 1996, AM J PSYCHIAT, V153, P1050; WESSELY S, 1995, EPIDEMIOL REV, V17, P139, DOI 10.1093/oxfordjournals.epirev.a036170	24	47	47	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 21	2005	330	7501					1190	1193		10.1136/bmj.38442.636181.E0	http://dx.doi.org/10.1136/bmj.38442.636181.E0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	929CU	15870118	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000229320500022
J	Quesenberry, PJ; Dooner, G; Dooner, M; Abedi, M				Quesenberry, PJ; Dooner, G; Dooner, M; Abedi, M			Ignoratio elenchi: Red herrings stem cell research	SCIENCE			English	Editorial Material							BONE-MARROW-CELLS; PLASTICITY; TRANSDIFFERENTIATE		Ctr Stem Cell Biol, Dept Res, Providence, RI 02908 USA		Quesenberry, PJ (corresponding author), Ctr Stem Cell Biol, Dept Res, Providence, RI 02908 USA.	pquesenberry@rwmc.org	Abedi, Mehrdad/ABC-3565-2021	Dooner, Mark/0000-0003-0653-6562				Abedi M, 2004, EXP HEMATOL, V32, P426, DOI 10.1016/j.exphem.2004.02.007; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; COLVIN GA, 2004, BLOOD, V104; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Keating A, 2005, BIOL BLOOD MARROW TR, V11, P2, DOI 10.1016/j.bbmt.2004.11.002; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lemischka I, 2002, EXP HEMATOL, V30, P848, DOI 10.1016/S0301-472X(02)00876-7; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wagers AJ, 2003, SCIENCE, V299, p1317B, DOI 10.1126/science.1079110	14	25	26	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1121	1122		10.1126/science.1104432	http://dx.doi.org/10.1126/science.1104432			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905387				2022-12-24	WOS:000229293400028
J	Tellinghuisen, TL; Marcotrigiano, J; Rice, CM				Tellinghuisen, TL; Marcotrigiano, J; Rice, CM			Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase	NATURE			English	Article							PROTEIN; NS5A; BOND	Hepatitis C virus (HCV) is a human pathogen affecting nearly 3% of the world's population(1). Chronic infections can lead to cirrhosis and liver cancer. The RNA replication machine of HCV is a multi-subunit membrane-associated complex. The nonstructural protein NS5A is an active component of HCV replicase(2,3), as well as a pivotal regulator of replication(2,4) and a modulator of cellular processes ranging from innate immunity to dysregulated cell growth(5,6). NS5A is a large phosphoprotein (56 - 58 kDa) with an amphipathic alpha-helix at its amino terminus that promotes membrane association(7-9). After this helix region, NS5A is organized into three domains(10). The N-terminal domain ( domain I) coordinates a single zinc atom per protein molecule(10). Mutations disrupting either the membrane anchor(7,8) or zinc binding(10) of NS5A are lethal for RNA replication. However, probing the role of NS5A in replication has been hampered by a lack of structural information about this multifunctional protein. Here we report the structure of NS5A domain I at 2.5-angstrom resolution, which contains a novel fold, a new zinc-coordination motif and a disulphide bond. We use molecular surface analysis to suggest the location of protein-, RNA- and membrane-interaction sites.	Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10021 USA	Rockefeller University	Marcotrigiano, J (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, 1230 York Ave Box 64, New York, NY 10021 USA.	marcotj@rockefeller.edu; ricec@rockefeller.edu	Marcotrigiano, Joseph/K-6697-2016	Marcotrigiano, Joseph/0000-0003-0346-3353	NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057973] Funding Source: Medline; NIAID NIH HHS [F32 AI051820] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P341	28	372	405	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					374	379		10.1038/nature03580	http://dx.doi.org/10.1038/nature03580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902263	Green Accepted			2022-12-24	WOS:000229185000051
J	Jouven, X; Empana, JP; Schwartz, PJ; Desnos, M; Courbon, D; Ducimetiere, P				Jouven, X; Empana, JP; Schwartz, PJ; Desnos, M; Courbon, D; Ducimetiere, P			Heart-rate profile during exercise as a predictor of sudden death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; BAROREFLEX SENSITIVITY; VENTRICULAR-TACHYCARDIA; RATE-VARIABILITY; CARDIAC DEATH; NERVOUS-SYSTEM; RATE RECOVERY; MORTALITY; RISK; REFLEXES	BACKGROUND: Changes in heart rate during exercise and recovery from exercise are mediated by the balance between sympathetic and vagal activity. Since alterations in the neural control of cardiac function contribute to the risk of sudden death, we tested the hypothesis that among apparently healthy persons, sudden death is more likely to occur in the presence of abnormal heart-rate profiles during exercise and recovery. METHODS: A total of 5713 asymptomatic working men (between the ages of 42 and 53 years), none of whom had clinically detectable cardiovascular disease, underwent standardized graded exercise testing between 1967 and 1972. We examined data on the subjects' resting heart rates, the increase in rate from the resting level to the peak exercise level, and the decrease in rate from the peak exercise level to the level one minute after the termination of exercise. RESULTS: During a 23-year follow-up period, 81 subjects died suddenly. The risk of sudden death from myocardial infarction was increased in subjects with a resting heart rate that was more than 75 beats per minute (relative risk, 3.92; 95 percent confidence interval, 1.91 to 8.00); in subjects with an increase in heart rate during exercise that was less than 89 beats per minute (relative risk, 6.18; 95 percent confidence interval, 2.37 to 16.11); and in subjects with a decrease in heart rate of less than 25 beats per minute after the termination of exercise (relative risk, 2.20; 95 percent confidence interval, 1.02 to 4.74). After adjustment for potential confounding variables, these three factors remained strongly associated with an increased risk of sudden death, with a moderate but significantly increased risk of death from any cause but not of nonsudden death from myocardial infarction. CONCLUSIONS: The heart-rate profile during exercise and recovery is a predictor of sudden death.	Univ Paris 05, Hop Europeen Georges Pompidou, Fac Rene Descartes, Serv Cardiol, F-75015 Paris, France; Hop Paul Brousse, INSERM, Avenir Unite 258, Villejuif, France; Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy; Policlin San Matteo, Ist Ricovera & Cura Carattere, I-27100 Pavia, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Pavia; IRCCS Fondazione San Matteo	Jouven, X (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, Fac Rene Descartes, Serv Cardiol, 20 Rue Leblanc, F-75015 Paris, France.	xavier.jouven@egp.aphp.fr	Schwartz, Peter J/J-4267-2016; Empana, Jean-Philippe/AAF-6923-2021	Schwartz, Peter J/0000-0003-0367-1048; Empana, Jean-Philippe/0000-0002-1469-7772				Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; BILLMAN GE, 1984, CIRCULATION, V69, P1182, DOI 10.1161/01.CIR.69.6.1182; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; DEVREEDESWAGEMAKER, 1997, J AM COLL CARDIOL, V30, P1500; FARB A, 1995, CIRCULATION, V92, P1701, DOI 10.1161/01.CIR.92.7.1701; Ghuran A, 2002, AM J CARDIOL, V89, P184, DOI 10.1016/S0002-9149(01)02198-1; HULL SS, 1994, CIRCULATION, V89, P548, DOI 10.1161/01.CIR.89.2.548; Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Jouven X, 2001, CARDIOVASC RES, V50, P373, DOI 10.1016/S0008-6363(01)00230-9; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; Landolina M, 1997, J AM COLL CARDIOL, V29, P568, DOI 10.1016/S0735-1097(96)00533-5; Lauer MS, 1996, CIRCULATION, V93, P1520, DOI 10.1161/01.CIR.93.8.1520; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; LOWN B, 1976, NEW ENGL J MED, V294, P1165; MALLIANI A, 1969, AM J PHYSIOL, V217, P703, DOI 10.1152/ajplegacy.1969.217.3.703; SCHWARTZ PJ, 1988, CIRCULATION, V78, P969, DOI 10.1161/01.CIR.78.4.969; Schwartz PJ, 1998, EUR HEART J, V19, pF72; SCHWARTZ PJ, 1992, CIRCULATION, V85, P77; Schwartz PJ, 2001, J CARDIOVASC ELECTR, V12, P500, DOI 10.1046/j.1540-8167.2001.00500.x; Smith ML, 1996, CIRCULATION, V93, P1033, DOI 10.1161/01.CIR.93.5.1033; SMITH ML, 1991, J AM COLL CARDIOL, V18, P1015, DOI 10.1016/0735-1097(91)90761-W; VANOLI E, 1995, J AM COLL CARDIOL, V25, P1609, DOI 10.1016/0735-1097(95)00046-7; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7; Weaver WD, 2002, NEW ENGL J MED, V347, P1223, DOI 10.1056/NEJMp020108; *WHO, 1967, INT CLASS DIS MAN IN, V1, P3	29	751	783	2	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1951	1958		10.1056/NEJMoa043012	http://dx.doi.org/10.1056/NEJMoa043012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888695				2022-12-24	WOS:000229017100005
J	Moore, P				Moore, P			Photocopiers for DNA	NATURE			English	Article																			0	0	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					237	237		10.1038/435237a	http://dx.doi.org/10.1038/435237a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889102	Bronze			2022-12-24	WOS:000229021100051
J	Klimanskaya, I; Chung, Y; Meisner, L; Johnson, J; West, MD; Lanza, R				Klimanskaya, I; Chung, Y; Meisner, L; Johnson, J; West, MD; Lanza, R			Human embryonic stem cells derived without feeder cells	LANCET			English	Article							GROWTH; CULTURE; LINES	Background Human embryonic stem cells are likely to play an important role in the future of regenerative medicine. However, exposure of existing human embryonic stem-cell lines to live animal cells and serum risks contamination with pathogens that could lead to human health risks. We aimed to derive an embryonic stem-cell line without exposure to cells or serum. Methods Frozen cleavage-stage embryos were thawed and cultured to the blastocyst stage. Inner cell masses were isolated by immunosurgery and plated onto extraceflular-matrix-coated plates that can be easily sterilised. Six established human embryonic stem-cell lines were also maintained with this serum and feeder free culture system. Findings A new stem-cell line was derived from human embryos under completely cell and serum free conditions. The cells maintained normal karyotype and markers of pluripotency, including octamer binding protein 4 (Oct-4), stage-specific embryonic antigen (SSEA)-3, SSEA-4, tumour-rejection antigen (TRA)-1-60, TRA-1-81, and alkaline phosphatase. After more than 6 months of undifferentiated proliferation, these cells retained the potential to form derivatives of all three embryonic germ layers both in vitro and in teratomas. These properties were also successfully maintained (for more than 30 passages) with the established stem-cell lines. Interpretation This system eliminates exposure of human embryonic stem cells and their progeny to animal and human feeder layers, and thus the risk of contamination with pathogenic agents capable of transmitting diseases to patients..	Adv Cell Technol, Worcester, MA 01605 USA; Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI USA; Wisconsin State Lab Hyg, Cytogenet Lab, Madison, WI USA; Wake Forest Univ, Bowman Gray Sch Med, Inst Regenerat Med, Winston Salem, NC USA	University of Wisconsin System; University of Wisconsin Madison; Wake Forest University; Wake Forest Baptist Medical Center	Lanza, R (corresponding author), Adv Cell Technol, 381 Plantat St, Worcester, MA 01605 USA.	rlanza@advancedcell.com		West, Michael/0000-0002-4842-5468; Lanza, Robert/0000-0002-3047-3074				Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; COOPER DKC, 2000, XENO PROMISE TRANSPL; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Klimanskaya I, 2004, HDB STEM CELLS, V1, P437; Lanzendorf SE, 2001, FERTIL STERIL, V76, P132, DOI 10.1016/S0015-0282(01)01825-8; Lee JB, 2005, BIOL REPROD, V72, P42, DOI 10.1095/biolreprod.104.033480; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; *US DEP HHS FDA CB, 2002, INF REC PHYS INV COC; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744	20	249	341	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1636	1641		10.1016/S0140-6736(05)66473-2	http://dx.doi.org/10.1016/S0140-6736(05)66473-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885296				2022-12-24	WOS:000228933700028
J	Orimo, A; Gupta, PB; Sgroi, DC; Arenzana-Seisdedos, F; Delaunay, T; Naeem, R; Carey, VJ; Richardson, AL; Weinberg, RA				Orimo, A; Gupta, PB; Sgroi, DC; Arenzana-Seisdedos, F; Delaunay, T; Naeem, R; Carey, VJ; Richardson, AL; Weinberg, RA			Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion	CELL			English	Article							ENDOTHELIAL PROGENITOR CELLS; EPITHELIAL-CELLS; CANCER-CELLS; MALIGNANT BREAST; PROGNOSTIC VALUE; TGF-BETA; CXCR4; SDF-1; STEM; RECRUITMENT	Fibroblasts often constitute the majority of the stromal cells within a breast carcinoma, yet the functional contributions of these cells to tumorigenesis are poorly understood. Using a coimplantation tumor xenograft model, we demonstrate that carcinoma-associated fibroblasts (CAFs) extracted from human breast carcinomas promote the growth of admixed breast carcinoma cells significantly more than do normal mammary fibroblasts derived from the same patients. The CAFs, which exhibit the traits of myofibroblasts, play a central role in promoting the growth of tumor cells through their ability to secrete stromal cell-derived factor 1 (SDF-1); CAFs promote angiogenesis by recruiting endothelial progenitor cells (EPCs) into carcinomas, an effect mediated in part by SDF-1. CAF-secreted SDF-1 also stimulates tumor growth directly, acting through the cognate receptor, CXCR4, which is expressed by carcinoma cells. Our findings indicate that fibroblasts within invasive breast carcinomas contribute to tumor promotion in large part through the secretion of SDF-1.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Mol Pathol Res Unit,Massachusetts Gen Hosp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat & Pathol, Houston, TX 77030 USA; Inst Pasteur, Unite Immunol Virale, F-75724 Paris, France; INRA, F-33883 Villenave Dornon, France	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine; Texas Children's Cancer Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Thomson, Axel/A-7893-2013; Sgroi, Dennis/AAV-2487-2021; Arenzana-Seisdedos, Fernando/E-5835-2016	Orimo, Akira/0000-0001-5330-7282	NATIONAL CANCER INSTITUTE [R21CA087081] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA 87081-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Anderson J, 2003, AIDS RES HUM RETROV, V19, P699, DOI 10.1089/088922203322280928; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bertolini F, 2003, CANCER RES, V63, P4342; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bogatkevich GS, 2001, J BIOL CHEM, V276, P45184, DOI 10.1074/jbc.M106441200; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Cardone A, 1997, PANMINERVA MED, V39, P174; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; DOUGLAS MR, 2002, EXPERT REV MOL MED, P1; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hatzopoulos AK, 1998, DEVELOPMENT, V125, P1457; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Jacobs TW, 1999, NEW ENGL J MED, V340, P430, DOI 10.1056/NEJM199902113400604; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; KASID A, 1985, SCIENCE, V228, P725, DOI 10.1126/science.4039465; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Moinfar F, 2000, CANCER RES, V60, P2562; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2001, CLIN CANCER RES, V7, P3097; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pinheiro Jose, 2000, MIXED EFFECTS MODELS; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Schober A, 2003, CIRCULATION, V108, P2491, DOI 10.1161/01.CIR.0000099508.76665.9A; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; SIEWEKE MH, 1990, SCIENCE, V248, P1656, DOI 10.1126/science.2163544; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031	60	2770	2892	6	279	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					335	348		10.1016/j.cell.2005.02.034	http://dx.doi.org/10.1016/j.cell.2005.02.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882617	Bronze			2022-12-24	WOS:000229031600005
J	Su, I; Dobenecker, MW; Dickinson, E; Oser, M; Basavaraj, A; Marqueron, R; Viale, A; Reinberg, D; Wulfing, C; Tarakhovsky, A				Su, I; Dobenecker, MW; Dickinson, E; Oser, M; Basavaraj, A; Marqueron, R; Viale, A; Reinberg, D; Wulfing, C; Tarakhovsky, A			Polycomb group protein Ezh2 controls actin polymerization and cell signaling	CELL			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; T-CELLS; IMMUNOLOGICAL SYNAPSE; LYSINE METHYLATION; GENE-EXPRESSION; RECEPTOR SIGNAL; VAV FAMILY; B-CELLS; TRANSDUCTION; CYTOSKELETON	Polycomb group protein Ezh2, one of the key regulators of development in organisms from flies to mice, exerts its epigenetic function through regulation of histone methylation. Here, we report the existence of the cytosolic Ezh2-containing methyltransferase complex and tie the function of this complex to regulation of actin polymerization in various cell types. Genetic evidence supports the essential role of cytosolic Ezh2 in actin polymerization-dependent processes such as antigen receptor signaling in T cells and PDGF-induced dorsal circular ruffle formation in fibroblasts. Revealed function of Ezh2 points to a broader usage of lysine methylation in regulation of both nuclear and extra-nuclear signaling processes.	Rockefeller Univ, Lab Lymphoocyte Signaling, New York, NY 10021 USA; Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst, Div Nucle Acids Enzymol, Piscataway, NJ 08854 USA; Mem Sloan Kettering Canc Ctr, Dept Mol Biol, Genom Core Lab, New York, NY 10021 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA	Rockefeller University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Su, I (corresponding author), Rockefeller Univ, Lab Lymphoocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	sui@mail.rockefeller.edu; tarakho@mail.rockefeller.edu	Su, I-hsin/A-2207-2011; Margueron, Raphael F/B-9996-2015	Su, I-hsin/0000-0002-5894-9580; Margueron, Raphael F/0000-0002-9093-7977; Reinberg, Danny/0000-0003-4288-2016; Wuelfing, Christoph/0000-0002-6156-9861; Basavaraj, Ashwin/0000-0002-9904-6230	NIAID NIH HHS [5R01 AI 050867, 5R01 AI 053545] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053545, R01AI050867] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hobert O, 1996, MOL CELL BIOL, V16, P3066; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8	48	287	291	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					425	436		10.1016/j.cell.2005.02.029	http://dx.doi.org/10.1016/j.cell.2005.02.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882624	Bronze			2022-12-24	WOS:000229031600012
J	Wills, TJ; Lever, C; Cacucci, F; Burgess, N; O'Keefe, J				Wills, TJ; Lever, C; Cacucci, F; Burgess, N; O'Keefe, J			Attractor dynamics in the hippocampal representation of the local environment	SCIENCE			English	Article							COMPLEMENTARY-LEARNING-SYSTEMS; PLACE CELLS; NETWORK MODEL; MEMORY; CA3; DISTINCT; INTEGRATION; NEURONS; FIELDS; CODES	Memories are thought to be attractor states of neuronal representations, with the hippocampus a likely substrate for context-dependent episodic memories. However, such states have not been directly observed. For example, the hippocampal place cell representation of location was previously found to respond continuously to changes in environmental shape alone. We report that exposure to novel square and circular environments made of different materials creates attractor representations for both shapes: Place cells abruptly and simultaneously switch between representations as environmental shape changes incrementally. This enables study of attractor dynamics in a cognitive representation and may correspond to the formation of distinct contexts in context-dependent memory.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1E 6BT, England	University of London; University College London; University of London; University College London	O'Keefe, J (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	j.okeefe@ucl.ac.uk	Burgess, Neil/B-2420-2009; Lever, Colin/B-4860-2008; Wills, Tom J/B-3621-2011	Burgess, Neil/0000-0003-0646-6584; Lever, Colin/0000-0002-8955-2885; Cacucci, Francesca/0000-0002-1968-5156; Wills, Thomas/0000-0002-1331-2869	MRC [G117/433] Funding Source: UKRI; Medical Research Council [G117/433] Funding Source: Medline; Wellcome Trust [071248] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Amit D. J., 1992, MODELLING BRAIN FUNC; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; FYHN M, 2004, SOC NEUR ABSTR; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; LEUTGEB JK, 2004, SOC NEUR ABSTR; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.3.CO;2-T; SQUIRE LR, 1988, TRENDS NEUROSCI, V11, P170, DOI 10.1016/0166-2236(88)90144-0; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004	31	395	400	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					873	876		10.1126/science.1108905	http://dx.doi.org/10.1126/science.1108905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879220	Green Submitted, Green Accepted			2022-12-24	WOS:000228986500054
J	Zong, H; Espinosa, S; Su, HH; Muzumdar, MD; Luo, LQ				Zong, H; Espinosa, S; Su, HH; Muzumdar, MD; Luo, LQ			Mosaic analysis with double markers in mice	CELL			English	Article							SITE-SPECIFIC RECOMBINATION; PROGENITOR-CELL MAINTENANCE; TAMOXIFEN-INDUCIBLE FORM; RED FLUORESCENT PROTEIN; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; NERVOUS-SYSTEM; LOXP RECOMBINATION; MOUSE CHROMOSOMES; CRE RECOMBINASE	We describe a method termed MADM (mosaic analysis with double markers) in mice that allows simultaneous labeling and gene knockout in clones of somatic cells or isolated single cells in vivo. Two reciprocally chimeric genes, each containing the N terminus of one marker and the C terminus of the other marker interrupted by a loxP-containing intron, are knocked in at identical locations on homologous chromosomes. Functional expression of markers requires Cre-mediated interchromosomal recombination. MADM reveals that interchromosomal recombination can be induced efficiently in vivo in both mitotic and postmitotic cells in all tissues examined. It can be used to create conditional knockouts in small populations of labeled cells, to determine cell lineage, and to trace neuronal connections. To illustrate the utility of MADM, we show that cerebellar granule cell progenitors are fated at an early stage to produce granule cells with axonal projections limited to specific sublayers of the cerebellar cortex.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu		Muzumdar, Mandar/0000-0001-7424-7223; Luo, Liqun/0000-0001-5467-9264				Altman J., 1997, DEV CEREBELLAR SYSTE; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Badea TC, 2003, J NEUROSCI, V23, P2314; BONNEROT C, 1993, CR ACAD SCI III-VIE, V316, P1207; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; CEPKO CL, 1993, METHOD ENZYMOL, V225, P933; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grueber WB, 2002, DEVELOPMENT, V129, P2867; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; Hashimoto M, 2004, J NEUROSCI, V24, P286, DOI 10.1523/JNEUROSCI.2529-03.2004; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kimmel RA, 2000, GENE DEV, V14, P1377; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koike H, 2002, EMBO REP, V3, P433, DOI 10.1093/embo-reports/kvf097; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; Metz CW, 1916, J EXP ZOOL, V21, P213, DOI 10.1002/jez.1400210204; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; XU T, 1993, DEVELOPMENT, V117, P1223; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199; Zugates CT, 2004, CURR OPIN NEUROBIOL, V14, P647, DOI 10.1016/j.conb.2004.08.005	67	386	394	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					479	492		10.1016/j.cell.2005.02.012	http://dx.doi.org/10.1016/j.cell.2005.02.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882628	Bronze			2022-12-24	WOS:000229031600016
J	Kapitein, LC; Peterman, EJG; Kwok, BH; Kim, JH; Kapoor, TM; Schmidt, CF				Kapitein, LC; Peterman, EJG; Kwok, BH; Kim, JH; Kapoor, TM; Schmidt, CF			The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinks	NATURE			English	Article							CELL-DIVISION; SPINDLES; MOTOR; DROSOPHILA; TUBULIN; MITOSIS; FAMILY; FLUX; NCD	During cell division, mitotic spindles are assembled by microtubule-based motor proteins(1,2). The bipolar organization of spindles is essential for proper segregation of chromosomes, and requires plus-end-directed homotetrameric motor proteins of the widely conserved kinesin-5 ( BimC) family(3). Hypotheses for bipolar spindle formation include the 'push-pull mitotic muscle' model, in which kinesin-5 and opposing motor proteins act between overlapping microtubules(2,4,5). However, the precise roles of kinesin-5 during this process are unknown. Here we show that the vertebrate kinesin-5 Eg5 drives the sliding of microtubules depending on their relative orientation. We found in controlled in vitro assays that Eg5 has the remarkable capability of simultaneously moving at similar to 20 nm s(-1) towards the plus-ends of each of the two microtubules it crosslinks. For anti-parallel microtubules, this results in relative sliding at similar to 40 nm s(-1), comparable to spindle pole separation rates in vivo(6). Furthermore, we found that Eg5 can tether microtubule plus-ends, suggesting an additional microtubule-binding mode for Eg5. Our results demonstrate how members of the kinesin-5 family are likely to function in mitosis, pushing apart interpolar microtubules as well as recruiting microtubules into bundles that are subsequently polarized by relative sliding.	Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Ctr Laser, NL-1081 HV Amsterdam, Netherlands; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Rockefeller University	Peterman, EJG (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	erwinp@nat.vu.nl; kapoor@mail.rockefeller.edu	Peterman, Erwin/G-5529-2010; Schmidt, Christoph F/G-3787-2011; Kapitein, Lukas C/J-4776-2016	Peterman, Erwin/0000-0003-1058-249X; Schmidt, Christoph F/0000-0003-2864-6973; Kapitein, Lukas C/0000-0001-9418-6739				Brust-Mascher I, 2002, MOL BIOL CELL, V13, P3967, DOI 10.1091/mbc.02-05-0069; Chui KK, 2000, J BIOL CHEM, V275, P38005, DOI 10.1074/jbc.M005948200; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; Crevel IMTC, 2004, CURR BIOL, V14, pR411, DOI 10.1016/j.cub.2004.05.030; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; GIBBONS IR, 1979, J BIOL CHEM, V254, P187; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HYMAN AA, 1991, J CELL SCI, P125; Kapoor TM, 1999, P NATL ACAD SCI USA, V96, P9106, DOI 10.1073/pnas.96.16.9106; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Kwok BH, 2004, CURR BIOL, V14, P1783, DOI 10.1016/j.cub.2004.09.052; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCINTOSH JR, 1969, NATURE, V224, P659, DOI 10.1038/224659a0; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Stock MF, 2003, J BIOL CHEM, V278, P52315, DOI 10.1074/jbc.M309419200; van Dijk MA, 2004, J PHYS CHEM B, V108, P6479, DOI 10.1021/jp049805+; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376	27	492	499	5	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					114	118		10.1038/nature03503	http://dx.doi.org/10.1038/nature03503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875026				2022-12-24	WOS:000228864600049
J	Lane, TW; Saito, MA; George, GN; Pickering, IJ; Prince, RC; Morel, FMM				Lane, TW; Saito, MA; George, GN; Pickering, IJ; Prince, RC; Morel, FMM			A cadmium enzyme from a marine diatom	NATURE			English	Editorial Material									Sandia Natl Labs, Biosyst Res Dept, Livermore, CA 94551 USA; Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA; Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 5E2, Canada; ExxonMobile Res & Engn Co, Annandale, NJ 08801 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	United States Department of Energy (DOE); Sandia National Laboratories; Woods Hole Oceanographic Institution; University of Saskatchewan; Exxon Mobil Corporation; Princeton University	Lane, TW (corresponding author), Sandia Natl Labs, Biosyst Res Dept, Livermore, CA 94551 USA.	mak@whoi.edu	Saito, Mak/ADT-4986-2022; Morel, Francois M M/A-8107-2008; Pickering, Ingrid J/A-4547-2013; George, Graham N/E-3290-2013	Pickering, Ingrid J/0000-0002-0936-2994; Lane, Todd/0000-0002-5816-2649; George, Graham/0000-0002-0420-7493; Prince, Roger/0000-0002-5174-4216					0	433	451	4	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					42	42		10.1038/435042a	http://dx.doi.org/10.1038/435042a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875011	Bronze			2022-12-24	WOS:000228864600032
J	Sack, AT; Camprodon, JA; Pascual-Leone, A; Goebel, R				Sack, AT; Camprodon, JA; Pascual-Leone, A; Goebel, R			The dynamics of interhemispheric compensatory processes in mental imagery	SCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE NEUROSCIENCE; FUNCTIONAL-ANATOMY; SPATIAL ATTENTION; MINDS IMAGE; PARIETAL; TRACKING; CLOCKS	The capacity to generate and analyze mental visual images is essential for many cognitive abilities. We combined triple-pulse transcranial magnetic Stimulation (tpTMS) and repetitive TMS (rTMS) to determine which distinct aspect of mental imagery is carried out by the left and right parietal lobe and to reveal interhemispheric compensatory interactions. The left parietal lobe was predominant in generating mental images, whereas the right parietal lobe was specialized in the spatial comparison of the imagined content. Furthermore, in case of an rTMS-induced left parietal lesion, the right parietal cortex could immediately compensate such a left parietal disruption by taking over the specific function of the left hemisphere.	Maastricht Univ, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Beth Israel Deaconess Med Ctr, Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Maastricht University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Sack, AT (corresponding author), Maastricht Univ, Fac Psychol, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	a.sack@psychology.unimaas.nl	Camprodon, Joan Albert/M-9093-2017; Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019	Camprodon, Joan Albert/0000-0003-1282-9257; Pascual-Leone, Alvaro/0000-0001-8975-0382; Sack, Alexander/0000-0002-1471-0885; Goebel, Rainer/0000-0003-1780-2467	NCRR NIH HHS [K24 RR018875, NCRR MO1 RR01032] Funding Source: Medline; NIMH NIH HHS [R01MH60734] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875, M01RR001032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060734] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		FARAH MJ, 1989, TRENDS NEUROSCI, V12, P395, DOI 10.1016/0166-2236(89)90079-9; FARAH MJ, 1985, NEUROPSYCHOLOGIA, V23, P115, DOI 10.1016/0028-3932(85)90049-1; Formisano E, 2002, NEURON, V35, P185, DOI 10.1016/S0896-6273(02)00747-X; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1335, DOI 10.1016/0028-3932(95)00067-D; KOSSLYN SM, 1980, IMAE MIND; Mellet E, 1996, J NEUROSCI, V16, P6504; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; PAIVIO A, 1978, J EXP PSYCHOL HUMAN, V4, P61, DOI 10.1037/0096-1523.4.1.61; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Sack AT, 2002, NEURON, V35, P195, DOI 10.1016/S0896-6273(02)00745-6; Thut G, 2003, CLIN NEUROPHYSIOL, V114, P2071, DOI 10.1016/S1388-2457(03)00205-0; TROJANO L, 1994, BRAIN COGNITION, V24, P213, DOI 10.1006/brcg.1994.1012; Trojano L, 2000, CEREB CORTEX, V10, P473, DOI 10.1093/cercor/10.5.473; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; WALSH V, 2003, NEUROCHRONOMETRICS M	17	151	155	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					702	704		10.1126/science.1107784	http://dx.doi.org/10.1126/science.1107784			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	922BO	15860630				2022-12-24	WOS:000228810900052
J	Basu, S; Gerchman, Y; Collins, CH; Arnold, FH; Weiss, R				Basu, S; Gerchman, Y; Collins, CH; Arnold, FH; Weiss, R			A synthetic multicellular system for programmed pattern formation	NATURE			English	Article							GENE-EXPRESSION; VIBRIO-FISCHERI; BACTERIA; LUXR; NETWORKS; LACTONES; GROWTH	Pattern formation is a hallmark of coordinated cell behaviour in both single and multicellular organisms(1-3). It typically involves cell-cell communication and intracellular signal processing. Here we show a synthetic multicellular system in which genetically engineered 'receiver' cells are programmed to formring-like patterns of differentiation based on chemical gradients of an acyl-homoserine lactone (AHL) signal that is synthesized by 'sender' cells. In receiver cells, 'band-detect' gene networks respond to user-defined ranges of AHL concentrations. By fusing different fluorescent proteins as outputs of network variants, an initially undifferentiated 'lawn' of receivers is engineered to form a bullseye pattern around a sender colony. Other patterns, such as ellipses and clovers, are achieved by placing senders in different configurations. Experimental and theoretical analyses reveal which kinetic parameters most significantly affect ring development over time. Construction and study of such synthetic multicellular systems can improve our quantitative understanding of naturally occurring developmental processes and may foster applications in tissue engineering, biomaterial fabrication and biosensing.	Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Princeton University; Princeton University; California Institute of Technology	Weiss, R (corresponding author), Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.	rweiss@princeton.edu	Gerchman, Yoram/H-4698-2019; Gerchman, Yoram/F-5226-2015	Gerchman, Yoram/0000-0002-8637-9589; Arnold, Frances H./0000-0002-4027-364X; Collins, Cynthia/0000-0003-1647-860X				Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; BENJACOB E, 1995, PHYS REV LETT, V75, P2899, DOI 10.1103/PhysRevLett.75.2899; Choi S. H., 1992, Molecular Marine Biology and Biotechnology, V1, P408; Collins CH, 2005, MOL MICROBIOL, V55, P712, DOI 10.1111/j.1365-2958.2004.04437.x; Egland KA, 1999, MOL MICROBIOL, V31, P1197, DOI 10.1046/j.1365-2958.1999.01261.x; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Golden JW, 1998, CURR OPIN MICROBIOL, V1, P623, DOI 10.1016/S1369-5274(98)80106-9; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; PTASHNE M, 1986, GENETIC SWITCH PHAGE; SCHERRER R, 1986, CAN J MICROBIOL, V32, P607, DOI 10.1139/m86-113; WEISS R, 2002, NSC 1 1 WORKSH NON S; WEISS R, 2001, THESIS MIT; WEISS R, 2000, DNA6 6 INT M DNA BAS, P1; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002	18	746	784	7	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1130	1134		10.1038/nature03461	http://dx.doi.org/10.1038/nature03461			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858574				2022-12-24	WOS:000228693300043
J	Geng, E; Kreiswirth, B; Burzynski, J; Schluger, NW				Geng, E; Kreiswirth, B; Burzynski, J; Schluger, NW			Clinical and radiographic correlates of primary and reactivation tuberculosis - A molecular epidemiology study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; COMPLEX STRAINS; SAN-FRANCISCO; TRANSMISSION; INFECTION; MANIFESTATIONS; IS6110	Context The traditional teaching that pulmonary tuberculosis characterized by lymphadencipathy, effusions, and lower or mid lung zone infiltrates on chest radiography represents "primary" disease from recently acquired infection, whereas upper lobe infiltrates and cavities represent secondary or reactivation disease acquired in the more distant past, is not based on well-established clinical evidence. Furthermore, it is not known whether the atypical radiograph common in human immunodeficiency virus (HIV)-associated tuberculosis is due to a preponderance of primary progressive disease or altered immunity. Objective To analyze the relationship between recently acquired and remotely acquired pulmonary tuberculosis, clinical and demographic variables, and radiographic features by using molecular fingerprinting and conventional epidemiology. Design, Setting, and Population A retrospective, hospital-based series of 456 patients treated at a New York City medical center between 1990 and 1999. Eligible patients had to have had at least 1 positive respiratory culture for Mycobacterium tuberculosis and available radiographic data. Main Outcome Measures Radiographic appearance as measured by the presence or absence of 6 features: upper lobe infiltrate, cavitary lesion, adenopathy, effusions, lower or mid lung zone infiltrate, and miliary pattern. Radiographs were considered typical if they had an upper lobe infiltrate or cavity whether or not other features were present. Atypical radiographs were those that had adenopathy, effusion, or mid lower lung zone infiltrates or had none of the above features. Results Human immunodeficiency virus infection was most commonly associated with an atypical radiographic appearance on chest radiograph with an odds ratio of 0.20 (95% confidence interval, 0.13-0.31). Although a clustered fingerprint, representing recently acquired disease, was associated with typical radiograph in univariate analysis (odds ratio, 0.68; 95% confidence interval, 0.47-0.99), the association was lost when adjusted for HIV status. Conclusions Time from acquisition of infection to development of clinical disease does not reliably predict the, radiographic appearance of tuberculosis. Human immunodeficiency virus status, a probable surrogate for the integrity of the host immune response, is the only independent predictor of radiographic appearance. The altered radiographic appearance of pulmonary tuberculosis in HIV is due to altered immunity rather than recent acquisition of infection and progression to active disease.	Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; Publ Hlth Res Inst, Newark, NJ USA; New York City Dept Hlth, TB Control Program, New York, NY 10013 USA	Columbia University; Columbia University; New York City Department of Health & Mental Hygiene	Schluger, NW (corresponding author), Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Coll Phys & Surg, 630 W 168th St PH-8 E, New York, NY 10032 USA.	ns311@columbia.edu			NHLBI NIH HHS [K24 HL004074] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004074] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; BASS JB, 1990, AM REV RESPIR DIS, V142, P725; Bauer J, 1999, J CLIN MICROBIOL, V37, P2602, DOI 10.1128/JCM.37.8.2602-2606.1999; Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; CHOYKE PL, 1983, RADIOLOGY, V148, P357, DOI 10.1148/radiology.148.2.6867325; Daley CL, 1995, TUBERCLE LUNG DIS, V76, P475, DOI 10.1016/0962-8479(95)90520-0; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; FARMAN DP, 1986, CHEST, V89, P75, DOI 10.1378/chest.89.1.75; FRASER RS, 1999, FRASER PARES DIAGNOS, P798; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Glynn JR, 1999, INT J TUBERC LUNG D, V3, P1055; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Jones BE, 1997, AM J RESP CRIT CARE, V156, P1270, DOI 10.1164/ajrccm.156.4.9609143; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Murray M, 2002, AM J EPIDEMIOL, V155, P565, DOI 10.1093/aje/155.6.565; Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448; Perlman DC, 1997, CLIN INFECT DIS, V25, P242, DOI 10.1086/514546; Post FA, 1995, TUBERCLE LUNG DIS, V76, P518, DOI 10.1016/0962-8479(95)90527-8; Rizzi EB, 2004, EUR J RADIOL, V52, P170, DOI 10.1016/j.ejrad.2004.04.007; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Soini H, 2001, J CLIN MICROBIOL, V39, P217, DOI 10.1128/JCM.39.1.217-221.2001; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; WOODRING JH, 1986, AM J ROENTGENOL, V146, P497, DOI 10.2214/ajr.146.3.497	26	125	130	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2740	2745		10.1001/jama.293.22.2740	http://dx.doi.org/10.1001/jama.293.22.2740			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933OV	15941803	Bronze			2022-12-24	WOS:000229643700022
J	Wright, SI; Bi, IV; Schroeder, SG; Yamasaki, M; Doebley, JF; McMullen, MD; Gaut, BS				Wright, SI; Bi, IV; Schroeder, SG; Yamasaki, M; Doebley, JF; McMullen, MD; Gaut, BS			The effects of artificial selection of the maize genome	SCIENCE			English	Article							MORPHOLOGICAL DIFFERENCES; DOMESTICATION; DIVERSITY; PATTERN; DEMOGRAPHY; GENETICS; TEOSINTE; MODELS	Domestication promotes rapid phenotypic evolution through artificial selection. We investigated the genetic history by which the wild grass teosinte (Zea mays ssp. parviglumis) was domesticated into modem maize (Z. mays ssp. mays). Analysis of single-nucleotide polymorphisms in 774 genes indicates that 2 to 4% of these genes experienced artificial selection. The remaining genes retain evidence of a population bottleneck associated with domestication. Candidate selected genes with putative function in plant growth are clustered near quantitative trait loci that contribute to phenotypic differences between maize and teosinte. If we assume that our sample of genes is representative, 1200 genes throughout the maize genome have been affected by artificial selection.	Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; York Univ, Dept Biol, N York, ON M3J 1P3, Canada; Univ Missouri, Dept Agron, Plant Sci Unit, Columbia, MO 65211 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; ARS, Plant Genet Res Unit, USDA, Columbia, MO 65211 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; York University - Canada; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Gaut, BS (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	bgaut@uci.edu	Yamasaki, Masanori/C-5193-2018; Wright, Stephen I/C-3113-2008	Yamasaki, Masanori/0000-0001-7759-3965; Wright, Stephen I/0000-0001-9973-9697; Schroeder, Steven/0000-0001-9103-5150				Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; BRESSANI R, 1958, CEREAL CHEM, V35, P227; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; DOEBLEY J, 1993, GENETICS, V134, P559; DOEBLEY J, 1991, GENETICS, V129, P285; DOEBLEY J, 1995, GENETICS, V141, P333; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Galtier N, 2000, GENETICS, V155, P981; Hilton H, 1998, GENETICS, V150, P863; Hudson RR, 2001, GENETICS, V159, P1805; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; TAJIMA F, 1989, GENETICS, V123, P597; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Wall JD, 2002, GENETICS, V162, P203; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Zhang LQ, 2002, GENETICS, V162, P851	25	591	629	6	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1310	1314		10.1126/science.1107891	http://dx.doi.org/10.1126/science.1107891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919994				2022-12-24	WOS:000229482300048
J	Kaur, R				Kaur, R			Breast cancer	LANCET			English	Editorial Material									Int Union Canc UICC, Reach Recovery Int Global Breast Canc Support Net, Geneva, Switzerland		Kaur, R (corresponding author), Int Union Canc UICC, Reach Recovery Int Global Breast Canc Support Net, Geneva, Switzerland.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1742	1742		10.1016/S0140-6736(05)66547-6	http://dx.doi.org/10.1016/S0140-6736(05)66547-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894100				2022-12-24	WOS:000229082300025
J	Beral, V; Bull, D; Reeves, G				Beral, V; Bull, D; Reeves, G		Million Women Study Collaborators	Endometrial cancer and hormone-replacement therapy in the Million Women Study	LANCET			English	Article							ESTROGEN REPLACEMENT; RISK; PROGESTIN	Background Postmenopausal women who use hormone-replacement therapy (HRT) containing oestrogen alone are at increased risk of endometrial cancer. To minimise this risk, many HRT users who have not had a hysterectomy use combined oestrogen-progestagen preparations or tibolone. Limited information is available on the incidence of endometrial cancer in users of these therapies. Methods 716 738 postmenopausal women in the UK without previous cancer or previous hysterectomy were recruited into the Million Women Study in 1996-2001, provided information about their use of HRT and other personal details, and were followed up for an average of 3.4 years, during which time 1320 incident endometrial cancers were diagnosed. Findings 320 953 women (45%) reported at recruitment that they had used HRT, among whom 69 577 (22%) last used continuous combined therapy (progestagen added daily to oestrogen), 145 486 (45%) last used cyclic combined therapy (progestagen added to oestrogen, usually for 10-14 days per month), 28 028 (9%) last used tibolone, and 14 204 (4%) last used oestrogen-only HRT. These HRT types had sharply contrasting effects on the overall risk of endometrial cancer (p<0.0001 for heterogeneity). Compared with never users of HRT, risk was: reduced with last use of continuous combined preparations (relative risk 0.71 [95% Cl 0.56-0.90]; p=0.005); increased with last use of tibolone (1.79 [1.43-2.25]; p<0.0001) and oestrogen only (1.45 [1.02-2.06]; p=0.04); and not significantly altered with last use of cyclic combined preparations (1.05 [0.91-1.22]; p=0.5). A woman's body-mass index significantly affected these associations, such that the adverse effects of tibolone and oestrogen-only HRT were greatest in non-obese women, and the beneficial effects of combined HRT were greatest in obese women. Interpretation Oestrogens and tibolone increase the risk of endometrial cancer. Progestagens counteract the adverse effect of oestrogens on the endometrium, the effect being greater the more days every month that they are added to oestrogen and the more obese that women are. However, combined oestrogen-progestagen HRT causes a greater increase in breast cancer than the other therapies do. Thus, when endometrial and breast cancers are added together, there is a greater increase in total cancer incidence with use of combined HRT, both continuous and cyclic, than with use of the other therapies.	Radcliffe Infirm, Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Oxford OX2 6HE, England	Cancer Research UK; Radcliffe Infirmary; University of Oxford	Beral, V (corresponding author), Radcliffe Infirm, Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Gibson Bldg,Woodstock Rd, Oxford OX2 6HE, England.	secretariat@millionwomenstudy.org						Abbott S, 2002, BJOG-INT J OBSTET GY, V109, P1319; Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; ARMITAGE M, 2004, MENOPAUSE HORMONE RE, P325; BAKKEN K, 2002, INT J CANCER, V112, P130; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 2005, BJOG-INT J OBSTET GY, V112, P692, DOI 10.1111/j.1471-0528.2005.00541.x; Beresford SAA, 1997, LANCET, V349, P458, DOI 10.1016/S0140-6736(96)07365-5; BRINTON LA, 1993, OBSTET GYNECOL, V81, P265; de Vries CS, 2005, DRUG SAFETY, V28, P241, DOI 10.2165/00002018-200528030-00005; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Hill DA, 2000, AM J OBSTET GYNECOL, V183, P1456, DOI 10.1067/mob.2000.108081; *IARC, 1999, IARC MON EV CARC RIS, V72; JICK SS, 1993, EPIDEMIOLOGY, V4, P20, DOI 10.1097/00001648-199301000-00005; *JOINT FORM COMM, 1999, BRIT NAT FORM; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Lukanova A, 2004, INT J CANCER, V108, P425, DOI 10.1002/ijc.11529; *NAT STAT, 2003, CANC STAT REG CA MB1, V31; Newcomb PA, 2003, CANCER CAUSE CONTROL, V14, P195, DOI 10.1023/A:1023066304473; PERSSON I, 1989, BRIT MED J, V298, P147, DOI 10.1136/bmj.298.6667.147; Pike MC, 1997, J NATL CANCER I, V89, P1110, DOI 10.1093/jnci/89.15.1110; SIITERI PK, 1987, AM J CLIN NUTR, V45, P277, DOI 10.1093/ajcn/45.1.277; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Townsend PP., 1988, HLTH DEPRIVATION INE; VOIGT LF, 1991, LANCET, V338, P274, DOI 10.1016/0140-6736(91)90417-N; Weiderpass E, 1999, J NATL CANCER I, V91, P1131, DOI 10.1093/jnci/91.13.1131; World Health Organization, 1998, INT CLASS DIS; Yazigi R, 2004, GYNECOL ONCOL, V93, P568, DOI 10.1016/j.ygyno.2004.02.003; Zeleniuch-Jacquotte A, 2001, BRIT J CANCER, V84, P975, DOI 10.1054/bjoc.2001.1704	29	441	465	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1543	1551						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866308				2022-12-24	WOS:000228754800026
J	Dimmeler, S				Dimmeler, S			Platelet-derived growth factor CC - A clinically useful angiogenic factor at last?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PDGF		Univ Frankfurt, Dept Mol Cardiol, D-6000 Frankfurt, Germany	Goethe University Frankfurt	Dimmeler, S (corresponding author), Univ Frankfurt, Dept Mol Cardiol, D-6000 Frankfurt, Germany.			Dimmeler, Stefanie/0000-0002-1045-2436				Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Li XR, 2005, J CLIN INVEST, V115, P118, DOI 10.1172/JCI200519189; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Vincent L, 2004, CANCER CELL, V6, P307, DOI 10.1016/j.ccr.2004.09.024	5	22	26	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1815	1816		10.1056/NEJMcibr050670	http://dx.doi.org/10.1056/NEJMcibr050670			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858193				2022-12-24	WOS:000228689000015
J	Bastien, GJ; Schepens, B; Willems, PA; Heglund, NC				Bastien, GJ; Schepens, B; Willems, PA; Heglund, NC			Energetics of load carrying in Nepalese porters	SCIENCE			English	Article							HUMAN WALKING; COST		Catholic Univ Louvain, Fac Med, Unite Physiol & Biomecan Locomot, B-3000 Louvain, Belgium	Universite Catholique Louvain	Heglund, NC (corresponding author), Catholic Univ Louvain, Fac Med, Unite Physiol & Biomecan Locomot, B-3000 Louvain, Belgium.	norman.heglund@loco.ucl.ac.be						Bastien GJ, 2005, EUR J APPL PHYSIOL, V94, P76, DOI 10.1007/s00421-004-1286-z; Cavagna GA, 2002, J EXP BIOL, V205, P3413; HEGLUND NC, 1995, NATURE, V375, P52, DOI 10.1038/375052a0; MALOIY GMO, 1986, NATURE, V319, P668, DOI 10.1038/319668a0	4	68	69	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1755	1755		10.1126/science.1111513	http://dx.doi.org/10.1126/science.1111513			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961662				2022-12-24	WOS:000229926800044
J	Sangrithi, MN; Bernal, JA; Madine, M; Philpott, A; Lee, J; Dunphy, WG; Venkitaraman, AR				Sangrithi, MN; Bernal, JA; Madine, M; Philpott, A; Lee, J; Dunphy, WG; Venkitaraman, AR			Initiation of DNA replication requires the RECQL4 protein mutated in Rothmund-Thomson syndrome	CELL			English	Article							SISTER-CHROMATID COHESION; S-PHASE; WERNER-SYNDROME; FISSION YEAST; HELICASE; PHOSPHORYLATION; COMPLEX; BRCA2; CDC45; RECOMBINATION	How the replication machinery is loaded at origins of DNA replication is poorly understood. Here, we implicate in this process the Xenopus laevis homolog (xRTS) of the RECOL4 helicase mutated in Rothmund-Thomson syndrome. xRTS, which bears homology to the yeast replication factors SId2/DRC1, is essential for DNA replication in egg extracts. xRTS can be replaced in extracts by its human homolog, while RECOL4 depletion from mammalian cells induces proliferation failure, suggesting an evolutionarily conserved function. xRTS accumulates on chromatin during replication initiation, after prereplication-complex (pre-RC) proteins, Cut5, SId5, or Cdc45 but before replicative polymerases. xRTS depletion suppresses the loading of RPA, the ssDNA binding protein that marks unwound origins before polymerase recruitment. However, xRTS is unaffected by xRPA depletion. Thus, xRTS functions after pre-RC formation to promote loading of replication factors at origins, a previously unrecognized activity necessary for initiation. This role connects defective replication initiation to a chromosome-fragility disorder.	Univ Cambridge, Canc Res UK Dept Oncol, Cambridge CB2 2XZ, England; Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 2XZ, England; CALTECH, Div Biol, Pasadena, CA 91125 USA	Cancer Research UK; University of Cambridge; California Institute of Technology	Venkitaraman, AR (corresponding author), Univ Cambridge, Canc Res UK Dept Oncol, Hills Rd, Cambridge CB2 2XZ, England.	arv22@cam.ac.uk	Bernal, Juan A/N-4544-2014	Bernal, Juan A/0000-0002-9933-5550; Philpott, Anna/0000-0003-3789-2463; Sangrithi, Mahesh/0000-0002-0008-4588	NIGMS NIH HHS [GM070891] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070891] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; COX LS, 1990, J CELL SCI, V97, P177; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; Ichikawa Koji, 2002, Nihon Yakurigaku Zasshi, V119, P219; JENKINS TM, 1992, SCIENCE, V258, P475, DOI 10.1126/science.1411545; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Li WH, 2004, J CELL BIOL, V165, P801, DOI 10.1083/jcb.200402095; Liao SR, 2000, GENE DEV, V14, P2570, DOI 10.1101/gad.822400; Lindor NM, 2000, AM J MED GENET, V90, P223, DOI 10.1002/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO;2-Z; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; MILLS AD, 1989, J CELL SCI, V94, P471; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Noguchi E, 2002, CURR BIOL, V12, P599, DOI 10.1016/S0960-9822(02)00739-X; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; Prince PR, 2001, GENE DEV, V15, P933, DOI 10.1101/gad.877001; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Siitonen HA, 2003, HUM MOL GENET, V12, P2837, DOI 10.1093/hmg/ddg306; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; VENNOS EM, 1995, DERMATOL CLIN, V13, P143, DOI 10.1016/S0733-8635(18)30117-7; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	41	216	219	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					887	898		10.1016/j.cell.2005.05.015	http://dx.doi.org/10.1016/j.cell.2005.05.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960976	Bronze			2022-12-24	WOS:000230011200011
J	Kerr, D				Kerr, D			As fit as a butcher's dog	LANCET			English	Editorial Material									Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England		Kerr, D (corresponding author), Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England.	david.kerr@rbch.nhs.uk							0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1981	1981		10.1016/S0140-6736(05)66668-8	http://dx.doi.org/10.1016/S0140-6736(05)66668-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936430				2022-12-24	WOS:000229587800036
J	Phillips-Silver, J; Trainor, LJ				Phillips-Silver, J; Trainor, LJ			Feeling the beat: Movement influences infant rhythm perception	SCIENCE			English	Article									McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada	McMaster University	Trainor, LJ (corresponding author), McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada.	LJT@mcmaster.ca		Trainor, Laurel/0000-0003-3397-2079				Brown S, 2000, ORIGINS OF MUSIC, P3; CLARK DL, 1977, SCIENCE, V196, P1228, DOI 10.1126/science.300899; Lackner J R, 1992, J Vestib Res, V2, P307; Lehrdal F., 1983, GENERATIVE THEORY TO; Trainor Laurel J., 2003, COGNITIVE NEUROSCIEN, P310; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084	6	376	381	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1430	1430		10.1126/science.1110922	http://dx.doi.org/10.1126/science.1110922			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933193				2022-12-24	WOS:000229619300042
J	Yip, CK; Kimbrough, TG; Felise, HB; Vuckovic, M; Thomas, NA; Pfuetzner, RA; Frey, EA; Finlay, BB; Miller, SI; Strynadka, NCJ				Yip, CK; Kimbrough, TG; Felise, HB; Vuckovic, M; Thomas, NA; Pfuetzner, RA; Frey, EA; Finlay, BB; Miller, SI; Strynadka, NCJ			Structural characterization of the molecular platform for type III secretion system assembly	NATURE			English	Article							NEEDLE COMPLEX; ASSOCIATION; MULTIMER; INSIGHTS; PROGRAM	Type III secretion systems ( TTSSs) are multi-protein macromolecular 'machines' that have a central function in the virulence of many Gram-negative pathogens by directly mediating the secretion and translocation of bacterial proteins ( termed effectors) into the cytoplasm of eukaryotic cells(1). Most of the 20 unique structural components constituting this secretion apparatus are highly conserved among animal and plant pathogens and are also evolutionarily related to proteins in the flagellar-specific export system. Recent electron microscopy experiments have revealed the gross 'needle-shaped' morphology of the TTSS2-4, yet a detailed understanding of the structural characteristics and organization of these protein components within the bacterial membranes is lacking. Here we report the 1.8-angstrom crystal structure of EscJ from enteropathogenic Escherichia coli (EPEC), a member of the YscJ/ PrgK family whose oligomerization represents one of the earliest events in TTSS assembly(5). Crystal packing analysis and molecular modelling indicate that EscJ could form a large 24-subunit 'ring' superstructure with extensive grooves, ridges and electrostatic features. Electron microscopy, labelling and mass spectrometry studies on the orthologous Salmonella typhimurium PrgK within the context of the assembled TTSS support the stoichiometry, membrane association and surface accessibility of the modelled ring. We propose that the YscJ/ PrgK protein family functions as an essential molecular platform for TTSS assembly.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; Dept Microbiol & Med, Seattle, WA 98195 USA; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of Washington; University of Washington Seattle; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca		Thomas, Nikhil/0000-0003-3037-425X; Yip, Calvin/0000-0003-1779-9501				Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x; EVANS PR, 1993, P CCP4 STUD WEEK DAT, P1114; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; JONES CJ, 1990, J MOL BIOL, V212, P377, DOI 10.1016/0022-2836(90)90132-6; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kimbrough TG, 2002, MICROBES INFECT, V4, P75, DOI 10.1016/S1286-4579(01)01512-X; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; LESLIE AGW, 1992, CCP4 ESF EAMCB NEWSL; Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Suzuki H, 2004, J MOL BIOL, V337, P105, DOI 10.1016/j.jmb.2004.01.034; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101	28	158	164	0	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					702	707		10.1038/nature03554	http://dx.doi.org/10.1038/nature03554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15931226				2022-12-24	WOS:000229476200056
J	Petersen, J; Hagan, IM				Petersen, J; Hagan, IM			Polo kinase links the stress pathway to cell cycle control and tip growth in fission yeast	NATURE			English	Article							SCHIZOSACCHAROMYCES-POMBE; GENETIC-CONTROL; DIVISION CYCLE; MAP KINASE; HISTONE H3; PHOSPHORYLATION; ADAPTATION; EXPRESSION; PROTEIN; LENGTH	Stress-activated mitogen-activated protein kinase cascades instigate a range of changes to enable eukaryotic cells to cope with particular insults. In Schizosaccharomyces pombe these responses include the transcription of specific gene sets and inhibition of entry into mitosis(1,2). The S. pombe stress response pathway (SRP) also promotes commitment to mitosis in unperturbed cell cycles to allow cells to match their rate of division with nutrient availability(1,3). The nature of this SRP function in cell cycle control is unknown. Entry into mitosis is controlled by mitosis-promoting factor (MPF; Cdc2/cyclin B) activity. Inhibitory phosphorylation of Cdc2 by Wee1 kinase inactivates MPF until Cdc25 removes this phosphate to promote mitosis(4). The balance between Wee1 and Cdc25 activities is influenced by the recruitment of polo kinase (Plo1) to the spindle pole body (SPB)(5). The SPB component Cut12 mediates this recruitment(5,6). Hyper-activating mutations in either cut12 or plo1 enable Cdc25-defective cells to enter mitosis(5,7). The hyperactive cut12.s11 mutation suppresses cdc25.22, as it promotes recruitment of active Plo1 to interphase SPBs(6,7). Here we show that the SRP promotes phosphorylation of Plo1 on Ser 402. In unperturbed cell cycles, SRP-mediated phosphorylation of Ser 402 promotes Plo1 recruitment to SPBs and thus commitment to mitosis. Ser 402 phosphorylation also ensures efficient reinitiation of cell tip growth and cell division during recovery from particular stresses. Thus, phosphorylation of Plo1 Ser 402 not only enables SRP signalling to modulate the timing of mitotic commitment in response to nutrient status in unperturbed cycles, but also promotes the return to normal cell cycle control after stress.	Paterson Inst Canc Res, Canc Res UK Cell Div Grp, Manchester M20 4BX, Lancs, England; Rockefeller Univ, New York, NY 10021 USA	Paterson Institute for Cancer Research; Rockefeller University	Hagan, IM (corresponding author), Paterson Inst Canc Res, Canc Res UK Cell Div Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	ihagan@picr.man.ac.uk		Petersen, Janni/0000-0003-0729-9335; Hagan, Iain/0000-0002-5858-9415				Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; HUDSON JD, 1990, GENETICS, V126, P309; MacIver FH, 2003, YEAST, V20, P587, DOI 10.1002/yea.983; MacIver FH, 2003, GENE DEV, V17, P1507, DOI 10.1101/gad.256003; MARKS J, 1985, EUR J CELL BIOL, V39, P27; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAY JW, 1986, NATURE, V322, P752, DOI 10.1038/322752a0; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mulvihill DP, 1999, MOL BIOL CELL, V10, P2771, DOI 10.1091/mbc.10.8.2771; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; OGDEN JE, 1986, CURR GENET, V10, P509, DOI 10.1007/BF00447384; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Toone WM, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P57; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9	28	95	98	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					507	512		10.1038/nature03590	http://dx.doi.org/10.1038/nature03590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917811				2022-12-24	WOS:000229337800057
J	Gould, DB; Phalan, FC; Breedveld, GJ; van Mil, SE; Smith, RS; Schimenti, JC; Aguglia, U; van der Knaap, MS; Heutink, P; John, SWM				Gould, DB; Phalan, FC; Breedveld, GJ; van Mil, SE; Smith, RS; Schimenti, JC; Aguglia, U; van der Knaap, MS; Heutink, P; John, SWM			Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly	SCIENCE			English	Article							IV COLLAGEN; CAENORHABDITIS-ELEGANS; MOUSE; HEMIPLEGIA; LETHALITY; MICE	Porencephaly is a rare neurological disease, typically manifest in infants, which is characterized by the existence of degenerative cavities in the brain. To investigate the molecular pathogenesis of porencephaly, we studied a mouse mutant that develops porencephaly secondary to focal disruptions of vascular basement membranes. Half of the mutant mice died with cerebral hemorrhage within a day of birth, and similar to 18% of survivors had porencephaly. We show that vascular defects are caused by a semidominant mutation ill the procollagen type IV alpha 1 gene (CoNa1) in mice, which inhibits the secretion of mutant and normal type IV collagen. We also show that COL4A1 mutations segregate with porencephaly in human families. Because not all mutant mice develop porencephaly, we propose that CoNa1 mutations conspire with environmental trauma in causing the disease.	Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Erasmus Med Ctr, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Human Genet, Sect Med Genom, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Ctr Neurogenom & Cognit Res, NL-1081 BT Amsterdam, Netherlands; Univ Catanzaro, Reg Epilepsy Ctr, I-89100 Reggio Di Calabria, Italy; Free Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1081 BT Amsterdam, Netherlands; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Howard Hughes Medical Institute; Jackson Laboratory; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Magna Graecia University of Catanzaro; Vrije Universiteit Amsterdam; Tufts University	John, SWM (corresponding author), Howard Hughes Med Inst, Bar Harbor, ME 04609 USA.	swmj@jax.org	Aguglia, Umberto/AAB-9898-2019	Aguglia, Umberto/0000-0002-4574-2951; Heutink, Peter/0000-0001-5218-1737	NCI NIH HHS [CA34196] Funding Source: Medline; NEI NIH HHS [EY11721] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011721, R29EY011721] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguglia U, 2004, NEUROLOGY, V62, P1613, DOI 10.1212/01.WNL.0000123113.46672.68; BERG RA, 1983, ARCH NEUROL-CHICAGO, V40, P567, DOI 10.1001/archneur.1983.04050080067013; BLUMBERG B, 1987, J BIOL CHEM, V262, P5947; CATTANACH BM, 1993, MOUSE GENOME, V91, P853; Debus OM, 2004, ANN NEUROL, V56, P287, DOI 10.1002/ana.20184; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; GOULD DB, UNPUB; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; HAAR F, 1977, NEUROLOGY, V27, P849, DOI 10.1212/WNL.27.9.849; KEFALIDES NA, 1971, BIOCHEM BIOPH RES CO, V45, P226, DOI 10.1016/0006-291X(71)90073-8; Mancini GMS, 2004, EUR J PAEDIATR NEURO, V8, P45, DOI 10.1016/j.ejpn.2003.10.002; MAYNE R, 1984, J CELL BIOL, V98, P1637, DOI 10.1083/jcb.98.5.1637; MUTHUKUMARAN G, 1989, J BIOL CHEM, V264, P6310; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; PASTERNAK JF, 1980, AM J DIS CHILD, V134, P673, DOI 10.1001/archpedi.1980.02130190041010; POSCHL E, 2004, DEVELOPMENT; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; RENIERI A, 1994, NEPHRON, V67, P444, DOI 10.1159/000188020; SCHUPPAN D, 1980, FEBS LETT, V115, P297, DOI 10.1016/0014-5793(80)81191-4; SENSI A, 1990, CLIN GENET, V38, P396; SIBLEY MH, 1994, EMBO J, V13, P3278, DOI 10.1002/j.1460-2075.1994.tb06629.x; SMIT LME, 1984, BRAIN DEV-JPN, V6, P54, DOI 10.1016/S0387-7604(84)80010-8; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TRUEB B, 1982, J BIOL CHEM, V257, P5239; Urabe N, 2002, ARCH HISTOL CYTOL, V65, P133, DOI 10.1679/aohc.65.133; Vilain C, 2002, AM J MED GENET, V112, P198, DOI 10.1002/ajmg.10452; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; ZONANA J, 1986, J PEDIATR-US, V109, P671, DOI 10.1016/S0022-3476(86)80240-2	29	358	373	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1167	1171		10.1126/science.1109418	http://dx.doi.org/10.1126/science.1109418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905400				2022-12-24	WOS:000229293400043
J	Vermot, J; Pourquie, O				Vermot, J; Pourquie, O			Retinoic acid coordinates somitogenesis and left-right patterning in vertebrate embryos	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; CHICK-EMBRYO; SEGMENTATION CLOCK; NODAL EXPRESSION; SOMITE FORMATION; MOUSE; INFORMATION; PATHWAYS; GENE; BUD	A striking feature of the body plan of a majority of animals is bilateral symmetry. Almost nothing is known about the mechanisms controlling the symmetrical arrangement of the left and right body sides during development. Here we report that blocking the production of retinoic acid ( RA) in chicken embryos leads to a desynchronization of somite formation between the two embryonic sides, demonstrated by a shortened left segmented region. This defect is linked to a loss of coordination of the segmentation clock oscillations(1). The lateralization of this defect led us to investigate the relation between somitogenesis and the left - right asymmetry machinery(2,3) in RA-deficient embryos. Reversal of the situs in chick(4,5) or mouse(6) embryos lacking RA results in a reversal of the somitogenesis laterality defect. Our data indicate that RA is important in buffering the lateralizing influence of the left - right machinery, thus permitting synchronization of the development of the two embryonic sides.	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Pourquie, O (corresponding author), Stowers Inst Med Res, 1000E 50th St, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Vermot, Julien/I-6568-2016; Pourquié, Olivier/CAJ-5443-2022	Pourquié, Olivier/0000-0001-5189-1227; , Julien/0000-0002-8924-732X				Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; BRUECKNER M, 1989, P NATL ACAD SCI USA, V86, P5035, DOI 10.1073/pnas.86.13.5035; Buchberger A, 1998, DEV BIOL, V199, P201, DOI 10.1006/dbio.1998.8919; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.3.CO;2-X; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 1997, DEV BIOL, V189, P57, DOI 10.1006/dbio.1997.8662; Maden M, 1998, DEVELOPMENT, V125, P4133; Maden M, 2000, INT J DEV BIOL, V44, P151; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Pagan-Westphal SM, 1998, CELL, V93, P25, DOI 10.1016/S0092-8674(00)81143-5; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Schubert M, 2001, DEV BIOL, V240, P262, DOI 10.1006/dbio.2001.0460; Stratford T, 1996, CURR BIOL, V6, P1124, DOI 10.1016/S0960-9822(02)70679-9; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363	29	184	193	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					215	220		10.1038/nature03488	http://dx.doi.org/10.1038/nature03488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889094				2022-12-24	WOS:000229021100043
J	Blank, S; Schillinger, JA; Harbatkin, D				Blank, S; Schillinger, JA; Harbatkin, D			Lymphogranuloma venereum in the industrialised world	LANCET			English	Editorial Material									New York City Dept Hlth & Mental Hyg, Bur Sexually Transmitted Dis Control, New York, NY 10013 USA; Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; Callen Lorde Community Hlth Ctr, New York, NY USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA	Blank, S (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Sexually Transmitted Dis Control, New York, NY 10013 USA.	sblank@health.nyc.gov						*CDC, 2004, MMWR-MORBID MORTAL W, V53, P955; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; GOTZ HM, 2004, EURASURVEILLANC 0122; *HLTH PROT AG, 2005, CDR WKLY        0415; Koo D, 1996, J Public Health Manag Pract, V2, P4; Nieuwenhuis RF, 2004, CLIN INFECT DIS, V39, P996, DOI 10.1086/423966; PERINE PL, 1999, SEXUALLY TRANSMITTED, P423	7	33	33	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 7	2005	365	9471					1607	1608		10.1016/S0140-6736(05)66490-2	http://dx.doi.org/10.1016/S0140-6736(05)66490-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885284				2022-12-24	WOS:000228933700009
J	Anderson, B; Cole, WW; Barrett, SCH				Anderson, B; Cole, WW; Barrett, SCH			Specialized bird perch aids cross-pollination	NATURE			English	Editorial Material									Univ KwaZulu Natal, Sch Bot & Zool, ZA-3209 Pietermaritzburg, South Africa; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada	University of Kwazulu Natal; University of Toronto	Anderson, B (corresponding author), Univ KwaZulu Natal, Sch Bot & Zool, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa.	barrett@botany.utoronto.ca	Barrett, Spencer C.H./S-5782-2019; Barrett, Spencer CH/M-3751-2013; ANDERSON, BRUCE/E-5853-2011	Barrett, Spencer C.H./0000-0002-7762-3455; Anderson, Bruce/0000-0002-7264-4505				Barrett SCH, 1996, TRENDS ECOL EVOL, V11, P73, DOI 10.1016/0169-5347(96)81046-9; BROWN NE, 1932, T ROY SOC S AFR, V20, P261; Goldblatt Peter, 1999, Adansonia (Paris), V21, P25; WESTERKAMP C, 1990, BOT ACTA, V103, P366, DOI 10.1111/j.1438-8677.1990.tb00176.x	4	51	52	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					41	42		10.1038/435041a	http://dx.doi.org/10.1038/435041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875009				2022-12-24	WOS:000228864600031
J	Brown, SA; Ripperger, J; Kadener, S; Fleury-Olela, F; Vilbois, F; Rosbash, M; Schibler, U				Brown, SA; Ripperger, J; Kadener, S; Fleury-Olela, F; Vilbois, F; Rosbash, M; Schibler, U			PERIOD1-associated proteins modulate the negative limb of the mammalian circadian oscillator	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; COURTSHIP SONG; CLOCK; CELLS	The clock proteins PERIOD1 (PER1) and PERIOD2 (PER2) play essential roles in a negative transcriptional feedback loop that generates circadian rhythms in mammalian cells. We identified two PER1-associated factors, NONO and WDR5, that modulate PER activity. The reduction of NONO expression by RNA interference (RNAi) attenuated circadian rhythms in mammalian cells, and fruit flies carrying a hypomorphic allele were nearly arrhythmic. WDR5, a subunit of histone methyltransferase complexes, augmented PER-mediated transcriptional repression, and its reduction by RNAi diminished circadian histone methylations at the promoter of a clock gene.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Univ Geneva, Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA; Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland	University of Geneva; University of Geneva; Brandeis University; Howard Hughes Medical Institute	Brown, SA (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	steven.brown@molbio.unige.ch; Ueli.schibler@molbio.unige.ch	Brown, Steven/E-4955-2013					Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; RENDAHL KG, 1992, J NEUROSCI, V12, P390; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; STANEWSKY R, 1993, GENETICS, V135, P419; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	18	212	231	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					693	696		10.1126/science.1107373	http://dx.doi.org/10.1126/science.1107373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860628				2022-12-24	WOS:000228810900050
J	Ali, M; Emch, M; von Seidlein, L; Yunus, M; Sack, DA; Rao, M; Holmgren, J; Clemens, JD				Ali, M; Emch, M; von Seidlein, L; Yunus, M; Sack, DA; Rao, M; Holmgren, J; Clemens, JD			Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis	LANCET			English	Article							FIELD TRIAL; IMMUNIZATION	Background Decisions about the use of killed oral cholera vaccines, which confer moderate levels of direct protection to vaccinees, can depend on whether the vaccines also provide indirect (herd) protection when high levels of vaccine coverage are attained. We reanalysed data from a field trial in Bangladesh to ascertain whether there is evidence of indirect protection from killed oral cholera vaccines. Methods We analysed the first year of surveillance data from a placebo-controlled trial of B subunit-killed whole-cell and killed whole-cell-only oral cholera vaccines in children and adult women in Bangladesh. We calculated whether there was an inverse, monotonic trend for the relation between the level of vaccine coverage in a residential cluster and the incidence of cholera in individual vaccine recipients or placebo recipients residing in the cluster after controlling for potential confounding variables. Findings Vaccine coverage of the targeted population ranged from 4% to 65%. Incidence rates of cholera among placebo recipients were inversely related to levels of vaccine coverage (7.01 cases per 1000 in the lowest quintile of coverage vs 1.47 cases per 1000 in the highest quintile; p<0.0001 for trend). Receipt of vaccine by an individual and the level of vaccine coverage of the individual's cluster were independently related to a reduced risk of cholera. Moreover, after adjustment for the level of vaccine coverage of the cluster, vaccine protective efficacy remained significant (55% [95% CI 41-66], p<0.0001). Interpretation in addition to providing direct protection to vaccine recipients, killed oral cholera vaccines confer significant herd protection to neighbouring non-vaccinated individuals. Use of these vaccines could have a major effect on the burden of cholera in endemic settings.	Int Vaccine Inst, Seoul 151818, South Korea; Portland State Univ, Dept Geog, Portland, OR 97207 USA; ICDDR B, Ctr Hlth & Populat Res, Dhaka, Bangladesh; NIAID, NIH, Bethesda, MD 20892 USA; Univ Gothenburg, Dept Med Microbiol & Immunol, Gothenburg, Sweden; NICHHD, Bethesda, MD 20892 USA	International Vaccine Institute; Portland State University; International Centre for Diarrhoeal Disease Research (ICDDR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Gothenburg; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Clemens, JD (corresponding author), Int Vaccine Inst, SNU Res Pk,San 4-8 Bongcheon 7 Dong, Seoul 151818, South Korea.	jclemens@ivi.int	Ali, Mohammad/E-2365-2017	Ali, Mohammad/0000-0003-1410-388X; Holmgren, Jan/0000-0003-1784-5918	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI053214] Funding Source: NIH RePORTER; NIAID NIH HHS [1R03AI53214-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali M, 2001, J HEALTH POPUL NUTR, V19, P100; Anderson R M, 1990, Lancet, V335, P641; BLACK RE, 1987, INFECT IMMUN, V55, P1116, DOI 10.1128/IAI.55.5.1116-1120.1987; CLEMENS JD, 1986, LANCET, V2, P124; CLEMENS JD, 1987, J INFECT DIS, V155, P79, DOI 10.1093/infdis/155.1.79; CLEMENS JD, 1992, AM J EPIDEMIOL, V135, P865, DOI 10.1093/oxfordjournals.aje.a116382; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; CLEMENS JD, 1988, J INFECT DIS, V158, P60, DOI 10.1093/infdis/158.1.60; CLEMENS JD, 1990, AM J EPIDEMIOL, V131, P400, DOI 10.1093/oxfordjournals.aje.a115515; CLEMENS JD, 1992, J INFECT DIS, V166, P1029, DOI 10.1093/infdis/166.5.1029; Cox DR, 1958, PLANNING EXPT; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; FOX JP, 1995, AM J EPIDEMIOL, V141, P187, DOI 10.1093/oxfordjournals.aje.a117420; GLASS RI, 1985, J INFECT DIS, V151, P236, DOI 10.1093/infdis/151.2.236; GLASS RI, 1982, AM J EPIDEMIOL, V116, P959, DOI 10.1093/oxfordjournals.aje.a113498; GREENLAND S, 1988, INT J EPIDEMIOL, V17, P456, DOI 10.1093/ije/17.2.456; Longini IM, 2002, STAT MED, V21, P481, DOI 10.1002/sim.994; MURPHY TV, 1993, JAMA-J AM MED ASSOC, V269, P246, DOI 10.1001/jama.269.2.246; Snedecor GW, 1980, STAT METHODS, V7th; *WHO GLOB TASK FOR, 2002, WHO M 10 11 DEC 2002; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	21	228	236	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					44	49		10.1016/S0140-6736(05)66550-6	http://dx.doi.org/10.1016/S0140-6736(05)66550-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	15993232				2022-12-24	WOS:000230277600033
J	Kim, J; Wu, HH; Lander, AD; Lyons, KM; Matzuk, MM; Calof, AL				Kim, J; Wu, HH; Lander, AD; Lyons, KM; Matzuk, MM; Calof, AL			GDF11 controls the timing of progenitor cell competence in developing retina	SCIENCE			English	Article							GANGLION-CELLS; RAT RETINA; NEURAL RETINA; FROG RETINA; BHLH GENES; DIFFERENTIATION; MOUSE; AUTOREGULATION; RETINOGENESIS; EXPRESSION	The orderly generation of cell types in the developing retina is thought to be regulated by changes in the competence of multipotent progenitors. Here, we show that a secreted factor, growth and differentiation factor 11 (GDF11), controls the numbers of retinal ganglion cells (RGCs), as well as amacrine and photoreceptor cells, that form during development. GDF11 does not affect proliferation of progenitors-a major mode of GDF11 action in other tissues-but instead controls duration of expression of Maths, a gene that confers competence for RGC genesis, in progenitor cells. Thus, GDF11 governs the temporal windows during which multipotent progenitors retain competence to produce distinct neural progeny.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Los Angeles; Baylor College of Medicine	Calof, AL (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	alcalof@uci.edu	Lander, Arthur/L-2827-2019; Lander, Arthur D/C-9008-2011; Calof, Anne/A-8644-2013; Kim, Joon/C-1833-2011	Lander, Arthur/0000-0002-4380-5525; Lander, Arthur D/0000-0002-4380-5525; Calof, Anne/0000-0003-3676-2499; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD032067] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003583] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44528] Funding Source: Medline; NICHD NIH HHS [HD32067, HD38761] Funding Source: Medline; NIDCD NIH HHS [DC03583] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Brown NL, 2001, DEVELOPMENT, V128, P2497; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Federman SM, 2000, J BONE MINER RES, V15, pS463; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gonzalez-Hoyuela M, 2001, DEVELOPMENT, V128, P117; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Liu W, 2000, DEV DYNAM, V217, P320, DOI 10.1002/(SICI)1097-0177(200003)217:3<320::AID-DVDY10>3.0.CO;2-F; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Morrow EM, 1999, DEVELOPMENT, V126, P23; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Rapaport DH, 2001, J NEUROBIOL, V49, P129, DOI 10.1002/neu.1070; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; SPARROW JR, 1990, DEV BRAIN RES, V51, P69, DOI 10.1016/0165-3806(90)90259-2; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; WAID DK, 1995, NEURON, V14, P117, DOI 10.1016/0896-6273(95)90245-7; Waid DK, 1998, DEVELOPMENT, V125, P1059; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; XIANG MQ, 1993, NEURON, V11, P689, DOI 10.1016/0896-6273(93)90079-7; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	32	168	184	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1927	1930		10.1126/science.1110175	http://dx.doi.org/10.1126/science.1110175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976303	Green Submitted			2022-12-24	WOS:000230120000045
J	Shenfield, F				Shenfield, F			Semantics and ethics of human embryonic stem-cell research	LANCET			English	Editorial Material									UCL Hosp, Reprod Med Unit, London WC1E 6AY, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Shenfield, F (corresponding author), UCL Hosp, Reprod Med Unit, London WC1E 6AY, England.	mfi@easynet.co.uk						*DEP HLTH, 2000, STEM CELL RES MED PR; *EUR COUNC EUR, 1996, CONV PROT HUM RIGHTS; *EUR GROUP ETH SCI, 2002, AD OP ETH ASP HUM CE; Shenfield F, 2002, HUM REPROD, V17, P1409; Shenfield F, 2001, HUM REPROD, V16, P1046; SHENFIELD F, 1995, HUM REPROD, V10, P253, DOI 10.1093/oxfordjournals.humrep.a135924; Shenfield F., 2002, ETHICAL DILEMMAS REP; WARNOCK M, 1984, REPORT COMMITTEE ENQ	8	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2005	365	9477					2071	2073		10.1016/S0140-6736(05)66555-5	http://dx.doi.org/10.1016/S0140-6736(05)66555-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	936LZ	15964431				2022-12-24	WOS:000229858800008
J	Liu, YF; Chen, WM; Lin, YF; Yang, RC; Lin, MW; Li, LH; Chang, YH; Jou, YS; Lin, PY; Su, JS; Huang, SF; Hsiao, KJ; Fann, CSJ; Hwang, HW; Chen, YT; Tsai, SF				Liu, YF; Chen, WM; Lin, YF; Yang, RC; Lin, MW; Li, LH; Chang, YH; Jou, YS; Lin, PY; Su, JS; Huang, SF; Hsiao, KJ; Fann, CSJ; Hwang, HW; Chen, YT; Tsai, SF			Type II collagen gene variants and inherited osteonecrosis of the femoral head	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPONDYLOEPIPHYSEAL DYSPLASIA; AVASCULAR NECROSIS; COL2A1 MUTATION; SERINE SUBSTITUTION; CARTILAGE; GLYCINE; HYPOCHONDROGENESIS; LINKAGE; FAMILY; BONE	BACKGROUND: Avascular necrosis of the femoral head (ANFH) causes disability that often requires surgical intervention. Most cases of ANFH are sporadic, but we identified three families in which there was autosomal dominant inheritance of the disease and mapped the chromosomal position of the gene to 12q13. METHODS: We carried out haplotype analysis in the families, selected candidate genes from the critical interval for ANFH on 12q13, and sequenced the promoter and exonic regions of the type II collagen gene (COL2A1) from persons with inherited and sporadic forms of ANFH. RESULTS: We identified a G(rightarrow)A transition in exon 50 of COL2A1 in affected members of a four-generation family with ANFH. This transition predicts the replacement of glycine with serine at codon 1170 in a GXY repeat of type II collagen. Another pedigree was shown to harbor the same transition, but the mutant allele occurred on a different haplotype background. In a third family, a G(rightarrow)A transition in exon 33 of the gene, causing a glycine-to-serine change at codon 717, was detected. No mutation was found in the COL2A1 coding region in sporadic cases of ANFH. CONCLUSIONS: All the patients with familial ANFH whom we studied carried COL2A1 mutations. In families with ANFH, haplotype and sequence analysis of the COL2A1 gene can be used to identify carriers of the mutant allele before the onset of clinical symptoms, allowing the initiation of measures that may delay progression of the disease.	Natl Yang Ming Univ, Sch Med, Inst Genet, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Med, Genome Res Ctr, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; Vet Gen Hosp, Dept Orthoped & Traumatol, Taipei, Taiwan; Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; Natl Hlth Res Inst, Div Mol & Genom Med, Taipei, Taiwan; Taipei Municipal Chung Hsing Hosp, Div Orthoped & Traumatol, Taipei, Taiwan; Chang Gung Mem Hosp, Dept Pathol, Taipei 10591, Taiwan; Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Academia Sinica - Taiwan	Tsai, SF (corresponding author), Natl Hlth Res Inst, Div Mol & Genom Med, 35 Keyan Rd, Zhunan Town 350, Miaoli County, Taiwan.	petsai@nhri.org.tw	Jou, Yuh-Shan/O-5921-2018; Tsai, Shih-Feng/E-3997-2010; Fann, Cathy SJ/F-9410-2010; Huang, Shiu-Feng Kathy/E-3977-2010	Jou, Yuh-Shan/0000-0001-5090-3732; Fann, Cathy SJ/0000-0001-9025-2276; Hwang, Hun-Way/0000-0003-0522-1577				Agarwala S, 2002, RHEUMATOLOGY, V41, P346, DOI 10.1093/rheumatology/41.3.346-a; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; BONAVENTURE J, 1995, BIOCHEM J, V307, P823, DOI 10.1042/bj3070823; CHAN D, 1995, J BIOL CHEM, V270, P1747, DOI 10.1074/jbc.270.4.1747; CHAN D, 1991, J BIOL CHEM, V266, P12487; Chen WM, 2004, AM J HUM GENET, V75, P310, DOI 10.1086/422702; Christgau S, 2001, BONE, V29, P209, DOI 10.1016/S8756-3282(01)00504-X; COLE WG, 1993, J MED GENET, V30, P27, DOI 10.1136/jmg.30.1.27; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3, DOI 10.1302/0301-620X.67B1.3155745; Gardeniers JW, 1993, ARCO NEWS LETT, V5, P79; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HORTON WA, 1992, P NATL ACAD SCI USA, V89, P4583, DOI 10.1073/pnas.89.10.4583; Korkko J, 2000, AM J MED GENET, V92, P95, DOI 10.1002/(SICI)1096-8628(20000515)92:2<95::AID-AJMG3>3.0.CO;2-9; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Lieberman Jay R, 2003, Instr Course Lect, V52, P337; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P29; Mont M.A., 1998, CLIN ORTHOPAEDICS RE, V355, pS314, DOI [10.1097/00003086-199810001-00032, DOI 10.1097/00003086-199810001-00032]; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; Mortier GR, 2000, J MED GENET, V37, P263, DOI 10.1136/jmg.37.4.263; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; RITVANIEMI P, 1994, HUM MUTAT, V3, P261, DOI 10.1002/humu.1380030314; Rozen S, 2000, Methods Mol Biol, V132, P365; URBANIAK JR, 1995, J BONE JOINT SURG AM, V77A, P681, DOI 10.2106/00004623-199505000-00004; VISSING H, 1989, J BIOL CHEM, V264, P18265; WILLIAMS CJ, 1995, HUM MOL GENET, V4, P309, DOI 10.1093/hmg/4.2.309; WINTERPACHT A, 1995, HUM GENET, V95, P437; WINTERPACHT A, 1994, HUM MUTAT, V4, P257, DOI 10.1002/humu.1380040405	30	116	134	3	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2005	352	22					2294	2301		10.1056/NEJMoa042480	http://dx.doi.org/10.1056/NEJMoa042480			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930VY	15930420				2022-12-24	WOS:000229446400006
J	Cochella, L; Green, R				Cochella, L; Green, R			An active role for tRNA in decoding beyond codon : anticodon pairing	SCIENCE			English	Article							AMINOACYL-TRANSFER-RNA; ELONGATION-FACTOR TU; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; GTP HYDROLYSIS; RIBOSOME; SPECIFICITY; DISCRIMINATION; RECOGNITION; SELECTION	During transfer RNA (tRNA) selection, a cognate codon:anticodon interaction triggers a series of events that ultimately results in the acceptance of that tRNA into the ribosome for peptide-bond formation. High-fidelity discrimination between the cognate tRNA and near- and noncognate ones depends both on their differential dissociation rates from the ribosome and on specific acceleration of forward rate constants by cognate species. Here we show that a mutant tRNA(Trp) carrying a single substitution in its D-arm achieves elevated levels of miscoding by accelerating these forward rate constants independent of codon:anticodon pairing in the decoding center. These data provide evidence for a direct role for tRNA in signaling its own acceptance during decoding and support its fundamental role during the evolution of protein synthesis.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	ragreen@jhmi.edu	Cochella, Luisa/B-6536-2016; Cochella, Luisa/AHD-8261-2022	Cochella, Luisa/0000-0003-4018-7722; Cochella, Luisa/0000-0003-4018-7722	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059425, R01GM059425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUCKINGHAM RH, 1977, P NATL ACAD SCI USA, V74, P5496, DOI 10.1073/pnas.74.12.5496; COCHELLA L, UNPUB; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; FAVRE A, 1975, NUCLEIC ACIDS RES, V2, P1421, DOI 10.1093/nar/2.8.1421; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; HIRSH, 1971, J MOL BIOL, V58, P439, DOI 10.1016/0022-2836(71)90362-7; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; SMITH D, 1989, J MOL BIOL, V206, P489, DOI 10.1016/0022-2836(89)90496-8; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; VACHER J, 1979, J MOL BIOL, V129, P287; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Woese CR, 2001, RNA, V7, P1055, DOI 10.1017/S1355838201010615; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	23	182	188	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1178	1180		10.1126/science.1111408	http://dx.doi.org/10.1126/science.1111408			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905403	Green Accepted			2022-12-24	WOS:000229293400046
J	Jones, T; Ehardt, CL; Butynski, TM; Davenport, TRB; Mpunga, NE; Machaga, SJ; De Luca, DW				Jones, T; Ehardt, CL; Butynski, TM; Davenport, TRB; Mpunga, NE; Machaga, SJ; De Luca, DW			The highland mangabey Lophocebus kipunji: A new species of African monkey	SCIENCE			English	Article							UDZUNGWA MOUNTAINS; CONSERVATION; HOTSPOTS; PRIMATES	A distinct species of mangabey was independently found at two sites 370 kilometers apart in southern Tanzania (Mount Rungwe and Livingstone in the Southern Highlands and Ndundulu in the Udzungwa Mountains). This new species is described here and given the name "highland mangabey" Lophocebus kipunji sp. nov. We place this monkey in Lophocebus, because it possesses noncontrasting black eyelids and is arboreal. L. kipunji is distinguished from other mangabeys by the color of its pelage; long, upright crest; off-white tail and ventrum; and loud call. This find has implications for primate evolution, African biogeography, and forest conservation.	Udzungwa Mt Natl Pk, Mangula, Tanzania; Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; Conservat Int, Nairobi, Kenya; Wildlife Conservat Soc, So Highlands Conservat Programme, Mbeya, Tanzania	University System of Georgia; University of Georgia	Jones, T (corresponding author), Udzungwa Mt Natl Pk, Box 99, Mangula, Tanzania.	tembomkubwa@gmail.com						Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Burgess N.D., 2000, Journal of East African Natural History, V87, P37, DOI 10.2982/0012-8317(1998)87[37:FIOTEA]2.0.CO;2; Davenport TRB, 2002, ORYX, V36, P224; DAVENPORT TRB, 2004, SOC CONS BIOL ABST, V48, P20; Dinesen L, 2001, BIOL CONSERV, V99, P223, DOI 10.1016/S0006-3207(00)00218-4; Doody K., 2001, W KILOMBERO SCARP FO; DOWSETT RJ, 1990, SURVEY FAUNA FLORA N, P111; Ehardt C. L., 2001, AFRICAN PRIMATES, V4, P15; Ehardt CL, 2005, INT J PRIMATOL, V26, P557, DOI 10.1007/s10764-005-4366-y; EHARDT CL, 1999, CONSERVATION ENDANGE; Fleagle JG, 1999, P NATL ACAD SCI USA, V96, P1157, DOI 10.1073/pnas.96.3.1157; GROVES C P, 1978, Primates, V19, P1, DOI 10.1007/BF02373224; Groves CP, 2001, PRIMATE TAXONOMY; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Harris EE, 1998, MOL BIOL EVOL, V15, P892, DOI 10.1093/oxfordjournals.molbev.a025993; HARRISON MJS, 1988, J ZOOL, V215, P561, DOI 10.1111/j.1469-7998.1988.tb02860.x; Homewood K.M., 1981, International Journal of Primatology, V2, P47, DOI 10.1007/BF02692299; International Union for Conservation of Nature (IUCN), 2012, IUCN RED LIST CAT CR; Kingdon J., 1997, KINGDOM FIELD GUIDE; Marshall AR, 2005, INT J PRIMATOL, V26, P127, DOI 10.1007/s10764-005-0011-z; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; PERKIN A, COMMUNICATION; Range F, 2004, ETHOLOGY, V110, P301, DOI 10.1111/j.1439-0310.2004.00973.x; WAKEHAMDAWSON A, 2002, B ZOOL NOMENCLATURE, V59, P18; Waser P.M., 1982, P117	25	93	101	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1161	1164		10.1126/science.1109191	http://dx.doi.org/10.1126/science.1109191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905399				2022-12-24	WOS:000229293400041
J	Royle, SJ; Bright, NA; Lagnado, L				Royle, SJ; Bright, NA; Lagnado, L			Clathrin is required for the function of the mitotic spindle	NATURE			English	Article							RECEPTOR TRAFFICKING; PROTEINS; KINETOCHORES; IDENTIFICATION; SEGREGATION; DYNAMICS; LINK	Clathrin has an established function in the generation of vesicles that transfer membrane and proteins around the cell(1-4). The formation of clathrin-coated vesicles occurs continuously in nondividing cells(5), but is shut down during mitosis(6), when clathrin concentrates at the spindle apparatus(7,8). Here, we show that clathrin stabilizes fibres of the mitotic spindle to aid congression of chromosomes. Clathrin bound to the spindle directly by the amino-terminal domain of clathrin heavy chain. Depletion of clathrin heavy chain using RNA interference prolonged mitosis; kinetochore fibres were destabilized, leading to defective congression of chromosomes to the metaphase plate and persistent activation of the spindle checkpoint. Normal mitosis was rescued by clathrin triskelia but not the N-terminal domain of clathrin heavy chain, indicating that stabilization of kinetochore fibres was dependent on the unique structure of clathrin. The importance of clathrin for normal mitosis may be relevant to understanding human cancers that involve gene fusions of clathrin heavy chain.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2XY, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Royle, SJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	sjr51@mrc-lmb.cam.ac.uk	Gimenez, Luis E Diaz/D-9291-2011	Royle, Stephen/0000-0001-8927-6967	Medical Research Council [U.1051.02.006(78794), MC_U105178794] Funding Source: Medline; MRC [MC_U105178794] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Argani P, 2003, ONCOGENE, V22, P5374, DOI 10.1038/sj.onc.1206686; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Bright NA, 1997, J CELL SCI, V110, P2027; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; HEPLER PK, 1970, J CELL BIOL, V45, P438, DOI 10.1083/jcb.45.2.438; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; KIRCHHAUSEN T, 1986, J ULTRA MOL STRUCT R, V94, P199, DOI 10.1016/0889-1605(86)90067-4; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; MARO B, 1985, J EMBRYOL EXP MORPH, V90, P287; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Waters JC, 1996, J CELL SCI, V109, P2823; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518	30	194	198	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1152	1157		10.1038/nature03502	http://dx.doi.org/10.1038/nature03502			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858577	Green Accepted			2022-12-24	WOS:000228693300048
J	Ashikari, M; Sakakibara, H; Lin, SY; Yamamoto, T; Takashi, T; Nishimura, A; Angeles, ER; Qian, Q; Kitano, H; Matsuoka, M				Ashikari, M; Sakakibara, H; Lin, SY; Yamamoto, T; Takashi, T; Nishimura, A; Angeles, ER; Qian, Q; Kitano, H; Matsuoka, M			Cytokinin oxidase regulates rice grain production	SCIENCE			English	Article							QUANTITATIVE TRAIT LOCUS; ORYZA-SATIVA L.; GREEN-REVOLUTION; PHOTOPERIOD SENSITIVITY; DRAFT SEQUENCE; FLOWERING TIME; ARABIDOPSIS; MAIZE; GENES; YIELD	Most agriculturally important traits are regulated by genes known as quantitative trait loci (QTLs) derived from natural allelic variations. We here show that a QTL that increases grain productivity in rice, Gn1a, is a gene for cytokinin oxidase/ dehydrogenase (OsCKX2), an enzyme that degrades the phytohormone cytokinin. Reduced expression of OsCKX2 causes cytokinin accumulation in inflorescence meristems and increases the number of reproductive organs, resulting in enhanced grain yield. QTL pyramiding to combine loci for grain number and plant height in the same genetic background generated lines exhibiting both beneficial traits. These results provide a strategy for tailormade crop improvement.	Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Honda Res Inst Japan Co Ltd, Chiba 2920818, Japan; China Natl Rice Res Inst, Hangzhou 310006, Peoples R China	Nagoya University; RIKEN; Honda Motor Company; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Matsuoka, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	makoto@agr.nagoya-u.ac.jp	Ding, Cheng-Qiang/B-6287-2011; qian, qian/AAH-8708-2021; Yamamoto, Toshio/AAX-7146-2020; Sakakibara, Hitoshi/A-6040-2010	Yamamoto, Toshio/0000-0002-5209-7735; Sakakibara, Hitoshi/0000-0001-5449-6492				ARMSTRONG D, 1994, CYTOKININ CHEM ACTIV, pCH11; ASHIKARI M, 2002, BREED SCI; Austin DF, 2000, CROP SCI, V40, P30, DOI 10.2135/cropsci2000.40130x; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; *FAO, STAT FOOD INS WORLD; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Ho JC, 2002, THEOR APPL GENET, V105, P440, DOI 10.1007/s00122-002-0945-x; Khush G, 2003, NUTR REV, V61, pS114, DOI 10.1301/nr.2003.jun.S114-S116; Khush GS, 2001, P NUTR SOC, V60, P15, DOI 10.1079/PNS200075; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; MILLER CO, 1955, J AM CHEM SOC, V77, P1392, DOI 10.1021/ja01610a105; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; MOK MC, 1994, CYTOKININ CHEM ACTIV, pCH12; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; *RIC CHROM 10 SEQ, 2003, SCIENCE NEW YORK NY, V0300; Salse J, 2004, PLANT J, V38, P396, DOI 10.1111/j.1365-313X.2004.02058.x; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sasaki T, 2005, PLANT CELL PHYSIOL, V46, P3, DOI 10.1093/pcp/pci503; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; *UN POP FUND, 2004, STAT WORLD POP; Veldboom LR, 1996, CROP SCI, V36, P1310, DOI 10.2135/cropsci1996.0011183X003600050040x; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Yano M, 2001, CURR OPIN PLANT BIOL, V4, P130, DOI 10.1016/S1369-5266(00)00148-5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	37	1149	1407	35	549	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					741	745		10.1126/science.1113373	http://dx.doi.org/10.1126/science.1113373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	15976269				2022-12-24	WOS:000230938200041
J	Ohinata, Y; Payer, B; O'Carroll, D; Ancelin, K; Ono, Y; Sano, M; Barton, SC; Obukhanych, T; Nussenzweig, M; Tarakhovsky, A; Saitou, M; Surani, MA				Ohinata, Y; Payer, B; O'Carroll, D; Ancelin, K; Ono, Y; Sano, M; Barton, SC; Obukhanych, T; Nussenzweig, M; Tarakhovsky, A; Saitou, M; Surani, MA			Blimp1 is a critical determinant of the germ cell lineage in mice	NATURE			English	Article							CLONAL ANALYSIS; MOUSE EMBRYO; GENE-EXPRESSION; SPECIFICATION; FATE; GASTRULATION; MATURATION; GENERATION; EXCISION; PROGRAM	Germ cell fate in mice is induced in pluripotent epiblast cells in response to signals from extraembryonic tissues. The specification of approximately 40 founder primordial germ cells and their segregation from somatic neighbours are important events in early development. We have proposed that a critical event during this specification includes repression of a somatic programme that is adopted by neighbouring cells. Here we show that Blimp1 ( also known as Prdm1), a known transcriptional repressor, has a critical role in the foundation of the mouse germ cell lineage, as its disruption causes a block early in the process of primordial germ cell formation. Blimp1-deficient mutant embryos form a tight cluster of about 20 primordial germ cell-like cells, which fail to show the characteristic migration, proliferation and consistent repression of homeobox genes that normally accompany specification of primordial germ cells. Furthermore, our genetic lineage-tracing experiments indicate that the Blimp1-positive cells originating from the proximal posterior epiblast cells are indeed the lineage-restricted primordial germ cell precursors.	Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge CB2 1QN, England; RIKEN Kobe Inst, Ctr Dev Biol, Lab Mammalian Germ Cell Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10021 USA; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Kyoto Univ, Grad Sch Biostudies, Lab Mol Cell Biol & Dev, Sakyo Ku, Kyoto 6068502, Japan	University of Cambridge; RIKEN; Howard Hughes Medical Institute; Rockefeller University; Japan Science & Technology Agency (JST); Kyoto University	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Tennis Court Rd, Cambridge CB2 1QN, England.	saitou@cdb.riken.jp; as10021@mole.bio.cam.ac.uk	Payer, Bernhard/F-7353-2010; Ancelin, Katia/R-1719-2019; Nussenzweig, Michel/AAE-7292-2019	Payer, Bernhard/0000-0002-4694-2082; Surani, Azim/0000-0002-8640-4318; O'Carroll, Donal/0000-0002-8626-2217; Ancelin, Katia/0000-0002-2117-9754	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Cox WG, 1999, J HISTOCHEM CYTOCHEM, V47, P1443, DOI 10.1177/002215549904701110; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P349; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; LAWSON KA, 1991, DEVELOPMENT, V113, P891; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Mesnard D, 2004, CURR BIOL, V14, P184, DOI 10.1016/j.cub.2004.01.026; Nagy A., 2003, MANIPULATING MOUSE E; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Perea-Gomez A, 2004, CURR BIOL, V14, P197, DOI 10.1016/j.cub.2004.01.030; Rossant J, 2004, DEV CELL, V7, P155, DOI 10.1016/j.devcel.2004.07.012; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Surani MA, 2004, COLD SPRING HARB SYM, V69, P1, DOI 10.1101/sqb.2004.69.40; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361	34	741	786	1	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					207	213		10.1038/nature03813	http://dx.doi.org/10.1038/nature03813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	15937476				2022-12-24	WOS:000230459500030
J	Kamphuis, S; Kuis, W; de Jager, W; Teklenburg, G; Massa, M; Gordon, G; Boerhof, M; Rijkers, GT; Uiterwaal, CS; Otten, HG; Sette, A; Albani, S; Prakken, BJ				Kamphuis, S; Kuis, W; de Jager, W; Teklenburg, G; Massa, M; Gordon, G; Boerhof, M; Rijkers, GT; Uiterwaal, CS; Otten, HG; Sette, A; Albani, S; Prakken, BJ			Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis	LANCET			English	Article							HEAT-SHOCK PROTEINS; RHEUMATOID-ARTHRITIS; VACCINE DESIGN; HUMAN HSP60; INTERLEUKIN-10; AUTOIMMUNITY; RECOGNITION; REMISSION; TOOLS	Background juvenile idiopathic arthritis is a heterogeneous autoimmune disease characterised by chronic inflammation of one or more joints. In patients with this disease, T-cell reactivity to autologous heat-shock protein 60 (HSP60) is associated with a favourable prognosis. We sought to identify HSP60 T-cell epitopes to find potential targets for HSP60 immunotherapy and to assess whether immune responses to these epitopes contribute to the distinct clinical outcome of this disease. Methods We identified eight potential epitopes using a computer algorithm from both self and microbial HSP60 binding to many HLA-DR molecules. We analysed the pattern of T-cell responses induced by these HSP60 peptides in peripheral-blood mononuclear cells (PBMC) of 57 patients with juvenile idiopathic arthritis, 27 healthy controls, and 20 disease controls. We undertook in-vitro MHC binding studies with the identified peptides, and HLA class II typing of a subset of patients with juvenile idiopathic arthritis. Findings Five of the eight peptides identified yielded proliferative T-cell responses in 50-70% of PBMC from patients with juvenile idiopathic arthritis irrespective of MHC genotype, but not in PBMC from healthy or disease controls. Although PBMC from both patients with juvenile idiopathic arthritis and healthy controls produced interferon gamma in response to these peptides, only PBMC from patients with the disease produced interleukin 10. Interpretation The recorded T-cell-induction in juvenile idiopathic arthritis is tolerogenic. In patients with oligoarticular disease, the immune responses to the HSP60 epitopes identified could contribute to disease remission. Relevance to practice The broad recognition of these HSP60 epitopes in a population of patients with polymorphic MHC genotypes opens the way for HSP60-peptide immunotherapy, representing a novel treatment option to specifically modulate the immune system in patients with juvenile idiopathic arthritis.	Univ Med Ctr Utrecht, Dept Paediat Immunol, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, IACOPO Inst Translat Med, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands; IRCCS San Matteo, Biotechnol Lab, Pavia, Italy; La Jolla Inst Allergy & Immunol, La Jolla, CA USA; Univ Calif San Diego, Dept Med & Paediat, San Diego, CA 92103 USA; Univ Calif San Diego, IACOPO Inst Translat Med, San Diego, CA 92103 USA; Androclus Therapeut, Milan, Italy	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; IRCCS Fondazione San Matteo; La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego	Prakken, BJ (corresponding author), Univ Med Ctr Utrecht, Dept Paediat Immunol, KC-03-063-0,POB 85090, NL-3508 AB Utrecht, Netherlands.	b.prakken@wkz.azu.nl	Massa, Margherita/K-4682-2016; Kamphuis, Sylvia/AAJ-8195-2020; Sette, Alessandro/AFO-8916-2022; Rijkers, Ger/AAW-6143-2020; Rijkers, Ger/R-7236-2019	Massa, Margherita/0000-0001-8037-0439; Rijkers, Ger/0000-0001-6948-6123; de Jager, Wilco/0000-0002-0014-0682				Abulafia-Lapid R, 1999, J AUTOIMMUN, V12, P121, DOI 10.1006/jaut.1998.0262; ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; Bason C, 2003, LANCET, V362, P1971, DOI 10.1016/S0140-6736(03)15016-7; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Cohen IR, 2004, J CLIN INVEST, V114, P1227, DOI 10.1172/JCI200422396; COHEN IR, 1991, IMMUNOL TODAY, V12, P105, DOI 10.1016/0167-5699(91)90093-9; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; DEGRAEFFMEEDER ER, 1995, J CLIN INVEST, V95, P934, DOI 10.1172/JCI117801; DEGRAEFFMEEDER ER, 1991, LANCET, V337, P1368, DOI 10.1016/0140-6736(91)93057-G; Gaston JSH, 1997, AUTOIMMUNITY, V26, P33, DOI 10.3109/08916939709009548; Lillicrap MS, 2004, INT IMMUNOL, V16, P405, DOI 10.1093/intimm/dxh032; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nepom GT, 2002, ARTHRITIS RHEUM, V46, P5, DOI 10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S; Petty RE, 2004, J RHEUMATOL, V31, P390; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Prakken ABJ, 1996, ARTHRITIS RHEUM-US, V39, P1826, DOI 10.1002/art.1780391108; Prakken B, 2000, NAT MED, V6, P1406, DOI 10.1038/82231; Prakken BJ, 2004, P NATL ACAD SCI USA, V101, P4228, DOI 10.1073/pnas.0400061101; Prakken BJ, 2003, SPRINGER SEMIN IMMUN, V25, P47, DOI 10.1007/s00281-003-0128-7; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Sette A, 2000, SCIENCE, V290, P2074; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Southwood S, 1998, J IMMUNOL, V160, P3363; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; VANDERZEE R, 1995, PEPTIDES 1994, P841; vanRoon JAG, 1997, J CLIN INVEST, V100, P459, DOI 10.1172/JCI119553; Woo P, 1998, LANCET, V351, P969	28	130	140	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					50	56		10.1016/S0140-6736(05)66827-4	http://dx.doi.org/10.1016/S0140-6736(05)66827-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	15993233				2022-12-24	WOS:000230277600034
J	Peters, CJ				Peters, CJ			Marburg and ebola - Arming ourselves against the deadly filoviruses	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Peters, CJ (corresponding author), Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA.								0	29	30	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2571	2573		10.1056/NEJMp058109	http://dx.doi.org/10.1056/NEJMp058109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972860	Bronze			2022-12-24	WOS:000229953700001
J	Poh, M; Boyer, M; Solan, A; Dahl, SLM; Pedrotty, D; Banik, SSR; McKee, JA; Klinger, RY; Counter, CM; Niklason, LE				Poh, M; Boyer, M; Solan, A; Dahl, SLM; Pedrotty, D; Banik, SSR; McKee, JA; Klinger, RY; Counter, CM; Niklason, LE			Blood vessels engineered from human cells	LANCET			English	Article							IN-VITRO	Tissue engineering has made considerable progress in the past decade, but advances have stopped short of clinical application for most tissues. We postulated that an obstacle in engineering human tissues is the limited replicative capacity of adult somatic cells. To test this hypothesis, the effectiveness of telomerase expression to extend cellular lifespan was assessed in a model of human vascular tissue engineering. Telomerase expression in vascular cells isolated from elderly patients enabled the successful culture of engineered autologous blood vessels. Engineered vessels may one day provide a source of bypass conduit for patients with atherosclerotic disease.	Duke Univ, Med Ctr, Dept Anesthesia, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27708 USA; Univ Pittsburgh, Pittsburgh, PA USA	Duke University; Duke University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Niklason, LE (corresponding author), Duke Univ, Med Ctr, Dept Anesthesia, CIEMAS Room 1395,100 Sci Dr, Durham, NC 27708 USA.	nikla001@mc.duke.edu		Boyer, Matthew/0000-0002-8970-2046; Counter, Christopher M/0000-0003-0748-3079	NCI NIH HHS [CA-82481] Funding Source: Medline; NHLBI NIH HHS [HL-63766, F32-HL-71407] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063766, F32HL071407] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Counter CM, 2003, LANCET, V361, P1345, DOI 10.1016/S0140-6736(03)13042-5; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489	6	167	178	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2005	365	9477					2122	2124		10.1016/S0140-6736(05)66735-9	http://dx.doi.org/10.1016/S0140-6736(05)66735-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936LZ	15964449				2022-12-24	WOS:000229858800029
J	Smith, C				Smith, C			Getting down to details	NATURE			English	Article																			0	13	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 16	2005	435	7044					991	996		10.1038/435991a	http://dx.doi.org/10.1038/435991a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959523	Bronze			2022-12-24	WOS:000229799700056
J	Greenberger, MD; Vogelstein, R				Greenberger, MD; Vogelstein, R			Pharmacist refusals: A threat to women's health	SCIENCE			English	Editorial Material									Natl Womens Law Ctr, Washington, DC 20036 USA		Greenberger, MD (corresponding author), Natl Womens Law Ctr, Washington, DC 20036 USA.	riaser@nwlc.org						*AMWA, 2005, STAT AMWA SUPP PHARM; *APHA, 2003, POL STAT 2003 15; WINCKLER SC, 2004, UNPUB COMMUNICA 0701; 2005, N CAROLINA BOARD PHA, V26, P1; 2005, SUNDAY MIRROR   0227; 2005, FINANCIAL TIMES 0331	6	6	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1557	1558		10.1126/science.1114466	http://dx.doi.org/10.1126/science.1114466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947159				2022-12-24	WOS:000229827000026
J	Yarovinsky, F; Zhang, DK; Andersen, JF; Bannenberg, GL; Serhan, CN; Hayden, MS; Hieny, S; Sutterwala, FS; Flavell, RA; Ghosh, S; Sher, A				Yarovinsky, F; Zhang, DK; Andersen, JF; Bannenberg, GL; Serhan, CN; Hayden, MS; Hieny, S; Sutterwala, FS; Flavell, RA; Ghosh, S; Sher, A			TLR11 activation of dendritic cells by a protozoan profilin-like protein	SCIENCE			English	Article							TOXOPLASMA-GONDII INFECTION; TOLL-LIKE RECEPTOR-5; CUTTING EDGE; STRANDED-RNA; IL-12; RECOGNITION; RESISTANCE; PARASITE; IMMUNITY; GENE	Mammalian Toll-like receptors (TLRs) play an important role in the innate recognition of pathogens by dendritic cells (DCs). Although TLRs are clearly involved in the detection of bacteria and viruses, relatively little is known about. their function in the innate response to eukaryotic microorganisms. Here we identify a profilin-like molecule from the protozoan parasite Toxoplasma gondii that generates a potent interleukin-12 (IL-12) response in murine DCs that is dependent on myeloid differentiation factor 88. T. gondii profilin activates DCs through TLR11 and is the first chemically defined ligand for this TLR. Moreover, TLR11 is required in vivo for parasite-induced IL-12 production and optimal resistance to infection, thereby establishing a role for the receptor in host recognition of protozoan pathogens.	NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAID, Med Entomol Sect, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Yarovinsky, F (corresponding author), NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	fyarovinsky@niaid.nih.gov; asher@niaid.nih.gov	Hayden, Matthew/C-1263-2008; Bannenberg, Gerard/AAF-6216-2020; Sutterwala, Fayyaz/AAH-5859-2021; Cassel, Suzanne/AAI-3947-2021	Cassel, Suzanne/0000-0003-2492-1923; Bannenberg, Gerard/0000-0001-7763-6224; Yarovinsky, Felix/0000-0001-5825-8002	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000579, R01AI045806, R01AI059440, Z01AI005093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI05093, R01-AI59440, 1R01AI045806-01A1] Funding Source: Medline; NIGMS NIH HHS [R01-GM38765] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; POLLARD TD, 1994, ANNU REV CELL BIOL, V10, P207, DOI 10.1146/annurev.cellbio.10.1.207; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rosenberg B, 2005, INT J CANCER, V114, P756, DOI 10.1002/ijc.20801; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; YAROVINSKY F, UNPUB; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	28	707	774	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1626	1629		10.1126/science.1109893	http://dx.doi.org/10.1126/science.1109893			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15860593				2022-12-24	WOS:000229827000057
J	Pai, M; Gokhale, K; Joshi, R; Dogra, S; Kalantri, S; Mendiratta, DK; Narang, P; Daley, CL; Granich, RM; Mazurek, GH; Reingold, AL; Riley, LW; Colford, JM				Pai, M; Gokhale, K; Joshi, R; Dogra, S; Kalantri, S; Mendiratta, DK; Narang, P; Daley, CL; Granich, RM; Mazurek, GH; Reingold, AL; Riley, LW; Colford, JM			Mycobacterium tuberculosis infection in health care workers in rural India - Comparison of a whole-blood interferon gamma assay with tuberculin skin testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	101st International Conference of the American-Thoracic-Society	MAY 20-25, 2005	San Diego, CA	Amer Thorac Soc, Fogarty AIDS Int Training & Res Program			ANNUAL RISK; PREVALENCE; DIAGNOSIS; ESAT-6; REACTIVITY; RESPONSES	Context Mycobacterium tuberculosis infection in health care workers has not been adequately studied in developing countries using newer diagnostic tests. Objectives To estimate latent tuberculosis infection prevalence in healthcare workers using the tuberculin skin test (TST) and a whole-blood interferon gamma (IFN-gamma) assay; to determine agreement between the tests; and to compare their correlation with risk factors. Design, Setting, and Participants A cross-sectional comparison study of 726 health care workers aged 18 to 61 years (median age, 22 years) with no history of active tuberculosis conducted from January to May 2004, at a rural medical school in India. A total of 493 (68%) of the health care workers had direct contact with patients with tuberculosis and 514 (71%) had BCG vaccine scars. Interventions Tuberculin skin testing was performed using 1-TU dose of purified protein derivative RT23, and the IFN-gamma assay was performed by measuring IFN-gamma response to early secreted antigenic target 6, culture filtrate protein 10, and a portion of tuberculosis antigen TB7.7. Main Outcome Measures Agreement between TST and the IFN-gamma assay, and comparison of the tests with respect to their association with risk factors. Results A large proportion of the health care workers were latently infected; 360 (50%) were positive by either TST or IFN-gamma assay, and 226 (31%) were positive by both tests. The prevalence estimates of TST and IFN-gamma assay positivity were comparable (41%; 95% confidence interval[CI], 38%-45% and 40%; 95% Cl, 37%-43%, respectively). Agreement between the tests was high (81.4%; kappa=0.61; 95% Cl, 0.56-0.67). Increasing age and years in the health profession were significant risk factors for both IFN-gamma assay and TST positivity. BCG vaccination had little impact on TST and IFN-gamma assay results. Conclusions Our study showed high latent tuberculosis infection prevalence in Indian health care workers, high agreement between TST and IFN-gamma assay, and similar association between positive test results and risk factors. Although TST and IFN-gamma assay appear comparable in this population, they have different performance and operational characteristics; therefore, the decision to select one test over the other will depend on the population, purpose of testing, and resource availability.	Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA; Mahatma Gandi Inst Med Sci, Dept Med, Sevagram, India; Mahatma Gandi Inst Med Sci, Dept Microbiol, Sevagram, India; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; Off WHO Representat India, New Delhi, India	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Mahatma Gandhi Institute of Medical Sciences, Sevagram; Mahatma Gandhi Institute of Medical Sciences, Sevagram; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; World Health Organization	Pai, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, 140 Warren Hall, Berkeley, CA 94720 USA.	madhupai@berkeley.edu	PAL, MRINAL/ABG-9676-2020; Daley, Charles L./AAC-3231-2021; Kalantri, Shriprakash/ABG-9318-2021; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Kalantri, Shriprakash/0000-0002-1633-1029; Pai, Madhukar/0000-0003-3667-4536; Narang, Pratibha/0000-0001-6135-1857; Colford, John/0000-0002-3288-6956; Joshi, Rajnish/0000-0002-4702-0522	FIC NIH HHS [1-D43-TW00003-16] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Alonso-Echanove J, 2001, CLIN INFECT DIS, V33, P589, DOI 10.1086/321892; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; [Anonymous], GUID PREV TUB HLTH C; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Arend SM, 2002, J INFECT DIS, V186, P1797, DOI 10.1086/345760; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Chadha V. K., 2004, Indian Journal of Pediatrics, V71, P1063, DOI 10.1007/BF02829815; Chadha V K, 2003, J Indian Med Assoc, V101, P144; Chadha V. K., 2003, Indian Journal of Tuberculosis, V50, P125; Chadha V. K., 2000, Indian Journal of Tuberculosis, V47, P139; Chadha Vineet K., 2001, Indian Journal of Pediatrics, V68, P53, DOI 10.1007/BF02728860; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P116; Chadha VK, 2004, INT J TUBERC LUNG D, V8, P1437; Chadha VK, 2003, INT J TUBERC LUNG D, V7, P172; CHAKRABORTY AK, 1976, INDIAN J MED RES, V64, P639; Do AN, 1999, INT J TUBERC LUNG D, V3, P377; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Geluk A, 2002, INFECT IMMUN, V70, P2544, DOI 10.1128/IAI.70.5.2544-2548.2002; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Gopinath KG, 2004, J HOSP INFECT, V57, P339, DOI 10.1016/j.jhin.2004.03.029; GRANICH R, 2003, J INDIAN MED ASSOC, V101, P156; Granich Reuben, 2003, J Indian Med Assoc, V101, P150; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kassim S, 2000, INT J TUBERC LUNG D, V4, P321; Khatri GR, 2002, NEW ENGL J MED, V347, P1420, DOI 10.1056/NEJMsa020098; Lalvani A, 2003, THORAX, V58, P916, DOI 10.1136/thorax.58.11.916; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Mazurek Gerald H, 2003, MMWR Recomm Rep, V52, P15; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Menzies D, 2003, AM J RESP CRIT CARE, V167, P599, DOI 10.1164/rccm.200208-873BC; MENZIES RI, 2000, LUNG BIOL HEALTH DIS, V144, P279; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Narang P, 1999, INT J TUBERC LUNG D, V3, P478; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Rao KG, 2004, INT J TUBERC LUNG D, V8, P1392; *REV NAT TUB CONTR, 1997, TECHN GUID TUB CONTR; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; Sepkowitz KA, 1996, TUBERCLE LUNG DIS, V77, P81, DOI 10.1016/S0962-8479(96)90081-7; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895	45	275	281	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2746	2755		10.1001/jama.293.22.2746	http://dx.doi.org/10.1001/jama.293.22.2746			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	933OV	15941804	Bronze			2022-12-24	WOS:000229643700023
J	Mattson, MP				Mattson, MP			The need for controlled studies of the effects of meal frequency on health	LANCET			English	Editorial Material							DIETARY RESTRICTION; GLUCOSE-METABOLISM; DISEASE; TERM		NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mattson, MP (corresponding author), NIA, Neurosci Lab, Intramural Res Program, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012		NATIONAL INSTITUTE ON AGING [ZIAAG000315, Z01AG000315] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adlouni A, 1997, ANN NUTR METAB, V41, P242, DOI 10.1159/000177999; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Aybak M, 1996, EUR J APPL PHYSIOL, V73, P552, DOI 10.1007/BF00357678; BEAUCHENE RE, 1986, J GERONTOL, V41, P13, DOI 10.1093/geronj/41.1.13; Bell HE, 1997, ACTA MATH HUNG, V77, P57, DOI 10.1023/A:1006531605931; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; FABRY P, 1964, LANCET, V2, P614; GEHRIG JJ, 1988, KIDNEY INT, V34, P620, DOI 10.1038/ki.1988.226; GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36; HOFMEKLER O, 2001, WARRIOR DIET; JENKINS DJA, 1989, NEW ENGL J MED, V321, P929, DOI 10.1056/NEJM198910053211403; Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Martin A, 2000, BRIT J NUTR, V84, P337, DOI 10.1017/S0007114500001616; Mattson MP, 2003, ANN INTERN MED, V139, P441, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00012; Mattson MP, 2003, J NEUROCHEM, V84, P417, DOI 10.1046/j.1471-4159.2003.01586.x; Rocha NS, 2002, TERATOGEN CARCIN MUT, V22, P129, DOI 10.1002/tcm.10005; Rollo F, 2002, P NATL ACAD SCI USA, V99, P12594, DOI 10.1073/pnas.192184599; Speechly DP, 1999, APPETITE, V33, P285, DOI 10.1006/appe.1999.0265; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wan RQ, 2003, J NUTR, V133, P1921, DOI 10.1093/jn/133.6.1921; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zhu HY, 1999, BRAIN RES, V842, P224, DOI 10.1016/S0006-8993(99)01827-2; Zimmet P, 2003, J INTERN MED, V254, P114, DOI 10.1046/j.1365-2796.2003.01170.x	26	47	47	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2005	365	9475					1978	1980		10.1016/S0140-6736(05)66667-6	http://dx.doi.org/10.1016/S0140-6736(05)66667-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936428				2022-12-24	WOS:000229587800035
J	Wyers, F; Rougemaille, M; Badis, G; Rousselle, JC; Dufour, ME; Boulay, J; Regnault, B; Devaux, F; Namane, A; Seraphin, B; Libri, D; Jacquier, A				Wyers, F; Rougemaille, M; Badis, G; Rousselle, JC; Dufour, ME; Boulay, J; Regnault, B; Devaux, F; Namane, A; Seraphin, B; Libri, D; Jacquier, A			Cryptic Pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase	CELL			English	Article							MESSENGER-RNA; RIBOSOMAL-RNA; YEAST EXOSOME; PROTEIN; POLYADENYLATION; DEGRADATION; COMPLEXES; CYTOPLASM; INHIBIT; FAMILY	Since detection of an RNA molecule is the major criterion to define transcriptional activity, the fraction of the genome that is expressed is generally considered to parallel the complexity of the transcriptome. We show here that several supposedly silent intergenic regions in the genome of S. cerevisiae are actually transcribed by RNA polymerase 11, suggesting that the expressed fraction of the genome is higher than anticipated. Surprisingly, however, RNAs originating from these regions are rapidly degraded by the combined action of the exosome and a new poly(A) polymerase activity that is defined by the Trf4 protein and one of two RNA binding proteins, Air1p or Air2p. We show that such a polyadenylation-assisted degradation mechanism is also responsible for the degradation of several Pol I and Pol III transcripts. Our data strongly support the existence of a posttranscriptional quality control mechanism limiting inappropriate expression of genetic information.	Inst Pasteur, URA 2171, CNRS, Unite Genet Interact Macromol, F-75724 Paris, France; Inst Pasteur, URA 2185, CNRS, PT Proteom, F-75724 Paris, France; Inst Pasteur, PT Puces ADN, F-75724 Paris, France; CNRS, UPR 2167, Ctr Mol Genet, F-99190 Gif Sur Yvette, France; CNRS, UPR 2167, Equipe Labelisee Ligue, F-99190 Gif Sur Yvette, France; CNRS, Ecole Normale Super, Genet Mol Lab, UMR 8541, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Seraphin, B (corresponding author), Inst Pasteur, URA 2171, CNRS, Unite Genet Interact Macromol, F-75724 Paris, France.	bertrand.seraphin@cgm.cnrs-gif.fr; dominico.libri@cgm.cnrs-gif.fr; jacquier@pasteur.fr	Badis-Breard, Gwenael/AAE-3783-2019; DEVAUX, Frédéric/N-2288-2019; Namane, Abdelkader/O-1857-2013	DEVAUX, Frédéric/0000-0002-0039-9096; Namane, Abdelkader/0000-0001-7180-7619; Seraphin, Bertrand/0000-0002-5168-1921; REGNAULT, Beatrice/0000-0002-3914-1914; JACQUIER, ALAIN/0000-0001-5707-9184; Badis-Breard, Gwenael/0000-0003-2078-3076; Rougemaille, Mathieu/0000-0002-9675-3888				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Aloy P, 2002, EMBO REP, V3, P628, DOI 10.1093/embo-reports/kvf135; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Castano IB, 1996, NUCLEIC ACIDS RES, V24, P2404, DOI 10.1093/nar/24.12.2404; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; EGYHAZI E, 1976, CELL, V7, P507, DOI 10.1016/0092-8674(76)90201-4; Fleischmann J, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-17; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liang S, 1996, MOL CELL BIOL, V16, P5139; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schurer H, 2001, BIOL CHEM, V382, P1147, DOI 10.1515/BC.2001.144; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774; Westendorp RGJ, 2004, EMBO REP, V5, P2, DOI 10.1038/sj.embor.7400059	40	666	681	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					725	737		10.1016/j.cell.2005.04.030	http://dx.doi.org/10.1016/j.cell.2005.04.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935759	Bronze			2022-12-24	WOS:000229658000011
J	Dalton, R				Dalton, R			California stem-cell institute fights legal challenges	NATURE			English	News Item								The Californian stem-cell institute, California Institute for Regenerative Medicine, fights legal challenges.										2005, NATURE, V434, P427	1	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2005	435	7042					544	544						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15957195				2022-12-24	WOS:000229476200008
J	Dalziel, SR; Walker, NK; Parag, V; Martell, C; Rea, HH; Rodgers, A; Harding, JE				Dalziel, SR; Walker, NK; Parag, V; Martell, C; Rea, HH; Rodgers, A; Harding, JE			Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randornised controlled trial	LANCET			English	Article							BIRTH-WEIGHT; GLUCOCORTICOID TREATMENT; PRENATAL EXPOSURE; BLOOD-PRESSURE; INDEX; AGE	Background Antenatal betamethasone treatment is widely used for the prevention of neonatal respiratory distress syndrome in preterm infants and substantially reduces neonatal mortality and morbidity. Fetal exposure to excess glucocorticoids has been proposed as one of the core mechanisms of the fetal origins of adult disease hypothesis. We assessed whether antenatal exposure to betamethasone for the prevention of neonatal respiratory distress syndrome affects cardiovascular risk factors at 30 years of age. Methods We followed up at age 30 years 534 individuals whose mothers participated in a double-blind, placebo-controlled, randomised trial of antenatal betamethasone for the prevention of neonatal respiratory distress syndrome. Mothers received two doses of betamethasone or placebo given by intramuscular injection 24 h apart. Follow-up assessments included anthropometry; measurement of blood pressure, blood lipids (after overnight fasting), and early morning cortisol levels; and a 75 g oral glucose tolerance test. Findings There were no differences between those exposed to betamethasone and to placebo in body size, blood lipids, blood pressure, plasma cortisol, prevalence of diabetes, or history of cardiovascular disease. After a 75 g oral glucose tolerance test, participants exposed to betamethasone had higher plasma insulin concentrations at 30 min (60.5 vs 52.0 mIU/L; ratio of geometric means 1.16 [95% CI 1.03 to 1.31], p=0.02) and lower glucose concentrations at 120 min (4.8 vs 5.1 mmol/L; difference -0.26 mmol/L [-0.53 to 0.001, p=0.05) than did those exposed to placebo. Interpretation Antenatal exposure to betamethasone might result in insulin resistance in adult offspring, but has no clinical effect on cardiovascular risk factors at 30 years of age. Thus, obstetricians should continue to use a single course of antenatal betamethasone for the prevention of neonatal respiratory distress syndrome.	Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand; Univ Auckland, Div Maori & Pacific Hlth, Auckland 1, New Zealand; Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Harding, JE (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019, Auckland 1, New Zealand.	j.harding@auckland.ac.nz	Harding, Jane E/J-5853-2015	Harding, Jane E/0000-0003-2697-1422; Rodgers, Anthony/0000-0003-1282-1896				Aghajafari F, 2002, AM J OBSTET GYNECOL, V186, P843, DOI 10.1067/mob.2002.121624; [Anonymous], 1994, NIH Consens Statement, V12, P1; [Anonymous], 1999, SAS SYST WIND; Barker DJP, 1998, MOTHERS BABIES HLTH; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Crowley P, 2007, COCHRANE DB SYST REV, V18, DOI [10.1002/14651858.CD000065, DOI 10.1002/14651858.CD000065, 10.1002/14651858.CD000065.pub2, DOI 10.1002/14651858.CD000065.PUB2]; Davis P, 1999, AUST NZ J PUBL HEAL, V23, P27, DOI 10.1111/j.1467-842X.1999.tb01201.x; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Dodic M, 1998, CLIN SCI, V94, P149, DOI 10.1042/cs0940149; Doyle LW, 2000, CLIN SCI, V98, P137, DOI 10.1042/CS19990211; Erickson K, 2001, OBSTET GYNECOL, V97, P140, DOI 10.1016/S0029-7844(00)01122-4; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Halliday HL, 2003, COCHRANE DB SYST REV, V1; Halliday HL, 2003, COCHRANE DB SYST REV, V1; Halliday HL, 2003, COCHRANE DB SYST REV, V1; Howie RN, 1977, PRE TERM LAB P 5 STU, p:281; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Kind KL, 2002, EXP PHYSIOL, V87, P469, DOI 10.1111/j.1469-445X.2002.tb00060.x; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Liu L, 2001, AM J PHYSIOL-ENDOC M, V280, pE729, DOI 10.1152/ajpendo.2001.280.5.E729; MACARTHUR BA, 1982, PEDIATRICS, V70, P99; MACEWAN I, 1995, UPPER LIMITS RESPONS; Martin Joyce A, 2003, Natl Vital Stat Rep, V52, P1; Meadow WL, 2003, OBSTET GYNECOL, V102, P356, DOI 10.1016/S0029-7844(03)00510-6; NORTONK, 1996, ANTHROPOMETRICA; Nyirenda MJ, 2001, J ENDOCRINOL, V170, P653, DOI 10.1677/joe.0.1700653; Phillips DIW, 2000, HYPERTENSION, V35, P1301, DOI 10.1161/01.HYP.35.6.1301; THOMPSON JMD, 1994, NEW ZEAL MED J, V107, P1; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	31	322	331	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2005	365	9474					1856	1862		10.1016/S0140-6736(05)66617-2	http://dx.doi.org/10.1016/S0140-6736(05)66617-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931JK	15924982				2022-12-24	WOS:000229481400024
J	Skotheim, JM; Mahadevan, L				Skotheim, JM; Mahadevan, L			Physical limits and design principles for plant and fungal movements	SCIENCE			English	Article								The typical scales for plant and fungal movements vary over many orders of magnitude in time and length, but they are ultimately based on hydraulics and mechanics. We show that quantification of the length and time scales involved in plant and fungal motions leads to a natural classification, whose physical basis can be understood through an analysis of the mechanics of water transport through an elastic tissue. Our study also suggests a design principle for nonmuscular hydraulically actuated structures: Rapid actuation requires either small size or the enhancement of motion on large scales via elastic instabilities.	Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Univ Cambridge, Ctr Math Sci, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; Harvard Univ, Biol Labs, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; University of Cambridge; Harvard University	Mahadevan, L (corresponding author), Harvard Univ, Div Engn & Appl Sci, Pierce Hall,29 Oxford St, Cambridge, MA 02138 USA.	lm@deas.harvard.edu	Skotheim, Jan/C-3238-2015	Skotheim, Jan/0000-0001-8420-6820				ASHIDA JOJI, 1934, MEM COLL SCI KYOTO IMP UNIV SER B, V9, P141; Attenborough D, 1995, PRIVATE LIFE PLANTS; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Comandon J, 1938, CR SOC BIOL, V129, P620; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; FRENSCH J, 1989, PLANT PHYSIOL, V91, P719, DOI 10.1104/pp.91.2.719; HEATH O. V. S., 1938, NEW PHYTOL, V37, P385, DOI 10.1111/j.1469-8137.1938.tb06954.x; PAGE RM, 1964, SCIENCE, V146, P925, DOI 10.1126/science.146.3646.925; Skotheim JM, 2004, P ROY SOC A-MATH PHY, V460, P1995, DOI 10.1098/rspa.2003.1270; SWAINE MD, 1977, NEW PHYTOL, V78, P695, DOI 10.1111/j.1469-8137.1977.tb02174.x	10	218	223	7	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1308	1310		10.1126/science.1107976	http://dx.doi.org/10.1126/science.1107976			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919993				2022-12-24	WOS:000229482300047
J	Nee, S				Nee, S			The great chain of being	NATURE			English	Editorial Material									Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Nee, S (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.							Dawkins R., 2004, THE ANCESTORS TALE; Gee H, 2002, NATURE, V420, P611, DOI 10.1038/420611a; Lovejoy A. O., 1965, GREAT CHAIN BEING; Nee S, 2004, NATURE, V429, P804, DOI 10.1038/429804a; Smith J. M., 1995, MAJOR TRANSITIONS EV	5	21	24	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					429	429		10.1038/435429a	http://dx.doi.org/10.1038/435429a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917787	Bronze			2022-12-24	WOS:000229337800032
J	Poynter, JN; Gruber, SB; Higgins, PDR; Almog, R; Bonner, JD; Rennert, HS; Low, M; Greenson, JK; Rennert, G				Poynter, JN; Gruber, SB; Higgins, PDR; Almog, R; Bonner, JD; Rennert, HS; Low, M; Greenson, JK; Rennert, G			Statins and the risk of colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIINFLAMMATORY DRUG-USE; COENZYME-A REDUCTASE; INDUCED APOPTOSIS; RANDOMIZED-TRIAL; PRAVASTATIN; PREVENTION; INHIBITORS; ASPIRIN; TOLERABILITY; DISEASE	Background Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase and effective lipid-lowering agents. Statins inhibit the growth of colon-cancer cell lines, and secondary analyses of some, but not all, clinical trials suggest that they reduce the risk of colorectal cancer. Methods The Molecular Epidemiology of Colorectal Cancer study is a population-based case-control study of patients who received a diagnosis of colorectal cancer in northern Israel between 1998 and 2004 and controls matched according to age, sex, clinic, and ethnic group. We used a structured interview to determine the use of statins in the two groups and verified self-reported statin use by examining prescription records in a subgroup of patients for whom prescription records were available. Results In analyses including 1953 patients with colorectal cancer and 2015 controls, the use of statins for at least five years (vs. the nonuse of statins) was associated with a significantly reduced relative risk of colorectal cancer (odds ratio, 0.50; 95 percent confidence interval, 0.40 to 0.63). This association remained significant after adjustment for the use or nonuse of aspirin or other nonsteroidal antiinflammatory drugs; the presence or absence of physical activity, hypercholesterolemia, and a family history of colorectal cancer; ethnic group; and level of vegetable consumption (odds ratio, 0.53; 95 percent confidence interval, 0.38 to 0.74). The use of fibric-acid derivatives was not associated with a significantly reduced risk of colorectal cancer (odds ratio, 1.08; 95 percent confidence interval, 0.59 to 2.01). Self-reported statin use was confirmed for 276 of the 286 participants (96.5 percent) who reported using statins and whose records were available. Conclusions The use of statins was associated with a 47 percent relative reduction in the risk of colorectal cancer after adjustment for other known risk factors. Because the absolute risk reduction is likely low, further investigation of the overall benefits of statins in preventing colorectal cancer is warranted.	Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Technion Israel Inst Technol, Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Natl Canc Control Ctr, Clalit Hlth Serv, Haifa, Israel	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services	Gruber, SB (corresponding author), Univ Michigan, Div Med & Mol Genet, 4301 MSRB 3, Ann Arbor, MI 48109 USA.	sgruber@umich.edu		Poynter, Jenny/0000-0002-8460-3938; Rennert, Gad/0000-0002-8512-068X	NCI NIH HHS [R01 CA081488, 1R01CA81488] Funding Source: Medline; NHGRI NIH HHS [T32 HG000040] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081488] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Agarwal B, 1999, GASTROENTEROLOGY, V117, P838, DOI 10.1016/S0016-5085(99)70342-2; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; BAT L, 1986, CANCER-AM CANCER SOC, V58, P1167, DOI 10.1002/1097-0142(19860901)58:5<1167::AID-CNCR2820580532>3.0.CO;2-R; Bernini F, 2001, CARDIOVASC DRUG THER, V15, P211, DOI 10.1023/A:1011908004965; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; BUCHWALD H, 1992, LANCET, V339, P1154, DOI 10.1016/0140-6736(92)90744-N; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Downs JR, 2001, AM J CARDIOL, V87, P1074, DOI 10.1016/S0002-9149(01)01464-3; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Hentosh P, 2001, MOL CARCINOGEN, V32, P154, DOI 10.1002/mc.1074; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kaye JA, 2004, BRIT J CANCER, V90, P635, DOI 10.1038/sj.bjc.6601566; KELSEY JL, 1996, METHODS OBSERVATIONA, P239; Niell BL, 2003, AM J HUM GENET, V73, P1250, DOI 10.1086/379926; PELEG II, 1994, ARCH INTERN MED, V154, P394, DOI 10.1001/archinte.154.4.394; Pfeffer MA, 2002, CIRCULATION, V105, P2341, DOI 10.1161/01.CIR.0000017634.00171.24; Rao CV, 2002, CANCER DETECT PREV, V26, P419, DOI 10.1016/S0361-090X(02)00119-8; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Rosenberg L, 1998, CANCER-AM CANCER SOC, V82, P2326, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Swamy MV, 2002, INT J ONCOL, V20, P753; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; 2005, ISRAEL NATL CANC REG	34	607	630	1	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2005	352	21					2184	2192		10.1056/NEJMoa043792	http://dx.doi.org/10.1056/NEJMoa043792			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929HS	15917383				2022-12-24	WOS:000229333300006
J	Djiane, A; Yogev, S; Mlodzik, M				Djiane, A; Yogev, S; Mlodzik, M			The apical determinants aPKC and dPatj regulate Frizzled-dependent planar cell polarity in the Drosophila eye	CELL			English	Article							PROTEIN-KINASE-C; EPITHELIAL POLARITY; DISCS LOST; ASYMMETRIC LOCALIZATION; SIGNALING SPECIFICITY; TISSUE POLARITY; PDZ DOMAIN; CRUMBS; NEUROBLASTS; COMPLEXES	Planar cell polarity (PCP) is a common feature of many vertebrate and invertebrate epithelia and is perpendicular to their apical/basal (A/B) polarity axis. While apical localization of PCP determinants such as Frizzled (Fz1) is critical for their function, the link between A/B polarity and PCP is poorly understood. Here, we describe a direct molecular link between A/B determinants and Fz1-mediated PCP establishment in the Drosophila eye. We demonstrate that dPatj binds the cytoplasmic tail of Fz1 and propose that it recruits aPKC, which in turn phosphorylates and inhibits Fz1. Accordingly, components of the aPKC complex and dPatj produce PCP defects in the eye. We also show that during PCP signaling, aPKC and dPatj are downregulated, while Bazooka is upregulated, suggesting an antagonistic effect of Bazooka on dPatj/aPKC. We propose a model whereby the dPatj/aPKC complex regulates PCP by inhibiting Fz1 in cells where it should not be active.	Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Mlodzik, M (corresponding author), Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY 10029 USA.	marek.mlodzik@mssm.edu		Djiane, Alexandre/0000-0001-6210-2713				Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Axelrod JD, 2001, GENE DEV, V15, P1182; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boutros M, 2000, SCIENCE, V288, P1825, DOI 10.1126/science.288.5472.1825; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Hong Y, 2003, P NATL ACAD SCI USA, V100, P12712, DOI 10.1073/pnas.2135347100; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Li YH, 2004, EMBO J, V23, P2723, DOI 10.1038/sj.emboj.7600294; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pielage J, 2003, DEV CELL, V5, P841, DOI 10.1016/S1534-5807(03)00358-7; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wolff Tanya, 1993, P1277; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu J, 2004, PLOS BIOL, V2, P1004, DOI 10.1371/journal.pbio.0020158	45	144	147	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 20	2005	121	4					621	631		10.1016/j.cell.2005.03.014	http://dx.doi.org/10.1016/j.cell.2005.03.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907474	Bronze			2022-12-24	WOS:000229331200017
J	Bissell, P; Anderson, C				Bissell, P; Anderson, C			Enhanced access to emergency contraception	LANCET			English	Editorial Material							PREGNANCY		Univ Nottingham, Sch Pharm, Ctr Pharm Hlth & Soc, Nottingham NG7 2RD, England	University of Nottingham	Bissell, P (corresponding author), Univ Nottingham, Sch Pharm, Ctr Pharm Hlth & Soc, Nottingham NG7 2RD, England.	Paul.Bissell@nottingham.ac.uk		Anderson, Claire/0000-0002-5406-2296				ANDERSON C, 2001, MANCHESTER SALFORD T; Bissell P, 2003, SOC SCI MED, V57, P2367, DOI 10.1016/S0277-9536(03)00129-1; *IND ADV GROUP SEX, 2004, ANN REP 2003 2004; Litt IF, 2005, JAMA-J AM MED ASSOC, V293, P98, DOI 10.1001/jama.293.1.98; MARSH B, 2003, DAILY MAIL      1018; McLeod A, 2001, BRIT MED J, V323, P199, DOI 10.1136/bmj.323.7306.199; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Stammers T, 2001, BRIT MED J, V322, P1245, DOI 10.1136/bmj.322.7296.1245; Ziebland S, 2005, SOC SCI MED, V60, P1767, DOI 10.1016/j.socscimed.2004.08.022; Ziebland S, 1999, SOC SCI MED, V49, P1409, DOI 10.1016/S0277-9536(99)00249-X	10	6	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2005	365	9472					1668	1670		10.1016/S0140-6736(05)66526-9	http://dx.doi.org/10.1016/S0140-6736(05)66526-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	925VV	15894084				2022-12-24	WOS:000229082300006
J	Eghbali-Fatourechi, GZ; Lamsam, J; Fraser, D; Nagel, D; Riggs, BL; Khosla, S				Eghbali-Fatourechi, GZ; Lamsam, J; Fraser, D; Nagel, D; Riggs, BL; Khosla, S			Circulating osteoblast-lineage cells in humans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE TURNOVER; GROWTH; BLOOD	BACKGROUND: Although current evidence suggests that only a minuscule number of osteoblast-lineage cells are present in peripheral blood, we hypothesized that such cells circulate but that their concentration has been vastly underestimated owing to the use of assays that required adherence to plastic. We further reasoned that the concentration of these cells is elevated during times of increased bone formation, such as during pubertal growth. METHODS: We used flow cytometry with antibodies to bone-specific proteins to identify circulating osteoblast-lineage cells in 11 adolescent males and 11 adult males (mean [+/-SD] age, 14.5+/-0.7 vs. 37.7+/-7.6 years). Gene expression and in vitro and in vivo bone-forming assays were used to establish the osteoblastic lineage of sorted cells. RESULTS: Cells positive for osteocalcin and cells positive for bone-specific alkaline phosphatase were detected in the peripheral blood of adult subjects (1 to 2 percent of mononuclear cells). There were more than five times as many cells positive for osteocalcin in the circulation of adolescent boys (whose markers of bone formation were clearly increased as a result of pubertal growth) as compared with adult subjects (P<0.001). The percentage of cells positive for osteocalcin correlated with markers of bone formation. Sorted osteocalcin-positive cells expressed osteoblastic genes, formed mineralized nodules in vitro, and formed bone in an in vivo transplantation assay. Increased values were also found in three adults with recent fractures. CONCLUSIONS: Osteoblast-lineage cells circulate in physiologically significant numbers, correlate with markers of bone formation, and are markedly higher during pubertal growth; therefore, they may represent a previously unrecognized circulatory component to the process of bone formation.	Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Khosla, S (corresponding author), Mayo Clin, Coll Med, Endocrine Res Unit, 200 1st St SW,5-194 Joseph, Rochester, MN 55905 USA.	khosla.sundeep@mayo.edu	Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372	NCRR NIH HHS [M01 RR00585] Funding Source: Medline; NIA NIH HHS [AG-024901, AG-004875] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004875, R21AG024901] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7; Dominici M, 2004, P NATL ACAD SCI USA, V101, P11761, DOI 10.1073/pnas.0404626101; EASTELL R, 1992, CLIN SCI, V83, P375, DOI 10.1042/cs0830375; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; FRIERSON HF, 1990, DIAGN CYTOPATHOL, V6, P243, DOI 10.1002/dc.2840060404; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Ingle BM, 1999, OSTEOPOROSIS INT, V10, P399, DOI 10.1007/s001980050246; KASSEM M, 1991, APMIS, V99, P262, DOI 10.1111/j.1699-0463.1991.tb05148.x; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; LONG MW, 1990, J CLIN INVEST, V86, P1387, DOI 10.1172/JCI114852; LONG MW, 1995, J CLIN INVEST, V96, P2541; LONG MW, 1995, J CLIN INVEST, V95, P881, DOI 10.1172/JCI117738; Mankani MH, 2004, RADIOLOGY, V230, P369, DOI 10.1148/radiol.2302011529; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; STEWART CA, 1974, PATHOLOGY, V6, P287, DOI 10.3109/00313027409068999; THIEDE MA, 1994, ENDOCRINOLOGY, V135, P929, DOI 10.1210/en.135.3.929; Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130	21	304	320	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1959	1966		10.1056/NEJMoa044264	http://dx.doi.org/10.1056/NEJMoa044264			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888696				2022-12-24	WOS:000229017100006
J	Li, WK; Kamtekar, S; Xiong, Y; Sarkis, GJ; Grindley, NDF; Steitz, TA				Li, WK; Kamtekar, S; Xiong, Y; Sarkis, GJ; Grindley, NDF; Steitz, TA			Structure of a synaptic gamma delta resolvase tetramer covalently linked to two cleaved DNAs	SCIENCE			English	Article							SITE-SPECIFIC RECOMBINATION; TN3 RESOLVASE; CRYSTAL-STRUCTURE; COMPLEX; ARCHITECTURE; MUTANTS; MODEL; SUBUNITS; IDENTIFY; INVITRO	The structure of a Synaptic intermediate of the site-specific recombinase gamma delta resolvase covalently linked through Ser(10) to two cleaved duplex DNAs has been determined at 3.4 angstrom resolution. This resolvase, activated for recombination by mutations, forms a tetramer whose structure is substantially changed from that of a presynaptic complex between dimeric resolvase and the cleavage site DNA. Because the two cleaved DNA duplexes that are to be recombined lie on opposite sides of the core tetramer, large movements of both protein and DNA are required to achieve strand exchange. The two dimers linked to the DNAs that are to be recombined are held together by a flat interface. This may allow a 180 degrees rotation of one dimer relative to the other in order to reposition the DNA duplexes for strand exchange.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028470, R01GM057510, R01GM028470] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57510, GM28470] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold PH, 1999, EMBO J, V18, P1407, DOI 10.1093/emboj/18.5.1407; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen Y, 2003, ANNU REV BIOPH BIOM, V32, P135, DOI 10.1146/annurev.biophys.32.110601.141732; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CRAIG NL, 2002, MOBILE DNA, V2; Dhar G, 2004, CELL, V119, P33, DOI 10.1016/j.cell.2004.09.010; Grindley NDF, 2002, MOBILE DNA, P272; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; HATFULL GF, 1986, P NATL ACAD SCI USA, V83, P5429, DOI 10.1073/pnas.83.15.5429; HUGHES RE, 1990, CELL, V63, P1331, DOI 10.1016/0092-8674(90)90428-H; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Leschziner AE, 2003, MOL CELL, V12, P775, DOI 10.1016/S1097-2765(03)00351-4; McIlwraith MJ, 1997, J MOL BIOL, V266, P108, DOI 10.1006/jmbi.1996.0765; Murley LL, 1998, CELL, V95, P553, DOI 10.1016/S0092-8674(00)81622-0; Nollmann M, 2004, MOL CELL, V16, P127, DOI 10.1016/j.molcel.2004.09.027; REED RR, 1981, CELL, V25, P721, DOI 10.1016/0092-8674(81)90179-3; RICE PA, 1994, STRUCTURE, V2, P371, DOI 10.1016/S0969-2126(00)00039-3; RICE PA, 1994, EMBO J, V13, P1514, DOI 10.1002/j.1460-2075.1994.tb06413.x; SANDERSON MR, 1990, CELL, V63, P1323, DOI 10.1016/0092-8674(90)90427-G; Sarkis GJ, 2001, MOL CELL, V8, P623, DOI 10.1016/S1097-2765(01)00334-3; STARK WM, 1989, CELL, V58, P779, DOI 10.1016/0092-8674(89)90111-6; STARK WM, 1994, J MOL BIOL, V239, P25, DOI 10.1006/jmbi.1994.1348; WASSERMAN SA, 1985, SCIENCE, V229, P171, DOI 10.1126/science.2990045; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0	24	95	99	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1210	1215		10.1126/science.1112064	http://dx.doi.org/10.1126/science.1112064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	15994378				2022-12-24	WOS:000231395400037
J	Lindenbach, BD; Evans, MJ; Syder, AJ; Wolk, B; Tellinghuisen, TL; Liu, CC; Maruyama, T; Hynes, RO; Burton, DR; McKeating, JA; Rice, CM				Lindenbach, BD; Evans, MJ; Syder, AJ; Wolk, B; Tellinghuisen, TL; Liu, CC; Maruyama, T; Hynes, RO; Burton, DR; McKeating, JA; Rice, CM			Complete replication of hepatitis C virus in cell culture	SCIENCE			English	Article							EFFICIENT REPLICATION; PROTEASE INHIBITOR; RNA REPLICATION; CD81; MUTATIONS; REPLICON; ENTRY	Many aspects of the hepatitis C virus (HCV) life cycle have not been reproduced in cell culture, which has slowed research progress on this important human pathogen. Here, we describe a full-length HCV genome that replicates and produces virus particles that are infectious in cell culture (HCVcc). Replication of HCVcc was robust, producing nearly 10(5) infectious units per milliliter within 48 hours. Virus particles were filterable and neutralized with a monoclonal antibody against the viral glycoprotein E2. Viral entry was dependent on cellular expression of a putative HCV receptor, CD81. HCVcc replication was inhibited by interferon-alpha and by several HCV-specific antiviral compounds, suggesting that this in vitro system will aid in the search for improved antivirals.	Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Rockefeller University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Scripps Research Institute; Scripps Research Institute	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, 1230 York Ave, New York, NY 10021 USA.	ricec@rockefeller.edu		McKeating, Jane/0000-0002-7229-5886; Evans, Matthew/0000-0002-4991-3877	Medical Research Council [G0400802] Funding Source: Medline; NCI NIH HHS [CA10702, CA85883, CA57973] Funding Source: Medline; NIAID NIH HHS [AI50798, AI51820, AI40034] Funding Source: Medline; NIDDK NIH HHS [DK70497] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085883, R01CA057973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI051820, R01AI050798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK070497] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agapov EV, 2004, J VIROL, V78, P2414, DOI 10.1128/JVI.78.5.2414-2425.2004; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P18; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Date T, 2004, J BIOL CHEM, V279, P22371, DOI 10.1074/jbc.M311120200; Fujita N, 2001, J MED VIROL, V63, P108, DOI 10.1002/1096-9071(20000201)63:2<108::AID-JMV1004>3.0.CO;2-6; Heller T, 2005, P NATL ACAD SCI USA, V102, P2579, DOI 10.1073/pnas.0409666102; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lin K, 2004, ANTIMICROB AGENTS CH, V48, P4784, DOI 10.1128/AAC.48.12.4784-4792.2004; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; PIETSCHMANN T, 2004, 11 INT S HCV REL VIR; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; SAKSENA AK, 2002, Patent No. 02008244; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WAKITA T, 2004, 11 INT S HCV REL VIR; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	27	1837	2013	4	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					623	626		10.1126/science.1114016	http://dx.doi.org/10.1126/science.1114016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	15947137	Green Submitted			2022-12-24	WOS:000230735200052
J	Chen, DL; Kon, N; Li, MY; Zhang, WZ; Qin, J; Gu, W				Chen, DL; Kon, N; Li, MY; Zhang, WZ; Qin, J; Gu, W			ARF-BP1/mule is a critical mediator of the ARF tumor suppressor	CELL			English	Article							UBIQUITIN-PROTEIN LIGASE; RING-FINGER DOMAIN; CELL-CYCLE ARREST; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; NUCLEAR EXPORT; P53 PATHWAY; G(2) ARREST; DNA-DAMAGE; IN-VIVO	Although the importance of the ARF tumor suppressor in p53 regulation is well established, numerous studies indicate that ARF also suppresses cell growth in a p53/Mdm2-independent manner. To understand the mechanism of ARF-mediated tumor suppression we identified a ubiquitin ligase, ARF-BP1, as a key factor associated with ARF in vivo. ARF-BP1 harbors a signature HECT motif, and its ubiquitin ligase activity is inhibited by ARK Notably, inactivation of ARFBP1, but not Mdm2, suppresses the growth of p53 null cells in a manner reminiscent of ARF induction. Surprisingly, in p53 wild-type cells, ARF-BP1 directly binds and ubiquitinates p53, and inactivation of endogenous ARF-BP1 is crucial for ARF-mediated p53 stabilization. Thus, our study modifies the current view of ARF-mediated p53 activation and reveals that ARF-BP1 is a critical mediator of both the p53-independent and p53-dependent tumor suppressor functions of ARE As such, ARF-BP1 may serve as a potential target for therapeutic intervention in tumors regardless of p53 status.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; Baylor Coll Med, Dept Biochem & Cell Biol, Houston, TX 77030 USA	Columbia University; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, Dept Pathol, 1150 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu						Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CUMMINS JM, 2004, NATURE, V428, P486, DOI [DOI 10.1038/NATURE02501, 10.1038/nature02501]; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GU J, 1994, MOL BRAIN RES, V24, P77, DOI 10.1016/0169-328X(94)90120-1; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuo ML, 2003, CANCER RES, V63, P1046; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; LUNA RMD, 1995, NATURE, V378, P203; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Modestou M, 2001, CANCER RES, V61, P3145; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prives C, 1999, J PATHOL, V187, P112; QUELLE DE, 1995, CELL, V83, P993; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yarbrough WG, 2002, CANCER RES, V62, P1171; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	69	429	455	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1071	1083		10.1016/j.cell.2005.03.037	http://dx.doi.org/10.1016/j.cell.2005.03.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989956	Bronze			2022-12-24	WOS:000230448000013
J	Schartl, M; Hornung, U; Hissmann, K; Schauer, J; Fricke, H				Schartl, M; Hornung, U; Hissmann, K; Schauer, J; Fricke, H			Relatedness among east African coelacanths	NATURE			English	Editorial Material							LATIMERIA-CHALUMNAE; HOME		Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; Max Planck Inst Seewiesen, Arbeitsgrp Fricke, D-82327 Tutzing, Germany	University of Wurzburg; Max Planck Society	Schartl, M (corresponding author), Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany.	hfricke@jago-sub.de		Schartl, Manfred/0000-0001-9882-5948				Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; de Ruijter WPM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013714; DURVILLE C, 2005, COELACANTH FISH CAUG; Fricke H, 2000, MAR BIOL, V136, P379, DOI 10.1007/s002270050697; FRICKE H, 1994, MAR BIOL, V120, P171, DOI 10.1007/BF00349676; Hissmann K, 2000, MAR BIOL, V136, P943, DOI 10.1007/s002270000294; Holder MT, 1999, P NATL ACAD SCI USA, V96, P12616, DOI 10.1073/pnas.96.22.12616; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; SCHLIEWEN U, 1993, NATURE, V363, P405, DOI 10.1038/363405a0	9	13	14	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					901	901		10.1038/435901a	http://dx.doi.org/10.1038/435901a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959506	Bronze			2022-12-24	WOS:000229799700034
J	Fitzpatrick, JW; Lammertink, M; Luneau, MD; Gallagher, TW; Harrison, BR; Sparling, GM; Rosenberg, KV; Rohrbaugh, RW; Swarthout, ECH; Wrege, PH; Swarthout, SB; Dantzker, MS; Charif, RA; Barksdale, TR; Remsen, JV; Simon, SD; Zollner, D				Fitzpatrick, JW; Lammertink, M; Luneau, MD; Gallagher, TW; Harrison, BR; Sparling, GM; Rosenberg, KV; Rohrbaugh, RW; Swarthout, ECH; Wrege, PH; Swarthout, SB; Dantzker, MS; Charif, RA; Barksdale, TR; Remsen, JV; Simon, SD; Zollner, D			Ivory-billed woodpecker (Campephilus principalis) persists in continental North America	SCIENCE			English	Article								The ivory-billed woodpecker (Campephilus principalis), long suspected to be extinct, has been rediscovered in the Big Woods region of eastern Arkansas. Visual encounters during 2004 and 2005, and analysis of a video clip from April 2004, confirm the existence of at least one mate. Acoustic signatures consistent with Campephilus display drums also have been heard from the region. Extensive efforts to find birds away from the primary encounter site remain unsuccessful, but potential habitat for a thinly distributed source population is vast (over 220,000 hectares).	Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1092 AD Amsterdam, Netherlands; Univ Arkansas, Dept Engn Technol, Little Rock, AR 72204 USA; Univ Arkansas, Dept Informat Technol, Little Rock, AR 72204 USA; Oakwood Coll, Dept Commun, Huntsville, AL 35896 USA; Birdman Prod, Choteau, MT 59422 USA; Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; Nature Conservancy, Little Rock, AR 72205 USA	Cornell University; University of Amsterdam; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Oakwood University; Louisiana State University System; Louisiana State University; Nature Conservancy	Fitzpatrick, JW (corresponding author), Cornell Univ, Cornell Lab Ornithol, 159 Sapsucker Woods Rd, Ithaca, NY 14850 USA.	jwf7@cornell.edu	Charif, Russell/AAA-8506-2021; Zöllner, Dana/AAP-2725-2020	Zöllner, Dana/0000-0002-0413-2700; Charif, Russell/0000-0002-2228-4740				ALLEN ARTHUR A., 1937, AUK, V54, P164; American Ornithologists' Union, 1998, CHECKL N AM BIRDS; BLUME D, 1996, SCHWARZSPECHT GRUSPE; Bull EL, 1995, BIRDS N AM; Christensen Hans, 2002, Dansk Ornitologisk Forenings Tidsskrift, V96, P187; Eckelberry D., 1961, DISCOVERY GREAT MOME, P195; Hoose Phillip M., 2004, RACE SAVE LORD GOD B; Jackson J.A, 2002, BIRDS N AM; Jackson JJ, 2004, SEARCH IVORY BILLED; LAMB GR, 1957, 1 INT COMM BIRD PRES; Lammertink Martjan, 1995, Bird Conservation International, V5, P53; Tanner JT., 1942, 1 NAT AUD SOC; The Nature Conservancy, 2002, CONS PLANN MISS RIV; TJERNBERG M, 1993, ORNIS FENNICA, V70, P155; 1991, BIRDS PREY NATURAL H, P111	15	107	116	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2005	308	5727					1460	1462		10.1126/science.1114103	http://dx.doi.org/10.1126/science.1114103			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15860589				2022-12-24	WOS:000229619300051
J	Feng, L; Zhou, SP; Gu, LC; Gell, DA; Mackay, JP; Weiss, MJ; Gow, AJ; Shi, YG				Feng, L; Zhou, SP; Gu, LC; Gell, DA; Mackay, JP; Weiss, MJ; Gow, AJ; Shi, YG			Structure of oxidized alpha-haemoglobin bound to AHSP reveals a protective mechanism for haem	NATURE			English	Article							STABILIZING PROTEIN; SULFHEME PROTEINS; HYDROGEN-PEROXIDE; MYOGLOBIN; BINDING; SULFMYOGLOBIN; DEGRADATION; THALASSEMIA; INSIGHTS	The synthesis of haemoglobin A (HbA) is exquisitely coordinated during erythrocyte development to prevent damaging effects from individual alpha- and beta-subunits(1,2). The alpha-haemoglobin-stabilizing protein (AHSP) binds alpha-haemoglobin (alpha Hb), inhibits the ability of alpha Hb to generate reactive oxygen species and prevents its precipitation on exposure to oxidant stress(3-5). The structure of AHSP bound to ferrous alpha Hb is thought to represent a transitional complex through which alpha Hb is converted to a non-reactive, hexacoordinate ferric form(5). Here we report the crystal structure of this ferric alpha Hb - AHSP complex at 2.4 angstrom resolution. Our findings reveal a striking bis-histidyl configuration in which both the proximal and the distal histidines coordinate the haem iron atom. To attain this unusual conformation, segments of alpha Hb undergo drastic structural rearrangements, including the repositioning of several alpha-helices. Moreover, conversion to the ferric bis-histidine configuration strongly and specifically inhibits redox chemistry catalysis and haem loss from alpha Hb. The observed structural changes, which impair the chemical reactivity of haem iron, explain how AHSP stabilizes alpha Hb and prevents its damaging effects in cells.	Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Princeton University; University of Pennsylvania; University of Sydney	Gow, AJ (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	gow@email.chop.edu; yshi@molbio.princeton.edu	Weiss, Mitchell J/A-1245-2013; Gow, Andrew/AAR-2309-2020; Weiss, Mitchell J/W-9814-2018; Mackay, Joel P/D-6834-2011; Gow, Andrew/N-8566-2013	Gow, Andrew/0000-0003-0876-5158; Weiss, Mitchell J/0000-0003-2460-3036; Mackay, Joel P/0000-0001-7508-8033; Gow, Andrew/0000-0003-0876-5158; Gell, David/0000-0003-0382-1181; Shi, Yigong/0000-0003-2030-168X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK061692] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alayash AI, 1999, J BIOL CHEM, V274, P2029, DOI 10.1074/jbc.274.4.2029; ArredondoPeter R, 1997, PLANT PHYSIOL, V115, P1259, DOI 10.1104/pp.115.3.1259; BAGLIONI C, 1966, BIBL HAEMATOL, V29, P1056; BERZOFSKY JA, 1972, J BIOL CHEM, V247, P3783; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P3367; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNN HF, 1987, BLOOD, V69, P1; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Hankeln T, 2002, J BIOL CHEM, V277, P29012, DOI 10.1074/jbc.M204009200; Herold S, 2001, J BIOL INORG CHEM, V6, P543, DOI 10.1007/s007750100231; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Nagababu E, 2000, BIOCHEMISTRY-US, V39, P12503, DOI 10.1021/bi992170y; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; NATHAN DG, 1966, AM J MED, V41, P815, DOI 10.1016/0002-9343(66)90039-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perazzolli M, 2004, PLANT CELL, V16, P2785, DOI 10.1105/tpc.104.025379; Rachmilewitz EA, 2001, DISORDERS HEMOGLOBIN, P233; Reeder BJ, 2002, BIOCHEMISTRY-US, V41, P367, DOI 10.1021/bi011335b; Rifkind JM, 2004, ANTIOXID REDOX SIGN, V6, P657, DOI 10.1089/152308604773934422; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; SCOTT MD, 1993, J CLIN INVEST, V91, P1706, DOI 10.1172/JCI116380; Sugimoto H, 2004, J MOL BIOL, V339, P873, DOI 10.1016/j.jmb.2004.04.024; Svistunenko DA, 2000, BIOCHEM J, V351, P595, DOI 10.1042/0264-6021:3510595; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832	30	92	100	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					697	701		10.1038/nature03609	http://dx.doi.org/10.1038/nature03609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15931225				2022-12-24	WOS:000229476200055
J	Oremland, RS; Kulp, TR; Blum, JS; Hoeft, SE; Baesman, S; Miller, LG; Stolz, JF				Oremland, RS; Kulp, TR; Blum, JS; Hoeft, SE; Baesman, S; Miller, LG; Stolz, JF			A microbial arsenic cycle in a salt-saturated, extreme environment	SCIENCE			English	Article							MONO LAKE WATER; REDUCTION; CALIFORNIA; SEDIMENTS; SULFATE; ECOLOGY	Searles Lake is a salt-saturated, alkaline brine unusually rich in the toxic element arsenic. Arsenic speciation changed from arsenate [As(V)] to arsenite (As(III)) with sediment depth. Incubated anoxic sediment slurries displayed dissimilatory As(V)-reductase activity that was markedly stimulated by H-2 or sulfide, whereas aerobic slurries had rapid As(III)-oxidase activity. An anaerobic, extremely haloalkaliphilic bacterium was isolated from the sediment that grew via As(V) respiration, using either lactate or sulfide as its electron donor. Hence, a full biogeochemical cycle of arsenic occurs in Searles Lake, driven in part by inorganic electron donors.	US Geol Survey, Menlo Pk, CA 94025 USA; Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA	United States Department of the Interior; United States Geological Survey; Duquesne University	Oremland, RS (corresponding author), US Geol Survey, MS 480,345 Middlefield Rd, Menlo Pk, CA 94025 USA.	roremlan@usgs.gov		Miller, Laurence/0000-0002-7807-3475; Baesman, Shaun/0000-0003-0741-8269				Bard A. J., 1985, STANDARD POTENTIALS; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Blum JS, 2001, ARCH MICROBIOL, V175, P208; Brandt KK, 2001, MICROBIAL ECOL, V41, P1; DiPasquale MM, 1998, MICR EXTREM UNUSUAL, P149; FELMY AR, 1986, GEOCHIM COSMOCHIM AC, V50, P2771, DOI 10.1016/0016-7037(86)90226-7; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Hoeft SE, 2004, APPL ENVIRON MICROB, V70, P2741, DOI 10.1128/AEM.70.5.2741-2747.2004; Hoeft SE, 2002, GEOMICROBIOL J, V19, P23, DOI 10.1080/014904502317246147; Hollibaugh JT, 2005, GEOCHIM COSMOCHIM AC, V69, P1925, DOI 10.1016/j.gca.2004.10.011; JAVOR B, 1989, HYPERSALINE ENV; KULP TR, UNPUB; Liu A, 2004, FEMS MICROBIOL ECOL, V48, P323, DOI 10.1016/j.femsec.2004.02.008; Newman DK, 1998, GEOMICROBIOL J, V15, P255, DOI 10.1080/01490459809378082; OREMLAND RS, 1987, GEOCHIM COSMOCHIM AC, V51, P2915, DOI 10.1016/0016-7037(87)90367-X; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Oremland RS, 2004, FEMS MICROBIOL ECOL, V48, P15, DOI 10.1016/j.femsec.2003.12.016; Oremland RS, 2002, APPL ENVIRON MICROB, V68, P4795, DOI 10.1128/AEM.68.10.4795-4802.2002; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Oremland RS, 2000, GEOCHIM COSMOCHIM AC, V64, P3073, DOI 10.1016/S0016-7037(00)00422-1; OREN A, 1988, ADV MICROB ECOL, V10, P193; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Oren A, 1998, MICR EXTREM UNUSUAL, P1; SMITH GI, 1979, US GEOL SURV PROF PA, V1043, P143; Sorensen KB, 2004, APPL ENVIRON MICROB, V70, P1608, DOI 10.1128/AEM.70.3.1608-1616.2004; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569	27	130	139	5	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1305	1308		10.1126/science.1110832	http://dx.doi.org/10.1126/science.1110832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919992				2022-12-24	WOS:000229482300046
J	Rose, R; Weyand, M; Lammers, M; Ishizaki, T; Ahmadian, MR; Wittinghofer, A				Rose, R; Weyand, M; Lammers, M; Ishizaki, T; Ahmadian, MR; Wittinghofer, A			Structural and mechanistic insights into the interaction between Rho and mammalian Dia	NATURE			English	Article							DIAPHANOUS-RELATED FORMIN; SMALL G-PROTEIN; CRYSTAL-STRUCTURE; ACTIN NUCLEATION; EFFECTOR RECOGNITION; SMALL GTPASE; MDIA1; DOMAIN; SWITCH; REORGANIZATION	Formins are involved in a variety of cellular processes that require the remodelling of the cytoskeleton. They contain formin homology domains FH1 and FH2, which initiate actin assembly(1,2). The Diaphanous-related formins form a subgroup that is characterized by an amino-terminal Rho GTPase-binding domain (GBD) and an FH3 domain, which bind somehow to the carboxy-terminal Diaphanous autoregulatory domain ( DAD) to keep the protein in an inactive conformation(3,4). Upon binding of activated Rho proteins, the DAD is released and the ability of the formin to nucleate and elongate unbranched actin filaments is induced. Here we present the crystal structure of RhoC in complex with the regulatory N terminus of mammalian Diaphanous 1 (mDia1) containing the GBD/FH3 region, an all-helical structure with armadillo repeats. Rho uses its 'switch' regions for interacting with two subdomains of GBD/FH3. We show that the FH3 domain of mDia1 forms a stable dimer and we also identify the DAD-binding site. Although binding of Rho and DAD on the N-terminal fragment of mDia1 are mutually exclusive, their binding sites are only partially overlapping. On the basis of our results, we propose a structural model for the regulation of mDia1 by Rho and DAD.	Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, Otto Hahn Str 11, D-44227 Dortmund, Germany.	Alfred.wittinghofer@mpi-dortmund.mpg.de	Lammers, Michael/AAX-1164-2020	Lammers, Michael/0000-0003-4168-4640				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; EHRESMAN.B, 1973, ANAL BIOCHEM, V54, P454, DOI 10.1016/0003-2697(73)90374-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Kato T, 2001, J CELL SCI, V114, P775; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Krebs A, 2001, J CELL SCI, V114, P3663; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Rose R, 2005, ACTA CRYSTALLOGR F, V61, P225, DOI 10.1107/S1744309105001065; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	30	197	206	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					513	518		10.1038/nature03604	http://dx.doi.org/10.1038/nature03604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15864301				2022-12-24	WOS:000229337800058
J	Stein, AJ; Fuchs, G; Fu, CM; Wolin, SL; Reinisch, KM				Stein, AJ; Fuchs, G; Fu, CM; Wolin, SL; Reinisch, KM			Structural insights into RNA quality control: The Ro autoantigen binds misfolded RNAs via its central cavity	CELL			English	Article							SMALL CYTOPLASMIC RIBONUCLEOPROTEINS; 5S RIBOSOMAL-RNA; PROTEIN; RECOGNITION; EVOLUTION; DOMAIN	The Ro 60 kDa autoantigen is a major target of the immune response in patients with systemic lupus erythematosus. In vertebrate cells, Ro binds misfolded small RNAs and likely functions in RNA quality control. In eukaryotes and bacteria, Ro also associates with small RNAs called Y RNAs. We present structures of unliganded Ro and Ro complexed with two RNAs at 1.95 and 2.2 angstrom resolution, respectively. Ro consists of a von Willebrand factor A domain and a doughnut-shaped domain composed of HEAT repeats. In the complex, a fragment of Y RNA binds on the outer surface of the HEAT-repeat ring, and single-stranded RNA binds in the toroid hole. Mutagenesis supports a binding site for misfolded RNAs that encompasses both sites, with a single-stranded end inserted into the toroid cavity. Our experiments suggest that one role of Y RNAs may be to regulate access of other RNAs to Ro.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Reinisch, KM (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	karin.reinisch@yale.edu	Wolin, Sandra/H-2333-2016	Wolin, Sandra/0000-0001-6730-0399; Fuchs, Gabriele/0000-0002-6838-2100	NCRR NIH HHS [P41 RR012408] Funding Source: Medline; NIGMS NIH HHS [R01 GM073863-04, R01 GM048410, R01 GM073863-01, R01 GM 48410, R01 GM070521, R01 GM073863-02, R01 GM073863, R01 GM073863-03, R01 GM 70521] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070521, R01GM048410, R01GM073863] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Baldwin ET, 1998, STRUCTURE, V6, P923, DOI 10.1016/S0969-2126(98)00093-8; Bateman A, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-49; Batey RT, 2001, J MOL BIOL, V307, P229, DOI 10.1006/jmbi.2000.4454; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buyon JP, 2004, LUPUS, V13, P705, DOI 10.1191/0961203304lu2008oa; CARTER DM, 1971, J BIOL CHEM, V246, P2502; Chen XG, 2000, GENE DEV, V14, P777; Chen XG, 2004, J MOL MED, V82, P232, DOI 10.1007/s00109-004-0529-0; Chen XG, 2003, CURR BIOL, V13, P2206, DOI 10.1016/j.cub.2003.11.028; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; FARRIS AD, 1995, GENE, V154, P193, DOI 10.1016/0378-1119(94)00823-B; Green CD, 1998, RNA, V4, P750, DOI 10.1017/S1355838298971667; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; HENDRICK JP, 1981, MOL CELL BIOL, V1, P1138, DOI 10.1128/MCB.1.12.1138; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Kickhoefer VA, 2001, J CELL BIOL, V152, P157, DOI 10.1083/jcb.152.1.157; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; NICHOLLS A, 1993, GRASP GRAPHICAL REPR; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; OBRIEN CA, 1993, P NATL ACAD SCI USA, V90, P7250, DOI 10.1073/pnas.90.15.7250; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Patel P, 2002, DERMATOL CLIN, V20, P373, DOI 10.1016/S0733-8635(02)00016-5; PRUIJN GJM, 1991, NUCLEIC ACIDS RES, V19, P5173, DOI 10.1093/nar/19.19.5173; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Shi H, 1996, RNA, V2, P769; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANHORN DJ, 1995, RNA, V1, P293; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WOLIN SL, 1984, P NATL ACAD SCI-BIOL, V81, P1996, DOI 10.1073/pnas.81.7.1996; Xue DH, 2003, P NATL ACAD SCI USA, V100, P7503, DOI 10.1073/pnas.0832411100	37	134	137	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					529	539		10.1016/j.cell.2005.03.009	http://dx.doi.org/10.1016/j.cell.2005.03.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907467	Green Accepted, Bronze			2022-12-24	WOS:000229331200010
J	Wilson, JF				Wilson, JF			Is sleep the new vital sign?	ANNALS OF INTERNAL MEDICINE			English	News Item							INSULIN-RESISTANCE; APNEA; RISK; DEPRIVATION; DURATION; INTERNS; MEN					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Namen AM, 2001, SOUTHERN MED J, V94, P874; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Quan SF, 2004, GERIATRICS-US, V59, P37; Roehrs T, 2004, SLEEP, V27, P887, DOI 10.1093/sleep/27.5.887; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2002, JAMA-J AM MED ASSOC, V288, P1471, DOI 10.1001/jama.288.12.1471-a; Tamakoshi A, 2004, SLEEP, V27, P51; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Williamson AM, 2000, OCCUP ENVIRON MED, V57, P649, DOI 10.1136/oem.57.10.649	17	26	26	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2005	142	10					877	880		10.7326/0003-4819-142-10-200505170-00026	http://dx.doi.org/10.7326/0003-4819-142-10-200505170-00026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926CE	15897548				2022-12-24	WOS:000229099600022
J	Dale, VH; Crisafulli, CM; Swanson, FJ				Dale, VH; Crisafulli, CM; Swanson, FJ			Ecology - 25 years of ecological change at Mount St. Helens	SCIENCE			English	Editorial Material									Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; US Forest Serv, USDA, Pacific NW Res Stn, Forestry Sci Lab, Olympia, WA 98512 USA; US Forest Serv, USDA, Pacific NW Res Stn, Forestry Sci Lab, Corvallis, OR 97331 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Dale, VH (corresponding author), Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.	dalevh@ornl.gov	Dale, Virginia H/GSO-3448-2022; Dale, Virginia H/ABI-6672-2020; Dale, Virginia H/B-6023-2009	Dale, Virginia H/0000-0002-4123-7202; 				Dale V, 2005, ECOLOGICAL RESPONSES; Dzurisin D, 2005, EOS T AGU, V86, P25, DOI DOI 10.1029/2005EO030001; Lipman P.W., 1981, 1250 USGS, DOI [DOI 10.3133/PP1250, 10.3133/pp1250]	3	21	25	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					961	962		10.1126/science.1109684	http://dx.doi.org/10.1126/science.1109684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890864				2022-12-24	WOS:000229190700024
J	Kawakami, Y; Raya, A; Raya, RM; Rodriguez-Esteban, C; Belmonte, JCI				Kawakami, Y; Raya, A; Raya, RM; Rodriguez-Esteban, C; Belmonte, JCI			Retinoic acid signalling links left-right asymmetric patterning and bilaterally symmetric somitogenesis in the zebrafish embryo	NATURE			English	Article							SEGMENTATION CLOCK; NODAL EXPRESSION; VERTEBRATE SEGMENTATION; PRESOMITIC MESODERM; SOMITE SEGMENTATION; AXIS FORMATION; MOTOR PROTEIN; EARLY STEP; GENES; OSCILLATOR	During embryogenesis, cells are spatially patterned as a result of highly coordinated and stereotyped morphogenetic events. In the vertebrate embryo, information on laterality is conveyed to the node, and subsequently to the lateral plate mesoderm, by a complex cascade of epigenetic and genetic events, eventually leading to a left - right asymmetric body plan. At the same time, the paraxial mesoderm is patterned along the anterior - posterior axis in metameric units, or somites, in a bilaterally symmetric fashion. Here we characterize a cascade of laterality information in the zebrafish embryo and show that blocking the early steps of this cascade ( before it reaches the lateral plate mesoderm) results in random left - right asymmetric somitogenesis. We also uncover a mechanism mediated by retinoic acid signalling that is crucial in buffering the influence of the flow of laterality information on the left - right progression of somite formation, and thus in ensuring bilaterally symmetric somitogenesis.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	; Raya, Angel/E-6205-2010	Kawakami, Yasuhiko/0000-0002-0043-9705; Raya, Angel/0000-0003-2189-9775				Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; Campione M, 1999, DEVELOPMENT, V126, P1225; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Henry CA, 2002, DEVELOPMENT, V129, P3693; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; KANE DA, 1993, DEVELOPMENT, V119, P447; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 2003, BIOESSAYS, V25, P1002, DOI 10.1002/bies.10339; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Oates AC, 2002, DEVELOPMENT, V129, P2929; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Rodriguez-Esteban C, 2001, DEVELOPMENT, V128, P3189; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sawada A, 2000, DEVELOPMENT, V127, P1691; Stickney HL, 2000, DEV DYNAM, V219, P287; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; VERMOT J, NATURE; Weinmaster G, 2003, ANNU REV CELL DEV BI, V19, P367, DOI 10.1146/annurev.cellbio.19.111301.115434; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6; Zile MH, 2000, DEV BIOL, V223, P323, DOI 10.1006/dbio.2000.9754	50	208	224	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					165	171		10.1038/nature03512	http://dx.doi.org/10.1038/nature03512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889082				2022-12-24	WOS:000229021100030
J	Moore, P				Moore, P			Simplifying the probe set	NATURE			English	Article																			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					238	238		10.1038/435238a	http://dx.doi.org/10.1038/435238a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889103	Bronze			2022-12-24	WOS:000229021100052
J	Berk, DR; Falkovitz-Halpern, MS; Hill, DW; Albin, C; Arrieta, A; Bork, JM; Cohan, D; Nilson, B; Petru, A; Ruiz, J; Weintrub, PS; Wenman, W; Maldonado, YA				Berk, DR; Falkovitz-Halpern, MS; Hill, DW; Albin, C; Arrieta, A; Bork, JM; Cohan, D; Nilson, B; Petru, A; Ruiz, J; Weintrub, PS; Wenman, W; Maldonado, YA		California Pediat HIV Study Grp	Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PROTEASE INHIBITOR; 1-INFECTED INFANTS; COMBINATION THERAPY; DISEASE PROGRESSION; FOLLOW-UP; CHILDREN; ZIDOVUDINE	Context The effect of early antiretroviral therapy (ART) on the early progression of perinatal human immunodeficiency virus (HIV) infection is not well defined. Objective To examine early disease progression and survival in a population-based cohort with perinatal HIV infection in relation to year of birth and use of ART. Design, Setting, and Patients Retrospective study of temporal trends in early progression of perinatal HIV infection among 205 HIV-infected children in Northern California born between January 1, 1988, and December 31, 2001, and followed up through age 3 years. Main Outcome Measures Prevalence of and age at progression to a first US Centers for Disease Control and Prevention category C diagnosis relative to year of birth, type of ART, and age at initiation of therapy. Results Of 205 children, 134 (65%)received ART and/or Pneumocystis jiroveci pneumonia prophylaxis. By age 3 years, 81 (40%) progressed to a category C diagnosis, 41 (51%) of whom died. Untreated children were significantly more likely to progress to a category C diagnosis (62% [44/71] untreated vs 28% [37/134] treated children, P<.001); none of 23 infants who received triple ART progressed to category C. However, even without triple ART, very early mono/dual ART (by age 2 months vs 3-4 months) was associated with delayed and decreased progression to category C (P=.02). Of 33 children born between January 1, 1996, and December 31, 2001, only 7 (21%) progressed to category C (P=.02 compared with 1988-1995), 6 of 7 of whom received no therapy. More recent year of birth and more advanced therapy were associated with improved survival. Conclusions This population-based cohort demonstrated decreased early HIV progression and improved survival at age 3 years, associated with more advanced therapy. Although limited by small sample size, the findings suggest that very early treatment, even without triple ART, was associated with improved outcome.	Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, Stanford, CA 94305 USA; Santa Clara Valley Med Ctr, Dept Pediat, San Jose, CA 95128 USA; Childrens Hosp Orange Cty, Orange, CA 92668 USA; Loma Linda Univ, Childrens Hosp, Loma Linda, CA 92350 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco Gen Hosp, Bay Area Perinatal AIDS Ctr, San Francisco, CA USA; Univ Med Ctr, Specialty Serv, Fresno, CA USA; Calif Dept Hlth Serv, Off AIDS, Sacramento, CA USA; Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; Univ Calif Davis, Sacramento, CA 95817 USA	Stanford University; Santa Clara Valley Medical Center; Childrens Hospital of Orange County; Children's Hospital Los Angeles; Loma Linda University; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; California Department of Health Care Services; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Davis	Maldonado, YA (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, G312B ID,MC 5208, Stanford, CA 94305 USA.	bonniem@stanford.edu						Aboulker JP, 2004, AIDS, V18, P237, DOI [10.1097/01.aids.0000111388.02002.6b, 10.1097/00002030-200401230-00013]; Aboulker JP, 2001, ARCH DIS CHILD, V84, P230, DOI 10.1136/adc.84.3.230; Abrams EJ, 2003, AIDS, V17, P867, DOI 10.1097/00002030-200304110-00012; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; AUGER I, 1988, NATURE, V336, P575, DOI 10.1038/336575a0; Barnett AA, 1996, LANCET, V347, P678; Blanche S, 1997, J ACQ IMMUN DEF SYND, V14, P442, DOI 10.1097/00042560-199704150-00008; BLANCHE S, 1990, AM J DIS CHILD, V144, P1210, DOI 10.1001/archpedi.1990.02150350042021; Blazevic V, 2001, CLIN DIAGN LAB IMMUN, V8, P943, DOI 10.1128/CDLI.8.5.943-948.2001; *CAL DEP HLTH SERV, 2001, CAL CHILDB WOM COMP; Centers for Disease Control and Prevention, 2005, HIV AIDS SURV REP; Chougnet C, 2001, J INFECT DIS, V184, P201, DOI 10.1086/322006; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper ER, 1998, J PEDIATR-US, V132, P808, DOI 10.1016/S0022-3476(98)70308-7; de Martino M, 2000, JAMA-J AM MED ASSOC, V284, P190, DOI 10.1001/jama.284.2.190; DULIEGE AM, 1992, PEDIATR INFECT DIS J, V11, P630; Englund JA, 1997, NEW ENGL J MED, V336, P1704, DOI 10.1056/NEJM199706123362403; Faye A, 2004, CLIN INFECT DIS, V39, P1692, DOI 10.1086/425739; Faye A, 2002, PEDIATR INFECT DIS J, V21, P518, DOI 10.1097/00006454-200206000-00008; *FDA, 1990, ONCOLOGY HUNTINGT, V4, P96; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Hainaut M, 2000, EUR J PEDIATR, V159, P778, DOI 10.1007/PL00008346; Jankelevich S, 2001, J INFECT DIS, V183, P1116, DOI 10.1086/319274; *JOINT UN PROGR HI, 2003, AIDS EP UPD; Krogstad P, 1999, CLIN INFECT DIS, V28, P1109, DOI 10.1086/514759; LOBATO MN, 1995, J PEDIATR-US, V126, P710, DOI 10.1016/S0022-3476(95)70397-7; LOYAL JK, 2002, 14 INT AIDS C JUL 7; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Luzuriaga K, 2004, NEW ENGL J MED, V350, P2471, DOI 10.1056/NEJMoa032706; Luzuriaga K, 1999, J VIROL, V73, P362, DOI 10.1128/JVI.73.1.362-367.1999; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; Magder LS, 2005, JAIDS-J ACQ IMM DEF, V38, P87, DOI 10.1097/00126334-200501010-00016; MALDONADO YA, 1995, J INFECT DIS, V171, P689, DOI 10.1093/infdis/171.3.689; Maldonado YA, 1998, PEDIATR INFECT DIS J, V17, P398, DOI 10.1097/00006454-199805000-00010; MAWHINNEY S, 1993, J ACQ IMMUN DEF SYND, V6, P1139; MCKINNEY RE, 1991, NEW ENGL J MED, V324, P1018, DOI 10.1056/NEJM199104113241503; Mueller BU, 1998, PEDIATRICS, V101, P335, DOI 10.1542/peds.101.3.335; Nachman SA, 2000, JAMA-J AM MED ASSOC, V283, P492, DOI 10.1001/jama.283.4.492; Palumbo P, 2002, CLIN LAB MED, V22, P759, DOI 10.1016/S0272-2712(02)00010-0; Rich KC, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e8; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; SANCHEZ JM, 2003, PEDIATR INFECT DIS J, V22, P863; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; Stephenson J, 1997, JAMA-J AM MED ASSOC, V277, P614, DOI 10.1001/jama.277.8.614; Sullivan JL, 2001, NEW ENGL J MED, V345, P1568, DOI 10.1056/NEJM200111223452111; *US PUBL HLTH SERV, 1995, MMWR-MORBID MORTAL W, V44, P1; Wade NA, 2004, JAIDS-J ACQ IMM DEF, V36, P1075, DOI 10.1097/00126334-200408150-00011; Walker AS, 2004, AIDS, V18, P1915, DOI 10.1097/00002030-200409240-00007; Wiznia A, 2000, AIDS RES HUM RETROV, V16, P1113, DOI 10.1089/088922200414956; *WORK GROUP ANT TH, 2004, GUID US ANT AG PED H; 1994, MMWR MORB MORTAL WKL, V43, P285	52	47	48	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2221	2231		10.1001/jama.293.18.2221	http://dx.doi.org/10.1001/jama.293.18.2221			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886377	Bronze			2022-12-24	WOS:000228981100023
J	Kroymann, J; Mitchell-Olds, T				Kroymann, J; Mitchell-Olds, T			Epistasis and balanced polymorphism influencing complex trait variation	NATURE			English	Article							ARABIDOPSIS-THALIANA; GENETIC-VARIATION; DNA POLYMORPHISM; KINASE; ARCHITECTURE; DROSOPHILA; EVOLUTION; ENCODES; LOCUS	Complex traits such as human disease, growth rate, or crop yield are polygenic, or determined by the contributions from numerous genes in a quantitative manner. Although progress has been made in identifying major quantitative trait loci (QTL), experimental constraints have limited our knowledge of small-effect QTL, which may be responsible for a large proportion of trait variation(1-3). Here, we identified and dissected a one-centimorgan chromosome interval in Arabidopsis thaliana without regard to its effect on growth rate, and examined the signature of historical sequence polymorphism among Arabidopsis accessions. We found that the interval contained two growth rate QTL within 210 kilobases. Both QTL showed epistasis; that is, their phenotypic effects depended on the genetic background. This amount of complexity in such a small area suggests a highly polygenic architecture of quantitative variation, much more than previously documented(4). One QTL was limited to a single gene. The gene in question displayed a nucleotide signature indicative of balancing selection, and its phenotypic effects are reversed depending on genetic background. If this region typifies many complex trait loci, then non-neutral epistatic polymorphism may be an important contributor to genetic variation in complex traits.	Max Planck Inst Chem Ecol, Dept Genet & Evolut, D-07745 Jena, Germany	Max Planck Society	Kroymann, J (corresponding author), Max Planck Inst Chem Ecol, Dept Genet & Evolut, Hans Knoell Str 8, D-07745 Jena, Germany.	kroymann@ice.mpg.de	Kroymann, Juergen/AAY-8562-2021; Kroymann, Juergen/B-4317-2013; Mitchell-Olds, Thomas/K-8121-2012	Kroymann, Juergen/0000-0002-4573-6498; Mitchell-Olds, Thomas/0000-0003-3439-9921				Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; Becraft PW, 1996, SCIENCE, V273, P1406, DOI 10.1126/science.273.5280.1406; Dilda CL, 2002, GENETICS, V162, P1655; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Haubold B, 2002, GENETICS, V161, P1269; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Lauter N, 2002, GENETICS, V160, P333; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; TAJIMA F, 1989, GENETICS, V123, P585; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2	22	214	221	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2005	435	7038					95	98		10.1038/nature03480	http://dx.doi.org/10.1038/nature03480			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875023				2022-12-24	WOS:000228864600045
J	Panakova, D; Sprong, H; Marois, E; Thiele, C; Eaton, S				Panakova, D; Sprong, H; Marois, E; Thiele, C; Eaton, S			Lipoprotein particles are required for Hedgehog and Wingless signalling	NATURE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CELL-ADHESION MOLECULE; INTERCELLULAR TRANSFER; SONIC HEDGEHOG; MULTIVESICULAR BODY; DROSOPHILA; PROTEIN; RECEPTOR; GRADIENT; DOMAIN	Wnt and Hedgehog family proteins are secreted signalling molecules (morphogens) that act at both long and short range to control growth and patterning during development. Both proteins are covalently modified by lipid, and the mechanism by which such hydrophobic molecules might spread over long distances is unknown. Here we show that Wingless, Hedgehog and glycophosphatidylinositol-linked proteins copurify with lipoprotein particles, and co-localize with them in the developing wing epithelium of Drosophila. In larvae with reduced lipoprotein levels, Hedgehog accumulates near its site of production, and fails to signal over its normal range. Similarly, the range of Wingless signalling is narrowed. We propose a novel function for lipoprotein particles, in which they act as vehicles for the movement of lipid-linked morphogens and glycophosphatidylinositol-linked proteins.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Thiele, C (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	thiele@mpi-cbg.de; eaton@mpi-cbg.de	Eaton, Suzanne/D-7698-2017; Marois, Eric/AAZ-5549-2021; Marois, Eric/H-9246-2016	Eaton, Suzanne/0000-0002-8319-284X; Marois, Eric/0000-0003-4147-3747; Marois, Eric/0000-0003-4147-3747; Sprong, Hein/0000-0002-0218-4320; Panakova, Daniela/0000-0002-8739-6225				Anderson SM, 1996, P NATL ACAD SCI USA, V93, P5894, DOI 10.1073/pnas.93.12.5894; Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Butler SJ, 1997, DEVELOPMENT, V124, P781; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Camejo G, 1998, ATHEROSCLEROSIS, V139, P205, DOI 10.1016/S0021-9150(98)00107-5; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Denzer K, 2000, J CELL SCI, V113, P3365; Dunn DE, 1996, P NATL ACAD SCI USA, V93, P7938, DOI 10.1073/pnas.93.15.7938; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; Incardona JP, 1996, MOL BIOL CELL, V7, P613, DOI 10.1091/mbc.7.4.613; Klueg KM, 1999, J CELL SCI, V112, P3289; Kutty RK, 1996, J BIOL CHEM, V271, P20641, DOI 10.1074/jbc.271.34.20641; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Mahley RW, 1999, J LIPID RES, V40, P1; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; Micchelli CA, 2002, DEVELOPMENT, V129, P843; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; NEUMANN CJ, 1997, DEVELOPMENT, V124, P861; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strigini M, 1997, DEVELOPMENT, V124, P4697; Sundermeyer K, 1996, INSECT BIOCHEM MOLEC, V26, P735, DOI 10.1016/S0965-1748(96)00060-4; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; TAYLOR AM, 1993, MECH DEVELOP, V42, P89, DOI 10.1016/0925-4773(93)90101-3; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; van der Horst DJ, 2002, MOL CELL BIOCHEM, V239, P113, DOI 10.1023/A:1020541010547; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Vervoort M, 2000, BIOESSAYS, V22, P460, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;460::AID-BIES8&gt;3.0.CO;2-G; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams KP, 1999, J CELL SCI, V112, P4405; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	48	494	513	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					58	65		10.1038/nature03504	http://dx.doi.org/10.1038/nature03504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875013				2022-12-24	WOS:000228864600035
J	Jeffcoate, W; Bakker, K				Jeffcoate, W; Bakker, K			World Diabetes Day: footing the bill	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England; Int Diabet Federat, Consultat Sect Diabet Foot, Heemstede, Netherlands		Jeffcoate, W (corresponding author), The Lancet, 32 Jamestown Rd, London NW1 7BY, England.	william.jeffcoate@lancet.com						Apelqvist J, 2000, DIABETES-METAB RES, V16, pS84, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR113>3.0.CO;2-S; *INT WORK GROUP DI, 2003, INT CONS DIAB FOOT P; Meltzer DD, 2002, J AM PODIAT MED ASSN, V92, P425, DOI 10.7547/87507315-92-8-425; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Tennvall GR, 2004, CLIN INFECT DIS, V39, pS132, DOI 10.1086/383275; Tentolouris N, 2004, DIABETES CARE, V27, P1598, DOI 10.2337/diacare.27.7.1598; Tsalikian E, 2004, DIABETES CARE, V27, P722; Vileikyte L, 2004, DIABETES-METAB RES, V20, pS13, DOI 10.1002/dmrr.437	8	43	44	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1527	1527		10.1016/S0140-6736(05)66437-9	http://dx.doi.org/10.1016/S0140-6736(05)66437-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866295				2022-12-24	WOS:000228754800010
J	Cohen, J; Schleifer, R; Tate, T				Cohen, J; Schleifer, R; Tate, T			AIDS in Uganda: the human-rights dimension	LANCET			English	Editorial Material									HIV AIDS & Human Rights Programme, New York, NY 10118 USA; Childrens Rights Div Human Rights Watch, New York, NY 10118 USA		Cohen, J (corresponding author), HIV AIDS & Human Rights Programme, New York, NY 10118 USA.	cohenj@hrw.org						ANGELO I, 2004, MONITOR         1129; Bruckner H, 2005, J ADOLESCENT HEALTH, V36, P271, DOI 10.1016/j.jadohealth.2005.01.005; COHEN J, 2005, HUMAN RIGHTS WAT MAR, P29; Hauser T., 2004, 42 AIAA AER SCI M EX, P1088; *HIV AIDS INT MOD, 2004, 4 PRES DIAL YOUNG LE, P19; *I MED COMM HIV PR, 2001, NO TIM LOS GETT MOR, P118; KARANJA L, 2003, HUMAN RIGHTS WAT AUG, P15; KEMPNER ME, 2001, SEXUALLY HLTH AM ABS; KIRBY D, 2001, EMERGING ANSWERS RES, P5; Manlove J., 2004, NOT YET PROGRAMS DEL; SCHLEIFER R, 2002, HUMAN RIGHTS WAT SEP, P19; *UG MIN ED SPORTS, 2004, IN PRESS PIASCY HDB, P22; *US HR COMM GOV RE, 2004, CONT FED FUND ABST O	13	14	15	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 18	2005	365	9477					2075	2076		10.1016/S0140-6736(05)66716-5	http://dx.doi.org/10.1016/S0140-6736(05)66716-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	936LZ	15964433				2022-12-24	WOS:000229858800010
J	Douglass, AD; Vale, RD				Douglass, AD; Vale, RD			Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells	CELL			English	Article							IMMUNOLOGICAL SYNAPSE FORMATION; GPI-ANCHORED PROTEINS; LIPID RAFTS; BACTERIAL CHEMOTAXIS; DYNAMIC RECRUITMENT; TYROSINE KINASES; LIVING CELLS; ACTIVATION; RECEPTOR; LAT	Membrane subdomains have been implicated in T cell signaling, although their properties and mechanisms of formation remain controversial. Here, we have used single-molecule and scanning confocal imaging to characterize the behavior of GFP-tagged signaling proteins in Jurkat T cells. We show that the coreceptor CD2, the adaptor protein LAT, and tyrosine kinase Lck cocluster in discrete microdomains in the plasma membrane of signaling T cells. These microdomains require protein-protein interactions mediated through phosphorylation of LAT and are not maintained by interactions with actin or lipid rafts. Using a two color imaging approach that allows tracking of single molecules relative to the CD2/LAT/Lck clusters, we demonstrate that these microdomains exclude and limit the free diffusion of molecules in the membrane but also can trap and immobilize specific proteins. Our data suggest that diffusional trapping through protein-protein interactions creates microdomains that concentrate or exclude cell surface proteins to facilitate T cell signaling.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA.	vale@cmp.ucsf.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM038499-16, R01 GM038499] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Bachmann MF, 1999, J EXP MED, V190, P1383, DOI 10.1084/jem.190.10.1383; Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Bierer B E, 1993, Semin Immunol, V5, P249, DOI 10.1006/smim.1993.1029; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Green JM, 2000, J IMMUNOL, V164, P3591, DOI 10.4049/jimmunol.164.7.3591; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Ike H, 2003, CHEMPHYSCHEM, V4, P620, DOI 10.1002/cphc.200300670; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; KILLEEN N, 1992, EMBO J, V11, P4329, DOI 10.1002/j.1460-2075.1992.tb05532.x; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lee SJE, 2002, TRENDS IMMUNOL, V23, P492, DOI 10.1016/S1471-4906(02)02285-8; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9; Mello BA, 2004, BIOPHYS J, V87, P1578, DOI 10.1529/biophysj.104.042739; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Tanimura N, 2003, J CELL BIOL, V160, P125, DOI 10.1083/jcb.200207096; Trautmann A, 2003, CURR OPIN IMMUNOL, V15, P249, DOI 10.1016/S0952-7915(03)00040-2; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Weis RM, 2003, J BACTERIOL, V185, P3636, DOI 10.1128/JB.185.12.3636-3643.2003; Weiss M, 2004, TRENDS CELL BIOL, V14, P267, DOI 10.1016/j.tcb.2004.03.012; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yang HL, 2001, J BIOL CHEM, V276, P18775, DOI 10.1074/jbc.M009852200; YURCHAK LK, 1995, MOL CELL BIOL, V15, P6914, DOI 10.1128/mcb.15.12.6914; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2005, J IMMUNOL, V174, P31, DOI 10.4049/jimmunol.174.1.31	65	596	615	1	82	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 17	2005	121	6					937	950		10.1016/j.cell.2005.04.009	http://dx.doi.org/10.1016/j.cell.2005.04.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960980	Bronze, Green Accepted			2022-12-24	WOS:000230011200015
J	Turvey, ST; Green, OR; Holdaway, RN				Turvey, ST; Green, OR; Holdaway, RN			Cortical growth marks reveal extended juvenile development in New Zealand moa	NATURE			English	Article							BONE MICROSTRUCTURE; PERIOSTEAL BONE; LIFE-HISTORY; EVOLUTION; AGE; EXTINCTION; SEQUENCES; DINOSAURS; RATES; BIRDS	Cyclical growth marks in cortical bone, deposited before attainment of adult body size, reflect osteogenetic changes caused by annual rhythms and are a general phenomenon in non-avian ectothermic and endothermic tetrapods(1). However, the growth periods of ornithurines (the theropod group including all modern birds) are usually apomorphically shortened to less than a year(2,3), so annual growth marks are almost unknown in this group(4-6). Here we show that cortical growth marks are frequent in long bones of New Zealand's moa (Aves: Dinornithiformes), a recently extinct ratite order. Moa showed the exaggerated K-selected life-history strategy formerly common in the New Zealand avifauna, and in some instances took almost a decade to attain skeletal maturity. This indicates that reproductive maturity in moa was extremely delayed relative to all extant birds. The two presently recognized moa families (Dinornithidae and Emeidae) also showed different postnatal growth rates, which were associated with their relative differences in body size. Both species of giant Dinornis moa attained their massive stature (up to 240 kg live mass) by accelerating their juvenile growth rate compared to the smaller emeid moa species, rather than by extending the skeletal growth period.	Univ Canterbury, Sch Biol Sci, Christchurch 8020, New Zealand; Zool Soc London, Inst Zool, London NW1 4RY, England; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Palaecol Res Ltd, Christchurch 8004, New Zealand	University of Canterbury; Zoological Society of London; University of Oxford	Turvey, ST (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8020, New Zealand.	samuel.turvey@ioz.ac.uk						Amprino R., 1947, ARCH BIOL SCI, V58, P315; Bennett P.M., 2002, EVOL ECOL; Broughton JM, 2002, IBIS, V144, P143, DOI 10.1046/j.0019-1019.2001.00004.x; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; CHINSAMY A, 1995, SENCKENBERG, V181, P317; Chinsamy Anusuya, 2002, P421; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CRACRAFT J, 1974, IBIS, V116, P494, DOI 10.1111/j.1474-919X.1974.tb07648.x; Davies S.J.J.F., 2002, RATITES TINAMOUS; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Ricqles A, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P411; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; HALL BK, 1993, BONE, V7; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; HOUDE P, 1987, AUK, V104, P125, DOI 10.2307/4087243; Huynen L, 2003, NATURE, V425, P175, DOI 10.1038/nature01838; Johnson CN, 2002, P ROY SOC B-BIOL SCI, V269, P2221, DOI 10.1098/rspb.2002.2130; KLOMP NI, 1992, IBIS, V134, P245, DOI 10.1111/j.1474-919X.1992.tb03806.x; Lydekker R., 1891, CATALOGUE FOSSIL BIR; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Worthy TH, 2002, LOST WORLD MOA	30	67	70	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					940	943		10.1038/nature03635	http://dx.doi.org/10.1038/nature03635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959513				2022-12-24	WOS:000229799700046
J	Bix, M; Kim, S; Rao, A				Bix, M; Kim, S; Rao, A			Opposites attract in differentiating T cells	SCIENCE			English	Editorial Material							LOCUS-CONTROL REGION; RANGE INTRACHROMOSOMAL INTERACTIONS; TH2 CYTOKINE LOCUS; ENHANCER; BET		Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; CBR Inst Biomed Res, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Bix, M (corresponding author), Univ Washington, Sch Med, Dept Immunol, 1959 NE Pacific St,HSC I6071, Seattle, WA 98195 USA.	arao@cbr.med.harvard.edu		Bix, Mark/0000-0003-4617-0497	NHLBI NIH HHS [P01 HL67664] Funding Source: Medline; NIAID NIH HHS [R01 AI44432, R01 AI48636] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432, R01AI048636] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; SPILIANAKIS CG, 2005, NATURE          0508; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5	16	5	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1563	1565		10.1126/science.1114167	http://dx.doi.org/10.1126/science.1114167			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947163				2022-12-24	WOS:000229827000030
J	Robison, BH; Reisenbichler, KR; Sherlock, RE				Robison, BH; Reisenbichler, KR; Sherlock, RE			Giant larvacean houses: Rapid carbon transport to the deep sea floor	SCIENCE			English	Article							PARTICULATE ORGANIC-MATTER; BENTHIC BOUNDARY-LAYER; EASTERN NORTH PACIFIC; ABYSSAL NE PACIFIC; MONTEREY-BAY; CENTRAL CALIFORNIA; OCEAN; FOOD; FLUX; DISCREPANCY	An unresolved issue in ocean science is the discrepancy between the food requirements of the animals living on the deep sea floor and their food supply, as measured by sediment traps. A 10-year time-series study of the water column off Monterey Bay, California, revealed that the discarded mucus feeding structures of giant larvaceans carry a substantial portion of the upper ocean's productivity to the deep seabed. These abundant, rapidly sinking, carbon-rich vectors are not detected by conventional,sampling methods and thus have not been included in calculations of vertical nutrient flux or in oceanic carbon budgets.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	Robison, BH (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	robr@mbari.org						AGASSIZ A, 1888, 3 CRUISES US COAST G, V1; ALLDREDGE AL, 1976, LIMNOL OCEANOGR, V21, P14, DOI 10.4319/lo.1976.21.1.0014; ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; ALLDREDGE AL, 1972, SCIENCE, V177, P885, DOI 10.1126/science.177.4052.885; Baldwin RJ, 1998, DEEP-SEA RES PT II, V45, P643, DOI 10.1016/S0967-0645(97)00097-0; BARHAM EG, 1979, SCIENCE, V205, P1129, DOI 10.1126/science.205.4411.1129; Beaulieu SE, 1998, DEEP-SEA RES PT II, V45, P781, DOI 10.1016/S0967-0645(98)00003-4; Berelson W., 2001, OCEANOGRAPHY, V14, P59, DOI DOI 10.5670/0CEAN0G.2001.07; BURD AB, 2002, EOS, V83, P573; Chavez FP, 2002, PROG OCEANOGR, V54, P205, DOI 10.1016/S0079-6611(02)00050-2; DAVOLL PJ, 1990, DEEP-SEA RES, V37, P285, DOI 10.1016/0198-0149(90)90128-I; DEIBEL D, 1986, MAR BIOL, V93, P429, DOI 10.1007/BF00401110; Druffel ERM, 1999, SCIENCE, V284, P1139, DOI 10.1126/science.284.5417.1139; FENAUX R, 1998, BIOL PELAGIC TUNICAT, pCH15; FRANCOIS R, 2001, OCEANOGRAPHY, V14, P65; GALT CP, 1979, FISH B-NOAA, V77, P514; HAMNER WM, 1992, DEEP-SEA RES, V39, P1299, DOI 10.1016/0198-0149(92)90070-A; Hopcroft RR, 1999, J PLANKTON RES, V21, P1923, DOI 10.1093/plankt/21.10.1923; Hunt James C., 1999, Plankton Biology and Ecology, V46, P75; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Pilskaln CH, 1996, J MAR RES, V54, P1149, DOI 10.1357/0022240963213772; Reimers CE, 1992, GLOBAL BIOGEOCHEM CY, V6, P199, DOI 10.1029/92GB00105; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; ROEMMICH D, 1995, SCIENCE, V268, P352, DOI 10.1126/science.268.5209.352-b; Silver MW, 1998, LIMNOL OCEANOGR, V43, P498, DOI 10.4319/lo.1998.43.3.0498; Smith KL, 1999, SCIENCE, V284, P1174, DOI 10.1126/science.284.5417.1174; Smith KL, 2002, DEEP-SEA RES PT I, V49, P971, DOI 10.1016/S0967-0637(02)00006-7; SMITH KL, 1994, LIMNOL OCEANOGR, V39, P1101, DOI 10.4319/lo.1994.39.5.1101; SMITH KL, 1987, LIMNOL OCEANOGR, V32, P201, DOI 10.4319/lo.1987.32.1.0201; Volkman JK, 2002, J OCEANOGR, V58, P265, DOI 10.1023/A:1015809708632	31	125	131	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1609	1611		10.1126/science.1109104	http://dx.doi.org/10.1126/science.1109104			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947183				2022-12-24	WOS:000229827000051
J	Krishnan, R; Lindquist, SL				Krishnan, R; Lindquist, SL			Structural insights into a yeast prion illuminate nucleation and strain diversity	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENETIC-VARIATION; NEURONAL ISOFORM; SPECIES BARRIER; PSI+ PRIONS; BETA-HELIX; SUP35 GENE; PROTEIN; INHERITANCE; FIBERS	Self-perpetuating changes in the conformations of amyloidogenic proteins play vital roles in normal biology and disease. Despite intense research, the architecture and conformational conversion of amyloids remain poorly understood. Amyloid conformers of Sup35 are the molecular embodiment of the yeast prion known as [ PSI], which produces heritable changes in phenotype through self-perpetuating changes in protein folding. Here we determine the nature of Sup35' s cooperatively folded amyloid core, and use this information to investigate central questions in prion biology. Specific segments of the amyloid core form intermolecular contacts in a 'Head-to-Head', 'Tail-to-Tail' fashion, but the 'Central Core' is sequestered through intramolecular contacts. The Head acquires productive interactions first, and these nucleate assembly. Variations in the length of the amyloid core and the nature of intermolecular interfaces form the structural basis of distinct prion 'strains', which produce variant phenotypes in vivo. These findings resolve several problems in yeast prion biology and have broad implications for other amyloids.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, SL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Lindquist_admin@wi.mit.edu	Krishnan, Rajaraman/R-4874-2019	Krishnan, Rajaraman/0000-0002-5189-4097	NIGMS NIH HHS [R01 GM025874, R37 GM025874] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025874, R01GM025874] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Bradley ME, 2004, MOL MICROBIOL, V51, P1649, DOI 10.1111/j.1365-2958.2003.03955.x; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Caughey B, 2000, NAT MED, V6, P751, DOI 10.1038/77476; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Garzon-Rodriguez W, 2000, J BIOL CHEM, V275, P22645, DOI 10.1074/jbc.M000756200; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101; Jensen MA, 2001, GENETICS, V159, P527; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kamen DE, 2000, BIOCHEMISTRY-US, V39, P15932, DOI 10.1021/bi001900v; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; KUSHNIROV VV, 1990, YEAST, V6, P461, DOI 10.1002/yea.320060603; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Scheibel T, 2004, P NATL ACAD SCI USA, V101, P2287, DOI 10.1073/pnas.0308754101; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499	51	402	409	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					765	772		10.1038/nature03679	http://dx.doi.org/10.1038/nature03679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944694	Green Accepted			2022-12-24	WOS:000229638700040
J	Reynolds, E				Reynolds, E			There is more to treatment of epilepsy than control of seizures	LANCET			English	Editorial Material									Kings Coll London, Inst Epileptol, Weston Educ Ctr, London SE5 9PJ, England	University of London; King's College London	Reynolds, E (corresponding author), Kings Coll London, Inst Epileptol, Weston Educ Ctr, London SE5 9PJ, England.	Reynolds@buckles.u-net.com							0	1	1	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1981	1981		10.1016/S0140-6736(05)66669-X	http://dx.doi.org/10.1016/S0140-6736(05)66669-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936429				2022-12-24	WOS:000229587800037
J	von Plessen, C; Aslaksen, A				von Plessen, C; Aslaksen, A			Improving the quality of palliative care for ambulatory patients with lung cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem Most patients with advanced lung cancer currently receive much of their health care, including chemotherapy, as outpatients. Patients have to deal with the complex and time consuming logistics of ambulatory cancer care. At the same time, members of staff often waste considerable time and energy in organisational aspects of care that could be better used in direct interaction with patients. Design Quality improvement study using direct observation and run and flow charts, and focus group meetings with patients and families regarding perceptions of the clinic and with staff regarding satisfaction with working conditions. Setting Thoracic oncology outpatient clinic at a Norwegian university hospital where patients receive chemotherapy and complementary palliative care. Key measures for improvement Waiting time and time wasted during consultations; calmer working situation at the clinic; satisfaction among patients. Strategies for change Rescheduled patients' appointments, automated retrieval of blood test results, systematic reporting in patients' files, design of an information leaflet, and refurnishing of the waiting area at the clinic. Effects of change Interventions resulted in increased satisfaction for patients and staff, reduced waiting time, and reduced variability of waiting time. Lessons learnt Direct observation, focus groups, questionnaires on patients' satisfaction, and measurement of process time were useful in systematically improving care in this outpatient clinic. The description of this experience can serve as an example for the improvement of a microsystem, particularly in other settings with similar problems.	Haukeland Univ Hosp, Dept Thorac Med, N-5021 Bergen, Norway; Haukeland Univ Hosp, Dept Radiol, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	von Plessen, C (corresponding author), Haukeland Univ Hosp, Dept Thorac Med, N-5021 Bergen, Norway.	christian.von.plessen@helse-bergen.no	von Plessen, Christian/AFZ-7617-2022	von Plessen, Christian/0000-0002-6134-6780				Batalden P B, 1997, Qual Manag Health Care, V5, P1; Benson RJ, 2001, CLIN ONCOL-UK, V13, P138; Chang VT, 2000, CANCER, V88, P2164, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5; KLEINER A, 1994, 5 DISCIPLINE FIELDBO, P479; Lock Karen K, 2002, Can J Nurs Res, V34, P83; Mitchell Geoff, 2002, Aust Fam Physician, V31, P129; Nelson EC, 1998, ANN INTERN MED, V128, P460, DOI 10.7326/0003-4819-128-6-199803150-00007; Nelson EC, 1996, JOINT COMM J QUAL IM, V22, P243, DOI 10.1016/S1070-3241(16)30228-0; Nelson Eugene C, 2002, Jt Comm J Qual Improv, V28, P472; Newell S, 1999, EUR J CANCER CARE, V8, P73; Zimber J, 2001, MMW Fortschr Med, V143, P22	11	17	17	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2005	330	7503					1309	1313		10.1136/bmj.330.7503.1309	http://dx.doi.org/10.1136/bmj.330.7503.1309			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15933354	Green Published			2022-12-24	WOS:000229655700025
J	Young, AER; Chambers, TL				Young, AER; Chambers, TL			Standards for care of critically ill children with burns	LANCET			English	Editorial Material									N Bristol NHS Trust, S W Paediat Burn Serv, Bristol BS16 1LE, Avon, England; N Bristol NHS Trust, Dept Paediat, Bristol BS16 1LE, Avon, England	North Bristol NHS Trust; North Bristol NHS Trust	Young, AER (corresponding author), N Bristol NHS Trust, S W Paediat Burn Serv, Bristol BS16 1LE, Avon, England.	Amber.Young@north-bristol.swest.nhs.uk	Young, Amber/H-2988-2018	Young, Amber/0000-0001-7205-492X				*DEP HLTH NHS EX H, 1997, PAED INT CAR FRAM FU; Frame JD, 2003, LANCET, V361, P980, DOI 10.1016/S0140-6736(03)12840-1; Kennedy I., 2001, CM5207; National Service framework for Children, 2004, YOUNG PEOPL MAT SERV; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; Radcliffe J, 1998, BRIT MED J, V316, P1547	6	1	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2005	365	9475					1911	1913		10.1016/S0140-6736(05)66639-1	http://dx.doi.org/10.1016/S0140-6736(05)66639-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936407				2022-12-24	WOS:000229587800008
J	Huber, GW; Chheda, JN; Barrett, CJ; Dumesic, JA				Huber, GW; Chheda, JN; Barrett, CJ; Dumesic, JA			Production of liquid alkanes by aqueous-phase processing of biomass-derived carbohydrates	SCIENCE			English	Article							ALDOL CONDENSATION; CATALYSTS; GLUCOSE; WATER; FUEL	Liquid alkanes with the number of carbon atoms ranging from C-7 to C-15 were selectively produced from biomass-derived carbohydrates by acid-catalyzed dehydration, which was followed by aldol condensation over solid base catalysts to form large organic compounds. These molecules were then converted into alkanes by dehydration/hydrogenation over bifunctional catalysts that contained acid and metal sites in a four-phase reactor, in which the aqueous organic reactant becomes more hydrophobic and a hexadecane alkane stream removes hydrophobic species from the catalyst before they go on further to form coke. These liquid alkanes are of the appropriate molecular weight to be used as transportation fuel components, and they contain 90% of the energy of the carbohydrate and H-2 feeds.	Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA.	dumesic@engr.wisc.edu	Huber, George/Y-2473-2019; Barrett, Christopher J/B-7474-2008; Huber, George/D-2569-2018	Huber, George/0000-0002-7838-6893; Barrett, Christopher J/0000-0001-6194-9066; 				CHEN NY, 1986, CHEMTECH, V16, P506; Choudary BM, 1999, J MOL CATAL A-CHEM, V142, P361, DOI 10.1016/S1381-1169(98)00301-X; Climent MJ, 2004, J CATAL, V225, P316, DOI 10.1016/j.jcat.2004.04.027; COLLINS P, 1995, MONOSACCHARIDES; ELLIOTT DC, 1991, ENERG FUEL, V5, P399, DOI 10.1021/ef00027a008; GUTSCHE CD, 1967, J AM CHEM SOC, V89, P1235, DOI 10.1021/ja00981a033; Huber GW, 2004, ANGEW CHEM INT EDIT, V43, P1549, DOI 10.1002/anie.200353050; Huber GW, 2003, SCIENCE, V300, P2075, DOI 10.1126/science.1085597; Katzen R, 2000, ADV BIOCHEM ENG BIOT, V70, P77; KATZEN R, 1981, FUELS BIOMASS WASTES, P393; Klass DL., 1998, BIOMASS RENEWABLE EN; Lewkowski J, 2001, ARKIVOC, P17, DOI 10.3998/ark.5550190.0002.102; LOURVANIJ K, 1993, IND ENG CHEM RES, V32, P11, DOI 10.1021/ie00013a002; Ma FR, 1999, BIORESOURCE TECHNOL, V70, P1, DOI 10.1016/S0960-8524(99)00025-5; Moreau C, 1998, IND CROP PROD, V7, P95, DOI 10.1016/S0926-6690(97)00037-X; Moreau C, 1996, APPL CATAL A-GEN, V145, P211, DOI 10.1016/0926-860X(96)00136-6; OWEN K, 1990, AUTOMOTIVE FUELS HDB; Rao KK, 1998, J CATAL, V173, P115, DOI 10.1006/jcat.1997.1878; Sasaki M, 2002, GREEN CHEM, V4, P285, DOI 10.1039/b203968k; Serra-Holm V, 2000, APPL CATAL A-GEN, V198, P207, DOI 10.1016/S0926-860X(99)00510-4; Shabaker JW, 2003, J CATAL, V215, P344, DOI 10.1016/S0021-9517(03)00032-0; Shapouri H., 2002, 814 USDA OFF CHIEF E; WEISS MA, 2003, PUBLICATION MIT LAB; WEISZ PB, 1979, SCIENCE, V206, P57, DOI 10.1126/science.206.4414.57; Zhang WC, 1998, J CHEM SOC PERK T 1, P3131, DOI 10.1039/a806553e	25	1320	1443	23	797	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1446	1450		10.1126/science.1111166	http://dx.doi.org/10.1126/science.1111166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933197	Green Published			2022-12-24	WOS:000229619300047
J	Sutherland, WJ				Sutherland, WJ			The best solution	NATURE			English	Editorial Material									Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Sutherland, WJ (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.		Sutherland, William/B-1291-2013	Sutherland, William/0000-0002-6498-0437				Alexander RM, 1996, OPTIMA ANIMALS; Lucas P., 2004, DENT FUNCTIONAL MORP; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP	3	39	39	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2005	435	7042					569	569		10.1038/435569a	http://dx.doi.org/10.1038/435569a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15931199				2022-12-24	WOS:000229476200025
J	Aldaz, H; Rice, LM; Stearns, T; Agard, DA				Aldaz, H; Rice, LM; Stearns, T; Agard, DA			Insights into microtubule nucleation from the crystal structure of human gamma-tubulin	NATURE			English	Article							ALPHA-BETA-TUBULIN	Microtubules are hollow polymers of alpha beta-tubulin that show GTP-dependent assembly dynamics and comprise a critical part of the eukaryotic cytoskeleton. Initiation of new microtubules in vivo requires gamma-tubulin, organized as an oligomer within the 2.2-MDa gamma-tubulin ring complex (gamma-TuRC) of higher eukaryotes(1-3). Structural insight is lacking regarding gamma-tubulin, its oligomerization and how it promotes microtubule assembly. Here we report the 2.7-angstrom crystal structure of human gamma-tubulin bound to GTP-gamma S ( a non-hydrolysable GTP analogue). We observe a 'curved' conformation for gamma-tubulin -GTP gamma S, similar to that seen for GDP-bound, unpolymerized alpha beta-tubulin(4). Tubulins are thought to represent a distinct class of GTP-binding proteins, and conformational switching in gamma-tubulin might differ from the nucleotide-dependent switching of signalling GTPases. A crystal packing interaction replicates the lateral contacts between alpha- and beta-tubulins in the microtubule(5), and this association probably forms the basis for gamma-tubulin oligomerization within the gamma-TuRC. Laterally associated gamma-tubulins in the gamma-TuRC might promote microtubule nucleation by providing a template that enhances the intrinsically weak lateral interaction between alpha beta-tubulin heterodimers. Because they are dimeric, alpha beta-tubulins cannot form microtubule-like lateral associations in the curved conformation(5). The lateral array of gamma-tubulins we observe in the crystal reveals a unique functional property of a monomeric tubulin.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94143 USA.	agard@msg.ucsf.edu		Stearns, Tim/0000-0002-0671-6582				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	15	139	140	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					523	527		10.1038/nature03586	http://dx.doi.org/10.1038/nature03586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917813				2022-12-24	WOS:000229337800060
J	Fauci, AS				Fauci, AS			Race against time	NATURE			English	Editorial Material							VACCINE; VIRUS		NIAID, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, US Dept HHS, 9000 Rockville Pike, Bethesda, MD 20892 USA.							Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; CLEMENTS ML, 1984, LANCET, V1, P705; Gensheimer KF, 2003, EMERG INFECT DIS, V9, P1645, DOI 10.3201/eid0912.030289; Kilbourne ED, 1999, NAT MED, V5, P1119, DOI 10.1038/13436; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3	6	38	39	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					423	424		10.1038/435423a	http://dx.doi.org/10.1038/435423a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917781	Green Published			2022-12-24	WOS:000229337800027
J	Ho, D				Ho, D			Is China prepared for microbial threats?	NATURE			English	Editorial Material									Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA	Rockefeller University	Ho, D (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.								0	7	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					421	422		10.1038/435421a	http://dx.doi.org/10.1038/435421a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917780	Green Published, Bronze			2022-12-24	WOS:000229337800026
J	Wolfe, JM; Horowitz, TS; Kenner, NM				Wolfe, JM; Horowitz, TS; Kenner, NM			Rare items often missed in visual searches	NATURE			English	Editorial Material									Brigham & Womens Hosp, Visual Attent Lab, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wolfe, JM (corresponding author), Brigham & Womens Hosp, Visual Attent Lab, Cambridge, MA 02139 USA.	wolfe@search.bwh.harvard.edu	Horowitz, Todd S/J-3376-2013; Wolfe, Jeremy M/A-9248-2016; Wolfe, Jeremy M/C-1621-2012	Wolfe, Jeremy M/0000-0002-6475-1984; Wolfe, Jeremy M/0000-0002-6475-1984; Horowitz, Todd/0000-0001-5571-6266	NEI NIH HHS [R01 EY017001] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY017001] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Chun MM, 1996, COGNITIVE PSYCHOL, V30, P39, DOI 10.1006/cogp.1996.0002; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; Gur D, 2003, ACAD RADIOL, V10, P1324, DOI 10.1016/S1076-6332(03)00466-5; Kundel HL, 2000, PROC SPIE, V3981, P135, DOI 10.1117/12.383100; Mackworth J, 1970, VIGILANCE ATTENTION; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Wickens C. D., 1993, WORKLOAD TRANSITION, P139; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016	8	328	332	4	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					439	440		10.1038/435439a	http://dx.doi.org/10.1038/435439a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917795	Green Accepted			2022-12-24	WOS:000229337800039
J	Okie, S				Okie, S			Traumatic brain injury in the war zone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189	2	551	580	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2005	352	20					2043	2047		10.1056/NEJMp058102	http://dx.doi.org/10.1056/NEJMp058102			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927GJ	15901856				2022-12-24	WOS:000229180100001
J	Stano, NM; Jeong, YJ; Donmez, I; Tummalapalli, P; Levin, MK; Patel, SS				Stano, NM; Jeong, YJ; Donmez, I; Tummalapalli, P; Levin, MK; Patel, SS			DNA synthesis provides the driving force to accelerate DNA unwinding by a helicase	NATURE			English	Article							SINGLE-STRANDED-DNA; REPLICATION FORK; BACTERIOPHAGE T7; BINDING PROTEIN; GENE-4 PROTEIN; POLYMERASE; PURIFICATION; MECHANISMS; DEFICIENT	Helicases are molecular motors that use the energy of nucleoside 5'-triphosphate (NTP) hydrolysis to translocate along a nucleic acid strand and catalyse reactions such as DNA unwinding. The ring-shaped helicase(1) of bacteriophage T7 translocates along single-stranded ( ss) DNA at a speed of 130 bases per second(2); however, T7 helicase slows down nearly tenfold when unwinding the strands of duplex DNA(3). Here, we report that T7 DNA polymerase, which is unable to catalyse strand displacement DNA synthesis by itself, can increase the unwinding rate to 114 base pairs per second, bringing the helicase up to similar speeds compared to its translocation along ssDNA. The helicase rate of stimulation depends upon the DNA synthesis rate and does not rely on specific interactions between T7 DNA polymerase and the carboxy-terminal residues of T7 helicase. Efficient duplex DNA synthesis is achieved only by the combined action of the helicase and polymerase. The strand displacement DNA synthesis by the DNA polymerase depends on the unwinding activity of the helicase, which provides ssDNA template. The rapid trapping of the ssDNA bases by the DNA synthesis activity of the polymerase in turn drives the helicase to move forward through duplex DNA at speeds similar to those observed along ssDNA.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; Kookmin Univ, Dept Bio & Nanochem, Seoul 136702, South Korea; Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Kookmin University; University of Connecticut	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	patelss@umdnj.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055310] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; CHA TA, 1989, J BIOL CHEM, V264, P12220; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2579, DOI 10.1073/pnas.90.7.2579; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KIM YT, 1992, J BIOL CHEM, V267, P15022; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Levin M.K., 2003, MOL MOTORS, P179; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MOK M, 1987, J BIOL CHEM, V262, P16644; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wang H, 2002, APPL PHYS A-MATER, V75, P315, DOI 10.1007/s003390201340	25	128	130	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					370	373		10.1038/nature03615	http://dx.doi.org/10.1038/nature03615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902262	Green Accepted			2022-12-24	WOS:000229185000050
J	Christiansen, SC; Cannegieter, SC; Koster, T; Vandenbroucke, JP; Rosendaal, FR				Christiansen, SC; Cannegieter, SC; Koster, T; Vandenbroucke, JP; Rosendaal, FR			Thrombophilia, clinical factors, and recurrent venous thrombotic events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEEP-VEIN THROMBOSIS; FACTOR-V-LEIDEN; ACTIVATED PROTEIN-C; PROTHROMBIN GENE; RISK-FACTOR; HETEROZYGOUS CARRIERS; PLASMA-LEVELS; 1ST EPISODE; FACTOR-VIII; THROMBOEMBOLISM	Context Data on the recurrence rate of venous thrombotic events and the effect of several risk factors, including thrombophilia, remain controversial. The potential benefit of screening for thrombophilia with respect to prophylactic strategies and duration of anticoagulant treatment is not yet known. Objectives To estimate the recurrence rate of thrombotic events in patients after a first thrombotic event and its determinants, including thrombophilic abnormalities. Design, Setting, and Patients Prospective follow-up study of 474 consecutive patients aged 18 to 70 years without a known malignancy treated for a first objectively confirmed thrombotic event at anticoagulation clinics in the Netherlands. The Leiden Thrombophilia Study (LETS) was conducted from 1988 through 1992 and patients were followed up through 2000. Main Outcome Measures Recurrent thrombotic event based on thrombophilic risk factors, sex, type of initial thrombotic event (idiopathic or provoked), oral contraceptive use, elevated levels of factors VIII, IX, XI, fibrinogen, homocysteine, and anticoagulant deficiencies. Results A total of 474 patients were followed up for mean (SD) of 7.3 (2.7) years and complete follow-up was achieved in 447 (94%). Recurrence of thrombotic events occurred in 90 patients during a total of 3477 patient-years. The rate of thrombotic event recurrence was 25.9 per 1000 patient-years (95% confidence interval [CI], 20.8-31.8 per 1000 patient-years). The incidence rate of recurrence was highest during the first 2 years (31.9 per 1000 patient-years; 95% Cl, 20.3-43.5 per 1000 patient-years). The risk of thrombotic event recurrence was 2.7 times (95% Cl, 1.8-4.2 times) higher in men than in women. Patients whose initial thrombotic event was idiopathic had a higher risk of a thrombotic event recurrence than patients whose initial event was provoked (hazard ratio [HR], 1.9; 95% Cl, 1.2-2.9). Women who used oral contraceptives during follow-up had a higher thrombotic event recurrence rate (28.0 per,1000 patient-years; 95% Cl, 15.9-49.4 per 1000 patient-years) than those who did not (12.9 per 1000 patient-years; 95% Cl, 7.9-21.2 per 1000 patient-years). Recurrence risks of a thrombotic event by laboratory abnormality ranged from an HR of 0.6 (95% Cl, 0.3-1.1) in patients with elevated levels of factor XI to an HR of 1.8 (95% Cl, 0.9-3.7) for patients with anticoagulant deficiencies. Conclusions Prothrombotic abnormalities do not appear to play an important role in the risk of a recurrent thrombotic event. Testing for prothrombotic defects has little consequence with respect to prophylactic strategies. Clinical factors are probably more important than laboratory abnormalities in determining the duration of anticoagulation therapy.	Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Hematol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, POB 9600, NL-2300 RC Leiden, Netherlands.	F.R.Rosendaal@lumc.nl	Christiansen, Sverre/AAD-5214-2020; Vandenbroucke, Jan/AAM-3928-2020; Cannegieter, Suzanne/W-3696-2019; Rosendaal, Frits/Q-3842-2017	Vandenbroucke, Jan/0000-0001-5668-6716; Cannegieter, Suzanne/0000-0003-4707-2303; Rosendaal, Frits/0000-0003-2558-7496; Christiansen, Sverre Christian/0000-0002-0378-0474				ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Baglin T, 2004, J THROMB HAEMOST, V2, P2152, DOI 10.1111/j.1538-7836.2004.01050.x; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; De Stefano V, 2001, BRIT J HAEMATOL, V113, P630, DOI 10.1046/j.1365-2141.2001.02827.x; DENHEIJER M, 1995, LANCET, V345, P882, DOI 10.1016/S0140-6736(95)90008-X; denHeijer M, 1996, NEW ENGL J MED, V334, P759, DOI 10.1056/NEJM199603213341203; Eichinger S, 1997, THROMB HAEMOSTASIS, V77, P624; Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14; Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566; Eichinger S, 2002, ARCH INTERN MED, V162, P2357, DOI 10.1001/archinte.162.20.2357; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; HULL RD, 1983, CIRCULATION, V67, P901, DOI 10.1161/01.CIR.67.4.901; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; KOSTER T, 1994, THROMB HAEMOSTASIS, V71, P719; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Lensing AWA, 1999, THROMB HAEMOSTASIS, V82, P1564; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Miles JS, 2001, J AM COLL CARDIOL, V37, P215, DOI 10.1016/S0735-1097(00)01080-9; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 2002, ANN INTERN MED, V137, P955, DOI 10.7326/0003-4819-137-12-200212170-00008; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; RIDKER PM, 1995, CIRCULATION, V92, P2800, DOI 10.1161/01.CIR.92.10.2800; Rintelen C, 1996, THROMB HAEMOSTASIS, V75, P229; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; Simioni P, 2003, J THROMB HAEMOST, V1, P16, DOI 10.1046/j.1538-7836.2003.00094.x; Simioni P, 2000, BLOOD, V96, P3329; vanderMeer FJM, 1997, THROMB HAEMOSTASIS, V78, P631; Vlieg AV, 2000, BLOOD, V95, P3678; Weltermann A, 2003, J THROMB HAEMOST, V1, P28, DOI 10.1046/j.1538-7836.2003.00038.x; DOCUMENT CLIN VALIDI	41	417	438	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2005	293	19					2352	2361		10.1001/jama.293.19.2352	http://dx.doi.org/10.1001/jama.293.19.2352			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926JX	15900005				2022-12-24	WOS:000229120600022
J	Matsumoto, S; Okitsu, T; Wanaga, Y; Noguchi, H; Nagata, H; Yonekawa, Y; Yamada, Y; Fukuda, K; Tsukiyama, K; Suzuki, H; Kawasaki, Y; Shimodaira, M; Matsuoka, K; Shibata, T; Kasai, Y; Maekawa, T; Shapiro, AMJ; Tanaka, K				Matsumoto, S; Okitsu, T; Wanaga, Y; Noguchi, H; Nagata, H; Yonekawa, Y; Yamada, Y; Fukuda, K; Tsukiyama, K; Suzuki, H; Kawasaki, Y; Shimodaira, M; Matsuoka, K; Shibata, T; Kasai, Y; Maekawa, T; Shapiro, AMJ; Tanaka, K			Insulin independence after living-donor distal pancreatectomy and islet allotransplantation	LANCET			English	Article							TRANSPLANTATION; PRESERVATION; PANCREAS	Rising demand for islet transplantation will lead to severe donor shortage in the near future, especially in countries where cadaveric organ donation is scarce. We undertook a successful transplantation of living-donor islets for unstable diabetes. The recipient was a 27-year-old woman who had had brittle, insulin-dependent diabetes mellitus for 12 years. The donor, who was a healthy 56-year-old woman and mother of the recipient, underwent a distal pancreatectomy. After isolation, 408 114 islet equivalents were transplanted immediately. The transplants functioned immediately and the recipient became insulin-independent 22 days after the operation. The donor had no complications and both women showed healthy glucose tolerance. Transplantation of living-donor islets from the distal pancreas can be sufficient to reverse brittle diabetes.	Kyoto Univ Hosp, Transplantat Unit, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Transplantat & Immunol, Kyoto, Japan; Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan; Kyoto Univ Hosp, Radiol & Nucl Med Serv, Kyoto 6068507, Japan; Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 6068507, Japan; Univ Alberta, Clin Islet TRansplant Programme, Edmonton, AB, Canada	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; University of Alberta	Matsumoto, S (corresponding author), Kyoto Univ Hosp, Transplantat Unit, Sakyo Ku, Kyoto 6068507, Japan.	shinichi@kuhp.kyoto-u.ac.jp	Yamada, Yuichiro/G-4766-2011	Noguchi, Hirofumi/0000-0002-0880-6805				GRUESSNER RWG, 2002, TRANSPLANT REV, V16, P108; Hathout E, 2003, ARCH DIS CHILD, V88, P591, DOI 10.1136/adc.88.7.591; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Matsumoto S, 2004, TRANSPLANTATION, V78, P839, DOI 10.1097/01.TP.0000130177.03326.D5; Matsumoto S, 2003, AM J TRANSPLANT, V3, P53, DOI 10.1034/j.1600-6143.2003.30110.x; Ryan EA, 2005, DIABETES CARE, V28, P343, DOI 10.2337/diacare.28.2.343; Sawada T, 2003, TRANSPLANTATION, V75, P1965, DOI 10.1097/01.TP.0000068871.09469.E0; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SUTHERLAND D E R, 1980, Diabetes, V29, P31	9	167	178	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1642	1644		10.1016/S0140-6736(05)66383-0	http://dx.doi.org/10.1016/S0140-6736(05)66383-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15889479				2022-12-24	WOS:000228933700029
J	Eichinger, L; Pachebat, JA; Glockner, G; Rajandream, MA; Sucgang, R; Berriman, M; Song, J; Olsen, R; Szafranski, K; Xu, Q; Tunggal, B; Kummerfeld, S; Madera, M; Konfortov, BA; Rivero, F; Bankier, AT; Lehmann, R; Hamlin, N; Davies, R; Gaudet, P; Fey, P; Pilcher, K; Chen, G; Saunders, D; Sodergren, E; Davis, P; Kerhornou, A; Nie, X; Hall, N; Anjard, C; Hemphill, L; Bason, N; Farbrother, P; Desany, B; Just, E; Morio, T; Rost, R; Churcher, C; Cooper, J; Haydock, S; van Driessche, N; Cronin, A; Goodhead, I; Muzny, D; Mourier, T; Pain, A; Lu, M; Harper, D; Lindsay, R; Hauser, H; James, K; Quiles, M; Babu, MM; Saito, T; Buchrieser, C; Wardroper, A; Felder, M; Thangavelu, M; Johnson, D; Knights, A; Loulseged, H; Mungall, K; Oliver, K; Price, C; Quail, MA; Urushihara, H; Hernandez, J; Rabbinowitsch, E; Steffen, D; Sanders, M; Ma, J; Kohara, Y; Sharp, S; Simmonds, M; Spiegler, S; Tivey, A; Sugano, S; White, B; Walker, D; Woodward, J; Winckler, T; Tanaka, Y; Shaulsky, G; Schleicher, M; Weinstock, G; Rosenthal, A; Cox, EC; Chisholm, RL; Gibbs, R; Loomis, WF; Platzer, M; Kay, RR; Williams, J; Dear, PH; Noegel, AA; Barrell, B; Kuspa, A				Eichinger, L; Pachebat, JA; Glockner, G; Rajandream, MA; Sucgang, R; Berriman, M; Song, J; Olsen, R; Szafranski, K; Xu, Q; Tunggal, B; Kummerfeld, S; Madera, M; Konfortov, BA; Rivero, F; Bankier, AT; Lehmann, R; Hamlin, N; Davies, R; Gaudet, P; Fey, P; Pilcher, K; Chen, G; Saunders, D; Sodergren, E; Davis, P; Kerhornou, A; Nie, X; Hall, N; Anjard, C; Hemphill, L; Bason, N; Farbrother, P; Desany, B; Just, E; Morio, T; Rost, R; Churcher, C; Cooper, J; Haydock, S; van Driessche, N; Cronin, A; Goodhead, I; Muzny, D; Mourier, T; Pain, A; Lu, M; Harper, D; Lindsay, R; Hauser, H; James, K; Quiles, M; Babu, MM; Saito, T; Buchrieser, C; Wardroper, A; Felder, M; Thangavelu, M; Johnson, D; Knights, A; Loulseged, H; Mungall, K; Oliver, K; Price, C; Quail, MA; Urushihara, H; Hernandez, J; Rabbinowitsch, E; Steffen, D; Sanders, M; Ma, J; Kohara, Y; Sharp, S; Simmonds, M; Spiegler, S; Tivey, A; Sugano, S; White, B; Walker, D; Woodward, J; Winckler, T; Tanaka, Y; Shaulsky, G; Schleicher, M; Weinstock, G; Rosenthal, A; Cox, EC; Chisholm, RL; Gibbs, R; Loomis, WF; Platzer, M; Kay, RR; Williams, J; Dear, PH; Noegel, AA; Barrell, B; Kuspa, A			The genome of the social amoeba Dictyostelium discoideum	NATURE			English	Article							HORIZONTAL GENE-TRANSFER; SIGNAL-TRANSDUCTION; ABC TRANSPORTERS; CELL-ADHESION; PROTEIN; DIFFERENTIATION; EVOLUTION; SEQUENCE; EXPRESSION; CELLULOSE	The social amoebae are exceptional in their ability to alternate between unicellular and multicellular forms. Here we describe the genome of the best-studied member of this group, Dictyostelium discoideum. The gene-dense chromosomes of this organism encode approximately 12,500 predicted proteins, a high proportion of which have long, repetitive amino acid tracts. There are many genes for polyketide synthases and ABC transporters, suggesting an extensive secondary metabolism for producing and exporting small molecules. The genome is rich in complex repeats, one class of which is clustered and may serve as centromeres. Partial copies of the extrachromosomal ribosomal DNA ( rDNA) element are found at the ends of each chromosome, suggesting a novel telomere structure and the use of a common mechanism to maintain both the rDNA and chromosomal termini. A proteome-based phylogeny shows that the amoebozoa diverged from the animal - fungal lineage after the plant - animal split, but Dictyostelium seems to have retained more of the diversity of the ancestral genome than have plants, animals or fungi.	MRC Ctr, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cologne, Ctr Biochem, D-50931 Cologne, Germany; Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; Inst Mol Biotechnol, D-07745 Jena, Germany; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Northwestern Univ, Ctr Med Genet, DictyBase, Chicago, IL 60611 USA; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Munich, Adolf Butenandt Inst Cell Biol, D-80336 Munich, Germany; Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Inst Pasteur, Unite Genom Microorganismes Pathogenes, F-75724 Paris, France; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 2XZ, England; Natl Inst Genet, Ctr Genet Resource Informat, Shizuoka 4118540, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan; Goethe Univ Frankfurt, Biozentrum, Inst Pharmazeut Biol, D-60439 Frankfurt, Germany; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	MRC Laboratory Molecular Biology; University of Cologne; University of Cologne; Wellcome Trust Sanger Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Diego; Northwestern University; University of Tsukuba; University of Munich; University of Cambridge; Hokkaido University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of York - UK; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; Goethe University Frankfurt; Princeton University; University of Dundee	Dear, PH (corresponding author), MRC Ctr, Mol Biol Lab, Cambridge CB2 2QH, England.	phd@mrc-lmb.cam.ac.uk	Quail, michael/ABE-6131-2020; Hall, Neil/A-8717-2013; Eichinger, Ludwig/AAJ-8895-2021; Goodhead, Ian/ABC-9200-2020; Lu, Mingyang/F-6865-2013; Mohan, Babu P./I-7362-2019; Dear, Paul H/A-1162-2012; Weinstock, George M/C-6314-2013; Mourier, Tobias/C-1164-2015; Fey, Petra/O-5977-2015; Glöckner, Gernot/A-7800-2010; Driemeier, David/H-3461-2012; Rivero, Francisco/N-2969-2013; Puigbò, Pere/A-2214-2008; Chisholm, Rex L/B-3418-2009; Pain, Arnab/L-5766-2015; Anjard, Christophe/H-5012-2017	Hall, Neil/0000-0002-7995-3810; Eichinger, Ludwig/0000-0003-1594-6117; Weinstock, George M/0000-0002-2997-4592; Mourier, Tobias/0000-0003-2727-1903; Fey, Petra/0000-0002-4532-2703; Glöckner, Gernot/0000-0002-9061-1061; Driemeier, David/0000-0003-3766-0654; Rivero, Francisco/0000-0001-5435-6991; Chisholm, Rex L/0000-0002-5638-3990; Pain, Arnab/0000-0002-1755-2819; Buchrieser, Carmen/0000-0003-3477-9190; Pachebat, Justin/0000-0003-3369-3205; Davis, Paul/0000-0001-5545-0824; Kerr, Alan/0000-0001-9093-0348; MORIO, Takahiro/0000-0002-4007-881X; Hall, Neil/0000-0003-2808-0009; Harper, David/0000-0002-8313-3516; Kuspa, Adam/0000-0002-9156-149X; Rost, Rene/0000-0002-5393-0370; Kummerfeld, Sarah/0000-0002-0089-2358; Anjard, Christophe/0000-0002-6905-1493; Shaulsky, Gad/0000-0002-0532-0551; Kerhornou, Arnaud/0000-0002-2890-295X; Kay, Robert R/0000-0001-9836-7967; Goodhead, Ian/0000-0002-3110-9442	Medical Research Council [MC_U105115237] Funding Source: Medline; NICHD NIH HHS [R01 HD035925] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035925] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrade AC, 2000, MOL GEN GENET, V263, P966, DOI 10.1007/PL00008697; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Anjard C, 1998, DEV BIOL, V193, P146, DOI 10.1006/dbio.1997.8804; Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Blanton RL, 2000, P NATL ACAD SCI USA, V97, P2391, DOI 10.1073/pnas.040565697; Blumberg DD, 2002, J MUSCLE RES CELL M, V23, P817, DOI 10.1023/A:1024440014857; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; BURGER G, 1995, J MOL BIOL, V245, P522, DOI 10.1006/jmbi.1994.0043; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; CAPPELLO J, 1984, MOL CELL BIOL, V4, P2207, DOI 10.1128/MCB.4.10.2207; CAPPELLO J, 1985, CELL, V43, P105, DOI 10.1016/0092-8674(85)90016-9; Chibalina Margarita V., 2004, BMC Developmental Biology, V4, P1; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; COX EC, 1990, P NATL ACAD SCI USA, V87, P8247, DOI 10.1073/pnas.87.21.8247; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; DEAR PH, 1993, NUCLEIC ACIDS RES, V21, P13, DOI 10.1093/nar/21.1.13; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; DYNES JL, 1994, GENE DEV, V8, P948, DOI 10.1101/gad.8.8.948; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; FREEZE H, 1978, BIOCHIM BIOPHYS ACTA, V539, P529, DOI 10.1016/0304-4165(78)90086-7; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GINSBURG GT, 1995, J EUKARYOT MICROBIOL, V42, P200, DOI 10.1111/j.1550-7408.1995.tb01565.x; Glockner G, 2002, NATURE, V418, P79, DOI 10.1038/nature00847; Glockner G, 2001, GENOME RES, V11, P585, DOI 10.1101/gr.GR-1622RR; Good JR, 2003, DEVELOPMENT, V130, P2953, DOI 10.1242/dev.00523; Good JR, 2000, DEV BIOL, V220, P53, DOI 10.1006/dbio.2000.9611; Goodwin TJD, 2000, GENOME RES, V10, P174, DOI 10.1101/gr.10.2.174; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Iranfar N, 2001, MOL BIOL CELL, V12, P2590, DOI 10.1091/mbc.12.9.2590; Iyer LM, 2004, TRENDS GENET, V20, P292, DOI 10.1016/j.tig.2004.05.007; Jain R, 2002, THEOR POPUL BIOL, V61, P489, DOI 10.1006/tpbi.2002.1596; Katoh M, 2004, P NATL ACAD SCI USA, V101, P7005, DOI 10.1073/pnas.0306983101; Kawata T, 1997, CELL, V89, P909, DOI 10.1016/S0092-8674(00)80276-7; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kessin RH, 1996, P NATL ACAD SCI USA, V93, P4857, DOI 10.1073/pnas.93.10.4857; KESSIN RH, 2001, DICTYOSTELIUM EVOLUT, V14, P294; Kibler K, 2003, DEV BIOL, V264, P506, DOI 10.1016/j.ydbio.2003.08.025; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; Konfortov BA, 2000, GENOME RES, V10, P1737, DOI 10.1101/gr.141700; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; KUSPA A, 1992, GENOMICS, V13, P49, DOI 10.1016/0888-7543(92)90201-3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loomis WF, 1995, EXPERIENTIA, V51, P1110, DOI 10.1007/BF01944728; LOOMIS WF, 1995, GENETICS, V141, P147; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Maeda M, 2003, EUKARYOT CELL, V2, P627, DOI 10.1128/EC.2.3.627-637.2003; McClintock B, 1938, GENETICS, V23, P315; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; MORRISON A, 1994, DEV BIOL, V163, P457, DOI 10.1006/dbio.1994.1162; MULLER K, 1978, NATURE, V274, P445, DOI 10.1038/274445a0; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Nara T, 2000, GENE, V257, P209, DOI 10.1016/S0378-1119(00)00411-X; Noegel AA, 2000, J CELL SCI, V113, P759; Ogawa S, 2000, MOL GEN GENET, V263, P514, DOI 10.1007/PL00008685; OLSEN R, IN PRESS J MOL EVOL; Raisley B, 2004, DEV BIOL, V265, P433, DOI 10.1016/j.ydbio.2003.09.035; Raper K. B., 1984, DICTYOSTELIDS; Raper KB, 1935, J AGRIC RES, V50, P0135; RAPER KENNETH B., 1940, JOUR ELISHA MITCHELL SCI SOC, V56, P241; Richards TA, 2003, PROTIST, V154, P17, DOI 10.1078/143446103764928468; Rivero F, 2002, J MUSCLE RES CELL M, V23, P737, DOI 10.1023/A:1024423611223; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schoonbeek HJ, 2002, MOL PLANT MICROBE IN, V15, P1165, DOI 10.1094/MPMI.2002.15.11.1165; SHAULSKY G, 1995, GENE DEV, V9, P1111, DOI 10.1101/gad.9.9.1111; Skriwan C, 2002, INT J MED MICROBIOL, V291, P615, DOI 10.1078/1438-4221-00177; SMITH SS, 1991, BIOCHEM J, V277, P273, DOI 10.1042/bj2770273; Soler-Lopez M, 2004, MOL CELL, V13, P791, DOI 10.1016/S1097-2765(04)00130-3; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; Sucgang R, 2003, NUCLEIC ACIDS RES, V31, P2361, DOI 10.1093/nar/gkg348; Su┬ll D., 1995, TRNA STRUCTURE BIOSY; Szafranski K, 2004, MOL GENET GENOMICS, V271, P98, DOI 10.1007/s00438-003-0961-9; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thomason P, 2000, J CELL SCI, V113, P3141; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; Trusov YA, 1996, NUCLEIC ACIDS RES, V24, P995, DOI 10.1093/nar/24.6.995; Urushihara H, 2004, NUCLEIC ACIDS RES, V32, P1647, DOI 10.1093/nar/gkh262; Van Driessche N, 2002, DEVELOPMENT, V129, P1543; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881; Wang YZ, 2001, EUR J BIOCHEM, V268, P4334, DOI 10.1046/j.1432-1327.2001.02354.x; West CM, 2002, EUKARYOT CELL, V1, P281, DOI 10.1128/EC.1.2.281-292.2002; Xu QK, 2004, EUKARYOT CELL, V3, P1101, DOI 10.1128/EC.3.5.1101-1110.2004; Zhang HY, 2003, BIOINFORMATICS, V19, P1391, DOI 10.1093/bioinformatics/btg168; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zhang P, 2001, DIFFERENTIATION, V67, P72, DOI 10.1046/j.1432-0436.2001.067003072.x; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	98	967	5106	7	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					43	57		10.1038/nature03481	http://dx.doi.org/10.1038/nature03481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875012	Green Accepted, Bronze			2022-12-24	WOS:000228864600034
J	Adams, PC; Reboussin, DM; Barton, JC; McLaren, CE; Eckfeldt, JH; McLaren, GD; Dawkins, FW; Acton, RT; Harris, EL; Gordeuk, VR; Leiendecker-Foster, C; Speechley, M; Snively, BM; Holup, JL; Thomson, E; Sholinsky, P; Acton, RT; Barton, JC; Dixon, D; Rivers, CA; Tucker, D; Ware, JC; McLaren, CE; McLaren, GD; Anton-Culver, H; Baca, JA; Bent, TC; Brunner, LC; Dao, MM; Jorgensen, KS; Kuniyoshi, J; Le, HD; Masatsugu, MK; Meyskens, FL; Morohashi, D; Nguyen, HP; Panagon, SN; Phung, C; Raymundo, V; Ton, T; Walker, AP; Wenzel, LB; Ziogas, A; Adams, PC; Bloch, E; Chakrabarti, S; Fleischhauer, A; Harrison, H; Jia, K; Larson, S; Lin, E; Lopez, M; Nguyen, L; Pepper, C; Power, T; Speechley, M; Sun, D; Woelfle, D; Jordan, J; Hogan, B; Moses, G; Harris, EL; Aickin, M; Baker, E; Erwin, M; Holup, J; Lloyd, C; Press, N; Press, RD; Reiss, J; Ritenbaugh, C; Uchida, A; Vogt, T; Yim, D; Gordeuk, VR; Dawkins, FW; Fadojutimi-Akinsiku, M; Castro, O; White-Coleman, D; Gerald, M; Harrison, BW; Lewis-Jack, O; Murray, RF; McDonald-Pinkett, S; Romagoza, J; Williams, R; Eckfeldt, JH; Leiendecker-Foster, C; McGlennen, RC; Rynders, G; Tsai, MY; Reboussin, DM; Snively, BM; Anderson, R; Bostic, E; Craven, BL; Ellis, S; Furberg, C; Griffin, J; Hall, M; Harris, D; Henkin, L; Jackson, S; Jewett, T; King, MD; Lohman, K; Lovato, L; Michaleckyj, J; Palla, S; Parks, T; Passmore, L; Phatak, PD; Rich, S; Ruggiero, A; Vitolins, M; Wolgast, G; Zaccaro, D; Sholinsky, P; Bookman, E; Chang, H; Fabsitz, R; Jaquish, C; Manolio, T; O'Neill, L; Thomson, E				Adams, PC; Reboussin, DM; Barton, JC; McLaren, CE; Eckfeldt, JH; McLaren, GD; Dawkins, FW; Acton, RT; Harris, EL; Gordeuk, VR; Leiendecker-Foster, C; Speechley, M; Snively, BM; Holup, JL; Thomson, E; Sholinsky, P; Acton, RT; Barton, JC; Dixon, D; Rivers, CA; Tucker, D; Ware, JC; McLaren, CE; McLaren, GD; Anton-Culver, H; Baca, JA; Bent, TC; Brunner, LC; Dao, MM; Jorgensen, KS; Kuniyoshi, J; Le, HD; Masatsugu, MK; Meyskens, FL; Morohashi, D; Nguyen, HP; Panagon, SN; Phung, C; Raymundo, V; Ton, T; Walker, AP; Wenzel, LB; Ziogas, A; Adams, PC; Bloch, E; Chakrabarti, S; Fleischhauer, A; Harrison, H; Jia, K; Larson, S; Lin, E; Lopez, M; Nguyen, L; Pepper, C; Power, T; Speechley, M; Sun, D; Woelfle, D; Jordan, J; Hogan, B; Moses, G; Harris, EL; Aickin, M; Baker, E; Erwin, M; Holup, J; Lloyd, C; Press, N; Press, RD; Reiss, J; Ritenbaugh, C; Uchida, A; Vogt, T; Yim, D; Gordeuk, VR; Dawkins, FW; Fadojutimi-Akinsiku, M; Castro, O; White-Coleman, D; Gerald, M; Harrison, BW; Lewis-Jack, O; Murray, RF; McDonald-Pinkett, S; Romagoza, J; Williams, R; Eckfeldt, JH; Leiendecker-Foster, C; McGlennen, RC; Rynders, G; Tsai, MY; Reboussin, DM; Snively, BM; Anderson, R; Bostic, E; Craven, BL; Ellis, S; Furberg, C; Griffin, J; Hall, M; Harris, D; Henkin, L; Jackson, S; Jewett, T; King, MD; Lohman, K; Lovato, L; Michaleckyj, J; Palla, S; Parks, T; Passmore, L; Phatak, PD; Rich, S; Ruggiero, A; Vitolins, M; Wolgast, G; Zaccaro, D; Sholinsky, P; Bookman, E; Chang, H; Fabsitz, R; Jaquish, C; Manolio, T; O'Neill, L; Thomson, E		HEIRS Study Res Investigators	Hemochromatosis and iron-overload screening in a racially diverse population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEREDITARY HEMOCHROMATOSIS; AFRICAN-AMERICANS; GENE HFE; PREVALENCE; MUTATION; HEPATITIS; FIBROSIS; ORIGIN	BACKGROUND: Iron overload and hemochromatosis are common, treatable conditions. HFE genotypes, levels of serum ferritin, transferrin saturation values, and self-reported medical history were studied in a multiethnic primary care population. METHODS: Participants were recruited from primary care practices and blood-drawing laboratories. Blood samples were tested for transferrin saturation, serum ferritin, and C282Y and H63D mutations of the HFE gene. Before genetic screening, participants were asked whether they had a history of medical conditions related to iron overload. RESULTS: Of the 99,711 participants, 299 were homozygous for the C282Y mutation. The estimated prevalence of C282Y homozygotes was higher in non-Hispanic whites (0.44 percent) than in Native Americans (0.11 percent), Hispanics (0.027 percent), blacks (0.014 percent), Pacific Islanders (0.012 percent), or Asians (0.000039 percent). Among participants who were homozygous for the C282Y mutation but in whom iron overload had not been diagnosed (227 participants), serum ferritin levels were greater than 300 microg per liter in 78 of 89 men (88 percent) and greater than 200 microg per liter in 79 of 138 women (57 percent). Pacific Islanders and Asians had the highest geometric mean levels of serum ferritin and mean transferrin saturation despite having the lowest prevalence of C282Y homozygotes. There were 364 participants in whom iron overload had not been diagnosed (29 C282Y homozygotes) who had a serum ferritin level greater than 1000 microg per liter. Among men, C282Y homozygotes and compound heterozygotes were more likely to report a history of liver disease than were participants without HFE mutations. CONCLUSIONS: The C282Y mutation is most common in whites, and most C282Y homozygotes have elevations in serum ferritin levels and transferrin saturation. The C282Y mutation does not account for high mean serum ferritin levels and transferrin saturation values in nonwhites.	London Hlth Sci Ctr, Dept Med, London, ON N6A 5A5, Canada; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27103 USA; So Iron Disorders Ctr, Birmingham, AL USA; Univ Calif Irvine, Dept Med, Div Hematol & Oncol, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92717 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN USA; Vet Affairs Long Beach Healthcare Syst, Long Beach, CA USA; Howard Univ, Dept Med, Washington, DC 20059 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR USA; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; Kaiser Permanente Ctr Hlth Res, Honolulu, HI USA; NHGRI, Bethesda, MD 20892 USA; NHLBI, Epidemiol & Biometry Program, Bethesda, MD 20892 USA	London Health Sciences Centre; Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Howard University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Kaiser Permanente; Western University (University of Western Ontario); Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Adams, PC (corresponding author), London Hlth Sci Ctr, Dept Med, 339 Windermere Rd, London, ON N6A 5A5, Canada.	padams@uwo.ca	Adams, Paul/G-2868-2011; Ellis, Shellie/GXG-6869-2022; Gordeuk, Victor/AAG-6577-2019; Ellis, Shellie/I-4811-2015	Ellis, Shellie/0000-0002-3599-0804; Adams, Paul/0000-0002-9921-2956; Barton, James/0000-0003-2876-8276	NCRR NIH HHS [M01-RR00032, M01-RR10284, M01-RR00827] Funding Source: Medline; NHLBI NIH HHS [N01-HC-05190, N01-HC-05189, N01-HC-05188, UH1-HL03679-05, N01-HC-05186, N01-HC-05192, N01-HC-05185, N01-HC-05191] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005189, N01HC005186, N01HC005192, N01HC005190, N01HC005185, N01HC005191, N01HC005188] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827, M01RR000032, M01RR010284] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH1HL003679] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams PC, 1996, HEPATOLOGY, V23, P724, DOI 10.1002/hep.510230411; Adams PC, 1997, HEPATOLOGY, V25, P162, DOI 10.1002/hep.510250130; Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182/blood-2003-10-3564; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Asberg A, 2001, SCAND J GASTROENTERO, V36, P1108; Bacon BR, 1999, ANN INTERN MED, V130, P953, DOI 10.7326/0003-4819-130-12-199906150-00002; Bacon BR, 2001, GASTROENTEROLOGY, V120, P718, DOI 10.1053/gast.2001.21913; Barton JC, 2003, BLOOD CELL MOL DIS, V31, P310, DOI 10.1016/S1079-9796(03)00166-9; Beaton M, 2002, HEPATOLOGY, V36, P673, DOI 10.1053/jhep.2002.35343; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Cox D. R., 1974, THEORETICAL STAT; DIBISCEGLIE AM, 1992, GASTROENTEROLOGY, V102, P2108, DOI 10.1016/0016-5085(92)90339-Z; EASON RJ, 1990, AUST NZ J MED, V20, P226, DOI 10.1111/j.1445-5994.1990.tb01024.x; GORDEUK VR, 1986, LANCET, V1, P1310; Gordeuk VR, 2003, BLOOD CELL MOL DIS, V31, P299, DOI 10.1016/S1079-9796(03)00164-5; Ioannou GN, 2004, GASTROENTEROLOGY, V126, P1293, DOI 10.1053/j.gastro.2004.01.020; Kng C, 2001, J CLIN GASTROENTEROL, V33, P69, DOI 10.1097/00004836-200107000-00017; Lucotte G, 2003, BLOOD CELL MOL DIS, V31, P262, DOI 10.1016/S1079-9796(03)00133-5; McLaren CE, 2003, AM J MED SCI, V325, P53, DOI 10.1097/00000441-200302000-00001; Merryweather-Clarke AT, 2000, GENET TEST, V4, P183, DOI 10.1089/10906570050114902; Morrison ED, 2003, ANN INTERN MED, V139, P235, DOI 10.7326/0003-4819-139-3-200308050-00022; Morrison ED, 2003, ANN INTERN MED, V138, P627, DOI 10.7326/0003-4819-138-8-200304150-00008; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; OLIVER M, 1995, DIGEST DIS SCI, V40, P1589, DOI 10.1007/BF02285215; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Olynyk JK, 2004, MAYO CLIN PROC, V79, P309, DOI 10.4065/79.3.309; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Riggio O, 1997, AM J GASTROENTEROL, V92, P1298; Rochette J, 1999, AM J HUM GENET, V64, P1056, DOI 10.1086/302318; Steinberg KK, 2001, JAMA-J AM MED ASSOC, V285, P2216, DOI 10.1001/jama.285.17.2216; Tung BY, 2003, GASTROENTEROLOGY, V124, P318, DOI 10.1053/gast.2003.50046; Weir B., 1996, GENETIC DATA ANAL; Yamashita C, 2003, CLIN GASTROENTEROL H, V1, P388, DOI 10.1053/S1542-3565(03)00187-3	33	518	537	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1769	1778		10.1056/NEJMoa041534	http://dx.doi.org/10.1056/NEJMoa041534			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858186	Green Published			2022-12-24	WOS:000228689000007
J	Singh, DK; Kumar, D; Siddiqui, Z; Basu, SK; Kumar, V; Rao, KVS				Singh, DK; Kumar, D; Siddiqui, Z; Basu, SK; Kumar, V; Rao, KVS			The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CELL ANTIGEN RECEPTOR; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; B-LYMPHOCYTES; NADPH OXIDASE; IN-VIVO; ACTIVATION; KINASE; IDENTIFICATION	Activation of cell-surface receptors stimulates generation of intracellular signals that, in turn, direct the cellular response. However, mechanisms that ensure combinatorial control of these signaling events are not well understood. We show here that the Ca2+ and reactive oxygen intermediates generated upon BCR activation rapidly engage in a cooperative interaction that acts in a feedback manner to amplify the early signal generated. This cooperativity acts by regulating the concentration of the oxidant produced. The latter exerts its influence through a pulsed inactivation of receptor-coupled phosphatases, where the amplitude of this pulse is determined by oxidant concentration. The extent of phosphatase inhibition, in turn, dictates what proportion of receptor-proximal kinases are activated and, as a result, the net strength of the initial signal. It is the strength of this initial signal that finally determines the eventual duration of BCR signaling and the rate of its transmission through downstream pathways.	Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Rao, KVS (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	kanury@icgeb.res.in	Singh, Dinesh/S-3636-2019; Kumar, Vikas/D-3406-2009; Singh, Dinesh/A-1045-2009	Singh, Dinesh/0000-0002-3594-2431; Singh, Dinesh/0000-0002-3594-2431				Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315, DOI 10.1128/MCB.12.5.2315; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fuentes-Panana EM, 2004, IMMUNOL REV, V197, P26, DOI 10.1111/j.0105-2896.2004.0105.x; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hua CT, 1998, J BIOL CHEM, V273, P28332, DOI 10.1074/jbc.273.43.28332; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Kubohara Y, 1999, BIOCHEM BIOPH RES CO, V263, P790, DOI 10.1006/bbrc.1999.1468; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; NAKAMURA Y, 1991, BIOCHEMISTRY-US, V30, P4880, DOI 10.1021/bi00234a007; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 1999, CELL, V97, P675, DOI 10.1016/S0092-8674(00)80779-5; Qin SF, 2000, P NATL ACAD SCI USA, V97, P7118, DOI 10.1073/pnas.130198197; Reth M, 2004, NAT REV IMMUNOL, V4, P269, DOI 10.1038/nri1335; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Saito K, 2003, IMMUNITY, V19, P669, DOI 10.1016/S1074-7613(03)00297-8; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yadava N, 1997, MOL BIOCHEM PARASIT, V84, P69, DOI 10.1016/S0166-6851(96)02782-X; Yoshida K, 2001, MOL PHARMACOL, V60, P1431, DOI 10.1124/mol.60.6.1431; Zhang S, 1998, ACM SIGPLAN NOTICES, V33, P11, DOI 10.1145/277633.277635	38	166	171	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					281	293		10.1016/j.cell.2005.02.036	http://dx.doi.org/10.1016/j.cell.2005.02.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851034	Bronze			2022-12-24	WOS:000228705000015
J	Pagani, M; Zachos, JC; Freeman, KH; Tipple, B; Bohaty, S				Pagani, M; Zachos, JC; Freeman, KH; Tipple, B; Bohaty, S			Marked decline in atmospheric carbon dioxide concentrations during the Paleogene	SCIENCE			English	Article							DRILLING PROJECT LEG-71; ISOTOPE FRACTIONATION; C-4 PHOTOSYNTHESIS; SOUTHWEST ATLANTIC; EMILIANIA-HUXLEYI; FALKLAND PLATEAU; MIDDLE EOCENE; CO2; EVOLUTION; OCEAN	The relation between the partial pressure of atmospheric carbon dioxide (pCO(2)) and Paleogene climate is poorly resolved. We used stable carbon isotopic values of di-unsaturated alkenones extracted from deep sea cores to reconstruct pCO(2) from the middle Eocene to the late Oligocene (similar to 45 to 25 million years ago). Our results demonstrate that pCO(2) ranged between 1000 to 1500 parts per million by volume in the middle to late Eocene, then decreased in several steps during the Oligocene, and reached modem levels by the latest Oligocene. The fall in pCO(2) likely allowed for a critical expansion of ice sheets on Antarctica and promoted conditions that forced the onset of terrestrial C-4 photosynthesis.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Yale University; University of California System; University of California Santa Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pagani, M (corresponding author), Yale Univ, Dept Geol & Geophys, 210 Whitney Ave, New Haven, CT 06511 USA.		Zachos, James C/A-7674-2008; Freeman, Katherine H/H-5140-2011; Pagani, Mark/B-3233-2008	Zachos, James C/0000-0001-8439-1886; Freeman, Katherine H/0000-0002-3350-7671; 				BACKMAN J, 1986, PALAEOGEOGR PALAEOCL, V57, P103, DOI 10.1016/0031-0182(86)90009-X; BASOV IA, 1983, INITIAL REP DEEP SEA, V71, P445; Berggren WA, 1995, GEOCHRONOLOGY TIME S, V54, P129, DOI DOI 10.2110/PEC.95.04.0129; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Bidigare RR, 1999, GLOBAL BIOGEOCHEM CY, V13, P251, DOI 10.1029/1998GB900011; Bidigare RR, 1997, GLOBAL BIOGEOCHEM CY, V11, P279, DOI 10.1029/96GB03939; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Browning JV, 1996, GEOLOGY, V24, P639, DOI 10.1130/0091-7613(1996)024<0639:GIOLTM>2.3.CO;2; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; CONTE MH, 1994, HAPTOPHYTE ALGAE, P351; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Eek MK, 1999, DEEP-SEA RES PT II, V46, P2863, DOI 10.1016/S0967-0645(99)00086-7; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; Ennyu A, 2002, MAR MICROPALEONTOL, V46, P317, DOI 10.1016/S0377-8398(02)00079-8; EREZ J, 1983, GEOCHIM COSMOCHIM AC, V47, P1025, DOI 10.1016/0016-7037(83)90232-6; Fox DL, 2003, GEOLOGY, V31, P809, DOI 10.1130/G19580.1; FREEMAN KH, 2005, HIST ATMOSPHERIC CO2, P35, DOI DOI 10.1007/0-387-27048-5_3; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; KELLOGG EA, 1999, C4 PLANT BIOL, P313; Laws EA, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000GC000057; LECKIE RM, 1993, P OCEAN DRILLING PRO, V0130; MILLER K G, 1991, Palaios, V6, P17, DOI 10.2307/3514951; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Pagani M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2002PA000756; Pagani M, 2000, PALEOCEANOGRAPHY, V15, P486, DOI 10.1029/1999PA000484; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Popp BN, 1998, PALEOCEANOGRAPHY, V13, P35, DOI 10.1029/97PA02594; Popp BN, 1998, GEOCHIM COSMOCHIM AC, V62, P69, DOI 10.1016/S0016-7037(97)00333-5; Popp BN, 1999, RECONSTRUCTING OCEAN HISTORY, P381; PUJOL C, 1983, INITIAL REP DEEP SEA, V72, P623; RAYMO ME, 1991, GEOLOGY, V19, P344, DOI 10.1130/0091-7613(1991)019<0344:GESTCC>2.3.CO;2; Riebesell U, 2000, GEOCHIM COSMOCHIM AC, V64, P4179, DOI 10.1016/S0016-7037(00)00474-9; Robert C, 1997, GEOLOGY, V25, P587, DOI 10.1130/0091-7613(1997)025<0587:ACWCDE>2.3.CO;2; ROMANEK CS, 1992, GEOCHIM COSMOCHIM AC, V56, P419, DOI 10.1016/0016-7037(92)90142-6; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; ROYER DL, 2001, NATURE, V292, P2310; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Schrag DP, 1999, CHEM GEOL, V161, P215, DOI 10.1016/S0009-2541(99)00088-1; Shackleton N.J., 1975, INITIAL REPORTS DEEP, V29, P743, DOI [DOI 10.2973/DSDP.PROC.29.117.1975, 10.2973/DSDP.PROC.29.117.1975]; SHACKLETON NJ, 1984, INITIAL REP DEEP SEA, V74, P599; Stott L.D., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P849, DOI 10.2973/odp.proc.sr.113.187.1990; VALENTINE PC, 1987, INITIAL REP DEEP SEA, V95, P359; WEI WC, 1989, MAR MICROPALEONTOL, V14, P119, DOI 10.1016/0377-8398(89)90034-0; Weiss RF., 1974, MAR CHEM, V2, P203, DOI [DOI 10.1016/0304-4203(74)90015-2, 10.1016/0304-4203(74)90015-2]; WISE SW, 1983, INITIAL REP DEEP SEA, V71, P481; Young John W., COMMUNICATION; YOUNGDAHL CK, 1990, INT J IMPACT ENG, V9, P71, DOI 10.1016/0734-743X(90)90023-O; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; Zachos JC, 1999, CHEM GEOL, V161, P165, DOI 10.1016/S0009-2541(99)00085-6; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	58	642	679	8	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					600	603		10.1126/science.1110063	http://dx.doi.org/10.1126/science.1110063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	15961630				2022-12-24	WOS:000230735200045
J	Reese, C; Heise, F; Mayer, A				Reese, C; Heise, F; Mayer, A			Trans-SNARE pairing can precede a hemifusion intermediate in intracellular membrane fusion	NATURE			English	Article							VACUOLE FUSION; INFLUENZA HEMAGGLUTININ; YEAST VACUOLES; VIRAL FUSION; LATE STEP; EXOCYTOSIS; DOCKING; PEPTIDES	The question concerning whether all membranes fuse according to the same mechanism has yet to be answered satisfactorily. During fusion of model membranes or viruses, membranes dock, the outer membrane leaflets mix ( termed hemifusion), and finally the fusion pore opens and the contents mix(1,2). Viral fusion proteins consist of a membrane-disturbing 'fusion peptide' and a helical bundle that pin the membranes together(2-4). Although SNARE ( soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complexes form helical bundles with similar topology, it is unknown whether SNARE-dependent fusion events on intracellular membranes proceed through a hemifusion state. Here we identify the first hemifusion state for SNARE-dependent fusion of native membranes, and place it into a sequence of molecular events: formation of helical bundles by SNAREs precedes hemifusion; further progression to pore opening requires additional peptides. Thus, SNARE-dependent fusion may proceed along the same pathway as viral fusion: both use a docking mechanism via helical bundles(5,6) and additional peptides to destabilize the membrane and efficiently induce lipid mixing(7-9). Our results suggest that a common lipidic intermediate(3) may underlie all fusion reactions of lipid bilayers.	Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland; Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany	University of Lausanne; Ruprecht Karls University Heidelberg	Mayer, A (corresponding author), Univ Lausanne, Dept Biochim, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	Andreas.Mayer@unil.ch	Mayer, Andreas/AAE-4315-2020	Mayer, Andreas/0000-0001-6131-313X				Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Coorssen JR, 2003, J CELL SCI, V116, P2087, DOI 10.1242/jcs.00374; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; REESE C, UNPUB J CELL BIOL; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Szule JA, 2003, J BIOL CHEM, V278, P24251, DOI 10.1074/jbc.C300197200; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; VOGEL SS, 1993, J BIOL CHEM, V268, P25764; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Zimmerberg J, 2001, TRENDS CELL BIOL, V11, P233, DOI 10.1016/S0962-8924(01)02003-7; Zimmerberg J, 1999, ADV DRUG DELIVER REV, V38, P197, DOI 10.1016/S0169-409X(99)00029-0	30	93	97	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					410	414		10.1038/nature03722	http://dx.doi.org/10.1038/nature03722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	15924133				2022-12-24	WOS:000230623400046
J	Ng, KL; Li, JD; Cheng, MY; Leslie, FM; Lee, AG; Zhou, QY				Ng, KL; Li, JD; Cheng, MY; Leslie, FM; Lee, AG; Zhou, QY			Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling	SCIENCE			English	Article							NEURONAL MIGRATION; SUBVENTRICULAR ZONE; POSTNATAL NEUROGENESIS; DIRECTIONAL GUIDANCE; FOREBRAIN; PROTEIN; IDENTIFICATION; RECEPTORS; CELLS; RAT	Neurogenesis persists in the olfactory bulb (OB) of the adult mammalian brain. New interneurons are continually added to the OB from the subventricular zone (SVZ) via the rostral migratory stream (RMS). Here we show that secreted prokineticin 2 (PK2) functions as a chemoattractant for SVZ-derived neuronal progenitors. Within the OB, PK2 may also act as a detachment signal for chain-migrating progenitors arriving from the RMS. PK2 deficiency in mice leads to a marked reduction in OB size, loss of normal OB architecture, and the accumulation of neuronal progenitors in the RMS. These findings define an essential role for G protein-coupled PK2 signaling in postnatal and adult OB neurogenesis.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Zhou, QY (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	qzhou@uci.edu		Cheng, Michelle/0000-0003-3241-5174; Li, Jia-Da/0000-0002-4236-3518				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BAYER SA, 1983, EXP BRAIN RES, V50, P329; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Betarbet R, 1996, INT J DEV NEUROSCI, V14, P921, DOI 10.1016/S0736-5748(96)00066-4; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KISHI K, 1990, ARCH HISTOL CYTOL, V53, P219, DOI 10.1679/aohc.53.219; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Li J. P. H., UNPUB; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Liu GF, 2003, J NEUROSCI, V23, P6651; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Mollay C, 1999, EUR J PHARMACOL, V374, P189, DOI 10.1016/S0014-2999(99)00229-0; Negri L, 2002, BRIT J PHARMACOL, V137, P1147, DOI 10.1038/sj.bjp.0704995; Ng K., UNPUB; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Ward M, 2003, J NEUROSCI, V23, P5170; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040	34	232	252	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1923	1927		10.1126/science.1112103	http://dx.doi.org/10.1126/science.1112103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976302				2022-12-24	WOS:000230120000044
J	Avorn, J				Avorn, J			Torcetrapid and atorvastatin - Should marketing drive the research agenda?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ESTER TRANSFER PROTEIN; CHOLESTEROL; INHIBITOR		Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Avorn J, 2004, POWERFUL MED BENEFIT; Brousseau ME, 2005, ARTERIOSCL THROM VAS, V25, P1057, DOI 10.1161/01.ATV.0000161928.16334.dd; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Davidson M, 2005, J AM COLL CARDIOL, V45, p394A; Fischer MA, 2004, JAMA-J AM MED ASSOC, V291, P1850, DOI 10.1001/jama.291.15.1850	5	23	24	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2573	2576		10.1056/NEJMp058075	http://dx.doi.org/10.1056/NEJMp058075			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972861				2022-12-24	WOS:000229953700002
J	Ward, MD				Ward, MD			Snapshots of crystal growth	SCIENCE			English	Editorial Material							ATOMIC-FORCE MICROSCOPY; CRYSTALLIZATION; SURFACES; MECHANISMS; KINETICS		Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Ward, MD (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	wardx004@umn.edu						BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; De Yoreo JJ, 2004, SCIENCE, V306, P1301, DOI 10.1126/science.1100889; DEYOREO JJ, 1994, PHYS REV LETT, V73, P838, DOI 10.1103/PhysRevLett.73.838; DURBIN SD, 1992, J CRYST GROWTH, V122, P71, DOI 10.1016/0022-0248(92)90228-B; Feeling-Taylor AR, 2004, BIOPHYS J, V87, P2621, DOI 10.1529/biophysj.104.039743; HILLIER AC, 1994, SCIENCE, V263, P1261, DOI 10.1126/science.263.5151.1261; Jung T, 2004, LANGMUIR, V20, P8587, DOI 10.1021/la0488755; LAND TA, 1995, PHYS REV LETT, V75, P2774, DOI 10.1103/PhysRevLett.75.2774; Last JA, 1998, CHEM MATER, V10, P422, DOI 10.1021/cm970582s; Liu XG, 2005, SCIENCE, V307, P1763, DOI 10.1126/science.1109487; MANNE S, 1993, J CRYST GROWTH, V130, P333, DOI 10.1016/0022-0248(93)90874-V; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; Reviakine I, 2003, J AM CHEM SOC, V125, P11684, DOI 10.1021/ja030194t; Sheng XX, 2005, P NATL ACAD SCI USA, V102, P267, DOI 10.1073/pnas.0406835101; Sours RE, 2005, J PHYS CHEM B, V109, P9989, DOI 10.1021/jp0455733; Ward MD, 2001, CHEM REV, V101, P1697, DOI 10.1021/cr000020j; WEISENHORN AL, 1989, APPL PHYS LETT, V54, P2651, DOI 10.1063/1.101024; Yip CM, 1998, BIOPHYS J, V74, P2199, DOI 10.1016/S0006-3495(98)77929-9	20	21	23	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1566	1567		10.1126/science.1111099	http://dx.doi.org/10.1126/science.1111099			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947165				2022-12-24	WOS:000229827000032
J	Akiyama, K; Matsuzaki, K; Hayashi, H				Akiyama, K; Matsuzaki, K; Hayashi, H			Plant sesquiterpenes induce hyphal branching in arbuscular mycorrhizal fungi	NATURE			English	Article							SEED-GERMINATION STIMULANT; STRIGA-LUTEA LOUR; SYNTHETIC ANALOGS; RED-CLOVER; OROBANCHE; (+)-STRIGOL; RECOGNITION; SIGNALS; GROWTH	Arbuscular mycorrhizal (AM) fungi form mutualistic, symbiotic associations with the roots of more than 80% of land plants(1). The fungi are incapable of completing their life cycle in the absence of a host root. Their spores can germinate and grow in the absence of a host, but their hyphal growth is very limited. Little is known about the molecular mechanisms that govern signalling and recognition between AM fungi and their host plants. In one of the first stages of host recognition, the hyphae of AM fungi show extensive branching in the vicinity of host roots before formation of the appressorium(2-4), the structure used to penetrate the plant root. Host roots are known to release signalling molecules that trigger hyphal branching(5-7), but these branching factors have not been isolated. Here we have isolated a branching factor from the root exudates of Lotus japonicus and used spectroscopic analysis and chemical synthesis to identify it as a strigolactone, 5-deoxy-strigol. Strigolactones are a group of sesquiterpene lactones, previously isolated as seed-germination stimulants for the parasitic weeds Striga and Orobanche(8). The natural strigolactones 5-deoxy-strigol, sorgolactone and strigol, and a synthetic analogue, GR24, induced extensive hyphal branching in germinating spores of the AM fungus Gigaspora margarita at very low concentrations.	Osaka Prefecture Univ, Grad Sch Agr & Biol Sci, Div Appl Biol Chem, Osaka 5998531, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320112, Japan	Osaka Metropolitan University; Japan Science & Technology Agency (JST)	Akiyama, K (corresponding author), Osaka Prefecture Univ, Grad Sch Agr & Biol Sci, Div Appl Biol Chem, Osaka 5998531, Japan.	akiyama@biochem.osakafu-u.ac.jp	Akiyama, Kohki/B-4668-2012	Akiyama, Kohki/0000-0002-9171-9058				BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; BERGMANN C, 1993, J PLANT PHYSIOL, V142, P338, DOI 10.1016/S0176-1617(11)80432-3; Bouwmeester HJ, 2003, CURR OPIN PLANT BIOL, V6, P358, DOI 10.1016/S1369-5266(03)00065-7; BROOKS DW, 1985, J ORG CHEM, V50, P3779, DOI 10.1021/jo00220a020; Buee M, 2000, MOL PLANT MICROBE IN, V13, P693, DOI 10.1094/MPMI.2000.13.6.693; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; COOK CE, 1972, J AM CHEM SOC, V94, P6198, DOI 10.1021/ja00772a048; FRISCHMUTH K, 1991, TETRAHEDRON, V47, P9793, DOI 10.1016/S0040-4020(01)80719-5; Giovannetti M, 1996, NEW PHYTOL, V133, P65, DOI 10.1111/j.1469-8137.1996.tb04342.x; GIOVANNETTI M, 1994, NEW PHYTOL, V127, P703, DOI 10.1111/j.1469-8137.1994.tb02973.x; GIOVANNETTI M, 1993, NEW PHYTOL, V125, P587, DOI 10.1111/j.1469-8137.1993.tb03907.x; HAUCK C, 1992, J PLANT PHYSIOL, V139, P474, DOI 10.1016/S0176-1617(11)80497-9; JOHNSON AW, 1981, J CHEM SOC PERK T 1, P1734, DOI 10.1039/p19810001734; MANGNUS EM, 1992, J AGR FOOD CHEM, V40, P1066, DOI 10.1021/jf00018a032; MOSSE B, 1975, PHYSIOL PLANT PATHOL, V5, P215, DOI 10.1016/0048-4059(75)90088-0; MULLER S, 1992, J PLANT GROWTH REGUL, V11, P77, DOI 10.1007/BF00198018; Nagahashi G, 1999, BIOTECHNOL TECH, V13, P893, DOI 10.1023/A:1008938527757; Nagahashi G, 2000, MYCOL RES, V104, P1453, DOI 10.1017/S0953756200002860; NAKANO S, 1995, BIOSCI BIOTECH BIOCH, V59, P1699, DOI 10.1271/bbb.59.1699; Parniske M, 2004, CURR OPIN PLANT BIOL, V7, P414, DOI 10.1016/j.pbi.2004.05.011; Sato D, 2003, J AGR FOOD CHEM, V51, P1162, DOI 10.1021/jf025997z; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; SIAME BA, 1993, J AGR FOOD CHEM, V41, P1486, DOI 10.1021/jf00033a025; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Sugimoto Y, 1998, J ORG CHEM, V63, P1259, DOI 10.1021/jo9718408; Tamasloukht M, 2003, PLANT PHYSIOL, V131, P1468, DOI 10.1104/pp.012898; Westwood JH, 2000, WEED SCI, V48, P742, DOI 10.1614/0043-1745(2000)048[0742:COTOAS]2.0.CO;2; Yasuda N, 2003, PHYTOCHEMISTRY, V62, P1115, DOI 10.1016/S0031-9422(02)00679-9; Yokota T, 1998, PHYTOCHEMISTRY, V49, P1967, DOI 10.1016/S0031-9422(98)00419-1; Yoneyama K, 2001, PHYSIOL PLANTARUM, V112, P25, DOI 10.1034/j.1399-3054.2001.1120104.x	30	1429	1550	44	865	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2005	435	7043					824	827		10.1038/nature03608	http://dx.doi.org/10.1038/nature03608			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944706				2022-12-24	WOS:000229638700052
J	Stockinger, P; Kvitsiani, D; Rotkopf, S; Tirian, L; Dickson, BJ				Stockinger, P; Kvitsiani, D; Rotkopf, S; Tirian, L; Dickson, BJ			Neural circuitry that governs Drosophila male courtship behavior	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; SEXUAL-DIMORPHISM; TARGETED EXPRESSION; FRUITLESS GENE; TASTE NEURONS; PHEROMONE; PATTERNS; MAP; TRANSMISSION; ORIENTATION	Male-specific fruitless (fru) products (Fru(M)) are both necessary and sufficient to "hardwire" the potential for male courtship behavior into the Drosophila nervous system. Fru(M) is expressed in similar to 2% of neurons in the male nervous system, but not in the female. We have targeted the insertion of GAL4 into the fru locus, allowing us to visualize and manipulate the Fru(M-)expressing neurons in the male as well as their counterparts in the female. We present evidence that these neurons are directly and specifically involved in male courtship behavior and that at least some of them are interconnected in a circuit. This circuit includes olfactory neurons required for the behavioral response to sex pheromones. Anatomical differences in this circuit that might account for the dramatic differences in male and female sexual behavior are not apparent.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Dickson, BJ (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	barry.dickson@imba.oeaw.ac.at	Dickson, Barry/AAE-7632-2019; Stockinger, Petra/AAC-7359-2020	Dickson, Barry/0000-0003-0715-892X; Stockinger, Petra/0000-0002-9533-0437; Kvitsiani, Duda/0000-0003-3175-1774				Anholt RRH, 1996, GENETICS, V143, P293; AVERHOFF WW, 1974, BEHAV GENET, V4, P207, DOI 10.1007/BF01074155; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Cropper EC, 2004, NEUROSIGNALS, V13, P70, DOI 10.1159/000076159; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; HALDER N, 1964, GENETICS, V50, P1269; HALL JC, 1979, GENETICS, V92, P437; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HOFBAUER A, 1991, THESIS U WURZBURG WU; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; Kido A, 2002, J NEUROBIOL, V52, P302, DOI 10.1002/neu.10100; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; KULKARNI SJ, 1987, GENETICS, V115, P461; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Luo MM, 2004, CURR OPIN NEUROBIOL, V14, P428, DOI 10.1016/j.conb.2004.07.001; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schlote, 1984, DROS INFORM SERV, V60, P210; SCHNEIDERMAN AM, 1982, NATURE, V298, P844, DOI 10.1038/298844a0; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; SHOREY HH, 1970, ANIM BEHAV, V18, P159, DOI 10.1016/0003-3472(70)90085-0; Song HJ, 2002, GENETICS, V162, P1703; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	49	411	421	1	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					795	807		10.1016/j.cell.2005.04.026	http://dx.doi.org/10.1016/j.cell.2005.04.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935765	Bronze			2022-12-24	WOS:000229658000017
J	Bartlett, S				Bartlett, S			Life, the universe, and everything	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Bartlett, S (corresponding author), Lancet, London NW1 7BY, England.							Adams Douglas, 1979, HITCHHIKERS GUIDE GA; *CHANDR XRAY OBS, 2005, PLAN PROT XRAY SUP F; *HUBBL, 1994, HUBBL CONF AB PROT D; WILGOREN J, 2005, NY TIMES        0506	4	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 28	2005	365	9474					1836	1836		10.1016/S0140-6736(05)66600-7	http://dx.doi.org/10.1016/S0140-6736(05)66600-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931JK	15924970				2022-12-24	WOS:000229481400009
J	Daley, DO; Rapp, M; Granseth, E; Melen, K; Drew, D; von Heijne, G				Daley, DO; Rapp, M; Granseth, E; Melen, K; Drew, D; von Heijne, G			Global topology analysis of the Escherichia coli inner membrane proteome	SCIENCE			English	Article							MULTIDRUG TRANSPORTER EMRE; GREEN FLUORESCENT PROTEIN; X-RAY-STRUCTURE; CONDUCTING CHANNEL; SELECTIVITY; PREDICTION; EVOLUTION; ANGSTROM; EFFLUX	The protein complement of cellular membranes is notoriously resistant to standard proteomic analysis and structural studies. As a result, membrane proteomes remain ill-defined. Here, we report a global topology analysis of the Escherichia coli inner membrane proteome. Using C-terminal tagging with the alkaline phosphatase and green fluorescent protein, we established the periplasmic or cytoplasmic locations of the C termini for 601 inner membrane proteins. By constraining a topology prediction algorithm with this data, we derived high-quality topology models for the 601 proteins, providing a firm foundation for future functional studies of this and other membrane proteomes. We also estimated the overexpression potential for 397 green fluorescent protein fusions; the results suggest that a large fraction of all inner membrane proteins can be produced in sufficient quantities for biochemical and structural work.	Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; AlbaNova, Stockholm Bioinformat Ctr, SE-10691 Stockholm, Sweden	Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/F-5576-2011; Drew, David/AAY-3455-2020; Rapp, Mikaela/K-2298-2015; von Heijne, Gunnar/AAH-9389-2019	von Heijne, Gunnar/0000-0002-4490-8569; Daley, Daniel/0000-0002-6425-5059; Drew, David/0000-0001-8866-6349				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; DREW D, IN PRESS PROTEIN SCI; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Paulsen IT, 1996, MOL MICROBIOL, V19, P1167, DOI 10.1111/j.1365-2958.1996.tb02462.x; Rapp M, 2004, PROTEIN SCI, V13, P937, DOI 10.1110/ps.03553804; Saaf A, 1999, P NATL ACAD SCI USA, V96, P8540, DOI 10.1073/pnas.96.15.8540; Shimizu T, 2004, J MOL BIOL, V339, P1, DOI 10.1016/j.jmb.2004.03.048; Ubarretxena-Belandia I, 2004, FEBS LETT, V564, P234, DOI 10.1016/S0014-5793(04)00228-5; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; WU JH, 1992, J BIOL CHEM, V267, P12570	25	385	1023	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1321	1323		10.1126/science.1109730	http://dx.doi.org/10.1126/science.1109730			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919996				2022-12-24	WOS:000229482300051
J	Vinuesa, CG; Cook, MC; Angelucci, C; Athanasopoulos, V; Rui, LX; Hill, KM; Yu, D; Domaschenz, H; Whittle, B; Lambe, T; Roberts, IS; Copley, RR; Bell, JI; Cornall, RJ; Goodnow, CC				Vinuesa, CG; Cook, MC; Angelucci, C; Athanasopoulos, V; Rui, LX; Hill, KM; Yu, D; Domaschenz, H; Whittle, B; Lambe, T; Roberts, IS; Copley, RR; Bell, JI; Cornall, RJ; Goodnow, CC			A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity	NATURE			English	Article							B-CELL; INDUCIBLE COSTIMULATOR; IN-VIVO; IMMUNE-RESPONSES; GERMINAL-CENTERS; DENDRITIC CELLS; CO-STIMULATION; CBL-B; ICOS; ACTIVATION	Despite the sequencing of the human and mouse genomes, few genetic mechanisms for protecting against autoimmune disease are currently known. Here we systematically screen the mouse genome for autoimmune regulators to isolate a mouse strain, sanroque, with severe autoimmune disease resulting from a single recessive defect in a previously unknown mechanism for repressing antibody responses to self. The sanroque mutation acts within mature T cells to cause formation of excessive numbers of follicular helper T cells and germinal centres. The mutation disrupts a repressor of ICOS, an essential co-stimulatory receptor for follicular T cells, and results in excessive production of the cytokine interleukin-21. sanroque mice fail to repress diabetes-causing T cells, and develop high titres of autoantibodies and a pattern of pathology consistent with lupus. The causative mutation is in a gene of previously unknown function, roquin (Rc3h1), which encodes a highly conserved member of the RING-type ubiquitin ligase protein family. The Roquin protein is distinguished by the presence of a CCCH zinc-finger found in RNA-binding proteins, and localization to cytosolic RNA granules implicated in regulating messenger RNA translation and stability.	Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia; Australian Natl Univ, Sch Med, Canberra, ACT 2601, Australia; Australian Phenom Facil, Canberra, ACT 2601, Australia; Univ Oxford, Oxford OX3 9DU, England; John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Australian National University; John Curtin School of Medical Research; Australian National University; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia.	carola.vinuesa@anu.edu.au; chris.goodnow@anu.edu.au	rui, li/GYR-3791-2022; li, rui/GSD-4367-2022; Yu, Di/C-2163-2009; Goodnow, Christopher C/V-8108-2018; Cook, matthew/F-4151-2019; Lambe, Teresa/E-5733-2016; Vinuesa, Carola G/B-1108-2010	Yu, Di/0000-0003-1721-8922; Goodnow, Christopher C/0000-0001-5296-6155; Cook, matthew/0000-0002-3331-9363; Lambe, Teresa/0000-0001-7711-897X; Vinuesa, Carola G/0000-0001-9799-0298; Angelucci, Constanza/0000-0002-7169-202X; Athanasopoulos, Vicki/0000-0002-5764-5948				Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; Anderson P, 2002, J CELL SCI, V115, P3227; Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Fillatreau S, 2003, J EXP MED, V197, P195, DOI 10.1084/jem.20021750; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Greve B, 2004, J IMMUNOL, V173, P157, DOI 10.4049/jimmunol.173.1.157; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Hutloff A, 2004, ARTHRITIS RHEUM-US, V50, P3211, DOI 10.1002/art.20519; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Iwai H, 2003, J IMMUNOL, V171, P2848, DOI 10.4049/jimmunol.171.6.2848; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lesage S, 2002, J EXP MED, V196, P1175, DOI 10.1084/jem.20020735; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Mills DM, 2003, SEMIN IMMUNOL, V15, P325, DOI 10.1016/j.smim.2003.09.004; Morking PA, 2004, BIOCHEM BIOPH RES CO, V319, P169, DOI [10.1016/S0006-291X(04)00873-3, 10.1016/j.bbrc.2004.04.162]; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Okamoto S, 2004, EUR J IMMUNOL, V34, P3176, DOI 10.1002/eji.200324755; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; SCHERER MT, 1995, J EXP MED, V182, P1493, DOI 10.1084/jem.182.5.1493; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Walker LSK, 2000, IMMUNOL TODAY, V21, P333, DOI 10.1016/S0167-5699(00)01636-4; Wickens M, 2003, SCIENCE, V300, P753, DOI 10.1126/science.1084512; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	50	667	702	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					452	458		10.1038/nature03555	http://dx.doi.org/10.1038/nature03555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917799				2022-12-24	WOS:000229337800045
J	Dierks, T; Dickmanns, A; Preusser-Kunze, A; Schmidt, B; Mariappan, M; von Figura, K; Ficner, R; Rudolph, MG				Dierks, T; Dickmanns, A; Preusser-Kunze, A; Schmidt, B; Mariappan, M; von Figura, K; Ficner, R; Rudolph, MG			Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme	CELL			English	Article							CYSTEINE-SULFENIC ACID; CRYSTAL-STRUCTURE; POSTTRANSLATIONAL FORMATION; BACTERIAL SULFATASES; PROTEIN MODIFICATION; ARYLSULFATASE; GENE; PEROXIDASE; CONVERSION; FAMILY	Sulfatases are enzymes essential for degradation and remodeling of sulfate esters. Formylglycine (FGly), the key catalytic residue in the active site, is unique to sulfatases. In higher eukaryotes, FGly is generated from a cysteine precursor by the FGly-generating enzyme (FGE). Inactivity of FGE results in multiple sulfatase deficiency (MSD), a fatal autosomal recessive syndrome. Based on the crystal structure, we report that FGE is a single-domain monomer with a surprising paucity of secondary structure and adopts a unique fold. The effect of all 18 missense mutations found in MSD patients is explained by the FGE structure, providing a molecular basis of MSD. The catalytic mechanism of FGly generation was elucidated by six high-resolution structures of FGE in different redox environments. The structures allow formulation of a novel oxygenase mechanism whereby FGE utilizes molecular oxygen to generate FGly via a cysteine sulfenic acid intermediate.	Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; Univ Gottingen, Dept Mol Struct Biol, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	von Figura, K (corresponding author), Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany.	kfigura@gwdg.de; markus.rudolph@bio.uni-goettingen.de	Dierks, Thomas/A-3596-2012; mariappan, malaiyalam/K-9024-2012	Dierks, Thomas/0000-0001-6426-1339; Rudolph, Markus/0000-0003-0447-1101				AHMED SA, 1989, J BIOL CHEM, V264, P19864; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Cosma MP, 2004, HUM MUTAT, V23, P576, DOI 10.1002/humu.20040; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dickmanns A, 2005, J BIOL CHEM, V280, P15180, DOI 10.1074/jbc.M414317200; Dierks T, 1998, FEBS LETT, V423, P61, DOI 10.1016/S0014-5793(98)00065-9; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fang QH, 2004, J BIOL CHEM, V279, P14570, DOI 10.1074/jbc.M313855200; Ferrante P, 2002, EUR J HUM GENET, V10, P813, DOI 10.1038/sj.ejhg.5200887; Fey J, 2001, J BIOL CHEM, V276, P47021, DOI 10.1074/jbc.M108943200; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; GILMOUR R, 1994, BIOCHEM J, V300, P907, DOI 10.1042/bj3000907; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; HASCHKE RH, 1978, BIOCHEM BIOPH RES CO, V80, P1039, DOI 10.1016/0006-291X(78)91350-5; Hernandez-Guzman FG, 2003, J BIOL CHEM, V278, P22989, DOI 10.1074/jbc.M211497200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hopwood JJ, 2001, METABOLIC MOL BASES, P3725; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14225, DOI 10.1073/pnas.94.26.14225; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Luan P, 2000, TRAFFIC, V1, P270, DOI 10.1034/j.1600-0854.2000.010309.x; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Mariappan M, 2005, J BIOL CHEM, V280, P15173, DOI 10.1074/jbc.M413698200; Marquordt C, 2003, J BIOL CHEM, V278, P2212, DOI 10.1074/jbc.M209435200; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Miech C, 1998, J BIOL CHEM, V273, P4835, DOI 10.1074/jbc.273.9.4835; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POULOS TL, 1993, J BIOL CHEM, V268, P4429; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Selmer T, 1996, EUR J BIOCHEM, V238, P341, DOI 10.1111/j.1432-1033.1996.0341z.x; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Szameit C, 1999, J BIOL CHEM, V274, P15375, DOI 10.1074/jbc.274.22.15375; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Xin XN, 2004, J BIOL CHEM, V279, P48159, DOI 10.1074/jbc.M407486200; Yeh JI, 1996, BIOCHEMISTRY-US, V35, P9951, DOI 10.1021/bi961037s	54	146	162	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					541	552		10.1016/j.cell.2005.03.001	http://dx.doi.org/10.1016/j.cell.2005.03.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907468	Green Published, Bronze			2022-12-24	WOS:000229331200011
J	Hill, RA; Barton, RA				Hill, RA; Barton, RA			Red enhances human performance in contests	NATURE			English	Editorial Material							MALE COLORATION; MATE CHOICE; DOMINANCE; ANGER		Univ Durham, Evolutionary Anthropol Res Grp, Durham DH1 3HN, England	Durham University	Hill, RA (corresponding author), Univ Durham, Evolutionary Anthropol Res Grp, Durham DH1 3HN, England.	r.a.hill@durham.ac.uk	Hill, Russell/D-9113-2013	Hill, Russell/0000-0002-7601-5802				Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Cuthill IC, 1997, P ROY SOC B-BIOL SCI, V264, P1093, DOI 10.1098/rspb.1997.0151; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Drummond PD, 1997, PERS INDIV DIFFER, V23, P575, DOI 10.1016/S0191-8869(97)00077-9; Drummond PD, 2001, PSYCHOPHYSIOLOGY, V38, P190, DOI 10.1111/1469-8986.3820190; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Pryke SR, 2002, BEHAV ECOL, V13, P622, DOI 10.1093/beheco/13.5.622; Ryan Michael J., 1997, P179; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065	10	270	279	4	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 19	2005	435	7040					293	293		10.1038/435293a	http://dx.doi.org/10.1038/435293a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902246	Bronze			2022-12-24	WOS:000229185000034
J	Rich-Edwards, JW; Kleinman, K; Michels, KB; Stampfer, MJ; Manson, JE; Rexrode, KM; Hibert, EN; Willett, WC				Rich-Edwards, JW; Kleinman, K; Michels, KB; Stampfer, MJ; Manson, JE; Rexrode, KM; Hibert, EN; Willett, WC			Longitudinal study of birth weight and adult body mass index in predicting risk of coronary heart disease and stroke in women	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; FETAL ORIGINS; EARLY GROWTH; CHILDHOOD; DEATH; ASSOCIATION; COHORT	Objectives To determine whether birth weight and adult body size interact to predict coronary heart disease in women, as has been observed for men. To determine whether birth weight and adult body size interact to predict risk of stroke. Design Longitudinal cohort study. Setting and participants 66 111 female nurses followed since 1976 who were born of singleton, term pregnancies and reported their birth weight in 1992. Main outcome measures 1504 events of coronary heart disease (myocardial infarction or sudden cardiac death) and 1164 strokes. Results For each kilogram of higher birth weight, age adjusted hazard ratios from prospective analysis were 0.77 (95% confidence interval 0.69 to 0.87) for coronary heart disease and 0.89 (0.78 to 1.01) for total stroke. In combined prospective and retrospective analysis, hazard ratios were 0.84 (0.76 to 0.93) for total stroke, 0.83 (0.71 to 0.96) for ischaemic stroke, and 0.86 (0.66 to 1. 11) for haemorrhagic stroke. Exclusion of macrosomic infants (> 4536 g) yielded stronger estimates. Risk of coronary heart disease was especially high for women who crossed from a low centile of weight at birth to a high centile of body mass index. in adulthood. The association of lower birth weight with increased risk of stroke was apparent across categories of body mass index in adults and was not especially strong among heavier women. Conclusions Higher body mass index in adulthood is an especially strong risk factor for coronary heart disease among women who were small at birth. In this large cohort of women, size at birth and adiposity in adulthood interacted to predict events of coronary heart disease but not stroke events.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; Harvard Univ, Sch Med, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Rich-Edwards, JW (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave, Boston, MA 02215 USA.	janet_rich-edwards@hphc.org	Rexrode, Kathryn M/I-1177-2018	Kleinman, Ken/0000-0002-5600-5834; Rexrode, Kathryn/0000-0003-3387-8429				Bailey SCC, 2002, J TURBUL, V3; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; COX DR, 1972, J R STAT SOC B, V34, P187; Eriksson JG, 2000, STROKE, V31, P869, DOI 10.1161/01.STR.31.4.869; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; FORSEN T, 1990, BRIT MED J, V314, P1403; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Gunnarsdottir I, 2002, AM J CLIN NUTR, V76, P1290, DOI 10.1093/ajcn/76.6.1290; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Koupilova I, 1999, J HYPERTENS, V17, P19, DOI 10.1097/00004872-199917010-00004; Lawlor DA, 2004, AM J PUBLIC HEALTH, V94, P1386, DOI 10.2105/AJPH.94.8.1386; LEON D, 2001, BMJ-BRIT MED J, V323, P1033; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; OSMOND C, 1993, BRIT MED J, V307, P1919; Rich-Edwards J., 2004, Fetal nutrition and adult disease: programming of chronic disease through fetal exposure to undernutrition, P87, DOI 10.1079/9780851998213.0087; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Tilling K, 2004, EPIDEMIOLOGY, V15, P557, DOI 10.1097/01.ede.0000135172.67293.60; TROY LM, 1995, INT J OBESITY, V19, P570	26	154	165	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1115	1118A		10.1136/bmj.38434.629630.E0	http://dx.doi.org/10.1136/bmj.38434.629630.E0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15857857	Green Submitted, Green Published			2022-12-24	WOS:000229166900017
J	Thangaraj, K; Chaubey, G; Kivisild, T; Reddy, AG; Singh, VK; Rasalkar, AA; Singh, L				Thangaraj, K; Chaubey, G; Kivisild, T; Reddy, AG; Singh, VK; Rasalkar, AA; Singh, L			Reconstructing the origin of Andaman Islanders	SCIENCE			English	Article							MODERN HUMANS		Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; Estonian Bioctr, EE-51010 Tartu, Estonia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Estonian Biocentre	Singh, L (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	lalji@ccmb.res.in	Rasalkar, Avinash Arvind/ABA-6519-2021; Kivisild, Toomas/P-5889-2017; Thangaraj, Kumarasamy/G-5596-2010; Chaubey, Gyaneshwer/H-2753-2012; Chaubey, Gyaneshwer/AAC-6409-2019	Rasalkar, Avinash Arvind/0000-0003-2277-9556; Kivisild, Toomas/0000-0002-6297-7808; Chaubey, Gyaneshwer/0000-0003-2899-3852; Chaubey, Gyaneshwer/0000-0003-2899-3852; Thangaraj, Kumarasamy/0000-0002-0075-0106				Endicott P, 2003, AM J HUM GENET, V72, P1590, DOI 10.1086/375408; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; THANGARAJ K, UNPUB; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	9	215	222	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					996	996		10.1126/science.1109987	http://dx.doi.org/10.1126/science.1109987			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890876				2022-12-24	WOS:000229190700038
J	Sachs, JP; Anderson, RF				Sachs, JP; Anderson, RF			Increased productivity in the subantarctic ocean during Heinrich events	NATURE			English	Article							ICE CORE; THERMOHALINE CIRCULATION; CLIMATE-CHANGE; LABRADOR-SEA; TAYLOR DOME; IRON; SEDIMENT; MELTWATER; BIOMASS; RECORD	Massive iceberg discharges from the Northern Hemisphere ice sheets, 'Heinrich events', coincided with the coldest periods of the last ice age(1). There is widespread evidence for Heinrich events and their profound impact on the climate and circulation of the North Atlantic Ocean, but their influence beyond that region remains uncertain(1). Here we use a combination of molecular fingerprints of algal productivity and radioisotope tracers of sedimentation to document eight periods of increased productivity in the subpolar Southern Ocean during the past 70,000 years that occurred within 1,000-2,000 years of a Northern Hemisphere Heinrich event. We discuss possible causes for such a link, including increased supply of iron from upwelling and increased stratification during the growing season, which imply an alteration of the global ocean circulation during Heinrich events. The mechanisms linking North Atlantic iceberg discharges with subantarctic productivity remain unclear at this point. We suggest that understanding how the Southern Ocean was altered during these extreme climate perturbations is critical to understanding the role of the ocean in climate change.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Massachusetts Institute of Technology (MIT); Columbia University	Sachs, JP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave,Room E34-254, Cambridge, MA 02139 USA.	jsachs@mit.edu		Anderson, Robert/0000-0002-8472-2494				Abbott MR, 2000, DEEP-SEA RES PT II, V47, P3285, DOI 10.1016/S0967-0645(00)00069-2; Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Boyd P, 1999, J GEOPHYS RES-OCEANS, V104, P13395, DOI 10.1029/1999JC900009; Chase Z, 2001, PALEOCEANOGRAPHY, V16, P468, DOI 10.1029/2000PA000542; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; Little MG, 1997, PALEOCEANOGRAPHY, V12, P568, DOI 10.1029/97PA00823; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; Nilsson J, 2003, J PHYS OCEANOGR, V33, P2781, DOI 10.1175/1520-0485(2003)033<2781:TTCAVM>2.0.CO;2; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Piotrowski AM, 2004, EARTH PLANET SC LETT, V225, P205, DOI 10.1016/j.epsl.2004.06.002; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Rashid H, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000913; Rind D, 2001, J GEOPHYS RES-ATMOS, V106, P27355, DOI 10.1029/2001JD000954; Rohling EJ, 2004, NATURE, V430, P1016, DOI 10.1038/nature02859; Sachs JP, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000862; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; SMITH WO, 1985, SCIENCE, V227, P163, DOI 10.1126/science.227.4683.163; Steig EJ, 2000, GEOGR ANN A, V82A, P213, DOI 10.1111/j.0435-3676.2000.00122.x; Stoner JS, 2000, EARTH PLANET SC LETT, V183, P161, DOI 10.1016/S0012-821X(00)00272-7; van Kreveld S, 2000, PALEOCEANOGRAPHY, V15, P425, DOI 10.1029/1999PA000464; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Watson AJ, 1999, TELLUS B, V51, P453, DOI 10.1034/j.1600-0889.1999.00022.x; Weaver PPE, 1998, PALEOCEANOGRAPHY, V13, P70, DOI 10.1029/97PA02982; Webb DJ, 2001, NATURE, V409, P37, DOI 10.1038/35051171	30	83	86	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1118	1121		10.1038/nature03544	http://dx.doi.org/10.1038/nature03544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858571				2022-12-24	WOS:000228693300040
J	Diaconu, M; Kothe, U; Schlunzen, F; Fischer, N; Harms, JM; Tonevitsky, AG; Stark, H; Rodnina, MV; Wahl, MC				Diaconu, M; Kothe, U; Schlunzen, F; Fischer, N; Harms, JM; Tonevitsky, AG; Stark, H; Rodnina, MV; Wahl, MC			Structural basis for the function of the ribosomal L7/12 stalk in factor binding and GTPase activation	CELL			English	Article							ELONGATION-FACTOR TU; AMINOACYL-TRANSFER-RNA; PROTEIN L7/L12; CODON-RECOGNITION; SUBUNIT; SITE; VISUALIZATION; TRANSLOCATION; LOCALIZATION; TRANSLATION	The L7/12 stalk of the large subunit of bacterial ribosomes encompasses protein L10 and multiple copies of L7/12. We present crystal structures of Thermotoga maritima L10 in complex with three L7/12 N-terminaldomain dimers, refine the structure of an archaeal L10E N-terminal domain on the 50S subunit, and identify these elements in cryo-electron-microscopic reconstructions of Escherichia coli ribosomes. The mobile C-terminal helix alpha 8 of L10 carries three L7/12 dimers in T maritima and two in E. coli, in concordance with the different length of helix alpha 8 of L10 in these organisms. The stalk is organized into three elements (stalk base, L10 helix alpha 8-L7/12 N-terminaldomain complex, and L7/12 C-terminal domains) linked by flexible connections. Highly mobile L7/12 C-terminal domains promote recruitment of translation factors to the ribosome and stimulate GTP hydrolysis by the ribosome bound factors through stabilization of their active GTPase conformation.	Max Planck Inst Biophys Chem, Rontgenkristallog, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, 3D Kryoelektr Mikroskopie, D-37077 Gottingen, Germany; Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany; DESY, Max Planck Arbeitsgrppen Strukt Mol Biol, D-22607 Hamburg, Germany; Moscow MV Lomonosov State Univ, Dept Biol, Moscow 119899, Russia	Max Planck Society; Max Planck Society; Witten Herdecke University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Lomonosov Moscow State University	Wahl, MC (corresponding author), Max Planck Inst Biophys Chem, Rontgenkristallog, Fassberg 11, D-37077 Gottingen, Germany.	mwahl@gwdg.de	Schluenzen, Frank/P-9177-2019; Harms, Joerg/K-8786-2012; Tonevitsky, Alexander/R-5596-2019; Wahl, Markus C./D-6365-2017; Diaconu, Mihaela Stefania/C-3644-2012; Schluenzen, Frank/H-6274-2014; Rodnina, Marina V./AAD-4667-2019; Fischer, Niels/ABA-5342-2021; Kothe, Ute/K-5568-2019; Tonevitsky, Alexander G/F-8640-2014	Schluenzen, Frank/0000-0003-2849-0542; Harms, Joerg/0000-0002-9442-8264; Wahl, Markus C./0000-0002-2811-5307; Diaconu, Mihaela Stefania/0000-0002-1144-338X; Schluenzen, Frank/0000-0003-2849-0542; Rodnina, Marina V./0000-0003-0105-3879; Fischer, Niels/0000-0002-4609-4052; Kothe, Ute/0000-0002-2744-7334; Holger, Stark/0000-0002-6161-1118				Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BEAUCLERK AAD, 1984, J BIOL CHEM, V259, P6559; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Dey D, 1998, J BIOL CHEM, V273, P1670, DOI 10.1074/jbc.273.3.1670; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Kothe U, 2004, J MOL BIOL, V336, P1011, DOI 10.1016/j.jmb.2003.12.080; LILJAS A, 1987, BIOCHIMIE, V69, P1043, DOI 10.1016/0300-9084(87)90004-6; Mohr D, 2000, EMBO J, V19, P3458, DOI 10.1093/emboj/19.13.3458; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Montesano-Roditis L, 2001, J BIOL CHEM, V276, P14117, DOI 10.1074/jbc.M008430200; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; OLEINIKOV AV, 1993, J BIOL CHEM, V268, P917; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; ROSENDAHL G, 1993, J MOL BIOL, V234, P1013, DOI 10.1006/jmbi.1993.1655; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; SUBRAMANIAN AR, 1975, J MOL BIOL, V95, P1, DOI 10.1016/0022-2836(75)90330-7; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Vila-Sanjurjo A, 2003, P NATL ACAD SCI USA, V100, P8682, DOI 10.1073/pnas.1133380100; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; Wieden HJ, 2001, J MOL EVOL, V52, P129, DOI 10.1007/s002390010141; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	37	308	318	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					991	1004		10.1016/j.cell.2005.04.015	http://dx.doi.org/10.1016/j.cell.2005.04.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989950	Green Published, Bronze			2022-12-24	WOS:000230448000007
J	Nudleman, E; Wall, D; Kaiser, D				Nudleman, E; Wall, D; Kaiser, D			Cell-to-cell transfer of bacterial outer membrane lipoproteins	SCIENCE			English	Article							MYXOCOCCUS-XANTHUS; GLIDING MOTILITY; IV PILI; MOVEMENT; MYXOBACTERIA; STIMULATION	Myxococcus xanthus cells can glide forward by retracting type IV pili. Tgl, an outer membrane lipoprotein, is necessary to assemble pili. Tgl(+) mutants can be transiently "stimulated" if brought into end-to-end contact with tgl(+) donor cells. By separating the stimulated recipient cells from donor cells, we found that Tgl protein was transferred from the donors to the rescued recipient cells. Mutants lacking CglB lipoprotein, which is part of a second gliding engine, could also be stimulated, and CglB protein was transferred from donor to recipient cells. The high transfer efficiency of Tgl and CglB proteins suggests that donor and recipient cells briefly fuse their outer membranes.	Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr B300, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Sch Med, Beckman Ctr B300, Stanford, CA 94305 USA	Stanford University; Stanford University	Kaiser, D (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	kaiser@cmgm.stanford.edu		Wall, Daniel/0000-0002-0273-1371	NIGMS NIH HHS [GM23441] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023441, R01GM023441] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x; HODGKIN J, 1977, P NATL ACAD SCI USA, V74, P2938, DOI 10.1073/pnas.74.7.2938; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; KAISER D, 1983, CELL MOTIL CYTOSKEL, V3, P227, DOI 10.1002/cm.970030304; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2005, CURR OPIN MICROBIOL, V8, P216, DOI 10.1016/j.mib.2005.02.002; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; MACRAE TH, 1976, CAN J MICROBIOL, V22, P1589, DOI 10.1139/m76-234; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Nudleman E, 2004, J MOL MICROB BIOTECH, V7, P52, DOI 10.1159/000077869; NUDLEMAN E, UNPUB; Rodriguez AM, 1999, J BACTERIOL, V181, P4381, DOI 10.1128/JB.181.14.4381-4390.1999; Thanassi DG, 2002, J MOL MICROB BIOTECH, V4, P11; Wall D, 1998, J BACTERIOL, V180, P759, DOI 10.1128/JB.180.3.759-761.1998; Wall D, 1999, J BACTERIOL, V181, P24, DOI 10.1128/JB.181.1.24-33.1999; Wolgemuth C, 2002, CURR BIOL, V12, P369, DOI 10.1016/S0960-9822(02)00716-9; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x	19	120	123	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					125	127		10.1126/science.1112440	http://dx.doi.org/10.1126/science.1112440			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994555				2022-12-24	WOS:000230212800073
J	Ninis, N; Phillips, C; Bailey, L; Pollock, JI; Nadel, S; Britto, J; Maconochie, I; Winrow, A; Coen, PG; Booy, R; Levin, M				Ninis, N; Phillips, C; Bailey, L; Pollock, JI; Nadel, S; Britto, J; Maconochie, I; Winrow, A; Coen, PG; Booy, R; Levin, M			The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases	BRITISH MEDICAL JOURNAL			English	Article							SEPTICEMIA; MANAGEMENT	Objective To determine whether suboptimal management in hospital could contribute to poor outcome in children admitted with meningococcal disease. Design Case-control study of childhood deaths from meningococcal disease, comparing hospital care in fatal mid non-fatal cases. Setting National statistics and hospital records. Subjects All children under 17 years who died from meningococcal disease (cases) matched by age with three survivors (controls) from the same region of the country. Main outcome measures Predefined criteria defined optimal management. A panel of paediatricians blinded to the outcome assessed case records using a standardised form and scored patients for suboptimal management. Results We identified 143 cases and 355 controls. Departures from optimal (per protocol) management occurred more frequently in the fatal cases than in the survivors. Multivariate analysis identified three factors independently associated with an increased risk of death: failure to be looked after by a paediatrician, failure of sufficient supervision of junior staff, and failure of staff to administer adequate inotropes. Failure to recognise complications of the disease was a significant risk factor for death, although not independently of absence of paediatric care (P=0.002). The odds ratio for death was 8.7 (95% confidence interval 2.3 to 33) with two failures, increasing with multiple failures. Conclusions Suboptimal healthcare delivery significantly reduces the likelihood of survival in children with meningococcal disease. Improved training of medical and nursing staff, adherence to published protocols, and increased supervision by consultants may improve the outcome for these children and also those with other life threatening illnesses.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Paediat, Infect Dis Unit, London W2 1PG, England; Royal Coll Paediat & Child Hlth, Res Unit, London W1W 6DE, England; Univ W England, Fac Hlth & Social Care, Bristol BS16 1DD, Avon, England; St Marys Hosp, Paediat Intens Care Unit, London W2 1PG, England; St Marys Hosp, Paediat Accid & Emergency Dept, London W2 1PG, England; Kingston Hosp, Dept Paediat, Kingston upon Thames KT2 7QB, Surrey, England; Univ London, Queen Marys Sch Med & Dent, London E1 1BB, England	Imperial College London; University of West England; Imperial College London; Imperial College London; University of London; Queen Mary University London	Ninis, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Paediat, Infect Dis Unit, London W2 1PG, England.	ninisn@gosh.nhs.uk	Booy, Robert/D-4188-2011	Maconochie, Ian/0000-0001-6319-8550; Levin, Michael/0000-0003-2767-6919				*ADV LIF SUPP GROU, 2001, ADV PAED LIF SUPP MA; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; JONES D, 1995, MENINGOCOCCAL DIS, P147; Nadel S, 1998, J ACCID EMERG MED, V15, P298; NADEL S, 1995, MENINGOCOCCAL DIS, P207; *OFF NAT STAT, 2000, MORT STAT DH2, V26; Pathan N, 2000, J ROY COLL PHYS LOND, V34, P436; Pollard AJ, 1999, ARCH DIS CHILD, V80, P290, DOI 10.1136/adc.80.3.290; Ramsay M, 1997, Commun Dis Rep CDR Rev, V7, pR49; Stuart J M, 1997, Commun Dis Rep CDR Rev, V7, pR3; THOMSON APJ, 1991, CRIT CARE MED, V19, P26, DOI 10.1097/00003246-199101000-00010; Thorburn K, 2001, ARCH DIS CHILD, V85, P382, DOI 10.1136/adc.85.5.382; Thornhill J, 2000, BJU INT, V85, P382	14	112	120	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 25	2005	330	7506					1475	1478		10.1136/bmj.330.7506.1475	http://dx.doi.org/10.1136/bmj.330.7506.1475			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942NR	15976421	Green Published, Bronze			2022-12-24	WOS:000230289600017
J	Kalo, P; Gleason, C; Edwards, A; Marsh, J; Mitra, RM; Hirsch, S; Jakab, J; Sims, S; Long, SR; Rogers, J; Kiss, GB; Downie, JA; Oldroyd, GED				Kalo, P; Gleason, C; Edwards, A; Marsh, J; Mitra, RM; Hirsch, S; Jakab, J; Sims, S; Long, SR; Rogers, J; Kiss, GB; Downie, JA; Oldroyd, GED			Nodulation signaling in legumes requires NSP2, a member of the GRAS family of transcriptional regulators	SCIENCE			English	Article							MEDICAGO-TRUNCATULA; CALCIUM SPIKING; NOD FACTORS; MUTANTS; IDENTIFICATION; TRANSDUCTION; SYMBIOSIS; GENE	Rhizobial bacteria enter a symbiotic interaction with legumes, activating diverse responses in roots through the lipochito oligosaccharide signaling molecule Nod factor. Here, we show that NSP2 from Medicago truncatula encodes a GRAS protein essential for Nod-factor signaling. NSP2 functions downstream of Nod-factor-induced calcium spiking and a calcium/calmodulin-dependent protein kinase. We show that NSP2-GFP expressed from a constitutive promoter is localized to the endoplasmic reticulum/nuclear envelope and relocalizes to the nucleus after Nod-factor elicitation. This work provides evidence that a GRAS protein transduces calcium signals in plants and provides a possible regulator of Nod-factor-inducible gene expression.	John Innes Ctr, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England; John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; Agr Biotechnol Ctr, Inst Genet, H-2100 Godollo, Hungary; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Wellcome Trust Sanger Institute; Stanford University	Oldroyd, GED (corresponding author), John Innes Ctr, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England.	giles.oldroyd@bbsrc.ac.uk	Oldroyd, Giles/ABA-7501-2020; Mitra, Raka/GQA-9960-2022; Oldroyd, Giles/ABD-8143-2021; Downie, Allan/I-3487-2012; Kalo, Peter/A-3919-2012	Oldroyd, Giles/0000-0002-5245-6355; Kalo, Peter/0000-0002-0404-8904; Downie, Allan/0000-0003-1011-4960; Mitra, Raka/0000-0002-2798-2038				Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; Kalo P, 2004, MOL GENET GENOMICS, V272, P235, DOI 10.1007/s00438-004-1055-z; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Long SR, 1996, PLANT CELL, V8, P1885, DOI 10.1105/tpc.8.10.1885; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P4701, DOI 10.1073/pnas.0400595101; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2003, PLANT PHYSIOL, V131, P1027, DOI 10.1104/pp.102.010710; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Walker SA, 2000, P NATL ACAD SCI USA, V97, P13413, DOI 10.1073/pnas.230440097	14	399	428	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1786	1789		10.1126/science.1110951	http://dx.doi.org/10.1126/science.1110951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961668				2022-12-24	WOS:000229926800054
J	Kowalewski, M; Hoffmeister, AP; Baumiller, TK; Bambach, RK				Kowalewski, M; Hoffmeister, AP; Baumiller, TK; Bambach, RK			Secondary evolutionary escalation between brachiopods and enemies of other prey	SCIENCE			English	Article							MESOZOIC MARINE REVOLUTION; DRILLING PREDATION; FOSSIL RECORD; COMPETITION; BEHAVIOR; MUSSELS; SNAILS	The fossil record of predation indicates that attacks on Paleozoic brachiopods were very rare, especially compared to those on post-Pateozoic mollusks, yet stratigraphically and geographically widespread. Drilling frequencies were very tow in the early Paleozoic (<<1%) and went up slightly in the mid-to-late Paleozoic. Present-day brachiopods revealed frequencies only slightly higher. The persistent rarity of drilling suggests that brachiopods were the secondary casualties of mistaken or opportunistic attacks by the enemies of other taxa. Such sporadic attacks became slightly more frequent as trophic systems escalated and predators diversified. Some evolutionarily persistent biotic interactions may be incidental rather than coevolutionary or escalatory in nature.	Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA; Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA	Virginia Polytechnic Institute & State University; University of Michigan System; University of Michigan; Harvard University	Kowalewski, M (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA.	michalk@vt.edu	Kowalewski, Michal/B-4263-2008; Baumiller, Tomasz K/C-3596-2012	Kowalewski, Michal/0000-0002-8575-4711; Baumiller, Tomasz K/0000-0002-4506-9330				AUSICH WI, 1979, J PALEONTOL, V53, P335; Bambach RK, 1999, GEOBIOS-LYON, V32, P131, DOI 10.1016/S0016-6995(99)80025-4; Baumiller TK, 1999, PALAEOGEOGR PALAEOCL, V147, P283, DOI 10.1016/S0031-0182(98)00165-5; Baumiller TK, 2004, PALAEOGEOGR PALAEOCL, V214, P85, DOI 10.1016/j.palaeo.2004.07.023; Baumiller TK, 2004, SCIENCE, V305, P1453, DOI 10.1126/science.1101009; Brett Carlton E., 2002, Paleontological Society Papers, V8, P93; Brett CE, 2003, T GEOBIOL, V20, P401; CADEE GC, 1984, LETHAIA, V17, P289, DOI 10.1111/j.1502-3931.1984.tb00674.x; Delance JH, 2004, PALAEOGEOGR PALAEOCL, V208, P23, DOI 10.1016/j.palaeo.2004.02.025; Dietl GP, 2004, SCIENCE, V306, P2229, DOI 10.1126/science.1106182; Harper EM, 2003, PALAEOGEOGR PALAEOCL, V210, P185, DOI 10.1016/S0031-0182(03)00624-2; Harper EM, 1998, PALAIOS, V13, P352, DOI 10.2307/3515323; Harper EM, 2000, PALAEOGEOGR PALAEOCL, V158, P15, DOI 10.1016/S0031-0182(99)00164-9; Harper EM, 2003, POLAR BIOL, V26, P208, DOI 10.1007/s00300-002-0455; Hoffmeister AP, 2004, ACTA PALAEONTOL POL, V49, P443; Hoffmeister AP, 2003, LETHAIA, V36, P107, DOI 10.1080/00241160310000408; HUGHES RN, 1984, J EXP MAR BIOL ECOL, V77, P45, DOI 10.1016/0022-0981(84)90050-9; KELLEY PH, 1993, PALAIOS, V8, P358, DOI 10.2307/3515266; Kelley PH, 1996, GEOL SOC SP, P373, DOI 10.1144/GSL.SP.1996.001.01.27; Kowalewski M, 1998, GEOLOGY, V26, P1091, DOI 10.1130/0091-7613(1998)026<1091:AFRFOH>2.3.CO;2; LABARBERA M, 1981, PALEOBIOLOGY, V7, P510, DOI 10.1017/S0094837300025550; Leighton LR, 2003, PALAEOGEOGR PALAEOCL, V210, P221, DOI 10.1016/S0031-0182(03)00627-8; Nebelsick JH, 1999, PALAIOS, V14, P127, DOI 10.2307/3515369; Rilov G, 2002, MAR ENVIRON RES, V54, P85, DOI 10.1016/S0141-1136(02)00096-X; SIGNOR PW, 1984, PALEOBIOLOGY, V10, P229, DOI 10.1017/S0094837300008174; SMITH SA, 1985, SCIENCE, V230, P1033, DOI 10.1126/science.230.4729.1033; Steer MA, 2003, J EXP MAR BIOL ECOL, V290, P165, DOI 10.1016/S0022-0981(03)00076-5; THAYER CW, 1985, SCIENCE, V228, P1527, DOI 10.1126/science.228.4707.1527; van Valen L., 1973, EVOL THEOR, V1, P1, DOI DOI 10.1038/344864A0; VERMEIJ G J, 1977, Paleobiology, V3, P245; Vermeij G.J., 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1981, SCIENCE, V214, P1024, DOI 10.1126/science.214.4524.1024; WALKER SE, 1993, PALAEONTOLOGY, V36, P735; WAREN A, 1994, VELIGER, V37, P141	34	70	72	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1774	1777		10.1126/science.1113408	http://dx.doi.org/10.1126/science.1113408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961667				2022-12-24	WOS:000229926800051
J	Somesh, BP; Reid, J; Liu, WF; Sogaard, TMM; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ				Somesh, BP; Reid, J; Liu, WF; Sogaard, TMM; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ			Multiple mechanisms confining RNA polymerase II ubiquitylation to polymerases undergoing transcriptional arrest	CELL			English	Article							TERMINAL REPEAT DOMAIN; LARGE SUBUNIT; STRUCTURAL BASIS; DNA-REPAIR; PROTEIN; UBIQUITIN; ELONGATION; COMPLEX; KINASE; GENE	In order to study mechanisms and regulation of RNA polymerase II (RNAPII) ubiquitylation and degradation, highly purified factors were used to reconstitute RNAPII ubiquitylation in vitro. We show that arrested RNAPII elongation complexes are the preferred substrates for ubiquitylation. Accordingly, not only DNA-damage-dependent but also DNA-damage-independent transcriptional arrest results in RNAPII ubiquitylation in vivo. Def1, known to be required for damage-induced degradation of RNAPII, stimulates ubiquitylation of RNAPII only in an elongation complex. Ubiquitylation of RNAPII is dependent on its C-terminal repeat domain (CTD). Moreover, CTD phosphorylation at serine 5, a hallmark of the initiating polymerase, but not at serine 2, a hallmark of the elongating polymerase, completely inhibits ubiqultylation. In agreement with this, ubiquitylated RNAPII is hypophosphorylated at serine 5 in vivo, and mutation of the serine 5 phosphatase SSU72 inhibits RNAPII degradation. These results identify several mechanisms that confine ubiquitylation of RNAPII to the forms of the enzyme that arrest during elongation.	Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Cancer Research UK; Memorial Sloan Kettering Cancer Center	Svejstrup, JQ (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk		Tempst, Paul/0000-0002-6680-3987; Svejstrup, Jesper/0000-0003-4964-6147; Sogaard, Teit Max Moscote/0000-0001-6224-4818; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Gavva NR, 1997, J BIOL CHEM, V272, P24105, DOI 10.1074/jbc.272.39.24105; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; HANSSON J, 1989, J BIOL CHEM, V264, P21788; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kobor MS, 1999, MOL CELL, V4, P55, DOI 10.1016/S1097-2765(00)80187-2; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; LI Y, 1994, P NATL ACAD SCI USA, V91, P2362, DOI 10.1073/pnas.91.6.2362; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; Mitsui A, 1999, P NATL ACAD SCI USA, V96, P6054, DOI 10.1073/pnas.96.11.6054; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Reid J, 2004, J BIOL CHEM, V279, P29875, DOI 10.1074/jbc.C400185200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SHERMAN F, 1991, P3; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	43	177	185	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					913	923		10.1016/j.cell.2005.04.010	http://dx.doi.org/10.1016/j.cell.2005.04.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960978	Bronze			2022-12-24	WOS:000230011200013
J	Blanford, S; Chan, BHK; Jenkins, N; Sim, D; Turner, RJ; Read, AF; Thomas, MB				Blanford, S; Chan, BHK; Jenkins, N; Sim, D; Turner, RJ; Read, AF; Thomas, MB			Fungal pathogen reduces potential for malaria transmission	SCIENCE			English	Article							METARHIZIUM-FLAVOVIRIDE; ENTOMOPATHOGENIC FUNGUS; BIOLOGICAL-CONTROL; MYCOINSECTICIDE; INSECTICIDES; LOCUSTS	Using a rodent malaria model, we found that exposure to surfaces treated with fungal entornopathogens following an infectious blood meal reduced the number of mosquitoes able to transmit malaria by a factor of about 80. Fungal infection, achieved through contact with both solid surfaces and netting for durations well within the typical post-feed resting periods, was sufficient to cause >90% mortality. Daily mortality rates escalated dramatically around the time of sporozoite maturation, and infected mosquitoes showed reduced propensity to blood feed. Residual sprays of fungal biopesticides might replace or supplement chemical insecticides for malaria control, particularly in areas of high insecticide resistance.	Univ London Imperial Coll Sci Technol & Med, Div Biol, Wye TN25 5AH, Kent, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Wye TN25 5AH, Kent, England; Univ Edinburgh, Inst Evolut, Sch Biol Sci, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Inst Immunol, Sch Biol Sci, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Inst Infect Res, Sch Biol Sci, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; Univ London Imperial Coll Sci Technol & Med, CABI Biosci, Dept Agr Sci, Wye TN25 5AH, Kent, England	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Edinburgh; University of Edinburgh; University of Edinburgh; Imperial College London	Thomas, MB (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Wye Campus, Wye TN25 5AH, Kent, England.	m.thomas@imperial.ac.uk		Chan, Brian/0000-0002-9451-4621	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BATEMAN RP, 1993, ANN APPL BIOL, V122, P145, DOI 10.1111/j.1744-7348.1993.tb04022.x; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Carucci D, 2004, NATURE, V430, P944, DOI 10.1038/430944a; Charlwood JD, 1997, AFR ENTOMOL, V5, P93; GELFAND H. M., 1955, TRANS ROY SOC TROP MED AND HYG, V49, P508, DOI 10.1016/0035-9203(55)90023-7; GILLIES MT, 1954, B ENTOMOL RES, V45, P375, DOI 10.1017/S000748530002719X; Greenwood B, 2004, NATURE, V430, P926, DOI 10.1038/430926a; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2004, NATURE, V430, P936, DOI 10.1038/430936a; Hemingway J, 2004, SCIENCE, V303, P1984, DOI 10.1126/science.1096548; LACEY LA, 1986, ANNU REV ENTOMOL, V31, P265, DOI 10.1146/annurev.en.31.010186.001405; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Rishikesh N., 1988, P1227; Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Scholte EJ, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-29; SCHOLTE EJ, IN PRESS J INVERTEBR; Scholte Ernst-Jan, 2003, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V14, P25; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; Thomas MB, 1998, ENTOMOL EXP APPL, V87, P93, DOI 10.1023/A:1003298103716; Thomas MB, 1997, PESTIC SCI, V49, P47, DOI 10.1002/(SICI)1096-9063(199701)49:1&lt;47::AID-PS471&gt;3.0.CO;2-O; THOMAS MB, 2004, BIOCONTROL NEWS INFO, V25, pN47; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	25	247	262	6	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1638	1641		10.1126/science.1108423	http://dx.doi.org/10.1126/science.1108423			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947189				2022-12-24	WOS:000229827000060
J	Todorov, A; Mandisodza, AN; Goren, A; Hall, CC				Todorov, A; Mandisodza, AN; Goren, A; Hall, CC			Inferences of competence from faces predict election outcomes	SCIENCE			English	Article							PERSON PERCEPTION; BEHAVIOR	We show that inferences of competence based solely on facial appearance predicted the outcomes of U.S. congressional elections better than chance (e.g., 68.8% of the Senate races in 2004) and also were linearly related to the margin of victory. These inferences were specific to competence and occurred within a 1-second exposure to the faces of the candidates. The findings suggest that rapid, unreflective trait inferences can contribute to voting choices, which are widely assumed to be based primarily on rational and, deliberative considerations.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University; Princeton University	Todorov, A (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	atodorov@princeton.edu						Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Bartels LM, 2000, AM J POLIT SCI, V44, P35, DOI 10.2307/2669291; BUDESHEIM TL, 1994, PERS SOC PSYCHOL B, V20, P339, DOI 10.1177/0146167294204001; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; COVER AD, 1977, AM J POLIT SCI, V21, P523, DOI 10.2307/2110580; DARWIN F, 1950, C DARWINS AUTOBIOGRA, P36; GILBERT D T, 1989, P189; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Keating CF, 1999, POLIT PSYCHOL, V20, P593, DOI 10.1111/0162-895X.00158; Kelley CM, 1998, ACTA PSYCHOL, V98, P127, DOI 10.1016/S0001-6918(97)00039-5; KELLEY HH, 1950, J PERS, V18, P431, DOI 10.1111/j.1467-6494.1950.tb01260.x; KINDER DR, 1980, POLITICAL BEHAV, V0002; MARTIN DS, 1978, AUST J PSYCHOL, V30, P255, DOI 10.1080/00049537808256378; Montepare JM, 1998, ADV EXP SOC PSYCHOL, V30, P93, DOI 10.1016/S0065-2601(08)60383-4; Mueller U, 1996, SOC FORCES, V74, P823, DOI 10.2307/2580383; QUATTRONE GA, 1988, AM POLIT SCI REV, V82, P719, DOI 10.2307/1962487; Todorov A, 2003, J EXP SOC PSYCHOL, V39, P549, DOI 10.1016/S0022-1031(03)00059-3; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Zaller J., 1992, NATURE ORIGINS MASS; Zebrowitz LA, 2002, PERS SOC PSYCHOL B, V28, P238, DOI 10.1177/0146167202282009; ZEBROWITZ LA, 1999, READING FACES WINDOW	24	841	847	4	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1623	1626		10.1126/science.1110589	http://dx.doi.org/10.1126/science.1110589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	936BH	15947187				2022-12-24	WOS:000229827000056
J	Bloche, MG				Bloche, MG			Managing conflict at the end of life	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Georgetown Univ, Washington, DC 20057 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bloche, MG (corresponding author), Georgetown Univ, Washington, DC 20057 USA.							Bercovitch Jacob, 1989, MEDIATION RES PROCES; Bloche MG, 2002, STANFORD LAW REV, V55, P919, DOI 10.2307/1229676; Dubler N. N., 2004, BIOETHICS MEDIATION; Frey B.S., 1999, EC VALUES ORG, P437; LYNCH RN, 2005, COMMUNICATION   0228	5	32	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2005	352	23					2371	2373		10.1056/NEJMp058104	http://dx.doi.org/10.1056/NEJMp058104			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933NL	15944420				2022-12-24	WOS:000229638900001
J	Menetrey, J; Bahloul, A; Wells, AL; Yengo, CM; Morris, CA; Sweeney, HL; Houdusse, A				Menetrey, J; Bahloul, A; Wells, AL; Yengo, CM; Morris, CA; Sweeney, HL; Houdusse, A			The structure of the myosin VI motor reveals the mechanism of directionality reversal	NATURE			English	Article							KINETIC MECHANISM; LEVER ARM; CALMODULIN; PROTEIN; PROCESSIVITY; BINDING; DOMAIN; MODEL	Here we solve a 2.4-angstrom structure of a truncated version of the reverse-direction myosin motor, myosin VI, that contains the motor domain and binding sites for two calmodulin molecules. The structure reveals only minor differences in the motor domain from that in plus-end directed myosins, with the exception of two unique inserts. The first is near the nucleotide-binding pocket and alters the rates of nucleotide association and dissociation. The second unique insert forms an integral part of the myosin VI converter domain along with a calmodulin bound to a novel target motif within the insert. This serves to redirect the effective 'lever arm' of myosin VI, which includes a second calmodulin bound to an 'IQ motif', towards the pointed ( minus) end of the actin filament. This repositioning largely accounts for the reverse directionality of this class of myosin motors. We propose a model incorporating a kinesin-like uncoupling/docking mechanism to provide a full explanation of the movements of myosin VI.	CNRS, Inst Curie, F-75248 Paris, France; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Pennsylvania	Houdusse, A (corresponding author), CNRS, Inst Curie, 26 Rue Ulm, F-75248 Paris, France.	lsweeney@mail.med.upenn.edu; anne.houdusse@curie.fr	Sweeney, H Lee/F-1862-2010; Ménétrey, Julie/AAM-6408-2021	BAHLOUL, Amel/0000-0001-7042-4616	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048931] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR048931-03, R01 AR048931] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Bahloul A, 2004, P NATL ACAD SCI USA, V101, P4787, DOI 10.1073/pnas.0306892101; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Millo H, 2004, MECH DEVELOP, V121, P1335, DOI 10.1016/j.mod.2004.06.007; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Robblee JP, 2004, J BIOL CHEM, V279, P38608, DOI 10.1074/jbc.M403504200; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sasaki N, 2003, BIOCHEMISTRY-US, V42, P90, DOI 10.1021/bi026051l; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; Tsiavaliaris G, 2004, NATURE, V427, P558, DOI 10.1038/nature02303; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200	42	164	169	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					779	785		10.1038/nature03592	http://dx.doi.org/10.1038/nature03592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944696	Green Accepted			2022-12-24	WOS:000229638700042
J	O'Donnell, KA; Wentzel, EA; Zeller, KI; Dang, CV; Mendell, JT				O'Donnell, KA; Wentzel, EA; Zeller, KI; Dang, CV; Mendell, JT			c-Myc-regulated microRNAs modulate E2F1 expression	NATURE			English	Article							TRANSCRIPTION FACTOR; GENOMIC TARGETS; IDENTIFICATION; GENES; LYMPHOMA; MECHANISM	MicroRNAs ( miRNAs) are 21 - 23 nucleotide RNA molecules that regulate the stability or translational efficiency of target messenger RNAs1. miRNAs have diverse functions, including the regulation of cellular differentiation, proliferation and apoptosis(2). Although strict tissue- and developmental-stage-specific expression is critical for appropriate miRNA function, mammalian transcription factors that regulate miRNAs have not yet been identified. The proto-oncogene c-MYC encodes a transcription factor that regulates cell proliferation, growth and apoptosis(3). Dysregulated expression or function of c-Myc is one of the most common abnormalities in human malignancy(4). Here we show that c-Myc activates expression of a cluster of six miRNAs on human chromosome 13. Chromatin immunoprecipation experiments show that c-Myc binds directly to this locus. The transcription factor E2F1 is an additional target of c-Myc that promotes cell cycle progression(5-7). We find that expression of E2F1 is negatively regulated by two miRNAs in this cluster, miR-17-5p and miR-20a. These findings expand the known classes of transcripts within the c-Myc target gene network, and reveal a mechanism through which c-Myc simultaneously activates E2F1 transcription and limits its translation, allowing a tightly controlled proliferative signal.	Johns Hopkins Univ, Sch Med, Program Human Genet & Mol Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Mendell, JT (corresponding author), Johns Hopkins Univ, Sch Med, Program Human Genet & Mol Biol, Baltimore, MD 21205 USA.	jmendell@jhmi.edu	Jackson, Benjamin L/C-4297-2012; Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Guo QM, 2000, CANCER RES, V60, P5922; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Levens D, 2002, P NATL ACAD SCI USA, V99, P5757, DOI 10.1073/pnas.102173199; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin YW, 1999, EUR J CANCER, V35, P1730, DOI 10.1016/S0959-8049(99)00205-1; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200	30	2259	2464	2	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2005	435	7043					839	843		10.1038/nature03677	http://dx.doi.org/10.1038/nature03677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944709				2022-12-24	WOS:000229638700055
J	Dye, C; Watt, CJ; Bleed, DM; Hosseini, SM; Raviglione, MC				Dye, C; Watt, CJ; Bleed, DM; Hosseini, SM; Raviglione, MC			Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISONIAZID PREVENTIVE THERAPY; PULMONARY TUBERCULOSIS; RESISTANT TUBERCULOSIS; COST-EFFECTIVENESS; HIV; CHEMOTHERAPY; TRANSMISSION; INFECTION; MORTALITY; EFFICACY	Context The United Nations Millennium Development Goals (MDGs) are stimulating more rigorous evaluations of the impact of DOTS (the WHO-recommended approach to tuberculosis control based on 5 essential elements) and other possible strategies for tuberculosis (TB) control. Objective To evaluate the prospects for detecting 70% of new sputum smear-positive cases and successfully treating 85% of these by the end of 2005, for reducing TB incidence, and for halving TB prevalence and deaths globally between 1990 and 2015, as specified by the MDGs. Data Sources TB case notifications (1980-2003) from DOTS and non-DOTS programs and cohort treatment outcomes (1994-2002) reported annually to the World Health Organization (WHO) by up to 200 countries, TB death registrations, and prevalence surveys of infection and disease. Study Selection Case notification series that reflect trends in incidence, treatment outcomes from DOTS cohorts, death statistics from countries with WHO-validated vital registration systems, and national prevalence surveys of infection and disease. Data Extraction Case reports, treatment outcomes, prevalence surveys - and death registrations from WHO's global TB database covering 1990-2003 to estimate TB incidence, prevalence, and death rates through 2015 for 9 epidemiologically different world regions. Data Synthesis TB incidence increased globally in 2003, but incidence, prevalence, and death rates were approximately stable or decreased in 7 of 9 regions. The exceptions were regions of Africa with low (<4% in adults 15-49 years) and high rates (>= 4%) of HIV infection. The global detection rate of new smear-positive cases by DOTS programs increased from 11% in 1995 to 45% in 2003 (with the lowest case-detection rates in Eastern Europe and the highest rates in the Western Pacific) and could reach 60% by 2005. More than 17 million patients were treated in DOTS programs between 1994 and 2003, with overall treatment success rates more than 80% since 1998. In 2003, overall reported treatment success was 82%, with much variation among regions. The highest rates were reported in the Western Pacific region (89%) and lowest rates in African countries with high and low HIV infection rates (71% and 74%, respectively), in established market economies (77%), and in Eastern Europe (75%). To halve the prevalence rate by 2015, TB control programs must reach global targets for detection (70%) and treatment success (85%) and also reduce the incidence rate by at least 2% annually. To halve the death rate, incidence must decrease more steeply, by at least 5% to 6% annually. Conclusion Reduction of TB incidence, prevalence, and deaths by 2015 could be achieved in most of the world, but the challenge will be greatest in Africa and Eastern Europe.	WHO, Stop TB Dept, CH-1211 Geneva, Switzerland	World Health Organization	Dye, C (corresponding author), WHO, Stop TB Dept, CH-1211 Geneva, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022	RAVIGLIONE, Mario/0000-0002-9331-2067; Dye, Christopher/0000-0002-2957-1793				AISU T, 1995, AIDS, V9, P267, DOI 10.1097/00002030-199509030-00008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; BARNUM HN, 1986, SOC SCI MED, V23, P847, DOI 10.1016/0277-9536(86)90212-1; Barry C, 2001, TUBERCULOSIS, V81, P1, DOI 10.1054/tube.2001.0288; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Borgdorff MW, 2004, EMERG INFECT DIS, V10, P1523, DOI 10.3201/eid1009.040349; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Chen XY, 2004, LANCET, V364, P417; Churchyard GJ, 2003, AIDS, V17, P2063, DOI 10.1097/00002030-200309260-00007; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; DYE C, IN PRESS DIS CONTROL; DYE C, 2003, CLIN TUBERCULOSIS; Elzinga G, 2004, LANCET, V363, P814, DOI 10.1016/S0140-6736(04)15698-5; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Frieden T, 2004, TOMANS TUBERCULOSIS; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1109; IRAWATI SR, 2004, INT J TUBERC LUNG S1, V11, pS98; Jamison D.T., 1993, DIS CONTROL PRIORITI; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P534, DOI 10.1016/0962-8479(95)90530-8; Lietman T, 2000, CLIN INFECT DIS, V30, pS316, DOI 10.1086/313881; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; MURRAY CJL, 1991, LANCET, V338, P1305, DOI 10.1016/0140-6736(91)92600-7; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Radhakrishna S, 2001, INT J TUBERC LUNG D, V5, P142; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; STOP TB, M 2 AD HOC COMM TB E; Styblo K, 1991, TUBERCULOSIS CAN BE, V2, P60; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; UN Millennium Project 2005, 2005, INV STRAT REV GLOB I; *UN STAT DIV, MILL IND DAT; Volmink J, 1997, BMJ-BRIT MED J, V315, P1403, DOI 10.1136/bmj.315.7120.1403; VOLMINK J, 2003, COCHRANE DATABASE SY; *WHO, 2004, INT POL COLL TB HIV; *WHO, 2005, WHOHTMTB2005349; *WHO, STOP TB DEP TUB; *WHO, 2000, 53 WORLD HLTH ASS ST; *WHO, 2004, 3 WHO; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; World Bank, 1993, WORLD DEV REP 1993 I; World Health Organization, 2002, WHOCDSTB2002297; World Health Organization, 1991, WHA441991REC1 WHO; World Hlth Org, 2002, INT J TUBERC LUNG D, V6, P378; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033; FIND DIAGNOSTICS	51	362	378	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2767	2775		10.1001/jama.293.22.2767	http://dx.doi.org/10.1001/jama.293.22.2767			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933OV	15941807				2022-12-24	WOS:000229643700026
J	Khan, SM; Franke-Fayard, B; Mair, GR; Lasonder, E; Janse, CJ; Mann, M; Waters, AP				Khan, SM; Franke-Fayard, B; Mair, GR; Lasonder, E; Janse, CJ; Mann, M; Waters, AP			Proteome analysis of separated male and female gametocytes reveals novel sex-specific Plasmodium biology	CELL			English	Article							HUMAN MALARIA PARASITE; GENE-EXPRESSION; FLOW-CYTOMETRY; DNA-SYNTHESIS; FALCIPARUM; KINASE; BERGHEI; IDENTIFICATION; TRANSMISSION; PURIFICATION	Gametocytes, the precursor cells of malaria-parasite gametes, circulate in the blood and are responsible for transmission from host to mosquito vector. The individual proteomes of male and female gametocytes were analyzed using mass spectrometry, following separation by flow sorting of transgenic parasites expressing green fluorescent protein, in a sex-specific manner. Promoter tagging in transgenic parasites confirmed the designation of stage and sex specificity of the proteins. The male proteome contained 36% (236 of 650) male-specific and the female proteome 19% (101 of 541) female-specific proteins, but they share only 69 proteins, emphasizing the diverged features of the sexes. Of all the malaria life-cycle stages analyzed, the male gametocyte has the most distinct proteome, containing many proteins involved in flagellar-based motility and rapid genome replication. By identification of gender-specific protein kinases and phosphatases and using targeted gene disruption of two kinases, new sex-specific regulatory pathways were defined.	Leiden Univ, Ctr Med, Dept Parasitol, Leiden, Netherlands; Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt Bioinformat, Odense, Denmark; Univ Nijmegen, Dept Mol Biol, NCMLS 191, Nijmegen, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Southern Denmark; Radboud University Nijmegen	Mann, M (corresponding author), Leiden Univ, Ctr Med, Dept Parasitol, Leiden, Netherlands.	mann@bmb.sdu.dk; waters@lumc.nl	Mann, Matthias/A-3454-2013; Waters, Andy P/C-9377-2009	Mann, Matthias/0000-0003-1292-4799; Waters, Andy P/0000-0001-8900-2982; Janse, Chris J/0000-0002-6410-6205; , Blandine/0000-0001-6041-4182; Mair, Gunnar/0000-0002-5187-3691; Lasonder, Edwin/0000-0003-2582-3444; Khan, Shahid/0000-0002-0533-4670	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Bailey TL, 1998, J COMPUT BIOL, V5, P211, DOI 10.1089/cmb.1998.5.211; Beetsma AL, 1998, EXP PARASITOL, V88, P69, DOI 10.1006/expr.1998.4203; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Carter R, 2001, VACCINE, V19, P2309, DOI 10.1016/S0264-410X(00)00521-1; Chen A, 1999, GENE, V234, P127, DOI 10.1016/S0378-1119(99)00165-1; CREASEY A, 1994, MOL BIOCHEM PARASIT, V65, P95, DOI 10.1016/0166-6851(94)90118-X; Doerig CM, 1996, GENE, V177, P1, DOI 10.1016/0378-1119(96)00281-8; Dorin D, 2005, MOL MICROBIOL, V55, P184, DOI 10.1111/j.1365-2958.2004.04393.x; Dorin D, 1999, J BIOL CHEM, V274, P29912, DOI 10.1074/jbc.274.42.29912; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hayward RE, 2000, MOL MICROBIOL, V35, P6, DOI 10.1046/j.1365-2958.2000.01730.x; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Horrocks P, 1998, MOL BIOCHEM PARASIT, V95, P171, DOI 10.1016/S0166-6851(98)00110-8; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; JANSE CJ, 1994, METHOD CELL BIOL, V42, P295; JANSE CJ, 1987, EXP PARASITOL, V64, P88, DOI 10.1016/0014-4894(87)90012-9; Janse CJ, 2004, MALARIA PARASITES: GENOMES AND MOLECULAR BIOLOGY, P445; JANSE CJ, 1986, T ROY SOC TROP MED H, V80, P154, DOI 10.1016/0035-9203(86)90219-1; JANSE CJ, 1985, PARASITOLOGY, V91, P19, DOI 10.1017/S0031182000056481; JANSE CJ, 1989, EXP PARASITOL, V68, P274, DOI 10.1016/0014-4894(89)90109-4; JANSE CJ, 1986, MOL BIOCHEM PARASIT, V20, P173, DOI 10.1016/0166-6851(86)90029-0; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Kaslow DC, 1997, INT J PARASITOL, V27, P183, DOI 10.1016/S0020-7519(96)00148-8; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lu K P, 1995, Prog Cell Cycle Res, V1, P187; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; Sinden RE, 2004, MALARIA PARASITES: GENOMES AND MOLECULAR BIOLOGY, P475; SINDEN RE, 1991, ACT LEIDENS, V60, P19; VAIDYA AB, 1993, MOL CELL BIOL, V13, P7349, DOI 10.1128/MCB.13.12.7349; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Spaendonk RML, 2001, J BIOL CHEM, V276, P22638, DOI 10.1074/jbc.M101234200; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Williamson KC, 1995, MOL BIOCHEM PARASIT, V75, P33, DOI 10.1016/0166-6851(95)02507-3	44	274	286	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					675	687		10.1016/j.cell.2005.03.027	http://dx.doi.org/10.1016/j.cell.2005.03.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935755	Bronze			2022-12-24	WOS:000229658000007
J	Lambert, S; Watson, A; Sheedy, DM; Martin, B; Carr, AM				Lambert, S; Watson, A; Sheedy, DM; Martin, B; Carr, AM			Gross chromosomal rearrangements and elevated recombination at an inducible site-specific replication fork barrier	CELL			English	Article							DNA-REPLICATION; RIBOSOMAL DNA; FISSION YEAST; S-PHASE; ESCHERICHIA-COLI; FRAGILE SITE; MATING-TYPE; SACCHAROMYCES-CEREVISIAE; CHECKPOINT RESPONSE; DELAYED REPLICATION	Genomic rearrangements linked to aberrant recombination are associated with cancer and human genetic diseases. Such recombination has indirectly been linked to replication fork stalling. Using fission yeast, we have developed a genetic system to block replication forks at nonhistone/DNA complexes located at a specific euchromatic site. We demonstrate that stalled replication forks lead to elevated intrachromosomal and ectopic recombination promoting site-specific gross chromosomal rearrangements. We show that recombination is required to promote cell viability when forks are stalled, that recombination proteins associate with sites of fork stalling, and that recombination participates in deleterious site-specific chromosomal rearrangements. Thus, recombination is a "double-edged sword," preventing cell death when the replisome disassembles at the expense of genetic stability.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Carr, AM (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	a.m.carr@sussex.ac.uk	; lambert, sarah/K-7750-2017	Watson, Adam/0000-0002-8140-8205; Carr, Antony Michael/0000-0002-2028-2389; lambert, sarah/0000-0002-1403-3204	MRC [G0001129] Funding Source: UKRI; Medical Research Council [G0001129] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; Arcangioli B, 2000, EMBO REP, V1, P145, DOI 10.1093/embo-reports/kvd023; Arcangioli B, 2000, EMBO J, V19, P1389, DOI 10.1093/emboj/19.6.1389; ARIT MF, 2003, GENOME RES, V100, P92; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Burkhalter MD, 2004, MOL CELL, V15, P409, DOI 10.1016/j.molcel.2004.06.024; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Caspari T, 2002, GENE DEV, V16, P1195, DOI 10.1101/gad.221402; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Codlin S, 2003, EMBO J, V22, P3431, DOI 10.1093/emboj/cdg330; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Dalgaard JZ, 2001, GENE DEV, V15, P2060, DOI 10.1101/gad.200801; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GAME JC, 1973, MUTAT RES, V20, P35, DOI 10.1016/0027-5107(73)90095-X; GLOVER TW, 1988, AM J HUM GENET, V43, P265; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gruber M, 2000, MOL CELL BIOL, V20, P5777, DOI 10.1128/MCB.20.15.5777-5787.2000; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Hansen RS, 1997, P NATL ACAD SCI USA, V94, P4587, DOI 10.1073/pnas.94.9.4587; Hartsuiker E, 2001, EMBO J, V20, P6660, DOI 10.1093/emboj/20.23.6660; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; KEIL RL, 1984, CELL, V39, P377, DOI 10.1016/0092-8674(84)90016-3; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Lee BS, 2004, MOL CELL BIOL, V24, P9813, DOI 10.1128/MCB.24.22.9813-9822.2004; LEE EH, 1989, P NATL ACAD SCI USA, V86, P9104, DOI 10.1073/pnas.86.23.9104; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Muriana PM, 1996, J FOOD PROTECT, P54, DOI 10.4315/0362-028X-59.13.54; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Rothstein R, 2000, GENE DEV, V14, P1; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Straube A, 2004, EUR J NEUROL, V11, P83, DOI 10.1046/j.1468-1331.2003.00754.x; STYRKARSDOTTIR U, 1993, CURR GENET, V23, P184, DOI 10.1007/BF00352020; Subramanian PS, 1996, AM J HUM GENET, V59, P407; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Virgin JB, 2001, GENETICS, V157, P63; Ward TR, 2000, MOL CELL BIOL, V20, P4948, DOI 10.1128/MCB.20.13.4948-4957.2000; Warren ST, 1996, SCIENCE, V271, P1374, DOI 10.1126/science.271.5254.1374; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	66	209	211	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					689	702		10.1016/j.cell.2005.03.022	http://dx.doi.org/10.1016/j.cell.2005.03.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935756	Bronze			2022-12-24	WOS:000229658000008
J	Sullivan, CS; Grundhoff, AT; Tevethia, S; Pipas, JM; Ganem, D				Sullivan, CS; Grundhoff, AT; Tevethia, S; Pipas, JM; Ganem, D			SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells	NATURE			English	Article							INTERFERING RNAS; MESSENGER-RNA; VIRUS; ANTIGEN; SV40	MicroRNAs ( miRNAs) are small (similar to 22-nucleotide) RNAs that in lower organisms serve important regulatory roles in development and gene expression, typically by forming imperfect duplexes with target messenger RNAs1. miRNAs have also been described in mammalian cells and in infections with Epstein - Barr virus (EBV), but the function of most of them is unknown. Although one EBV miRNA probably altered the processing of a viral mRNA(2), the regulatory significance of this event is uncertain, because other transcripts exist that can supply the targeted function(3). Here we report the identification of miRNAs encoded by simian virus 40 (SV40) and define their functional significance for viral infection. SVmiRNAs accumulate at late times in infection, are perfectly complementary to early viral mRNAs, and target those mRNAs for cleavage. This reduces the expression of viral T antigens but does not reduce the yield of infectious virus relative to that generated by a mutant lacking SVmiRNAs. However, wild-type SV40-infected cells are less sensitive than the mutant to lysis by cytotoxic T cells, and trigger less cytokine production by such cells. Thus, viral evolution has taken advantage of the miRNA pathway to generate effectors that enhance the probability of successful infection.	Univ Calif San Francisco, George Williams Hooper Fdn, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, George Williams Hooper Fdn, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, George Williams Hooper Fdn, Dept Med, San Francisco, CA 94143 USA; Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ganem, D (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	ganem@cgl.ucsf.edu		Grundhoff, Adam/0000-0003-0940-7045	NATIONAL CANCER INSTITUTE [R01CA073506] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA073506] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALWINE JC, 1980, J VIROL, V36, P701, DOI 10.1128/JVI.36.3.701-708.1980; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BATES MP, 1988, VIROLOGY, V162, P197, DOI 10.1016/0042-6822(88)90409-6; FURNARI FB, 1993, P NATL ACAD SCI USA, V90, P378, DOI 10.1073/pnas.90.2.378; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Mylin LM, 2000, J VIROL, V74, P6922, DOI 10.1128/JVI.74.15.6922-6934.2000; PEDEN KWC, 1980, SCIENCE, V209, P1392, DOI 10.1126/science.6251547; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Tremblay JD, 2001, METH MOL B, V165, P1; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	14	492	559	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					682	686		10.1038/nature03576	http://dx.doi.org/10.1038/nature03576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15931223				2022-12-24	WOS:000229476200052
J	Osterholm, MT				Osterholm, MT			A weapon the world needs	NATURE			English	Editorial Material									Univ Minnesota, Acad Hlth Ctr, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Univ Minnesota, Acad Hlth Ctr, Ctr Infect Dis Res & Policy, 420 Delaware St SE,MMC 263, Minneapolis, MN 55455 USA.							Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068	1	7	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					417	418		10.1038/435417a	http://dx.doi.org/10.1038/435417a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917778	Green Published			2022-12-24	WOS:000229337800024
J	Liou, GG; Tanny, JC; Kruger, RG; Walz, T; Moazed, D				Liou, GG; Tanny, JC; Kruger, RG; Walz, T; Moazed, D			Assembly of the SIR complex and its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacetylation	CELL			English	Article							SILENT MATING LOCI; SACCHAROMYCES-CEREVISIAE; TELOMERIC HETEROCHROMATIN; PROTEIN SIR2; SIR2/SIR4 COMPLEX; MOLECULAR-MODEL; N-TERMINUS; YEAST; CHROMATIN; GENE	Assembly of silent chromatin domains in budding yeast involves the deacetylation of histone tails by Sir2 and the association of the Sir3 and Sir4 proteins with hypoacetylated histone tails. Sir2 couples deacetylation to NAD hydrolysis and the synthesis of a metabolite, O-acetyl-ADP-ribose (AAR), but the functional significance of NAD hydrolysis or AAR, if any, is unknown. Here we examine the association of the Sir2, Sir3, and Sir4 proteins with each other and histone tails. Our analysis reveals that deacetylation of histone H4-lysine 16 (K16), which is critical for silencing in vivo, is also critical for the binding of Sir3 and Sir4 to histone H4 peptides in vitro. Moreover, AAR itself promotes the association of multiple copies of Sir3 with Sir2/Sir4 and induces a dramatic structural rearrangement in the SIR complex. These results suggest that Sir2 activity modulates the assembly of the SIR complex through both histone deacetylation and AAR synthesis.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol & Biochem, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Tanny, Jason/AAD-3624-2022; Liou, Gunn‐Guang/AAI-9787-2020; Liou, Gan-Guang/E-3976-2010	Walz, Thomas/0000-0003-2606-2835				APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Chang JF, 2003, STRUCTURE, V11, P637, DOI 10.1016/S0969-2126(03)00093-5; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Enomoto S, 2000, GENETICS, V155, P523; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Ghidelli S, 2001, EMBO J, V20, P4522, DOI 10.1093/emboj/20.16.4522; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guarente L, 2000, GENE DEV, V14, P1021; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; KLAR AJS, 1979, GENETICS, V93, P37; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Neuwald AF, 1999, GENOME RES, V9, P27; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; RINE J, 1987, GENETICS, V116, P9; RUDNER AD, 2005, IN PRESS MOL CELL BI; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Shore D, 2000, P NATL ACAD SCI USA, V97, P14030, DOI 10.1073/pnas.011506198; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Straube A, 2004, EUR J NEUROL, V11, P83, DOI 10.1046/j.1468-1331.2003.00754.x; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; THOMPSON JS, 1994, NATURE, V369, P245, DOI 10.1038/369245a0; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016	57	208	213	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					515	527		10.1016/j.cell.2005.03.035	http://dx.doi.org/10.1016/j.cell.2005.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907466	Bronze			2022-12-24	WOS:000229331200009
J	Merrifield, CJ; Perrais, D; Zenisek, D				Merrifield, CJ; Perrais, D; Zenisek, D			Coupling between clathrin-coated-pit invagination, cortactin recruitment, and membrane scission observed in live cells	CELL			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; DYNAMIC ACTIN; IMAGING ACTIN; N-WASP; ACIDIFICATION; LAMELLIPODIA; PROTEIN; SITES; ASSOCIATION; POPULATION	During clathrin-mediated endocytosis, membrane scission marks the isolation of a cargo-laden clathrin-coated pit (CCP) from the cell exterior. Here we used live-cell imaging of a pH-sensitive cargo to visualize the formation of clathrin-coated vesicles (CCVs) at single CCPs with a time resolution of seconds. We show that CCPs are highly dynamic and can produce multiple vesicles in succession. Using alternating evanescent field and epifluorescence illumination, we show that CCP invagination and scission are tightly coupled, with scission coinciding with maximal displacement of CCPs from the plasma membrane and with peak recruitment of cortactin-DsRed, a dynamin and F-actin binding protein. Finally, perturbing actin polymerization with latrunculin-B drastically reduces the efficiency of membrane scission and affects many aspects of CCP dynamics. We propose that CCP invagination, actin polymerization, and CCV formation are highly coordinated for efficient endocytosis.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; CNRS, UMR 5091, Lab Physiol Cellulaire Synapse, F-33077 Bordeaux, France; Univ Bordeaux 2, Inst Francois Magendie, F-33077 Bordeaux, France; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	MRC Laboratory Molecular Biology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Yale University	Merrifield, CJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	cjm@mrc-lmb.cam.ac.uk	Perrais, David/W-9360-2019; Zenisek, David/C-6555-2011	Perrais, David/0000-0002-5878-5408; 	MRC [MC_U105178789] Funding Source: UKRI; Medical Research Council [MC_U105178789] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; BRETSCHER MS, 1984, SCIENCE, V224, P681, DOI 10.1126/science.6719108; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Giardini PA, 2003, P NATL ACAD SCI USA, V100, P6493, DOI 10.1073/pnas.1031670100; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; Iversen TG, 2003, P NATL ACAD SCI USA, V100, P5175, DOI 10.1073/pnas.0534231100; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2000, J CELL SCI, V113, P4421; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mise-Omata S, 2003, BIOCHEM BIOPH RES CO, V301, P704, DOI 10.1016/S0006-291X(02)02972-8; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Rappoport JZ, 2003, J BIOL CHEM, V278, P47357, DOI 10.1074/jbc.C300390200; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Santini F, 2002, NAT CELL BIOL, V4, pE230, DOI 10.1038/ncb1002-e230; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Toomre D, 2000, J CELL BIOL, V149, P33, DOI 10.1083/jcb.149.1.33; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WILLINGHAM MC, 1983, P NATL ACAD SCI-BIOL, V80, P5617, DOI 10.1073/pnas.80.18.5617; WILLINGHAM MC, 1981, J HISTOCHEM CYTOCHEM, V29, P1003, DOI 10.1177/29.9.6169759; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774	47	359	363	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					593	606		10.1016/j.cell.2005.03.015	http://dx.doi.org/10.1016/j.cell.2005.03.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907472	Bronze			2022-12-24	WOS:000229331200015
J	Ramanan, S				Ramanan, S			An act of unkindness	LANCET			English	Editorial Material									St Francis Hosp & Med Ctr, Hartford, CT 06105 USA	Saint Francis Hospital & Medical Center	Ramanan, S (corresponding author), St Francis Hosp & Med Ctr, 114 Woodland St, Hartford, CT 06105 USA.	sramanan@stfranciscare.org							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1743	1743		10.1016/S0140-6736(05)66548-8	http://dx.doi.org/10.1016/S0140-6736(05)66548-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894101				2022-12-24	WOS:000229082300026
J	Edwards, J; Whitaker, D; Klionsky, S; Laskowski, MJ				Edwards, J; Whitaker, D; Klionsky, S; Laskowski, MJ			Botany - A record-breaking pollen catapult	NATURE			English	Article							BIOMECHANICS; POLLINATION; MECHANISM		Williams Coll, Dept Biol, Williamstown, MA 01267 USA; Williams Coll, Dept Phys, Williamstown, MA 01267 USA; Oberlin Coll, Dept Biol, Oberlin, OH 44074 USA	Williams College; Williams College; Oberlin College	Edwards, J (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	joan.edwards@williams.edu						BARRETT SCH, 1987, CAN J BOT, V65, P2036, DOI 10.1139/b87-278; Burrows M, 2003, NATURE, V424, P509, DOI 10.1038/424509a; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kelly D, 1996, NATURE, V384, P615, DOI 10.1038/384615a0; LOVELL JH, 1898, B TORREY BOT CLUB, V25, P382; Marie-Victorin F. E. C., 1935, FLORE LAURENTIENNE; MOSQUIN T, 1985, CAN FIELD NAT, V99, P1; Patek SN, 2004, NATURE, V428, P819, DOI 10.1038/428819a; Voet D., 1995, BIOCHEMISTRY	10	87	92	9	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					164	164		10.1038/435164a	http://dx.doi.org/10.1038/435164a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889081				2022-12-24	WOS:000229021100029
J	Zykov, V; Mytilinaios, E; Adams, B; Lipson, H				Zykov, V; Mytilinaios, E; Adams, B; Lipson, H			Self-reproducing machines	NATURE			English	Article									Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA; Cornell Univ, Dept Comp Sci, Ithaca, NY 14853 USA; Cornell Univ, Dept Math, Ithaca, NY 14853 USA; Cornell Univ, Dept Comp & Informat Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Zykov, V (corresponding author), Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA.	hod.lipson@cornell.edu						Adams B, 2003, LECT NOTES ARTIF INT, V2801, P1; Butler Z, 2002, DISTRIBUTED AUTONOMOUS ROBOTIC SYSTEMS 5, P37; Chirikjian GS, 2002, IEEE-ASME T MECH, V7, P462, DOI 10.1109/TMECH.2002.806232; EFSTATHIOS M, 2004, P 9 INT C ART LIF, P15; Jackman RJ, 1998, SCIENCE, V280, P2089, DOI 10.1126/science.280.5372.2089; LANGTON CG, 1984, PHYSICA D, V10, P135, DOI 10.1016/0167-2789(84)90256-2; Lohn J. D., 1997, IEEE Transactions on Evolutionary Computation, V1, P165, DOI 10.1109/4235.661547; Merkle R. C, 2004, KINEMATIC SELF REPLI; PENROSE LS, 1959, SCI AM, V200, P105, DOI 10.1038/scientificamerican0659-105; RUBENSTEIN M, 2004, P IROS 2004, P2661; Sipper M, 2001, SCI AM, V285, P34, DOI 10.1038/scientificamerican0801-34; VONNEUMANN J, 1970, ESSAYS CELLULAR AUTO, P4; Yim M, 2002, IEEE SPECTRUM, V39, P30, DOI 10.1109/6.981854	13	207	213	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					163	164		10.1038/435163a	http://dx.doi.org/10.1038/435163a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889080				2022-12-24	WOS:000229021100028
J	Gomes, ER; Jani, S; Gundersen, GG				Gomes, ER; Jani, S; Gundersen, GG			Nuclear movement regulated by Cdc42, MRCK, myosin, and actin flow establishes MTOC polarization in migrating cells	CELL			English	Article							MICROTUBULE-ORGANIZING CENTER; CYTOPLASMIC DYNEIN; SELECTIVE STABILIZATION; CDC42-BINDING KINASE; MITOTIC SPINDLE; GOLGI-APPARATUS; LEADING-EDGE; PHOSPHORYLATION; CENTROSOME; LIS1	The microtubule-organizing center (MTOC) is reoriented between the nucleus and the leading edge in many migrating cells and contributes to directional migration. Models suggest that the MTOC is moved to its position during reorientation. By direct imaging of wound-edge fibroblasts after triggering MTOC reorientation with soluble factors, we found instead that the nucleus moved away from the leading edge to reorient the MTOC, while the MTOC remained stationary. Rearward nuclear movement was coupled with actin retrograde flow and was regulated by a pathway involving Cdc42, MRCK, myosin, and actin. Nuclear movement was unaffected by the inhibition of dynein, Par6, or PKC zeta, yet these components were essential for MTOC reorientation, as they maintained the MTOC at the cell centroid. These results show that nuclear repositioning is an initial polarizing event in migrating cells and that the positions of the nucleus and the MTOC are established by separate regulatory pathways.	Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gundersen, GG (corresponding author), Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA.	ggg1@columbia.edu	Gomes, Edgar r/D-9000-2015; Gomes, Edgar/ABH-7441-2020	Gomes, Edgar r/0000-0002-6941-4872; Gomes, Edgar/0000-0002-6941-4872	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062938] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 062938] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; BERGMANN JE, 1983, P NATL ACAD SCI-BIOL, V80, P1367, DOI 10.1073/pnas.80.5.1367; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; EUTENEUER U, 1992, J CELL BIOL, V116, P1157, DOI 10.1083/jcb.116.5.1157; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; GOTLIEB AI, 1981, J CELL BIOL, V91, P589, DOI 10.1083/jcb.91.2.589; GREGORY WA, 1988, J NEUROSCI, V8, P1728; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Ketelaar T, 2002, PLANT CELL, V14, P2941, DOI 10.1105/tpc.005892; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Luo LQ, 1997, P NATL ACAD SCI USA, V94, P12963, DOI 10.1073/pnas.94.24.12963; Mikhailov A, 1998, CELL MOTIL CYTOSKEL, V41, P325, DOI 10.1002/(SICI)1097-0169(1998)41:4<325::AID-CM5>3.0.CO;2-D; MIKHAILOV AV, 1995, CELL MOTIL CYTOSKEL, V32, P173, DOI 10.1002/cm.970320303; Morris NR, 2003, CURR OPIN CELL BIOL, V15, P54, DOI 10.1016/S0955-0674(02)00004-2; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sakurada K, 1998, AM J PHYSIOL-CELL PH, V274, pC1563, DOI 10.1152/ajpcell.1998.274.6.C1563; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schliwa Manfred, 1993, Trends in Cell Biology, V3, P377; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; VONDASSOW G, 1994, J CELL BIOL, V127, P1637, DOI 10.1083/jcb.127.6.1637; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565	60	451	455	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					451	463		10.1016/j.cell.2005.02.022	http://dx.doi.org/10.1016/j.cell.2005.02.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882626	Bronze			2022-12-24	WOS:000229031600014
J	You, LR; Lin, FJ; Lee, CT; DeMayo, FJ; Tsai, MJ; Tsai, SY				You, LR; Lin, FJ; Lee, CT; DeMayo, FJ; Tsai, MJ; Tsai, SY			Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity	NATURE			English	Article							STEM-CELL NICHE; CARDIOVASCULAR DEVELOPMENT; EMBRYONIC ANGIOGENESIS; VESSEL FORMATION; RECEPTOR; MICE; PATHWAY; LIGAND; MOUSE; DIFFERENTIATION	Arteries and veins are anatomically, functionally and molecularly distinct. The current model of arterial - venous identity proposes that binding of vascular endothelial growth factor to its heterodimeric receptor - Flk1 and neuropilin 1 (NP-1; also called Nrp1) - activates the Notch signalling pathway in the endothelium, causing induction of ephrin B2 expression and suppression of ephrin receptor B4 expression to establish arterial identity(1-4). Little is known about vein identity except that it involves ephrin receptor B4 expression, because Notch signalling is not activated in veins; an unresolved question is how vein identity is regulated. Here, we show that COUP-TFII ( also known as Nr2f2), a member of the orphan nuclear receptor superfamily, is specifically expressed in venous but not arterial endothelium. Ablation of COUP-TFII in endothelial cells enables veins to acquire arterial characteristics, including the expression of arterial markers NP-1 and Notch signalling molecules, and the generation of haematopoietic cell clusters. Furthermore, ectopic expression of COUP-TFII in endothelial cells results in the fusion of veins and arteries in transgenic mouse embryos. Thus, COUP-TFII has a critical role in repressing Notch signalling to maintain vein identity, which suggests that vein identity is under genetic control and is not derived by a default pathway.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dev Biol Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Tsai, MJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	mtsai@bcm.tmc.edu; stsai@bcm.tmc.edu	Hsiao, Wei-Hung/B-9931-2013; DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; You, Li-Ru/0000-0003-1775-0097; LIN, FU-JUNG/0000-0003-4065-0983				Adams RH, 2003, J ANAT, V202, P105, DOI 10.1046/j.1469-7580.2003.00137.x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hogan B, 1994, MANIPULATING MOUSE E; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Krebs LT, 2000, GENE DEV, V14, P1343; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2001, DEVELOPMENT, V128, P3675; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	27	440	454	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					98	104		10.1038/nature03511	http://dx.doi.org/10.1038/nature03511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875024				2022-12-24	WOS:000228864600046
J	Albertsen, PC; Hanley, JA; Fine, J				Albertsen, PC; Hanley, JA; Fine, J			20-year outcomes following conservative management of clinically localized prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADICAL PROSTATECTOMY; NATURAL-HISTORY; UNITED-STATES; MEN; TRIAL; DEATH	Context The appropriate therapy for men with clinically localized prostate cancer is uncertain. A recent study suggested an increasing prostate cancer mortality rate for men who are alive more than 15 years following diagnosis. Objective To estimate 20-year survival based on-a competing risk analysis of men who were diagnosed with clinically localized prostate cancer and treated with observation or androgen withdrawal therapy alone, stratified by age at diagnosis and histological findings. Design, Setting, and Patients A retrospective population-based cohort study using Connecticut Tumor Registry data supplemented by hospital record and histology review of 767 men aged 55 to 74 years with clinically localized prostate cancer diagnosed between January 1, 1971, and December 31, 1984. Patients were treated with either observation or immediate or delayed androgen withdrawal therapy, with a median observation of 24 years. Main Outcome Measures Probability of mortality from prostate cancer or other competing medical conditions, given a patient's age at diagnosis and tumor grade. Results The prostate cancer mortality rate was 33 per 1000 person-years during the first 15 years of follow-up (95% confidence interval [CI], 28-38) and 18 per 1000 person-years after 15 years of follow-up (95% Cl, 10-29). The mortality rates for these 2 follow-up periods were not statistically different, after adjusting for differences in tumor histology (rate ratio, 1.1; 95% Cl, 0.6-1.9). Men with low-grade prostate cancers have a minimal risk of dying from prostate cancer during 20 years of follow-up (Gleason score of 2-4, 6 deaths per 1000 person-years; 95% Cl, 2-11). Men with high-grade prostate cancers have a high probability of dying from prostate cancer within 10 years of diagnosis (Gleason score of 8-10, 121 deaths per 1000 person-years; 95% Cl, 90156). Men with Gleason score of 5 or 6 tumors have an intermediate risk of prostate cancer death. Conclusion The annual mortality rate from prostate cancer appears to remain stable after 15 years from diagnosis, which does not support aggressive treatment for localized low-grade prostate cancer.	Univ Connecticut, Ctr Hlth, Div Urol, Farmington, CT 06030 USA; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada	University of Connecticut; McGill University	Albertsen, PC (corresponding author), Univ Connecticut, Ctr Hlth, Div Urol, 263 Farmington Ave, Farmington, CT 06030 USA.	albertsen@nso.uchc.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009578] Funding Source: NIH RePORTER; AHRQ HHS [HS09578] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Albertsen PC, 2000, J UROLOGY, V163, P519, DOI 10.1016/S0022-5347(05)67915-3; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; Donovan J, 2003, Health Technol Assess, V7, P1; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; ESPOSTI P L, 1971, Scandinavian Journal of Urology and Nephrology, V5, P199, DOI 10.3109/00365597109133601; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; MURPHY GP, 1982, J UROLOGY, V127, P928, DOI 10.1016/S0022-5347(17)54135-X; Penson DF, 2001, J NATL CANCER I, V93, P1822, DOI 10.1093/jnci/93.23.1822; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Schroder FH, 1997, BRIT J UROL, V79, P68, DOI 10.1111/j.1464-410X.1997.tb00804.x; Stamey TA, 2004, J UROLOGY, V172, P1297, DOI 10.1097/01.ju.0000139993.51181.5d; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Wilt T J, 1997, Oncology (Williston Park), V11, P1133	17	894	926	1	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2095	2101		10.1001/jama.293.17.2095	http://dx.doi.org/10.1001/jama.293.17.2095			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870412				2022-12-24	WOS:000228808200018
J	Berken, A; Thomas, C; Wittinghofer, A				Berken, A; Thomas, C; Wittinghofer, A			A new family of RhoGEFs activates the Rop molecular switch in plants	NATURE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; SALMONELLA-TYPHIMURIUM; GTPASE; DOMAIN; RAS; FLUORESCENCE; SUPERFAMILY; INHIBITOR; GUANOSINE; REGION	In plants, the small GTP-binding proteins called Rops work as signalling switches that control growth, development and plant responses to various environmental stimuli(1-3). Rop proteins ( Rho of plants, Rac-like and AtRac in Arabidopsis thaliana) belong to the Rho family of Ras-related GTP-binding proteins that turn on signalling pathways by switching from a GDP-bound inactive to a GTP-bound active conformation(4,5). Activation depends on guanine nucleotide exchange factors ( GEFs) that catalyse the otherwise slow GDP dissociation for subsequent GTP binding(6). Although numerous RhoGEFs exist in animals and yeasts(7), no Rop-specific GEFs have yet been identified in plants and so Rop activation has remained elusive(1-3,8). Here we describe a new family of RhoGEF proteins that are exclusive to plants. We define a unique domain within these RopGEFs, termed PRONE (plant-specific Rop nucleotide exchanger), which is exclusively active towards members of the Rop subfamily. It increases nucleotide dissociation from Rop more than a thousand-fold and forms a tight complex with nucleotide-free Rop. RopGEFs may represent the missing link in signal transduction from receptor kinases to Rops and their identification has implications for the evolution of the Rho molecular switch.	Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Max Planck Society	Berken, A (corresponding author), Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	antje.berken@mpi-dortmund.mpg.de		Thomas, Christoph/0000-0001-7441-1089				Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Cool RH, 1999, MOL CELL BIOL, V19, P6297; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; HARPER JW, 1993, CELL, V75, P805; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Qiu JL, 2002, PLANT CELL, V14, P101, DOI 10.1105/tpc.010346; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; ROSS MD, 1980, CLIN ONCOL, V6, P167; Rudolph MG, 1999, J BIOL CHEM, V274, P30501, DOI 10.1074/jbc.274.43.30501; Schmidt G, 1996, ONCOGENE, V12, P87; Valster AH, 2000, TRENDS CELL BIOL, V10, P141, DOI 10.1016/S0962-8924(00)01728-1; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948	30	193	224	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1176	1180		10.1038/nature03883	http://dx.doi.org/10.1038/nature03883			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	15980860				2022-12-24	WOS:000231416600050
J	Hafting, T; Fyhn, M; Molden, S; Moser, MB; Moser, EI				Hafting, T; Fyhn, M; Molden, S; Moser, MB; Moser, EI			Microstructure of a spatial map in the entorhinal cortex	NATURE			English	Article							HEAD-DIRECTION CELLS; HIPPOCAMPAL ENSEMBLE CODE; PATH-INTEGRATION; PLACE CELLS; FUNCTIONAL-ORGANIZATION; NEURONS; RAT; MEMORY; CA3; INFORMATION	The ability to find one's way depends on neural algorithms that integrate information about place, distance and direction, but the implementation of these operations in cortical microcircuits is poorly understood. Here we show that the dorsocaudal medial entorhinal cortex ( dMEC) contains a directionally oriented, topographically organized neural map of the spatial environment. Its key unit is the 'grid cell', which is activated whenever the animal's position coincides with any vertex of a regular grid of equilateral triangles spanning the surface of the environment. Grids of neighbouring cells share a common orientation and spacing, but their vertex locations ( their phases) differ. The spacing and size of individual fields increase from dorsal to ventral dMEC. The map is anchored to external landmarks, but persists in their absence, suggesting that grid cells may be part of a generalized, path-integration-based map of the spatial environment.	Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Hafting, Torkel/0000-0002-0928-3487				[Anonymous], 1998, NEURAL NETWORKS BRAI; Biegler R, 2000, ANIM LEARN BEHAV, V28, P257, DOI 10.3758/BF03200260; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; GALLISTER CR, 1990, ORG LEARNING; GERMROTH P, 1991, J COMP NEUROL, V305, P215, DOI 10.1002/cne.903050205; GOODRIDGE JP, 1995, BEHAV NEUROSCI, V109, P49, DOI 10.1037/0735-7044.109.1.49; Gothard KM, 1996, J NEUROSCI, V16, P8027; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; IKEDA J, 1989, BRAIN RES, V505, P176, DOI 10.1016/0006-8993(89)90134-0; Jeffery KJ, 1997, EXP BRAIN RES, V117, P131, DOI 10.1007/s002210050206; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; LINGENHOHL K, 1991, EXP BRAIN RES, V84, P57; Lorincz A, 2000, ANN NY ACAD SCI, V911, P83; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNaughton BL, 1996, J EXP BIOL, V199, P173; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nadel L., 1991, Hippocampus, V1, P221, DOI 10.1002/hipo.450010302; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Parron C, 2004, EXP BRAIN RES, V159, P349, DOI 10.1007/s00221-004-1960-8; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Rockland KS, 2004, EXP BRAIN RES, V158, P265, DOI 10.1007/s00221-004-2024-9; Samsonovich A, 1997, J NEUROSCI, V17, P5900; SARGOLINI F, 2004, SOC NEUR ABSTR, V30; SHARP PE, 1995, J NEUROSCI, V15, P173; Sharp PE, 1999, HIPPOCAMPUS, V9, P432, DOI 10.1002/(SICI)1098-1063(1999)9:4<432::AID-HIPO9>3.3.CO;2-G; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P436; vanHaeften T, 1997, J NEUROSCI, V17, P862; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	50	2151	2235	23	522	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					801	806		10.1038/nature03721	http://dx.doi.org/10.1038/nature03721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	15965463				2022-12-24	WOS:000231116500035
J	Pelkmans, L; Fava, E; Grabner, H; Hannus, M; Habermann, B; Krausz, E; Zerial, M				Pelkmans, L; Fava, E; Grabner, H; Hannus, M; Habermann, B; Krausz, E; Zerial, M			Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis	NATURE			English	Article							MEMBRANE DOMAINS; SIGNAL-TRANSDUCTION; CELL; TRANSPORT; ENTRY; SIMIAN-VIRUS-40; CAVEOLIN-1; RECEPTOR; COMPLEX; FUSION	Endocytosis is a key cellular process, encompassing different entry routes and endocytic compartments. To what extent endocytosis is subjected to high-order regulation by the cellular signalling machinery remains unclear. Using high-throughput RNA interference and automated image analysis, we explored the function of human kinases in two principal types of endocytosis: clathrin- and caveolae/raft-mediated endocytosis. We monitored this through infection of vesicular stomatitis virus, simian virus 40 and transferrin trafficking, and also through cell proliferation and apoptosis assays. Here we show that a high number of kinases are involved in endocytosis, and that each endocytic route is regulated by a specific kinase subset. Notably, one group of kinases exerted opposite effects on the two endocytic routes, suggesting coordinate regulation. Our analysis demonstrates that signalling functions such as those controlling cell adhesion, growth and proliferation, are built into the machinery of endocytosis to a much higher degree than previously recognized.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; MPI CBG High Throughput Technol Dev Studio, D-01307 Dresden, Germany; Scionics Comp Innovat GmbH, D-01307 Dresden, Germany; Ceniix Biosci GmbH, D-01307 Dresden, Germany	Max Planck Society; Max Planck Society	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Habermann, Bianca/N-4886-2016	Habermann, Bianca/0000-0002-2457-7504; Pelkmans, Lucas/0000-0002-6754-9730; Fava, Eugenio/0000-0002-3737-0334				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; LUCOCQ J, 1991, J CELL SCI, V100, P753; MACE G, UNPUB EMBO J; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Nguyen C, 2003, J CELL BIOL, V163, P697, DOI 10.1083/jcb.200310038; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; PELKMANS L, UNPUB NATURE; Razani B, 2001, EXP CELL RES, V271, P36, DOI 10.1006/excr.2001.5372; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WOODMAN PG, 1992, J CELL BIOL, V116, P331, DOI 10.1083/jcb.116.2.331; Xue LZ, 1998, CELL SIGNAL, V10, P339, DOI 10.1016/S0898-6568(98)00011-4; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	51	495	517	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					78	86		10.1038/nature03571	http://dx.doi.org/10.1038/nature03571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	15889048				2022-12-24	WOS:000230296600042
J	Balagadde, FK; You, LC; Hansen, CL; Arnold, FH; Quake, SR				Balagadde, FK; You, LC; Hansen, CL; Arnold, FH; Quake, SR			Long-term monitoring of bacteria undergoing programmed population control in a microchemostat	SCIENCE			English	Article							MICROBIOREACTOR; GROWTH	Using an active approach to preventing biofilm formation, we implemented a microfluidic bioreactor that enables long-term culture and monitoring of extremely small populations of bacteria with single-cell resolution. We used this device to observe the dynamics of Escherichia coli carrying a synthetic "population control" circuit that regulates cell density through a feedback mechanism based on quorum sensing. The microfluidic bioreactor enabled long-term monitoring of unnatural behavior programmed by the synthetic circuit, which included sustained oscillations in cell density and associated morphological changes, over hundreds of hours.	CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu		Arnold, Frances H./0000-0002-4027-364X				Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; FOX MS, 1955, J GEN PHYSIOL, V39, P267, DOI 10.1085/jgp.39.2.267; Kim JW, 1998, J KOREAN PHYS SOC, V33, pS462; Kostov Y, 2001, BIOTECHNOL BIOENG, V72, P346, DOI 10.1002/1097-0290(20010205)72:3<346::AID-BIT12>3.0.CO;2-X; LARSEN DH, 1964, J BACTERIOL, V88, P1380, DOI 10.1128/JB.88.5.1380-1387.1964; Maharbiz MM, 2004, BIOTECHNOL BIOENG, V85, P376, DOI 10.1002/bit.10835; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; NOVICK A, 1955, ANNU REV MICROBIOL, V9, P97, DOI 10.1146/annurev.mi.09.100155.000525; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; Smith HL., 1995, THEORY CHEMOSTAT DYN; TOPIWALA HH, 1971, BIOTECHNOL BIOENG, V13, P919, DOI 10.1002/bit.260130614; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Zanzotto A, 2004, BIOTECHNOL BIOENG, V87, P243, DOI 10.1002/bit.20140	17	441	463	6	233	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					137	140		10.1126/science.1109173	http://dx.doi.org/10.1126/science.1109173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994559				2022-12-24	WOS:000230212800077
J	Depaepe, V; Suarez-Gonzalez, N; Dufour, A; Passante, L; Gorski, JA; Jones, KR; Ledent, C; Vanderhaeghen, P				Depaepe, V; Suarez-Gonzalez, N; Dufour, A; Passante, L; Gorski, JA; Jones, KR; Ledent, C; Vanderhaeghen, P			Ephrin signalling controls brain size by regulating apoptosis of neural progenitors	NATURE			English	Article							CELL-DEATH; MOUSE NEOCORTEX; RECEPTORS; MIGRATION; SURVIVAL; PROLIFERATION; NEUROGENESIS; INHIBITION; NEURONS; CORTEX	Mechanisms controlling brain size include the regulation of neural progenitor cell proliferation, differentiation, survival and migration(1,2). Here we show that ephrin-A/EphA receptor signalling plays a key role in controlling the size of the mouse cerebral cortex by regulating cortical progenitor cell apoptosis. In vivo gain of EphA receptor function, achieved through ectopic expression of ephrin-A5 in early cortical progenitors expressing EphA7, caused a transient wave of neural progenitor cell apoptosis, resulting in premature depletion of progenitors and a subsequent dramatic decrease in cortical size. In vitro treatment with soluble ephrin-A ligands similarly induced the rapid death of cultured dissociated cortical progenitors in a caspase-3-dependent manner, thereby confirming a direct effect of ephrin/Eph signalling on apoptotic cascades. Conversely, in vivo loss of EphA function, achieved through EphA7 gene disruption, caused a reduction in apoptosis occurring normally in forebrain neural progenitors, resulting in an increase in cortical size and, in extreme cases, exencephalic forebrain overgrowth. Together, these results identify ephrin/Eph signalling as a physiological trigger for apoptosis that can alter brain size and shape by regulating the number of neural progenitors.	Univ Brussels, IRIBHM, B-1070 Brussels, Belgium; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Universite Libre de Bruxelles; University of Colorado System; University of Colorado Boulder	Vanderhaeghen, P (corresponding author), Univ Brussels, IRIBHM, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	pvdhaegh@ulb.ac.be		JONES, KEVIN/0000-0002-3802-7562; Vanderhaeghen, Pierre/0000-0001-7899-5720				Bagnard D, 2001, J NEUROSCI, V21, P3332, DOI 10.1523/JNEUROSCI.21-10-03332.2001; Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Gorski JA, 2002, J NEUROSCI, V22, P6309; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Raoul C, 2000, CURR OPIN NEUROBIOL, V10, P111, DOI 10.1016/S0959-4388(99)00055-0; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Wilkie AL, 2004, DEV BIOL, V267, P109, DOI 10.1016/j.ydbio.2003.11.006; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200; Yue Y, 1999, J NEUROSCI, V19, P10026; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	30	222	230	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1244	1250		10.1038/nature03651	http://dx.doi.org/10.1038/nature03651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15902206				2022-12-24	WOS:000230140500046
J	Petrides, M; Cadoret, GV; Mackey, S				Petrides, M; Cadoret, GV; Mackey, S			Orofacial somatomotor responses in the macaque monkey homologue of Broca's area	NATURE			English	Article							VENTROLATERAL PREFRONTAL CORTEX; FRONTAL EYE FIELDS; PREMOTOR CORTEX; MNEMONIC RETRIEVAL; GREAT APES; LANGUAGE; REGION; VARIABILITY; ACTIVATION; MOVEMENTS	In the ventrolateral frontal lobe of the human brain there is a distinct entity, cytoarchitectonic area 44 ( Broca's area), which is crucial in speech production(1-4). There has been controversy(5,6) over whether monkeys possess an area comparable to human area 44. We have addressed this question in the macaque monkey by combining quantitative architectonic analysis of the cortical areas within the ventrolateral frontal region with electrophysiological recording of neuron activity and electrical intracortical microstimulation. Here we show that, immediately in front of the ventral part of the agranular premotor cortical area 6, there is a distinct cortical area that is architectonically comparable to human area 44 and that this monkey area 44 is involved with the orofacial musculature. We suggest that area 44 might have evolved originally as an area exercising high-level control over orofacial actions, including those related to communicative acts, and that, in the human brain, area 44 eventually also came to control certain aspects of the speech act.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Petrides, M (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	petrides@ego.psych.mcgill.ca	Galantucci, Bruno/E-5770-2010					Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; Brodmann, 1909, VERGLEICHENDE LOKALI; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Cadoret G, 2001, EUR J NEUROSCI, V14, P1164, DOI 10.1046/j.0953-816x.2001.01737.x; CADORET G, 2004, SOC NEUROSCI PROG, V324, P3; Cantalupo C, 2001, NATURE, V414, P505, DOI 10.1038/35107134; Duffau H, 2003, NEUROIMAGE, V20, P1903, DOI 10.1016/S1053-8119(03)00203-9; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; HUERTA MF, 1987, J COMP NEUROL, V271, P473; Hurford JR, 2004, VIENNA S THEOR BIOL, P297; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; Matelli M., 2004, HUMAN NERVOUS SYSTEM, P973, DOI [10.1016/B978-012547626-3/50027-2, DOI 10.1016/B978-012547626-3/50027-2]; MOHR JP, 1976, STUDIES NEUROLINGUIS, P201; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Penfield W., 1959, SPEECH BRAIN MECH; Petrides M, 2002, NEUROBIOL LEARN MEM, V78, P528, DOI 10.1006/nlme.2002.4107; PETRIDES M, 1995, P NATL ACAD SCI USA, V92, P5803, DOI 10.1073/pnas.92.13.5803; Poeppel D, 2004, COGNITION, V92, P1, DOI 10.1016/j.cognition.2003.11.001; Rasmussen T., 1975, CEREBRAL LOCALIZATIO, P238, DOI DOI 10.1007/978-3-642-66204-1.J9; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Schleicher A, 2000, J CHEM NEUROANAT, V20, P31, DOI 10.1016/S0891-0618(00)00076-4; Sherwood CC, 2003, ANAT REC PART A, V271A, P276, DOI 10.1002/ar.a.10046; STANTON GB, 1989, J COMP NEUROL, V282, P415, DOI 10.1002/cne.902820308; TIAN JR, 1995, J NEUROPHYSIOL, V74, P2204, DOI 10.1152/jn.1995.74.5.2204; Tian JR, 1996, J NEUROPHYSIOL, V76, P2740, DOI 10.1152/jn.1996.76.4.2740; Tokuno H, 1997, J COMP NEUROL, V389, P34, DOI 10.1002/(SICI)1096-9861(19971208)389:1<34::AID-CNE3>3.0.CO;2-F	30	254	261	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2005	435	7046					1235	1238		10.1038/nature03628	http://dx.doi.org/10.1038/nature03628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988526				2022-12-24	WOS:000230140500044
J	Bell, T; Ager, D; Song, JI; Newman, JA; Thompson, IP; Lilley, AK; van der Gast, CJ				Bell, T; Ager, D; Song, JI; Newman, JA; Thompson, IP; Lilley, AK; van der Gast, CJ			Larger islands house more bacterial taxa	SCIENCE			English	Article							DISPERSAL		NERC, Ctr Ecol & Hydrol, Environm Biotechnol Sect, Oxford OX1 3SR, England; NERC, Ctr Ecol & Hydrol, Mol Microbial Ecol Sect, Oxford OX1 3SR, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Oxford; University of Oxford	van der Gast, CJ (corresponding author), NERC, Ctr Ecol & Hydrol, Environm Biotechnol Sect, Mansfield Rd, Oxford OX1 3SR, England.	cjvdg@ceh.ac.uk	van der Gast, Christopher/G-1153-2011; Newman, Jonathan/A-5932-2008	van der Gast, Christopher/0000-0003-1101-4048; Newman, Jonathan/0000-0003-3155-4084; Bell, Thomas/0000-0002-2615-3932; Song, Ji-Inn/0000-0002-0180-6423				Azovsky AI, 2002, ECOGRAPHY, V25, P273, DOI 10.1034/j.1600-0587.2002.250303.x; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002	6	184	208	5	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1884	1884		10.1126/science.1111318	http://dx.doi.org/10.1126/science.1111318			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976296				2022-12-24	WOS:000230120000031
J	Templeton, CN; Greene, E; Davis, K				Templeton, CN; Greene, E; Davis, K			Allometry of alarm calls: Black-capped chickadees encode information about predator size	SCIENCE			English	Article							MOBBING CALLS; EVOLUTION; URGENCY	Many animals produce alarm signals when they detect a potential predator, but we still know little about the information contained in these signals. Using presentations of 15 species of live predators, we show that acoustic features of the mobbing calls of black-capped chickadees (Poecile atricapilla) vary with the size of the predator. Companion playback experiments revealed that chickadees detect this information and that the intensity of mobbing behavior is related to the size and threat of the potential predator. This study demonstrates ani unsuspected level of complexity and sophistication in avian alarm calls.	Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; Univ Montana, Div Biol Sci, Florence, MT 59833 USA; Raptors Rockies, Florence, MT 59833 USA	University of Montana System; University of Montana; University of Montana System; University of Montana	Templeton, CN (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	ctemple2@u.washington.edu	Templeton, Christopher/AAY-4832-2021	Templeton, Christopher/0000-0001-8701-3186				Baker MC, 2002, WILSON BULL, V114, P510, DOI 10.1676/0043-5643(2002)114[0510:MCOBCC]2.0.CO;2; Blumstein Daniel T., 2002, Evolution of Communication, V3, P135, DOI 10.1075/eoc.3.2.03blu; Blumstein DT, 1999, BEHAVIOUR, V136, P731, DOI 10.1163/156853999501540; Bradbury Jack W., 1998, pi; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Dial KP, 2003, AUK, V120, P941, DOI 10.1642/0004-8038(2003)120[0941:EOALCO]2.0.CO;2; EVANS CS, 1993, ANIM BEHAV, V46, P23, DOI 10.1006/anbe.1993.1158; Evans CS, 1997, PERSP ETHOL, V12, P99; FICKEN MS, 1977, AUK, V94, P156; FICKEN MS, 1978, AUK, V95, P34, DOI 10.2307/4085493; Foresman K.R., 2001, WILD MAMMALS MONTANA; Greene E, 1998, ANIM BEHAV, V55, P511, DOI 10.1006/anbe.1997.0620; Hauser, 1996, EVOL COMMUN; HOWLAND HC, 1974, J THEOR BIOL, V47, P333, DOI 10.1016/0022-5193(74)90202-1; Hurd CR, 1996, BEHAV ECOL SOCIOBIOL, V38, P287, DOI 10.1007/s002650050244; Johnsgard P. A., 1990, HAWKS EAGLES FALCONS; Johnsgard P. A., 2002, N AM OWLS BIOL NATUR; Le Roux A, 2001, BEHAVIOUR, V138, P757, DOI 10.1163/156853901752233398; MACEDONIA JM, 1993, ETHOLOGY, V93, P177, DOI 10.1111/j.1439-0310.1993.tb00988.x; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; MARLER P, 1955, NATURE, V176, P6, DOI 10.1038/176006a0; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; NOWICKI S, 1983, BEHAV ECOL SOCIOBIOL, V12, P317, DOI 10.1007/BF00302899; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; SHERMAN PW, 1977, SCIENCE, V197, P1246, DOI 10.1126/science.197.4310.1246; Sibley D.A., 2014, SIBLEY GUIDE BIRDS, Vsecond; Smith S.M., 1991, BLACK CAPPED CHICKAD	28	435	443	8	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1934	1937		10.1126/science.1108841	http://dx.doi.org/10.1126/science.1108841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976305				2022-12-24	WOS:000230120000047
J	Westbrook, TF; Martin, ES; Schlabach, MR; Leng, YM; Liang, AC; Feng, B; Zhao, JJ; Roberts, TM; Mandel, G; Hannon, GJ; DePinho, RA; Chin, L; Elledge, SJ				Westbrook, TF; Martin, ES; Schlabach, MR; Leng, YM; Liang, AC; Feng, B; Zhao, JJ; Roberts, TM; Mandel, G; Hannon, GJ; DePinho, RA; Chin, L; Elledge, SJ			A genetic screen for candidate tumor suppressors identifies REST	CELL			English	Article							MAMMARY EPITHELIAL-CELLS; TGF-BETA; HUMAN CANCER; TRANSFORMATION; RAS; EXPRESSION; PATHWAY; ADENOCARCINOMA; PROLIFERATION; REQUIREMENTS	Tumorigenesis is a multistep process characterized by a myriad of genetic and epigenetic alterations. Identifying the causal perturbations that confer malignant transformation is a central goal in cancer biology. Here we report an RNAi-based genetic screen for genes that suppress transformation of human mammary epithelial cells. We identified genes previously implicated in proliferative control and epithelial cell function including two established tumor suppressors, TGFBR2 and PTEN. In addition, we uncovered a previously unrecognized tumor suppressor role for REST/ NRSF, a transcriptional repressor of neuronal gene expression. Array-CGH analysis identified REST as a frequent target of deletion in colorectal cancer. Furthermore, we detect a frameshift mutation of the REST gene in colorectal cancer cells that encodes a dominantly acting truncation capable of transforming epithelial cells. Cells lacking REST exhibit increased PI(3)K signaling and are dependent upon this pathway for their transformed phenotype. These results implicate REST as a human tumor suppressor and provide a novel approach to identifying candidate genes that suppress the development of human cancer.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Partners Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; SUNY Stony Brook, Howard Hughes Med Inst, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Partners Healthcare System; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cold Spring Harbor Laboratory	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Partners Ctr Genet & Genom, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Hannon, Gregory/AAB-3568-2019	DePinho, Ronald/0000-0002-5625-577X	NCI NIH HHS [R01CA93947, 5T32CA09361, U01 CA084313, 5 P50 CA090381-03, 5 P01 CA89021-04, R01CA99041] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA089021, T32CA009361, P50CA090381, R01CA099041, U01CA084313, R01CA093947] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Albert ML, 2004, NAT REV CANCER, V4, P36, DOI 10.1038/nrc1255; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; Neumann SB, 2004, MOL BRAIN RES, V120, P173, DOI 10.1016/j.molbrainres.2003.10.021; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang J, 2000, NATURE, V405, P755, DOI 10.1038/35015674; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005	45	396	416	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					837	848		10.1016/j.cell.2005.03.033	http://dx.doi.org/10.1016/j.cell.2005.03.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960972	Bronze			2022-12-24	WOS:000230011200007
J	Hatfield, SD; Shcherbata, HR; Fischer, KA; Nakahara, K; Carthew, RW; Ruohola-Baker, H				Hatfield, SD; Shcherbata, HR; Fischer, KA; Nakahara, K; Carthew, RW; Ruohola-Baker, H			Stem cell division is regulated by the microRNA pathway	NATURE			English	Article							DEPENDENT KINASE INHIBITOR; DROSOPHILA OVARY; CYCLE; PROLIFERATION; EMBRYOGENESIS; RENEWAL; DACAPO; ROLES; NICHE	One of the key characteristics of stem cells is their capacity to divide for long periods of time in an environment where most of the cells are quiescent. Therefore, a critical question in stem cell biology is how stem cells escape cell division stop signals. Here, we report the necessity of the microRNA (miRNA) pathway(1-4) for proper control of germline stem cell (GSC) division in Drosophila melanogaster. Analysis of GSCs mutant for dicer-1 (dcr-1), the double-stranded RNaseIII essential for miRNA biogenesis, revealed a marked reduction in the rate of germline cyst production. These dcr-1 mutant GSCs exhibit normal identity but are defective in cell cycle control. On the basis of cell cycle markers and genetic interactions, we conclude that dcr-1 mutant GSCs are delayed in the G1 to S transition, which is dependent on the cyclin-dependent kinase inhibitor Dacapo, suggesting that miRNAs are required for stem cells to bypass the normal G1/S checkpoint. Hence, the miRNA pathway might be part of a mechanism that makes stem cells insensitive to environmental signals that normally stop the cell cycle at the G1/S transition.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	University of Washington; University of Washington Seattle; Northwestern University	Ruohola-Baker, H (corresponding author), Univ Washington, Dept Biochem, J591,HSB, Seattle, WA 98195 USA.	r-carthew@northwestern.edu; hannele@u.washington.edu	Shcherbata, Halyna/J-5712-2017; Nakahara, Kenji/F-5780-2012	Shcherbata, Halyna/0000-0002-3855-0345; Nakahara, Kenji/0000-0002-9541-3208	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077581] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Calvi BR, 2004, METH MOL B, V247, P203; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Enright AJ, 2004, GENOME BIOL, V5; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; Gonczy P, 1996, DEVELOPMENT, V122, P2437; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Meyer CA, 2002, DEVELOPMENT, V129, P319; Nakahara K, 2004, CURR OPIN CELL BIOL, V16, P127, DOI 10.1016/j.ceb.2004.02.006; Newfeld SJ, 1997, DEVELOPMENT, V124, P3167; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Shcherbata HR, 2004, DEVELOPMENT, V131, P3169, DOI 10.1242/dev.01172; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019	30	546	607	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					974	978		10.1038/nature03816	http://dx.doi.org/10.1038/nature03816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15944714	Green Published			2022-12-24	WOS:000229799700053
J	Wang, HW; Nogales, E				Wang, HW; Nogales, E			Nucleotide-dependent bending flexibility of tubulin regulates microtubule assembly	NATURE			English	Article							SLOWLY HYDROLYZABLE ANALOG; ALPHA-BETA-TUBULIN; CRYOELECTRON MICROSCOPY; STRUCTURAL-CHANGES; GTP HYDROLYSIS; DYNAMICS; ENDS; INFORMATION; COLCHICINE; RESOLUTION	The atomic structure of tubulin in a polymerized, straight protofilament is clearly distinct from that in a curved conformation bound to a cellular depolymerizer. The nucleotide contents are identical, and in both cases the conformation of the GTP-containing, intra-dimer interface is indistinguishable from the GDP-containing, inter-dimer contact. Here we present two structures corresponding to the start and end points in the microtubule polymerization and hydrolysis cycles that illustrate the consequences of nucleotide state on longitudinal and lateral assembly. In the absence of depolymerizers, GDP-bound tubulin shows distinctive intra-dimer and inter-dimer interactions and thus distinguishes the GTP and GDP interfaces. A cold-stable tubulin polymer with the non-hydrolysable GTP analogue GMPCPP, containing semi-conserved lateral interactions, supports a model in which the straightening of longitudinal interfaces happens sequentially, starting with a conformational change after GTP binding that straightens the dimer enough for the formation of lateral contacts into a non-tubular intermediate. Closure into a microtubule does not require GTP hydrolysis.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	enogales@lbl.gov			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM051487] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREU JM, 1991, BIOCHEMISTRY-US, V30, P3777, DOI 10.1021/bi00229a027; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Heald R, 2002, J CELL SCI, V115, P3; HOWARD WD, 1986, BIOCHEMISTRY-US, V25, P8292, DOI 10.1021/bi00373a025; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Janosi IM, 1998, EUR BIOPHYS J BIOPHY, V27, P501, DOI 10.1007/s002490050160; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nicholson WV, 1999, CELL BIOCHEM BIOPHYS, V31, P175, DOI 10.1007/BF02738171; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Tran PT, 1997, J STRUCT BIOL, V118, P107, DOI 10.1006/jsbi.1997.3844; Wang HW, 2005, J STRUCT BIOL, V149, P65, DOI 10.1016/j.jsb.2004.08.006	20	232	238	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					911	915		10.1038/nature03606	http://dx.doi.org/10.1038/nature03606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959508	Green Accepted			2022-12-24	WOS:000229799700038
J	Hsu, CC; Kao, WHL; Coresh, J; Pankow, JS; Marsh-Manzi, J; Boerwinkle, E; Bray, MS				Hsu, CC; Kao, WHL; Coresh, J; Pankow, JS; Marsh-Manzi, J; Boerwinkle, E; Bray, MS			Apolipoprotein E and progression of chronic kidney disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIABETIC-NEPHROPATHY; ATHEROSCLEROSIS RISK; RENAL-FUNCTION; E POLYMORPHISM; ALZHEIMERS-DISEASE; APOE POLYMORPHISM; SERUM CREATININE; ALLELE; TYPE-1; LIPOPROTEINS	Context Apolipoprotein E (APOE) genetic variation has been implicated in diabetic nephropathy with the epsilon 2 allele increasing and the epsilon 4 allele decreasing risk. APOE allelic associations with chronic kidney disease beyond diabetic nephropathy are unknown, with no studies reported in high-risk African American populations. Objective To quantify the risk of chronic kidney disease progression associated with APOE in a population-based study including white, African American, diabetic, and nondiabetic individuals. Design, Setting, and Participants Prospective follow-up (through January 1, 2003) of Atherosclerosis Risk in Communities (ARIC) study participants, including 3859 African American and 10 661 white adults aged 45 to 64 years without severe renal dysfunction at baseline in 1987-1989, sampled from 4 US communities. Main Outcome Measures Incident chronic kidney disease progression, defined as hospitalization or death with kidney disease or increase in serum creatinine level of 0.4 mg/dL (35 mu mol/L) or more above baseline, examined by APOE genotypes and alleles. Results During median follow-up of 14 years, chronic kidney disease progression developed in 1060 individuals (incidence per 1000 person-years: 5.5 overall; 8.8 in African Americans and 4.4 in whites). Adjusting for major chronic kidney disease risk factors, F-2 moderately increased and epsilon 4 decreased risk of disease progression (likelihood ratio test, P=.03). Further adjustment for low- and high-density lipoprotein cholesterol and triglycerides did not attenuate relative risks (RRs) (epsilon 2: 1.08 [95% CI, 0.93-1.25] and epsilon 4: 0.85 [95% CI, 0.75-0.95] compared with epsilon 3; likelihood ratio test, P = .008). epsilon 4 decreased risk of end-stage renal disease (RR, 0.60 [95% CI, 0.43-0.84]). epsilon 2 was associated with a decline in renal function (RR, 1.25 [95% CI, 1.02-1.53]), though not with events, such as hospitalizations or end-stage renal disease. Risks were similar stratified by race, sex, diabetes, and hypertension (all P values for interaction >.05). Excess risk of chronic kidney disease in African Americans was not explained by APOE alleles. Conclusions APOE variation predicts chronic kidney disease progression, independent of diabetes, race, lipid, and nonlipid risk factors. Our study suggests that nonlipid-mediated pathways, such as cellular mechanisms of kidney remodeling, may be involved in the association of APOE alleles and progression of chronic kidney disease.	Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Dept Epidemiol, Baltimore, MD 21205 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; Univ Texas, Houston Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77004 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston	Coresh, J (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Dept Epidemiol, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.	coresh@jhu.edu		Pankow, James/0000-0001-7076-483X	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055018, N01HC055019, N01HC055016, N01HC055022, N01HC055020, N01HC055021] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073366, T32HL007024] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55015, HL73366, 5T32HL007024, N01-HC-55019, N01-HC-55018, N01-HC-55020, N01-HC-55021, N01-HC-55022, N01-HC-55016] Funding Source: Medline; ODCDC CDC HHS [UR6/CCU617218] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ODCDC CDC HHS		Araki S, 2000, DIABETES, V49, P2190, DOI 10.2337/diabetes.49.12.2190; Araki SI, 2003, DIABETES CARE, V26, P2416, DOI 10.2337/diacare.26.8.2416; Boize R, 1998, NEPHROL DIAL TRANSPL, V13, P72, DOI 10.1093/ndt/13.1.72; Chen GP, 2001, J BIOL CHEM, V276, P49142, DOI 10.1074/jbc.M104879200; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DIAMOND JR, 1991, KIDNEY INT, V39, pS29; ECKFELDT JH, 1994, ARCH PATHOL LAB MED, V118, P496; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eto M, 1995, CLIN GENET, V48, P288; Eto M, 2002, AM J KIDNEY DIS, V40, P243, DOI 10.1053/ajkd.2002.34502; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Freedman BI, 2000, CURR OPIN NEPHROL HY, V9, P273, DOI 10.1097/00041552-200005000-00011; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Ha SK, 1999, NEPHROL DIAL TRANSPL, V14, P2144, DOI 10.1093/ndt/14.9.2144; Hadjadj S, 2000, NEPHROL DIAL TRANSPL, V15, P1971, DOI 10.1093/ndt/15.12.1971; Hsieh MC, 2002, J NEPHROL, V15, P368; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ji ZS, 1998, J BIOL CHEM, V273, P13452, DOI 10.1074/jbc.273.22.13452; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kimura H, 1998, AM J KIDNEY DIS, V31, P666, DOI 10.1053/ajkd.1998.v31.pm9531184; Krop JS, 1999, ARCH INTERN MED, V159, P1777, DOI 10.1001/archinte.159.15.1777; Liberopoulos E, 2004, AM J KIDNEY DIS, V43, P223, DOI 10.1053/j.ajkd.2003.10.013; Liberopoulos EN, 2004, AM J KIDNEY DIS, V44, P300, DOI 10.1053/j.ajkd.2004.04.035; Liberopoulos EN, 2004, NEPHROL DIAL TRANSPL, V19, P2006, DOI 10.1093/ndt/gfh349; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Morrison AC, 2002, GENET EPIDEMIOL, V22, P233, DOI 10.1002/gepi.0191; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; *NAT HEART LUNG BL, 1987, ARIC MAN OP; Nishida Y, 1997, AM J KIDNEY DIS, V29, P919, DOI 10.1016/S0272-6386(97)90467-4; Oda H, 1999, KIDNEY INT, V56, pS25, DOI 10.1046/j.1523-1755.1999.07107.x; Onuma T, 1996, J AM SOC NEPHROL, V7, P1075; PERRONE RD, 1992, CLIN CHEM, V38, P1933; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Shcherbak N S, 2001, BMC Med Genet, V2, P8, DOI 10.1186/1471-2350-2-8; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tarnow L, 2000, NEPHROL DIAL TRANSPL, V15, P625, DOI 10.1093/ndt/15.5.625; Werle E, 1998, DIABETES CARE, V21, P994, DOI 10.2337/diacare.21.6.994; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; Yorioka N, 1999, NEPHRON, V83, P246, DOI 10.1159/000045517; Zeleny M, 2002, BIOCHEMISTRY-US, V41, P11820, DOI 10.1021/bi026202k	41	77	80	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2005	293	23					2892	2899		10.1001/jama.293.23.2892	http://dx.doi.org/10.1001/jama.293.23.2892			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	935MD	15956634	Bronze			2022-12-24	WOS:000229785500024
J	Schwab, JM; Failli, V; Chedotal, A				Schwab, JM; Failli, V; Chedotal, A			Injury-related dynamic myelin/oligodendrocyte axon-outgrowth inhibition in the central nervous system	LANCET			English	Review							GROWTH CONE; FUNCTIONAL RECOVERY; PROTEIN-SYNTHESIS; MYELIN; NOGO; REGENERATION; RAT; INVOLVEMENT; EXPRESSION; RECEPTOR	Context By contrast with the glial scar, myelin was considered a constitutive static inhibitory barrier unreactive to lesions in the central nervous system (CNS). However, recent results suggest considerable add-on inhibition of myelin as a result of CNS injury. Furthermore, catastrophic events cause morphological and biochemical changes in the axon itself This results in the accumulation of cytoskeleton components and intraaxonal transported proteins paralleled by extensive membrane remodelling at the axonal tip (a process called axotomy) which might modify the axonal response to its inhibitory environment. Starting point Ji-Eun Kim and colleagues recently reported an axonal subpopulation with a different capacity to respond to myelin inhibitors (Neuron 2004; 44: 439-51). Axonal specificity but also evidence for injury reactivity summarised here challenges our understanding of axon-growth inhibition in the injured CNS. This might be due to (i) qualitative and quantitative enrichment of the periaxonal environment by myelin/oligodendrocytes, (ii) increased axonal sensitivity to its inhibitory environment, and (iii) axons and lesion-induced, altered axonal signalling. Where next? Postlesional reactive inhibition of myelin or the oligodendrocyte necessitates the development of novel screening approaches and therapeutic agents to promote axonal regeneration. Moreover, we need to improve our understanding of the pathophysiology of the lesion to find more efficient experimental strategies to restore neurological function.	Univ Paris 06, CNRS, UMR 7102, Equipe Dev Neuronal, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Schwab, JM (corresponding author), Harvard Univ, Sch Med, Ctr Expt Therapeut, Brigham & Womens Hosp, Boston, MA 02115 USA.	jschwab@zeus.bwh.harvard.edu	Chedotal, Alain/F-2750-2017	Chedotal, Alain/0000-0001-7577-3794; Schwab, Jan/0000-0001-6784-4919				Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002; Bandtlow CE, 1997, EUR J NEUROSCI, V9, P2743, DOI 10.1111/j.1460-9568.1997.tb01703.x; Bartholdi D, 1998, GLIA, V23, P278, DOI 10.1002/(SICI)1098-1136(199807)23:3<278::AID-GLIA10>3.0.CO;2-Q; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; de la Houssaye BA, 1999, J NEUROSCI, V19, P10843, DOI 10.1523/JNEUROSCI.19-24-10843.1999; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Grimpe B, 2002, PROG BRAIN RES, V137, P333; Huber AB, 2002, J NEUROSCI, V22, P3553; Josephson A, 2003, CELL TISSUE RES, V311, P333, DOI 10.1007/s00441-002-0695-8; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Mandolesi G, 2004, FASEB J, V18, P1934, DOI 10.1096/fj.04-1805fje; Mikule K, 2003, J BIOL CHEM, V278, P21168, DOI 10.1074/jbc.M211828200; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; Pasterkamp RJ, 2001, BRAIN RES REV, V35, P36, DOI 10.1016/S0165-0173(00)00050-3; Schwab ME, 2002, PROG BRAIN RES, V137, P351; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; SOTELO C, 1971, LAB INVEST, V25, P653; Tang S, 2001, MOL CELL NEUROSCI, V18, P259, DOI 10.1006/mcne.2001.1020; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Zhou CM, 2003, BIOCHEM BIOPH RES CO, V309, P368, DOI 10.1016/j.bbrc.2003.08.006	24	16	19	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2005	365	9476					2055	2057		10.1016/S0140-6736(05)66699-8	http://dx.doi.org/10.1016/S0140-6736(05)66699-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934IB	15950719				2022-12-24	WOS:000229701400027
J	McClellan, AJ; Scott, MD; Frydman, J				McClellan, AJ; Scott, MD; Frydman, J			Folding and quality control of the VHL tumor suppressor proceed through distinct chaperone pathways	CELL			English	Article							UBIQUITIN-DEPENDENT DEGRADATION; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; INTERACTING PROTEINS; ABNORMAL PROTEINS; ELONGIN C; YEAST	The mechanisms by which molecular chaperones assist quality control of cytosolic proteins are poorly understood. Analysis of the chaperone requirements for degradation of misfolded variants of a cytosolic protein, the VHL tumor suppressor, reveals that distinct chaperone pathways mediate its folding and quality control. While both folding and degradation of VHL require Hsp70, the chaperonin TRiC is essential for folding but is dispensable for degradation. Conversely, the chaperone Hsp90 neither participates in VHL folding nor is required to maintain misfolded VHL solubility but is essential for its degradation. The cochaperone HOP/Sti1 p also participates in VHL quality control and may direct the triage decision by bridging the Hsp70-Hsp90 interaction. Our finding that a distinct chaperone complex is uniquely required for quality control provides evidence for active and specific chaperone participation in triage decisions and suggests that a hierarchy of chaperone interactions can control the alternate fates of a cytosolic protein.	Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Stanford Univ, BioX Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA.	jfrydman@stanford.edu	McClellan, Amie/V-8950-2019	, judith/0000-0003-2302-6943; McClellan, Amie/0000-0002-8033-6748	NIGMS NIH HHS [GM64992, GM56433] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056433, R01GM056433, F32GM064992] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams A, 1997, METHODS YEAST GENETI; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Bohen SP, 1998, MOL CELL BIOL, V18, P3330, DOI 10.1128/MCB.18.6.3330; Botuyan MV, 1999, P NATL ACAD SCI USA, V96, P9033, DOI 10.1073/pnas.96.16.9033; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Dougan DA, 2002, CELL MOL LIFE SCI, V59, P1607, DOI 10.1007/PL00012487; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Goasduff T, 2000, ARCH BIOCHEM BIOPHYS, V379, P321, DOI 10.1006/abbi.2000.1870; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Jackson T, 2000, BBA-GENE STRUCT EXPR, V1491, P161, DOI 10.1016/S0167-4781(00)00052-X; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; KANDROR O, 1994, J BIOL CHEM, V269, P23575; Kaser M, 2000, SEMIN CELL DEV BIOL, V11, P181, DOI 10.1006/scdb.2000.0166; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; McClellan AJ, 2001, NAT CELL BIOL, V3, pE51, DOI 10.1038/35055162; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Mitsui K, 2002, J NEUROSCI, V22, P9267; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NICOLET CM, 1989, MOL CELL BIOL, V9, P3638, DOI 10.1128/MCB.9.9.3638; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; URSIC D, 1994, MOL BIOL CELL, V5, P1065, DOI 10.1091/mbc.5.10.1065; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yamano T, 2002, J EXP MED, V196, P185, DOI 10.1084/jem.20011922; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	58	201	205	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					739	748		10.1016/j.cell.2005.03.024	http://dx.doi.org/10.1016/j.cell.2005.03.024			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935760	Bronze			2022-12-24	WOS:000229658000012
J	Anderson, JD; Johnson, TV; Schubert, G; Asmar, S; Jacobson, RA; Johnston, D; Lau, EL; Lewis, G; Moore, WB; Taylor, A; Thomas, PC; Weinwurm, G				Anderson, JD; Johnson, TV; Schubert, G; Asmar, S; Jacobson, RA; Johnston, D; Lau, EL; Lewis, G; Moore, WB; Taylor, A; Thomas, PC; Weinwurm, G			Amalthea's density is less than that of water	SCIENCE			English	Article							SMALL INNER SATELLITES; JUPITER; DISCOVERY; ORBITS	Radio Doppler data from the Galileo spacecraft's encounter with Amalthea, one of Jupiter's small inner moons, on 5 November 2002 yield a mass of (2.08 +/- 0.15) x 10(18) kilograms. Images of Amalthea from two Voyager spacecraft in 1979 and Galileo imaging between November 1996 and June 1997 yield a volume of (2.43 +/- 0.22) x 10(6) cubic kilometers. The satellite thus has a density of 857 +/- 99 kilograms per cubic meter. We suggest that Amalthea is porous and composed of water ice, as well as rocky material, and thus formed in a cold region of the solar system, possibly not at its present location near Jupiter.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Cornell Univ, Ctr Radio Phys & Space Res, Ithaca, NY 14853 USA; Vienna Univ Technol, Inst Geodesy & Geophys, A-1040 Vienna, Austria	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles; Cornell University; Technische Universitat Wien	Anderson, JD (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	john.d.anderson@jpl.nasa.gov						Anderson JD, 1999, ICARUS, V138, P309, DOI 10.1006/icar.1998.6075; Barnard E. E., 1892, AJ, V12, P81; Canup RM, 2002, ASTRON J, V124, P3404, DOI 10.1086/344684; DEIMAND D, 2001, TR0112 ERDCCRREL US; Drummond J.D., 1989, ASTEROIDS, VII, P171; Gundlach JH, 2000, PHYS REV LETT, V85, P2869, DOI 10.1103/PhysRevLett.85.2869; JEWITT DC, 1979, SCIENCE, V206, P951, DOI 10.1126/science.206.4421.951; JOHNSON TV, 1973, ICARUS, V18, P612, DOI 10.1016/0019-1035(73)90064-X; Lagerkvist C.-I., 1989, ASTEROIDS, P1162; LOCKNER DA, 1995, HDB PHYSICAL CONSTAN, V3, P127; Millis R. L., 1989, ASTEROIDS, V148; Simonelli DP, 2000, ICARUS, V147, P353, DOI 10.1006/icar.2000.6474; SYNNOTT SP, 1980, SCIENCE, V210, P786, DOI 10.1126/science.210.4471.786; SYNNOTT SP, 1984, ICARUS, V58, P178, DOI 10.1016/0019-1035(84)90036-8; SYNNOTT SP, 1981, SCIENCE, V212, P191, DOI 10.1126/science.212.4491.191; SYNNOTT SP, 1980, SCIENCE, V210, P1392; THOLEN DJ, 2000, ALLENS ASTROPHYSICAL, P302; Thomas P., 1986, IAU C 77 SOME BACKGR, P802; Thomas PC, 1998, ICARUS, V135, P360, DOI 10.1006/icar.1998.5976; *USA CORPS ENG, 1951, 4 SIPRE US ARM CORPS; Veverka J, 2000, SCIENCE, V289, P2088, DOI 10.1126/science.289.5487.2088; [No title captured]	22	53	53	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2005	308	5726					1291	1293		10.1126/science.1110422	http://dx.doi.org/10.1126/science.1110422			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919987				2022-12-24	WOS:000229482300041
J	Khamsi, R				Khamsi, R			Deadly combinations	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					406	406						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15952256				2022-12-24	WOS:000229337800016
J	Mihaylova, B; Briggs, A; Armitage, J; Parish, S; Gray, A; Collins, R				Mihaylova, B; Briggs, A; Armitage, J; Parish, S; Gray, A; Collins, R		Heart Protection Study Collaborati	Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20536 individuals	LANCET			English	Article								Background Statin therapy reduces the rates of heart attack, stroke, and revascularisation among a wide range of individuals. Reliable assessment of its cost-effectiveness in different circumstances is needed. Methods 20 536 adults (aged 40-80 years) with vascular disease or diabetes were randomly allocated 40 mg sinnivastatin daily (10 269) or placebo (10 267) for an average of 5 years. Comparisons were made of hospitalisation and statin costs (2001 UK prices) during the scheduled treatment period between all simvastatin-allocated versus all placebo-allocated participants. Cost-effectiveness was estimated among different categories of participant. Findings Allocation to simvastatin was associated with a highly significant 22% (95% Cl 16-27; p<0.0001) proportional reduction in hospitalisation costs for all vascular events, with similar proportional reductions in every subcategory of participant studied. During an average of 5 years, estimated absolute reductions in vascular event costs per person allocated 40 mg simvastatin daily ranged from UK 847 pound (SE 137) in the highest risk quintile studied to,[264 (48) in the lowest. Mean excess cost of statin therapy among participants allocated simvastatin was 1497 pound (8), with similar absolute increases in every subcategory. Costs of preventing a major vascular event with 40 mg simvastatin daily ranged from,C4500 (95% CI 2300-7400) among participants with a 42% 5-year major vascular event rate to 31 pound 100 (22 900-42 500) among those with a 12% rate (corresponding to 5-year major coronary event rates of 22% and 4%, respectively). Interpretation Statin therapy is cost effective for a wider range of individuals with vascular disease or diabetes than previously recognised (particularly with lower-priced generics). It would be appropriate to consider reducing the estimated level of vascular event risk at which statin therapy is recommended.	Radcliffe Infirm, Clin Trial Serv Unit, Heart Protect Study, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford	Mihaylova, B (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Heart Protect Study, Harkness Bldg, Oxford OX2 6HE, England.	hps@ctsu.ox.ac.uk		Mihaylova, Borislava/0000-0002-0951-1304; Briggs, Andrew/0000-0002-0777-1997				Caro J, 1997, BRIT MED J, V315, P1577, DOI 10.1136/bmj.315.7122.1577; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2004, LANCET, V363, P757; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2003, LANCET, V361, P2005; *DEP HLTH, 2003, GOV EXP PLANS DEP RE; Department of Health, 2004, PRESCR COST AN ENGL; Efron Bradley., 1994, INTRO BOOTSTRAP; FIELLER EC, 1954, J ROY STAT SOC B, V16, P175; Glasziou PP, 2002, MED J AUSTRALIA, V177, P428; *JOINT FORM COMM, 2001, BRIT NAT FORM, V41; Jonsson B, 1999, DIABETOLOGIA, V42, P1293, DOI 10.1007/s001250051441; Jonsson B, 1996, EUR HEART J, V17, P1001; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Meade T, 1999, EUR HEART J, V20, P725; *NHS EX, 2001, TRUST FIN RET; *NHS EX, 2002, TRUST FIN RET; *PRESCR PRIC AUTH, NHS EL DRUG TAR; Sniderman AD, 2004, AM J CARDIOL, V94, p30F, DOI 10.1016/j.amjcard.2004.07.052; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; *TAMR, 2003, INT REP JAN JUN; Wood D, 2000, BRIT MED J, V320, P705, DOI 10.1136/bmj.320.7236.705; ZOCOR DATASHEET	23	88	90	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2005	365	9473					1779	1785		10.1016/S0140-6736(05)63014-0	http://dx.doi.org/10.1016/S0140-6736(05)63014-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	928SI	15910950				2022-12-24	WOS:000229291600022
J	Hiesinger, PR; Fayyazuddin, A; Mehta, SQ; Rosenmund, T; Schulze, KL; Zhai, RG; Verstreken, P; Cao, Y; Zhou, Y; Kunz, J; Bellen, HJ				Hiesinger, PR; Fayyazuddin, A; Mehta, SQ; Rosenmund, T; Schulze, KL; Zhai, RG; Verstreken, P; Cao, Y; Zhou, Y; Kunz, J; Bellen, HJ			The v-ATPase V-0 subunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila	CELL			English	Article							READILY RELEASABLE POOL; VACUOLAR H+-ATPASE; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; SYNAPTOBREVIN; CELLS; YEAST; TRANSMISSION; MUTATIONS; SECRETION	The V-0 complex forms the proteolipid pore of an ATPase that acidifies vesicles. In addition, an independent function in membrane fusion has been proposed largely based on yeast vacuolar fusion experiments. We have isolated mutations in the largest V-0 component vha100-1 in flies in an unbiased genetic screen for synaptic malfunction. The protein is only required in neurons, colocalizes with markers for synaptic vesicles as well as active zones, and interacts with t-SNAREs. Loss of vha100-1 leads to vesicle accumulation in synaptic terminals, suggesting a deficit in release. The amplitude of spontaneous release events and release with hypertonic stimulation indicate normal levels of neurotransmitter loading, yet mutant embryos display severe defects in evoked synaptic transmission and FM1-43 uptake. Our data suggest that Vha100-1 functions downstream of SNAREs in synaptic vesicle fusion.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Zhai, R. Grace/AGZ-3936-2022; Verstreken, Patrik/AAC-7591-2022	Verstreken, Patrik/0000-0002-5073-5393; Zhai, Rong/0000-0002-7599-1430; Bellen, Hugo/0000-0001-5992-5989; Mehta, Sunil/0000-0003-3020-4939	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068098] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 068098, R01 GM068098, R01 GM068098-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CHOU TB, 1992, GENETICS, V131, P643; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Drose S, 1997, J EXP BIOL, V200, P1; FalkVairant J, 1996, P NATL ACAD SCI USA, V93, P5203, DOI 10.1073/pnas.93.11.5203; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; Hiesinger PR, 1999, J NEUROSCI, V19, P7548, DOI 10.1523/JNEUROSCI.19-17-07548.1999; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; ISRAEL M, 1986, P NATL ACAD SCI USA, V83, P9226, DOI 10.1073/pnas.83.23.9226; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; Jena BP, 2004, J CELL MOL MED, V8, P1, DOI 10.1111/j.1582-4934.2004.tb00255.x; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P17941, DOI 10.1074/jbc.M010790200; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Meinertzhagen Ian A., 1993, P1363; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Morel N, 2003, BIOL CELL, V95, P453, DOI 10.1016/S0248-4900(03)00075-3; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0; Perzov N, 2002, J EXP BIOL, V205, P1209; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pujol N, 2001, J BIOL CHEM, V276, P11913, DOI 10.1074/jbc.M009451200; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Sorensen JB, 2004, PFLUG ARCH EUR J PHY, V448, P347, DOI 10.1007/s00424-004-1247-8; Stowers RS, 1999, GENETICS, V152, P1631; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, J CELL SCI, V116, P3661, DOI 10.1242/jcs.00687; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	50	239	249	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					607	620		10.1016/j.cell.2005.03.012	http://dx.doi.org/10.1016/j.cell.2005.03.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907473	Bronze, Green Accepted			2022-12-24	WOS:000229331200016
J	Wang, D; Weaver, ND; Kesarwani, M; Dong, XN				Wang, D; Weaver, ND; Kesarwani, M; Dong, XN			Induction of protein secretory pathway is required for systemic acquired resistance	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; GENOMIC ANALYSIS; EXPRESSION; GENE; HOMOLOG; NPR1	In plants, systemic acquired resistance (SAR) is established as a result of NPR1-regulated expression of pathogenesis-related (PR) genes. Using gene expression profiling in Arabidopsis, we found that in addition to controlling the expression of PR genes, NPR1 also directly controls the expression of the protein secretory pathway genes. Up-regulation of these genes is essential for SAR, because mutations in some of them diminished the secretion of PR proteins (for example, PR1), resulting in reduced resistance. We provide evidence that NPR1 coordinately,regulates these secretion-related genes through a previously undescribed cis-element. Activation of this cis-element is controlled by a transcription factor that is translocated into the nucleus upon SAR induction.	Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Durham, NC 27708 USA	Duke University	Dong, XN (corresponding author), Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, POB 91000, Durham, NC 27708 USA.	xdong@duke.edu						Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chu TM, 2002, MATH BIOSCI, V176, P35, DOI 10.1016/S0025-5564(01)00107-9; DENECKE J, 1995, PLANT CELL, V7, P391, DOI 10.1105/tpc.7.4.391; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fu J, 2000, J BIOL CHEM, V275, P3984, DOI 10.1074/jbc.275.6.3984; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Lin BL, 2001, CELL STRESS CHAPERON, V6, P201, DOI 10.1379/1466-1268(2001)006<0201:GAOTHS>2.0.CO;2; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Noh SJ, 2003, GENE, V311, P81, DOI 10.1016/S0378-1119(03)00559-6; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vitale A, 1999, PLANT CELL, V11, P615, DOI 10.1105/tpc.11.4.615; WALTHERLARSEN H, 1993, PLANT MOL BIOL, V21, P1097, DOI 10.1007/BF00023606; Wick P, 2003, PLANT PHYSIOL, V132, P343, DOI 10.1104/pp.102.012633; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894	25	399	423	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1036	1040		10.1126/science.1108791	http://dx.doi.org/10.1126/science.1108791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890886				2022-12-24	WOS:000229190700051
J	Chinn, S; Jarvis, D; Melotti, R; Luczynska, C; Ackermann-Liebrich, U; Anto, JM; Cerveri, I; de Marco, R; Gislason, T; Heinrich, J; Janson, C; Kunzli, N; Leynaert, B; Neukirch, F; Schouten, J; Sunyer, J; Svanes, C; Vermeire, P; Wjst, M; Burney, P				Chinn, S; Jarvis, D; Melotti, R; Luczynska, C; Ackermann-Liebrich, U; Anto, JM; Cerveri, I; de Marco, R; Gislason, T; Heinrich, J; Janson, C; Kunzli, N; Leynaert, B; Neukirch, F; Schouten, J; Sunyer, J; Svanes, C; Vermeire, P; Wjst, M; Burney, P			Smoking cessation, lung function, and weight gain: a follow-up study	LANCET			English	Article							FORCED EXPIRATORY VOLUME; LONGITUDINAL CHANGES; PULMONARY-FUNCTION; ONE 2ND; DECLINE; ADULTS; SYMPTOMS; HABITS; FEV(1); GENDER	Background Only one population-based study in one country has reported effects of smoking cessation and weight change on lung function, and none has reported the net effect. We estimated the net benefit of smoking cessation, and the independent effects of smoking and weight change on change in ventilatory lung function in the international European Community Respiratory Health Survey. Methods 6654 participants in 27 centres had lung function measured in 1991-93, when aged 20-44 years, and in 1998-2002. Smoking information was obtained from detailed questionnaires. Changes in lung function were analysed by change in smoking and weight, adjusted for age and height, in men and women separately and together with interaction terms. Findings Compared with those who had never smoked, decline in FEV1 was lower in male sustained quitters (mean difference 5.4 mL per year, 95% CI 1.7 to 9.1) and those who quit between surveys (2.5 mL, -1.9 to 7.0), and greater in smokers (-4.8 mL, -7.9 to -1.6). In women, estimates were 1.3 mL per year (-1.5 to 4.1), 2.8 mL (-0.8 to 6.3) and -5.1 mL (-7.5 to -2.8), respectively.. These sex differences were not significant. FEV1 changed by -11.5 mL (-13.3 to -9.6) per kg weight gained in men, and by -3.7 mL per kg (-5.0 to -2.5) in women, which diminished the benefit of quitting by 38% in men, and by 17% in women. Interpretation Smoking cessation is beneficial for lung function, but maximum benefit needs control of weight gain, especially in men.	Kings Coll London, Dept Publ Hlth Sci, London SE1 3QD, England; Univ Verona, Dept Med & Publ Hlth, Div Epidemiol & Stat, I-37100 Verona, Italy; Univ Basel, Inst Social & Prevent Med, CH-4051 Basel, Switzerland; Univ Pompeu Fabra, Inst Med Res, Barcelona, Spain; Univ Pavia, IRCCS San Matteo Hosp, Div Resp Dis, I-27100 Pavia, Italy; Univ Hosp E7, Dept Allergy Resp Med & Sleep, Reykjavik, Iceland; GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany; Uppsala Univ, Uppsala, Sweden; Univ So Calif, Keck Sch Med, Los Angeles, CA USA; Univ Paris 07, INSERM, French Inst Hlth & Med Res, Unit 408, Paris, France; Univ Groningen Hosp, Dept Epidemiol, Groningen, Netherlands; Haukeland Hosp, Dept Thorac Med, Bergen, Norway; Univ Antwerp, B-2020 Antwerp, Belgium	University of London; King's College London; University of Verona; University of Basel; Pompeu Fabra University; IRCCS Fondazione San Matteo; University of Pavia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; University of Southern California; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Groningen; University of Bergen; Haukeland University Hospital; University of Antwerp	Chinn, S (corresponding author), Kings Coll London, Dept Publ Hlth Sci, 5th Floor Capital House,42 Weston St, London SE1 3QD, England.	sue.chinn@kcl.ac.uk	SESM, SESM/C-1440-2008; Svanes, Cecilie/N-7556-2017; Kuenzli, Nino/F-7195-2014; Sunyer, Jordi/G-6909-2014; Leynaert, Benedicte/N-5251-2018; de Marco, Roberto/A-5470-2008; Heinrich, Joachim/N-1720-2013; Anto, J M/H-2676-2014; Jarvis, Deborah/E-6494-2011	Svanes, Cecilie/0000-0001-8512-5192; Kuenzli, Nino/0000-0001-8360-080X; Sunyer, Jordi/0000-0002-2602-4110; Heinrich, Joachim/0000-0002-9620-1629; Anto, J M/0000-0002-4736-8529; Jarvis, Deborah/0000-0002-1753-3896; Burney, Peter/0000-0001-8635-5678; Cerveri, Isa/0000-0003-0337-043X; Leynaert, Benedicte/0000-0001-5045-2492; MELOTTI, Roberto/0000-0003-4115-317X	NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005521] Funding Source: NIH RePORTER; NCRR NIH HHS [2 S07 RR05521-28] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		*AM THOR SOC, 1995, AM J RESP CRIT CARE, V152, P1122; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Bottai M, 2002, EUR RESPIR J, V20, P665, DOI 10.1183/09031936.02.01282001; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; BURROWS B, 1986, AM REV RESPIR DIS, V133, P974; CAMILLI AE, 1987, AM REV RESPIR DIS, V135, P794, DOI 10.1164/arrd.1987.135.4.794; Carey IM, 1999, INT J OBESITY, V23, P979, DOI 10.1038/sj.ijo.0801029; CHEN Y, 1993, THORAX, V48, P375, DOI 10.1136/thx.48.4.375; Chinn S, 2004, THORAX, V59, P646, DOI 10.1136/thx.2004.021642; Connett JE, 2003, AM J EPIDEMIOL, V157, P973, DOI 10.1093/aje/kwg083; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DOCKERY DW, 1988, AM REV RESPIR DIS, V137, P286, DOI 10.1164/ajrccm/137.2.286; Harik-Khan RI, 2001, J CLIN EPIDEMIOL, V54, P399, DOI 10.1016/S0895-4356(00)00318-8; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; LANGE P, 1989, EUR RESPIR J, V2, P811; LANGE P, 1989, INT J EPIDEMIOL, V18, P882, DOI 10.1093/ije/18.4.882; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; Thun MJ, 1998, AM J EPIDEMIOL, V148, P831; TOWNSEND MC, 1991, PREV MED, V20, P621, DOI 10.1016/0091-7435(91)90059-D; Varner LM, 1999, J AM DIET ASSOC, V99, P1272, DOI 10.1016/S0002-8223(99)00312-0; Wang ML, 1996, AM J RESP CRIT CARE, V153, P1907, DOI 10.1164/ajrccm.153.6.8665054; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704; Wise RA, 1998, AM J RESP CRIT CARE, V157, P866, DOI 10.1164/ajrccm.157.3.9706076; XU X, 1994, EUR RESPIR J, V7, P1056	25	137	140	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1629	1635		10.1016/S0140-6736(05)66511-7	http://dx.doi.org/10.1016/S0140-6736(05)66511-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885295				2022-12-24	WOS:000228933700027
J	Dworkin, J; Losick, R				Dworkin, J; Losick, R			Developmental commitment in a bacterium	CELL			English	Article							BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; CELL-TYPE; SPORULATION; GENE; ENGULFMENT; COMPARTMENTALIZATION; ACTIVATION; INHIBITOR; SEPTATION	We investigated developmental commitment during sporulation in Bacillus subtilis. Sporulation is initiated by nutrient limitation and involves division of the developing cell into two progeny, the forespore and the mother cell, with different fates. Differentiation becomes irreversible following division when neither the forespore nor the mother cell can resume growth when provided with nutrients. We show that commitment is governed by the transcription factors sigma(F) and sigma(E), which are activated in the forespore and the mother cell, respectively. We further show that commitment involves spollQ, which is under the control of sigma(F), and spollP, which is under the control of both sigma(F) and sigma(E). In the presence of nutrients, the forespore can exhibit rodlike, longitudinal growth when SpollQ and SpollP are absent, whereas the mother cell can do so when SpollP alone is absent. Thus, developmental commitment of this single-celled organism, like that of the cells of complex, multicellular organisms, ensures that differentiation is maintained despite changes in the extracellular milieu.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Harvard University; Columbia University	Dworkin, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dworkin@microbiology.columbia.edu; losick@mcb.harvard.edu			NIGMS NIH HHS [GM 18568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM018568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; Bernhardt TG, 2001, J BIOL CHEM, V276, P6093, DOI 10.1074/jbc.M007638200; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; FRANDSEN N, 1995, J BACTERIOL, V177, P716, DOI 10.1128/jb.177.3.716-722.1995; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Fujita M, 2002, MOL MICROBIOL, V43, P27, DOI 10.1046/j.1365-2958.2002.02732.x; Garsin DA, 1998, J MOL BIOL, V284, P569, DOI 10.1006/jmbi.1998.2202; Gilbert S.F., 2000, DEV BIOL, V6th ed.; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Harwood C. R., 1990, MOL BIOL METHODS BAC; HO RK, 1993, SCIENCE, V261, P109, DOI 10.1126/science.8316841; Li ZS, 2004, J BACTERIOL, V186, P2221, DOI 10.1128/JB.186.7.2221-2223.2003; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; LondonoVallejo JA, 1997, MOL MICROBIOL, V24, P29, DOI 10.1046/j.1365-2958.1997.3181680.x; LONDONOVALLEJO JA, 1995, GENE DEV, V9, P503, DOI 10.1101/gad.9.4.503; MARGOLIS P, 1991, SCIENCE, V254, P562, DOI 10.1126/science.1948031; Parker GF, 1996, MICROBIOL-UK, V142, P3445, DOI 10.1099/13500872-142-12-3445; Piggot P, 2002, BACILLUS SUBTILIS IT, P483; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rubio A, 2004, EMBO J, V23, P1636, DOI 10.1038/sj.emboj.7600171; SETLOW B, 1991, J BACTERIOL, V173, P6270, DOI 10.1128/jb.173.19.6270-6278.1991; Spemann H, 1918, ARCH ENTWICKLUNG ORG, V43, P448, DOI 10.1007/BF02267308; STEINMETZ M, 1994, GENE, V142, P79, DOI 10.1016/0378-1119(94)90358-1; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Stragier P., 2002, BACILLUS SUBTILIS IT, P519; STRAUCH M, 1990, P NATL ACAD SCI USA, V87, P1801, DOI 10.1073/pnas.87.5.1801; SUSSMAN MD, 1991, J BACTERIOL, V173, P291, DOI 10.1128/jb.173.1.291-300.1991; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C	34	80	82	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					401	409		10.1016/j.cell.2005.02.032	http://dx.doi.org/10.1016/j.cell.2005.02.032			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882622	Bronze			2022-12-24	WOS:000229031600010
J	Tzou, WS; Douglas, PS; Srinivasan, SR; Chen, W; Berenson, G; Stein, JH				Tzou, WS; Douglas, PS; Srinivasan, SR; Chen, W; Berenson, G; Stein, JH			Advanced lipoprotein testing does not improve identification of subclinical atherosclerosis in young adults: The bogalusa heart study	ANNALS OF INTERNAL MEDICINE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK-FACTORS; CORONARY-ARTERY-DISEASE; MAGNETIC-RESONANCE-SPECTROSCOPY; CAROTID-ARTERY; MYOCARDIAL-INFARCTION; PARTICLE DIAMETER; ROC CURVE; DENSITY; MEN	Background: The clinical value of advanced lipoprotein testing relative to traditional lipid testing remains controversial. To date, no studies have evaluated associations between advanced lipoprotein testing and subclinical atherosclerosis in healthy young adults. Objective: To determine whether advanced lipoprotein testing using vertical-spin density-gradient ultracentrifugation better predicts carotid intima-media thickness, a validated measure of subclinical atherosclerosis, than does traditional lipoprotein testing in asymptornatic young adults. Design: Cross-sectional community-based study. Setting: Bogalusa, Louisiana. Participants: 311 randomly selected adults from the Bogalusa Heart Study who were 20 to 38 years of age. Measurements: The authors performed advanced lipoprotein testing using vertical-spin density-gradient ultracentrifugation, traditional testing using enzymatic methods, and Friedewald formula estimation of low-density lipoprotein cholesterol levels. A certified reader blinded to lipoprotein results determined carotid intimamedia thickness by B-mode ultrasonography. C-statistics from area under the receiver-operating characteristic curves (ALICs) derived from multivariable regression models were compared. Results: Lipid values obtained with advanced lipoprotein testing did not predict carotid intima-media thickness better than traditionally measured lipid values in 236 participants for whom all data were available. A model using traditional lipoprotein measures (AUC, 0.754 [95% Cl, 0.690 to 0.812]) did not differ significantly from a model using advanced lipoprotein measures (AUC, 0.779 [Cl, 0.662 to 0.871]) for prediction of carotid intimamedia thickness (P > 0.2). Subclass pattern of LDL, lipoprotein(a) cholesterol, intermediate-density lipoprotein cholesterol, high-density lipoprotein cholesterol subclasses, and very- low-density lipoprotein subclasses did not improve the performance of models for prediction of carotid intima-media thickness. Limitations: The study was cross-sectional, cardiac events were not determined, and only 1 method of advanced lipoprotein testing was used. Conclusions: Advanced lipoprotein testing using vertical-spin density-gradient ultracentrifugation did not improve prediction of carotid intima-media thickness in young adults and may not be useful for assessing cardiovascular risk in this population.	Univ Wisconsin, Sch Med, Dept Med, Sect Cardiovasc Med, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Stein, JH (corresponding author), Univ Wisconsin, Sch Med, Dept Med, Sect Cardiovasc Med, 600 Highland Ave,G7-341 CSC,MC 3248, Madison, WI 53792 USA.		Tzou, Wen-Shyong/H-4517-2014	Tzou, Wen-Shyong/0000-0002-6726-1390; Stein, James/0000-0002-2770-8223; Douglas, Pamela/0000-0001-9876-4049	NCRR NIH HHS [RR-1617601] Funding Source: Medline; NHLBI NIH HHS [HL-07936, HL-38844] Funding Source: Medline; NIA NIH HHS [AG-16592] Funding Source: Medline; NICHD NIH HHS [HD-043820] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD043820] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016176] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038844, U01HL038844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*ARIC STUD GROUP, 1991, J NEUROIMAGING, V1, P68; Belsley D.A., 1980, REGRESSION DIAGNOSTI; BERESON GS, 1980, CARDIOVASCULAR RISK; Blake GJ, 2002, CIRCULATION, V106, P1930, DOI 10.1161/01.CIR.0000033222.75187.B9; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; Colhoun HM, 2002, DIABETES, V51, P1949, DOI 10.2337/diabetes.51.6.1949; CORESH J, 1993, J LIPID RES, V34, P1687; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Freedman DS, 2004, INT J OBESITY, V28, P159, DOI 10.1038/sj.ijo.0802515; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; GENEST J, 1992, J AM COLL CARDIOL, V19, P792, DOI 10.1016/0735-1097(92)90520-W; Greenland P, 2000, CIRCULATION, V101, P723; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Karpe F, 2001, J LIPID RES, V42, P17; Kieltyka L, 2003, ATHEROSCLEROSIS, V170, P125, DOI 10.1016/S0021-9150(03)00244-2; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Krishnan Priya, 2003, J La State Med Soc, V155, P165; KULKARNI KR, 1995, J LIPID RES, V36, P2291; Kulkarni KR, 1999, ARTERIOSCL THROM VAS, V19, P2749, DOI 10.1161/01.ATV.19.11.2749; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; *NCEP, 1995, 953044 NIH; *NCEP, 2002, 025215 NIH; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Oren A, 2003, ARCH INTERN MED, V163, P1787, DOI 10.1001/archinte.163.15.1787; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Soedamah-Muthu SS, 2003, DIABETOLOGIA, V46, P674, DOI 10.1007/s00125-003-1094-8; Srinivasan SR, 2001, ATHEROSCLEROSIS, V159, P391, DOI 10.1016/S0021-9150(01)00514-7; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Stein JH, 1997, ARCH INTERN MED, V157, P1170, DOI 10.1001/archinte.157.11.1170; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7	37	13	17	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					742	750		10.7326/0003-4819-142-9-200505030-00009	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922GW	15867406				2022-12-24	WOS:000228825800003
J	Burris, S; Csete, J; Goumei, X; Dan, Z; Loff, B				Burris, S; Csete, J; Goumei, X; Dan, Z; Loff, B			Shanghai plans responses to AIDS	LANCET			English	Editorial Material									Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA; Johns Hopkins Sch Hyg & Publ Hlth, Ctr Law & Publ Hlth, Baltimore, MD USA; Canadian HIV AIDS Legal Network, Montreal, PQ, Canada; Shanghai Acad Social Sci, Ctr Publ Policy Study HIV AIDS, Shanghai, Peoples R China; Richard Wang & Co, Shanghai, Peoples R China; Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Johns Hopkins University; Shanghai Academy of Social Sciences; Monash University	Burris, S (corresponding author), Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA.	scott.burris@temple.edu	Loff, Bebe/G-9241-2014	Loff, Bebe/0000-0003-1963-6503; Burris, Scott/0000-0002-6013-5842				*STAT COUNC CHIN, 1998, 250 STAT COUNC CHIN; *STAT COUNC CHIN, 1998, GF199838 STAT COUNC; WHO, 2004, UNAIDS WHO POL STAT	3	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 30	2005	365	9470					1524	1525		10.1016/S0140-6736(05)66435-5	http://dx.doi.org/10.1016/S0140-6736(05)66435-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866293				2022-12-24	WOS:000228754800008
J	Zink, MC; Uhrlaub, J; DeWitt, J; Voelker, T; Bullock, B; Mankowski, J; Tarwater, P; Clements, J; Barber, S				Zink, MC; Uhrlaub, J; DeWitt, J; Voelker, T; Bullock, B; Mankowski, J; Tarwater, P; Clements, J; Barber, S			Neuroprotective and anti-human immunodeficiency virus, activity of minocycline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTRAL-NERVOUS-SYSTEM; ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; ANTIRETROVIRAL THERAPY; CEREBROSPINAL-FLUID; COGNITIVE IMPAIRMENT; HIV-INFECTION; AIDS DEMENTIA; GROWTH-FACTOR; MOUSE MODEL	Context The prevalence of human immunodeficiency virus (HIV) central nervous system (CNS) disease has not decreased despite highly active antiretroviral therapy. Current antiretroviral drugs are expensive, have significant adverse effects including neurotoxicity, and few cross the blood-brain barrier. Objective To examine the ability of minocycline, an antibiotic with potent anti-inflammatory and neuroprotective properties, to protect against encephalitis and neurodegeneration using a rapid, high viral load simian immunodeficiency virus (SIV) model of HIV-associated CNS disease that constitutes a rigorous in vivo test for potential therapeutics. Design and Subjects Five SIV-infected pigtailed macaques were treated with 4 mg/kg per day of minocycline beginning at early asymptomatic infection (21 days after inoculation). Another 6 macaques were inoculated with SIV but remained untreated. Blood and cerebrospinal fluid (CSF) samples were taken on days 7,10,14, 21, 28, 35, 43, 56, 70, 77, and 84, and all macaques were humanely killed at 84 days after inoculation, a time that corresponds to late-stage infection in HIV-infected individuals. Main Outcome Measures Blood and CSF samples were tested for viral load by real-time reverse transcription-polymerase chain reaction and levels of monocyte chemoattractant protein 1 were quantitated by enzyme-linked immunosorbent assay. The presence and severity of encephalitis was determined by microscopic examination of tissues. Central nervous system inflammation was further assessed by measuring infiltration and activation of macrophages, activation of p38 mitogen-activated protein kinase and expression of amyloid precursor protein by quantitative immunohistochemistry.. Results Minocycline-treated macaques had less severe encephalitis (P=.02), reduced CNS expression of neuroinflammatory markers (major histocompatibility complex class II, P=.03; macrophage marker CD68, P=.07; T-cell intracytoplasmic antigen 1, P=.03; CSF monocyte chemoattractant protein 1., P=.001), reduced activation of p38 mitogen-activated protein kinase (P<.001), less axonal degeneration (beta-amyloid precursor protein, P=.03), and lower CNS virus replication (viral RNA, P=.04; Viral antigen, P=.04). In in vitro analysis, minocycline suppression of HIV and SIV replication in cultured primary macrophages did not correlate with suppression of activation of p38-mitogen-activated protein kinase pathways, whereas suppression in primary lymphocytes correlated with suppression of p38 activation. Conclusions In this experimental SIV model of HIV CNS disease, minocycline reduced the severity of encephalitis, suppressed viral load in the brain, and decreased the expression of CNS inflammatory markers. In vitro, minocycline inhibited SIV and, HIV replication. These findings suggest that minocycline, a safe, inexpensive, and readily available antibiotic should be investigated as an anti-HIV therapeutic.	Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA; Univ Texas, Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Epidemiol, El Paso, TX 79968 USA	Johns Hopkins University; University of Texas System; University of Texas El Paso; University of Texas Health Science Center Houston	Zink, MC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Comparat Med, 733 N Broadway,Room 839, Baltimore, MD 21205 USA.	mczink@jhmi.edu	; Aljarah, Ali/Q-7105-2016	Uhrlaub, Jennifer/0000-0002-7745-0179; Aljarah, Ali/0000-0003-0535-090X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044815] Funding Source: NIH RePORTER; NIMH NIH HHS [MH069116] Funding Source: Medline; NINDS NIH HHS [NS44815] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Bahr GM, 2003, J ANTIMICROB CHEMOTH, V51, P1377, DOI 10.1093/jac/dkg244; Barber SA, 2004, AM J PATHOL, V164, P355, DOI 10.1016/S0002-9440(10)63125-2; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Clifford DB, 2002, NEUROLOGY, V59, P1568, DOI 10.1212/01.WNL.0000034177.47015.DA; Cohen PS, 1997, MOL MED, V3, P339, DOI 10.1007/BF03401812; Colovic M, 2003, J CHROMATOGR B, V791, P337, DOI 10.1016/S1570-0232(03)00247-2; Darcissac ECA, 2000, J VIROL, V74, P7794, DOI 10.1128/JVI.74.17.7794-7802.2000; Dore GJ, 1999, AIDS, V13, P1249, DOI 10.1097/00002030-199907090-00015; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; EVERALL I, 1993, J NEUROPATH EXP NEUR, V52, P561, DOI 10.1097/00005072-199311000-00002; Flaherty MT, 1997, J VIROL, V71, P5790, DOI 10.1128/JVI.71.8.5790-5798.1997; GELBARD HA, 1995, NEUROPATH APPL NEURO, V21, P208, DOI 10.1111/j.1365-2990.1995.tb01052.x; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gordon PH, 2004, NEUROLOGY, V62, P1845, DOI 10.1212/01.WNL.0000125321.92112.7E; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kinlaw WB, 2004, ENDOCRINOLOGY, V145, P484, DOI 10.1210/en.2003-1513; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Mankowski JL, 2002, J NEUROPATH EXP NEUR, V61, P85, DOI 10.1093/jnen/61.1.85; Mankowski JL, 2002, J INFECT DIS, V186, pS199, DOI 10.1086/344938; McArthur JC, 2000, NEUROLOGY, V54, P1080, DOI 10.1212/WNL.54.5.1080; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Metz LM, 2004, ANN NEUROL, V55, P756, DOI 10.1002/ana.20111; Montessori V, 2004, CAN MED ASSOC J, V170, P229; MURRAY EA, 1992, SCIENCE, V255, P1246, DOI 10.1126/science.1546323; Neuenburg JK, 2002, JAIDS-J ACQ IMM DEF, V31, P171, DOI 10.1097/00126334-200210010-00007; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Sacktor N, 2000, NEUROLOGY, V54, P233, DOI 10.1212/WNL.54.1.233; Schifitto G, 2001, NEUROLOGY, V57, P1313, DOI 10.1212/WNL.57.7.1313; Shapiro L, 1998, P NATL ACAD SCI USA, V95, P7422, DOI 10.1073/pnas.95.13.7422; SHARER LR, 1988, ANN NEUROL, V23, pS108, DOI 10.1002/ana.410230727; Si QS, 2004, J NEUROVIROL, V10, P284, DOI 10.1080/13550280490499533; Suk K, 2001, BRAIN RES, V900, P342, DOI 10.1016/S0006-8993(01)02326-5; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; YEN PKJ, 1975, J DENT RES, V54, P423; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478	43	168	177	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					2003	2011		10.1001/jama.293.16.2003	http://dx.doi.org/10.1001/jama.293.16.2003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855434	Bronze			2022-12-24	WOS:000228651500026
J	Choe, J; Kelker, MS; Wilson, IA				Choe, J; Kelker, MS; Wilson, IA			Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; LEUCINE-RICH REPEAT; GLYCOPROTEIN IB-ALPHA; NF-KAPPA-B; RIBONUCLEASE INHIBITOR; CUTTING EDGE; PROTEIN; RECOGNITION; DOMAIN; ACTIVATION	Toll-like receptors (TLRs) play key roles in activating immune responses during infection. The human TLR3 ectodomain structure at 2.1 angstroms reveals a large horseshoe-shaped solenoid assembled from 23 leucine-rich repeats (LRRs). Asparagines conserved in the 24-residue LRR motif contribute extensive hydrogen-bonding networks for solenoid stabilization. TLR3 is largely masked by carbohydrate, but one face is glycosylation-free, which suggests its potential role in ligand binding and oligomerization. Highly conserved surface residues and a TLR3-specific LRR insertion form a homodimer interface in the crystal, whereas two patches of positively charged residues and a second insertion would provide an appropriate binding site for double-stranded RNA.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu			NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, R01AI042266] Funding Source: NIH RePORTER; NCI NIH HHS [CA-58896] Funding Source: Medline; NIAID NIH HHS [T32 AI077606, AI-42266, R01 AI042266] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914	43	454	506	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					581	585		10.1126/science.1115253	http://dx.doi.org/10.1126/science.1115253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	15961631				2022-12-24	WOS:000230735200039
J	Leaman, D; Chen, PY; Fak, J; Yalcin, A; Pearce, M; Unnerstall, U; Marks, DS; Sander, C; Tuschl, T; Gaul, U				Leaman, D; Chen, PY; Fak, J; Yalcin, A; Pearce, M; Unnerstall, U; Marks, DS; Sander, C; Tuschl, T; Gaul, U			Antisense-mediated depletion reveals essential and specific functions of microRNAs in Drosophila development	CELL			English	Article							PROGRAMMED CELL-DEATH; C-ELEGANS; COMPUTATIONAL IDENTIFICATION; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; ENCODES; MELANOGASTER; ACTIVATION; STRIPES; TARGET	MicroRNAs are small noncoding RNAs that control gene function posttranscriptionally through mRNA degradation or translational inhibition. Much has been learned about the processing and mechanism of action of microRNAs, but little is known about their biological function. Here, we demonstrate that injection of 2'O-methyl antisense oligoribonucleotides into early Drosophila embryos leads to specific and efficient depletion of microRNAs and thus permits systematic loss-of-function analysis in vivo. Twenty-five of the forty-six embryonically expressed microRNAs show readily discernible defects; pleiotropy is moderate and family members display similar yet distinct phenotypes. Processes under microRNA regulation include cellularization and patterning in the blastoderm, morphogenesis, and cell survival. The largest microRNA family in Drosophila (miR-2/6/11/13/308) is required for suppressing embryonic apoptosis; this is achieved by differential posttranscriptional repression of the proapoptotic factors hid, grim, reaper, and sickle. Our findings demonstrate that microRNAs act as specific and essential regulators in a wide range of developmental processes.	Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10021 USA; Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Gaul, U (corresponding author), Rockefeller Univ, Lab Dev Neurogenet, 1230 York Ave, New York, NY 10021 USA.	gaul@mail.rockefeller.edu	Yalcin, Abdullah/AAG-4175-2019; Sander, Chris/H-1452-2011	Yalcin, Abdullah/0000-0001-8604-4749; Sander, Chris/0000-0001-6059-6270				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Boutla A, 2003, NUCLEIC ACIDS RES, V31, P4973, DOI 10.1093/nar/gkg707; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; CARROLL SB, 1990, CELL, V60, P9, DOI 10.1016/0092-8674(90)90711-M; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Christich A, 2002, CURR BIOL, V12, P137, DOI 10.1016/S0960-9822(01)00658-3; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Hipfner DR, 2002, GENETICS, V161, P1527; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 2004, EMBO REP, V5, P762, DOI 10.1038/sj.embor.7400207; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lecuit T, 2002, TRAFFIC, V3, P92, DOI 10.1034/j.1600-0854.2002.030202.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Mazumdar A, 2002, BIOESSAYS, V24, P1012, DOI 10.1002/bies.10184; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Nordstrom W, 1996, DEV BIOL, V180, P213, DOI 10.1006/dbio.1996.0296; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pick L, 1998, DEV GENET, V23, P1; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tittel JN, 2000, GENOME BIOL, V1, pS3; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Zhang S, 2002, CELL, V108, P45, DOI 10.1016/S0092-8674(01)00630-4	52	256	289	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1097	1108		10.1016/j.cell.2005.04.016	http://dx.doi.org/10.1016/j.cell.2005.04.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989958	Bronze, Green Published			2022-12-24	WOS:000230448000015
J	Michor, F; Hughes, TP; Iwasa, Y; Branford, S; Shah, NP; Sawyers, CL; Nowak, MA				Michor, F; Hughes, TP; Iwasa, Y; Branford, S; Shah, NP; Sawyers, CL; Nowak, MA			Dynamics of chronic myeloid leukaemia	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; COMPLETE CYTOGENETIC REMISSION; TIME QUANTITATIVE PCR; IMATINIB MESYLATE; BLAST CRISIS; ABL GENE; HEMATOPOIETIC PROGENITORS; CLINICAL RESISTANCE; TYROSINE KINASE; CHRONIC PHASE	The clinical success of the ABL tyrosine kinase inhibitor imatinib in chronic myeloid leukaemia (CML) serves as a model for molecularly targeted therapy of cancer(1-4), but at least two critical questions remain. Can imatinib eradicate leukaemic stem cells? What are the dynamics of relapse due to imatinib resistance, which is caused by mutations in the ABL kinase domain? The precise understanding of how imatinib exerts its therapeutic effect in CML and the ability to measure disease burden by quantitative polymerase chain reaction provide an opportunity to develop a mathematical approach. We find that a four-compartment model, based on the known biology of haematopoietic differentiation(5), can explain the kinetics of the molecular response to imatinib in a 169-patient data set. Successful therapy leads to a biphasic exponential decline of leukaemic cells. The first slope of 0.05 per day represents the turnover rate of differentiated leukaemic cells, while the second slope of 0.008 per day represents the turnover rate of leukaemic progenitors. The model suggests that imatinib is a potent inhibitor of the production of differentiated leukaemic cells, but does not deplete leukaemic stem cells. We calculate the probability of developing imatinib resistance mutations and estimate the time until detection of resistance. Our model provides the first quantitative insights into the in vivo kinetics of a human cancer.	Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; Inst Med & Vet Sci, Adelaide, SA 5000, Australia; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Med & Mol Pharmacol,Dept Urol,Mol Biol Inst, Los Angeles, CA 90095 USA	Harvard University; Institute Medical & Veterinary Science Australia; Kyushu University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Michor, F (corresponding author), Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	michor@fas.harvard.edu	Hughes, Tim/AAO-9975-2021; Branford, Susan/X-7733-2019; Nowak, Martin A/A-6977-2008; Sawyers, Charles/G-5327-2016; Iwasa, Yoh/G-5368-2010	Iwasa, Yoh/0000-0003-0691-1852; Branford, Susan/0000-0002-5095-7981				BEDI A, 1993, BLOOD, V81, P2898; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Branford S, 2004, BLOOD, V104, P2926, DOI 10.1182/blood-2004-03-1134; Branford S, 1999, BRIT J HAEMATOL, V107, P587; Branford S, 2003, BLOOD, V102, p414A; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Chu S, 2005, BLOOD, V105, P2093, DOI 10.1182/blood-2004-03-1114; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Higashi T, 2004, AM J HEMATOL, V76, P275, DOI 10.1002/ajh.20096; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Holtz MS, 2002, BLOOD, V99, P3792, DOI 10.1182/blood.V99.10.3792; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Holyoake TL, 2002, LEUKEMIA, V16, P549, DOI 10.1038/sj.leu.2402444; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810	27	610	628	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1267	1270		10.1038/nature03669	http://dx.doi.org/10.1038/nature03669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988530				2022-12-24	WOS:000230140500050
J	Diepstra, A; Niens, M; Vellenga, E; van Imhoff, GW; Nolte, IM; Schaapveld, M; van der Steege, G; van den Berg, A; Kibbelaar, RE; te Meerman, GJ; Poppema, S				Diepstra, A; Niens, M; Vellenga, E; van Imhoff, GW; Nolte, IM; Schaapveld, M; van der Steege, G; van den Berg, A; Kibbelaar, RE; te Meerman, GJ; Poppema, S			Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma	LANCET			English	Article							REED-STERNBERG CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; DISEASE; GENE; SUSCEPTIBILITY; POLYMORPHISM; POPULATION; EXPRESSION; PATTERNS; SUGGESTS	Background Associations of Hodgkin's lymphoma with HLA have been reported for many years. In 20-40% of patients with this disorder, Epstein-Barr virus (EBV) is present in the neoplastic cells. Because presentation of EBV antigenic peptides can elicit vigorous immune responses, we investigated associations of the HLA region with EBV-positive and EBV-negative Hodgkin's lymphoma. Methods In a retrospective, population-based study, patients with Hodgkin's lymphoma were reclassified according to the WHO classification, and EBV status was assessed by in-situ hybridisation of EBV-encoded small RNAs. Germline DNA was isolated from 200 patients diagnosed between 1987 and 2000 and from their first-degree relatives. Genotyping was done with 33 microsatellite markers spanning the entire HLA region and two single-nucleotide polymorphisms in the genes for tumour necrosis factor alpha and beta. Classic association analysis and the haplotype sharing statistic were used to compare patients with controls. Findings Classic association analysis (but not the haplotype sharing statistic) showed an association of consecutive markers D6S265 and D6S510 (p=0.0002 and 0.0003), located in the HLA class I region, with EBV-positive lymphomas. The haplotype sharing statistic (but not classic association analysis) showed a significant difference in mean haplotype sharing between patients and controls surrounding marker D6S273 (p=0.00003), located in HLA class III. Interpretation Areas within the HLA class I and class III regions are associated with susceptibility to Hodgkin's lymphoma, the association with class I being specific for EBV-positive disease. This finding strongly suggests that antigenic presentation of EBV-derived peptides is involved in the pathogenesis of EBV-involved Hodgkin's lymphoma. Relevance to practice Polymorphisms in the HLA region could explain ethnic variation in the incidence of Hodgkin's lymphoma. The association of EBV-positive Hodgkin's lymphoma with HLA class I suggests that this polymorphism might affect the proper presentation of EBV antigens to cytotoxic T lymphocytes.	Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; Univ Med Ctr Groningen, Dept Med Genet, Groningen, Netherlands; Univ Med Ctr Groningen, Dept Haematol, Groningen, Netherlands; Univ Med Ctr Groningen, Dept Med Biol, Groningen, Netherlands; Univ Groningen, Groningen, Netherlands; Comprehens Canc Ctr N Netherlands, Groningen, Netherlands; Lab Publ Hlth Friesland, Dept Pathol, Leeuwarden, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Diepstra, A (corresponding author), Univ Med Ctr Groningen, Dept Pathol & Lab Med, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands.	a.diepstra@path.umcg.nl	Schaapveld, Michael/ABC-9714-2020; van den Berg, Anke/H-1718-2011; Poppema, Sibrand/D-1204-2012	van den Berg, Anke/0000-0002-8894-2638; Schaapveld, Michael/0000-0003-4390-7182; Diepstra, Arjan/0000-0001-9239-1050				Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Beck J, 2001, SOURCE-NOTE HIST ART, V21, P1; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Boon M, 2001, NEUROGENETICS, V3, P221; Brinkman B M, 1995, J Inflamm, V46, P32; de Jong MM, 2003, HUM MOL GENET, V12, P2311, DOI 10.1093/hmg/ddg245; Ferraris AM, 1997, ANN HEMATOL, V74, P131, DOI 10.1007/s002770050270; Glaser SL, 2002, LEUKEMIA RES, V26, P261, DOI 10.1016/S0145-2126(01)00126-6; Glaser SL, 1996, BAILLIERE CLIN HAEM, V9, P401, DOI 10.1016/S0950-3536(96)80018-7; Harty LC, 2002, BLOOD, V99, P690, DOI 10.1182/blood.V99.2.690; HORS J, 1983, IMMUNOL REV, V70, P167, DOI 10.1111/j.1600-065X.1983.tb00714.x; KLITZ W, 1994, AM J HUM GENET, V54, P497; Leen A, 2001, J VIROL, V75, P8649, DOI 10.1128/JVI.75.18.8649-8659.2001; Levinson DF, 2001, AM J MED GENET, V105, P65, DOI 10.1002/1096-8628(20010108)105:1<65::AID-AJMG1064>3.3.CO;2-S; LEWONTIN RC, 1964, GENETICS, V49, P49; Libura J, 2002, ANTICANCER RES, V22, P921; MACK TM, 1995, NEW ENGL J MED, V332, P413, DOI 10.1056/NEJM199502163320701; Maggio EM, 2001, INT J CANCER, V94, P60, DOI 10.1002/ijc.1438; Mainou-Fowler T, 2000, LEUKEMIA LYMPHOMA, V38, P547, DOI 10.3109/10428190009059274; Meij P, 2002, INT J CANCER, V99, P93, DOI 10.1002/ijc.10309; MESSER G, 1991, J EXP MED, V173, P209, DOI 10.1084/jem.173.1.209; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; OZA AM, 1994, CANCER RES, V54, P5101; Poppema S, 2000, SEMIN CANCER BIOL, V10, P345, DOI 10.1006/scbi.2000.0327; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; STEIN HJ, 2001, PROGNOSTIC FACTORS C, P237; Taylor GM, 1999, BRIT J CANCER, V80, P1405, DOI 10.1038/sj.bjc.6690536; Taylor GM, 1996, LEUKEMIA, V10, P854; Wihlborg C, 1999, BRIT J HAEMATOL, V104, P346, DOI 10.1046/j.1365-2141.1999.01176.x	30	115	118	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 25	2005	365	9478					2216	2224		10.1016/S0140-6736(05)66780-3	http://dx.doi.org/10.1016/S0140-6736(05)66780-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938WT	15978930				2022-12-24	WOS:000230034800032
J	Gozlan, RE; St-Hilaire, S; Feist, SW; Martin, P; Kent, ML				Gozlan, RE; St-Hilaire, S; Feist, SW; Martin, P; Kent, ML			Biodiversity - Disease threat to European fish	NATURE			English	Editorial Material							SPHAEROTHECUM-DESTRUENS; INVASIONS; VIRUS		Winfrith Technol Ctr, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England; Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA; CEFAS Weymouth Lab, Weymouth DT4 8UB, Dorset, England; Oregon State Univ, Dept Microbiol, Ctr Fish Dis Res, Corvallis, OR 97331 USA	UK Centre for Ecology & Hydrology (UKCEH); Idaho; Idaho State University; Centre for Environment Fisheries & Aquaculture Science; Oregon State University	Gozlan, RE (corresponding author), Winfrith Technol Ctr, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England.	reg@ceh.ac.uk	Gozlan, Rodolphe/B-3973-2009; St-HIlaire, Sophie/GSI-8705-2022					Arkush KD, 2003, J EUKARYOT MICROBIOL, V50, P430, DOI 10.1111/j.1550-7408.2003.tb00269.x; Gilad O, 2002, DIS AQUAT ORGAN, V48, P101, DOI 10.3354/dao048101; GIURCA R, 1971, ROMANIEI B CERC PISC, V30, P99; Gozlan RE, 2002, J FISH BIOL, V61, P298, DOI 10.1006/jfbi.2002.2042; LELEK A, 1987, FRESHWATER FISHES EU; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Mendonca HL, 2004, DIS AQUAT ORGAN, V61, P187, DOI 10.3354/dao061187; St-Hilaire S, 2001, DIS AQUAT ORGAN, V46, P173, DOI 10.3354/dao046173; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Wolfram-Wais A, 1999, HYDROBIOLOGIA, V408, P123, DOI 10.1023/A:1017014130103	10	227	255	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1046	1046		10.1038/4351046a	http://dx.doi.org/10.1038/4351046a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973399				2022-12-24	WOS:000229970400034
J	Eder, M; Scherr, M				Eder, M; Scherr, M			MicroRNA and lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hannover Med Sch, Dept Hematol & Oncol, D-3000 Hannover, Germany	Hannover Medical School	Eder, M (corresponding author), Hannover Med Sch, Dept Hematol & Oncol, D-3000 Hannover, Germany.							Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637	3	89	98	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2005	352	23					2446	2448		10.1056/NEJMcibr051201	http://dx.doi.org/10.1056/NEJMcibr051201			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933NL	15944431				2022-12-24	WOS:000229638900016
J	Ritter, C; Maddelein, ML; Siemer, AB; Luhrs, T; Ernst, M; Meier, BH; Saupe, SJ; Riek, R				Ritter, C; Maddelein, ML; Siemer, AB; Luhrs, T; Ernst, M; Meier, BH; Saupe, SJ; Riek, R			Correlation of structural elements and infectivity of the HET-s prion	NATURE			English	Article							FUNGUS PODOSPORA-ANSERINA; SOLID-STATE NMR; HETEROKARYON INCOMPATIBILITY; SECONDARY STRUCTURE; AMYLOID FIBRILS; BACKBONE ASSIGNMENTS; H/D-EXCHANGE; IN-VIVO; PROTEIN; SCRAPIE	Prions are believed to be infectious, self-propagating polymers of otherwise soluble, host-encoded proteins(1,2). This concept is now strongly supported by the recent findings that amyloid fibrils of recombinant prion proteins from yeast(3-5), Podospora anserina(6) and mammals(7) can induce prion phenotypes in the corresponding hosts. However, the structural basis of prion infectivity remains largely elusive because acquisition of atomic resolution structural properties of amyloid fibrils represents a largely unsolved technical challenge. HET-s, the prion protein of P. anserina, contains a carboxy-terminal prion domain comprising residues 218 - 289. Amyloid fibrils of HET-s( 218 - 289) are necessary and sufficient for the induction and propagation of prion infectivity(6). Here, we have used fluorescence studies, quenched hydrogen exchange NMR and solid-state NMR to determine the sequence-specific positions of amyloid fibril secondary structure elements of HET-s( 218 - 289). This approach revealed four beta-strands constituted by two pseudo-repeat sequences, each forming a beta-strand-turn-beta- strand motif. By using a structure-based mutagenesis approach, we show that this conformation is the functional and infectious entity of the HET-s prion. These results correlate distinct structural elements with prion infectivity.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Bordeaux 2, CNRS,Unite Mixte Rech 5095, Inst Biochim & Genet Cellulaires, Lab Genet Mol Champignons, F-33077 Bordeaux, France; ETH Honggerberg, ETH Zurich, Phys Chem, CH-8093 Zurich, Switzerland	Salk Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Swiss Federal Institutes of Technology Domain; ETH Zurich	Riek, R (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	riek@salk.edu	MADDELEIN, Marie-Lise/G-5395-2010; Ernst, Matthias/A-6732-2010; Meier, Beat H/K-4066-2016	Ernst, Matthias/0000-0002-9538-6086; Meier, Beat H/0000-0002-9107-4464; saupe, sven/0000-0002-5589-721X; Riek, Roland/0000-0002-6333-066X	NINDS NIH HHS [R01 NS045774-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045774] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; Balguerie A, 2004, J CELL SCI, V117, P2599, DOI 10.1242/jcs.01116; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Bracken C, 1997, J BIOMOL NMR, V9, P94, DOI 10.1023/A:1018679819693; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Coustou-Linares V, 2001, MOL MICROBIOL, V42, P1325, DOI 10.1046/j.1365-2958.2001.02707.x; Dos Reis S, 2002, J BIOL CHEM, V277, P5703, DOI 10.1074/jbc.M110183200; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Laws DD, 2001, P NATL ACAD SCI USA, V98, P11686, DOI 10.1073/pnas.201404298; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LUHRS T, UNPUB NATURE; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Samoson A, 2002, CHEM PHYS LETT, V365, P292, DOI 10.1016/S0009-2614(02)01486-0; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Siemer AB, 2005, ANGEW CHEM INT EDIT, V44, P2441, DOI 10.1002/anie.200462952; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TURCQ B, 1991, MOL GEN GENET, V228, P265, DOI 10.1007/BF00282475; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Verel R, 2001, J MAGN RESON, V150, P81, DOI 10.1006/jmre.2001.2310; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067	30	374	378	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					844	848		10.1038/nature03793	http://dx.doi.org/10.1038/nature03793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944710	Green Accepted			2022-12-24	WOS:000229638700056
J	Beaglehole, R; Horton, R				Beaglehole, R; Horton, R			Chronic diseases of adults - a call for papers	LANCET			English	Editorial Material									WHO, CH-1211 Geneva, Switzerland; The Lancet, London NW1 7BY, England	World Health Organization	Beaglehole, R (corresponding author), WHO, CH-1211 Geneva, Switzerland.	beaglehole@WHO.int						LEEDER S, 2004, RACE TIME; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743	2	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1913	1914		10.1016/S0140-6736(05)66640-8	http://dx.doi.org/10.1016/S0140-6736(05)66640-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936408				2022-12-24	WOS:000229587800009
J	Cohen, MS; Zhang, C; Shokat, KM; Taunton, J				Cohen, MS; Zhang, C; Shokat, KM; Taunton, J			Structural bioinformatics-based design of selective, irreversible kinase inhibitors	SCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; PHOSPHORYLATION; IDENTIFICATION; COMPLEX; SITE; LCK	The active sites of 491 human protein kinase domains are highly conserved, which makes the design of selective inhibitors a formidable challenge. We used a structural bioinformatics approach to identify two selectivity filters, a threonine and a cysteine, at defined positions in the active site of p90 ribosomal protein S6 kinase (RSK). A fluoromethylketone inhibitor, designed to exploit both selectivity filters, potently and selectively inactivated RSK1 and RSK2 in mammalian cells. Kinases with only one selectivity filter were resistant to the inhibitor, yet they became sensitized after genetic introduction of the second selectivity filter. Thus, two amino acids that distinguish RSK from other protein kinases are sufficient to confer inhibitor sensitivity.	Univ Calif San Francisco, Program Chem & Chem Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Taunton, J (corresponding author), Univ Calif San Francisco, Program Chem & Chem Biol, San Francisco, CA 94143 USA.	taunton@cmp.ucsf.edu			NIGMS NIH HHS [R01 GM071434-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071434] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barker AJ, 2001, BIOORG MED CHEM LETT, V11, P1911, DOI 10.1016/S0960-894X(01)00344-4; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Burchat AF, 2000, BIOORG MED CHEM LETT, V10, P2171, DOI 10.1016/S0960-894X(00)00442-X; Buzko O, 2002, BIOINFORMATICS, V18, P1274, DOI 10.1093/bioinformatics/18.9.1274; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; COHEN M, UNPUB; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Hanauer A, 2002, J MED GENET, V39, P705, DOI 10.1136/jmg.39.10.705; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Tsigelny I, 1999, BIOPOLYMERS, V50, P513, DOI 10.1002/(SICI)1097-0282(19991015)50:5<513::AID-BIP5>3.0.CO;2-I; Vik TA, 1997, BIOCHEM BIOPH RES CO, V235, P398, DOI 10.1006/bbrc.1997.6794; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	21	401	494	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1318	1321		10.1126/science1108367	http://dx.doi.org/10.1126/science1108367			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919995	Green Accepted			2022-12-24	WOS:000229482300050
J	Bernal-Mizrachi, C; Gates, AC; Weng, S; Imamura, T; Knutsen, RH; DeSantis, P; Coleman, T; Townsend, RR; Muglia, LJ; Semenkovich, CF				Bernal-Mizrachi, C; Gates, AC; Weng, S; Imamura, T; Knutsen, RH; DeSantis, P; Coleman, T; Townsend, RR; Muglia, LJ; Semenkovich, CF			Vascular respiratory uncoupling increases blood pressure and atherosclerosis	NATURE			English	Article							BROWN ADIPOSE-TISSUE; IDENTIFICATION; METABOLISM; DEFICIENT; PROTEINS; RADICALS; LIPIDS; CELLS; MICE	The observations that atherosclerosis often occurs in nonsmokers without elevated levels of low-density lipoprotein cholesterol, and that most atherosclerosis loci so far identified in mice do not affect systemic risk factors associated with atherosclerosis(1), suggest that as-yet-unidentified mechanisms must contribute to vascular disease. Arterial walls undergo regional disturbances of metabolism(2) that include the uncoupling of respiration and oxidative phosphorylation, a process that occurs to some extent in all cells and may be characteristic of blood vessels being predisposed to the development of atherosclerosis(3). To test the hypothesis that inefficient metabolism in blood vessels promotes vascular disease, we generated mice with doxycycline-inducible expression of uncoupling protein-1 (UCP1) in the artery wall. Here we show that UCP1 expression in aortic smooth muscle cells causes hypertension and increases dietary atherosclerosis without affecting cholesterol levels. UCP1 expression also increases superoxide production and decreases the availability of nitric oxide, evidence of oxidative stress. These results provide proof of principle that inefficient metabolism in blood vessels can cause vascular disease.	Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Semenkovich, CF (corresponding author), Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA.	csemenko@im.wustl.edu		Semenkovich, Clay/0000-0003-1163-1871; Bernal-Mizrachi, Carlos/0000-0002-8991-7522	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088083] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK088083] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allayee H, 2003, ARTERIOSCL THROM VAS, V23, P1501, DOI 10.1161/01.ATV.0000090886.40027.DC; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; CORNWELL D G, 1981, Progress in Lipid Research, V20, P365, DOI 10.1016/0163-7827(81)90069-2; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; HAYASHIDA T, 1960, P SOC EXP BIOL MED, V103, P656, DOI 10.3181/00379727-103-25625; HEATON JM, 1972, J ANAT, V112, P35; HEUPER WC, 1944, ARCH PATHOL, V38, P162; JENNINGS RB, 1967, ARCH PATHOL, V84, P15; Kanski J, 2005, AM J PHYSIOL-HEART C, V288, pH371, DOI 10.1152/ajpheart.01030.2003; KLEIN PD, 1954, J BIOL CHEM, V211, P103; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; Levin M, 2003, ARTERIOSCL THROM VAS, V23, P1801, DOI 10.1161/01.ATV.0000092872.54026.8D; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Moessler H, 1996, DEVELOPMENT, V122, P2415; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; NOHL H, 1994, ANN BIOL CLIN-PARIS, V52, P199; PETTERSSON G, 1985, ACTA PHARMACOL TOX, V57, P184, DOI 10.1111/bcpt.1985.57.3.184; SANTERRE RF, 1974, EXP MOL PATHOL, V20, P397, DOI 10.1016/0014-4800(74)90069-0; SJODIN B, 1990, SPORTS MED, V10, P236; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; SMITH EB, 1962, BIOCHEM J, V84, pP49; SMITH EB, 1962, LANCET, V2, P530; Su B, 2001, CIRC RES, V89, P39, DOI 10.1161/hh1301.093615; SZEKELY M, 1970, EXPERIENTIA, V26, P1314, DOI 10.1007/BF02112999; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; WATTS HF, 1963, EVOLUTION ATHEROSCLE, P117; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890	30	141	150	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					502	506		10.1038/nature03527	http://dx.doi.org/10.1038/nature03527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917810				2022-12-24	WOS:000229337800056
J	Ballas, N; Grunseich, C; Lu, DD; Speh, JC; Mandel, G				Ballas, N; Grunseich, C; Lu, DD; Speh, JC; Mandel, G			REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis	CELL			English	Article							RESTRICTIVE SILENCER FACTOR; EMBRYONIC STEM-CELLS; RETT-SYNDROME; TARGET GENES; METHYLATION PATTERNS; HISTONE METHYLATION; REPRESSOR COMPLEX; ACTIVE REPRESSION; NEURAL INDUCTION; IN-VIVO	Regulation of neuronal gene expression is critical to central nervous system development. Here, we show that REST regulates the transitions from pluripotent to neural stem/progenitor cell and from progenitor to mature neuron. In the transition to progenitor cell, REST is degraded to levels just sufficient to maintain neuronal gene chromatin in an inactive state that is nonetheless poised for expression. As progenitors differentiate into neurons, REST and its corepressors dissociate from the RE1 site, triggering activation of neuronal genes. In some genes, the level of expression is adjusted further in neurons by CoREST/MeCP2 repressor complexes that remain bound to a site of methylated DNA distinct from the RE1 site. Expression profiling based on this mechanism indicates that REST defines a gene set subject to plasticity in mature neurons. Thus, a multistage repressor mechanism controls the orderly expression of genes during development while still permitting fine tuning in response to specific stimuli.	SUNY Stony Brook, Howard Hughes Med Inst, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ballas, N (corresponding author), SUNY Stony Brook, Howard Hughes Med Inst, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	nballas@notes.cc.sunysb.edu						Anderson D, 1997, MOL CELLULAR APPROAC, P26; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Casarosa S, 1999, DEVELOPMENT, V126, P525; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Koide T, 2001, GENE DEV, V15, P2111, DOI 10.1101/gad.908801; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nan XH, 2001, BRAIN DEV-JPN, V23, pS32, DOI 10.1016/S0387-7604(01)00333-3; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sasai Y, 1998, NEURON, V21, P455, DOI 10.1016/S0896-6273(00)80554-1; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; SUCOV HM, 1995, MOL NEUROBIOL, V10, P169, DOI 10.1007/BF02740674; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Van den Veyver IB, 2001, BRAIN DEV-JPN, V23, pS147, DOI 10.1016/S0387-7604(01)00376-X; Weston AD, 2003, J CELL BIOL, V161, P223, DOI 10.1083/jcb.200211117; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8	48	683	707	0	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 20	2005	121	4					645	657		10.1016/j.cell.2005.03.013	http://dx.doi.org/10.1016/j.cell.2005.03.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907476	Bronze			2022-12-24	WOS:000229331200019
J	Tews, I; Findeisen, F; Sinning, I; Schultz, A; Schultz, JE; Linder, JU				Tews, I; Findeisen, F; Sinning, I; Schultz, A; Schultz, JE; Linder, JU			The structure of a pH-sensing mycobacterial adenylyl cyclase holoenzyme	SCIENCE			English	Article							TUBERCULOSIS; CAMP	Class III adenylyl cyclases contain catalytic and regulatory domains, yet structural insight into their interactions is missing. We show that the mycobacterial adenylyl cyclase Rv1264 is rendered a pH sensor by its N-terminal domain. In the structure of the inhibited state, catalytic and regulatory domains share a large interface involving catalytic residues. In the structure of the active state, the two catalytic domains rotate by 55 degrees to form two catalytic sites at their interface. Two alpha helices serve as molecular switches. Mutagenesis is consistent with a regulatory role of the structural transition, and we suggest that the transition is regulated by pH.	Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; Inst Pharmazeut, D-72076 Tubingen, Germany	Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Tews, I (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ivo.tews@bzh.uni-heidelberg.de; juergen.linder@uni-tuebingen.de	Tews, Ivo/A-2750-2010	Tews, Ivo/0000-0002-4704-1139				Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; BARZU O, 1994, PROG NUCLEIC ACID RE, V49, P241; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; FINDEISEN F, UNPUB; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tews I., UNPUB; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	19	96	101	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1020	1023		10.1126/science.1107642	http://dx.doi.org/10.1126/science.1107642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890882				2022-12-24	WOS:000229190700046
J	Lucchetta, EM; Lee, JH; Fu, LA; Patel, NH; Ismagilov, RF				Lucchetta, EM; Lee, JH; Fu, LA; Patel, NH; Ismagilov, RF			Dynamics of Drosophila embryonic patterning network perturbed in space and time using microfluidics	NATURE			English	Article							EXPRESSION PATTERNS; POLY(DIMETHYLSILOXANE); PROTEIN; DEVICES	Biochemical networks are perturbed both by fluctuations in environmental conditions and genetic variation. These perturbations must be compensated for, especially when they occur during embryonic pattern formation. Complex chemical reaction networks displaying spatiotemporal dynamics have been controlled and understood by perturbing their environment in space and time(1-3). Here, we apply this approach using microfluidics to investigate the robust network in Drosophila melanogaster that compensates for variation in the Bicoid morphogen gradient. We show that the compensation system can counteract the effects of extremely unnatural environmental conditions-a temperature step-in which the anterior and posterior halves of the embryo are developing at different temperatures and thus at different rates. Embryonic patterning was normal under this condition, suggesting that a simple reciprocal gradient system is not the mechanism of compensation. Time-specific reversals of the temperature step narrowed down the critical period for compensation to between 65 and 100 min after onset of embryonic development. The microfluidic technology used here may prove useful to future studies, as it allows spatial and temporal regulation of embryonic development.	Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol Mol & Cell Biol, Berkeley, CA 94720 USA	University of Chicago; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ismagilov, RF (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	nipam@uclink.berkeley.edu; r-ismagilov@uchicago.edu		Fu, Lydia/0000-0003-2800-3388; Patel, Nipam/0000-0003-4328-654X	NIGMS NIH HHS [R01 GM077331, R01 GM077331-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077331] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JR, 2000, ANAL CHEM, V72, P3158, DOI 10.1021/ac9912294; DiGregorio PJ, 2001, J BIOL CHEM, V276, P1930, DOI 10.1074/jbc.M003911200; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FOE VE, 1993, DEV DROSOPHILA MELAN; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; Furlong EEM, 2001, NAT BIOTECHNOL, V19, P153, DOI 10.1038/84422; Hatch A, 2001, NAT BIOTECHNOL, V19, P461, DOI 10.1038/88135; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; NIEMUTH J, 1995, ROUX ARCH DEV BIOL, V204, P444, DOI 10.1007/BF00360852; PATEL NH, 1994, NATURE, V367, P429, DOI 10.1038/367429a0; Sakurai T, 2002, SCIENCE, V296, P2009, DOI 10.1126/science.1071265; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Stasiek JA, 2002, OPTO-ELECTRON REV, V10, P1; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Vanag VK, 2000, NATURE, V406, P389, DOI 10.1038/35019038; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Wolff J, 2001, SCIENCE, V294, P134, DOI 10.1126/science.1063597	21	345	358	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1134	1138		10.1038/nature03509	http://dx.doi.org/10.1038/nature03509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858575	Green Accepted, Bronze			2022-12-24	WOS:000228693300044
J	Lauer, P; Rinaudo, CD; Soriani, M; Margarit, I; Maione, D; Rosini, R; Taddei, AR; Mora, M; Rappuoli, R; Grandi, G; Telford, JL				Lauer, P; Rinaudo, CD; Soriani, M; Margarit, I; Maione, D; Rosini, R; Taddei, AR; Mora, M; Rappuoli, R; Grandi, G; Telford, JL			Genome analysis reveals pili in group B Streptococcus	SCIENCE			English	Article									Chiron Srl, I-53100 Siena, Italy; Univ Tuscia, Ctr Interdipartimentale Microscopia Elettron, Viterbo, Italy	Novartis; Tuscia University	Telford, JL (corresponding author), Chiron Srl, Via Fiorentina 1, I-53100 Siena, Italy.	john_telford@chiron.com	Telford, John Laird/ABG-8144-2020	SORIANI, Marco/0000-0002-9752-5844; Grandi, Guido/0000-0001-9724-2185	NIAID NIH HHS [U01-AI060693-01] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		LAUER P, UNPUB; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004	8	243	258	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					105	105		10.1126/science.1111563	http://dx.doi.org/10.1126/science.1111563			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994549				2022-12-24	WOS:000230212800066
J	Zhong, Q; Gao, WH; Du, FH; Wang, XD				Zhong, Q; Gao, WH; Du, FH; Wang, XD			Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis	CELL			English	Article							BCL-2 FAMILY; PROTEIN UBIQUITINATION; CELL-DIFFERENTIATION; SURVIVAL FACTOR; UBA DOMAIN; SEQUENCE; CLEAVAGE; DEATH; BINDING; MEMBER	The elimination of Mcl-1, an anti-apoptotic Bcl-2 family member, is an early and required step for DNA damage-induced apoptosis. The degradation of Mcl-1 can be blocked by proteasome inhibitors, suggesting a role for the ubiquitin proteasome pathway in apoptosis. Here, we demonstrate that Mcl-1 is ubiquinated at five lysines. Biochemical fractionation of cell extracts allowed us to identify a 482 kDa HECT-domain-containing ubiquitin ligase named Mule (Mcl-1 ubiquitin ligase E3) that is both required and sufficient for the polyubiquitination of Mcl-1. Mule also contains a region similar to the Bcl-2 homology region 3 (BH3) domain that allows Mule to specifically interact with Mcl-1. Elimination of Mule expression by RNA interference stabilizes Mcl-1 protein, resulting in an attenuation of the apoptosis induced by DNA-damage agents. Thus, Mule is a unique BH3-containing E3 ubiquitin ligase apical to Bcl-2 family proteins during DNA damage induced apoptosis.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	xwang@biochem.swmed.edu	Zhong, Qing/GLT-4858-2022	Zhong, Qing/0000-0001-6979-955X; Wang, Xiaodong/0000-0001-9885-356X	NIGMS NIH HHS [GMR01-57158] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057158] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; GU J, 1994, MOL BRAIN RES, V24, P77, DOI 10.1016/0169-328X(94)90120-1; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; Huang HM, 2000, BLOOD, V96, P1764, DOI 10.1182/blood.V96.5.1764.h8001764_1764_1771; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Le Gouill S, 2004, BLOOD, V104, P2886, DOI 10.1182/blood-2004-05-1760; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Piret JP, 2005, J BIOL CHEM, V280, P9336, DOI 10.1074/jbc.M411858200; Reed JC, 1997, SEMIN HEMATOL, V34, P9; Rinkenberger JL, 2000, GENE DEV, V14, P23; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Varshavsky A, 2000, Harvey Lect, V96, P93; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	40	656	671	6	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1085	1095		10.1016/j.cell.2005.06.009	http://dx.doi.org/10.1016/j.cell.2005.06.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989957	Bronze			2022-12-24	WOS:000230448000014
J	van Zanten, SV				van Zanten, SV			Upper gastrointestinal alarms: the 2-week rule	LANCET			English	Editorial Material							DYSPEPSIA; ENDOSCOPY; SYMPTOMS		Queen Elizabeth II Hlth Sci Ctr, Halifax, NS B3H 2Y9, Canada	Queen Elizabeth II Health Sciences Centre	van Zanten, SV (corresponding author), Queen Elizabeth II Hlth Sci Ctr, Victoria Gen Hosp Site, Halifax, NS B3H 2Y9, Canada.	Zanten@dal.ca						Axon ATR, 1997, GASTROENTEROLOGY, V112, P1376, DOI 10.1016/S0016-5085(97)70153-7; Department of Health, 2001, GUID COMM CANC SERV; Fransen GAJ, 2004, ALIMENT PHARM THERAP, V20, P1045, DOI 10.1111/j.1365-2036.2004.02251.x; Jacobson BC, 2003, AM J GASTROENTEROL, V98, P51, DOI 10.1111/j.1572-0241.2003.07186.x; Kapoor N, 2005, GUT, V54, P40, DOI 10.1136/gut.2004.039438; *NAT GUID RES DEV, 2004, DYSP MAN AD PRIM CAR; RYDER SD, 1994, BRIT MED J, V308, P827, DOI 10.1136/bmj.308.6932.827; *SIGN, 2003, CLIN LAUNCH SIGN DYS; Talley NJ, 1998, GASTROENTEROLOGY, V114, P582, DOI 10.1016/S0016-5085(98)70542-6; Vakil NB, 2004, CLIN GASTROENTEROL H, V2, P665, DOI 10.1016/S1542-3565(04)00289-7; van Zanten SJOV, 1999, AM J GASTROENTEROL, V94, P9; van Zanten SJOV, 2000, CAN MED ASSOC J, V162, pS3	12	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2005	365	9478					2163	2164		10.1016/S0140-6736(05)66757-8	http://dx.doi.org/10.1016/S0140-6736(05)66757-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938WT	15978912				2022-12-24	WOS:000230034800010
J	Kmita, M; Tarchini, B; Zakany, J; Logan, M; Tabin, CJ; Duboule, D				Kmita, M; Tarchini, B; Zakany, J; Logan, M; Tabin, CJ; Duboule, D			Early developmental arrest of mammalian limbs lacking HoxA/HoxD gene function	NATURE			English	Article							SONIC-HEDGEHOG; MICE LACKING; HOX GENES; AXIAL SKELETON; FORELIMB; ANTAGONISM; EVOLUTION; OUTGROWTH; DELETION; HOXD-11	Vertebrate HoxA and HoxD cluster genes are required for proper limb development(1-3). However, early lethality, compensation and redundancy have made a full assessment of their function difficult(3-5). Here we describe mice that are lacking all Hoxa and Hoxd functions in their forelimbs. We show that such limbs are arrested early in their developmental patterning and display severe truncations of distal elements, partly owing to the absence of Sonic hedgehog expression. These results indicate that the evolutionary recruitment of Hox gene function into growing appendages might have been crucial in implementing hedgehog signalling, subsequently leading to the distal extension of tetrapod appendages. Accordingly, these mutant limbs may be reminiscent of an ancestral trunk extension, related to that proposed for arthropods(6).	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva, Switzerland; Univ Geneva, Natl Res Ctr Frontiers Genet, CH-1211 Geneva, Switzerland; Natl Inst Med Res, Div Dev Biol, London NW7 1AA, England; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Geneva; University of Geneva; MRC National Institute for Medical Research; Harvard University; Harvard Medical School	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Sci 3,Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.	denis.duboule@zoo.unige.ch	kmita, marie/AAU-9620-2020	Kmita, Marie/0000-0003-4021-0478; duboule, denis/0000-0001-9961-2960; Tarchini, Basile/0000-0003-2708-6273	Medical Research Council [MC_U117560477] Funding Source: Medline; NICHD NIH HHS [R37 HD032443] Funding Source: Medline; MRC [MC_U117560477] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Dupe V, 1997, DEVELOPMENT, V124, P399; Favier B, 1996, DEVELOPMENT, V122, P449; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gonzalez-Crespo S, 1998, NATURE, V394, P196, DOI 10.1038/28197; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Medina-Martinez O, 2000, DEV BIOL, V222, P71, DOI 10.1006/dbio.2000.9683; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Sordino P, 1996, TRENDS ECOL EVOL, V11, P114, DOI 10.1016/0169-5347(96)81089-5; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; TABIN C, 1993, NATURE, V361, P692, DOI 10.1038/361692a0; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049	29	194	199	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1113	1116		10.1038/nature03648	http://dx.doi.org/10.1038/nature03648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973411				2022-12-24	WOS:000229970400052
J	Lochhead, PA; Sibbet, G; Morrice, N; Cleghon, V				Lochhead, PA; Sibbet, G; Morrice, N; Cleghon, V			Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DEPENDENT PROTEIN-KINASE; DUAL-SPECIFICITY; TYROSINE-PHOSPHORYLATION; DOWN-SYNDROME; CATALYTIC SUBUNIT; REGULATED KINASE; FAMILY; CELLS; INHIBITORS	Autophosphorylation of a critical residue in the activation loop of several protein kinases is an essential maturation event required for full enzyme activity. However, the molecular mechanism by which this happens is unknown. We addressed this question for two dual-specificity tyrosine-phosphorylation-regulated protein kinases (DYRKs), as they autophosphorylate their activation loop on an essential tyrosine but phosphorylate their substrates on serine and threonine. Here we demonstrate that autophosphorylation of the critical activation-loop tyrosine is intramolecular and mediated by the nascent kinase passing through a transitory intermediate form. This DYRK intermediate differs in residue and substrate specificity, as well as sensitivity to small-molecule inhibitors, compared with its mature counterpart. The intermediate's characteristics are lost upon completion of translation, making the critical tyrosine autophosphorylation a "one-off" inceptive event. This mechanism is likely to be shared with other kinases.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Dundee, MRC, Prot Phosphorylat Unit, Sch Life Sci, Dundee DD1 5EH, Scotland	Beatson Institute; University of Dundee	Lochhead, PA (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	p.lochhead@beatson.gla.ac.uk; v.cleghon@beatson.gla.ac.uk						Abe MK, 2001, J BIOL CHEM, V276, P21272, DOI 10.1074/jbc.M100026200; Abe MK, 1999, MOL CELL BIOL, V19, P1301; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Cauthron RD, 1998, MOL CELL BIOL, V18, P1416, DOI 10.1128/MCB.18.3.1416; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de Wit NJW, 2002, MELANOMA RES, V12, P57, DOI 10.1097/00008390-200202000-00009; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Hammerle B, 2003, J NEURAL TRANSM-SUPP, P129; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; Lee K, 2000, CANCER RES, V60, P3631; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Miller CT, 2003, CANCER RES, V63, P4136; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Sarno S, 2003, BIOCHEM J, V374, P639, DOI 10.1042/BJ20030674; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; SZYSZKA R, 1995, BIOCHEM BIOPH RES CO, V208, P418, DOI 10.1006/bbrc.1995.1354; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; Way G, 2002, MOL BIOL CELL, V13, P3344, DOI 10.1091/mbc.E01-10-0094; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3	44	216	219	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					925	936		10.1016/j.cell.2005.03.034	http://dx.doi.org/10.1016/j.cell.2005.03.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960979	Bronze			2022-12-24	WOS:000230011200014
J	Gales, NJ; Kasuya, T; Clapham, PJ; Brownell, RL				Gales, NJ; Kasuya, T; Clapham, PJ; Brownell, RL			Japan's whaling plan under scrutiny	NATURE			English	Editorial Material									Australian Antarctic Div, Kingston, Tas 7050, Australia; Teikyo Univ Sci & Technol, Yamanashi 4090193, Japan; Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; SW Fisheries Sci Ctr, Pacific Grove, CA 93950 USA	Australian Antarctic Division; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Gales, NJ (corresponding author), Australian Antarctic Div, Channel Highway, Kingston, Tas 7050, Australia.							Brownell RL, 2000, SCIENCE, V290, P1696; DELAMARE W, 1990, NATURE, V345, P771, DOI 10.1038/345771a0; NAGASAKI F, 1990, NATURE, V344, P189, DOI 10.1038/344189a0; Normile D, 2000, SCIENCE, V289, P2264, DOI 10.1126/science.289.5488.2264	4	45	45	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 16	2005	435	7044					883	884		10.1038/435883a	http://dx.doi.org/10.1038/435883a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959491	Green Submitted			2022-12-24	WOS:000229799700020
J	de Beaufort, I				de Beaufort, I			Patients in a persistent vegetative state - A dutch perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Erasmus Univ, Erasmus Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	de Beaufort, I (corresponding author), Erasmus Univ, Erasmus Med Ctr, Rotterdam, Netherlands.							*HLTH COUNC, 1994, PAT VEG TOEST; Lavrijsen J, 2005, BRAIN INJURY, V19, P67, DOI 10.1080/02699050410001720013; LAVRIJSEN JCM, IN PRESS J NEUROL NE; *ROYAL DUTCH MED A, 1997, MED HAND ROND LEV BI	4	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2005	352	23					2373	2375		10.1056/NEJMp058094	http://dx.doi.org/10.1056/NEJMp058094			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933NL	15944421				2022-12-24	WOS:000229638900002
J	Demir, E; Dickson, BJ				Demir, E; Dickson, BJ			fruitless splicing specifies male courtship behavior in Drosophila	CELL			English	Article							DETERMINATION GENE FRUITLESS; MALE-SPECIFIC MUSCLE; AXON GUIDANCE; EXPRESSION PATTERNS; SEXUAL ORIENTATION; FEMALE DROSOPHILA; MUTANT DROSOPHILA; MELANOGASTER; DOUBLESEX; PROTEIN	All animals exhibit innate behaviors that are specified during their development. Drosophila melanogaster males (but not females) perform an elaborate and innate courtship ritual directed toward females (but not males). Male courtship requires products of the fruitless (fru) gene, which is spliced differently in males and females. We have generated alleles of fru that are constitutively spliced in either the male or the female mode. We show that male splicing is essential for male courtship behavior and sexual orientation. More importantly, male splicing is also sufficient to generate male behavior in otherwise normal females. These females direct their courtship toward other females (or males engineered to produce female pheromones). The splicing of a single neuronal gene thus specifies essentially all aspects of a complex innate behavior.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Dickson, BJ (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	barry.dickson@imba.oeaw.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; Anand A, 2001, GENETICS, V158, P1569; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Billeter JC, 2002, ADV GENET, V47, P87, DOI 10.1016/S0065-2660(02)47003-4; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; CURRIE DA, 1995, DEVELOPMENT, V121, P2549; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; GAILEY DA, 1991, DEVELOPMENT, V113, P879; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; GILL KULBIR S., 1963, AMER ZOOL, V3, P507; Goeke S, 2003, NAT NEUROSCI, V6, P917, DOI 10.1038/nn1105; Goodwin SF, 2000, GENETICS, V154, P725; GREENSPAN RJ, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0495-72; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450; Horiuchi T, 2003, GENE DEV, V17, P2496, DOI 10.1101/gad.1137303; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Kido A, 2002, J NEUROBIOL, V52, P302, DOI 10.1002/neu.10100; LAWRENCE PA, 1984, CELL, V36, P775, DOI 10.1016/0092-8674(84)90357-X; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Ogilvie AD, 1996, LANCET, V347, P731, DOI 10.1016/S0140-6736(96)90079-3; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Schlote, 1984, DROS INFORM SERV, V60, P210; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; TAYLOR BJ, 1992, DEVELOPMENT, V114, P625; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; TAYLOR BJ, 1992, GENETICS, V132, P179; Tinbergen, 1951, STUDY INSTINCT; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Villella A, 1996, GENETICS, V143, P331; Villella A, 1997, GENETICS, V147, P1107; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475	52	328	336	3	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					785	794		10.1016/j.cell.2005.04.027	http://dx.doi.org/10.1016/j.cell.2005.04.027			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935764	Bronze			2022-12-24	WOS:000229658000016
J	Gigant, B; Wang, CG; Ravelli, RBG; Roussi, F; Steinmetz, MO; Curmi, PA; Sobel, A; Knossow, M				Gigant, B; Wang, CG; Ravelli, RBG; Roussi, F; Steinmetz, MO; Curmi, PA; Sobel, A; Knossow, M			Structural basis for the regulation of tubulin by vinblastine	NATURE			English	Article							STATHMIN-LIKE DOMAIN; VINCA ALKALOIDS; BETA-TUBULIN; BINDING-SITE; MICROTUBULE; COLCHICINE; MECHANISM; CRYSTALLOGRAPHY; LOCALIZATION; INHIBITION	Vinblastine is one of several tubulin-targeting Vinca alkaloids that have been responsible for many chemotherapeutic successes since their introduction in the clinic as antitumour drugs(1). In contrast with the two other classes of small tubulin-binding molecules (Taxol(2) and colchicine(3)), the binding site of vinblastine is largely unknown and the molecular mechanism of this drug has remained elusive. Here we report the X-ray structure of vinblastine bound to tubulin in a complex with the RB3 protein stathmin-like domain (RB3-SLD). Vinblastine introduces a wedge at the interface of two tubulin molecules and thus interferes with tubulin assembly. Together with electron microscopical and biochemical data, the structure explains vinblastine-induced tubulin self-association into spiral aggregates at the expense of microtubule growth(4). It also shows that vinblastine and the amino-terminal part of RB3-SLD binding sites share a hydrophobic groove on the alpha-tubulin surface that is located at an intermolecular contact in microtubules. This is an attractive target for drugs designed to perturb microtubule dynamics by interfacial interference, for which tubulin seems ideally suited because of its propensity to self-associate.	Lab Enzymol & Biochim Struct, CNRS, UPR 9063, F-91198 Gif Sur Yvette, France; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France; CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France; Paul Scherrer Inst, CH-5232 Villigen, Switzerland; Inst Fer Moulin, UPMC, INSERM, U706, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Knossow, M (corresponding author), Lab Enzymol & Biochim Struct, CNRS, UPR 9063, Batiment 34,1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	knossow@lebs.cnrs-gif.fr	Steinmetz, Michel O/AAA-3349-2022; CURMI, Patrick/G-4036-2013	Steinmetz, Michel O/0000-0001-6157-3687; CURMI, Patrick A./0000-0001-5045-8501; Ravelli, Raimond/0000-0001-6056-5888; Gigant, Benoit/0000-0002-5946-6759				Bau R, 2000, J CHEM SOC PERK T 1, P2079, DOI 10.1039/b001855o; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Ennifar E, 2002, ACTA CRYSTALLOGR D, V58, P1262, DOI 10.1107/S0907444902009526; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; HASKINS KM, 1981, J CELL SCI, V47, P237; HIMES RH, 1991, PHARMACOL THERAPEUT, V51, P257, DOI 10.1016/0163-7258(91)90081-V; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1991, CANCER RES, V51, P2212; Lobert S, 2000, BIOCHEMISTRY-US, V39, P12053, DOI 10.1021/bi001038r; Mitra A, 2004, BIOCHEMISTRY-US, V43, P13955, DOI 10.1021/bi0487387; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; NA GC, 1986, BIOCHEMISTRY-US, V25, P6214, DOI 10.1021/bi00368a057; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2003, CURR OPIN STRUC BIOL, V13, P256, DOI 10.1016/S0959-440X(03)00029-0; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Rai SS, 1996, J BIOL CHEM, V271, P14707, DOI 10.1074/jbc.271.25.14707; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Ravelli RBG, 2003, STRUCTURE, V11, P217, DOI 10.1016/S0969-2126(03)00006-6; Redeker V, 2000, J BIOL CHEM, V275, P6841, DOI 10.1074/jbc.275.10.6841; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; SACKETT DL, 1995, BIOCHEMISTRY-US, V34, P7010, DOI 10.1021/bi00021a012; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; TROUET ABL, 1987, Patent No. 4639456; Usui T, 2004, CHEM BIOL, V11, P799, DOI 10.1016/j.chembiol.2004.03.028; WEISENBE.RC, 1970, BIOCHEMISTRY-US, V9, P4110, DOI 10.1021/bi00823a012; WILSON L, 1982, J MOL BIOL, V159, P125, DOI 10.1016/0022-2836(82)90035-3	30	533	556	2	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					519	522		10.1038/nature03566	http://dx.doi.org/10.1038/nature03566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917812				2022-12-24	WOS:000229337800059
J	Morimoto, M; Takahashi, Y; Endo, M; Saga, Y				Morimoto, M; Takahashi, Y; Endo, M; Saga, Y			The Mesp2 transcription factor establishes segmental borders by suppressing Notch activity	NATURE			English	Article							LUNATIC-FRINGE EXPRESSION; SOMITE BOUNDARY FORMATION; VERTEBRATE SEGMENTATION; RETINOIC ACID; CLOCK; GENE; SOMITOGENESIS; MESODERM; GLYCOSYLTRANSFERASE; PATHWAY	The serially segmented ( metameric) structures of vertebrates are based on somites that are periodically formed during embryogenesis. A 'clock and wavefront' model has been proposed to explain the underlying mechanism of somite formation(1), in which the periodicity is generated by oscillation of Notch components ( the clock) in the posterior pre-somitic mesoderm (PSM)(2-6). This temporal periodicity is then translated into the segmental units in the 'wavefront'(7,8). The wavefront is thought to exist in the anterior PSM and progress backwards at a constant rate; however, there has been no direct evidence as to whether the levels of Notch activity really oscillate and how such oscillation is translated into a segmental pattern in the anterior PSM. Here, we have visualized endogenous levels of Notch1 activity in mice, showing that it oscillates in the posterior PSM but is arrested in the anterior PSM. Somite boundaries formed at the interface between Notch1-activated and - repressed domains. Genetic and biochemical studies indicate that this interface is generated by suppression of Notch activity by mesoderm posterior 2 (Mesp2) through induction of the lunatic fringe gene (Lfng). We propose that the oscillation of Notch activity is arrested and translated in the wavefront by Mesp2.	Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan; Natl Inst Hlth Sci, Cellular & Mol Toxicol Div, Setagaya Ku, Tokyo 1588501, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institute of Health Sciences - Japan	Saga, Y (corresponding author), Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan.	ysaga@lab.nig.ac.jp						Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Buchberger A, 1998, DEV BIOL, V199, P201, DOI 10.1006/dbio.1998.8919; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Sawada A, 2000, DEVELOPMENT, V127, P1691; Sawada A, 2001, DEVELOPMENT, V128, P4873; Sparrow DB, 1998, DEVELOPMENT, V125, P2041; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062	29	195	206	3	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					354	359		10.1038/nature03591	http://dx.doi.org/10.1038/nature03591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902259				2022-12-24	WOS:000229185000047
J	Gostin, LO				Gostin, LO			Ethics, the constitution, and the dying process - The case of Theresa Marie Schiavo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CRUZAN; DEATH; LIFE		Georgetown Univ, Ctr Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						*AM MED ASS, 1986, WITHH WITHDR LIF PRO; *AM NURS ASS, 1988, GUID WITHDR WITHH FO; BABINGTON C, 2005, WASH POST       0908, pA6; CERMINARA KL, KEY EVENTS CASE TM S; GOSTIN L, 1991, MILBANK Q, V69, P143, DOI 10.2307/3350124; Gostin LO, 1997, JAMA-J AM MED ASSOC, V278, P1523, DOI 10.1001/jama.278.18.1523; HULSE C, 2005, NY TIMES        0519, pA1; JOHNSON HM, 2005, WASHINGTON POST 0325, pA19; MEISEL A, 2004, RIGHT DIE LAW END LI; *PRES COMM STUD ET, 1983, DEC FOR LIF SUST TRE; SANGER D, 2003, NY TIMES, pA23; Wolfson Jay, 2003, REPORT GOVERNOR J BU	12	32	32	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2005	293	19					2403	2407		10.1001/jama.293.19.2403	http://dx.doi.org/10.1001/jama.293.19.2403			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	926JX	15900011				2022-12-24	WOS:000229120600028
J	Elachi, C; Wall, S; Allison, M; Anderson, Y; Boehmer, R; Callahan, P; Encrenaz, P; Flamini, E; Franceschetti, G; Gim, Y; Hamilton, G; Hensley, S; Janssen, M; Johnson, W; Kelleher, K; Kirk, R; Lopes, R; Lorenz, R; Lunine, J; Muhleman, D; Ostro, S; Paganelli, F; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Soderblom, L; Stiles, B; Stofan, E; Vetrella, S; West, R; Wood, C; Wye, L; Zebker, H				Elachi, C; Wall, S; Allison, M; Anderson, Y; Boehmer, R; Callahan, P; Encrenaz, P; Flamini, E; Franceschetti, G; Gim, Y; Hamilton, G; Hensley, S; Janssen, M; Johnson, W; Kelleher, K; Kirk, R; Lopes, R; Lorenz, R; Lunine, J; Muhleman, D; Ostro, S; Paganelli, F; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Soderblom, L; Stiles, B; Stofan, E; Vetrella, S; West, R; Wood, C; Wye, L; Zebker, H			Cassini radar views the surface of Titan	SCIENCE			English	Article							SATELLITES; GANYMEDE	The Cassini Titan Radar Mapper imaged about 1% of Titan's surface at a resolution of similar to 0.5 kilometer, and larger areas of the globe in lower resolution modes. The images reveal a complex surface, with areas of low relief and a variety of geologic features suggestive of dome-like volcanic constructs, flows, and sinuous channels. The surface appears to be young, with few impact craters. Scattering and dielectric properties are consistent with porous ice or organics. Dark patches in the radar images show high brightness temperatures and high emissivity and are consistent with frozen hydrocarbons.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Observ Paris, F-75014 Paris, France; Agenzia Spaziale Italiana, I-00198 Rome, Italy; Fac Ingn, I-80125 Naples, Italy; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Roma La Sapienza, I-00184 Rome, Italy; Politecn Bari, INFM, I-70126 Bari, Italy; Politecn Bari, Dipartimento Interateneo Fis, I-70126 Bari, Italy; Proxemy Res, Laytonville, MD 20882 USA; Planetary Sci Inst, Tucson, AZ 85719 USA; Stanford Univ, Stanford, CA 94305 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Agenzia Spaziale Italiana (ASI); United States Department of the Interior; United States Geological Survey; University of Arizona; California Institute of Technology; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Politecnico di Bari; Politecnico di Bari; Stanford University	Wall, S (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	steve.wall@jpl.nasa.gov	Lorenz, Ralph D/B-8759-2016; Lopes, Rosaly M.C./D-1608-2016	Lorenz, Ralph D/0000-0001-8528-4644; Lopes, Rosaly M.C./0000-0002-7928-3167; Lunine, Jonathan/0000-0003-2279-4131; zebker, howard/0000-0001-9931-5237				Black GJ, 2004, SCIENCE, V304, P553, DOI 10.1126/science.1096470; Black GJ, 2001, ICARUS, V151, P167, DOI 10.1006/icar.2001.6616; BOTT DC, 1986, HDB CONDUCTING POLYM, P1191; BUTLER BJ, 2004, B AM ASTRON SOC, V36, P1075; Campbell BA., 2002, RADAR REMOTE SENSING; Campbell DB, 2003, SCIENCE, V302, P431, DOI 10.1126/science.1088969; ENGEL S, 1995, PLANET SPACE SCI, V43, P1059, DOI 10.1016/0032-0633(95)00044-6; GROSSMAN AW, 1992, B AM ASTRON SOC, V24, P954; Harmon JK, 1999, PLANET SPACE SCI, V47, P1409, DOI 10.1016/S0032-0633(99)00068-9; JANKOWSKI DG, 1988, SCIENCE, V241, P1322, DOI 10.1126/science.241.4871.1322; Lorenz RD, 1996, PLANET SPACE SCI, V44, P1021, DOI 10.1016/0032-0633(95)00139-5; Lorenz RD, 2003, PLANET SPACE SCI, V51, P353, DOI 10.1016/S0032-0633(02)00148-4; Lorenz RD, 1997, PLANET SPACE SCI, V45, P1009, DOI 10.1016/S0032-0633(97)00085-8; LUNINE J, 2005, 36 ANN LUN PLAN SCI; LUNINE JI, 1993, REV GEOPHYS, V31, P133, DOI 10.1029/92RG02794; MCCAULEY JF, 1982, SCIENCE, V218, P1004, DOI 10.1126/science.218.4576.1004; MUHLEMAN DO, 1995, ANNU REV EARTH PL SC, V23, P337, DOI 10.1146/annurev.earth.23.1.337; OSTRO SJ, 1992, J GEOPHYS RES-PLANET, V97, P18227, DOI 10.1029/92JE01992; OSTRO SJ, 1993, REV MOD PHYS, V65, P1235, DOI 10.1103/RevModPhys.65.1235; Pappalardo RT, 2004, CAMB PLANET, P363; Patel JG, 1999, J GEOPHYS RES-PLANET, V104, P24057, DOI 10.1029/1998JE001021; PETERS KJ, 1992, PHYS REV B, V46, P801, DOI 10.1103/PhysRevB.46.801; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; SAUNDERS RS, 1992, J GEOPHYS RES-PLANET, V97, P13067, DOI 10.1029/92JE01397; Seidelmann PK, 2002, CELEST MECH DYN ASTR, V82, P83, DOI 10.1023/A:1013939327465; THOMPSON WR, 1990, ICARUS, V86, P336, DOI 10.1016/0019-1035(90)90224-W; TOMASKO M, IN PRESS NATURE	27	187	189	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					970	974		10.1126/science.1109919	http://dx.doi.org/10.1126/science.1109919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890871				2022-12-24	WOS:000229190700031
J	Tanaka, Y; Okada, Y; Hirokawa, N				Tanaka, Y; Okada, Y; Hirokawa, N			FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left-right determination	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; INTRAFLAGELLAR TRANSPORT; MOUSE; SHH; PATHWAYS; MICE; PROTEINS; POPULATIONS; INDUCTION; RECEPTOR	The precise specification of left - right asymmetry is an essential process for patterning internal organs in vertebrates. In mouse embryonic development, the symmetry-breaking process in left - right determination is initiated by a leftward extraembryonic fluid flow on the surface of the ventral node. However, it is not known whether the signal transduction mechanism of this flow is chemical or mechanical. Here we show that fibroblast growth factor (FGF) signalling triggers secretion of membrane-sheathed objects 0.3 - 5 mu m in diameter termed 'nodal vesicular parcels' (NVPs) that carry Sonic hedgehog and retinoic acid. These NVPs are transported leftward by the fluid flow and eventually fragment close to the left wall of the ventral node. The silencing effects of the FGF-receptor inhibitor SU5402 on NVP secretion and on a downstream rise in Ca2+ were sufficiently reversed by exogenous Sonic hedgehog peptide or retinoic acid, suggesting that FGF-triggered surface accumulation of cargo morphogens may be essential for launching NVPs. Thus, we propose that NVP flow is a new mode of extracellular transport that forms a left - right gradient of morphogens.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Okada, Yasushi/N-5067-2015	Okada, Yasushi/0000-0003-2601-3689; Tanaka, Yosuke/0000-0001-5376-5726				Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Kos FJ, 2002, IMMUNOL CELL BIOL, V80, P364, DOI 10.1046/j.1440-1711.2002.01098.x; Mathieu J, 2004, DEVELOPMENT, V131, P629, DOI 10.1242/dev.00964; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; STURM K, 1993, METHOD ENZYMOL, V225, P164; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; TANAKA Y, 1992, BRAIN RES, V596, P269, DOI 10.1016/0006-8993(92)91557-U; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yokoyama Takahiko, 2004, Anatomical Science International, V79, P47, DOI 10.1111/j.1447-073x.2004.00072.x; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	32	395	411	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					172	177		10.1038/nature03494	http://dx.doi.org/10.1038/nature03494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889083				2022-12-24	WOS:000229021100031
J	Hoepfner, S; Severin, F; Cabezas, A; Habermann, B; Runge, A; Giilooly, D; Stenmark, H; Zerial, M				Hoepfner, S; Severin, F; Cabezas, A; Habermann, B; Runge, A; Giilooly, D; Stenmark, H; Zerial, M			Modulation of receptor recycling and degradation by the endosomal kinesin KIF16B	CELL			English	Article							MEMBRANE-TRANSPORT; SUPERFAMILY PROTEINS; AXONAL-TRANSPORT; CELL-SURFACE; MOTOR; MICROTUBULES; DYNACTIN; IDENTIFICATION; MYOSIN; OVEREXPRESSION	Different classes of endosomes exhibit a characteristic intracellular steady-state distribution governed by interactions with the cytoskeleton. We found a kinesin-3, KIF16B, that transports early endosomes to the plus end of microtubules in a process regulated by the small GTPase Rab5 and its effector, the phosphatidylinositol-3-OH kinase hVPS34. In vivo, KIF16B overexpression relocated early endosomes to the cell periphery and inhibited transport to the degradative pathway. Conversely, expression of dominant-negative mutants or ablation of KIF16B by RNAi caused the clustering of early endosomes to the perinuclear region, delayed receptor recycling to the plasma membrane, and accelerated degradation. These results suggest that KIF16B, by regulating the plus end motility of early endosomes, modulates the intracellular localization of early endosomes and the balance between receptor recycling and degradation. We propose that this mechanism could have important implications for signaling.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Norwegian Radium Hosp, Dept Biochem, N-0310 Oslo, Norway; Univ Penn, Ctr Canc, HHMI, Philadelphia, PA 19104 USA	Max Planck Society; University of Oslo; Howard Hughes Medical Institute; University of Pennsylvania	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Stenmark, Harald/B-8868-2008; Habermann, Bianca/N-4886-2016; Cabezas, Alicia/K-6564-2014; Severin, Fedor/AAD-5444-2019	Habermann, Bianca/0000-0002-2457-7504; Cabezas, Alicia/0000-0002-2908-9147; Severin, Fedor/0000-0001-6703-1256				Allan V, 2000, CURR BIOL, V10, pR432, DOI 10.1016/S0960-9822(00)00550-9; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Aschenbrenner L, 2004, MOL BIOL CELL, V15, P2253, DOI 10.1091/mbc.E04-01-0002; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Dalby B., 1996, Molecular Biology of the Cell, V7, p487A; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goldstein LSB, 2001, TRENDS CELL BIOL, V11, P477, DOI 10.1016/S0962-8924(01)02143-2; Goodson HV, 1997, CURR OPIN CELL BIOL, V9, P18, DOI 10.1016/S0955-0674(97)80147-0; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HYMAN AA, 1991, J CELL SCI, P125; JIN MJ, 1993, J BIOL CHEM, V268, P18390; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miki H, 2003, GENOME RES, V13, P1455, DOI 10.1101/gr.984503; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Pollock N, 1999, J CELL BIOL, V147, P493, DOI 10.1083/jcb.147.3.493; Reilein AR, 2001, INT REV CYTOL, V204, P179, DOI 10.1016/S0074-7696(01)04005-0; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; VONMASSOW A, 1989, CELL MOTIL CYTOSKEL, V14, P562, DOI 10.1002/cm.970140413; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Yang ZH, 2001, MOL CELL BIOL, V21, P2463, DOI 10.1128/MCB.21.7.2463-2466.2001; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	52	236	246	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					437	450		10.1016/j.cell.2005.02.017	http://dx.doi.org/10.1016/j.cell.2005.02.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882625	Bronze			2022-12-24	WOS:000229031600013
J	Dubos, F; Leclerc, F				Dubos, F; Leclerc, F			Infants refusing to walk	LANCET			English	Editorial Material									Hop Jeanne de Flandre, F-59037 Lille, France	Universite de Lille - ISITE; CHU Lille	Leclerc, F (corresponding author), Hop Jeanne de Flandre, F-59037 Lille, France.	fleclerc@chru-lille.fr	Dubos, Francois/AGD-5638-2022	dubos, francois/0000-0003-2151-1638					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					93	93		10.1016/S0140-6736(05)66831-6	http://dx.doi.org/10.1016/S0140-6736(05)66831-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	15993238				2022-12-24	WOS:000230277600039
J	Fournier, D; Estoup, A; Orivel, J; Foucaud, J; Jourdan, H; Le Breton, J; Keller, L				Fournier, D; Estoup, A; Orivel, J; Foucaud, J; Jourdan, H; Le Breton, J; Keller, L			Clonal reproduction by males and females in the little fire ant	NATURE			English	Article							SEX; PARTHENOGENESIS; EVOLUTION	Sexual reproduction can lead to major conflicts between sexes and within genomes(1-4). Here we report an extreme case of such conflicts in the little fire ant Wasmannia auropunctata. We found that sterile workers are produced by normal sexual reproduction, whereas daughter queens are invariably clonally produced. Because males usually develop from unfertilized maternal eggs in ants and other haplodiploid species, they normally achieve direct fitness only through diploid female offspring. Hence, although the clonal production of queens increases the queen's relatedness to reproductive daughters, it potentially reduces male reproductive success to zero. In an apparent response to this conflict between sexes, genetic analyses reveal that males reproduce clonally, most likely by eliminating the maternal half of the genome in diploid eggs. As a result, all sons have nuclear genomes identical to those of their father. The obligate clonal production of males and queens from individuals of the same sex effectively results in a complete separation of the male and female gene pools. These findings show that the haplodiploid sex-determination system provides grounds for the evolution of extraordinary genetic systems and new types of sexual conflict.	INRA, Ctr Biol & Gest Populat, F-34988 Montferrier Sur Lez, France; Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR 5174, F-31062 Toulouse, France; IRD, Lab Zool Appl, Noumea 98948, New Caledonia; Univ Ryukyus, Lab Subtrop Zool, Okinawa 9030213, Japan; Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	INRAE; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Institut de Recherche pour le Developpement (IRD); University of the Ryukyus; University of Lausanne	Fournier, D (corresponding author), Univ Libre Bruxelles, CP 160-12,50 Ave FD Roosevelt, B-1050 Brussels, Belgium.	denis.fournier@ulb.ac.be; estoup@ensam.inra.fr	Jourdan, Herve/D-1452-2011; Orivel, Jerome/C-4034-2011; keller, laurent/AAI-7175-2020; Fournier, Denis/EZX-2474-2022	Jourdan, Herve/0000-0002-3756-4008; Orivel, Jerome/0000-0002-5636-3228; Fournier, Denis/0000-0003-4094-0390; Foucaud, Julien/0000-0003-2272-3149; keller, laurent/0000-0002-5046-9953				Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Baudry E, 2004, GENETICS, V167, P243, DOI 10.1534/genetics.167.1.243; Cahan SH, 2003, NATURE, V424, P306, DOI 10.1038/nature01744; Chapuisat M, 1998, MOL ECOL, V7, P1097, DOI 10.1046/j.1365-294x.1998.00422.x; Cole BJ, 1999, SCIENCE, V285, P891, DOI 10.1126/science.285.5429.891; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; CROZIER RH, 1985, BEHAV ECOL SOCIOBIOL, V18, P105, DOI 10.1007/BF00299039; EBERHARD WG, 1980, Q REV BIOL, V55, P231, DOI 10.1086/411855; Fournier D, 2005, MOL ECOL NOTES, V5, P239, DOI 10.1111/j.1471-8286.2005.00889.x; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Holldobler B., 1990, pi; HURST LD, 1992, P ROY SOC B-BIOL SCI, V248, P135, DOI 10.1098/rspb.1992.0053; KOENIGER N, 1989, APIDOLOGIE, V20, P391, DOI 10.1051/apido:19890503; Normark BB, 2003, ANNU REV ENTOMOL, V48, P397, DOI 10.1146/annurev.ento.48.091801.112703; NUR U, 1988, SCIENCE, V240, P512, DOI 10.1126/science.3358129; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parker JD, 2004, TRENDS ECOL EVOL, V19, P83, DOI 10.1016/j.tree.2003.10.001; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453; Pomiankowski A, 1999, MG BEH ECOL, P121; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Torres JA, 2001, SOCIOBIOLOGY, V37, P601; Ulloa-Chacon P., 1988, Actes des Colloques Insectes Sociaux, V4, P177; WERREN JH, 1987, NATURE, V327, P75, DOI 10.1038/327075a0	27	203	211	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1230	1234		10.1038/nature03705	http://dx.doi.org/10.1038/nature03705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988525	Green Published			2022-12-24	WOS:000230140500043
J	Gu, KY; Yang, B; Tian, DS; Wu, LF; Wang, DJ; Sreekala, C; Yang, F; Chu, ZQ; Wang, GL; White, FF; Yin, ZC				Gu, KY; Yang, B; Tian, DS; Wu, LF; Wang, DJ; Sreekala, C; Yang, F; Chu, ZQ; Wang, GL; White, FF; Yin, ZC			R gene expression induced by a type-III effector triggers disease resistance in rice	NATURE			English	Article							BACTERIAL-BLIGHT-RESISTANCE; XANTHOMONAS-ORYZAE PV; TRANSCRIPTIONAL ACTIVATION; PROTEIN; AVRBS3; IDENTIFICATION; CAMPESTRIS; ENCODES; AVRRPT2; RIN4	Disease resistance (R) genes in plants encode products that specifically recognise incompatible pathogens and trigger a cascade of events leading to disease resistance in the host plant(1). R-gene specificity is dictated by both host R genes and cognate avirulence (avr) genes in pathogens(2,3). However, the basis of gene-for-gene specificity is not well understood. Here, we report the cloning of the R gene Xa27 from rice and the cognate avr gene avrXa27 from Xanthomonas oryzae pv. oryzae. Resistant and susceptible alleles of Xa27 encode identical proteins. However, expression of only the resistant allele occurs when a rice plant is challenged by bacteria harbouring avrXa27, whose product is a nuclear localized type-III effector. Induction of Xa27 occurs only in the immediate vicinity of infected tissue, whereas ectopic expression of Xa27 resulted in resistance to otherwise compatible strains of the pathogen. Thus Xa27 specificity towards incompatible pathogens involves the differential expression of the R gene in the presence of the AvrXa27 effector.	Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; Natl Univ Singapore, Inst Mol Agrobiol, Singapore 117604, Singapore	National University of Singapore; Kansas State University; National University of Singapore	Yin, ZC (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore 117604, Singapore.	yinzc@tll.org.sg	Yang, Bing/D-3628-2019	Yang, Bing/0000-0002-2293-3384; ?, ??/0000-0002-3982-9858; YANG, Fan/0000-0002-9664-3953; Wang, Guo-Liang/0000-0001-8877-3064; Chellamma, Sreekala/0000-0002-4615-6719				Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Belkhadir Y, 2004, PLANT CELL, V16, P2822, DOI 10.1105/tpc.104.024117; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Gu K, 2004, THEOR APPL GENET, V108, P800, DOI 10.1007/s00122-003-1491-x; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; HOPKINS CM, 1992, MOL PLANT MICROBE IN, V5, P451, DOI 10.1094/MPMI-5-451; Iyer AS, 2004, MOL PLANT MICROBE IN, V17, P1348, DOI 10.1094/MPMI.2004.17.12.1348; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Levy M, 2004, PLANT PHYSIOL, V135, P2392, DOI 10.1104/pp.104.044859; Lim MTS, 2004, PLANT J, V40, P790, DOI 10.1111/j.1365-313X.2004.02251.x; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Radwan O, 2005, J EXP BOT, V56, P567, DOI 10.1093/jxb/eri030; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; SWARUP S, 1991, PHYTOPATHOLOGY, V81, P802, DOI 10.1094/Phyto-81-802; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; WANG GL, 1995, PLANT J, V7, P525, DOI 10.1046/j.1365-313X.1995.7030525.x; White SD, 1998, ADVANCES IN VETERINARY DERMATOLOGY, VOL 3, P291; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Yang B, 2000, P NATL ACAD SCI USA, V97, P9807, DOI 10.1073/pnas.170286897; Yin Z, 2000, THEOR APPL GENET, V100, P461, DOI 10.1007/s001220050060; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Zhu WG, 1998, MOL PLANT MICROBE IN, V11, P824, DOI 10.1094/MPMI.1998.11.8.824	29	406	533	3	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1122	1125		10.1038/nature03630	http://dx.doi.org/10.1038/nature03630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973413				2022-12-24	WOS:000229970400054
J	Warrick, DR; Tobalske, BW; Powers, DR				Warrick, DR; Tobalske, BW; Powers, DR			Aerodynamics of the hovering hummingbird	NATURE			English	Article							VORTEX WAKE; FLIGHT; HAWKMOTH; MECHANICS; KINEMATICS; FORCES; WINGS	Despite profound musculoskeletal differences, hummingbirds (Trochilidae) are widely thought to employ aerodynamic mechanisms similar to those used by insects. The kinematic symmetry of the hummingbird upstroke and downstroke(1-3) has led to the assumption that these halves of the wingbeat cycle contribute equally to weight support during hovering, as exhibited by insects of similar size(4). This assumption has been applied, either explicitly or implicitly, in widely used aerodynamic models(1,5-7) and in a variety of empirical tests(8,9). Here we provide measurements of the wake of hovering rufous hummingbirds (Selasphorus rufus) obtained with digital particle image velocimetry that show force asymmetry: hummingbirds produce 75% of their weight support during the downstroke and only 25% during the upstroke. Some of this asymmetry is probably due to inversion of their cambered wings during upstroke. The wake of hummingbird wings also reveals evidence of leading-edge vortices created during the downstroke, indicating that they may operate at Reynolds numbers sufficiently low to exploit a key mechanism typical of insect hovering(10,11). Hummingbird hovering approaches that of insects, yet remains distinct because of effects resulting from an inherently dissimilar-avian-body plan.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Univ Portland, Dept Biol, Portland, OR 97203 USA; George Fox Univ, Dept Biol, Newberg, OR 97132 USA	Oregon State University; University of Portland	Warrick, DR (corresponding author), Oregon State Univ, Dept Zool, 3029 Cordley Hall, Corvallis, OR 97331 USA.	warrickd@science.oregonstate.edu	Powers, Donald/A-1704-2009	Powers, Donald/0000-0003-1126-7141				Altshuler DL, 2004, J ZOOL, V264, P327, DOI 10.1017/s0952836904005813; Combes SA, 2003, J EXP BIOL, V206, P2999, DOI 10.1242/jeb.00502; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dudley R., 2000, BIOMECHANICS INSECT; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P79, DOI 10.1098/rstb.1984.0052; GREENEWALT CRAWFORD H., 1960, PROC AMER PHIL SOC, V104, P605; Hedrick TL, 2002, J EXP BIOL, V205, P1389; Norberg U., 1990, VERTEBRATE FLIGHT ME; Raffel M., 2000, PARTICLE IMAGE VELOC; RAYNER JMV, 1979, J FLUID MECH, V91, P697, DOI 10.1017/S0022112079000410; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Spedding GR, 2003, EXP FLUIDS, V34, P291, DOI 10.1007/S00348-002-0559-8; Stolpe M., 1939, Journal fuer Ornithologie, V87, P136, DOI 10.1007/BF01950821; Tobalske BW, 2003, J AVIAN BIOL, V34, P177, DOI 10.1034/j.1600-048X.2003.03006.x; Tobalske BW, 2004, J EXP BIOL, V207, P1345, DOI 10.1242/jeb.00889; Tytell ED, 2003, PHILOS T R SOC B, V358, P1559, DOI 10.1098/rstb.2003.1355; Usherwood JR, 2002, J EXP BIOL, V205, P1547; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P329, DOI 10.1098/rstb.1997.0024; WEISFOGH T, 1972, J EXP BIOL, V56, P79; WELLS DJ, 1993, J EXP BIOL, V178, P39; Willmott AP, 1997, PHILOS T ROY SOC B, V352, P303, DOI 10.1098/rstb.1997.0022; Willmott AP, 1997, J EXP BIOL, V200, P2705; Willmott AP, 1997, J EXP BIOL, V200, P2723; WOOTTON RJ, 1995, P ROY SOC B-BIOL SCI, V262, P181, DOI 10.1098/rspb.1995.0194	24	223	226	3	101	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1094	1097		10.1038/nature03647	http://dx.doi.org/10.1038/nature03647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973407	Green Submitted			2022-12-24	WOS:000229970400048
J	Smit, P; Raedts, J; Portyanko, V; Debelle, F; Gough, C; Bisseling, T; Geurts, R				Smit, P; Raedts, J; Portyanko, V; Debelle, F; Gough, C; Bisseling, T; Geurts, R			NSP1 of the GRAS protein family is essential for rhizobial Nod factor-induced transcription	SCIENCE			English	Article							RECEPTOR KINASE GENE; MEDICAGO-TRUNCATULA; BACTERIAL; FUNGAL; IDENTIFICATION; TRANSDUCTION; SYMBIOSIS; MUTANTS; CALCIUM	Rhizobial Nod factors induce in their legume hosts the expression of many genes and set in motion developmental processes leading to root nodule formation. Here we report the identification of the Medicago GRAS-type protein Nodulation signaling pathway 1 (NSP1), which is essential for all known Nod factor-induced changes in gene expression. NSP1 is constitutively expressed, and so it acts as a primary transcriptional regulator mediating all known Nod factor-induced transcriptional responses, and therefore, we named it a Nod factor response factor.	Univ Wageningen & Res Ctr, Dept Plant Sci, Mol Biol Lab, NL-6703 HA Wageningen, Netherlands; Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; INRA, CNRS, Lab Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France	Wageningen University & Research; University of Minnesota System; University of Minnesota Twin Cities; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Bisseling, T (corresponding author), Univ Wageningen & Res Ctr, Dept Plant Sci, Mol Biol Lab, NL-6703 HA Wageningen, Netherlands.	ton.bisseling@wur.nl	Bisseling, Ton/A-2421-2013					Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Borisov AY, 2003, PLANT PHYSIOL, V131, P1009, DOI 10.1104/pp.102.016071; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Imaizumi-Anraku H, 2005, NATURE, V433, P527, DOI 10.1038/nature03237; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P4701, DOI 10.1073/pnas.0400595101; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2003, PLANT PHYSIOL, V131, P1027, DOI 10.1104/pp.102.010710; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797	20	417	448	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1789	1791		10.1126/science.1111025	http://dx.doi.org/10.1126/science.1111025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961669				2022-12-24	WOS:000229926800055
J	Sigurdson, AJ; Ronckers, CM; Mertens, AC; Stovall, M; Smith, SA; Liu, Y; Berkow, RL; Hammond, S; Neglia, JP; Meadows, AT; Sklar, CA; Robison, LL; Inskip, PD				Sigurdson, AJ; Ronckers, CM; Mertens, AC; Stovall, M; Smith, SA; Liu, Y; Berkow, RL; Hammond, S; Neglia, JP; Meadows, AT; Sklar, CA; Robison, LL; Inskip, PD			Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study	LANCET			English	Article							2ND MALIGNANT NEOPLASMS; BONE-MARROW-TRANSPLANTATION; HODGKINS-DISEASE; EPIDEMIOLOGIC EVIDENCE; THERAPEUTIC RADIATION; RISK; RADIOTHERAPY; NEUROBLASTOMA; IRRADIATION; LEUKEMIA	Background Survivors of malignant disease in childhood who have had radiotherapy to the head, neck, or upper thorax have an increased risk of subsequent primary thyroid cancer, but the magnitude of risk over the therapeutic dose range has not been well established. We aimed to quantify the long-term risk of thyroid cancer after radiotherapy and chemotherapy. Methods In a nested case-control study, 69 cases with pathologically confirmed thyroid cancer and 265 matched controls without thyroid cancer were identified from 14 054 5-year survivors of cancer during childhood from the Childhood Cancer Survivor Study cohort. Childhood cancers were diagnosed between 1970 and 1986 with cohort follow-up to 2000. Findings Risk of thyroid cancer increased with radiation doses up to 20-29 Gy (odds ratio 9.8 [95% Cl 3.2-34.8]). At doses greater than 30 Gy, a fall in the dose-response relation was seen. Both the increased and decreased risks were more pronounced in those diagnosed with a first primary malignant disease before age 10 years than in those older than 10 years. Furthermore, the fall in risk remained when those diagnosed with Hodgkin's lymphoma were excluded. Chemotherapy for the first cancer was not associated with thyroid-cancer risk, and it did not modify the effect of radiotherapy. 29 (42%) cases had a first diagnosis of Hodgkin's lymphoma compared with 49 (19%) controls. 11 (42%) of those who had Hodgkin's lymphoma had subsequent thyroid cancers smaller than 1 cm compared with six (17%) of those who had other types of childhood cancer (p=0.07). Interpretation The reduction in radiation dose-response for risk of thyroid cancer after childhood exposure to thyroid doses higher than 30 Gy is consistent with a cell-killing effect. Standard long-term follow-up of patients who have had Hodgkin's lymphoma for detection of thyroid cancer should also be undertaken for survivors of any cancer during childhood who received radiotherapy to the thorax or head and neck region.	NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program, Seattle, WA 98104 USA; Univ Alabama Birmingham, Birmingham, AL USA; Childrens Hosp, Dept Lab Med & Pathol, Columbus, OH 43205 USA; Ohio State Univ, Coll Med, Columbus, OH 43210 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; UTMD Anderson Cancer Center; Fred Hutchinson Cancer Center; University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Memorial Sloan Kettering Cancer Center	Sigurdson, AJ (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, 6120 Execut Blvd,EPS 7092,MSC 7238, Bethesda, MD 20892 USA.	sigurdsa@mail.nih.gov	Ronckers, Cecile/GWN-0737-2022; Robison, Leslie/N-8122-2018	Ronckers, Cecile M./0000-0003-3524-4657; Neglia, Joseph/0000-0002-5525-0598	NATIONAL CANCER INSTITUTE [U24CA055727, U01CA055727] Funding Source: NIH RePORTER; NCI NIH HHS [U24 CA055727, CA 55727] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acharya S, 2003, CANCER-AM CANCER SOC, V97, P2397, DOI 10.1002/cncr.11362; BARNES ND, 1988, HORM RES, V30, P84, DOI 10.1159/000181034; Bhatia S, 2002, NAT REV CANCER, V2, P124, DOI 10.1038/nrc722; Black P, 1998, MED PEDIATR ONCOL, V31, P91, DOI 10.1002/(SICI)1096-911X(199808)31:2<91::AID-MPO8>3.0.CO;2-U; BOICE JD, 1987, J NATL CANCER I, V79, P1295; BOULAD F, 1995, BONE MARROW TRANSPL, V15, P71; DANGIO GJ, 1976, CANCER, V37, P1177, DOI 10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3; Davis S, 2004, RADIAT RES, V162, P241, DOI 10.1667/RR3233; de Vathaire F, 1999, BRIT J CANCER, V79, P1884, DOI 10.1038/sj.bjc.6690300; de Vathaire F, 1999, ARCH INTERN MED, V159, P2713, DOI 10.1001/archinte.159.22.2713; DEVATHAIRE F, 1988, LANCET, V2, P455; DEVATHAIRE F, 1992, BRIT J CANCER, V65, P425, DOI 10.1038/bjc.1992.87; Eden K, 2001, MED PEDIATR ONCOL, V36, P583, DOI 10.1002/mpo.1134; Garwicz S, 2000, INT J CANCER, V88, P672, DOI 10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO;2-N; Gilbert ES, 2003, RADIAT RES, V159, P161, DOI 10.1667/0033-7587(2003)159[0161:LCATFH]2.0.CO;2; Gold DG, 2003, CANCER-AM CANCER SOC, V97, P2588, DOI 10.1002/cncr.11356; Goldin LR, 2004, CANCER-AM CANCER SOC, V100, P1902, DOI 10.1002/cncr.20189; Gray L. H., 1965, CELLULAR RAD BIOL, P7; HALL EJ, 2000, RADIOBIOLOGY RADIOLO, P144; HANCOCK SL, 1991, NEW ENGL J MED, V325, P599, DOI 10.1056/NEJM199108293250902; HAWKINS MM, 1988, LANCET, V2, P804; Inskip PD, 2001, MED PEDIATR ONCOL, V36, P568, DOI 10.1002/mpo.1132; Inskip PD, 1999, MULTIPLE PRIMARY CANCERS, P91; LAND CE, 1981, MEASUREMENT RISKS, V21, P71; LITTLEY MD, 1990, BAILLIERE CLIN ENDOC, V4, P147, DOI 10.1016/S0950-351X(05)80321-0; Metayer C, 2000, J CLIN ONCOL, V18, P2435, DOI 10.1200/JCO.2000.18.12.2435; Michel G, 1997, J CLIN ONCOL, V15, P2238, DOI 10.1200/JCO.1997.15.6.2238; Moppett J, 2001, EUR J RADIOL, V38, P234, DOI 10.1016/S0720-048X(01)00342-4; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Oeffinger KC, 2003, AM FAM PHYSICIAN, V68, P1016; *PHIL MED SYST, RAD ONC SYST; PRESTON DL, 2003, EPICURE 2 10 PECAN; RIES LAG, 1996, CANC EPIDEMIOLOGY PR, P168; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Ron E, 1996, CANC EPIDEMIOLOGY PR, P1000; Rubino C, 2003, INT J CANCER, V107, P791, DOI 10.1002/ijc.11455; SHORE RE, 1992, RADIAT RES, V131, P98, DOI 10.2307/3578322; Sklar C, 2000, J CLIN ENDOCR METAB, V85, P3227, DOI 10.1210/jc.85.9.3227; SKLAR CA, 1995, INT J RADIAT ONCOL, V31, P1113, DOI 10.1016/0360-3016(94)00427-M; STOVALL M, 1995, MED PHYS, V22, P63, DOI 10.1118/1.597525; STOVALL M, 1989, MED PHYS, V16, P726, DOI 10.1118/1.596331; TRAVIS LB, 2003, JAMA-J AM MED ASSOC, V290, P165; TUCKER MA, 1991, CANCER RES, V51, P2885; *U MINN CANC CTR, CHILDH CANC SURV STU; *UN SCI COMM EFF A, 2000, 2000 REP GEN ASS ANN; van Santen HM, 2003, J CLIN ENDOCR METAB, V88, P3657, DOI 10.1210/jc.2003-030209; WILLIAMS ED, 1993, HISTOPATHOLOGY, V23, P387, DOI 10.1111/j.1365-2559.1993.tb01227.x; 1983, BR J RADIOL S, V17, P1	49	264	275	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2005	365	9476					2014	2023		10.1016/S0140-6736(05)66695-0	http://dx.doi.org/10.1016/S0140-6736(05)66695-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934IB	15950715				2022-12-24	WOS:000229701400023
J	Kratchmarova, I; Blagoev, B; Haack-Sorensen, M; Kassem, M; Mann, M				Kratchmarova, I; Blagoev, B; Haack-Sorensen, M; Kassem, M; Mann, M			Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation	SCIENCE			English	Article							RECEPTOR TYROSINE KINASES; ACTIVATED PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; OSTEOBLAST DIFFERENTIATION; QUANTITATIVE PROTEOMICS; PROGENITOR CELLS; EXPRESSION; IDENTIFICATION; ENDOCYTOSIS; INHIBITION	Closely related signals often lead to very different cellular outcomes. We found that the differentiation of human mesenchymal stem cells into bone-forming cells is stimulated by epidermal growth factor (EGF) but not platelet-derived growth factor (PDGF). We used mass spectrometry-based proteomics to comprehensively compare proteins that were tyrosine phosphorylated in response to EGF and PDGF and their associated partners. More than 90% of these signaling proteins were used by both ligands, whereas the phosphatidylinositol 3-kinase (PI3K) pathway was exclusively activated by PDGF, implicating it as a possible control point. Indeed, chemical inhibition of PI3K in PDGF-stimulated cells removed the differential effect of the two growth factors, bestowing full differentiation effect onto PDGF. Thus, quantitative proteomics can directly compare entire signaling networks and discover critical differences capable of changing cell fate.	Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Mann, M (corresponding author), Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense, Denmark.	mann@bmb.sdu.dk	Kassem, Moustapha/J-7688-2013; Kassem, Moustapha/O-3819-2019; Mann, Matthias/A-3454-2013	Kassem, Moustapha/0000-0003-1557-0869; Kassem, Moustapha/0000-0003-1557-0869; Mann, Matthias/0000-0003-1292-4799; Kratchmarova, Irina/0000-0001-6613-7315; Blagoev, Blagoy/0000-0002-3596-0066				Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fukuyama R, 2004, BIOCHEM BIOPH RES CO, V315, P636, DOI 10.1016/j.bbrc.2004.01.104; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; OKADA T, 1994, J BIOL CHEM, V269, P3563; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi HL, 2003, P NATL ACAD SCI USA, V100, P3305, DOI 10.1073/pnas.0532693100; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Reyes M, 2001, ANN NY ACAD SCI, V938, P231; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Szymkiewicz I, 2004, BIOCHEM J, V383, P1, DOI 10.1042/BJ20040913; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7	31	462	499	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1472	1477		10.1126/science.1107627	http://dx.doi.org/10.1126/science.1107627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933201				2022-12-24	WOS:000229619300055
J	Reverter, D; Lima, CD				Reverter, D; Lima, CD			Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex	NATURE			English	Article							SUMO CONJUGATION; ENZYME UBC9; PROTEIN; NUCLEOPORIN; RANBP2; RANGAP1; DOMAIN	SUMO-1 ( for small ubiquitin-related modifier) belongs to the ubiquitin (Ub) and ubiquitin-like (Ubl) protein family. SUMO conjugation occurs on specific lysine residues within protein targets, regulating pathways involved in differentiation, apoptosis, the cell cycle and responses to stress by altering protein function through changes in activity or cellular localization or by protecting substrates from ubiquitination(1,2). Ub/Ubl conjugation occurs in sequential steps and requires the concerted action of E2 conjugating proteins and E3 ligases(1,2). In addition to being a SUMO E3, the nucleoporin Nup358/RanBP2 localizes SUMO-conjugated RanGAP1 to the cytoplasmic face of the nuclear pore complex by means of interactions in a complex that also includes Ubc9, the SUMO E2 conjugating protein(3-6). Here we describe the 3.0-angstrom crystal structure of a four-protein complex of Ubc9, a Nup358/RanBP2 E3 ligase domain ( IR1-M) and SUMO-1 conjugated to the carboxy-terminal domain of RanGAP1. Structural insights, combined with biochemical and kinetic data obtained with additional substrates, support a model in which Nup358/ RanBP2 acts as an E3 by binding both SUMO and Ubc9 to position the SUMO - E2- thioester in an optimal orientation to enhance conjugation.	Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA.	limac@mskcc.org	Reverter, David/H-5360-2015	Reverter, David/0000-0002-5347-0992; Lima, Christopher/0000-0002-9163-6092	NIGMS NIH HHS [R01 GM065872] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065872] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Saitoh H, 2002, J BIOL CHEM, V277, P4755, DOI 10.1074/jbc.M104453200; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	29	369	387	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					687	692		10.1038/nature03588	http://dx.doi.org/10.1038/nature03588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15931224	Green Accepted			2022-12-24	WOS:000229476200053
J	Fouchier, R; Kuiken, T; Rimmelzwaan, G; Osterhaus, A				Fouchier, R; Kuiken, T; Rimmelzwaan, G; Osterhaus, A			Global task force for influenza	NATURE			English	Editorial Material									Erasmus MC, Natl Influenza Ctr, NL-3015 GE Rotterdam, Netherlands; Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Fouchier, R (corresponding author), Erasmus MC, Natl Influenza Ctr, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Osterhaus, Albert/0000-0002-6074-1172; Kuiken, Thijs/0000-0001-5501-9049				de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier Ron Am, 2005, Curr Opin Infect Dis, V18, P141; Kuiken T, 2003, CURR OPIN BIOTECH, V14, P641, DOI 10.1016/j.copbio.2003.10.010; Stohr K, 2004, SCIENCE, V306, P2195, DOI 10.1126/science.1108165; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	7	38	42	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					419	420		10.1038/435419a	http://dx.doi.org/10.1038/435419a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917779	Green Published, Bronze			2022-12-24	WOS:000229337800025
J	Nakayama, M; Abiru, N; Moriyama, H; Babaya, N; Liu, E; Miao, DM; Yu, LP; Wegmann, DR; Hutton, JC; Elliott, JF; Eisenbarth, GS				Nakayama, M; Abiru, N; Moriyama, H; Babaya, N; Liu, E; Miao, DM; Yu, LP; Wegmann, DR; Hutton, JC; Elliott, JF; Eisenbarth, GS			Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice	NATURE			English	Article							T-CELL-CLONES; MOUSE; TOLERANCE; MELLITUS; PEPTIDE; SUSCEPTIBILITY; DECARBOXYLASE; POPULATION; EXPRESSION; PREVENT	A fundamental question about the pathogenesis of spontaneous autoimmune diabetes is whether there are primary autoantigens. For type 1 diabetes it is clear that multiple islet molecules are the target of autoimmunity in man and animal models(1,2). It is not clear whether any of the target molecules are essential for the destruction of islet beta cells. Here we show that the proinsulin/ insulin molecules have a sequence that is a primary target of the autoimmunity that causes diabetes of the non-obese diabetic ( NOD) mouse. We created insulin 1 and insulin 2 gene knockouts combined with a mutated proinsulin transgene ( in which residue 16 on the B chain was changed to alanine) in NOD mice. This mutation abrogated the T-cell stimulation of a series of the major insulin autoreactive NOD T-cell clones(3). Female mice with only the altered insulin did not develop insulin autoantibodies, insulitis or autoimmune diabetes, in contrast with mice containing at least one copy of the native insulin gene. We suggest that proinsulin is a primary autoantigen of the NOD mouse, and speculate that organ-restricted autoimmune disorders with marked major histocompatibility complex (MHC) restriction of disease are likely to have specific primary autoantigens.	Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528501, Japan; Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan; Univ Alberta, Edmonton, AB T6G 2S2, Canada	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Nagasaki University; Kobe University; University of Alberta	Eisenbarth, GS (corresponding author), Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA.	george.eisenbarth@uchsc.edu		Babaya, Naru/0000-0003-2466-1228	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864, R01AI039213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055969, R01DK062718, R01DK032083] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI050864, R01 AI039213] Funding Source: Medline; NIDDK NIH HHS [R01 DK062718, R01 DK032083, R01 DK055969] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abiru N, 2000, J AUTOIMMUN, V14, P231, DOI 10.1006/jaut.2000.0369; Birk OS, 1996, P NATL ACAD SCI USA, V93, P1032, DOI 10.1073/pnas.93.3.1032; Bluestone JA, 2004, P NATL ACAD SCI USA, V101, P14622, DOI 10.1073/pnas.0405234101; Chatenoud L, 1997, J IMMUNOL, V158, P2947; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; DiLorenzo TP, 2002, CLIN IMMUNOL, V105, P332, DOI 10.1006/clim.2002.5298; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Ellerman KE, 2000, DIABETOLOGIA, V43, P890, DOI 10.1007/s001250051466; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; Jaeckel E, 2003, J EXP MED, V197, P1635, DOI 10.1084/jem.20030215; Kash SF, 1999, HORM METAB RES, V31, P340, DOI 10.1055/s-2007-978750; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Kubosaki A, 2004, DIABETOLOGIA, V47, P149, DOI 10.1007/s00125-003-1252-z; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Moriyama H, 2003, P NATL ACAD SCI USA, V100, P10376, DOI 10.1073/pnas.1834450100; Mukherjee R, 2003, J AUTOIMMUN, V21, P221, DOI 10.1016/S0896-8411(03)00114-8; Nakayama M, 2004, ANN NY ACAD SCI, V1037, P193, DOI 10.1196/annals.1337.031; Peterson JD, 1996, DIABETES, V45, P328, DOI 10.2337/diabetes.45.3.328; Simone E, 1997, P NATL ACAD SCI USA, V94, P2518, DOI 10.1073/pnas.94.6.2518; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Wong FS, 2002, P NATL ACAD SCI USA, V99, P5551, DOI 10.1073/pnas.072037299; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697	28	541	572	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					220	223		10.1038/nature03523	http://dx.doi.org/10.1038/nature03523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889095	Green Accepted			2022-12-24	WOS:000229021100044
J	Genin, A; Jaffe, JS; Reef, R; Richter, C; Franks, PJS				Genin, A; Jaffe, JS; Reef, R; Richter, C; Franks, PJS			Swimming against the flow: A mechanism of zooplankton aggregation	SCIENCE			English	Article							NEAR-BOTTOM DEPLETION; HYDROSTATIC-PRESSURE; VANCOUVER-ISLAND; GEORGES BANK; CORAL-REEFS; PLANKTON; SHELF; SEA; INVERTEBRATES; CIRCULATION	Zooplankton reside in a constantly flowing environment. However, information about their response to ambient flow has remained elusive, because of the difficulties of following the individual motions of these minute, nearly transparent animals in the ocean. Using a three-dimensional acoustic imaging system, we tracked >375,000 zooplankters at two coastal sites in the Red Sea. Resolution of their motion from that of the water showed that the animals effectively maintained their depth by swimming against upwelling and downwelling currents moving at rates of up to tens of body lengths per second, causing their accumulation at frontal zones. This mechanism explains how oceanic fronts become major feeding grounds for predators and targets for fishermen.	Interuniv Inst Marine Sci, Elat, Israel; Hebrew Univ Jerusalem, Elat, Israel; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Ctr Trop Marine Ecol, Bremen, Germany	Hebrew University of Jerusalem; University of California System; University of California San Diego; Scripps Institution of Oceanography; Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Genin, A (corresponding author), Interuniv Inst Marine Sci, Elat, Israel.	amatzia@vms.huji.ac.il	Richter, Claudio/AAT-1212-2020	Richter, Claudio/0000-0002-8182-6896; Reef, Ruth/0000-0001-6639-520X				Bottger R., 1987, Biological Oceanography, V4, P383; BULLOCK TH, 1997, MAR FRESHW BEHAV PHY, V28, P1; Cowles T.J., 1998, OCEANOGRAPHY, V11, P4, DOI [DOI 10.5670/OCEANOG.1998.08, DOI 10.5670/0CEAN0G.1998.08]; Dandonneau Y, 2003, SCIENCE, V302, P1548, DOI 10.1126/science.1090729; ENRIGHT JT, 1962, COMP BIOCHEM PHYSIOL, V7, P131, DOI 10.1016/0010-406X(62)90035-X; Epstein AW, 2001, DEEP-SEA RES PT II, V48, P395, DOI 10.1016/S0967-0645(00)00086-2; Etnoyer Peter, 2004, Oceanography, V17, P90; FORWARD RB, 1988, OCEANOGR MAR BIOL, V26, P361; FORWARD RB, 1989, MAR ECOL PROG SER, V57, P267, DOI 10.3354/meps057267; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; Gallager SM, 2004, MAR ECOL PROG SER, V267, P27, DOI 10.3354/meps267027; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Genin Amatzia, 2002, Oceanography, V15, P90; HARDY AC, 1954, J MAR BIOL ASSOC UK, V33, P409, DOI 10.1017/S0025315400008456; HARDY AC, 1936, DISCOVERY REP, V11, P513; HEALEY MC, 1990, CAN J FISH AQUAT SCI, V47, P1846, DOI 10.1139/f90-210; JAFFE JS, 1995, DEEP-SEA RES PT I, V42, P1495, DOI 10.1016/0967-0637(95)00030-A; LASKER R, 1970, MAR BIOL, V5, P345; Lavoie D, 2000, CAN J FISH AQUAT SCI, V57, P1853, DOI 10.1139/cjfas-57-9-1853; LINCOLN RJ, 1971, J EXP BIOL, V54, P677; Macdonald AG, 1999, COMP BIOCHEM PHYS A, V122, P13, DOI 10.1016/S1095-6433(98)10173-3; MACDONALD AG, 1972, J MAR BIOL ASSOC UK, V52, P213, DOI 10.1017/S002531540001866X; Mackas DL, 1997, CAN J FISH AQUAT SCI, V54, P2080, DOI 10.1139/cjfas-54-9-2080; Mauchline J., 1998, ADV MARINE BIOL, V33; Mohammadian MA, 1997, MAR ECOL PROG SER, V150, P113, DOI 10.3354/meps150113; Motro R, 2005, CORAL REEFS, V24, P95, DOI 10.1007/s00338-004-0451-5; Niemann H, 2004, MAR ECOL PROG SER, V269, P91, DOI 10.3354/meps269091; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Pershing AJ, 2001, DEEP-SEA RES PT II, V48, P283, DOI 10.1016/S0967-0645(00)00122-3; Shanks AL, 2000, LIMNOL OCEANOGR, V45, P230, DOI 10.4319/lo.2000.45.1.0230; SIMARD Y, 1986, MAR ECOL PROG SER, V32, P203, DOI 10.3354/meps032203; WISHNER KF, 1995, CONT SHELF RES, V15, P475, DOI 10.1016/0278-4343(94)00057-T; Yahel R, 2005, CORAL REEFS, V24, P75, DOI 10.1007/s00338-004-0449-z; YODER JA, 1994, NATURE, V371, P689, DOI 10.1038/371689a0	34	182	185	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					860	862		10.1126/science.1107834	http://dx.doi.org/10.1126/science.1107834			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879218				2022-12-24	WOS:000228986500050
J	Opelz, G				Opelz, G		Gerhard Opelz Collaborative Transp	Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies	LANCET			English	Article							CLASS-I; CROSS-MATCH; PRESENSITIZATION; ALLOANTIBODIES; RECIPIENTS; ANTIGENS; ELISA; ASSAY	Background The presence of panel-reactive antibodies (PRA) against HLA antigens before transplantation is associated with early rejection of kidney grafts from cadaver donors. Transplants from HLA-identical sibling donors do not provide a target for antibodies to HLA antigens and should therefore not be affected by PRA. Methods Data from the Collaborative Transplant Study were used to examine the influence of PRA on graft survival. Uncensored graft survival and death-censored graft survival were calculated, and the data were analysed by multivariate Cox's regression methods. Findings Among recipients of HLA-identical sibling transplants, 3001 patients with no PRA had significantly higher 10-year graft survival (72.4% [SE 1.1]) than 803 patients with 1-50% PRA (63.3% [2.5]; p=0.0006) or 244 patients with more than 50% PRA (55.5% [4.0]; p<0.0001). The effect of PRA became apparent after the first post-transplant year and was, therefore, strikingly different from the early steep decline in graft survival during the first year associated with PRA in recipients of cadaver kidneys. We could not discern whether graft loss was a direct effect of non-HLA humoral sensitisation or whether PRA served as an indicator of heightened immunity against non-HLA transplantation antigens. Interpretation PRA reactivity is strongly associated with long-term graft loss in kidney transplants from HLA-identical sibling donors. Relevance to practice Our findings suggest that non-HLA immunity has a much stronger role in clinical transplantation than previously thought. In contrast to immunity against HLA mediated by antibodies present before transplantation, which leads to early acute graft rejection, non-HLA immunity is associated with chronic graft loss. The possibility of identifying recipients at increased risk of late graft loss before transplantation could be used to devise specific immunosuppressive strategies for these patients.	Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Opelz, G (corresponding author), Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany.	gerhard.opelz@med.uni-heidelberg.de						BARGER B, 1989, TRANSPLANTATION, V47, P240; Bryan CF, 2001, CLIN TRANSPLANT, V15, P28, DOI 10.1034/j.1399-0012.2001.00005.x; Buelow R, 1995, TRANSPLANTATION, V60, P1594, DOI 10.1097/00007890-199560120-00037; COX DR, 1972, J R STAT SOC B, V34, P187; DUNN OJ, 1974, APPLIED STATISTICS A, P236; Fuller TC, 1997, HUM IMMUNOL, V56, P94, DOI 10.1016/S0198-8859(97)00174-2; GALE RP, 1978, LANCET, V1, P170; KAO KJ, 1993, TRANSPLANTATION, V55, P192, DOI 10.1097/00007890-199301000-00036; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KATZNELSON S, 1998, CLIN TRANS, P285; OPELZ G, 1987, TRANSPLANT P, V19, P3737; OPELZ G, 1992, REV IMMUNOGENET, V1, P334; Pei R, 2003, TRANSPLANTATION, V75, P43, DOI 10.1097/00007890-200301150-00008; Perez-Rodriguez M, 2002, TISSUE ANTIGENS, V59, P440, DOI 10.1034/j.1399-0039.2002.590516.x; PETTAWAY CA, 1987, TRANSPLANTATION, V44, P529, DOI 10.1097/00007890-198710000-00014; RODEY GE, 1994, HUM IMMUNOL, V39, P272, DOI 10.1016/0198-8859(94)90270-4; Simpson E, 2001, EUR J IMMUNOGENET, V28, P505, DOI 10.1046/j.0960-7420.2001.00252.x; Susal C, 2002, TRANSPLANTATION, V73, P1269; TALBOT D, 1989, TRANSPLANTATION, V47, P552, DOI 10.1097/00007890-198903000-00030; TERASAKI PI, 1971, POSTGRAD MED J, V47, P89, DOI 10.1136/pgmj.47.544.89; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; *U HEID, COLL TRANSPL STUD; Zachary AA, 2001, HUM IMMUNOL, V62, P236, DOI 10.1016/S0198-8859(00)00253-6	23	259	269	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1570	1576		10.1016/S0140-6736(05)66458-6	http://dx.doi.org/10.1016/S0140-6736(05)66458-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866311				2022-12-24	WOS:000228754800029
J	Falsey, AR; Hennessey, PA; Formica, MA; Cox, C; Walsh, EE				Falsey, AR; Hennessey, PA; Formica, MA; Cox, C; Walsh, EE			Respiratory syncytial virus infection in elderly and high-risk adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSE TRANSCRIPTION-PCR; DISEASE BURDEN; VIRAL CULTURE; UNITED-STATES; INFLUENZA; COMMUNITY; PNEUMONIA; MORTALITY; ILLNESS; VACCINATION	BACKGROUND: Respiratory syncytial virus (RSV) is an increasingly recognized cause of illness in adults. Data on the epidemiology and clinical effects in community-dwelling elderly persons and high-risk adults can help in assessing the need for vaccine development. METHODS: During four consecutive winters, we evaluated all respiratory illnesses in prospective cohorts of healthy elderly patients (greater/equal 65 years of age) and high-risk adults (those with chronic heart or lung disease) and in patients hospitalized with acute cardiopulmonary conditions. RSV infection and influenza A were diagnosed on the basis of culture, reverse-transcriptase polymerase chain reaction, and serologic studies. RESULTS: A total of 608 healthy elderly patients and 540 high-risk adults were enrolled in prospective surveillance, and 1388 hospitalized patients were enrolled. A total of 2514 illnesses were evaluated. RSV infection was identified in 102 patients in the prospective cohorts and 142 hospitalized patients, and influenza A was diagnosed in 44 patients in the prospective cohorts and 154 hospitalized patients. RSV infection developed annually in 3 to 7 percent of healthy elderly patients and in 4 to 10 percent of high-risk adults. Among healthy elderly patients, RSV infection generated fewer office visits than influenza; however, the use of health care services by high-risk adults was similar in the two groups. In the hospitalized cohort, RSV infection and influenza A resulted in similar lengths of stay, rates of use of intensive care (15 percent and 12 percent, respectively), and mortality (8 percent and 7 percent, respectively). On the basis of the diagnostic codes of the International Classification of Diseases, 9th Revision, Clinical Modification at discharge, RSV infection accounted for 10.6 percent of hospitalizations for pneumonia, 11.4 percent for chronic obstructive pulmonary disease, 5.4 percent for congestive heart failure, and 7.2 percent for asthma. CONCLUSIONS: RSV infection is an important illness in elderly and high-risk adults, with a disease burden similar to that of nonpandemic influenza A in a population in which the prevalence of vaccination for influenza is high. An effective RSV vaccine may offer benefits for these adults.	Rochester Gen Hosp, Infect Dis Unit, Dept Med, Rochester, NY 14621 USA; Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; NICHHD, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD 20892 USA	Rochester General Hospital; University of Rochester; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Falsey, AR (corresponding author), Rochester Gen Hosp, Infect Dis Unit, Dept Med, 1425 Portland Ave, Rochester, NY 14621 USA.	ann.falsey@viahealth.org			NIAID NIH HHS [R01-AI-45969] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045969] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRAUNWALD E, 2001, HEART DIS TXB CARDIO, P640; *CDCP, INFL SEAS SUMM 1999; Centers for Disease Control and Prevention, INFL SEAS SUMM; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Falsey AR, 2003, J CLIN MICROBIOL, V41, P4160, DOI 10.1128/JCM.41.9.4160-4165.2003; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; Falsey AR, 2002, J CLIN MICROBIOL, V40, P817, DOI 10.1128/JCM.40.3.817-820.2002; FALSEY AR, 1992, J AM GERIATR SOC, V40, P115, DOI 10.1111/j.1532-5415.1992.tb01929.x; Fleiss J, 1981, STAT METHODS RATES P, V2nd, P113; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Griffin MR, 2002, ARCH INTERN MED, V162, P1229, DOI 10.1001/archinte.162.11.1229; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; Harmon M., 1989, DIAGNOSTIC PROCEDURE, P631; HART RJC, 1984, J INFECTION, V8, P259, DOI 10.1016/S0163-4453(84)94075-1; JOHNSON KM, 1962, NEW ENGL J MED, V267, P68, DOI 10.1056/NEJM196207122670204; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; LaMontagne JR, 1997, LANCET, V349, P149, DOI 10.1016/S0140-6736(05)60974-9; LAWTON MP, 1971, J AM GERIATR SOC, V19, P465, DOI 10.1111/j.1532-5415.1971.tb01206.x; MCINTOSH K, 1970, AM J EPIDEMIOL, V91, P585, DOI 10.1093/oxfordjournals.aje.a121171; Morens DM, 2003, JAMA-J AM MED ASSOC, V289, P227, DOI 10.1001/jama.289.2.227; Neuzil KM, 2003, CLIN INFECT DIS, V37, P201, DOI 10.1086/375604; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Nicholson KG, 1997, BRIT MED J, V315, P1060, DOI 10.1136/bmj.315.7115.1060; POPOVIC JR, 2001, DHHS PUBLICATION; Simoes EAF, 2001, LANCET, V358, P1382, DOI 10.1016/S0140-6736(01)06488-1; SORVILLO FJ, 1984, J INFECTION, V9, P252, DOI 10.1016/S0163-4453(84)90530-9; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; VIKERFORS T, 1987, AM REV RESPIR DIS, V136, P561, DOI 10.1164/ajrccm/136.3.561; Walsh EE, 2002, J AM GERIATR SOC, V50, P1498, DOI 10.1046/j.1532-5415.2002.50404.x; Walsh EE, 2001, J MED VIROL, V63, P259, DOI 10.1002/1096-9071(200103)63:3&lt;259::AID-JMV1010&gt;3.0.CO;2-X; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; 1983, BR MED J CLIN RES ED, V287, P1618	38	1274	1320	2	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1749	1759		10.1056/NEJMoa043951	http://dx.doi.org/10.1056/NEJMoa043951			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858184				2022-12-24	WOS:000228689000005
J	Takano, A; Endo, T; Yoshihisa, T				Takano, A; Endo, T; Yoshihisa, T			tRNA actively shuttles between the nucleus and cytosol in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPORT; TRANSPORT; AMINOACYLATION; TRANSCRIPTION; TRANSLATION; CYTOPLASM; PATHWAY	Previous evidence suggested that transfer RNAs (tRNAs) cross the nuclear envelope to the cytosol only once after maturing in the nucleus. We now present evidence for nuclear import of tRNAs in yeast. Several export mutants accumulate mature tRNAs in the nucleus even in the absence of transcription. Import requires energy but not the Ran cycle. These results indicate that tRNAs shuttle between the nucleus and cytosol.	Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Core Res Evolut Sci & Technol, Japan Sci & Technol Corp, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Yoshihisa, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	tyoshihi@biochem.chem.nagoya-u.ac.jp						Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; AZPIROZ R, 1993, MOL BIOL CELL, V4, P21, DOI 10.1091/mbc.4.1.21; Bohnsack MT, 2002, EMBO J, V21, P6205, DOI 10.1093/emboj/cdf613; Feng WQ, 2002, P NATL ACAD SCI USA, V99, P5412, DOI 10.1073/pnas.082682699; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grosshans H, 2000, GENE DEV, V14, P830; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KADOWAKI T, 1994, J CELL BIOL, V126, P649, DOI 10.1083/jcb.126.3.649; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; WILLIS I, 1984, EMBO J, V3, P1573, DOI 10.1002/j.1460-2075.1984.tb02013.x; Wolfe CL, 1996, J BIOL CHEM, V271, P4679; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757	19	130	136	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					140	142		10.1126/science.1113346	http://dx.doi.org/10.1126/science.1113346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15905365				2022-12-24	WOS:000230212800078
J	Ram, RJ; VerBerkmoes, NC; Thelen, MP; Tyson, GW; Baker, BJ; Blake, RC; Shah, M; Hettich, RL; Banfield, JF				Ram, RJ; VerBerkmoes, NC; Thelen, MP; Tyson, GW; Baker, BJ; Blake, RC; Shah, M; Hettich, RL; Banfield, JF			Community proteomics of a natural microbial biofilm	SCIENCE			English	Article							ACID-MINE DRAINAGE; LEPTOSPIRILLUM-FERROOXIDANS; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY; YEAST PROTEOME; IRON; IDENTIFICATION; CHROMATOGRAPHY; METABOLISM; PEPTIDE	Using genomic and mass spectrometry-based proteomic methods, we evaluated gene expression, identified key activities, and examined partitioning of metabolic functions in a natural acid mine drainage (AMD) microbial biofilm community. We detected 2033 proteins from the five most abundant species in the biofilm, including 48% of the predicted proteins from the dominant biofilm organism, Leptospirillum group II. Proteins involved in protein refolding and response to oxidative stress appeared to be highly expressed, which suggests that damage to biomolecules is a key challenge for survival. We validated and estimated the relative abundance and cellular localization of 357 unique and 215 conserved novel proteins and determined that one abundant novel protein is a cytochrome central to iron oxidation and AMD formation.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Tennessee, Grad Sch Genome Sci & Technol, Oak Ridge Natl Lab, Oak Ridge, TN 37830 USA; Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN 37831 USA; Lawrence Livermore Natl Lab, Biosci Directorate, Livermore, CA 94551 USA; Xavier Univ, Coll Pharm, New Orleans, LA 70125 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Xavier University of Louisiana	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	jill@seismo.berkeley.edu	Hettich, Robert L/N-1458-2016; Thelen, Michael/C-6834-2008; Baker, Brett/P-1783-2014; Tyson, Gene/C-6558-2013	Hettich, Robert L/0000-0001-7708-786X; Thelen, Michael/0000-0002-2479-5480; Baker, Brett/0000-0002-5971-1021; Banfield, Jill/0000-0001-8203-8771; Tyson, Gene/0000-0001-8559-9427				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLAKE R, 2000, ENV MICROBE METAL IN, P53; BLAKE RC, 1993, FEMS MICROBIOL REV, V11, P9; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/10635150118513; Druschel GK, 2004, GEOCHEM T, V5, P13, DOI 10.1186/1467-4866-5-13; Essader AS, 2005, PROTEOMICS, V5, P24, DOI 10.1002/pmic.200400888; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; HART A, 1991, FEMS MICROBIOL LETT, V81, P89; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; LUTHER GW, 1987, GEOCHIM COSMOCHIM AC, V51, P3193, DOI 10.1016/0016-7037(87)90127-X; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Parro V, 2003, P NATL ACAD SCI USA, V100, P7883, DOI 10.1073/pnas.1230487100; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; RAM RS, UNPUB; Standing KG, 2003, CURR OPIN STRUC BIOL, V13, P595, DOI 10.1016/j.sbi.2003.09.005; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; VerBerkmoes NC, 2002, J PROTEOME RES, V1, P239, DOI 10.1021/pr025508a; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Zhu WH, 2004, J PROTEOME RES, V3, P538, DOI 10.1021/pr034109s	26	501	539	0	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1915	1920		10.1126/science. 1109070	http://dx.doi.org/10.1126/science. 1109070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15879173				2022-12-24	WOS:000230120000042
J	Kawaoka, Y				Kawaoka, Y			Clinical implications of basic research: How ebola virus infects cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Tokyo, Int Res Ctr Infect Dis, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Int Res Ctr Infect Dis, Tokyo, Japan.							CHANDRAN K, IN PRESS SCIENCE; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876	5	16	21	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2645	2646		10.1056/NEJMcibr051754	http://dx.doi.org/10.1056/NEJMcibr051754			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972874				2022-12-24	WOS:000229953700016
J	Lee, CS; Friedman, JR; Fulmer, JT; Kaestner, KH				Lee, CS; Friedman, JR; Fulmer, JT; Kaestner, KH			The initiation of liver development is dependent on Foxa transcription factors	NATURE			English	Article							GUT ENDODERM; GLUCOSE-HOMEOSTASIS; GENE; DIFFERENTIATION; CHROMATIN; HNF3; ORGANOGENESIS; NUCLEOSOME; EXPRESSION; HNF-3-BETA	The specification of the vertebrate liver is thought to occur in a two-step process, beginning with the establishment of competence within the foregut endoderm for responding to organ-specific signals, followed by the induction of liver-specific genes. On the basis of expression and in vitro studies, it has been proposed that the Foxa transcription factors establish competence by opening compacted chromatin structures within liver-specific target genes(1). Here we show that Foxa1 and Foxa2 (forkhead box proteins A1 and A2) are required in concert for hepatic specification in mouse. In embryos deficient for both genes in the foregut endoderm, no liver bud is evident and expression of the hepato-blast marker alpha-fetoprotein (Afp) is lost. Furthermore, Foxa1/Foxa2-deficient endoderm cultured in the presence of exogenous fibroblast growth factor 2 (FGF2) fails to initiate expression of the liver markers albumin and transthyretin. Thus, Foxa1 and Foxa2 are required for the establishment of competence within the foregut endoderm and the onset of hepatogenesis.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kaestner, KH (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	kaestner@mail.med.upenn.edu	Friedman, Joshua/Q-9367-2019	Friedman, Joshua/0000-0001-9382-8429				ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Bossard P, 2000, DEVELOPMENT, V127, P4915; Bossard P, 1998, DEVELOPMENT, V125, P4909; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Clotman F, 2002, DEVELOPMENT, V129, P1819; Coffinier C, 2002, DEVELOPMENT, V129, P1829; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Crowe AJ, 1999, J BIOL CHEM, V274, P25113, DOI 10.1074/jbc.274.35.25113; Deutsch G, 2001, DEVELOPMENT, V128, P871; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Holmqvist PH, 2005, EXP CELL RES, V304, P593, DOI 10.1016/j.yexcr.2004.12.002; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kaestner KH, 2000, TRENDS ENDOCRIN MET, V11, P281, DOI 10.1016/S1043-2760(00)00271-X; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Keng VW, 2000, BIOCHEM BIOPH RES CO, V276, P1155, DOI 10.1006/bbrc.2000.3548; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	27	414	433	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					944	947		10.1038/nature03649	http://dx.doi.org/10.1038/nature03649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959514				2022-12-24	WOS:000229799700047
J	Reilly, JJ; Armstrong, J; Dorosty, AR; Emmett, PM; Ness, A; Rogers, I; Steer, C; Sherriff, A				Reilly, JJ; Armstrong, J; Dorosty, AR; Emmett, PM; Ness, A; Rogers, I; Steer, C; Sherriff, A		Avon Longitudinal Study Parents Ch	Early life risk factors for obesity in childhood: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; ADULT OBESITY; CHILDREN; WEIGHT; PREVENTION; OVERWEIGHT; ADIPOSITY; BEHAVIORS; EXPOSURE; UK	Objective To identify risk factors in early life (up to 3 years of age) for obesity in children in the United Kingdom. Design Prospective cohort study. Setting Avon longitudinal study of parents and children, United Kingdom. Participants 8234 children in cohort aged 7 years and a subsample of 909 children (children in focus) with data on additional early growth related risk factors for obesity. Main outcome measures Obesity at age 7 years, defined as a body mass index >= 95th centile relative to reference data for the UK population in 1990. Results Eight of 25 putative risk factors were associated with a risk of obesity in the final models: parental obesity (both parents: adjusted odds ratio, 10.44, 95% confidence interval 5.11 to 21.32), very early (by 43 months) body mass index or adiposity rebound (15.00, 5.32 to 42.30), more than eight hours spent watching television per week at age 3 years (1.55, 1.13 to 2.12), catch-up growth (2.60, 1.09 to 6.16), standard deviation score for weight at age 8 months (3.13, 1.43 to 6.85) and 18 months (2.65, 1, 25 to 5.59); weight gain in first year (1.06, 1.02 to 1.10 per 100 g increase); birth weight, per 100 g (1.05, 1.03 to 1.07); and short (< 10.5 hours) sleep duration at age 3 years (1.45, 1.10 to 1.89). Conclusion Eight factors in early life are associated with an increased risk of obesity in childhood.	Univ Glasgow, Div Dev Med, Yorkhill Hosp, Glasgow G3 8SJ, Lanark, Scotland; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Inst Child Hlth, Bristol BS8 1TH, Avon, England; Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran	University of Glasgow; University of Bristol; Tehran University of Medical Sciences	Reilly, JJ (corresponding author), Univ Glasgow, Div Dev Med, Yorkhill Hosp, Glasgow G3 8SJ, Lanark, Scotland.	jjr2y@clinmed.gla.ac.uk	Ness, Andy R/M-7612-2013; Dorosty-Motlagh, Ahmad-Reza/E-1003-2018; Emmett, Pauline/AAL-6815-2021	Ness, Andy R/0000-0003-3548-9523; Dorosty-Motlagh, Ahmad-Reza/0000-0002-6937-7776; Emmett, Pauline/0000-0003-1076-4779; Rogers, Imogen/0000-0001-7275-2437; sherriff, andrea/0000-0002-1016-037X	Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		Armstrong J, 2002, LANCET, V359, P2003, DOI 10.1016/S0140-6736(02)08837-2; Birch LL, 1998, PEDIATRICS, V101, P539; Bogen DL, 2004, OBES RES, V12, P1527, DOI 10.1038/oby.2004.190; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dietz WH, 2000, AM J CLIN NUTR, V72, P335; Dietz WH, 1997, J NUTR, V127, pS1884, DOI 10.1093/jn/127.9.1884S; Dietz WH, 2001, JAMA-J AM MED ASSOC, V285, P2506, DOI 10.1001/jama.285.19.2506; Dorosty AR, 2000, PEDIATRICS, V105, P1115, DOI 10.1542/peds.105.5.1115; Francis LA, 2003, OBES RES, V11, P143, DOI 10.1038/oby.2003.23; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; Grove KL, 2001, J CLIN ENDOCR METAB, V86, P5420, DOI 10.1210/jc.86.11.5420; North K, 2000, EUR J CLIN NUTR, V54, P73, DOI 10.1038/sj.ejcn.1600896; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Reilly JJ, 2002, ARCH DIS CHILD, V86, P392, DOI 10.1136/adc.86.6.392; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Reilly JJ, 1999, LANCET, V354, P1874, DOI 10.1016/S0140-6736(99)04555-9; Reilly JJ, 2000, INT J OBESITY, V24, P1623, DOI 10.1038/sj.ijo.0801436; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; STEULER N, 2002, PEDIATRICS, V109, P194; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; Whitaker RC, 2003, ARCH PEDIAT ADOL MED, V157, P725, DOI 10.1001/archpedi.157.8.725	25	1090	1128	1	196	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2005	330	7504					1357	1359		10.1136/bmj.38470.670903.E0	http://dx.doi.org/10.1136/bmj.38470.670903.E0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936FE	15908441	Green Published			2022-12-24	WOS:000229840100017
J	Hammock, EAD; Young, LJ				Hammock, EAD; Young, LJ			Microsatellite instability generates diversity in brain and sociobehavioral traits	SCIENCE			English	Article							PAIR-BOND FORMATION; PRAIRIE VOLES; MICROTUS-OCHROGASTER; SOCIAL RECOGNITION; ARGININE-VASOPRESSIN; PARTNER PREFERENCE; OLFACTORY-BULB; MATING SYSTEM; RECEPTOR; PATTERNS	Repetitive microsatellites mutate at relatively high rates and may contribute to the rapid evolution of species-typical traits. We show that individual alleles of a repetitive polymorphic microsatellite in the 5' region of the prairie vole vasopressin 1a receptor (avpr1a) gene modify gene expression in vitro. In vivo, we observe that this regulatory polymorphism predicts both individual differences in receptor distribution patterns and socio-behavioral traits. These data suggest that individual differences in gene expression patterns may be conferred via polymorphic microsatellites in the cis-regulatory regions of genes and may contribute to normal variation in behavioral traits.	Emory Univ, Yerkes Natl Primate Res Ctr, Ctr Behav Neurosci, Dept Psychiat & Behav Sci, Atlanta, GA 30329 USA	Emory University	Young, LJ (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Ctr Behav Neurosci, Dept Psychiat & Behav Sci, Atlanta, GA 30329 USA.	Edunn2@emory.edu; Lyoun03@emory.edu	Young, Larry/HGE-5031-2022; Hammock, Elizabeth/G-1897-2011		NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH064692, R29MH056897, F31MH067397, R01MH056897] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00165] Funding Source: Medline; NIMH NIH HHS [MH64692, MH67397, MH56897] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Dluzen DE, 1998, PEPTIDES, V19, P999, DOI 10.1016/S0196-9781(98)00047-3; ENGELMANN M, 1994, PHYSIOL BEHAV, V55, P145, DOI 10.1016/0031-9384(94)90022-1; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; *GENBANK, NW114825 GENBANK; *GENBANK, AF208541 GENBANK; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; HAMMOCK E, IN PRESS GENES BRAIN; Hammock EAD, 2004, MOL BIOL EVOL, V21, P1057, DOI 10.1093/molbev/msh104; Hammock EAD, 2002, EUR J NEUROSCI, V16, P399, DOI 10.1046/j.1460-9568.2002.02083.x; INSEL TR, 1994, J NEUROSCI, V14, P5381; JANNETT FJ, 1982, J MAMMAL, V63, P495, DOI 10.2307/1380450; Kashi Y, 1997, TRENDS GENET, V13, P74, DOI 10.1016/S0168-9525(97)01008-1; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; KING DG, 1994, SCIENCE, V263, P595, DOI 10.1126/science.263.5147.595-b; KIRKPATRICK B, 1994, PHYSIOL BEHAV, V55, P885, DOI 10.1016/0031-9384(94)90075-2; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; Phelps SM, 2003, J COMP NEUROL, V466, P564, DOI 10.1002/cne.10902; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Roberts RL, 1998, ANIM BEHAV, V55, P1131, DOI 10.1006/anbe.1997.0659; SHAPIRO LE, 1990, J COMP PSYCHOL, V104, P268, DOI 10.1037/0735-7036.104.3.268; Thibonnier M, 2000, J MOL CELL CARDIOL, V32, P557, DOI 10.1006/jmcc.2000.1108; THOMAS JA, 1979, BEHAV ECOL SOCIOBIOL, V5, P171, DOI 10.1007/BF00293304; WANG ZX, 1994, P NATL ACAD SCI USA, V91, P400, DOI 10.1073/pnas.91.1.400; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; WILLIAMS JR, 1992, PHYSIOL BEHAV, V52, P635, DOI 10.1016/0031-9384(92)90390-N; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 1997, BEHAV NEUROSCI, V111, P599, DOI 10.1037/0735-7044.111.3.599; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	38	385	396	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1630	1634		10.1126/science.1111427	http://dx.doi.org/10.1126/science.1111427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947188				2022-12-24	WOS:000229827000058
J	Cooke, CA; Best, RM				Cooke, CA; Best, RM			Intraocular glasses	LANCET			English	Editorial Material									Royal Victoria Hosp, Dept Ophthalmol, Belfast B12 6BA, Antrim, North Ireland		Cooke, CA (corresponding author), Royal Victoria Hosp, Dept Ophthalmol, Belfast B12 6BA, Antrim, North Ireland.	carolecooke322@ntlworld.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1960	1960		10.1016/S0140-6736(05)66663-9	http://dx.doi.org/10.1016/S0140-6736(05)66663-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936425				2022-12-24	WOS:000229587800031
J	Sullivan, AK; Curtis, H; Sabin, CA; Johnson, MA				Sullivan, AK; Curtis, H; Sabin, CA; Johnson, MA			Newly diagnosed FHV infections: review in UK and Ireland	BRITISH MEDICAL JOURNAL			English	Review									Chelsea & Westminster Healthcare NHS Trust, London SW10 9NH, England; British HIV Assoc, London, England; UCL Royal Free & Univ Coll Med Sch, London, England; UCL Royal Free Hampstead NHS Trust, London, England	University of London; University College London; UCL Medical School; University of London; University College London	Sullivan, AK (corresponding author), Chelsea & Westminster Healthcare NHS Trust, London SW10 9NH, England.	Ann.Sullivan@Chelwest.nhs.uk	Sabin, Caroline/C-2464-2008	Sabin, Caroline/0000-0001-5173-2760; Curtis, Hilary/0000-0002-1440-1812				Curtis H, 2003, HIV Med, V4, P11, DOI 10.1046/j.1468-1293.2003.00137.x; Miners A H, 2001, HIV Med, V2, P52, DOI 10.1046/j.1468-1293.2001.00048.x; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; POZNIAK A, 2003, HIV MED S, V4, pS1	4	119	127	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 4	2005	330	7503					1301	1302		10.1136/bmj.38398.590602.E0	http://dx.doi.org/10.1136/bmj.38398.590602.E0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15894552	Green Published, Bronze			2022-12-24	WOS:000229655700021
J	Merchant, RC; Mayer, KH				Merchant, RC; Mayer, KH			Perspectives on new recommendations for nonoccupational HIV postexposure prophylaxis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EXPOSURE		Brown Med Sch, Dept Emergency Med, Providence, RI USA; Brown Med Sch, Dept Med, Providence, RI USA; Brown Med Sch, Dept Community Hlth, Providence, RI USA	Brown University; Brown University; Brown University	Merchant, RC (corresponding author), Rhode Isl Hosp, Dept Emergency Med, 593 Eddy St,Potter 228, Providence, RI 02903 USA.	rmerchant@lifespan.org						*AIDS I NEW YORK D, 1998, HIV PROPH FOLL SEX A; *AIDS I NEW YORK S, 2004, HIV PROPH FOLL NON E; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Bassett IV, 2004, CLIN INFECT DIS, V39, P395, DOI 10.1086/422459; *CAL TASK FORC NON, 2005, OFF HIV POST EXP PRO; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; *DEP HLTH COMM MAS, 2000, CLIN ADV HIV PROPH N; Merchant RC, 2003, ACAD EMERG MED, V10, P1345, DOI 10.1197/S1069-6563(03)00537-2; MERCHANT RC, 2002, NONOCCUPATIONAL HIV; MYLES JE, 2001, OFFERING HIV PROPHYL; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; *PAN CLIN PRACT TR, 2004, GUID US ANT AG HIV 1; Rey D, 2000, AIDS CARE, V12, P695, DOI 10.1080/09540120020014228; 1996, MMWR MORB MORTAL WKL, V45, P468	14	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2005	293	19					2407	2409		10.1001/jama.293.19.2407	http://dx.doi.org/10.1001/jama.293.19.2407			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926JX	15900012				2022-12-24	WOS:000229120600029
J	Mansour, D; Fraser, IS				Mansour, D; Fraser, IS			Missed contraceptive pills and the critical pill-free interval	LANCET			English	Editorial Material									Newcastle Primary Care Trust, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Sydney, Dept Obstet & Gynaecol, Sydney, NSW 2006, Australia	University of Sydney	Mansour, D (corresponding author), Newcastle Primary Care Trust, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	diana.mansour@newcastle-pct.nhs.uk						[Anonymous], 2004, SEL PRACT REC CONTR; Baer WC, 2004, J AM PLANN ASSOC, V70, P371; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; Creinin MD, 2002, CONTRACEPTION, V66, P147, DOI 10.1016/S0010-7824(02)00344-X; HAMILTON CJCM, 1989, AM J OBSTET GYNECOL, V161, P1159, DOI 10.1016/0002-9378(89)90655-8; KORVER T, 1995, BRIT J OBSTET GYNAEC, V102, P601; LANDGREN BM, 1991, CONTRACEPTION, V43, P149, DOI 10.1016/0010-7824(91)90042-E; Pierson RA, 2003, FERTIL STERIL, V80, P34, DOI 10.1016/S0015-0282(03)00556-9; Trussell J, 2004, CONTRACEPTION, V70, P89, DOI 10.1016/j.contraception.2004.03.009; *WHO, 2004, MED EL CRIT CONTR; 2005, J FAM PLANN REPROD H, V31, P153	11	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1670	1671		10.1016/S0140-6736(05)66527-0	http://dx.doi.org/10.1016/S0140-6736(05)66527-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894085				2022-12-24	WOS:000229082300007
J	Ramaekers, VT; Rothenberg, SP; Sequeira, JM; Opladen, T; Blau, N; Quadros, EV; Selhub, J				Ramaekers, VT; Rothenberg, SP; Sequeira, JM; Opladen, T; Blau, N; Quadros, EV; Selhub, J			Autoantibodies to folate receptors in the cerebral folate deficiency syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CEREBROSPINAL-FLUID; BINDING-PROTEIN; ACID; 5-METHYLTETRAHYDROFOLATE; TRANSPORT	In infantile-onset cerebral folate deficiency, 5-methyltetrahydrofolate (5MTHF) levels in the cerebrospinal fluid are low, but folate levels in the serum and erythrocytes are normal. We examined serum specimens from 28 children with cerebral folate deficiency, 5 of their mothers, 28 age-matched control subjects, and 41 patients with an unrelated neurologic disorder. Serum from 25 of the 28 patients and 0 of 28 control subjects contained high-affinity blocking autoantibodies against membrane-bound folate receptors that are present on the choroid plexus. Oral folinic acid normalized 5MTHF levels in the cerebrospinal fluid and led to clinical improvement. Cerebral folate deficiency is a disorder in which autoantibodies can prevent the transfer of folate from the plasma to the cerebrospinal fluid.	Univ Klinikum Aachen, Dept Pediat, Div Pediat Neurol, D-52074 Aachen, Germany; SUNY Downstate Med Ctr, Dept Med, Brooklyn, NY USA; Univ Childrens Hosp, Div Clin Chem & Biochem, Zurich, Switzerland; Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Vitamin Metab & Aging Lab, Boston, MA 02111 USA	RWTH Aachen University; RWTH Aachen University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University Children's Hospital Zurich; Tufts University; United States Department of Agriculture (USDA)	Ramaekers, VT (corresponding author), Univ Klinikum Aachen, Dept Pediat, Div Pediat Neurol, Pauwelsstr 30, D-52074 Aachen, Germany.	vramaekers@ukaachen.de		Blau, Nenad/0000-0003-4347-3230				ANTONY AC, 1992, BLOOD, V79, P2807; Blau N, 2003, NEUROLOGY, V61, P642, DOI 10.1212/01.WNL.0000082726.08631.E7; BLAU N, 2003, PHYSICIAN GUIDE LAB, P96; HENDERSON GB, 1990, ANNU REV NUTR, V10, P319, DOI [10.1146/annurev.nutr.10.1.319, 10.1146/annurev.nu.10.070190.001535]; HOLM J, 1991, BIOCHEM J, V280, P267, DOI 10.1042/bj2800267; LEVITT M, 1971, J CLIN INVEST, V50, P1301, DOI 10.1172/JCI106609; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Ramaekers VT, 2002, NEUROPEDIATRICS, V33, P301, DOI 10.1055/s-2002-37082; Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471; Rothenberg SP, 2004, NEW ENGL J MED, V350, P134, DOI 10.1056/NEJMoa031145; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SVENDSEN IB, 1982, CARLSBERG RES COMMUN, V47, P371, DOI 10.1007/BF02907775; Wang YH, 2001, BBA-BIOMEMBRANES, V1513, P49, DOI 10.1016/S0005-2736(01)00340-6; Wright AJA, 2003, BRIT J NUTR, V90, P363, DOI 10.1079/BJN2003908; Wu DF, 1999, PHARMACEUT RES, V16, P415, DOI 10.1023/A:1018829920158	16	179	186	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1985	1991		10.1056/NEJMoa043160	http://dx.doi.org/10.1056/NEJMoa043160			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888699	Bronze			2022-12-24	WOS:000229017100009
J	Storm, C; Pastore, JJ; MacKintosh, FC; Lubensky, TC; Janmey, PA				Storm, C; Pastore, JJ; MacKintosh, FC; Lubensky, TC; Janmey, PA			Nonlinear elasticity in biological gels	NATURE			English	Article							ACTIN GELS; MODULUS	The mechanical properties of soft biological tissues are essential to their physiological function and cannot easily be duplicated by synthetic materials. Unlike simple polymer gels, many biological materials - including blood vessels(1), mesentery tissue(2), lung parenchyma(3), cornea(4) and blood clots(5) - stiffen as they are strained, thereby preventing large deformations that could threaten tissue integrity. The molecular structures and design principles responsible for this nonlinear elasticity are unknown. Here we report a molecular theory that accounts for strain-stiffening in a range of molecularly distinct gels formed from cytoskeletal and extracellular proteins and that reveals universal stress - strain relations at low to intermediate strains. The input to this theory is the force - extension curve for individual semi-flexible filaments and the assumptions that biological networks composed of these filaments are homogeneous, isotropic, and that they strain uniformly. This theory shows that systems of filamentous proteins arranged in an open crosslinked mesh invariably stiffen at low strains without requiring a specific architecture or multiple elements with different intrinsic stiffness.	Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; Vrije Univ Amsterdam, Div Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Vrije Universiteit Amsterdam; University of Pennsylvania	Storm, C (corresponding author), Leiden Univ, LION, Inst Lorentz Theoret Phys, POB 9506, NL-2300 RA Leiden, Netherlands.	cstorm@lorentz.leidenuniv.nl	MacKintosh, Frederick/AAB-9332-2021; Storm, Cornelis/K-1486-2013; MacKintosh, Fred C/A-9450-2008	MacKintosh, Frederick/0000-0002-2607-9541; Storm, Cornelis/0000-0002-4391-8984; MacKintosh, Fred C/0000-0002-2607-9541				FIXMAN M, 1973, J CHEM PHYS, V58, P1564, DOI 10.1063/1.1679396; Fung Y.C., 1994, 1 COURSE CONTINUUM M; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; HJORTDAL JO, 1995, ACTA OPHTHALMOL SCAN, V73, P12; JANMEY PA, 1986, BIOPOLYMERS, V25, P1337, DOI 10.1002/bip.360250712; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; KARAKAPLAN AD, 1980, ASME, V102, P124; Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306; Landau L. D., 1980, STAT PHYS; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Morse DC, 1998, PHYS REV E, V58, pR1237, DOI 10.1103/PhysRevE.58.R1237; Shadwick RE, 1999, J EXP BIOL, V202, P3305; Shah JV, 1997, RHEOL ACTA, V36, P262, DOI 10.1007/BF00366667; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; TELOAR LRG, 1975, PHYS RUBBER ELASTICI; Wang LZ, 2000, THROMB RES, V100, P537, DOI 10.1016/S0049-3848(00)00362-5; Wilhelm J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108103; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200	29	1181	1193	12	455	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					191	194		10.1038/nature03521	http://dx.doi.org/10.1038/nature03521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889088	Green Submitted			2022-12-24	WOS:000229021100036
J	Xu, F; Zhang, KL; Grunstein, M				Xu, F; Zhang, KL; Grunstein, M			Acetylation in histone H3 globular domain regulates gene expression in yeast	CELL			English	Article							NUCLEOSOME CORE PARTICLE; SACCHAROMYCES-CEREVISIAE; SWI/SNF COMPLEX; ORDERED RECRUITMENT; LYSINE 9; PROMOTER; BINDING; TRANSCRIPTION; HETEROCHROMATIN; PROTEINS	In Saccharomyces cerevisiae, known histone acetylation sites regulating gene activity are located in the N-terminal tails protruding from the nucleosome core. We report lysine 56 in histone H3 as a novel acetylation site that is located in the globular domain, where it extends toward the DNA major groove at the entry-exit points of the DNA superhelix as it wraps around the nucleosome. We show that K56 acetylation is enriched preferentially at certain active genes, such as those coding for histones. SPT10, a putative acetyltransferase, is required for cell cycle-specific K56 acetylation at histone genes. This allows recruitment of the nucleosome remodeling factor Snf5 and subsequent transcription. These findings indicate that histone H3 K56 acetylation at the entry-exit gate enables recruitment of the SWI/SNF nucleosome remodeling complex and so regulates gene activity.	Univ Calif Los Angeles, Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Riverside, Dept Chem, Mass Spectrometry Facil, Riverside, CA 92521 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Riverside	Grunstein, M (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	mg@mbi.ucla.edu		Xu, Feng/0000-0003-2016-7521	NIGMS NIH HHS [GM 23674, GM 42421] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023674, R01GM042421, R37GM023674] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Dimova D, 1999, MOL CELL, V4, P75, DOI 10.1016/S1097-2765(00)80189-6; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Geng FQ, 2004, EMBO J, V23, P127, DOI 10.1038/sj.emboj.7600035; Geng FQ, 2001, MOL CELL BIOL, V21, P4311, DOI 10.1128/MCB.21.13.4311-4320.2001; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hess D, 2004, MOL CELL BIOL, V24, P135, DOI 10.1128/MCB.24.1.135-143.2004; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Langst G, 2001, MOL CELL, V8, P1085, DOI 10.1016/S1097-2765(01)00397-5; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	52	314	318	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					375	385		10.1016/j.cell.2005.03.011	http://dx.doi.org/10.1016/j.cell.2005.03.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882620	Bronze			2022-12-24	WOS:000229031600008
J	Quiroga, RQ; Reddy, L; Kreiman, G; Koch, C; Fried, I				Quiroga, RQ; Reddy, L; Kreiman, G; Koch, C; Fried, I			Invariant visual representation by single neurons in the human brain	NATURE			English	Article							MEDIAL TEMPORAL-LOBE; INFEROTEMPORAL CORTEX; OBJECT RECOGNITION; MONKEY; FACES; MEMORY; HIPPOCAMPUS; POTENTIALS; AMYGDALA; CORTICES	It takes a fraction of a second to recognize a person or an object even when seen under strikingly different conditions. How such a robust, high-level representation is achieved by neurons in the human brain is still unclear(1-6). In monkeys, neurons in the upper stages of the ventral visual pathway respond to complex images such as faces and objects and show some degree of invariance to metric properties such as the stimulus size, position and viewing angle(2,4,7-12). We have previously shown that neurons in the human medial temporal lobe (MTL) fire selectively to images of faces, animals, objects or scenes(13,14). Here we report on a remarkable subset of MTL neurons that are selectively activated by strikingly different pictures of given individuals, landmarks or objects and in some cases even by letter strings with their names. These results suggest an invariant, sparse and explicit code, which might be important in the transformation of complex visual percepts into long-term and more abstract memories.	CALTECH, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90095 USA; MIT, Cambridge, MA 02142 USA; Tel Aviv Univ, Tel Aviv Med Ctr, Funct Neurosurg Unit, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	California Institute of Technology; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Quiroga, RQ (corresponding author), Univ Leicester, Dept Engn, Leicester LE1 7RH, Leics, England.	rodri@vis.caltech.edu	Reddy, Leila/C-2181-2009	Koch, Christof/0000-0001-6482-8067				Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; Hampson RE, 2004, P NATL ACAD SCI USA, V101, P3184, DOI 10.1073/pnas.0400162101; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Koch Christof, 2004, QUEST CONSCIOUSNESS; Konorski J., 1967, INTEGRATIVE ACTIVITY; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LOGOTHETIS NK, 1995, CEREB CORTEX, V3, P270; Macmillan N. A., 1991, DETECTION THEORY USE; MCCARTHY G, 1989, J NEUROSCI, V9, P4253; MISHASHITA Y, 1988, NATURE, V335, P817; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Saleem KS, 1996, J NEUROSCI, V16, P4757; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Suzuki WA, 1996, SEMIN NEUROSCI, V8, P3, DOI 10.1006/smns.1996.0002; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	30	1017	1035	12	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1102	1107		10.1038/nature03687	http://dx.doi.org/10.1038/nature03687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973409				2022-12-24	WOS:000229970400050
J	Dou, YL; Milne, TA; Tackett, AJ; Smith, ER; Fukuda, A; Wysocka, J; Allis, CD; Chait, BT; Hess, JL; Roeder, RG				Dou, YL; Milne, TA; Tackett, AJ; Smith, ER; Fukuda, A; Wysocka, J; Allis, CD; Chait, BT; Hess, JL; Roeder, RG			Physical association and coordinate function of the H3K4 methyltransferase MLL1 and the H4K16 acetyltransferase MOF	CELL			English	Article							HISTONE H4 ACETYLATION; CHROMATIN IN-VITRO; DOSAGE COMPENSATION; MASS-SPECTROMETRY; GENE-EXPRESSION; METHYLATION; COMPLEX; DROSOPHILA; TRANSCRIPTION; TRITHORAX	A stable complex containing MILL1 and MOF has been immunoaffinity purified from a human cell line that stably expresses an epitope-tagged WDR5 subunit. Stable interactions between MILL1 and MOF were confirmed by reciprocal immunoprecipitation, cosedimentation, and cotransfection analyses, and interaction sites were mapped to MLL1 C-terminal and MOF zinc finger domains. The purified complex has a robust MILL1-mediated histone methyltransferase activity that can effect mono-, di-, and trimethylation of H3 K4 and a MOF-mediated histone acetyltransferase activity that is specific for H4 K16. Importantly, both activities are required for optimal transcription activation on a chromatin template in vitro and on an endogenous MLL1 target gene, Hox a9, in vivo. These results indicate an activator-based mechanism for joint MILLI1 and MOF recruitment and targeted methylation and acetylation and provide a molecular explanation for the closely correlated distribution of H3 K4 methylation and H4 K16 acetylation on active genes.	Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Rockefeller University; Rockefeller University; Rockefeller University; University of Pennsylvania	Roeder, RG (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA.	roeder@mail.rockefeller.edu	Milne, Tom/E-1872-2016	Milne, Tom/0000-0002-0413-4271				Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2004, METHOD ENZYMOL, V377, P460; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fujimoto S, 1998, GENE, V209, P77, DOI 10.1016/S0378-1119(98)00014-6; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Krutchinsky AN, 2000, J AM SOC MASS SPECTR, V11, P493, DOI 10.1016/S1044-0305(00)00114-8; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luger K, 1999, METHOD ENZYMOL, V304, P3; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Neal KC, 2000, BBA-GENE STRUCT EXPR, V1490, P170, DOI 10.1016/S0167-4781(99)00211-0; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Owen-Hughes T, 1999, METH MOL B, V119, P319; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; VAQUERO A, 2002, SCI AGING KNOWLEDGE, pRE4; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang KL, 2002, MOL CELL PROTEOMICS, V1, P500, DOI 10.1074/mcp.M200031-MCP200	51	507	549	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					873	885		10.1016/j.cell.2005.04.031	http://dx.doi.org/10.1016/j.cell.2005.04.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960975	Bronze			2022-12-24	WOS:000230011200010
J	McClenahan, J				McClenahan, J			A good man	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											McClenahan, J (corresponding author), 413 Stuart Circle,Apartment B2, Richmond, VA 23220 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2005	142	11					944	945		10.7326/0003-4819-142-11-200506070-00016	http://dx.doi.org/10.7326/0003-4819-142-11-200506070-00016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932LX	15941705				2022-12-24	WOS:000229556300012
J	Cliffe, LJ; Humphreys, NE; Lane, TE; Potten, CS; Booth, C; Grencis, RK				Cliffe, LJ; Humphreys, NE; Lane, TE; Potten, CS; Booth, C; Grencis, RK			Accelerated intestinal epithelial cell turnover: A new mechanism of parasite expulsion	SCIENCE			English	Article							TRICHURIS-MURIS; INFECTION; RESISTANCE; IL-13; MICE	The functional integrity of the intestinal epithelial barrier forms a major defense against invading pathogens, including gastrointestinal-dwelting nematodes, which are ubiquitous in their distribution worldwide. Here, we show that an increase in the rate of epithelial. cell turnover in the large intestine acts like an "epithelia[ escalator" to expel Trichuris and that the rate of epithelial cell movement is under immune control by the cytokine interieukin-13 and the chemokine CXCL10. This host protective mechanism against intestinal pathogens has implications for our wider understanding of the multifunctional role played by intestinal epithelium in mucosal defense.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Epistem Ltd, Manchester M13 9XX, Lancs, England	University of Manchester; University of California System; University of California Irvine	Grencis, RK (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	Richard.K.Grencis@manchester.ac.uk	Eckhardt, Erik/G-1567-2010		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Artis D, 1999, EXP PARASITOL, V92, P144, DOI 10.1006/expr.1999.4407; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Bancroft AJ, 1998, J IMMUNOL, V160, P3453; Betts CJ, 1999, PARASITE IMMUNOL, V21, P45, DOI 10.1046/j.1365-3024.1999.00200.x; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; Koyama K, 2002, PARASITE IMMUNOL, V24, P527, DOI 10.1046/j.1365-3024.2002.00497.x; LEE TDG, 1983, INT J PARASITOL, V13, P349, DOI 10.1016/S0020-7519(83)80039-3; MacDonald TT, 2003, INT J MED MICROBIOL, V293, P87, DOI 10.1078/1438-4221-00247; Montresor A., 2002, HELMINTH CONTROL SCH; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1	12	307	315	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1463	1465		10.1126/science.1108661	http://dx.doi.org/10.1126/science.1108661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933199				2022-12-24	WOS:000229619300052
J	Mahawar, KK				Mahawar, KK			Misguided enthusiasm	LANCET			English	Editorial Material									Arrowe Pk Hosp, Wirral CH49 5PE, Merseyside, England		Mahawar, KK (corresponding author), Arrowe Pk Hosp, Wirral CH49 5PE, Merseyside, England.	kamal_mahawat@hotmail.com	Mahawar, Kamal/L-1884-2019	Mahawar, Kamal/0000-0003-2551-3462					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2005	365	9474					1901	1901		10.1016/S0140-6736(05)66624-X	http://dx.doi.org/10.1016/S0140-6736(05)66624-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931JK	15924989				2022-12-24	WOS:000229481400031
J	Ward, H; Cassell, J; Williams, S; Aylin, P				Ward, H; Cassell, J; Williams, S; Aylin, P			Dr Foster's case notes - Hospital indicators of poor sexual health	BRITISH MEDICAL JOURNAL			English	Article									Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Ward, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Ward, Helen/A-1836-2009; Aylin, Paul/A-1073-2014	Ward, Helen/0000-0001-8238-5036; Aylin, Paul/0000-0003-4589-1743; Cassell, Jackie/0000-0003-0777-0385				Department of Health, 2004, CHOOS HLTH MAK HLTH; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; Sowter MC, 2001, BRIT J OBSTET GYNAEC, V108, P204, DOI 10.1111/j.1471-0528.2001.00037.x; 2004, FOCUS PREVENTION HIV	4	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 21	2005	330	7501					1173	+		10.1136/bmj.330.7501.1173	http://dx.doi.org/10.1136/bmj.330.7501.1173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929CU	15905255	Green Published			2022-12-24	WOS:000229320500014
J	Charras, GT; Yarrow, JC; Horton, MA; Mahadevan, L; Mitchison, TJ				Charras, GT; Yarrow, JC; Horton, MA; Mahadevan, L; Mitchison, TJ			Non-equilibration of hydrostatic pressure in blebbing cells	NATURE			English	Article							MEMBRANE; EXTENSION; MIGRATION; MOTILITY; KINASE; FLOW	Current models for protrusive motility in animal cells focus on cytoskeleton-based mechanisms, where localized protrusion is driven by local regulation of actin biochemistry(1-3). In plants and fungi, protrusion is driven primarily by hydrostatic pressure(4-6). For hydrostatic pressure to drive localized protrusion in animal cells(7,8), it would have to be locally regulated, but current models treating cytoplasm as an incompressible viscoelastic continuum(9) or viscous liquid(10) require that hydrostatic pressure equilibrates essentially instantaneously over the whole cell. Here, we use cell blebs as reporters of local pressure in the cytoplasm. When we locally perfuse blebbing cells with cortex-relaxing drugs to dissipate pressure on one side, blebbing continues on the untreated side, implying non-equilibration of pressure on scales of approximately 10 mu m and 10 s. We can account for localization of pressure by considering the cytoplasm as a contractile, elastic network infiltrated by cytosol. Motion of the fluid relative to the network generates spatially heterogeneous transients in the pressure field, and can be described in the framework of poroelasticity(11,12).	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; UCL, London Ctr Nanotechnol, London WC1E 6JF, England; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; University of London; University College London; Harvard University; Harvard University	Charras, GT (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	gcharras@hms.harvard.edu	Charras, Guillaume/F-8571-2014	Charras, Guillaume/0000-0002-7902-0279	NIGMS NIH HHS [R01 GM048027] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048027] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBRECHTBUEHLER G, 1981, COLD SPRING HARB SYM, V46, P45; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Boal D. H., 2002, MECH CELL; Burton K, 1997, NATURE, V385, P450, DOI 10.1038/385450a0; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Drury JL, 1999, BIOPHYS J, V76, P110, DOI 10.1016/S0006-3495(99)77183-3; EVANS E, 1984, J CELL BIOL, V98, P1201, DOI 10.1083/jcb.98.4.1201; FISHKIND DJ, 1991, J CELL BIOL, V114, P967, DOI 10.1083/jcb.114.5.967; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Harold FM, 2002, FUNGAL GENET BIOL, V37, P271, DOI 10.1016/S1087-1845(02)00528-5; Mahadevan L, 2000, SCIENCE, V288, P95, DOI 10.1126/science.288.5463.95; Messerli MA, 2003, PLANTA, V217, P147, DOI 10.1007/s00425-003-0972-0; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; MONEY NP, 1992, P NATL ACAD SCI USA, V89, P4245, DOI 10.1073/pnas.89.10.4245; O'Connell CB, 2001, CURR BIOL, V11, P702, DOI 10.1016/S0960-9822(01)00181-6; POPOV S, 1993, SCIENCE, V259, P244, DOI 10.1126/science.7678471; Rafelski SM, 2004, ANNU REV BIOCHEM, V73, P209, DOI 10.1146/annurev.biochem.73.011303.073844; Takayama S, 2003, CHEM BIOL, V10, P123, DOI 10.1016/S1074-5521(03)00019-X; TILNEY LG, 1985, J CELL BIOL, V100, P1273, DOI 10.1083/jcb.100.4.1273; TRINKAUS JP, 1973, DEV BIOL, V30, P68, DOI 10.1016/0012-1606(73)90049-3; Wang H.F., 2000, PRI SER GEO; Yarrow JC, 2005, CHEM BIOL, V12, P385, DOI 10.1016/j.chembiol.2005.01.015; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	29	457	469	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					365	369		10.1038/nature03550	http://dx.doi.org/10.1038/nature03550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902261	Green Accepted			2022-12-24	WOS:000229185000049
J	Pop, VJ; Vulsma, T				Pop, VJ; Vulsma, T			Maternal hypothyroxinaemia during (early) gestation	LANCET			English	Editorial Material							SUBCLINICAL THYROID-DYSFUNCTION; CLINICAL ENDOCRINOLOGISTS; AMERICAN ASSOCIATION; JOINT STATEMENT; FOLLOW-UP; PREGNANCY; DEFICIENCY; MANAGEMENT; DISORDERS		Tilburg Univ, Dept Clin Hlth Psychol, NL-5000 LE Tilburg, Netherlands; Univ Amsterdam, Emma Childrens Hosp AMC, Dept Paediat Endocrinol, Amsterdam, Netherlands	Tilburg University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Pop, VJ (corresponding author), Tilburg Univ, Dept Clin Hlth Psychol, NL-5000 LE Tilburg, Netherlands.	v.j.m.pop@uvt.nl						de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Mandel SJ, 2005, THYROID, V15, P44, DOI 10.1089/thy.2005.15.44; Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Utiger RD, 1999, NEW ENGL J MED, V341, P601, DOI 10.1056/NEJM199908193410809; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vermiglio F, 2004, J CLIN ENDOCR METAB, V89, P6054, DOI 10.1210/jc.2004-0571; ZIMMERMANN M, 2005, P WHO TECHN CONS CON	10	34	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1604	1606		10.1016/S0140-6736(05)66489-6	http://dx.doi.org/10.1016/S0140-6736(05)66489-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885283	Green Submitted			2022-12-24	WOS:000228933700008
J	Adolfsson, J; Mansson, R; Buza-Vidas, N; Hultquist, A; Liuba, K; Jensen, CT; Bryder, D; Yang, LP; Borge, OJ; Thoren, LAM; Anderson, K; Sitnicka, E; Sasaki, Y; Sigvardsson, M; Jacobsen, SEW				Adolfsson, J; Mansson, R; Buza-Vidas, N; Hultquist, A; Liuba, K; Jensen, CT; Bryder, D; Yang, LP; Borge, OJ; Thoren, LAM; Anderson, K; Sitnicka, E; Sasaki, Y; Sigvardsson, M; Jacobsen, SEW			Identification of Flt3(+) lympho-myeloid stem cells lacking erythro-megakaryocytic potential: A revised road map for adult blood lineage commitment	CELL			English	Article							HEMATOPOIETIC PROGENITOR CELLS; MOUSE BONE-MARROW; SELF-RENEWAL; B-CELL; TRANSCRIPTION FACTORS; REPOPULATING ACTIVITY; DENDRITIC CELLS; DEFICIENT MICE; FETAL LIVER; IN-VITRO	All blood cell lineages derive from a common hematopoietic stem cell (HSC). The current model implicates that the first lineage commitment step of adult pluripotent HSCs results in a strict separation into common lymphoid and common myeloid precursors. We present evidence for a population of cells which, although sustaining a high proliferative and combined lympho-myeloid differentiation potential, have lost the ability to adopt erythroid and megakaryocyte lineage fates. Cells in the Lin-Sca-1+c-kit+ HSC compartment coexpressing high levels of the tyrosine kinase receptor Flt3 sustain granulocyte, monocyte, and B and T cell potentials but in contrast to Lin-Sca-1(+)ckit(+)Flt3(-) HSCs fail to produce significant erythroid and megakaryocytic progeny. This distinct lineage restriction site is accompanied by downregulation of genes for regulators of erythroid and megakaryocyte development. In agreement with representing a lymphoid primed progenitor, Lin(-)Sca-l(+)c-kit(+)CD34(+)Flt3(+) cells display upregulated IL-7 receptor gene expression. Based on these observations, we propose a revised road map for adult blood lineage development.	Lund Univ, Hematopoiet Stem Cell Lab, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, S-22184 Lund, Sweden	Lund University	Jacobsen, SEW (corresponding author), Lund Univ, Hematopoiet Stem Cell Lab, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, S-22184 Lund, Sweden.	sten.jacobsen@med.lu.se	Jacobsen, Sten Eirik W/D-3974-2018; Bryder, David/Q-6292-2019; Mansson, Robert/D-4372-2014	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Mansson, Robert/0000-0003-0738-0328; Hultquist, Anne/0000-0003-4355-230X; Bryder, David/0000-0002-8761-4237; Sigvardsson, Mikael/0000-0001-8527-7276				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Cumano A, 2001, CURR OPIN IMMUNOL, V13, P166, DOI 10.1016/S0952-7915(00)00200-4; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Delassus S, 1999, BLOOD, V94, P1495, DOI 10.1182/blood.V94.5.1495.417a08_1495_1503; Ema H, 2003, CURR OPIN GENET DEV, V13, P508, DOI 10.1016/j.gde.2003.08.011; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Hansen JD, 1998, IMMUNOL REV, V166, P199, DOI 10.1111/j.1600-065X.1998.tb01264.x; HARRISON DE, 1988, P NATL ACAD SCI USA, V85, P822, DOI 10.1073/pnas.85.3.822; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; KEMPF RA, 1980, INT J RADIAT ONCOL, V6, P252, DOI 10.1016/0360-3016(80)90047-4; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Lu M, 2002, J IMMUNOL, V169, P3519, DOI 10.4049/jimmunol.169.7.3519; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; METCALF D, 1993, BLOOD, V82, P3515; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; NAKAHATA T, 1982, J CELL PHYSIOL, V113, P455, DOI 10.1002/jcp.1041130314; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; OGAWA M, 1993, BLOOD, V81, P2844; Orkin S H, 1998, Stem Cells, V16 Suppl 2, P79; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; Veiby OP, 1996, BLOOD, V88, P1256, DOI 10.1182/blood.V88.4.1256.bloodjournal8841256; Vieira Paulo, 2004, Methods Mol Biol, V271, P67; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; WHITNEY JB, 1978, BIOCH GENET, V271, P67; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	54	873	893	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					295	306		10.1016/j.cell.2005.02.013	http://dx.doi.org/10.1016/j.cell.2005.02.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851035	Bronze			2022-12-24	WOS:000228705000016
J	Brandes, M; Willimann, K; Moser, B				Brandes, M; Willimann, K; Moser, B			Professional antigen-presentation function by human gamma delta T cells	SCIENCE			English	Article							ADAPTIVE IMMUNE-RESPONSE; DENDRITIC CELLS; IN-VIVO; ACTIVATION; RECEPTOR; IMMUNOTHERAPY; RECOGNITION; COMPLEX; SYSTEM; CANCER	Human gamma delta T cells are considered to play a vital role in protective immunity through cytokine secretion and cytotoxic activity. We report that cells expressing the V delta 2V delta 2(+)-T cell receptor (V delta 2(+) T cells) also display principal characteristics of professional antigen-presenting cells such as dendritic cells. Thus, when activated, these cells efficiently processed and displayed antigens and provided co-stimulatory signals sufficient for strong induction of naive alpha beta T cell proliferation and differentiation. We suggest that, upon microbial activation, V delta 2(+) T cells participate in the induction of adaptive immune responses and that these cells may be a useful tool in vaccine development and immunotherapy.	Japan Sci & Technol Agcy, Int Cooperat Res Project, Quantum Spin Informat Project, Atsugi, Kanagawa 2430198, Japan; Harvard Univ, Ctr Nanoscale Syst, Cambridge, MA 02138 USA; Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1130033, Japan	Japan Science & Technology Agency (JST); Harvard University; University of Tokyo	Moser, B (corresponding author), Japan Sci & Technol Agcy, Int Cooperat Res Project, Quantum Spin Informat Project, Morinosato Wakamiya 3-1, Atsugi, Kanagawa 2430198, Japan.	bernhard.moser@izb.unibe.ch		Moser, Bernhard/0000-0002-4354-4572				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Brandes M, 2003, BLOOD, V102, P3693, DOI 10.1182/blood-2003-04-1016; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chen ZW, 2003, TRENDS IMMUNOL, V24, P213, DOI 10.1016/S1471-4906(03)00032-2; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Germain RN, 2004, CURR OPIN IMMUNOL, V16, P120, DOI 10.1016/j.coi.2003.11.001; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; INABA K, 1989, J EXP MED, V170, P527, DOI 10.1084/jem.170.2.527; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Langenkamp A, 2002, EUR J IMMUNOL, V32, P2046, DOI 10.1002/1521-4141(200207)32:7<2046::AID-IMMU2046>3.0.CO;2-M; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Leslie DS, 2002, J EXP MED, V196, P1575, DOI 10.1084/jem.20021515; Morita CT, 2000, SPRINGER SEMIN IMMUN, V22, P191, DOI 10.1007/s002810000042; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; Petersen TR, 2004, INT IMMUNOL, V16, P889, DOI 10.1093/intimm/dxh098; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; WYMANN MP, 1990, J BIOL CHEM, V265, P619	35	483	524	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					264	268		10.1126/science.1110267	http://dx.doi.org/10.1126/science.1110267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	15933162				2022-12-24	WOS:000230449800034
J	Hinnerwisch, J; Fenton, WA; Furtak, KJ; Farr, GW; Horwich, AL				Hinnerwisch, J; Fenton, WA; Furtak, KJ; Farr, GW; Horwich, AL			Loops in the central channel of ClpA chaperone mediate protein binding, unfolding, and translocation	CELL			English	Article							SPECIFICITY-ENHANCING FACTOR; MOLECULAR CHAPERONE; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; HSP100 CHAPERONE; DEGRADATION; PROTEASES; ATPASE; PORE	The cylindrical Hsp100 chaperone CipA mediates ATP-dependent unfolding of substrate proteins bearing "tag" sequences, such as the 11-residue ssrA sequence appended to proteins translationally stalled at ribosomes. Unfolding is coupled to translocation through a central channel into the associating protease, ClpP. To explore the topology and mechanism of ClpA action, we carried out chemical crosslinking and functional studies. Whereas a tag from RepA protein crosslinked proximally to the flexible N domains, the ssrA sequence in GFP-ssrA crosslinked distally in the channel to a segment of the distal ATPase domain (D2). Single substitutions placed in this D2 loop, and also in two apparently cooperating proximal (D1) loops, abolished binding of ssrA substrates and unfolded proteins lacking tags and blocked unfolding of GFP-RepA. Additionally, a substitution adjoining the D2 loop allowed binding of ssrA proteins but impaired their translocation. This loop, as in homologous nucleic-acid translocases, may bind substrates proximally and, coupled with ATP hydrolysis, translocate them distally, exerting mechanical force that mediates unfolding.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Yale University; Howard Hughes Medical Institute; Yale University; Scripps Research Institute	Horwich, AL (corresponding author), Yale Univ, Sch Med, Dept Genet, 295 Congress Ave, New Haven, CT 06510 USA.	horwich@csb.yale.edu						DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoskins JR, 2002, ADV PROTEIN CHEM, V59, P413; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; HUANG GS, 1995, P NATL ACAD SCI USA, V92, P6878, DOI 10.1073/pnas.92.15.6878; Ishikawa T, 2004, J STRUCT BIOL, V146, P180, DOI 10.1016/j.jsb.2003.11.018; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kim DY, 2003, J BIOL CHEM, V278, P50664, DOI 10.1074/jbc.M305882200; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Levchenko I, 2003, MOL CELL, V12, P365, DOI 10.1016/j.molcel.2003.08.014; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Piszczek G, 2005, J BIOL CHEM, V280, P12221, DOI 10.1074/jbc.M411733200; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; SINGH SK, 1994, J BIOL CHEM, V269, P29537; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Song HK, 2003, MOL CELL, V12, P75, DOI 10.1016/S1097-2765(03)00271-5; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	33	190	190	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1029	1041		10.1016/j.cell.2005.04.012	http://dx.doi.org/10.1016/j.cell.2005.04.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989953	Bronze			2022-12-24	WOS:000230448000010
J	Hunte, C; Screpanti, E; Venturi, M; Rimon, A; Padan, E; Michel, H				Hunte, C; Screpanti, E; Venturi, M; Rimon, A; Padan, E; Michel, H			Structure of a Na+/H+ antiporter and insights into mechanism of action and regulation by pH	NATURE			English	Article							DEPENDENT CONFORMATIONAL-CHANGE; ESCHERICHIA-COLI; GLYCEROL-3-PHOSPHATE TRANSPORTER; PLASMA-MEMBRANE; NHAA; PROTEIN; PROTON; ARABIDOPSIS; EXCHANGER; ANGSTROM	The control by Na+/ H+ antiporters of sodium/proton concentration and cell volume is crucial for the viability of all cells. Adaptation to high salinity and/or extreme pH in plants and bacteria or in human heart muscles requires the action of Na+/H+ antiporters. Their activity is tightly controlled by pH. Here we present the crystal structure of pH-downregulated NhaA, the main antiporter of Escherichia coli and many enterobacteria. A negatively charged ion funnel opens to the cytoplasm and ends in the middle of the membrane at the putative ion-binding site. There, a unique assembly of two pairs of short helices connected by crossed, extended chains creates a balanced electrostatic environment. We propose that the binding of charged substrates causes an electric imbalance, inducing movements, that permit a rapid alternating-access mechanism. This ion-exchange machinery is regulated by a conformational change elicited by a pH signal perceived at the entry to the cytoplasmic funnel.	Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany; Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Max Planck Society; Hebrew University of Jerusalem	Hunte, C (corresponding author), Max Planck Inst Biophys, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	carola.hunte@mpibp-frankfurt.mpg.de; etana@vms.huji.ac.il; hartmut.michel@mpibp-frankfurt.mpg.de	Hunte, Carola/E-4071-2015	Hunte, Carola/0000-0002-0826-3986				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; Auer M, 2001, BIOCHEMISTRY-US, V40, P6628, DOI 10.1021/bi010138+; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Engelhardt S, 2002, CIRC RES, V90, P814, DOI 10.1161/01.RES.0000014966.97486.C0; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jencks W P, 1980, Adv Enzymol Relat Areas Mol Biol, V51, P75; Jin J, 2002, J BACTERIOL, V184, P4722, DOI 10.1128/JB.184.17.4722-4732.2002; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KLINGENBERG M, 1985, ADP ATP CARRIER MITO; Krulwich TA, 2001, BBA-BIOENERGETICS, V1505, P158, DOI 10.1016/S0005-2728(00)00285-1; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Myers ML, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P279; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; Rimon A, 2002, BIOCHEMISTRY-US, V41, P14897, DOI 10.1021/bi0261342; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; Rothman A, 1996, J BIOL CHEM, V271, P32288, DOI 10.1074/jbc.271.50.32288; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Venturi M, 2000, J BIOL CHEM, V275, P4734, DOI 10.1074/jbc.275.7.4734; VIITANEN P, 1984, P NATL ACAD SCI-BIOL, V81, P1629, DOI 10.1073/pnas.81.6.1629; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wakabayashi S, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P35; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; West IC, 1997, BBA-REV BIOMEMBRANES, V1331, P213, DOI 10.1016/S0304-4157(97)00007-5; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; ZILBERSTEIN D, 1982, J BIOL CHEM, V257, P3687	50	523	528	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1197	1202		10.1038/nature03692	http://dx.doi.org/10.1038/nature03692			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988517				2022-12-24	WOS:000230140500035
J	Lavados, PM; Sacks, C; Prina, L; Escobar, A; Tossi, C; Araya, F; Feuerhake, W; Galvez, M; Salinas, R; Alvarez, G				Lavados, PM; Sacks, C; Prina, L; Escobar, A; Tossi, C; Araya, F; Feuerhake, W; Galvez, M; Salinas, R; Alvarez, G			Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-year community-based prospective study (PISCIS project)	LANCET			English	Article							ACUTE CEREBROVASCULAR-DISEASE; TRANSIENT ISCHEMIC ATTACKS; RISK-FACTORS; INTRACEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; ETHNIC-DIFFERENCES; SUBTYPES; OXFORDSHIRE; EPIDEMIOLOGY; POPULATION	Background The epidemiology of stroke in Latin-American populations and variation of subtypes between communities are unclear. Our aim was to ascertain prospectively the incidence of first-ever stroke in the predominantly Hispanic-Mestizo population of Iquique, a city in the northern desert region of Chile. Methods We prospectively identified all possible cases of stroke and transient ischaemic attacks between July 1, 2000, and June 30, 2002, from several overlapping sources. Patients were rapidly assessed by two field neurologists. Standard definitions for incident cases, stroke, transient ischaemic attack, pathological type, and infarction subtype were used. All cases identified were adjudicated by at least two stroke neurologists and followed up at 6 months. Incidence rates of first-ever strokes were calculated from the population of Iquique (214 526) according to the national census of 2002. Findings Of 380 cases of stroke identified, 292 were incident. CT scans were done in 267 (91%) patients and the mean time to scan was 2.2 days. The hospital admission rate was 71% (207/292). The overall age-adjusted incidence rate of first-ever stroke was 140.1 per 100 000 (95% CI 124.0-156.2). The incidence rates per 100 000 according to pathological type were: infarcts 87.3, intracerebral haemorrhage 27.6, and subarachnoid haemorrhage 6.2. The 30-day and 6-month case-fatality rates were 23.3% and 33.0%, respectively. Interpretation Our results show incidence rates of stroke similar to those reported in other community studies. Although the proportion of intracerebral haemorrhages was higher than reported in previous studies, the overall incidence was not, which could indicate a slightly lower incidence of ischaemic strokes in this population than in other countries. The prognosis was similar to that found in other population-based studies.	Clin Alemana Santiago, Dept Med, Serv Neurol, Programa Enfermedades Cerebrovasc, Santiago, Chile; Serv Salud Metropolitano Oriente, Inst Neurocirugia, Unidad Neurointens, Santiago, Chile; Univ Chile, Dept Ciencias Neurol, Santiago, Chile; Univ Valparaiso, Dept Med, Unidad Neurol, Valparaiso, Chile; Hosp Reg Iquique, Med Serv, Unidad Neurol, Iquique, Chile; Hosp Salvador, Serv Salud Metropolitano Oriente, Serv Neurol, Santiago, Chile; Serv Salud Metropolitano Oriente, Inst Neurocirugia Invest Cerebr Alfonso Asenjo, Serv Neuroradiol, Santiago, Chile; Inst Salud Publ Chile, Santiago, Chile	Clinica Alemana; Universidad de Chile; Universidad de Valparaiso; Universidad de Chile	Lavados, PM (corresponding author), Clin Alemana Santiago, Dept Med, Serv Neurol, Programa Enfermedades Cerebrovasc, Santiago, Chile.	pablolavados@yahoo.com	Lavados, Pablo M/E-9918-2016	Lavados, Pablo M/0000-0002-9118-9093				AHMAD OB, 2002, AGE STANDARDISATION; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Alvarez G, 1997, REV MED CHILE, V125, P561; BAMFORD J, 1988, J NEUROL NEUROSUR PS, V51, P1373, DOI 10.1136/jnnp.51.11.1373; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bonita R, 1997, STROKE, V28, P758, DOI 10.1161/01.STR.28.4.758; BONITA R, 1993, LANCET, V342, P1470, DOI 10.1016/0140-6736(93)92938-P; Bruno A, 1996, NEUROLOGY, V47, P405, DOI 10.1212/WNL.47.2.405; Bustos P, 2003, REV MED CHILE, V131, P973; Carolei A, 1997, STROKE, V28, P2500, DOI 10.1161/01.STR.28.12.2500; Coull AJ, 2004, STROKE, V35, P2041, DOI 10.1161/01.STR.0000137605.48864.2f; DELBRUTTO OH, 1993, STROKE, V24, P1833, DOI 10.1161/01.STR.24.12.1833; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; DENNIS MS, 1989, STROKE, V20, P333, DOI 10.1161/01.STR.20.3.333; Diaz V, 2003, NEUROEPIDEMIOLOGY, V22, P339, DOI 10.1159/000072923; Ellekjaer H, 1997, STROKE, V28, P2180, DOI 10.1161/01.STR.28.11.2180; Feigin VL, 2004, STROKE, V35, P2045; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; FEIGIN VL, 1995, MAYO CLIN PROC, V70, P847; Frey JL, 1998, STROKE, V29, P29, DOI 10.1161/01.STR.29.1.29; Fustinoni O, 2000, STROKE, V31, P1013, DOI 10.1161/01.STR.31.5.1013; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Hajat C, 2001, STROKE, V32, P37, DOI 10.1161/01.STR.32.1.37; Hankey GJ, 1994, TRANSIENT ISCHAEMIC; HOPPE A, 2004, P 5 WORLD STROK C JU, P199; Hsu RT, 1999, INT J EPIDEMIOL, V28, P853, DOI 10.1093/ije/28.5.853; *INE, 2004, RES CENS 2002; *INE, 2003, CHIL AN EST VIT 2000; Keir SL, 2002, J NEUROL, V249, P1226, DOI 10.1007/s00415-002-0816-z; KEYFITZ N, 1966, HUM BIOL, V38, P309; Kolominsky-Rabas PL, 1998, STROKE, V29, P2501, DOI 10.1161/01.STR.29.12.2501; LAURIA G, 1995, STROKE, V26, P1787, DOI 10.1161/01.STR.26.10.1787; Lavados P, 2000, STROKE, V31, P2789; Lee JW, 2003, LANCET, V362, P2083, DOI 10.1016/S0140-6736(03)15107-0; MEDINA E, 1992, REV MED CHILE, V120, P702; *MIN SAL CHIL, 2003, BAS DAT EGR HOSP DEP; Nogales-Gaete J, 2000, REV MED CHILE, V128, P1227; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sacco RL, 1998, AM J EPIDEMIOL, V147, P259, DOI 10.1093/oxfordjournals.aje.a009445; SACKS C, 1999, P 54 ANN M CHIL SOC, P25; SANDERCOCK PAG, 1989, BRIT MED J, V298, P75, DOI 10.1136/bmj.298.6666.75; Saposnik G, 2003, STROKE, V34, P2103, DOI 10.1161/01.STR.0000088063.74250.DB; Saposnik G, 2000, STROKE, V31, P2385, DOI 10.1161/01.STR.31.10.2385; Sarti C, 2000, STROKE, V31, P1588, DOI 10.1161/01.STR.31.7.1588; Schulz UGR, 2003, STROKE, V34, P2050, DOI 10.1161/01.STR.0000079818.08343.8C; Smadja D, 2001, STROKE, V32, P2741, DOI 10.1161/hs1201.099385; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; TAPIA J, 1992, REV MED CHILE, V120, P1414; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; URAKAMI K, 1987, STROKE, V18, P396, DOI 10.1161/01.STR.18.2.396; Vemmos KN, 2000, J NEUROL NEUROSUR PS, V69, P595, DOI 10.1136/jnnp.69.5.595; Vemmos KN, 1999, STROKE, V30, P363, DOI 10.1161/01.STR.30.2.363; Wardlaw JM, 2003, J NEUROL NEUROSUR PS, V74, P77, DOI 10.1136/jnnp.74.1.77; Warlow CP, 1998, LANCET, V352, pSIII1; WARLOW CP, 2001, STROKE PRACTICAL GUI, P416; Wein TH, 1999, STROKE, V30, P1501, DOI 10.1161/01.STR.30.8.1501; Wolfe CDA, 2002, J NEUROL NEUROSUR PS, V72, P211, DOI 10.1136/jnnp.72.2.211	60	184	196	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2005	365	9478					2206	2215		10.1016/S0140-6736(05)66779-7	http://dx.doi.org/10.1016/S0140-6736(05)66779-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938WT	15978929				2022-12-24	WOS:000230034800031
J	Hohmann, AG; Suplita, RL; Bolton, NM; Neely, MH; Fegley, D; Mangieri, R; Krey, JF; Walker, JM; Holmes, PV; Crystal, JD; Duranti, A; Tontini, A; Mor, M; Tarzia, G; Piomelli, D				Hohmann, AG; Suplita, RL; Bolton, NM; Neely, MH; Fegley, D; Mangieri, R; Krey, JF; Walker, JM; Holmes, PV; Crystal, JD; Duranti, A; Tontini, A; Mor, M; Tarzia, G; Piomelli, D			An endocannabinoid mechanism for stress-induced analgesia	NATURE			English	Article							STIMULUS-EVOKED ACTIVITY; DORSAL-HORN; NEURONS; BRAIN; SUPPRESSION; INHIBITORS; RECEPTORS; LIPASE; ESTERS; FORMS	Acute stress suppresses pain by activating brain pathways that engage opioid or non-opioid mechanisms. Here we show that an opioid-independent form of this phenomenon, termed stress-induced analgesia(1), is mediated by the release of endogenous marijuana-like (cannabinoid) compounds in the brain. Blockade of cannabinoid CB1 receptors in the periaqueductal grey matter of the midbrain prevents non-opioid stress-induced analgesia. In this region, stress elicits the rapid formation of two endogenous cannabinoids, the lipids 2-arachidonoylglycerol(2) (2-AG) and anandamide(3). A newly developed inhibitor of the 2-AG-deactivating enzyme, monoacylglycerol lipase(4,5), selectively increases 2-AG concentrations and, when injected into the periaqueductal grey matter, enhances stress-induced analgesia in a CB1-dependent manner. Inhibitors of the anandamide-deactivating enzyme fatty-acid amide hydrolase(6), which selectively elevate anandamide concentrations, exert similar effects. Our results indicate that the coordinated release of 2-AG and anandamide in the periaqueductal grey matter might mediate opioid-independent stress-induced analgesia. These studies also identify monoacylglycerol lipase as a previously unrecognized therapeutic target.	Univ Georgia, Dept Psychol, Neurosci & Behav Program, Athens, GA 30602 USA; Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Drug Discovery, Irvine, CA 92697 USA; Brown Univ, Dept Psychol, Schrier Res Lab, Providence, RI 02912 USA; Brown Univ, Dept Neurosci, Schrier Res Lab, Providence, RI 02912 USA; Univ Urbino Carlo Bo, Inst Med Chem, I-61029 Urbino, Italy; Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy	University System of Georgia; University of Georgia; University of California System; University of California Irvine; University of California System; University of California Irvine; Brown University; Brown University; University of Urbino; University of Parma	Hohmann, AG (corresponding author), Univ Georgia, Dept Psychol, Neurosci & Behav Program, Athens, GA 30602 USA.	ahohmann@uga.edu; piomelli@uci.edu	Mangieri, Regina/N-1602-2019; Mor, Marco/D-2394-2009	Mangieri, Regina/0000-0002-4499-6183; Mor, Marco/0000-0003-0199-1849				AKIL H, 1986, ANN NY ACAD SCI, V467, P140, DOI 10.1111/j.1749-6632.1986.tb14625.x; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; CANNON JT, 1982, BRAIN RES, V243, P315, DOI 10.1016/0006-8993(82)90255-4; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HOHMANN AG, 1995, LIFE SCI, V56, P2111, DOI 10.1016/0024-3205(95)00196-D; Hohmann AG, 1999, J NEUROPHYSIOL, V81, P575, DOI 10.1152/jn.1999.81.2.575; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; LEWIS JW, 1980, SCIENCE, V208, P623, DOI 10.1126/science.7367889; Martin WJ, 1996, J NEUROSCI, V16, P6601; MARTIN WJ, 1995, LIFE SCI, V56, P2103, DOI 10.1016/0024-3205(95)00195-C; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Meng ID, 1998, NATURE, V395, P381, DOI 10.1038/26481; Mor M, 2004, J MED CHEM, V47, P4998, DOI 10.1021/jm031140x; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Tarzia G, 2003, J MED CHEM, V46, P2352, DOI 10.1021/jm021119g; TERMAN GW, 1986, BRAIN RES, V368, P101, DOI 10.1016/0006-8993(86)91046-2; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Valverde O, 2000, EUR J NEUROSCI, V12, P533, DOI 10.1046/j.1460-9568.2000.00929.x; Vaughan CW, 2000, MOL PHARMACOL, V57, P288; Walker JM, 2005, HANDB EXP PHARMACOL, V168, P509; Walker JM, 1999, P NATL ACAD SCI USA, V96, P12198, DOI 10.1073/pnas.96.21.12198; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	30	558	590	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1108	1112		10.1038/nature03658	http://dx.doi.org/10.1038/nature03658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973410	Green Published			2022-12-24	WOS:000229970400051
J	Tleyjeh, IM; Steckelberg, JM; Murad, HS; Anavekar, NS; Ghomrawi, HMK; Mirzoyev, Z; Moustafa, SE; Hoskin, TL; Mandrekar, JN; Wilson, WR; Baddour, LM				Tleyjeh, IM; Steckelberg, JM; Murad, HS; Anavekar, NS; Ghomrawi, HMK; Mirzoyev, Z; Moustafa, SE; Hoskin, TL; Mandrekar, JN; Wilson, WR; Baddour, LM			Temporal trends in infective endocarditis - A population-based study in Olmsted County, Minnesota	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	54th Annual Scientific Session of the American-College-of-Cardiology	MAR 06-09, 2005	Orlando, FL	Amer Coll Cardiol			PATIENT CHARACTERISTICS; EPIDEMIOLOGY; DIAGNOSIS; MORTALITY; SPECTRUM; CRITERIA; DENMARK; ADULTS	Context Limited data exist regarding population-based epidemiologic changes in incidence of infective endocarditis (IE). Objective To evaluate temporal trends in the incidence and clinical characteristics of I E. Design, Setting, and Patients Population-based survey using the resources of the Rochester Epidemiology Project of Olmsted County, Minnesota. One hundred seven IE episodes occurred in 102 Olmsted County residents between 1970 and 2000. The modified Duke criteria were used to validate the diagnosis of definite or possible IE. Main Outcome Measures Incidence of IE, proportion of patients with underlying heart disease, and causative microorganisms and clinical characteristics. Results Age- and sex-adjusted incidence of, IE ranged from 5.0 to 7.0 cases per 100000 person-years during the study period and did not change significantly over time (P=.42 for trend). Infective endocarditis caused by viridans group streptococci was the most common organism-specific subgroup, with an annual adjusted incidence of 1.7 to 3.5 cases per 100000; in comparison, IE due to Staphylococcus aureus had an annual adjusted incidence of 1.0 to 2.2 cases per 100000. No time trend was detected for either pathogen group (P=.63 and P=.66, respectively). An increasing temporal trend was observed in the proportions of prosthetic valve IE cases (P=.09). Among people with underlying heart disease, there was an increasing temporal trend in mitral valve prolapse (P=.04) and a decreasing trend in rheumatic heart disease (P=.08). However, the absolute numbers were small. There was no time trend in rates of valve surgery or 6-month mortality during the study period (P=.97 and P=.59, respectively). Conclusions In this community-based temporal trend study, we found no substantial change in the incidence of IE over the past 3 decades. Viridans group streptococci continue to outnumber S aureus as the most common causative organisms of IE in this population.	Mayo Clin, Mayo Clin Coll Med, Dept Med, Rochester, MN USA; Mayo Clin, Mayo Clin Coll Med, Div Infect Dis, Rochester, MN USA; Mayo Clin, Mayo Clin Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; Mayo Clin, Mayo Clin Coll Med, Div Biostat, Rochester, MN USA; Univ Illinois, Michael Reese Hosp, Dept Med, Chicago, IL USA; Univ Minnesota, Div Hlth Serv Res & Policy, Minneapolis, MN USA; Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Michael Reese Hospital & Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Ottawa; University of Ottawa Heart Institute	Tleyjeh, IM (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	tleyjeh.imad@mayo.edu		Ghomrawi, Hassan/0000-0003-1291-5278; Tleyjeh, Imad/0000-0002-5551-0353	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59205] Funding Source: Medline; NIAMS NIH HHS [AR30582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAYLISS R, 1986, J ROY COLL PHYS LOND, V20, P15; Benn M, 1997, J INTERN MED, V242, P15, DOI 10.1046/j.1365-2796.1997.00153.x; BERLIN JA, 1995, AM J CARDIOL, V76, P933, DOI 10.1016/S0002-9149(99)80264-1; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Fonager K, 2003, SCAND J INFECT DIS, V35, P27, DOI 10.1080/0036554021000026993; GRIFFIN MR, 1985, JAMA-J AM MED ASSOC, V254, P1199, DOI 10.1001/jama.254.9.1199; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; KING JW, 1988, AM J MED SCI, V295, P517, DOI 10.1097/00000441-198806000-00005; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MCKINSEY DS, 1987, AM J MED, V82, P681, DOI 10.1016/0002-9343(87)90001-5; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; NISSEN H, 1992, EUR HEART J, V13, P872, DOI 10.1093/oxfordjournals.eurheartj.a060285; Roder BL, 1999, ARCH INTERN MED, V159, P462, DOI 10.1001/archinte.159.5.462; STECKELBERG JM, 1990, AM J MED, V88, P582, DOI 10.1016/0002-9343(90)90521-E; Targonski P, 2001, ANN EPIDEMIOL, V11, P264, DOI 10.1016/S1047-2797(00)00220-9; VANDERMEER JTM, 1992, ARCH INTERN MED, V152, P1863, DOI 10.1001/archinte.152.9.1863; VONREYN CF, 1981, ANN INTERN MED, V94, P505, DOI 10.7326/0003-4819-94-4-505; WHITBY M, 1985, INT J CARDIOL, V7, P391, DOI 10.1016/0167-5273(85)90093-2	22	229	241	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2005	293	24					3022	3028		10.1001/jama.293.24.3022	http://dx.doi.org/10.1001/jama.293.24.3022			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937SG	15972564	Bronze			2022-12-24	WOS:000229945200017
J	Scolding, N				Scolding, N			Stem-cell therapy: hope and hype	LANCET			English	Editorial Material							PURKINJE NEURONS; REPAIR		Univ Bristol, Frenchay Hosp, Dept Neurol, Inst Clin Neurosci, Bristol BS16 1LE, Avon, England	University of Bristol	Scolding, N (corresponding author), Univ Bristol, Frenchay Hosp, Dept Neurol, Inst Clin Neurosci, Bristol BS16 1LE, Avon, England.	n.j.scolding@bristol.ac.uk						Blau HM, 2002, NATURE, V419, P437, DOI 10.1038/419437a; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Gussoni E, 2002, J CLIN INVEST, V110, P807, DOI 10.1172/JCI200216098; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; KITE M, 2000, TIMES LOND      1216; Klimanskaya I, 2005, LANCET, V365, P1636, DOI 10.1016/S0140-6736(05)66473-2; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; LAPHAM LW, 1968, SCIENCE, V159, P310, DOI 10.1126/science.159.3812.310; Pochampally RR, 2004, P NATL ACAD SCI USA, V101, P9282, DOI 10.1073/pnas.0401558101; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Rice CM, 2004, LANCET, V364, P193, DOI 10.1016/S0140-6736(04)16633-6; Rice CM, 2003, TRANSFUSION MED, V13, P351, DOI 10.1111/j.1365-3148.2003.00463.x; SAMPLE I, 2004, GUARDIAN        0819; Sigurjonsson OE, 2005, P NATL ACAD SCI USA, V102, P5227, DOI 10.1073/pnas.0501029102; Smith LC, 2004, CLONING STEM CELLS, V6, P126, DOI 10.1089/1536230041372319; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; 2001, LANCET, V358, P163	22	10	11	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2005	365	9477					2073	2075		10.1016/S0140-6736(05)66554-3	http://dx.doi.org/10.1016/S0140-6736(05)66554-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936LZ	15964432				2022-12-24	WOS:000229858800009
J	Scholte, EJ; Ng'habi, K; Kihonda, J; Takken, W; Paaijmans, K; Abdulla, S; Killeen, GF; Knols, BGJ				Scholte, EJ; Ng'habi, K; Kihonda, J; Takken, W; Paaijmans, K; Abdulla, S; Killeen, GF; Knols, BGJ			An entomopathogenic fungus for control of adult African malaria mosquitoes	SCIENCE			English	Article							INSECTICIDE-TREATED NETS; SOUTH-AFRICA	Biological control of malaria mosquitoes in Africa has rarely been used in vector control programs. Recent developments in this field show that certain fungi are virulent to adult Anopheles mosquitoes. Practical delivery of an entomopathogenic fungus that infected and killed adult Anopheles gambiae, Africa's main malaria vector, was achieved in rural African village houses. An entomological inoculation rate model suggests that implementation of this vector control method, even at the observed moderate coverage during a field study in Tanzania, would significantly reduce malaria transmission intensity.	Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands; Ifakara Hlth Res & Dev Ctr, Ifakara, Tanzania; Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; IAEA, Agcy Labs Seibersdorf, A-2444 Seibersdorf, Austria	Wageningen University & Research; Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; International Atomic Energy Agency	Knols, BGJ (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, POB 8031, NL-6700 EH Wageningen, Netherlands.	B.Knols@IAEA.org	Paaijmans, Krijn/ABC-9928-2020					[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Boucias D.G., 1998, PRINCIPLES INSECT PA, P177; Curtis CF, 2000, B WORLD HEALTH ORGAN, V78, P1389; Fillinger U, 2003, TROP MED INT HEALTH, V8, P37, DOI 10.1046/j.1365-3156.2003.00979.x; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hargreaves K, 2003, MED VET ENTOMOL, V17, P417, DOI 10.1111/j.1365-2915.2003.00460.x; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kouznetsov R L, 1977, Trop Doct, V7, P81; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; PAPIEROK B, 2001, P 8 EUR M IOBC WPRS; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Scholte EJ, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-29; SCHOLTE EJ, IN PRESS J INVERTEBR; *WHO, 1993, WHO TECH REP SER, V839; World Health Organization (WHO), 1975, WHO OFFS PUBL, V13	17	254	268	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1641	1642		10.1126/science.1108639	http://dx.doi.org/10.1126/science.1108639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947190				2022-12-24	WOS:000229827000061
J	Wardle, DA; Zackrisson, O				Wardle, DA; Zackrisson, O			Effects of species and functional group loss on island ecosystem properties	NATURE			English	Article							MICROBIAL BIOMASS; CURRENT KNOWLEDGE; PLANT DIVERSITY; MODEL SYSTEMS; PRODUCTIVITY; BIODIVERSITY; COMMUNITIES; RICHNESS; AREA	Considerable recent attention has focused on predicting how the losses of species and functional groups influence ecosystem properties(1,2), but the extent to which these effects vary among ecosystems remains poorly understood(3,4). Island systems have considerable scope for studying how biotic and abiotic factors influence processes in different ecosystems, because they enable the simultaneous study of large numbers of independent replicate systems at ecologically meaningful spatial scales(5-7). We studied a group of 30 islands in northern Sweden, for which island size determined disturbance history, and therefore vegetation successional stage and biotic and abiotic ecosystem properties. On each island we conducted a seven-year study that involved experimental removals of combinations of both plant functional groups and plant species. We show that although losses of functional groups and species often impaired key ecosystem processes, these effects were highly context-dependent and strongly influenced by island size. Our study provides evidence that the consequences of biotic loss for ecosystem functioning vary greatly among ecosystems and depend on the specific abiotic and biotic attributes of the system.	Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, S-90183 Umea, Sweden; Landcare Res, Lincoln 8152, New Zealand	Swedish University of Agricultural Sciences; Landcare Research - New Zealand	Wardle, DA (corresponding author), Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, S-90183 Umea, Sweden.	david.wardle@svek.slu.se	Wardle, David A./F-6031-2011	Wardle, David A./0000-0002-0476-7335				ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Anderson WB, 1999, OECOLOGIA, V118, P324, DOI 10.1007/s004420050733; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Diaz S, 2003, TRENDS ECOL EVOL, V18, P140, DOI 10.1016/S0169-5347(03)00007-7; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gonzalez A, 2002, J ANIM ECOL, V71, P594, DOI 10.1046/j.1365-2656.2002.00625.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mulder CPH, 1999, ECOL LETT, V2, P237; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Schmid B, 2002, TRENDS ECOL EVOL, V17, P113, DOI 10.1016/S0169-5347(01)02422-3; Spiller DA, 1997, OIKOS, V78, P15, DOI 10.2307/3545795; *TECHN IND SYST, 1997, IND SIM DET NITR PHO; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.1890/1051-0761(2002)012[0354:COSHFT]2.0.CO;2; Vitousek PM, 2002, J BIOGEOGR, V29, P573, DOI 10.1046/j.1365-2699.2002.00707.x; Wardle DA, 1998, BIOL REV, V73, P305, DOI 10.1017/S0006323198005192; WARDLE DA, 1993, FUNCT ECOL, V7, P346, DOI 10.2307/2390215; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 2002, J BIOGEOGR, V29, P583, DOI 10.1046/j.1365-2699.2002.00708.x; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; WARDLE DA, 2002, COMMUNICATIES ECOSYS	27	198	218	9	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2005	435	7043					806	810		10.1038/nature03611	http://dx.doi.org/10.1038/nature03611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944702	Green Published			2022-12-24	WOS:000229638700048
J	Summerskill, W				Summerskill, W			Our children, our future	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Summerskill, W (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1914	1914		10.1016/S0140-6736(05)66641-X	http://dx.doi.org/10.1016/S0140-6736(05)66641-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936409				2022-12-24	WOS:000229587800010
J	Lee, SJ; Matsuura, Y; Liu, SM; Stewart, M				Lee, SJ; Matsuura, Y; Liu, SM; Stewart, M			Structural basis for nuclear import complex dissociation by RanGTP	NATURE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; EXPORT; KARYOPHERINS; DOMAIN; BIND	Nuclear protein import is mediated mainly by the transport factor importin-beta that binds cytoplasmic cargo, most often via the importin-alpha adaptor, and then transports it through nuclear pore complexes. This active transport is driven by disassembly of the import complex by nuclear RanGTP(1-4). The switch I and II loops of Ran change conformation with nucleotide state(5-7), and regulate its interactions with nuclear trafficking components. Importin-beta consists of 19 HEAT repeats that are based on a pair of antiparallel alpha-helices ( referred to as the A- and B-helices). The HEAT repeats stack to yield two C-shaped arches, linked together to form a helicoidal molecule that has considerable conformational flexibility(1,8) (-12). Here we present the structure of full-length yeast importin-beta (Kap95p or karyopherin-beta) complexed with RanGTP, which provides a basis for understanding the crucial cargo-release step of nuclear import. We identify a key interaction site where the RanGTP switch I loop binds to the carboxy-terminal arch of Kap95p. This interaction produces a change in helicoidal pitch that locks Kap95p in a conformation that cannot bind importin-alpha or cargo. We suggest an allosteric mechanism for nuclear import complex disassembly by RanGTP.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ms@mrc-lmb.cam.ac.uk						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	23	164	168	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					693	696		10.1038/nature03578	http://dx.doi.org/10.1038/nature03578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15864302				2022-12-24	WOS:000229476200054
J	Lawton, J; Ahmad, N; Hallowell, N; Hanna, L; Douglas, M				Lawton, J; Ahmad, N; Hallowell, N; Hanna, L; Douglas, M			Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICATION; ADHERENCE; KNOWLEDGE; HEALTH	Objective To explore British Pakistani and British. Indian patients' perceptions and experiences of taking oral hypoglycaemic agents (OHAs). Design Observational cross sectional study using in-depth interviews in English or Punjabi. Setting and participants 32 patients of Pakistani and Indian origin with type 2 diabetes, recruited from primary care and community sources in Edinburgh, Scotland. Results Respondents reported complex and ambivalent views about OHAs, which reflected their ambivalent attitudes towards Western drugs in general. Respondents considered OHAs to be an important part of the diabetic regimen because they perceived British healthcare professionals to be competent and trustworthy prescribers, and they considered the medicines available in Britain to be superior to those on the Indian subcontinent. Despite this, some respondents made deliberate efforts to reduce their tablet intake without being advised to do so. Reasons for this included perceptions that drugs worked by providing relief of symptoms and concerns that OHAs could be detrimental to health if taken for long periods, in conjunction with other drugs, or without traditional foods. Conclusions British Pakistani and Indian patients' perceptions of their ORAs may partly derive from popular ideas about drugs on the Indian subcontinent. Cultural factors need to be understood and taken into consideration to ensure that these patients are given appropriate advice and to avoid unnecessary changes to prescriptions.	Univ Edinburgh, Sch Clin Sci & Community Hlth, Res Unit Hlth Behav & Change, Edinburgh EH8 9AG, Midlothian, Scotland; Lothian NHS Board, Edinburgh EH8 9RS, Midlothian, Scotland	University of Edinburgh	Lawton, J (corresponding author), Univ Edinburgh, Sch Clin Sci & Community Hlth, Res Unit Hlth Behav & Change, Edinburgh EH8 9AG, Midlothian, Scotland.	J.Lawton@ed.ac.uk		Douglas, Margaret/0000-0003-1560-5451				Aadil N, 2004, BMJ-BRIT MED J, V329, P778, DOI 10.1136/bmj.329.7469.778; [Anonymous], [No title captured]; BENSON J, 2002, BRIT MED J, V325, P1314; BHOPAL RS, 1988, COMMUNITY MED, V10, P215; Cambridge Jan, 1999, TRANSLATOR, V5, P201, DOI DOI 10.1080/13556509.1999.10799041; CONRAD P, 1985, SOC SCI MED, V20, P29, DOI 10.1016/0277-9536(85)90308-9; DCOSTA FD, 2000, PRACTICAL DIABETES, V8, P64, DOI DOI 10.1002/PDI.1960080208; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Evans JMM, 2002, DIABETIC MED, V19, P685, DOI 10.1046/j.1464-5491.2002.00749.x; Gillam S, 1999, BRIT MED J, V319, P1215, DOI 10.1136/bmj.319.7219.1215; HUNTE PA, 1992, SOC SCI MED, V34, P1385, DOI 10.1016/0277-9536(92)90147-I; Lau DT, 2004, DIABETES CARE, V27, P2149, DOI 10.2337/diacare.27.9.2149; McLean CA, 2003, ETHNIC HEALTH, V8, P41, DOI 10.1080/13557850303558; Miller N H, 1997, Am J Med, V102, P43; NICHTER N, 1996, ANTHR INT HLTH ASIAN; Pardhan S, 2004, EYE, V18, P509, DOI 10.1038/sj.eye.6700680; Ponnusankar S, 2004, PATIENT EDUC COUNS, V54, P55, DOI 10.1016/s0738-3991(03)00193-9; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; QIDWAI W, 2002, JCPSP-J COLL PHYSICI, V12, P651; Saradamma RD, 2000, SOC SCI MED, V50, P891, DOI 10.1016/S0277-9536(99)00380-9; Sin CH, 2004, AGEING SOC, V24, P257, DOI 10.1017/S0144686X03001545; Strauss A., 1990, BASICS QUALITATIVE R; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; tain RPS of G, 1997, COMPLIANCE CONCORDAN	24	68	69	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2005	330	7502					1247	1249		10.1136/bmj.38460.642789.E0	http://dx.doi.org/10.1136/bmj.38460.642789.E0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930WX	15883139	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000229448900019
J	Gilbert, M; Mitchell, A; Bourn, D; Mawdsley, J; Cliton-Hadley, R; Wint, W				Gilbert, M; Mitchell, A; Bourn, D; Mawdsley, J; Cliton-Hadley, R; Wint, W			Cattle movements and bovine tuberculosis in Great Britain	NATURE			English	Article							DISEASE; PREDICTION; EPIDEMIC; DYNAMICS	For 20 years, bovine tuberculosis (BTB) has been spreading in Great Britain ( England, Wales and Scotland) and is now endemic in the southwest and parts of central England and in southwest Wales, and occurs sporadically elsewhere. Although its transmission pathways remain poorly understood, the disease's distribution was previously modelled statistically by using environmental variables and measures of their seasonality(1). Movements of infected animals have long been considered a critical factor in the spread of livestock diseases, as reflected in strict import/export regulations, the extensive movement restrictions imposed during the 2001 foot-and-mouth disease outbreak(2,3), the tracing procedures after a new case of BTB has been confirmed and the Government's recently published strategic framework for the sustainable control on BTB4. Since January 2001 it has been mandatory for stock-keepers in Great Britain to notify the British Cattle Movement Service of all cattle births, movements and deaths(5). Here we show that movements as recorded in the Cattle Tracing System data archive, and particularly those from areas where BTB is reported, consistently outperform environmental, topographic and other anthropogenic variables as the main predictor of disease occurrence. Simulation distribution models for 2002 and 2003, incorporating all predictor categories, are presented and used to project distributions for 2004 and 2005.	Environm Res Grp Oxford Ltd, Oxford OX1 3QE, England; Univ Libre Bruxelles, B-1050 Brussels, Belgium; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England	Universite Libre de Bruxelles; Veterinary Laboratories Agency	Wint, W (corresponding author), Environm Res Grp Oxford Ltd, POB 346, Oxford OX1 3QE, England.	william.wint@zoo.ox.ac.uk	Clifton-Hadley, Richard S/C-2503-2011; Mitchell, Andrew P/L-6141-2014; Gilbert, Marius/C-6969-2009	Gilbert, Marius/0000-0003-3708-3359; Wint, William/0000-0003-0916-0847				BOURNE FJ, 2001, EPIDEMIOLOGICAL INVE; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Defra, 2005, GOV STRAT FRAM SUST; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Hay SI, 1999, TROP MED INT HEALTH, V4, P58, DOI 10.1046/j.1365-3156.1999.00355.x; HAY SI, 2000, ADV PARASITOLOGY, V47; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P121, DOI 10.1098/rspb.2002.2191; Hengeveld R., 1989, DYNAMICS BIOL INVASI; Krebs J., 1997, PB3423 HMSO; Mitchell A, 2005, ANIM SCI, V80, P265, DOI 10.1079/ASC50020265; *NAO, 2003, ID TRACK LIV ENGL; Russell CA, 2004, P ROY SOC B-BIOL SCI, V271, P21, DOI 10.1098/rspb.2003.2559; Shigesada N, 1997, BIOL INVASIONS THEOR; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Wint GRW, 2002, TRENDS MICROBIOL, V10, P441, DOI 10.1016/S0966-842X(02)02444-7	17	270	272	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					491	496		10.1038/nature03548	http://dx.doi.org/10.1038/nature03548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917808	Green Published			2022-12-24	WOS:000229337800054
J	Kepinski, S; Leyser, O				Kepinski, S; Leyser, O			The Arabidopsis F-box protein TIR1 is an auxin receptor	NATURE			English	Article							AUX/IAA PROTEINS; SCF; DEGRADATION; GENETICS; GROWTH; GENES	Despite 100 years of evidence showing a pivotal role for indole-3-acetic acid (IAA or auxin) in plant development, the mechanism of auxin perception has remained elusive. Central to auxin response are changes in gene expression, brought about by auxin-induced interaction between the Aux/IAA transcriptional repressor proteins and the ubiquitin - ligase complex SCFTIR1, thus targeting for them proteolysis. Regulated SCF-mediated protein degradation is a widely occurring signal transduction mechanism. Target specificity is conferred by the F-box protein subunit of the SCF (TIR1 in the case of Aux/IAAs) and there are multiple F-box protein genes in all eukaryotic genomes examined so far. Although SCF - target interaction is usually regulated by signal-induced modification of the target, we have previously shown that auxin signalling involves the modification of SCFTIR1. Here we show that this modification involves the direct binding of auxin to TIR1 and thus that TIR1 is an auxin receptor mediating transcriptional responses to auxin.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; SLU, Umea Plant Sci Ctr, S-90183 Umea, Sweden	University of York - UK; Swedish University of Agricultural Sciences; Umea University	Kepinski, S (corresponding author), Univ York, Dept Biol, Box 373, York YO10 5YW, N Yorkshire, England.	ssk2@york.ac.uk; hmol1@york.ac.uk	Leyser, Ottoline/AAC-5577-2019	Leyser, Ottoline/0000-0003-2161-3829	Biotechnology and Biological Sciences Research Council [BBS/B/09392] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Berleth T, 2004, CURR OPIN PLANT BIOL, V7, P553, DOI 10.1016/j.pbi.2004.07.016; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Gray WM, 2002, PLANT CELL, V14, P2137, DOI 10.1105/tpc.003178; Isaacs HV, 1998, EMBO J, V17, P3413, DOI 10.1093/emboj/17.12.3413; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Leyser O, 2002, ANNU REV PLANT BIOL, V53, P377, DOI 10.1146/annurev.arplant.53.100301.135227; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Tian Q, 2003, PLANT J, V36, P643, DOI 10.1046/j.1365-313X.2003.01909.x; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Yang XQ, 2004, PLANT J, V40, P772, DOI 10.1111/j.1365-313X.2004.02254.x; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	30	1186	1327	10	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					446	451		10.1038/nature03542	http://dx.doi.org/10.1038/nature03542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917798				2022-12-24	WOS:000229337800044
J	Essers, MAG; de Vries-Smits, LMM; Barker, N; Polderman, PE; Burgering, BMT; Korswagen, HC				Essers, MAG; de Vries-Smits, LMM; Barker, N; Polderman, PE; Burgering, BMT; Korswagen, HC			Functional interaction between beta-catenin and FOXO in oxidative stress signaling	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; FORKHEAD TRANSCRIPTION FACTORS; CELL-CYCLE; C-ELEGANS; GENE-EXPRESSION; DAF-16; ACTIVATION; PATHWAY; RAS	beta-Catenin is a multifunctional protein that mediates Writ signaling by binding to members of the T cell factor (TCF) family of transcription factors. Here, we report an evolutionarily conserved interaction of beta-catenin with FOXO transcription factors, which are regulated by insulin and oxidative stress signaling. beta-Catenin binds directly to FOXO and enhances FOXO transcriptional activity in mammalian cells. In Caenorhabditis elegans, loss of the beta-catenin BAR-1 reduces the activity of the FOXO ortholog DAF-16 in dauer formation and life span. Association of beta-catenin with FOXO was enhanced in cells exposed to oxidative stress. Furthermore, BAR-1 was required for the oxidative stress-induced expression of the DAF-16 target gene sod-3 and for resistance to oxidative damage. These results demonstrate a role for beta-catenin in regulating FOXO function that is particularly important under conditions of oxidative stress.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; Univ Med Ctr, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Univ Med Ctr, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Burgering, BMT (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	b.m.t.burgering@med.uu.nl; rkors@niob.knaw.nl	Barker, Nick/AAE-9833-2021; Barker, Nick/A-5535-2011; Korswagen, Hendrik/I-8782-2012; Essers, Marieke A.G./B-7758-2017; Barker, Nick/AAS-2774-2020	Barker, Nick/0000-0003-3566-4475; Essers, Marieke A.G./0000-0003-3117-1809; 				Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; ESSERS MA, UNPUB; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Tissenbaum HA, 2002, DEV CELL, V2, P9, DOI 10.1016/S1534-5807(01)00098-3; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	20	583	618	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1181	1184		10.1126/science.1109083	http://dx.doi.org/10.1126/science.1109083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905404				2022-12-24	WOS:000229293400047
J	Hao, ZY; Duncan, GS; Chang, CC; Elia, A; Fang, M; Wakeham, A; Okada, H; Calzascia, T; Jang, YJ; Annick, YT; Yeh, WC; Ohashi, P; Wang, XD; Mak, TW				Hao, ZY; Duncan, GS; Chang, CC; Elia, A; Fang, M; Wakeham, A; Okada, H; Calzascia, T; Jang, YJ; Annick, YT; Yeh, WC; Ohashi, P; Wang, XD; Mak, TW			Specific ablation of the apoptotic functions of cytochrome c reveals a differential requirement for cytochrome c and apaf-1 in apoptosis	CELL			English	Article							FAMILY MEMBER BIM; CELL-DEATH; PARAVENTRICULAR NUCLEUS; CASPASE ACTIVATION; GROWTH-HORMONE; FACTOR BRN-2; FACTOR-I; MICE; DEFICIENCY; BAX	As components of the apoptosome, a caspase-activating complex, cytochrome c (Cyt c) and Apaf-1 are thought to play critical roles during apoptosis. Due to the obligate function of Cyt c in electron transport, its requirement for apoptosis in animals has been difficult to establish. We generated "knockin" mice expressing a mutant Cyt c (KA allele), which retains normal electron transfer function but fails to activate Apaf-1. Most KA/KA mice displayed embryonic or perinatal lethality caused by defects in the central nervous system, and surviving mice exhibited impaired lymphocyte homeostasis. Although fibroblasts from the KA/KA mice were resistant to apoptosis, their thymocytes were markedly more sensitive to death stimuli than Apaf-1(-/-) thymocytes. Upon treatment with gamma irradiation, procaspases were efficiently activated in apoptotic KA/KA thymocytes, but Apaf-1 oligomerization was not observed. These studies indicate the existence of a Cyt c- and apoptosome-independent but Apaf-1-dependent mechanism(s) for caspase activation.	Univ Toronto, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Univ Hlth Network, Toronto, ON, Canada; Univ Toronto, Dept Immunol, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hao, ZY (corresponding author), Univ Toronto, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada.	zyhao@uhnres.utoronto.ca; tmak@uhnres.utoronto.ca	Duncan, Gordon/AIE-7011-2022	Chang, Chia-Che/0000-0003-3509-3713; Wang, Xiaodong/0000-0001-9885-356X; Calzascia, Thomas/0000-0001-8225-6744; Ohashi, Pamela S./0000-0003-2915-9317	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057158] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM R01 57158] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Buller KM, 2003, NEUROSCIENCE, V118, P189, DOI 10.1016/S0306-4522(02)00808-4; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dorshkind K, 2000, ENDOCR REV, V21, P292, DOI 10.1210/er.21.3.292; Dorshkind K, 2003, CLIN IMMUNOL, V109, P197, DOI 10.1016/S1521-6616(03)00181-5; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hefco V, 2004, BRAIN BEHAV IMMUN, V18, P158, DOI 10.1016/S0889-1591(03)00114-4; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kluck RM, 2000, J BIOL CHEM, V275, P16127, DOI 10.1074/jbc.275.21.16127; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; RATHMELL JC, 2002, CELL S, V109, P97; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Wrona D, 2003, BRAIN BEHAV IMMUN, V17, P453, DOI 10.1016/S0889-1591(03)00065-5; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	46	208	225	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					579	591		10.1016/j.cell.2005.03.016	http://dx.doi.org/10.1016/j.cell.2005.03.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907471	Bronze			2022-12-24	WOS:000229331200014
J	Youngren, KK; Coveney, D; Peng, XN; Bhattacharya, C; Schmidt, LS; Nickerson, ML; Lamb, BT; Deng, JM; Behringer, RR; Capel, B; Rubin, EM; Nadeau, JH; Matin, A				Youngren, KK; Coveney, D; Peng, XN; Bhattacharya, C; Schmidt, LS; Nickerson, ML; Lamb, BT; Deng, JM; Behringer, RR; Capel, B; Rubin, EM; Nadeau, JH; Matin, A			The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours	NATURE			English	Article							RNA-BINDING PROTEIN; MESSENGER-RNA; STEM-CELLS; MOUSE CHROMOSOME-18; MICE; TERATOMAS; DEFICIENCY; CYCLOOXYGENASE-2; TRANSCRIPTION; EXPRESSION	In mice, the Ter mutation causes primordial germ cell (PGC) loss in all genetic backgrounds(1). Ter is also a potent modifier of spontaneous testicular germ cell tumour (TGCT) susceptibility in the 129 family of inbred strains, and markedly increases TGCT incidence in 129-Ter/Termales(2-4). In 129-Ter/Ter mice, some of the remaining PGCs transform into undifferentiated pluripotent embryonal carcinoma cells(2-6), and after birth differentiate into various cells and tissues that compose TGCTs. Here, we report the positional cloning of Ter, revealing a point mutation that introduces a termination codon in the mouse orthologue (Dnd1) of the zebrafish dead end (dnd) gene. PGC deficiency is corrected both with bacterial artificial chromosomes that contain Dnd1 and with a Dnd1-encoding transgene. Dnd1 is expressed in fetal gonads during the critical period when TGCTs originate. DND1 has an RNA recognition motif and is most similar to the apobec complementation factor, a component of the cytidine to uridine RNA-editing complex. These results suggest that Ter may adversely affect essential aspects of RNA biology during PGC development. DND1 is the first protein known to have an RNA recognition motif directly implicated as a heritable cause of spontaneous tumorigenesis. TGCT development in the 129-Ter mouse strain models paediatric TGCT in humans. This work will have important implications for our understanding of the genetic control of TGCT pathogenesis and PGC biology.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; SAIC Frederick Inc, Basic Res Program, Frederick, MD 21702 USA; NCI, Immunobiol Lab, Frederick, MD 21702 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genome Sci Dept, Berkeley, CA 94720 USA	University of Texas System; UTMD Anderson Cancer Center; Case Western Reserve University; Case Western Reserve University; Duke University; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Nadeau, JH (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA.	jhn4@case.edu; amatin@mdanderson.org			NATIONAL CANCER INSTITUTE [R01CA093754] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016672, R01 CA075056, R01 CA093754] Funding Source: Medline; NHLBI NIH HHS [R01 HL063054] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASADA Y, 1994, NAT GENET, V6, P363, DOI 10.1038/ng0494-363; Barbouti A, 2003, CANCER RES, V63, P1202; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Donovan PJ, 2003, CURR OPIN GENET DEV, V13, P463, DOI 10.1016/j.gde.2003.08.010; Drabkin HA, 1999, ONCOGENE, V18, P2589, DOI 10.1038/sj.onc.1202601; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Jinawath N, 2004, CANCER SCI, V95, P430, DOI 10.1111/j.1349-7006.2004.tb03227.x; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; SAKURAI T, 1995, DEV GROWTH DIFFER, V37, P293, DOI 10.1046/j.1440-169X.1995.t01-2-00007.x; SAKURAI T, 1994, MAMM GENOME, V5, P333, DOI 10.1007/BF00356550; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Shao JY, 2000, J BIOL CHEM, V275, P33951, DOI 10.1074/jbc.M002324200; STEVENS LC, 1973, J NATL CANCER I, V50, P235, DOI 10.1093/jnci/50.1.235; STEVENS LC, 1967, J NATL CANCER I, V38, P549; STEVENS LC, 1961, J NATL CANCER I, V27, P443; Tsuei DJ, 2004, ONCOGENE, V23, P5815, DOI 10.1038/sj.onc.1207773; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yao HHC, 2003, DEVELOPMENT, V130, P5895, DOI 10.1242/dev.00836	30	270	290	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					360	364		10.1038/nature03595	http://dx.doi.org/10.1038/nature03595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902260	Green Accepted			2022-12-24	WOS:000229185000048
J	Kemper, AR; Cohn, LM; Fant, KE; Dombkowski, KJ; Hudson, SR				Kemper, AR; Cohn, LM; Fant, KE; Dombkowski, KJ; Hudson, SR			Follow-up testing among children with elevated screening blood lead levels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION; GUIDELINES; HEALTH	Context Follow-up testing after an abnormal screening blood lead level is a key component of lead poisoning prevention. Objectives To measure the proportion of children with elevated screening lead levels who have follow-up testing and to determine factors associated with such care. Design, Setting, and Participants Retrospective, observational cohort study of 3682 Michigan Medicaid-enrolled children aged 6 years or younger who had a screening blood lead level of at least 10 mu g/dL (0.48 mu mol/L) between,January 1, 2002, and June 30, 2003. Main Outcome Measure Testing within 180 days of an elevated screening lead level. Results Follow-up testing was received by 53.9% (95% confidence interval [01, 52.2%-55.5%) of the children. In multivariate analysis adjusting for age, screening blood lead level results, and local health department catchment area, the relative risk of follow-up testing was lower for Hispanic or nonwhite children than for white children (0.91; 95% Cl, 0.87-0.94), for children living in urban compared with rural areas (0.92; 95% Cl, 0.89-0.96), and for children living in high- compared with low-risk lead areas (0.94; 95% Cl, 0.92-0.96). Among children who did not have follow-up testing, 58.6% (95% Cl, 56.3%-61.0%) had at least 1 medical encounter in the 6-month period after the elevated screening blood lead level, including encounters for evaluation and management (39.3 %; 95% Cl, 36.9%-41.6%) or preventive care (13.2 %; 95% Cl, 11.6%-14.8%). Conclusions The rate of follow-up testing after an abnormal screening blood lead level was low, and children with increased likelihood of lead poisoning were less likely to receive follow-up testing. At least half of the children had a missed opportunity for follow-up testing. The observed disparities of care may increase the burden of cognitive impairment among at-risk children.	Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; Michigan Dept Community Hlth, Childhood Lead Poisoning Prevent Program, Lansing, MI USA	University of Michigan System; University of Michigan; MDHHS - Michigan Department of Health & Human Services	Kemper, AR (corresponding author), 6E18 300 N Ingalls Bldg, Ann Arbor, MI 48109 USA.	kempera@med.umich.edu		Kemper, Alex/0000-0001-5491-3997				*AM MED ASS, 2003, CURR PROC TERM 2004; BRODY DJ, 1994, JAMA-J AM MED ASSOC, V272, P277, DOI 10.1001/jama.272.4.277; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; *CDCP, 2002, MAN EL BLOOD LEADS L; *CDCP, 1997, SCREEN YYOUNG CHILDR; Hoyle T, 2004, J PUBLIC HEALTH MAN, V10, pS66; Kaufmann RB, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.6.e79; Meyer Pamela A, 2003, MMWR Surveill Summ, V52, P1; Papadouka Vikki, 2004, J Public Health Manag Pract, VSuppl, pS72; Piecoro LT, 2001, HEALTH SERV RES, V36, P357; ROPER WL, PREVENTING LEAD POIS; Sox CM, 2003, JAMA-J AM MED ASSOC, V290, P1057, DOI 10.1001/jama.290.8.1057; *US DEP COMM CENS, METR MICR STAT AR; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; *US GAO, 1998, MED EL BLOOD LEAD LE; Wall TC, 2002, AMBUL PEDIATR, V2, P449, DOI 10.1367/1539-4409(2002)002<0449:CWVSGA>2.0.CO;2; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	17	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2232	2237		10.1001/jama.293.18.2232	http://dx.doi.org/10.1001/jama.293.18.2232			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886378	Bronze			2022-12-24	WOS:000228981100024
J	Hampton, T				Hampton, T			Breaking barriers in transdermal drug delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								The first successful method of transdermal drug administration was in the formof a skin patch. Since then the use of patches has constantly progressed as new, less irritating chemical permeation enhancers are developed. This form of drug delivery is now applied in areas such as contraception, hormone-replacement and smoking cessation.										Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102	1	13	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2083	2083		10.1001/jama.293.17.2083	http://dx.doi.org/10.1001/jama.293.17.2083			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870404				2022-12-24	WOS:000228808200005
J	Block, BA; Teo, SLH; Walli, A; Boustany, A; Stokesbury, MJW; Farwell, CJ; Weng, KC; Dewar, H; Williams, TD				Block, BA; Teo, SLH; Walli, A; Boustany, A; Stokesbury, MJW; Farwell, CJ; Weng, KC; Dewar, H; Williams, TD			Electronic tagging and population structure of Atlantic bluefin tuna	NATURE			English	Article							THUNNUS-THYNNUS; EAST ATLANTIC; TEMPERATURE; SATELLITE; GULF; MOVEMENTS; BIOLOGY; FISH	Electronic tags that archive or transmit stored data to satellites have advanced the mapping of habitats used by highly migratory fish in pelagic ecosystems(1-6). Here we report on the electronic tagging of 772 Atlantic bluefin tuna in the western Atlantic Ocean in an effort to identify population structure. Reporting electronic tags provided accurate location data(7-9) that show the extensive migrations of individual fish (n = 330). Geoposition data delineate two populations, one using spawning grounds in the Gulf of Mexico and another from the Mediterranean Sea. Transatlantic movements of western-tagged bluefin tuna reveal site fidelity to known spawning areas in the Mediterranean Sea. Bluefin tuna that occupy western spawning grounds move to central and eastern Atlantic foraging grounds. Our results are consistent with two populations of bluefin tuna with distinct spawning areas that overlap on North Atlantic foraging grounds. Electronic tagging locations, when combined with US pelagic longline observer and logbook catch data, identify hot spots for spawning bluefin tuna in the northern slope waters of the Gulf of Mexico. Restrictions on the time and area where longlining occurs would reduce incidental catch mortalities on western spawning grounds.	Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA; Monterey Bay Aquarium, Monterey, CA 93940 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	Stanford University; Monterey Bay Aquarium Research Institute; Dalhousie University	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Weng, Kevin Chi-Ming/C-4709-2013	Weng, Kevin Chi-Ming/0000-0002-7069-7152				Apostolaki Panayiota, 2004, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V56, P1121; Atwood TC, 2003, CAN J ZOOL, V81, P1589, DOI 10.1139/Z03-144; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; Block BA, 1998, MAR TECHNOL SOC J, V32, P37; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; CAREY FG, 1973, COMP BIOCHEM PHYSIOL, V44, P375, DOI 10.1016/0300-9629(73)90490-8; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Cort J.L., 1991, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V35, P213; EKSTROM PA, 2004, NATL I POLAR RES, V58, P210; Fromentin JM, 2003, SCI MAR, V67, P51, DOI 10.3989/scimar.2003.67s151; Hill C., 2001, ELECT TAGGING TRACKI, P315, DOI DOI 10.1007/978-94-017-1402-0_17; Landeira-Fernandez AM, 2004, AM J PHYSIOL-REG I, V286, pR398, DOI 10.1152/ajpregu.00392.2003; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Mather F. J., 1995, 370 NOAA; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; National Research Council, 1994, ASS ATL BLUEF TUN; Nemerson D, 2000, FISH B-NOAA, V98, P118; Rivas L. R., 1954, Bulletin of Marine Science of the Gulf and Caribbean, V4, P302; Rooker JR, 2003, FISH OCEANOGR, V12, P75, DOI 10.1046/j.1365-2419.2003.00223.x; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Stokesbury MJW, 2004, CAN J FISH AQUAT SCI, V61, P1976, DOI 10.1139/F04-130; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; TURNER SC, 1994, ICCAT COLL VOL SCI P, V42, P170; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; [No title captured]	30	574	593	3	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1121	1127		10.1038/nature03463	http://dx.doi.org/10.1038/nature03463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858572				2022-12-24	WOS:000228693300041
J	Ofri, D				Ofri, D			They sent me here	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Sch Med, New York, NY 10003 USA	New York University	Ofri, D (corresponding author), NYU, Sch Med, New York, NY 10003 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1746	1748		10.1056/NEJMp038252	http://dx.doi.org/10.1056/NEJMp038252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858183				2022-12-24	WOS:000228689000004
J	Kravitz, RL; Epstein, RM; Feldman, MD; Franz, CE; Azari, R; Wilkes, MS; Hinton, L; Franks, P				Kravitz, RL; Epstein, RM; Feldman, MD; Franz, CE; Azari, R; Wilkes, MS; Hinton, L; Franks, P			Influence of patients' requests for direct-to-consumer advertised antidepressants - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY IMPROVEMENT PROGRAMS; STANDARDIZED PATIENTS; PRIMARY-CARE; PRESCRIPTION DRUGS; OFFICE PRACTICE; DEPRESSION; GUIDELINES; PHYSICIAN; DISORDERS; PROMOTION	Context Direct-to-consumer (DTC) advertising of prescription drugs in the United States is both ubiquitous and controversial. Critics charge that it leads to overprescribing, while proponents counter that it helps avert underuse of effective treatments, especially for conditions that are poorly recognized or stigmatized. Objective To ascertain the effects of patients' DTC-related requests on physicians' initial treatment decisions in patients with depressive symptoms. Design Randomized trial using standardized patients (SPs). Six SP roles were created by crossing 2 conditions (major depression or adjustment disorder with depressed mood) with 3 request types (brand-specific, general, or none). Setting Off ices of primary care physicians in Sacramento, Calif; San Francisco, Calif; and Rochester, NY, between May 2003 and May 2004. Participants One hundred fifty-two family physicians and general internists recruited from solo and group practices and health maintenance organizations; cooperation rates ranged from 53% to 61%. Interventions The SPs were randomly assigned to make 298 unannounced visits, with assignments constrained so physicians saw 1 SP with major depression and 1 with adjustment disorder. The SPs. made a brand-specific drug request, a general drug request, or no request (control condition) in approximately one third of visits. Main Outcome Measures Data on prescribing, mental health referral, and primary care follow-up obtained from SP written reports, visit audiorecordings, chart review, and analysis of written prescriptions and drug samples. The effects of request type on prescribing were evaluated using contingency tables and confirmed in generalized linear mixed models that accounted for clustering and adjusted for site, physician, and visit characteristics. Results Standardized patient role fidelity was excellent, and the suspicion rate that physicians had seen an SP was 13%. In major depression, rates of antidepressant prescribing were 53%, 76%, and 31% for SPs making brand-specific, general, and no requests, respectively (P<.001). In adjustment disorder, antidepressant prescribing rates were 55%, 39%, and 10%, respectively (P<.001). The results were confirmed in multivariate models. Minimally acceptable initial care (any combination of an antidepressant, mental health referral, or follow-up within 2 weeks) was offered to 98% of SPs in the major depression role making a general request, 90% of those making a brand-specific request, and 56% of those,making no request (P<.001). Conclusions Patients' requests have a profound effect on physician prescribing in major depression and adjustment disorder. Direct-to-consumer advertising may have competing effects on quality, potentially both averting underuse and promoting overuse.	Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Stat, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Psychiat, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Family & Community Med, Sacramento, CA 95817 USA; Univ Rochester, Sch Med & Dent, Dept Family Med, Rochester, NY USA; Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Ctr Improve Commun Hlth Care, Rochester, NY USA; Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Rochester; University of Rochester; University of Rochester; University of California System; University of California San Francisco	Kravitz, RL (corresponding author), Univ Calif Davis, Ctr Hlth Serv Res, 2103 Stockton Blvd,Suite 2224,GB, Sacramento, CA 95817 USA.	rlkravitz@ucdavis.edu	Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X; Franz, Carol/0000-0002-8987-1755	NIA NIH HHS [K23 AG019809, K23-AG19809] Funding Source: Medline; NIMH NIH HHS [R01 MH064683-03, R01 MH064683-02, R01 MH064683-01A1, R01 MH064683] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG019809] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; *AM PSYCH ASS, 2000, DIAGN STAT MAN MENT, P775; *AM PSYCH ASS, 2000, DIAGN STAT MAN MENT, P349; Anderson IM, 2000, J PSYCHOPHARMACOL, V14, P3, DOI 10.1177/026988110001400101; Barbey JT, 1998, J CLIN PSYCHIAT, V59, P42; Barret JE, 2001, J FAM PRACTICE, V50, P405; Becker H, 2003, WESTERN J NURS RES, V25, P746, DOI 10.1177/0193945903253002; Bell RA, 2000, J FAM PRACTICE, V49, P329; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; Bell RA, 1999, J FAM PRACTICE, V48, P446; Beullens J, 1997, FAM PRACT, V14, P58, DOI 10.1093/fampra/14.1.58; Carney PA, 1999, J FAM PRACTICE, V48, P958; Cohen LJ, 1997, ANN PHARMACOTHER, V31, P782, DOI 10.1177/106002809703100620; CooperPatrick L, 1997, J GEN INTERN MED, V12, P431, DOI 10.1046/j.1525-1497.1997.00075.x; Donohue JM, 2004, MED CARE, V42, P1176, DOI 10.1097/00005650-200412000-00004; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P22; Glassman P A, 2000, Jt Comm J Qual Improv, V26, P644; Gorter S, 2002, J RHEUMATOL, V29, P1496; Guiton G, 2004, ADV HEALTH SCI EDUC, V9, P179, DOI 10.1023/B:AHSE.0000038174.87790.7b; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hollon MF, 1999, JAMA-J AM MED ASSOC, V281, P382, DOI 10.1001/jama.281.4.382; Holmer AF, 1999, JAMA-J AM MED ASSOC, V281, P380, DOI 10.1001/jama.281.4.380; Judd LL, 2004, AM J PSYCHIAT, V161, P1864, DOI 10.1176/appi.ajp.161.10.1864; *KAIS FAM FDN, 2004, PRESCR DRUG TRENDS; Kramer PD, 1997, LISTENING PROZAC; Kravitz RL, 2000, WESTERN J MED, V173, P221, DOI 10.1136/ewjm.173.4.221; Kravitz RL, 2003, ARCH INTERN MED, V163, P1673, DOI 10.1001/archinte.163.14.1673; Kravitz RL, 2002, HEALTH SERV RES, V37, P217; Kravitz RL, 2002, MED CARE, V40, P38, DOI 10.1097/00005650-200201000-00006; Luck J, 2002, BMJ-BRIT MED J, V325, P679, DOI 10.1136/bmj.325.7366.679; *MAN MAJ DEPR DIS, 2000, VET HLTH ADM DEP DEF; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Mello MM, 2003, JAMA-J AM MED ASSOC, V289, P477, DOI 10.1001/jama.289.4.477; Mintzes B, 2002, BRIT MED J, V324, P278, DOI 10.1136/bmj.324.7332.278; *NAT I HLTH CAR MA, 2000, RES BRIEF PRESCR DRU, P8; *OFF MED POL DIV D, ATT BEH ASS DIR TO C; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Raingruber B, 2002, ARCH PSYCHIAT NURS, V16, P201, DOI 10.1053/apnu.2002.36230; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; Rost K, 1993, J Rural Health, V9, P57, DOI 10.1111/j.1748-0361.1993.tb00495.x; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P213, DOI 10.1016/S0163-8343(02)00198-6; TAMBLYN RM, 1992, ACAD MED, V67, pS22, DOI 10.1097/00001888-199210000-00027; Unutzer J, 2001, ARCH GEN PSYCHIAT, V58, P935, DOI 10.1001/archpsyc.58.10.935; van der Klink JJL, 2003, SCAND J WORK ENV HEA, V29, P478, DOI 10.5271/sjweh.756; Weissman JS, 2004, HEALTH AFFAIR, V23, pW4219, DOI 10.1377/hlthaff.W4.219; WEISSMAN JS, 2003, HLTH AFF MILLWO 0226, DOI DOI 10.1377/HLTHAFF.W3.28; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Wells KB, 1999, ARCH FAM MED, V8, P529, DOI 10.1001/archfami.8.6.529; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110; ZAMANIYAN F, 2003, DRUG ADVERTISING SPE	50	425	428	0	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					1995	2002		10.1001/jama.293.16.1995	http://dx.doi.org/10.1001/jama.293.16.1995			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919XS	15855433	Green Accepted, Bronze			2022-12-24	WOS:000228651500025
J	Pfander, B; Moldovan, GL; Sacher, M; Hoege, C; Jentsch, S				Pfander, B; Moldovan, GL; Sacher, M; Hoege, C; Jentsch, S			SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase	NATURE			English	Article							DAMAGE-INDUCED MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; DNA HELICASE; POSTREPLICATION REPAIR; UBIQUITIN CONJUGATION; RAD6 PATHWAY; YEAST; REPLICATION; MUTANTS; PROTEIN	Damaged DNA, if not repaired before replication, can lead to replication fork stalling and genomic instability(1-3); however, cells can switch to different damage bypass modes that permit replication across lesions. Two main bypasses are controlled by ubiquitin modification of proliferating cell nuclear antigen ( PCNA), a homotrimeric DNA-encircling protein that functions as a polymerase processivity factor and regulator of replication-linked functions(4,5). Upon DNA damage, PCNA is modified at the conserved lysine residue 164 by either mono-ubiquitin or a lysine-63-linked multi-ubiquitin chain(5), which induce error-prone or error-free replication bypasses of the lesions(5,6). In S phase, even in the absence of exogenous DNA damage, yeast PCNA can be alternatively modified by the small ubiquitin-related modifier protein SUMO5; however the consequences of this remain controversial(5-7). Here we show by genetic analysis that SUMO-modified PCNA functionally cooperates with Srs2, a helicase that blocks recombinational repair by disrupting Rad51 nucleoprotein filaments(8,9). Moreover, Srs2 displays a preference for interacting directly with the SUMO-modified form of PCNA, owing to a specific binding site in its carboxy-terminal tail. Our finding suggests a model in which SUMO-modified PCNA recruits Srs2 in S phase in order to prevent unwanted recombination events of replicating chromosomes.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	Jentsch@biochem.mpg.de	Pfander, Boris/A-8703-2013	George-Lucian, Moldovan/0000-0003-3825-149X; Pfander, Boris/0000-0003-2180-5054				ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; AGUILERA A, 1988, GENETICS, V119, P779; Aylon Y, 2004, MUTAT RES-REV MUTAT, V566, P231, DOI 10.1016/j.mrrev.2003.10.001; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; PALLADINO F, 1992, GENETICS, V132, P23; RONG L, 1993, J BIOL CHEM, V268, P1252; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; SCHIESTL RH, 1990, GENETICS, V124, P817; Smirnova M, 2003, MUTAT RES-FUND MOL M, V532, P117, DOI 10.1016/j.mrfmmm.2003.08.026; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tsurimoto T., 1999, FRONT BIOSCI, V4, P849; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383	28	462	478	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					428	433		10.1038/nature03665	http://dx.doi.org/10.1038/nature03665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	15931174				2022-12-24	WOS:000230623400050
J	Seligson, DB; Horvath, S; Shi, T; Yu, H; Tze, S; Grunstein, M; Kurdistani, SK				Seligson, DB; Horvath, S; Shi, T; Yu, H; Tze, S; Grunstein, M; Kurdistani, SK			Global histone modification patterns predict risk of prostate cancer recurrence	NATURE			English	Article							TARGETED RECRUITMENT; ACETYLATION; CHROMATIN; ANTIGEN; P300	Aberrations in post-translational modifications of histones have been shown to occur in cancer cells but only at individual promoters(1); they have not been related to clinical outcome. Other than being targeted to promoters, modifications of histones, such as acetylation and methylation of lysine and arginine residues, also occur over large regions of chromatin including coding regions and non-promoter sequences, which are referred to as global histone modifications(2). Here we show that changes in global levels of individual histone modifications are also associated with cancer and that these changes are predictive of clinical outcome. Through immunohistochemical staining of primary prostatectomy tissue samples, we determined the percentage of cells that stained for the histone acetylation and dimethylation of five residues in histones H3 and H4. Grouping of samples with similar patterns of modifications identified two disease subtypes with distinct risks of tumour recurrence in patients with low-grade prostate cancer. These histone modification patterns were predictors of outcome independently of tumour stage, preoperative prostate-specific antigen levels, and capsule invasion. Thus, widespread changes in specific histone modifications indicate previously undescribed molecular heterogeneity in prostate cancer and might underlie the broad range of clinical behaviour in cancer patients.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	skurdistani@mednet.ucla.edu		Kurdistani, Siavash/0000-0003-3295-3511; , Tao/0000-0001-5489-2655				Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BREIMAN L., 1984, CLASSIFICATION REGRE; Bunting PS, 2002, CLIN CHIM ACTA, V315, P71, DOI 10.1016/S0009-8981(01)00717-3; Cleveland W., 1993, VISUALIZING DATA; Debes JD, 2003, CANCER RES, V63, P7638; Farkas A, 1998, UROLOGY, V52, P444, DOI 10.1016/S0090-4295(98)00242-8; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Han M, 2001, J UROLOGY, V166, P416, DOI 10.1016/S0022-5347(05)65955-1; Jacobson S, 1999, CURR OPIN GENET DEV, V9, P175, DOI 10.1016/S0959-437X(99)80027-6; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Muraoka M, 1996, ONCOGENE, V12, P1565; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Shi T, 2005, MODERN PATHOL, V18, P547, DOI 10.1038/modpathol.3800322; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127	24	780	847	1	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1262	1266		10.1038/nature03672	http://dx.doi.org/10.1038/nature03672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988529				2022-12-24	WOS:000230140500049
J	Govindarajulu, M; Pfeffer, PE; Jin, HR; Abubaker, J; Douds, DD; Allen, JW; Bucking, H; Lammers, PJ; Shachar-Hill, Y				Govindarajulu, M; Pfeffer, PE; Jin, HR; Abubaker, J; Douds, DD; Allen, JW; Bucking, H; Lammers, PJ; Shachar-Hill, Y			Nitrogen transfer in the arbuscular mycorrhizal symbiosis	NATURE			English	Article							FUNGUS GLOMUS-INTRARADICES; IN-VITRO; GENE-EXPRESSION; TRANSPORT; CARBON; ASSIMILATION; ROOTS; METABOLISM; TRANSLOCATION; CARBOHYDRATE	Most land plants are symbiotic with arbuscular mycorrhizal fungi (AMF), which take up mineral nutrients from the soil and exchange them with plants for photosynthetically fixed carbon. This exchange is a significant factor in global nutrient cycles(1) as well as in the ecology(2), evolution(3) and physiology(4) of plants. Despite its importance as a nutrient, very little is known about how AMF take up nitrogen and transfer it to their host plants(5). Here we report the results of stable isotope labelling experiments showing that inorganic nitrogen taken up by the fungus outside the roots is incorporated into amino acids, translocated from the extraradical to the intraradical mycelium as arginine, but transferred to the plant without carbon. Consistent with this mechanism, the genes of primary nitrogen assimilation are preferentially expressed in the extraradical tissues, whereas genes associated with arginine breakdown are more highly expressed in the intraradical mycelium. Strong changes in the expression of these genes in response to nitrogen availability and form also support the operation of this novel metabolic pathway in the arbuscular mycorrhizal symbiosis.	New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA; ARS, USDA, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	New Mexico State University; United States Department of Agriculture (USDA); Michigan State University	Lammers, PJ (corresponding author), New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA.	ppfeffer@arserrc.gov; plammers@nmsu.edu	Allen, James/AAG-6465-2019; Lammers, Peter/K-6661-2018; Shachar-Hill, Yair/B-6165-2013	Lammers, Peter/0000-0002-7312-0797; Shachar-Hill, Yair/0000-0001-8793-5084; Bucking, Heike/0000-0002-4040-0944; Abubaker, Jehad/0000-0003-0681-7305				Allen MF, 2003, ANNU REV PHYTOPATHOL, V41, P271, DOI 10.1146/annurev.phyto.41.052002.095518; AMES RN, 1983, NEW PHYTOL, V95, P381, DOI 10.1111/j.1469-8137.1983.tb03506.x; Bago B, 2003, PLANT PHYSIOL, V131, P1496, DOI 10.1104/pp.102.007765; Bago B, 2002, PLANT PHYSIOL, V128, P108, DOI 10.1104/pp.010466; Bago B, 1996, NEW PHYTOL, V133, P273, DOI 10.1111/j.1469-8137.1996.tb01894.x; Bago B, 2001, NEW PHYTOL, V149, P4, DOI 10.1046/j.1469-8137.2001.00016.x; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Breuninger M, 2004, FUNGAL GENET BIOL, V41, P542, DOI 10.1016/j.fgb.2004.01.003; Bucking H, 2005, NEW PHYTOL, V165, P899, DOI 10.1111/j.1469-8137.2004.01274.x; CLIQUET JB, 1993, PLANT PHYSIOL, V101, P865, DOI 10.1104/pp.101.3.865; HARRISON MJ, 1995, NATURE, V378, P626, DOI 10.1038/378626a0; He XH, 2003, CRIT REV PLANT SCI, V22, P531, DOI 10.1080/713608315; Hildebrandt U, 2002, PHYSIOL PLANTARUM, V115, P125, DOI 10.1034/j.1399-3054.2002.1150115.x; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Johansen A, 1996, NEW PHYTOL, V133, P705, DOI 10.1111/j.1469-8137.1996.tb01939.x; KALDORF M, 1994, MYCORRHIZA, V5, P23, DOI 10.1007/BF00204016; Lammers PJ, 2001, PLANT PHYSIOL, V127, P1287, DOI 10.1104/pp.010375; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MARTIN F, 1986, NEW PHYTOL, V102, P85, DOI 10.1111/j.1469-8137.1986.tb00800.x; MARTIN F, 1985, FEBS LETT, V182, P350, DOI 10.1016/0014-5793(85)80331-8; Nielsen JS, 2002, NEW PHYTOL, V154, P809, DOI 10.1046/j.1469-8137.2002.00412.x; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; Pfeffer PE, 2004, NEW PHYTOL, V163, P617, DOI 10.1111/j.1469-8137.2004.01152.x; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; StArnaud M, 1996, MYCOL RES, V100, P328, DOI 10.1016/S0953-7562(96)80164-X; Toussaint JP, 2004, CAN J MICROBIOL, V50, P251, DOI [10.1139/w04-009, 10.1139/W04-009]; Vallorani L, 2002, NEW PHYTOL, V154, P779, DOI 10.1046/j.1469-8137.2002.00409.x; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	30	605	675	20	535	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					819	823		10.1038/nature03610	http://dx.doi.org/10.1038/nature03610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944705				2022-12-24	WOS:000229638700051
J	de Oliveira, AM; White, KL; Leschinsky, DP; Beecham, BD; Vogt, TM; Moolenaar, RL; Perz, JF; Safranek, TJ				de Oliveira, AM; White, KL; Leschinsky, DP; Beecham, BD; Vogt, TM; Moolenaar, RL; Perz, JF; Safranek, TJ			An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; TRANSMISSION	Background: Approximately 2.7 million persons in the United States have chronic hepatitis C virus (HCV) infection. Health care-associated HCV transmission can occur if aseptic technique is not followed. The authors suspected a health care-associated HCV outbreak after the report of 4 HCV infections among patients at the same hematology/oncology clinic. Objective: To determine the extent and mechanism of HCV transmission among clinic patients. Design: Epidemiologic analysis through a cohort study. Setting: Hematology/oncology clinic in eastern Nebraska. Participants: Patients who visited the clinic from March 2000 through December 2001. Measurements: HCV infection status, relevant medical history, and clinic-associated exposures. Bivariate analysis and logistic regression were used to identify risk factors for HCV infection. Results: Of 613 clinic patients contacted, 494 (81%) underwent HCV testing. The authors documented infection in 99 patients who lacked previous evidence of HCV infection; all had begun treatment at the clinic before July 2001. Hepatitis C virus genotype 3a was present in all 95 genotyped samples and presumably originated from a patient with chronic hepatitis C who began treatment in March 2000. Infection with HCV was statistically significantly associated with receipt of saline flushes (P < 0.001). Shared saline bags were probably contaminated when syringes used to draw blood from venous catheters were reused to withdraw saline solution. The clinic corrected this procedure in July 2001. Limitation: The delay between outbreak and investigation (> 1 year) may have contributed to an underestimate of cases. Conclusions: This large health care-associated HCV outbreak was related to shared saline bags contaminated through syringe reuse. Effective infection-control programs are needed to ensure high standards of care in outpatient care facilities, such as hematology/oncology clinics.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; Nebraska Hlth & Human Serv Syst, Lincoln, NE USA	Centers for Disease Control & Prevention - USA	de Oliveira, AM (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Highway,MS F-22, Atlanta, GA 30341 USA.	acq7@cdc.gov						Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bruguera M, 2002, J CLIN MICROBIOL, V40, P4363, DOI 10.1128/JCM.40.11.4363-4366.2002; CHIARELLO LA, 2001, SEMIN INFECT CONTROL, V1, P44; Delarocque-Astagneau E, 2002, INFECT CONT HOSP EP, V23, P328, DOI 10.1086/502060; Desenclos JC, 2001, INFECT CONT HOSP EP, V22, P701, DOI 10.1086/501849; Esteban JI, 1996, NEW ENGL J MED, V334, P555, DOI 10.1056/NEJM199602293340902; Garner JS, 1996, INFECT CONT HOSP EP, V17, P54, DOI 10.1017/S0195941700006123; Herwaldt LA, 1998, INFECT CONT HOSP EP, V19, P41; Jarvis WR, 2001, EMERG INFECT DIS, V7, P170, DOI 10.3201/eid0702.010202; Krause G, 2003, INFECT CONT HOSP EP, V24, P122, DOI 10.1086/502176; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Nguyen GT, 2000, AM J INFECT CONTROL, V28, P392, DOI 10.1067/mic.2000.110298; Widell A, 1999, ANN INTERN MED, V130, P130, DOI 10.7326/0003-4819-130-2-199901190-00007; Williams IT, 2004, CLIN INFECT DIS, V38, P1592, DOI 10.1086/420935; 2001, EMERG INFECT DIS, V7, P170; 1998, MMWR MORB MORTAL REC, V47, P1; 2003, MMWR MORB MORTAL WKL, V52, P901; 1992, MMWR MORB MORAL WKLY, V41, P783	19	67	68	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2005	142	11					898	902		10.7326/0003-4819-142-11-200506070-00007	http://dx.doi.org/10.7326/0003-4819-142-11-200506070-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932LX	15941696				2022-12-24	WOS:000229556300003
J	Chesebro, B; Trifilo, M; Race, R; Meade-White, K; Teng, C; LaCasse, R; Raymond, L; Favara, C; Baron, G; Priola, S; Caughey, B; Masliah, E; Oldstone, M				Chesebro, B; Trifilo, M; Race, R; Meade-White, K; Teng, C; LaCasse, R; Raymond, L; Favara, C; Baron, G; Priola, S; Caughey, B; Masliah, E; Oldstone, M			Anchorless prion protein results in infectious amyloid disease without clinical scrapie	SCIENCE			English	Article							CELL-FREE FORMATION; SPONGIFORM ENCEPHALOPATHIES; PRECURSOR PROTEIN; NEURONAL PRP; MICE; RESISTANT; BRAIN; CONVERSION; PATHOLOGY; PLAQUES	In prion and Alzheimer's diseases, the roles played by amyloid versus nonamyloid deposits in brain damage remain unresolved. In scrapie-infected transgenic mice expressing prion protein (PrP) lacking the glycosylphosphatidylinositol (GPI) membrane anchor, abnormal protease-resistant PrPres was deposited as amyloid plaques, rather than the usual nonamyloid form of PrPres. Although PrPres amyloid plaques induced brain damage reminiscent of Alzheimer's disease, clinical manifestations were minimal. In contrast, combined expression of anchorless and wild-type PrP produced accelerated clinical scrapie. Thus, the PrP GPI anchor may play a role in the pathogenesis of prion diseases.	NIAID, Rocky Mt Labs, Lab Persistent Viral Dis, Hamilton, MT 59840 USA; Scripps Res Inst, Dept Neuropharmacol, Div Virol, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Chesebro, B (corresponding author), NIAID, Rocky Mt Labs, Lab Persistent Viral Dis, Hamilton, MT 59840 USA.	bchesebro@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000752, ZIAAI000752, Z01AI000580, ZIAAI000580, Z01AI000265, ZIAAI000937, Z01AI000937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004342] Funding Source: NIH RePORTER; NIA NIH HHS [AG004342] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CHANDLER RL, 1961, LANCET, V1, P1378; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FRASER H, 1973, LANCET, V1, P617; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Masliah E, 1996, J NEUROSCI, V16, P5795; Masliah E, 2001, J NEUROPATH EXP NEUR, V60, P357, DOI 10.1093/jnen/60.4.357; McBride PA, 1998, EXP NEUROL, V149, P447, DOI 10.1006/exnr.1997.6740; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; Rall GF, 1997, P NATL ACAD SCI USA, V94, P4659, DOI 10.1073/pnas.94.9.4659; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; SNOW AD, 1989, ACTA NEUROPATHOL, V77, P337, DOI 10.1007/BF00687367; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377	40	494	507	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2005	308	5727					1435	1439		10.1126/science.1110837	http://dx.doi.org/10.1126/science.1110837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933194				2022-12-24	WOS:000229619300044
J	King-Jones, K; Charles, JP; Lam, G; Thummel, CS				King-Jones, K; Charles, JP; Lam, G; Thummel, CS			The ecdysone-induced DHR4 orphan nuclear receptor coordinates growth and maturation in Drosophila	CELL			English	Article							STEROID-HORMONE ECDYSONE; DNA-BINDING PROPERTIES; MANDUCA-SEXTA L; TOBACCO HORNWORM; GENE-EXPRESSION; INDUCIBLE GENE; BROAD-COMPLEX; BODY-SIZE; FAT-BODY; MOLECULAR ANALYSIS	A critical determinant of insect body size is the time at which the larva stops feeding and initiates wandering in preparation for metamorphosis. No genes have been identified that regulate growth by contributing to this key developmental decision to terminate feeding. We show here that mutations in the DHR4 orphan nuclear receptor result in larvae that precociously leave the food to form premature prepupae, resulting in abbreviated larval development that translates directly into smaller and lighter animals. In addition, we show that DHR4 plays a central role in the genetic cascades triggered by the steroid hormone ecdysone at the onset of metamorphosis, acting as both a repressor of the early ecdysone-induced regulatory genes and an inducer of the beta FTZ-Fl midprepupal competence factor. We propose that DHR4 coordinates growth and maturation in Drosophila by mediating endocrine responses to the attainment of critical weight during larval development.	Univ Utah, Sch Med, Dept Human Genet, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Bourgogne 1, CNRS, UMR 5548, Fac Sci Gabriel, F-21000 Dijon, France	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Thummel, CS (corresponding author), Univ Utah, Sch Med, Dept Human Genet, Howard Hughes Med Inst, 15 N 2030 E Room 5100, Salt Lake City, UT 84112 USA.	carl.thummel@genetics.utah.edu	CHARLES, jean-philippe/Q-2427-2017	CHARLES, jean-philippe/0000-0001-7285-5532				ANDRES AJ, 1993, DEV BIOL, V160, P388, DOI 10.1006/dbio.1993.1315; Ashburner M, 1974, Cold Spring Harb Symp Quant Biol, V38, P655; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Beadle GW, 1938, BIOL BULL-US, V75, P447, DOI 10.2307/1537573; Britton JS, 1998, DEVELOPMENT, V125, P2149; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; CARROLL SB, 1987, DNA CLONING, P89; Charles JP, 1999, EUR J BIOCHEM, V266, P181, DOI 10.1046/j.1432-1327.1999.00842.x; Chen JH, 2002, INSECT BIOCHEM MOLEC, V32, P657, DOI 10.1016/S0965-1748(01)00144-8; CLEVER U, 1964, SCIENCE, V146, P794, DOI 10.1126/science.146.3645.794; Crossgrove K, 1996, DEV BIOL, V180, P745, DOI 10.1006/dbio.1996.0343; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; DIBELLO PR, 1991, GENETICS, V129, P385; DOMINICK OS, 1985, J EXP BIOL, V117, P45; Hiruma K, 2001, DEV BIOL, V232, P265, DOI 10.1006/dbio.2001.0165; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Kageyama Y, 1997, GENES CELLS, V2, P559, DOI 10.1046/j.1365-2443.1997.1460344.x; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; KISS I, 1988, GENETICS, V118, P247; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; Lam GT, 1997, DEVELOPMENT, V124, P1757; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; MARONI G, 1983, DROS INFORM SERV, V59, P142; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; RESTIFO LL, 1992, ROUX ARCH DEV BIOL, V201, P221, DOI 10.1007/BF00188753; Riddiford LM, 2001, VITAM HORM, V60, P1; Riddiford Lynn M., 1993, P899; ROUNTREE DB, 1986, J EXP BIOL, V120, P41; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Sokolowski MB, 2003, NEURON, V39, P6, DOI 10.1016/S0896-6273(03)00398-2; Stern D, 2003, CURR BIOL, V13, pR267, DOI 10.1016/S0960-9822(03)00197-0; Stern DL, 1999, DEVELOPMENT, V126, P1091; STONE BL, 1993, CELL, V75, P307, DOI 10.1016/0092-8674(93)80072-M; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; Urness LD, 1995, EMBO J, V14, P6239, DOI 10.1002/j.1460-2075.1995.tb00314.x; Weller J, 2001, INSECT BIOCHEM MOLEC, V31, P827, DOI 10.1016/S0965-1748(00)00188-0; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; WOODARD CT, 1994, CELL, V79, P607, DOI 10.1016/0092-8674(94)90546-0; Yamada M, 2000, DEVELOPMENT, V127, P5083; Zinke I, 1999, DEVELOPMENT, V126, P5275	50	82	88	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					773	784		10.1016/j.cell.2005.03.030	http://dx.doi.org/10.1016/j.cell.2005.03.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935763	Bronze			2022-12-24	WOS:000229658000015
J	Korkegian, A; Black, ME; Baker, D; Stoddard, BL				Korkegian, A; Black, ME; Baker, D; Stoddard, BL			Computational thermostabilization of an enzyme	SCIENCE			English	Article							PROTEIN DESIGN; CYTOSINE DEAMINASE; GENE-THERAPY; STABILITY; YEAST; SPECIFICITY; SEQUENCES; RECEPTOR; CANCER; ANALOG	Thermostabilizing an enzyme while maintaining its activity for industrial or biomedical applications can be difficult with traditional selection methods. We describe a rapid computational approach that identified three mutations within a model enzyme that produced a 10 degrees C increase in apparent melting temperature T(m) and a 30-fold increase in half-life at 50 degrees C, with no reduction in catalytic efficiency. The effects of the mutations were synergistic, giving an increase in excess of the sum of their individual effects. The redesigned enzyme induced an increased, temperature-dependent bacterial growth rate under conditions that required its activity, thereby coupling molecular and metabolic engineering.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Pullman, WA 99164 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington State University	Stoddard, BL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	bstoddar@fhcrc.org	Black, Margaret/I-2957-2015; Baker, David/K-8941-2012	Black, Margaret/0000-0002-3152-5112; Baker, David/0000-0001-7896-6217	NCI NIH HHS [R01 CA097328, CA97328, R01 CA085939, CA85939] Funding Source: Medline; NIGMS NIH HHS [T32-GM08268, T32 GM008268, GM49857, R01 GM049857, R01 GM059224, GM59224] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097328, R01CA085939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059224, T32GM008268] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benson DE, 2002, BIOCHEMISTRY-US, V41, P3262, DOI 10.1021/bi011359i; Berg DT, 2003, P NATL ACAD SCI USA, V100, P4423, DOI 10.1073/pnas.0736918100; Black ME, 2001, GENET ENG P, V23, P113; Dahiyat BI, 1999, CURR OPIN BIOTECH, V10, P387, DOI 10.1016/S0958-1669(99)80070-6; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Eidsness MK, 1997, BIOCHEMISTRY-US, V36, P10406, DOI 10.1021/bi970110r; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Gordon DB, 1999, CURR OPIN STRUC BIOL, V9, P509, DOI 10.1016/S0959-440X(99)80072-4; Greco O, 2001, J CELL PHYSIOL, V187, P22, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO;2-H; Hubbard S., 1993, NACCESS DEP BIOCH MO; Ireton GC, 2003, STRUCTURE, V11, P961, DOI 10.1016/S0969-2126(03)00153-9; KATSURAGI T, 1989, AGR BIOL CHEM TOKYO, V53, P1313, DOI 10.1080/00021369.1989.10869490; Kievit E, 1999, CANCER RES, V59, P1417; KORKEGIAN A, UNPUB; Kraemer-Pecore CM, 2001, CURR OPIN CHEM BIOL, V5, P690, DOI 10.1016/S1367-5931(01)00267-8; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Luo P, 2002, PROTEIN SCI, V11, P1218, DOI 10.1110/ps.4580102; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Mendes J, 2002, CURR OPIN STRUC BIOL, V12, P441, DOI 10.1016/S0959-440X(02)00345-7; REES DC, 1995, STRUCTURE, V3, P251, DOI 10.1016/S0969-2126(01)00155-1; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Scandurra R, 1998, BIOCHIMIE, V80, P933, DOI 10.1016/S0300-9084(00)88890-2; Schramm VL, 1998, ANNU REV BIOCHEM, V67, P693, DOI 10.1146/annurev.biochem.67.1.693; Shifman JM, 2002, J MOL BIOL, V323, P417, DOI 10.1016/S0022-2836(02)00881-1; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Street AG, 1999, STRUCTURE, V7, pR105, DOI 10.1016/S0969-2126(99)80062-8; Venclovas C, 2003, PROTEINS, V53, P585, DOI 10.1002/prot.10530	35	282	306	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					857	860		10.1126/science.1107387	http://dx.doi.org/10.1126/science.1107387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879217	Green Accepted			2022-12-24	WOS:000228986500049
J	Meier, T; Polzer, P; Diederichs, K; Welte, W; Dimroth, P				Meier, T; Polzer, P; Diederichs, K; Welte, W; Dimroth, P			Structure of the rotor ring of F-type Na+-ATPase from Ilyobacter tartaricus	SCIENCE			English	Article							ESCHERICHIA-COLI; SUBUNIT C; MOLECULAR ARCHITECTURE; ROTARY MOTOR; O MOTOR; SYNTHASE; ROTATION; MECHANISM; SELECTIVITY; GENERATION	In the crystal structure of the membrane-embedded rotor ring of the sodium ion-translocating adenosine 5'-triphosphate (ATP) synthase of llyobacter tartaricus at 2.4 angstrom resolution, 11 c subunits are assembled into an hourglass-shaped cylinder with 11-fold symmetry. Sodium ions are bound in a locked conformation close to the outer surface of the cylinder near the middle of the membrane. The structure supports an ion-translocation mechanism in the intact ATP synthase in which the binding site converts from the locked conformation into one that opens toward subunit a as the rotor ring moves through the subunit a/c interface.	Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; ETH, Inst Mikrobiol, CH-8093 Zurich, Switzerland	University of Konstanz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Diederichs, K (corresponding author), Univ Konstanz, Fachbereich Biol, M656, D-78457 Constance, Germany.	kay.diederichs@uni-konstanz.de; dimroth@micro.biol.ethz.ch						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aksimentiev A, 2004, BIOPHYS J, V86, P1332, DOI 10.1016/S0006-3495(04)74205-8; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2003, STRUCTURE, V11, P1469, DOI 10.1016/j.str.2003.11.011; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Feniouk BA, 2004, BIOPHYS J, V86, P4094, DOI 10.1529/biophysj.103.036962; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; FRAUENFELDER H, 1979, NATURE, V280, P558, DOI 10.1038/280558a0; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Hermolin J, 1999, J BIOL CHEM, V274, P17011, DOI 10.1074/jbc.274.24.17011; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; KAIM G, 1993, EUR J BIOCHEM, V218, P937, DOI 10.1111/j.1432-1033.1993.tb18450.x; Kaim G, 1997, BIOCHEMISTRY-US, V36, P9185, DOI 10.1021/bi970831q; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2001, FEBS LETT, V505, P353, DOI 10.1016/S0014-5793(01)02837-X; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.biophys.20.1.267; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Wehrle F, 2002, J MOL BIOL, V322, P369, DOI 10.1016/S0022-2836(02)00731-3; Xing JH, 2004, BIOPHYS J, V87, P2148, DOI 10.1529/biophysj.104.042093	34	316	326	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					659	662		10.1126/science.1111199	http://dx.doi.org/10.1126/science.1111199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860619	Green Submitted			2022-12-24	WOS:000228810900039
J	Sharland, M; Kendall, H; Yeates, D; Randall, A; Hughes, G; Glasziou, P; Mant, D				Sharland, M; Kendall, H; Yeates, D; Randall, A; Hughes, G; Glasziou, P; Mant, D			Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis, and rheumatic fever in children: time trend analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTIONS		Univ Oxford, Div Publ Hlth & Primary Care, Hlth Care Epidemiol Unit, Oxford OX3 7LF, England; Univ London St Georges Hosp, Paediat Infect Dis Unit, London SW17 0QT, England; Prescript Pricing Author, Pharmaceut Directorate, Newcastle Upon Tyne NE1 6SN, Tyne & Wear, England; Med & Healthcare Prod Regulatory Agcy, GPRD Div, London SW8 5NQ, England	University of Oxford; St Georges University London; The Medicines & Healthcare Products Regulatory Agency	Mant, D (corresponding author), Univ Oxford, Div Publ Hlth & Primary Care, Hlth Care Epidemiol Unit, Oxford OX3 7LF, England.	david.mant@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009; Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X; Hughes, Gwenda/0000-0003-2090-7702; sharland, mike/0000-0001-8626-8291	MRC [G0000340] Funding Source: UKRI; Medical Research Council [G0000340] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arroll B, 2003, BRIT J GEN PRACT, V53, P871; *DEP HLTH STAND ME, 2000, PATH LEAST RES MAIN; Little P, 2002, BRIT J GEN PRACT, V52, P187; Majeed A, 2004, BRIT MED J, V329, P879, DOI 10.1136/bmj.329.7471.879; Van Zuijlen DA, 2001, PEDIATR INFECT DIS J, V20, P140, DOI 10.1097/00006454-200102000-00004	5	110	110	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2005	331	7512					328	329		10.1136/bmj.38503.706887.AE1	http://dx.doi.org/10.1136/bmj.38503.706887.AE1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955WZ	15967760	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000231259800020
J	Cadwell, K; Coscoy, L				Cadwell, K; Coscoy, L			Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase	SCIENCE			English	Article							MHC CLASS-I; COMPLEX CLASS-I; DOWN-REGULATION; HERPESVIRUS K3; IMMUNE EVASION; PROTEINS; ENDOCYTOSIS	Ubiquitination controls a broad range of cellular functions. The last step of the ubiquitination pathway is regulated by enzyme type 3 (E3) ubiquitin ligases. E3 enzymes are responsible for substrate specificity and catalyze the formation of an isopeptide bond between a lysine residue of the substrate (or the N terminus of the substrate) and ubiquitin. MIR1 and MIR2 are two E3 ubiquitin ligases encoded by Kaposi's sarcoma-associated herpesvirus that mediate the ubiquitination of major histocompatibility complex class I (MHC 1) molecules and subsequent internalization. Here, we found that MIR1, but not MIR2, promoted down-regulation of MHC I molecules lacking lysine residues in their intracytoplasmic domain. In the presence of MIR1, these MHC I molecules were ubiquitinated, and their association with ubiquitin was sensitive to P beta(2)-mercaptoethanol, unlike lysine-ubiquitin bonds. This form of ubiquitination required a cysteine residue in the intracytoplasmic tail of MHC I molecules. An MHC I molecule containing a single cysteine residue in an artificial glycine and atanine intracytoplasmic domain was endocytosed and degraded in the presence of MIR1. Thus, ubiquitination can occur on proteins lacking accessible lysines or an accessible N terminus.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Coscoy, L (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 142 Life Sci Addit Room 3200, Berkeley, CA 94720 USA.	lcoscoy@berkeley.edu		Cadwell, Ken/0000-0002-5860-0661	NCI NIH HHS [1R01CA108447-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108447] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Fruh K, 2002, VIRUS RES, V88, P55, DOI 10.1016/S0168-1702(02)00120-X; Furman MH, 2002, J CLIN INVEST, V110, P875, DOI 10.1172/JCI200216831; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Lorenzo ME, 2002, J VIROL, V76, P5522, DOI 10.1128/JVI.76.11.5522-5531.2002; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097	15	298	311	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					127	130		10.1126/science.1110340	http://dx.doi.org/10.1126/science.1110340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994556				2022-12-24	WOS:000230212800074
J	Henshaw, D				Henshaw, D			Tension pneumothoraces	LANCET			English	Editorial Material									Kalgoorlie Reg Hosp, Kalgoorlie, WA 6430, Australia		Henshaw, D (corresponding author), Kalgoorlie Reg Hosp, Kalgoorlie, WA 6430, Australia.	David.Henshaw@health.wa.gov.au							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 25	2005	365	9478					2243	2243		10.1016/S0140-6736(05)66784-0	http://dx.doi.org/10.1016/S0140-6736(05)66784-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938WT	15978934				2022-12-24	WOS:000230034800036
J	Mirica, LM; Vance, M; Rudd, DJ; Hedman, B; Hodgson, KO; Solomon, EI; Stack, TDP				Mirica, LM; Vance, M; Rudd, DJ; Hedman, B; Hodgson, KO; Solomon, EI; Stack, TDP			Tyrosinase reactivity in a model complex: An alternative hydroxylation mechanism	SCIENCE			English	Article							SIDE-ON PEROXO; <CU-2(MU-O)(2)>(2+) CORE; PHENOLASE ACTIVITY; DIOXYGEN; OXYGENATION; BINDING; LIGAND; INTERMEDIATE; REDUCTION; CHEMISTRY	The binuclear copper enzyme tyrosinase activates O-2 to form a mu-eta(2):eta(2)-peroxodicopper(II) complex, which oxidizes phenols to catechols. Here, a synthetic mu-eta(2):eta(2)-peroxodicopper(II) complex, with an absorption spectrum similar to that of the enzymatic active oxidant, is reported to rapidly hydroxylate phenolates at -80 degrees C. Upon phenolate addition at extreme temperature in solution (-120 degrees C), a reactive intermediate consistent with a bis-mu-oxodicopper(III)phenolate complex, with the O-O bond fully cleaved, is observed experimentally. The subsequent hydroxylation step has the hallmarks of an electrophilic aromatic substitution mechanism, similar to tyrosinase. Overall, the evidence for sequential O-O bond cleavage and C-O bond formation in this synthetic complex suggests an alternative intimate mechanism to the concerted or late stage O-O bond scission generally accepted for the phenol hydroxylation reaction performed by tyrosinase.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Hedman, B (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hedman@ssrl.slac.stanford.edu; hodgson@ssrl.slac.stanford.edu; edward.solomon@stanford.edu; stack@stanford.edu	Mirica, Liviu M./R-1978-2017	Mirica, Liviu M./0000-0003-0584-9508; Solomon, Edward/0000-0003-0291-3199	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031450, R01DK031450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050730, R01GM050730] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01209] Funding Source: Medline; NIDDK NIH HHS [DK31450] Funding Source: Medline; NIGMS NIH HHS [GM50730] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen P, 2002, J INORG BIOCHEM, V88, P368, DOI 10.1016/S0162-0134(01)00349-X; Decker H, 2000, ANGEW CHEM INT EDIT, V39, P1591, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1591::AID-ANIE1591>3.0.CO;2-H; DuBois JL, 1997, J AM CHEM SOC, V119, P8578, DOI 10.1021/ja9717673; DuBois JL, 2000, J AM CHEM SOC, V122, P5775, DOI 10.1021/ja993134p; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Halfen JA, 1996, SCIENCE, V271, P1397, DOI 10.1126/science.271.5254.1397; Henson MJ, 1999, J AM CHEM SOC, V121, P10332, DOI 10.1021/ja9918425; Holland PL, 1999, ANGEW CHEM INT EDIT, V38, P1139, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1139::AID-ANIE1139>3.0.CO;2-0; Itoh S, 2001, J AM CHEM SOC, V123, P6708, DOI 10.1021/ja015702i; Kim M, 2002, NAT STRUCT BIOL, V9, P591, DOI 10.1038/nsb824; Lewis EA, 2004, CHEM REV, V104, P1047, DOI 10.1021/cr020633r; Mahadevan V, 2000, J AM CHEM SOC, V122, P10249, DOI 10.1021/ja002527h; Mahadevan V, 1997, J AM CHEM SOC, V119, P11996, DOI 10.1021/ja972946n; Mahapatra S, 1997, ANGEW CHEM INT EDIT, V36, P130, DOI 10.1002/anie.199701301; Mandal S, 2000, J ORG CHEM, V65, P4804, DOI 10.1021/jo991625m; Mirica LM, 2004, CHEM REV, V104, P1013, DOI 10.1021/cr020632z; Mirica LM, 2002, J AM CHEM SOC, V124, P9332, DOI 10.1021/ja026905p; Pidcock E, 1998, J AM CHEM SOC, V120, P7841, DOI 10.1021/ja980687b; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Santagostini L, 2000, CHEM-EUR J, V6, P519, DOI 10.1002/(SICI)1521-3765(20000204)6:3<519::AID-CHEM519>3.0.CO;2-I; SCOTT RA, 1985, METHOD ENZYMOL, V117, P414; Siegbahn PEM, 2003, J BIOL INORG CHEM, V8, P567, DOI 10.1007/s00775-003-0449-4; Solomon EI, 2001, ANGEW CHEM INT EDIT, V40, P4570, DOI 10.1002/1521-3773(20011217)40:24<4570::AID-ANIE4570>3.0.CO;2-4; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; WILCOX DE, 1985, J AM CHEM SOC, V107, P4015, DOI 10.1021/ja00299a043; Yamazaki S, 2003, J AM CHEM SOC, V125, P13034, DOI 10.1021/ja036425d	26	256	259	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1890	1892		10.1126/science.1112081	http://dx.doi.org/10.1126/science.1112081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	940BZ	15976297				2022-12-24	WOS:000230120000034
J	Cote, ML; Kardia, SLR; Wenzlaff, AS; Ruckdeschel, JC; Schwartz, AG				Cote, ML; Kardia, SLR; Wenzlaff, AS; Ruckdeschel, JC; Schwartz, AG			Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; CHRONIC-BRONCHITIS; FAMILIAL RISK; AGE; AGGREGATION; INFORMATION	Context Evidence exists that lung cancer aggregates in families and recent findings of a chromosomal region linked to lung cancer susceptibility support a genetic component to risk. Family studies of early-onset lung cancer patients offer a unique opportunity to evaluate lifetime risk of lung cancer in relatives. Objective To measure lung cancer aggregation and estimate lifetime risk among relatives of early-onset cases and population-based controls. Design and Setting Familial aggregation and cumulative risk estimates from interview data of incident cases and concurrently ascertained controls between 1990 and 2003 in metropolitan Detroit, Mich. Participants The study included 7576 biological mothers, fathers, and siblings of 692 early-onset cases and 773 frequency-matched controls. One third of the population was black. Main Outcome Measures Cumulative lifetime risk of lung cancer, stratified by race and smoking behavior in relatives of early-onset cases and controls. Results Smokers with a family history of early-onset lung cancer in a first-degree relative had a higher risk of developing lung cancer with increasing age than smokers without a family history. An increase in risk occurs after age 60 years in these individuals, with 17.1% (SE 2.4%) of white case relatives and 25.1% (SE 5.8%) of black case relatives diagnosed with lung cancer by age 70 years. Relatives of black cases were at statistically significant increased risk of lung cancer compared with relatives of white cases (odds ratio, 2.07, 95% confidence interval, 1.29-3.32) after adjusting for age, sex, pack-years, pneumonia, and chronic obstructive lung disease. Conclusions First-degree relatives of black individuals with early-onset lung cancer have greater risk of lung cancer than their white counterparts, and these risks are further amplified by cigarette smoking. These data provide estimates of lung cancer risk that can be used to offer counseling to family members of patients with early-onset lung cancer.	Wayne State Univ, Karmanos Canc Inst, Populat Studies & Prevent Program, Detroit, MI USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Michigan System; University of Michigan	Cote, ML (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	cotem@med.wayne.edu	Ruckdeschel, John/AAU-2137-2020	Ruckdeschel, John/0000-0002-7977-4257	NCI NIH HHS [R01-CA60691, N01 CN65064] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA060691] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM CANC SOC, WHAT ARE KEY STAT LU; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Bromen K, 2000, AM J EPIDEMIOL, V152, P497, DOI 10.1093/aje/152.6.497; CUPPLES LA, 1991, AM J HUM GENET, V49, P76; DOLL R, 1952, BMJ-BRIT MED J, V2, P1271, DOI 10.1136/bmj.2.4797.1271; Etzel CJ, 2003, CANCER RES, V63, P8531; Gauderman WJ, 2000, AM J EPIDEMIOL, V151, P41, DOI 10.1093/oxfordjournals.aje.a010120; Kreuzer M, 1998, AM J EPIDEMIOL, V147, P1028; Li XJ, 2004, INT J CANCER, V112, P451, DOI 10.1002/ijc.20436; Mayne ST, 1999, CANCER EPIDEM BIOMAR, V8, P1065; McLaughlin J K, 1990, Epidemiology, V1, P408, DOI 10.1097/00001648-199009000-00013; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; OOI WL, 1986, J NATL CANCER I, V76, P217; PICKLE LW, 1983, AM J EPIDEMIOL, V118, P99, DOI 10.1093/oxfordjournals.aje.a113621; Ries LAG, SEER CANC STAT REV 1; *SAS I INC, 1999, SAS SYST WIND COMP P; Schwartz AG, 1996, AM J EPIDEMIOL, V144, P554, DOI 10.1093/oxfordjournals.aje.a008965; Schwartz AG, 1999, GENET EPIDEMIOL, V17, P1, DOI 10.1002/(SICI)1098-2272(1999)17:1<1::AID-GEPI1>3.0.CO;2-C; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Silverman EK, 2002, HUM MOL GENET, V11, P623, DOI 10.1093/hmg/11.6.623; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Sullivan F, 1999, COMPUT SCI ENG, V1, P2; TAGER I, 1978, INT J EPIDEMIOL, V7, P55, DOI 10.1093/ije/7.1.55; Theis B, 1994, Eur J Cancer Prev, V3, P321, DOI 10.1097/00008469-199407000-00004; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; TOKUHATA GEORGE K., 1963, JOUR NATL CANCER INST, V30, P289; Vink JM, 2003, ADDICTION, V98, P923, DOI 10.1046/j.1360-0443.2003.00405.x; Yang P, 1999, GENET EPIDEMIOL, V17, P253, DOI 10.1002/(SICI)1098-2272(199911)17:4<253::AID-GEPI2>3.0.CO;2-K; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	70	77	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2005	293	24					3036	3042		10.1001/jama.293.24.3036	http://dx.doi.org/10.1001/jama.293.24.3036			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937SG	15972566	Bronze			2022-12-24	WOS:000229945200019
J	Wysocka, J; Swigut, T; Milne, TA; Dou, YL; Zhang, X; Burlingame, AL; Roeder, RG; Brivanlou, AH; Allis, CD				Wysocka, J; Swigut, T; Milne, TA; Dou, YL; Zhang, X; Burlingame, AL; Roeder, RG; Brivanlou, AH; Allis, CD			WDR5 associates with histone H3 methylated at K4 and is essential for H3K4 methylation and vertebrate development	CELL			English	Article							METHYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; LYSINE-4 METHYLATION; PROTEINS; HETEROCHROMATIN; RECOGNITION; MAINTENANCE; BINDING; GROWTH; MENIN	Histone H3 lysine 4 (K4) methylation has been linked to the transcriptional activation in a variety of eukaryotic species. Here we show that a common component of MLL1, MLL2, and hSetl H3 K4 methyltransferase complexes, the WD40-repeat protein WDR5, directly associates with histone H3 di- and trimethylated at K4 and with H3-K4-dimethylated nucleosomes. WDR5 is required for binding of the methyltransferase complex to the K4-dimethylated H3 tail as well as for global H3 K4 trimethylation and HOX gene activation in human cells. WDR5 is essential for vertebrate development, in that WDR5-depleted X. laevis tadpoles exhibit a variety of developmental defects and abnormal spatial Hox gene expression. Our results are the first demonstration that a WD40-repeat protein acts as a module for recognition of a specific histone modification and suggest a mechanism for reading and writing an epigenetic mark for gene activation.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Vertebrate Embryol, New York, NY 10021 USA; Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA; Univ Calif San Francisco, Mass Spectrometry Facil, San Francisco, CA 94143 USA	Rockefeller University; Rockefeller University; Rockefeller University; University of California System; University of California San Francisco	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA.	alliscd@rockefeller.edu	Milne, Tom/E-1872-2016	Milne, Tom/0000-0002-0413-4271; Swigut, Tomek/0000-0002-7649-6781	NCRR NIH HHS [RR001614, RR015804] Funding Source: Medline; NIGMS NIH HHS [R01 GM066977, GM 53512] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015804, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053512, R01GM066977, R01GM053512] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; BRIVANLOU AH, 1989, DEVELOPMENT, V106, P611; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hollmann M, 2002, MOL GENET GENOMICS, V268, P425, DOI 10.1007/s00438-002-0768-0; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Ko C, 2003, BIOCHEM BIOPH RES CO, V300, P9, DOI 10.1016/S0006-291X(02)02699-2; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; *R DEV COR TEAM, 2004, LANG ENV STAT COMP; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	32	617	641	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					859	872		10.1016/j.cell.2005.03.036	http://dx.doi.org/10.1016/j.cell.2005.03.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960974	Bronze			2022-12-24	WOS:000230011200009
J	LaCava, J; Houseley, J; Saveanu, C; Petfalski, E; Thompson, E; Jacquier, A; Tollervey, D				LaCava, J; Houseley, J; Saveanu, C; Petfalski, E; Thompson, E; Jacquier, A; Tollervey, D			RNA degradation by the exosome is promoted by a nuclear polyade nylation complex	CELL			English	Article							CYTOPLASMIC POLY(A) POLYMERASE; YEAST NUCLEOLAR PROTEIN; 3' END FORMATION; HUMAN PM-SCL; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; ESCHERICHIA-COLI; GLOBAL ANALYSIS; POLYADENYLATION	The exosome complex of 3'-5' exonucleases participates in RNA maturation and quality control and can rapidly degrade RNA-protein complexes in vivo. However, the purified exosome showed weak in vitro activity, indicating that rapid RNA degradation requires activating cofactors. This work identifies a nuclear polyadenylation complex containing a known exosome cofactor, the RNA helicase Mtr4p; a poly(A) polymerase, Trf4p; and a zinc knuckle protein, Air2p. In vitro, the Trf4p/Air2p/Mtr4p polyadenylation complex (TRAMP) showed distributive RNA polyadenylation activity. The presence of the exosome suppressed poly(A) tail addition, while TRAMP stimulated exosome degradation through structured RNA substrates. In vivo analyses showed that TRAMP is required for polyadenylation and degradation of rRNA and snoRNA precursors that are characterized exosome substrates. Poly(A) tails stimulate RNA degradation in bacteria, suggesting that this is their ancestral function. We speculate that this function was maintained in eukaryotic nuclei, while cytoplasmic mRNA poly(A) tails acquired different roles in translation.	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Inst Pasteur, CNRS, Genet Interact Macromol URA 2171, F-75015 Paris, France	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tollervey, D (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	d.tollervey@ed.ac.uk	Saveanu, Cosmin/Q-1251-2019; Saveanu, Cosmin/K-6494-2015; LaCava, John P/H-2840-2013; Houseley, Jon/AAF-7409-2021; Tollervey, David/AAR-6662-2020	Saveanu, Cosmin/0000-0002-1677-7936; Saveanu, Cosmin/0000-0002-1677-7936; LaCava, John P/0000-0002-6307-7713; Tollervey, David/0000-0003-2894-2772; Houseley, Jonathan/0000-0001-8509-1500; JACQUIER, ALAIN/0000-0001-5707-9184	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Castano IB, 1996, NUCLEIC ACIDS RES, V24, P2404, DOI 10.1093/nar/24.12.2404; Castano IB, 1996, GENE DEV, V10, P2564, DOI 10.1101/gad.10.20.2564; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; KRUPP G, 1991, J MOL BIOL, V217, P637, DOI 10.1016/0022-2836(91)90522-8; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132; Li ZW, 1998, P NATL ACAD SCI USA, V95, P12158, DOI 10.1073/pnas.95.21.12158; Liang S, 1996, MOL CELL BIOL, V16, P5139; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mohanty BK, 2002, MOL MICROBIOL, V45, P1315, DOI 10.1046/j.1365-2958.2002.03097.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; Shevchenko A, 1997, J PROTEIN CHEM, V16, P481, DOI 10.1023/A:1026361427575; SYERS F, 2005, CELL, V121, P725; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000	41	698	706	4	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					713	724		10.1016/j.cell.2005.04.029	http://dx.doi.org/10.1016/j.cell.2005.04.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935758	Bronze			2022-12-24	WOS:000229658000010
J	Moore, BD; Foley, WJ				Moore, BD; Foley, WJ			Tree use by koalas in a chemically complex landscape	NATURE			English	Article							PHASCOLARCTOS-CINEREUS; FOLIAR CHEMISTRY; FOOD PREFERENCE; SNOWSHOE HARE; VARIED DIETS; EUCALYPTUS; HERBIVORY; SELECTION; POPULATIONS; NUTRIENTS	Although defence against herbivores is often argued to be the main action of plant secondary metabolites (PSMs)(1), very few examples have demonstrated that intraspecific variation in PSM concentrations influences foraging by wild vertebrate herbivores(2,3). Experiments with captive animals often indicate that PSM concentrations influence how much herbivores eat from individual plants(3-7), but these experiments do not replicate the subtle tradeoffs in diet selection faced by wild animals, which must avoid predators and extremes of weather, interact with conspecifics, and achieve a balanced, nutritious diet, while avoiding intoxication by PSMs. We characterized the foliar chemistry of every tree from two Eucalyptus species available to a population of koalas (Phascolarctos cinereus) and considered rates of tree visitation over a ten-year period. We show that visitation rate was most strongly influenced by tree size, but that koalas also visited trees less frequently if the foliage contained either high concentrations of deterrent PSMs known as formylated phloroglucinol compounds, or low concentrations of nitrogen. Consequently, plant chemistry restricts the use of trees by this herbivore, and thus limits the food available to koalas and potentially influences koala populations.	Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia	Australian National University	Moore, BD (corresponding author), James Cook Univ N Queensland, Sch Trop Biol, Townsville, Qld 4811, Australia.	Ben.Moore@jcu.edu.au	Moore, Ben D/C-3447-2008; Moore, Ben/AAE-7885-2020; Foley, William J/C-8069-2009	Moore, Ben D/0000-0002-6995-4721; Moore, Ben/0000-0002-6995-4721; Foley, William J/0000-0001-8587-1814				BRYANT JP, 1983, SCIENCE, V222, P1023, DOI 10.1126/science.222.4627.1023; DANELL K, 1991, ECOLOGY, V72, P1350, DOI 10.2307/1941107; DEGABRIELE R, 1981, AUST J ECOL, V6, P139, DOI 10.1111/j.1442-9993.1981.tb01284.x; DEGABRIELE R, 1983, AUST J ECOL, V8, P75, DOI 10.1111/j.1442-9993.1983.tb01520.x; DUNCAN AJ, 1994, CAN J ZOOL, V72, P1715, DOI 10.1139/z94-231; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; FARENTINOS RC, 1981, SCIENCE, V213, P1273, DOI 10.1126/science.213.4513.1273; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; HINDELL MA, 1985, AUST WILDLIFE RES, V12, P137; HUME ID, 1999, MARSUPIAL NUTR, pCH5; Lawler IR, 2000, ECOLOGY, V81, P1327, DOI 10.1890/0012-9658(2000)081[1327:FCOAST]2.0.CO;2; MARTIN RW, 1985, AUST WILDLIFE RES, V12, P355; MARTIN RW, 1999, KOALA NATURAL HIST C, pCH4; McIlwee AM, 2001, OECOLOGIA, V128, P539, DOI 10.1007/s004420100692; Moore BD, 2004, CONSERVATION OF AUTRALIA'S, SECOND EDITION, P549; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; Moore BD, 2004, ECOL MONOGR, V74, P553, DOI 10.1890/03-4038; Moore BD, 2004, J CHEM ECOL, V30, P1743, DOI 10.1023/B:JOEC.0000042399.06553.c6; O'Reilly-Wapstra JM, 2002, OECOLOGIA, V130, P289, DOI 10.1007/s004420100797; Provenza FD, 2003, SMALL RUMINANT RES, V49, P257, DOI 10.1016/S0921-4488(03)00143-3; PROVENZA FD, 1995, J RANGE MANAGE, V48, P2, DOI 10.2307/4002498; SCHMITZ OJ, 1992, OIKOS, V65, P295, DOI 10.2307/3545021; Scrivener NJ, 2004, EVOL ECOL RES, V6, P77; ULLREY DE, 1981, AUST J ZOOL, V29, P839, DOI 10.1071/ZO9810839; Villalba JJ, 2002, OIKOS, V97, P282, DOI 10.1034/j.1600-0706.2002.970214.x; Vourc'h G, 2001, OECOLOGIA, V126, P84, DOI 10.1007/s004420000491; WESTOBY M, 1978, AM NAT, V112, P627, DOI 10.1086/283303; White T. C. R., 1993, INADEQUATE ENV NITRO	29	134	141	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					488	490		10.1038/nature03551	http://dx.doi.org/10.1038/nature03551			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917807				2022-12-24	WOS:000229337800053
J	Backes, H; Neubauer, FM; Dougherty, MK; Achilleos, N; Andre, N; Arridge, CS; Bertucci, C; Jones, GH; Khurana, KK; Russell, CT; Wennmacher, A				Backes, H; Neubauer, FM; Dougherty, MK; Achilleos, N; Andre, N; Arridge, CS; Bertucci, C; Jones, GH; Khurana, KK; Russell, CT; Wennmacher, A			Titan's magnetic field signature during the first Cassini encounter	SCIENCE			English	Article							MHD MODEL; IONOSPHERE; MAGNETOSPHERE; SIMULATION; SATURN	The magnetic field signature obtained by Cassini during its first close encounter with Titan on 26 October 2004 is presented and explained in terms of an advanced model. Titan was inside the saturnian magnetosphere. A magnetic field minimum before closest approach marked Cassini's entry into the magnetic ionopause layer. Cassini then left the northern and entered the southern magnetic tail lobe. The magnetic field before and after the encounter was approximately constant for &SIM; 20 Titan radii, but the field orientation changed exactly at the location of Titan's orbit. No evidence of an internal magnetic field at Titan was detected.	Univ Cologne, Inst Geophys & Meteorol, D-50678 Cologne, Germany; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; Univ Toulouse 3, Ctr Etud Spatiale Rayonnements, F-31062 Toulouse, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University of Cologne; Imperial College London; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles	Backes, H (corresponding author), Univ Cologne, Inst Geophys & Meteorol, Albertus Magnus Pl, D-50678 Cologne, Germany.	backes@geo.uni-koeln.de	Wennmacher, Lex/HHM-2644-2022; Bertucci, Cesar/GOG-8941-2022; Russell, Christopher T/E-7745-2012; Achilleos, Nicholas/C-1647-2008; Arridge, Christopher S/A-2894-2009; Jones, Geraint H./C-1682-2008	Russell, Christopher T/0000-0003-1639-8298; Arridge, Christopher S/0000-0002-0431-6526; Jones, Geraint H./0000-0002-5859-1136; Khurana, Krishan/0000-0002-2856-1171; Achilleos, Nicholas/0000-0002-5886-3509; Bertucci, Cesar/0000-0002-2540-5384				ALFVEN H, 1957, TELLUS, V9, P92, DOI 10.1111/j.2153-3490.1957.tb01855.x; BACKES H, 2004, THESIS U COLOGNE GER; Brecht SH, 2000, J GEOPHYS RES-SPACE, V105, P13119, DOI 10.1029/1999JA900490; Cravens TE, 1998, PLANET SPACE SCI, V46, P1193, DOI 10.1016/S0032-0633(98)00051-8; Dougherty MK, 2004, SPACE SCI REV, V114, P331, DOI 10.1007/s11214-004-1432-2; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; HARTLE RE, 1982, J GEOPHYS RES-SPACE, V87, P1383, DOI 10.1029/JA087iA03p01383; IP WH, 1990, ASTROPHYS J, V362, P354, DOI 10.1086/169271; Kabin K, 1999, J GEOPHYS RES-SPACE, V104, P2451, DOI 10.1029/1998JA900080; KELLER CN, 1994, J GEOPHYS RES-SPACE, V99, P6511, DOI 10.1029/93JA02680; KELLER CN, 1992, J GEOPHYS RES-SPACE, V97, P12117, DOI 10.1029/92JA00231; KIVELSON MG, 1983, J GEOPHYS RES-SPACE, V88, P49, DOI 10.1029/JA088iA01p00049; Ledvina SA, 1998, PLANET SPACE SCI, V46, P1175, DOI 10.1016/S0032-0633(98)00052-X; Nagy AF, 2001, J GEOPHYS RES-SPACE, V106, P6151, DOI 10.1029/2000JA000183; NESS NF, 1982, J GEOPHYS RES-SPACE, V87, P1369, DOI 10.1029/JA087iA03p01369; Neubauer F.M., 1984, SATURN, P760; RICHARDS PG, 1994, J GEOPHYS RES-SPACE, V99, P8981, DOI 10.1029/94JA00518; SCHARDT AW, 1984, SATURN, P417; Wahlund JE, 2005, SCIENCE, V308, P986, DOI 10.1126/science.1109807	19	116	116	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					992	995		10.1126/science.1109763	http://dx.doi.org/10.1126/science.1109763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890875				2022-12-24	WOS:000229190700037
J	Mahaffy, PR				Mahaffy, PR			Intensive Titan exploration begins	SCIENCE			English	Article								The Cassini Orbiter spacecraft first skimmed through the tenuous upper atmosphere of Titan on 26 October 2004. This moon of Saturn is unique in our solar system, with a dense nitrogen atmosphere that is cold enough in places to rain methane, the feedstock for the atmospheric chemistry that produces hydrocarbons, nitrite compounds, and Titan's orange haze. The data returned from this flyby supply new information on the magnetic field and plasma environment around Titan, expose new facets of the dynamics and chemistry of Titan's atmosphere, and provide the first glimpses of what appears to be a complex, fluid-processed, geologically young Titan surface.	NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Mahaffy, PR (corresponding author), NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Code 661, Greenbelt, MD 20771 USA.	paul.r.mahaffy@nasa.gov	Mahaffy, Paul/E-4609-2012	Mahaffy, Paul/0000-0003-1896-1726				Backes H, 2005, SCIENCE, V308, P992, DOI 10.1126/science.1109763; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; Lorenz R. D., 2002, LIFTING TITANS VEIL; Mitchell DG, 2005, SCIENCE, V308, P989, DOI 10.1126/science.1109805; Niemann HB, 2002, SPACE SCI REV, V104, P553, DOI 10.1023/A:1023680305259; Owen T, 2002, SPACE SCI REV, V104, P347, DOI 10.1023/A:1023684406168; Shemansky DE, 2005, SCIENCE, V308, P978, DOI 10.1126/science.1111790; Wahlund JE, 2005, SCIENCE, V308, P986, DOI 10.1126/science.1109807; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wolf AA, 2002, SPACE SCI REV, V104, P101, DOI 10.1023/A:1023692724823	12	18	19	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					969	970		10.1126/science.1113205	http://dx.doi.org/10.1126/science.1113205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890870				2022-12-24	WOS:000229190700030
J	Arribas, J				Arribas, J			Matrix metalloproteases and tumor invasion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER CELLS; RECEPTOR		Vall Hebron Univ Hosp Res Inst, Med Oncol Res Program, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Arribas, J (corresponding author), Vall Hebron Univ Hosp Res Inst, Med Oncol Res Program, Barcelona, Spain.		Arribas, Joaquin/M-4482-2014	Arribas, Joaquin/0000-0002-0504-0664				Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Kamath L, 2001, CANCER RES, V61, P5933	5	14	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					2020	2021		10.1056/NEJMcibr055002	http://dx.doi.org/10.1056/NEJMcibr055002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888705				2022-12-24	WOS:000229017100016
J	Umina, PA; Weeks, AR; Kearney, MR; McKechnie, SW; Hoffmann, AA				Umina, PA; Weeks, AR; Kearney, MR; McKechnie, SW; Hoffmann, AA			A rapid shift in a classic clinal pattern in Drosophila reflecting climate change	SCIENCE			English	Article							METABOLICALLY RELATED ADH; ALCOHOL-DEHYDROGENASE; NATURAL-POPULATIONS; INVERSION POLYMORPHISMS; LATITUDINAL CLINES; TPI POLYMORPHISMS; MELANOGASTER; GENETICS; GPDH; ASSOCIATIONS	Geographical clines in genetic polymorphisms are widely used as evidence of climatic selection and are expected to shift with climate change. We show that the classic latitudinal cline in the alcohol dehydrogenase polymorphism of Drosophila melanogaster has shifted over 20 years in eastern coastal Austratia. Southern high-latitude populations now have the genetic constitution of more northerly populations, equivalent to a shift of 40 in latitude. A similar shift was detected for a genetically independent inversion polymorphism, whereas two other linked polymorphisms exhibiting weaker clinal patterns have remained relatively stable. These genetic changes are likely to reflect increasingly warmer and drier conditions and may serve as sensitive biomarkers for climate change.	La Trobe Univ, Ctr Environm Stress & Adaptat Res, Bundoora, Vic 3086, Australia; Monash Univ, Sch Biol Sci, Ctr Environm Stress & Adaptat Res, Clayton, Vic 3800, Australia	La Trobe University; Monash University	Hoffmann, AA (corresponding author), La Trobe Univ, Ctr Environm Stress & Adaptat Res, Bundoora, Vic 3086, Australia.	ary@unimelb.edu.au	Hoffmann, Ary/R-2972-2019; Weeks, Andrew/ABC-3048-2020; Hoffmann, Ary/C-2961-2011; Kearney, Michael/R-3404-2017	Hoffmann, Ary/0000-0001-9497-7645; Kearney, Michael/0000-0002-3349-8744; Weeks, Andrew/0000-0003-3081-135X; Umina, Paul/0000-0002-1835-3571				ALAHIOTIS SN, 1982, GENETICA, V59, P81, DOI 10.1007/BF00133290; ANDERSON AR, IN PRESS MOL ECOL; ANDERSON PR, 1987, GENETICA, V75, P81, DOI 10.1007/BF00055251; ANDERSON PR, 1984, NATURE, V308, P729, DOI 10.1038/308729a0; Andolfatto P, 1999, GENETICS, V153, P1297; BERRY A, 1993, GENETICS, V134, P869; BOCK IR, 1981, GENET BIOL DROSOPHIL, P299; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; COYNE JA, 1987, GENETICS, V117, P727; DAVID JR, 1975, EXPERIENTIA, V31, P164, DOI 10.1007/BF01990682; Dobzhansky T, 1943, GENETICS, V28, P162; Endler J.A., 1986, Monographs in Population Biology, pviii; Etges WJ, 2004, BIOL J LINN SOC, V81, P395, DOI 10.1111/j.1095-8312.2004.00306.x; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kamping A, 1999, J EVOLUTION BIOL, V12, P809, DOI 10.1046/j.1420-9101.1999.00083.x; Kennington WJ, 2003, GENETICS, V165, P667; KNIBB WR, 1982, GENETICA, V58, P213, DOI 10.1007/BF00128015; MCKENZIE JA, 1983, GENETIC STUDIES DROS, P201; NIELSEN KM, 1985, GENET SEL EVOL, V17, P41, DOI 10.1186/1297-9686-17-1-41; OAKESHOTT JG, 1984, GENETICA, V63, P21, DOI 10.1007/BF00137461; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; Rodriguez-Trelles F, 1998, EVOL ECOL, V12, P829, DOI 10.1023/A:1006546616462; 't Land JV, 2000, EVOLUTION, V54, P201, DOI 10.1554/0014-3820(2000)054[0201:LVFTEL]2.0.CO;2; VANDELDEN W, 1978, GENETICS, V90, P161; VANDELDEN W, 1984, POPULATION BIOL EVOL, P127; VIGUE CL, 1973, BIOCHEM GENET, V9, P213, DOI 10.1007/BF00485735; Weeks AR, 2002, ECOL LETT, V5, P756, DOI 10.1046/j.1461-0248.2002.00380.x; ZILLMAN JW, 2003, YB AUSTR	29	288	305	3	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					691	693		10.1126/science.1109523	http://dx.doi.org/10.1126/science.1109523			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860627				2022-12-24	WOS:000228810900049
J	Lawrence, T; Bebien, M; Liu, GY; Nizet, V; Karin, M				Lawrence, T; Bebien, M; Liu, GY; Nizet, V; Karin, M			IKK alpha limits macrophage NF-kappa B activation and contributes to the resolution of inflammation	NATURE			English	Article							C-REL; PHOSPHORYLATION; KINASE; TRANSCRIPTION; RECOGNITION; UBIQUITINATION; DEGRADATION; EXPRESSION; RECEPTORS; EXCHANGE	Inflammation and innate immunity involve signalling pathways leading to the production of inflammatory mediators. Usually such responses are self-limiting, but aberrant resolution of inflammation results in chronic diseases(1). Much attention has focused on pro-inflammatory signalling but little is known about the mechanisms that resolve inflammation. The I kappa B kinase (IKK) complex contains two catalytic subunits, IKK alpha and IKK beta, and controls the activation of NF-kappa B transcription factors, which play a pivotal role in inflammation(2). Ample evidence indicates that IKK beta mediates NF-kappa B activation in response to pro-inflammatory cytokines and microbial products. IKK alpha regulates an alternative pathway important for lymphoid organogenesis(2), but the role of IKK alpha in inflammation is unknown. Here we describe a new role for IKK alpha in the negative regulation of macrophage activation and inflammation. IKK alpha contributes to suppression of NF-kappa B activity by accelerating both the turnover of the NF-kappa B subunits RelA and c-Rel, and their removal from pro-inflammatory gene promoters. Inactivation of IKK alpha in mice enhances inflammation and bacterial clearance. Hence, the two IKK catalytic subunits have evolved opposing but complimentary roles needed for the intricate control of inflammation and innate immunity.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Div Paediat Infect Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Lawrence, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Kennedy Inst, 1 Aspenlea Rd, London W6 8LH, England.	t.lawrence@imperial.ac.uk	Nizet, Victor/AAF-3190-2019; Lawrence, Toby/GLU-3895-2022	Lawrence, Toby/0000-0003-0967-6122; Nizet, Victor/0000-0003-3847-0422				Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen E, 1998, J BIOL CHEM, V273, P35201, DOI 10.1074/jbc.273.52.35201; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Fognani C, 2000, ONCOGENE, V19, P2224, DOI 10.1038/sj.onc.1203543; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Martin AG, 2000, J BIOL CHEM, V275, P24383, DOI 10.1074/jbc.M909396199; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Puliti M, 2004, INFECT IMMUN, V72, P4891, DOI 10.1128/IAI.72.8.4891-4894.2004; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	30	537	570	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1138	1143		10.1038/nature03491	http://dx.doi.org/10.1038/nature03491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858576				2022-12-24	WOS:000228693300045
J	Sharp, SP; McGowan, A; Wood, MJ; Hatchwell, BJ				Sharp, SP; McGowan, A; Wood, MJ; Hatchwell, BJ			Learned kin recognition cues in a social bird	NATURE			English	Article							LONG-TAILED TITS; AEGITHALOS-CAUDATUS; SEYCHELLES WARBLER; KINSHIP; DISCRIMINATION; BEHAVIOR; FITNESS; HELPERS; CALLS	In many cooperatively breeding birds, kin selection has an important role in the evolution and maintenance of social behaviour, and 'helpers' can maximize indirect fitness gains by preferentially allocating care to close relatives(1-3). Although there is evidence for kin-biased helping behaviour in several species(1,4,5), the mechanism of kin recognition underlying this behaviour is poorly understood(2). Vocalizations are the most commonly used cues in avian recognition systems(6,7), but the effectiveness of vocal signals as reliable recognition cues must depend on how they are acquired(6-9). However, there have been no experimental studies of the development of vocal recognition cues in cooperative birds; indeed, the ontogeny of all bird vocalizations other than song is poorly known in any species(10-12). Here, we show that cooperatively breeding long-tailed tits (Aegithalos caudatus) can discriminate between kin and non-kin according to the individual-specific characteristics of contact calls, and show experimentally that individuals learn these calls from provisioning adults during the nestling period. Finally, we show that the pattern of cooperative behaviour in this species is consistent with the use of recognition cues learned through association.	Univ Sheffield, Dept Anim & Plant Sci, Evolut & Behav Grp, Sheffield S10 2TN, S Yorkshire, England; Univ Exeter Cornwall, Ctr Ecol & Conservat, Marine Turtle Res Grp, Penryn TR10 9EZ, England; Univ Oxford, Dept Zool, Edward Grey Inst Field Ornithol, Oxford OX1 3PS, England	University of Sheffield; University of Exeter; University of Oxford	Sharp, SP (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Evolut & Behav Grp, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	s.sharp@sheffield.ac.uk	Sharp, Stuart P/F-8246-2014; Hatchwell, Ben J/C-5433-2016; Wood, Matthew/HDN-1469-2022; Wood, Matthew J/B-6124-2011	Sharp, Stuart P/0000-0002-3059-2532; Hatchwell, Ben J/0000-0002-1039-4782; Wood, Matthew J/0000-0003-0920-8396; Wood, Matthew/0000-0002-5436-6011	Natural Environment Research Council [NER/A/S/2002/00779] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baptista Luis F., 1996, P39; BEECHER MD, 1988, BEHAV GENET, V18, P465, DOI 10.1007/BF01065515; BrittanPowell EF, 1997, J COMP PSYCHOL, V111, P226; Dickinson Janis L., 2004, P48, DOI 10.1017/CBO9780511606816.004; EMLEN ST, 1988, BEHAV ECOL SOCIOBIOL, V23, P305, DOI 10.1007/BF00300577; GASTON AJ, 1973, IBIS, V115, P330, DOI 10.1111/j.1474-919X.1973.tb01974.x; HALPIN ZT, 1991, KIN RECOGNITION, P220; Hatchwell BJ, 2004, BEHAV ECOL, V15, P1, DOI 10.1093/beheco/arg091; Hatchwell BJ, 2002, ANIM BEHAV, V64, P55, DOI 10.1006/anbe.2002.3033; Hatchwell BJ, 2001, J ANIM ECOL, V70, P820, DOI 10.1046/j.0021-8790.2001.00541.x; Hatchwell BJ, 2001, P ROY SOC B-BIOL SCI, V268, P885, DOI 10.1098/rspb.2001.1598; Hughes M, 1998, ETHOLOGY, V104, P232; Komdeur J, 2004, P ROY SOC B-BIOL SCI, V271, P963, DOI 10.1098/rspb.2003.2665; Komdeur J, 1999, TRENDS ECOL EVOL, V14, P237, DOI 10.1016/S0169-5347(98)01573-0; KOMDEUR J, 1994, P ROY SOC B-BIOL SCI, V256, P47, DOI 10.1098/rspb.1994.0047; Maccoll ADC, 2004, J ANIM ECOL, V73, P1137, DOI 10.1111/j.0021-8790.2004.00887.x; MacColl ADC, 2003, ANIM BEHAV, V66, P955, DOI 10.1006/anbe.2003.2268; MacColl ADC, 2002, AM NAT, V160, P186, DOI 10.1086/341013; Marler P., 1971, P389; Price JJ, 1998, P ROY SOC B-BIOL SCI, V265, P497, DOI 10.1098/rspb.1998.0322; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790; Sherman Paul W., 1997, P69; WALDMAN B, 1987, J THEOR BIOL, V128, P159, DOI 10.1016/S0022-5193(87)80167-4	23	191	197	1	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1127	1130		10.1038/nature03522	http://dx.doi.org/10.1038/nature03522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858573				2022-12-24	WOS:000228693300042
J	Lindor, NM; Rabe, K; Petersen, GM; Haile, R; Casey, G; Baron, J; Gallinger, S; Bapat, B; Aronson, M; Hopper, J; Jass, J; LeMarchand, L; Grove, J; Potter, J; Newcomb, P; Terdiman, JP; Conrad, P; Moslein, G; Goldberg, R; Ziogas, A; Anton-Culver, H; de Andrade, M; Siegmund, K; Thibodeau, SN; Boardman, LA; Seminara, D				Lindor, NM; Rabe, K; Petersen, GM; Haile, R; Casey, G; Baron, J; Gallinger, S; Bapat, B; Aronson, M; Hopper, J; Jass, J; LeMarchand, L; Grove, J; Potter, J; Newcomb, P; Terdiman, JP; Conrad, P; Moslein, G; Goldberg, R; Ziogas, A; Anton-Culver, H; de Andrade, M; Siegmund, K; Thibodeau, SN; Boardman, LA; Seminara, D			Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency - Familial colorectal cancer type X	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MICROSATELLITE INSTABILITY; MUTATION CARRIERS; KINDREDS; GENES	Context Approximately 60% of families that meet the Amsterdam-I criteria (AC-I) for hereditary nonpolyposis colorectal cancer (HNPCC) have a hereditary abnormality in a DNA mismatch repair (MMR) gene. Cancer incidence in AC-I families with MMR gene mutations is reported to be very high, but cancer incidence for individuals in AC-I families with no evidence of an MMR defect is unknown. Objective To determine if cancer risks in AC-I families with no apparent deficiency in DNA MMR are different from cancer risks in AC-I families with DNA MMR abnormalities. Design, Setting, and Participants Identification (1997-2001) of 161 AC-I pedigrees from multiple population- and clinic-based sources,in North America and Germany, with families grouped into those with (group A) or without (group B) MMR deficiency by tumor testing. A total of 3422 relatives were included in the analyses. Main Outcome Measures Cancer incidence in groups A and B (excluding the 3 affected members used to define each pedigree as AC-I) and computed age- and sex-adjusted standardized incidence ratios (SIRs) using Surveillance, Epidemiology, and End Results data. Results Group A families from both population- and clinic-based series showed increased incidence of the HNPCC-related cancers. Group B families showed increased incidence only for colorectal cancer (SIR, 2.3; 95% confidence interval,. 1.7-3.0) and to a lesser extent than group A (SIR, 6.1; 95% confidence interval, 5.2-7.2) (P<.001). Conclusions Families who fulfill AC-I criteria but who have no evidence of a DNA MMR defect do not share the same cancer incidence as families with HNPCC-Lynch syndrome (ie, hereditary MMR deficiency). Relatives in such families have a lower incidence of colorectal cancer than those in families with HNPCC-Lynch syndrome, and incidence may not be increased for other cancers. These families should not be described or counseled as having HNPCC-Lynch syndrome. To facilitate distinguishing these entities, the designation of "familial colorectal cancer type V is suggested to describe this type of familial aggregation of colorectal cancer.	Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Gastroenterol, Rochester, MN 55905 USA; Univ So Calif, Los Angeles, CA USA; Cleveland Clin, Cleveland, OH 44106 USA; Dartmouth Coll Sch Med, Hanover, NH USA; Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Melbourne, Melbourne, Vic, Australia; McGill Univ, Montreal, PQ, Canada; Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; Univ San Francisco, Dept Canc Biol, San Francisco, CA 94117 USA; Univ Dusseldorf, Dept Surg, D-4000 Dusseldorf, Germany; Univ N Carolina, Chapel Hill, NC USA; Univ Calif Irvine, Irvine, CA USA; NCI, Div Canc Control & Populat Sci, Clin & Genet Epidemiol Res Branch, NIH, Bethesda, MD 20892 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Southern California; Cleveland Clinic Foundation; Dartmouth College; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Melbourne; McGill University; Cancer Research Center of Hawaii; University of Hawaii System; Fred Hutchinson Cancer Center; University of San Francisco; Heinrich Heine University Dusseldorf; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lindor, NM (corresponding author), Mayo Clin & Mayo Fdn, Dept Med Genet, 200 1st St SW, Rochester, MN 55905 USA.	nlindor@mayo.edu	Gallinger, Steven/E-4575-2013; Bapat, Bharati/B-5839-2014	de Andrade, Mariza/0000-0003-2329-2686; Potter, John/0000-0001-5439-1500	NATIONAL CANCER INSTITUTE [U01CA074799, U01CA078296, U01CA074794, K22CA095011, U01CA074783, U01CA074806, U01CA074800, U24CA074800, U01CA097735] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA074799, UO1 CA074800, UO1 CA074799, U01 CA074794, UO1 CA074806, UO1 CA078296, U01 CA097735, U24 CA074800-13, UO1 CA074794, CA-95-011, U01 CA074783, U01 CA074806, U24 CA074800, U01 CA078296, U01 CA074800, UO1 CA097735, UO1 CA074783] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; BERGSTALH EJ, 1986, SAS I INC TECHNICAL, V31; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; Buttin BM, 2004, AM J HUM GENET, V74, P1262, DOI 10.1086/421332; COX DR, 1953, BIOMETRIKA, V40, P354, DOI 10.1093/biomet/40.3-4.354; Efron B., 1982, REGIONAL C SERIES AP, V38; Jarvinen HJ, 2000, ANN CHIR GYNAECOL, V89, P207; JASS JR, 1995, LANCET, V346, P1200, DOI 10.1016/S0140-6736(95)92902-9; Kakar S, 2003, CANCER-AM CANCER SOC, V97, P1421, DOI 10.1002/cncr.11206; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Lucci-Cordisco E, 2001, Fam Cancer, V1, P93; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; *NAT CANC I, 2003, SURV EP END RES SEER; *NAT COMPR CANC NE, 2005, NAT COMPR CANC NETW; Scott RJ, 2001, AM J HUM GENET, V68, P118, DOI 10.1086/316942; Smith RA, 2004, CA-CANCER J CLIN, V54, P41, DOI 10.3322/canjclin.54.1.41; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#	18	407	422	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					1979	1985		10.1001/jama.293.16.1979	http://dx.doi.org/10.1001/jama.293.16.1979			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855431	Green Accepted, Bronze			2022-12-24	WOS:000228651500023
J	Yuan, GC; Liu, YJ; Dion, MF; Slack, MD; Wu, LF; Altschuler, SJ; Rando, OJ				Yuan, GC; Liu, YJ; Dion, MF; Slack, MD; Wu, LF; Altschuler, SJ; Rando, OJ			Genome-scale identification of nucleosome positions in S-cerevisiae	SCIENCE			English	Article							RNA-POLYMERASE-II; DNA TARGET SITES; IN-VIVO; EQUILIBRIUM ACCESSIBILITY; CHROMATIN-STRUCTURE; PROMOTER ELEMENTS; CHROMOSOME-III; YEAST; TRANSCRIPTION; GENE	The positioning of nucleosomes along chromatin has been implicated in the regulation of gene expression in eukaryotic cells, because packaging DNA into nucleosomes affects sequence accessibility. We developed a tiled microarray approach to identify at high resolution the translational positions of 2278 nucleosomes over 482 kilobases of Saccharomyces cerevisiae DNA, including almost all of chromosome III and 223 additional regulatory regions. The majority of the nucleosomes identified were well-positioned. We found a stereotyped chromatin organization at Pol II promoters consisting of a nucleosome-free region similar to 200 base pairs upstream of the start codon flanked on both sides by positioned nucleosomes. The nucleosome-free sequences were evolutionarily conserved and were enriched in poly-deoxyadenosine or poly-deoxythymidine sequences. Most occupied transcription factor binding motifs were devoid of nucleosomes, strongly suggesting that nucleosome positioning is a global determinant of transcription factor access.	Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	Harvard University	Rando, OJ (corresponding author), Harvard Univ, Bauer Ctr Genom Res, 7 Divin Ave, Cambridge, MA 02138 USA.	orando@cgr.harvard.edu		Dion, Michael/0000-0002-0434-4236				Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Durbin, 1998, BIOL SEQUENCE ANAL P; Ercan S, 2004, MOL CELL BIOL, V24, P10026, DOI 10.1128/MCB.24.22.10026-10035.2004; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; KARLIN S, 1993, NUCLEIC ACIDS RES, V21, P703, DOI 10.1093/nar/21.3.703; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; SAUNDERS MJ, 1990, MOL CELL BIOL, V10, P5721, DOI 10.1128/MCB.10.11.5721; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Stunkel W, 1997, MOL CELL BIOL, V17, P4397; Teng Y, 2001, Nucleic Acids Res, V29, pE64, DOI 10.1093/nar/29.13.e64; van Holde KE., 1989, SPRINGER SERIES MOL; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; WALTZ RD, 1994, AQUAT INSECT, V16, P165, DOI 10.1080/01650429409361551	28	893	921	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					626	630		10.1126/science.1112178	http://dx.doi.org/10.1126/science.1112178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	15961632				2022-12-24	WOS:000230735200053
J	Manoli, DS; Foss, M; Villella, A; Taylor, BJ; Hall, JC; Baker, BS				Manoli, DS; Foss, M; Villella, A; Taylor, BJ; Hall, JC; Baker, BS			Male-specific fruitless specifies the neural substrates of Drosophila courtship behaviour	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPRESSION PATTERNS; GENETIC DISSECTION; SEXUAL-DIMORPHISM; MELANOGASTER; NEURONS; IDENTIFICATION; ABLATION; MUTANTS; COMPLEX	Robust innate behaviours are attractive systems for genetically dissecting how environmental cues are perceived and integrated to generate complex behaviours. During courtship, Drosophila males engage in a series of innate, stereotyped behaviours that are coordinated by specific sensory cues. However, little is known about the specific neural substrates mediating this complex behavioural programme(1). Genetic, developmental and behavioural studies have shown that the fruitless (fru) gene encodes a set of male-specific transcription factors (Fru(M)) that act to establish the potential for courtship in Drosophila(2). Fru(M) proteins are expressed in similar to 2% of central nervous system neurons, at least one subset of which coordinates the component behaviours of courtship(3,4). Here we have inserted the yeast GAL4 gene into the fru locus by homologous recombination and show that ( 1) Fru(M) is expressed in subsets of all peripheral sensory systems previously implicated in courtship, ( 2) inhibition of Fru(M) function in olfactory system components reduces olfactory-dependent changes in courtship behaviour, ( 3) transient inactivation of all Fru(M)-expressing neurons abolishes courtship behaviour, with no other gross changes in general behaviour, and ( 4) 'masculinization' of Fru(M)-expressing neurons in females is largely sufficient to confer male courtship behaviour. Together, these data demonstrate that Fru(M) proteins specify the neural substrates of male courtship.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Stanford University; Stanford University; Oregon State University; Brandeis University	Baker, BS (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	bbaker@pmgm2.stanford.edu		Manoli, Devanand/0000-0002-7238-2330				Acebes A, 2004, CURR BIOL, V14, P704, DOI 10.1016/j.cub.2004.04.003; Acebes A, 2003, J EXP BIOL, V206, P3095, DOI 10.1242/jeb.00522; Anand A, 2001, GENETICS, V158, P1569; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Boekhoff-Falk G, 2005, DEV DYNAM, V232, P550, DOI 10.1002/dvdy.20207; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; EWING AW, 1979, J COMP PHYSIOL, V130, P87, DOI 10.1007/BF02582977; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Goodwin SF, 2000, GENETICS, V154, P725; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; KEIL TA, 1989, TISSUE CELL, V21, P139, DOI 10.1016/0040-8166(89)90028-1; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Scott KC, 1999, GENETICS, V153, P787; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Shyamala BV, 1999, J GENET, V78, P87, DOI 10.1007/BF02924560; Smith SA, 1996, J COMP NEUROL, V364, P311; Song HJ, 2002, GENETICS, V162, P1703; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; VAIAS LJ, 1993, BEHAV GENET, V23, P91, DOI 10.1007/BF01067558; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017	30	290	297	6	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					395	400		10.1038/nature03859	http://dx.doi.org/10.1038/nature03859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	15959468				2022-12-24	WOS:000230623400043
J	Mesecke, N; Terziyska, N; Kozany, C; Baumann, F; Neupert, W; Hell, K; Herrmann, JM				Mesecke, N; Terziyska, N; Kozany, C; Baumann, F; Neupert, W; Hell, K; Herrmann, JM			A disulfide relay system in the intermembrane space of mitochondria that mediates protein import	CELL			English	Article							SMALL TIM PROTEINS; SUPEROXIDE-DISMUTASE; SULFHYDRYL OXIDASE; BOND FORMATION; YEAST; GENE; COMPLEX; TRANSLOCATION; MEMBRANE; MIA40	We describe here a pathway for the import of proteins into the intermembrane space (IMS) of mitochondria. Substrates of this pathway are proteins with conserved cysteine motifs, which are critical for import. After passage through the TOM channel, these proteins are covalently trapped by Mia40 via disulfide bridges. Mia40 contains cysteine residues, which are oxidized by the sulfhydryl oxidase Erv1. Depletion of Erv1 or conditions reducing Mia40 prevent protein import. We propose that Erv1 and Mia40 function as a disulfide relay system that catalyzes the import of proteins into the IMS by an oxidative folding mechanism. The existence of a disulfide exchange system in the IMS is unexpected in view of the free exchange of metabolites between IMS and cytosol via porin channels. We suggest that this process reflects the evolutionary origin of the IMS from the periplasmic space of the prokaryotic ancestors of mitochondria.	Univ Munich, Inst Physiol Chem, D-81377 Munich, Germany	University of Munich	Herrmann, JM (corresponding author), Univ Munich, Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	hannes.herrmann@bio.med.uni-muenchen.de	Wagener, Nikola/L-3202-2017; Baumann, Frank/F-7737-2016					Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Becher D, 1999, YEAST, V15, P1171, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1171::AID-YEA443>3.0.CO;2-T; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Curran SP, 2004, J BIOL CHEM, V279, P43744, DOI 10.1074/jbc.M404878200; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gerber J, 2001, J BIOL CHEM, V276, P23486, DOI 10.1074/jbc.M100134200; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2001, METHOD CELL BIOL, V65, P217, DOI 10.1016/S0091-679X(01)65013-1; Hiniker A, 2004, TRENDS BIOCHEM SCI, V29, P516, DOI 10.1016/j.tibs.2004.08.002; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Jensen RE, 2002, BBA-MOL CELL RES, V1592, P25, DOI 10.1016/S0167-4889(02)00261-6; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KOCHLER CM, 2004, ANNU REV CELL DEV BI, V20, P309; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Lutz T, 2003, EMBO J, V22, P4400, DOI 10.1093/emboj/cdg421; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Williams JC, 2005, J BIOL CHEM, V280, P15202, DOI 10.1074/jbc.M410705200	40	432	445	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1059	1069		10.1016/j.cell.2005.04.011	http://dx.doi.org/10.1016/j.cell.2005.04.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989955	Bronze			2022-12-24	WOS:000230448000012
J	Perry, AL; Low, PJ; Ellis, JR; Reynolds, JD				Perry, AL; Low, PJ; Ellis, JR; Reynolds, JD			Climate change and distribution shifts in marine fishes	SCIENCE			English	Article								We show that the distributions of both exploited and nonexploited North Sea fishes have responded markedly to recent increases in sea temperature, with nearly two-thirds of species shifting in mean latitude or depth or both over 25 years. For species with northerly or southerly range margins in the North Sea, half have shown boundary shifts with warming, and all but one shifted northward. Species with shifting distributions have faster life cycles and smaller body sizes than nonshifting species. Further temperature rises are likely to have profound impacts on commercial fisheries through continued shifts in distribution and alterations in community interactions.	Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft NR33 0HT, Suffolk, England	University of East Anglia; Centre for Environment Fisheries & Aquaculture Science	Perry, AL (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	a.perry@uea.ac.uk; reynolds@uea.ac.uk	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074				Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Brander K, 2003, ICES MARINE SCI S, V219, P261; DAAN N, 2003, N10 ICES; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; *ICES ADV COMM FIS, 2004, 2004ACFM24; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jennings S, 1999, FISH RES, V40, P125, DOI 10.1016/S0165-7836(98)00208-2; Knijn RJ, 1993, ICES COOPERATIVE RES, P194; MURAWSKI SA, 1993, T AM FISH SOC, V122, P647, DOI 10.1577/1548-8659(1993)122<0647:CCAMFD>2.3.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; REYNOLDS JD, 2001, CONSERVATION EXPLOIT, P145; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Strahler A., 1997, PHYS GEOGRAPHY SCI S; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas M, 1998, REHABILITATED ESTUARINE ECOSYSTEMS, P115; *UK CLIM IMP PROGR, UKCIPO2 SCEN GAT MAP; Wood C.M., 1997, GLOBAL WARMING IMPLI	19	2014	2090	25	973	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1912	1915		10.1126/science.1111322	http://dx.doi.org/10.1126/science.1111322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15890845	Green Submitted			2022-12-24	WOS:000230120000041
J	Akram, R				Akram, R			I am a better doctor now	LANCET			English	Editorial Material									Univ Hosp Aintree, Aintree Cardiac Ctr, Liverpool L9 7AL, Merseyside, England		Akram, R (corresponding author), Univ Hosp Aintree, Aintree Cardiac Ctr, Liverpool L9 7AL, Merseyside, England.	razasida@hotmail.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2005	365	9477					2149	2149		10.1016/S0140-6736(05)66740-2	http://dx.doi.org/10.1016/S0140-6736(05)66740-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936LZ	15964455				2022-12-24	WOS:000229858800034
J	Muotri, AR; Chu, VT; Marchetto, MCN; Deng, W; Moran, JV; Gage, FH				Muotri, AR; Chu, VT; Marchetto, MCN; Deng, W; Moran, JV; Gage, FH			Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; LINE-1; GENE; TRANSCRIPTION; NEUROGENESIS; EXPRESSION; SEQUENCE; DIFFERENTIATION; DISRUPTION	Revealing the mechanisms for neuronal somatic diversification remains a central challenge for understanding individual differences in brain organization and function. Here we show that an engineered human LINE-1 (for long interspersed nuclear element-1; also known as L1) element can retrotranspose in neuronal precursors derived from rat hippocampus neural stem cells. The resulting retrotransposition events can alter the expression of neuronal genes, which, in turn, can influence neuronal cell fate in vitro. We further show that retrotransposition of a human L1 in transgenic mice results in neuronal somatic mosaicism. The molecular mechanism of action is probably mediated through Sox2, because a decrease in Sox2 expression during the early stages of neuronal differentiation is correlated with increases in both L1 transcription and retrotransposition. Our data therefore indicate that neuronal genomes might not be static, but some might be mosaic because of de novo L1 retrotransposition events.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Michigan, Sch Med, Dept Human Genet & Internal Med, Ann Arbor, MI 48109 USA	Salk Institute; University of Michigan System; University of Michigan	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu						Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; DeBerardinis RJ, 1998, NAT GENET, V20, P288, DOI 10.1038/3104; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; GRIMALDI G, 1984, EMBO J, V3, P1753, DOI 10.1002/j.1460-2075.1984.tb02042.x; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; HOGAN J, 1994, MANIPULATING MOUSE E; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lietz M, 2003, EUR J BIOCHEM, V270, P2, DOI 10.1046/j.1432-1033.2003.03360.x; MIKI Y, 1992, CANCER RES, V52, P643; Moran J.V., 2002, MOBILE DNA, P836; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Naef F, 2002, GENOME BIOL, V3; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Prak ETL, 2003, P NATL ACAD SCI USA, V100, P1832, DOI 10.1073/pnas.0337627100; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Yang N, 2003, NUCLEIC ACIDS RES, V31, P4929, DOI 10.1093/nar/gkg663; Zapala MA, 2002, GENOME BIOL, V3; Zappone MV, 2000, DEVELOPMENT, V127, P2367	44	655	680	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					903	910		10.1038/nature03663	http://dx.doi.org/10.1038/nature03663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959507	Green Published			2022-12-24	WOS:000229799700037
J	Haddad, MB; Wilson, TW; Iiaz, K; Marks, SM; Moore, M				Haddad, MB; Wilson, TW; Iiaz, K; Marks, SM; Moore, M			Tuberculosis and homelessness in the United States, 1994-2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	132nd Annual Meeting of the American-Public-Health-Association	NOV 06-10, 2004	Washington, DC	Amer Public Hlth Assoc			MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; OUTBREAK; SHELTER	Context Tuberculosis (TB) rates among US homeless persons cannot be calculated because they are not included in the US Census. However, homelessness is often associated with TB. Objectives To describe homeless persons with TB and to compare risk factors and disease characteristics between homeless and nonhomeless persons with TB. Design and Setting Cross-sectional analysis of all verified TB cases reported into the National TB Surveillance System from the 50 states and the District of Columbia from 1994 through 2003. Main Outcome Measures Number and proportion of TB cases associated with homelessness, demographic characteristics, risk factors, disease characteristics, treatment, and outcomes. Results Of 185870 cases of TB disease reported between 1994 and 2003, 11369 were among persons classified as homeless during the 12 months before diagnosis. The annual proportion of cases associated with homelessness was stable (6.1%-6.7%). Regional differences occurred with a higher proportion of TB cases associated with homelessness in western and some southern states. Most homeless persons with TB were male (87%) and aged 30 to 59 years. Black individuals represented the highest proportion of TB cases among the homeless and nonhomeless. The proportion of homeless persons with TB who were born outside the United States (18%) was lower than that for nonhomeless persons with TB (44%). At the time of TB diagnosis, 9% of homeless persons were incarcerated, usually in a local jail; 3% of nonhomeless persons with TB were incarcerated. Compared with nonhomeless persons, homeless persons with TB had a higher prevalence of substance use (54% alcohol abuse, 29.5% noninjected drug use, and 14% injected drug use), and 34% of those tested had coinfection with human immunodeficiency virus. Compared with nonhomeless persons, TB disease in homeless persons was more likely to be infectious but not more likely to be drug resistant. Health departments managed 81 % of TB cases in homeless persons. Directly observed therapy, used for 86% of homeless patients, was associated with timely completion of therapy. A similar proportion in both groups (9%) died from any cause during therapy. Conclusions Individual TB risk factors often overlap with risk factors for homelessness, and the social contexts in which TB occurs are often complex and important to consider in planning TB treatment. Nevertheless, given good case management, homeless persons with TB can achieve excellent treatment outcomes.	Ctr Dis Control & Prevent, Surveillance Epidemiol & Outbreak Invest Branch, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Haddad, MB (corresponding author), Ctr Dis Control & Prevent, Surveillance Epidemiol & Outbreak Invest Branch, Div TB Eliminat, 1600 Clifton Rd,Mailstop E-10, Atlanta, GA 30333 USA.	maryam.haddad@cdc.hhs.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2003, MMWR RECOMM REP; Asch S, 1998, ANN EMERG MED, V32, P144, DOI 10.1016/S0196-0644(98)70128-3; Baldwin GC, 1997, AM J RESP CRIT CARE, V156, P1606, DOI 10.1164/ajrccm.156.5.9704146; Barnes PF, 1996, JAMA-J AM MED ASSOC, V275, P305, DOI 10.1001/jama.275.4.305; *CDCP, 1995, CONTR TB CORR FAC; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P556; Centers for Disease Control, 2004, REP TUB US 2003; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1184; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P734; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1209; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; Curtis AB, 2000, INT J TUBERC LUNG D, V4, P308; *I MED, 2000, END NEGL EL TUB US; Iseman Michael D., 2000, CLIN GUIDE TUBERCULO; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; Knopf SA, 1914, J AMER MED ASSOC, V63, P1720; Lathan M, 2002, EMERG INFECT DIS, V8, P1249; Marks SM, 2000, AM J PUBLIC HEALTH, V90, P435, DOI 10.2105/AJPH.90.3.435; Mayaud C, 2001, Rev Pneumol Clin, V57, P259; NOLAN CM, 1991, AM REV RESPIR DIS, V143, P257, DOI 10.1164/ajrccm/143.2.257; Omidvari K, 1998, ALCOHOL CLIN EXP RES, V22, P567, DOI 10.1111/j.1530-0277.1998.tb04294.x; Perlman DC, 1997, J SUBST ABUSE TREAT, V14, P3, DOI 10.1016/S0740-5472(96)00182-1; Phelan JC, 1999, AM J PUBLIC HEALTH, V89, P1334, DOI 10.2105/AJPH.89.9.1334; Reichard AA, 2003, PUBLIC HEALTH REP, V118, P500, DOI 10.1093/phr/118.6.500; REICHMAN LB, 1979, ARCH INTERN MED, V139, P337, DOI 10.1001/archinte.139.3.337; ROSSI PH, 1987, SCIENCE, V235, P1336, DOI 10.1126/science.2950592; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; *URB I, 1999, HOM PROGR PEOPL THEY; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2	31	79	82	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2762	2766		10.1001/jama.293.22.2762	http://dx.doi.org/10.1001/jama.293.22.2762			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	933OV	15941806	Green Accepted, Bronze			2022-12-24	WOS:000229643700025
J	Kidd, AR; Miskowski, JA; Siegfried, KR; Sawa, H; Kimble, J				Kidd, AR; Miskowski, JA; Siegfried, KR; Sawa, H; Kimble, J			A beta-catenin identified by functional rather than sequence criteria and its role in Wnt/MAPK signaling	CELL			English	Article							C-ELEGANS EMBRYOS; CANONICAL WNT PATHWAY; NEMO-LIKE-KINASE; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTORS; VULVAL DEVELOPMENT; POLARITY SIGNALS; PROTEIN-KINASE; AXIS FORMATION; CELL POLARITY	Wnt/MAPK signaling is a common variant of Wnt signaling, in C. elegans and has been implicated in vertebrates. The sys-1 gene works with Wnt/MAPK signaling to control cell fates during C. elegans development. We report that the SYS-1 amino acid sequence is novel but that SYS-1 functions as P-catenin: SYS-1 rescues a bar-1/beta-catenin null mutant, binds the POP-1/TCF beta-catenin binding domain, and coactivates POP-1-dependent transcription. Moreover, we provide genetic and molecular evidence that SYS-1 levels are crucial to POP-1 activity. Our results suggest that Wnt/MAPK signaling promotes POP-1 export from the nucleus to accommodate the limiting availability of its SYS-1/beta-catenin transcriptional coactivator. Discovery of SYS-1/beta-catenin extends our definition of beta-catenins and brings together aspects of the canonical mechanism for Wnt signaling with the noncanonical Wnt/ MAPK mechanism. We discuss the idea that a similar pathway may be employed broadly in animal development.	Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; RIKEN, Ctr Dev Biol, Lab Cell Fate Decis, Kobe, Hyogo 6500047, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; RIKEN	Kimble, J (corresponding author), Univ Wisconsin, Mol & Cellular Biol Program, 433 Babcock Dr, Madison, WI 53706 USA.	jekimble@wisc.edu		Siegfried, Kellee/0000-0002-7951-392X; Sawa, Hitoshi/0000-0001-9774-7976	NIGMS NIH HHS [T32 GM07215, T32 GM07133] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, T32GM007133] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behrens J, 2000, J CELL SCI, V113, P911; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 1998, CURR OPIN CELL BIOL, V10, P366, DOI 10.1016/S0955-0674(98)80013-6; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Calvo D, 2001, EMBO J, V20, P7197, DOI 10.1093/emboj/20.24.7197; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Deshpande R, 2005, DEV BIOL, V278, P118, DOI 10.1016/j.ydbio.2004.10.020; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gleason JE, 2002, GENE DEV, V16, P1281, DOI 10.1101/gad.981602; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Herman MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1530, DOI 10.2741/1306; Herman MA, 2001, DEVELOPMENT, V128, P581; Huber F, 2000, AMA WINTER EDUC CONF, V11, P3; Inoue Takao, 2002, Gene Expression Patterns, V2, P235, DOI 10.1016/S1567-133X(02)00055-8; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maduro MF, 2002, DEV BIOL, V248, P128, DOI 10.1006/dbio.2002.0721; Maloof JN, 1999, DEVELOPMENT, V126, P37; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Miskowski J, 2001, DEV BIOL, V230, P61, DOI 10.1006/dbio.2000.9998; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Natarajan L, 2001, GENETICS, V159, P159; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park FD, 2003, DEVELOPMENT, V130, P3547, DOI 10.1242/dev.00563; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Siegfried KR, 2004, GENETICS, V166, P171, DOI 10.1534/genetics.166.1.171; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Usami N, 2003, ONCOGENE, V22, P7922, DOI 10.1038/sj.onc.1206533; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Waltzer L, 1999, CANCER METAST REV, V18, P231, DOI 10.1023/A:1006321324190; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177	63	109	118	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					761	772		10.1016/j.cell.2005.03.029	http://dx.doi.org/10.1016/j.cell.2005.03.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935762	Bronze			2022-12-24	WOS:000229658000014
J	Boyd, J				Boyd, J			Mouse models of gynecologic pathology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OVARIAN-CANCER		Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Boyd, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.							Connolly DC, 2003, CANCER RES, V63, P1389; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Seidman JD, 2002, BLAUSTEINS PATHOLOGY, P791; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002	5	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2005	352	21					2240	2242		10.1056/NEJMcibr051024	http://dx.doi.org/10.1056/NEJMcibr051024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929HS	15917391				2022-12-24	WOS:000229333300016
J	Lou, XL; Scheuss, V; Schneggenburger, R				Lou, XL; Scheuss, V; Schneggenburger, R			Allosteric modulation of the presynaptic Ca2+ sensor for vesicle fusion	NATURE			English	Article							PROTEIN-KINASE-C; TRANSMITTER RELEASE; CALCIUM SENSITIVITY; CHROMAFFIN CELLS; MEMBRANE-FUSION; PHORBOL ESTERS; POTENTIATION; POOL; NEUROTRANSMITTER; AUGMENTATION	Neurotransmitter release is triggered by an increase in the cytosolic Ca2+ concentration ([Ca2+](i)), but it is unknown whether the Ca2+-sensitivity of vesicle fusion is modulated during synaptic plasticity. We investigated whether the potentiation of neurotransmitter release by phorbol esters(1-3), which target presynaptic protein kinase C (PKC)/munc-13 signalling cascades(4-6), exerts a direct effect on the Ca2+-sensitivity of vesicle fusion. Using direct presynaptic Ca2+-manipulation and Ca2+ uncaging at a giant presynaptic terminal, the calyx of Held, we show that phorbol esters potentiate transmitter release by increasing the apparent Ca2+-sensitivity of vesicle fusion. Phorbol esters potentiate Ca2+-evoked release as well as the spontaneous release rate. We explain both effects by an increased fusion 'willingness' in a new allosteric model of Ca2+-activation of vesicle fusion. In agreement with an allosteric mechanism, we observe that the classically high Ca2+ cooperativity in triggering vesicle fusion (similar to 4) is gradually reduced below 3 mu M [Ca2+](i), reaching a value of < 1 at basal [Ca2+](i). Our data indicate that spontaneous transmitter release close to resting [Ca2+](i) is a consequence of an intrinsic property of the molecular machinery(7,8) that mediates synaptic vesicle fusion.	Max Planck Inst Biophys Chem, AG Synapt Dynam & Modulat, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Schneggenburger, R (corresponding author), Max Planck Inst Biophys Chem, AG Synapt Dynam & Modulat, Fassberg 11, D-37077 Gottingen, Germany.	rschneg@gwdg.de	Volker, Scheuss/G-7846-2015	Lou, Xuelin/0000-0002-0576-8575; Scheuss, Volker/0000-0002-0659-3228				Angleson JK, 2001, J NEUROPHYSIOL, V85, P287, DOI 10.1152/jn.2001.85.1.287; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DELANEY KR, 1994, J NEUROSCI, V14, P5885; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Li J, 1997, Q REV BIOPHYS, V30, P177, DOI 10.1017/S0033583597003326; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Yawo H, 1999, J PHYSIOL-LONDON, V515, P169, DOI 10.1111/j.1469-7793.1999.169ad.x; Zhu HL, 2002, P NATL ACAD SCI USA, V99, P17055, DOI 10.1073/pnas.232588899	28	204	220	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					497	501		10.1038/nature03568	http://dx.doi.org/10.1038/nature03568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917809				2022-12-24	WOS:000229337800055
J	Carter, NJ; Cross, RA				Carter, NJ; Cross, RA			Mechanics of the kinesin step	NATURE			English	Article							HAND-OVER-HAND; 8-NM STEP; ATP HYDROLYSIS; MYOSIN MOTOR; FORCE CLAMP; MOLECULES; CYCLE; PROCESSIVITY; MICROSCOPY; DEPENDENCE	Kinesin is a molecular walking machine that organizes cells by hauling packets of components directionally along microtubules. The physical mechanism that impels directional stepping is uncertain. We show here that, under very high backward loads, the intrinsic directional bias in kinesin stepping can be reversed such that the motor walks sustainedly backwards in a previously undescribed mode of ATP-dependent backward processivity. We find that both forward and backward 8-nm steps occur on the microsecond timescale and that both occur without mechanical substeps on this timescale. The data suggest an underlying mechanism in which, once ATP has bound to the microtubule-attached head, the other head undergoes a diffusional search for its next site, the outcome of which can be biased by an applied load.	Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England		Cross, RA (corresponding author), Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England.	r.cross@mcri.ac.uk	Cross, Robert A/F-1798-2011	Cross, Robert A/0000-0002-0004-7832				Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Coppin CM, 1996, P NATL ACAD SCI USA, V93, P1913, DOI 10.1073/pnas.93.5.1913; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hirose K, 1996, P NATL ACAD SCI USA, V93, P9539, DOI 10.1073/pnas.93.18.9539; Howard J., 2001, MECH MOTOR PROTEINS; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY AF, 1957, PROGR BIOPHYS BIOPHY, V7, P257; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kawaguchi K, 2000, BIOCHEM BIOPH RES CO, V272, P895, DOI 10.1006/bbrc.2000.2856; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Nishiyama M, 2003, BIOSYSTEMS, V71, P145, DOI 10.1016/S0303-2647(03)00122-9; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Schief WR, 2001, CURR OPIN CELL BIOL, V13, P19, DOI 10.1016/S0955-0674(00)00169-1; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Thomas N, 2002, P ROY SOC B-BIOL SCI, V269, P2363, DOI 10.1098/rspb.2002.2117; Tsiavaliaris G, 2004, NATURE, V427, P558, DOI 10.1038/nature02303; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	35	557	571	2	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					308	312		10.1038/nature03528	http://dx.doi.org/10.1038/nature03528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902249				2022-12-24	WOS:000229185000037
J	Norris, JM; Barriga, K; Hoffenberg, EJ; Taki, I; Miao, DM; Haas, JE; Emery, LM; Sokol, RJ; Erlich, HA; Eisenbarth, GS; Rewers, M				Norris, JM; Barriga, K; Hoffenberg, EJ; Taki, I; Miao, DM; Haas, JE; Emery, LM; Sokol, RJ; Erlich, HA; Eisenbarth, GS; Rewers, M			Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE TRANSGLUTAMINASE; CHILDREN; OATS; AUTOANTIBODIES; ANTIBODIES; GLIADIN; MARKERS	Context While gluten ingestion is responsible for the signs and symptoms of celiac disease, it is not known what factors are associated with initial appearance of the disease. Objective To examine whether the timing of gluten exposure in the infant diet was associated with the development of celiac disease autoimmunity (CDA). Design, Setting, and Patients Prospective observational study conducted in Denver, Colo, from 1994-2004 of 1560 children at increased risk for celiac disease or type 1 diabetes, as defined by possession of either HLA-DR3 or DR4 alleles, or having a first-degree relative with type 1 diabetes. The mean follow-up was 4.8 years. Main Outcome Measure Risk of CDA defined as being positive for tissue transglutaminase (tTG) autoantibody on 2 or more consecutive visits or being positive for tTG once and having a positive small bowel biopsy for celiac disease, by timing of introduction of gluten-containing foods into the diet Results Fifty-one children developed CDA. Findings adjusted for HLA-DR3 status indicated that children exposed to foods containing wheat, barley, or rye (gluten-containing foods) in the first 3 months of life Q [6%] CDA positive vs 40 [3%] CDA negative) had a 5-fold increased risk of CDA compared with children exposed to gluten-containing foods at 4 to 6 months (12 [23%] CDA positive vs 574 [38%) CDA negative) (hazard ratio [HR], 5.17; 95% confidence interval [CI], 1.44-18.57). Children not exposed to gluten until the seventh month or later (36 [71%] CDA positive vs 895 [59%] CDA negative) had a marginally increased risk of CDA compared with those exposed at 4 to 6 months (HR, 1.87; 95% Cl, 0.97-3.60). After restricting our case group to only the 25 CDA-positive children who had biopsy-diagnosed celiac disease, initial exposure to wheat, barley, or rye in the first 3 months Q [12%] CDA positive vs 40 [3%] CDA negative) or in the seventh month or later (19 [76%] CDA positive vs 912 [59%] CDA negative) significantly increased risk of CDA compared with exposure at 4 to 6 months (3 [12%] CDA positive vs 583 [38%] CDA negative) (HR, 22.97; 95% Cl, 4,55-115.93; P=.001; and HR, 3.98; 95% Cl, 1.18-13.46; P=.04, respectively). Conclusion Timing of introduction of gluten into the infant diet is associated with the appearance of CDA in children at increased risk for the disease.	Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80262 USA; Univ Colorado, Dept Pathol, Denver, CO 80262 USA; Hlth Sci Ctr, Denver, CO 80262 USA; Univ Colorado, Childrens Hosp, Dept Pediat, Sect Pediat Gastroenterol Hepatol & Nutr, Denver, CO 80262 USA; Univ Colorado, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Roche Mol Syst Inc, Dept Human Genet, Alameda, CA USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Roche Holding	Norris, JM (corresponding author), Univ Colorado, Dept Prevent Med & Biometr, 4200 E 9th Ave,Box B119, Denver, CO 80262 USA.	jill.norris@uchsc.edu			NCRR NIH HHS [M01RR00069] Funding Source: Medline; NIAID NIH HHS [AI 50864] Funding Source: Medline; NIDDK NIH HHS [DK49654, R01-DK32493, P30 DK 57516, DK32083, DK50979] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050979, R37DK032083, R01DK032083, P30DK057516, R01DK032493, R01DK049654] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison P. D, 1995, SURVIVAL ANAL USING; Ascher H, 1997, ARCH DIS CHILD, V76, P113, DOI 10.1136/adc.76.2.113; AURICCHIO S, 1983, J PEDIATR GASTR NUTR, V2, P428, DOI 10.1097/00005176-198302030-00006; Baldas V, 2000, GUT, V47, P628, DOI 10.1136/gut.47.5.628; Bao F, 1999, J AUTOIMMUN, V13, P143, DOI 10.1006/jaut.1999.0303; Bonamico M, 2001, AM J GASTROENTEROL, V96, P1536; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Collin P, 2002, ENDOCR REV, V23, P464, DOI 10.1210/er.2001-0035; Dieterich W, 1999, J INVEST DERMATOL, V113, P133, DOI 10.1046/j.1523-1747.1999.00627.x; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; FalthMagnusson K, 1996, PEDIAT ALLERG IMM-UK, V7, P1, DOI 10.1111/j.1399-3038.1996.tb00098.x; Farrell RJ, 2002, NEW ENGL J MED, V346, P180, DOI 10.1056/NEJMra010852; GRECO L, 1988, J PEDIATR GASTR NUTR, V7, P395, DOI 10.1097/00005176-198805000-00013; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P356, DOI 10.1067/mpd.2000.107582; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P361, DOI 10.1067/mpd.2000.109003; Hoffenberg EJ, 2003, J PEDIATR-US, V143, P308, DOI 10.1067/S0022-3476(03)00282-8; Hogberg L, 2004, GUT, V53, P649, DOI 10.1136/gut.2003.026948; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; JANATUINEN EK, 1995, NEW ENGL J MED, V333, P1033, DOI 10.1056/NEJM199510193331602; KLEINMAN RE, 1998, PEDIAT NUTR HDB, P43; Li RW, 2003, PEDIATRICS, V111, P1198; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Peters U, 2001, ANN NUTR METAB, V45, P135, DOI 10.1159/000046720; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Schapira M, 2003, ACTA GASTRO-ENT BELG, V66, P234; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Srinivasan U, 1996, BRIT MED J, V313, P1300, DOI 10.1136/bmj.313.7068.1300; Stern M, 2000, J PEDIATR GASTR NUTR, V31, P513, DOI 10.1097/00005176-200011000-00012; Storsrud S, 2003, EUR J CLIN NUTR, V57, P163, DOI 10.1038/sj.ejcn.1601525; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Ventura A, 2000, J PEDIATR-US, V137, P263, DOI 10.1067/mpd.2000.107160; Wieser H, 1998, CHANGING FEATURES OF COELIAC DISEASE, P25; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721	38	305	320	1	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2005	293	19					2343	2351		10.1001/jama.293.19.2343	http://dx.doi.org/10.1001/jama.293.19.2343			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926JX	15900004	Bronze			2022-12-24	WOS:000229120600021
J	Savage, E; Ramsay, M; White, J; Beard, S; Lawson, H; Hunjan, R; Brown, D				Savage, E; Ramsay, M; White, J; Beard, S; Lawson, H; Hunjan, R; Brown, D			Mumps outbreaks across England and Wales in 2004: observational, study	BRITISH MEDICAL JOURNAL			English	Article									Hlth Protect Agcy, Ctr Infect, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England; Hlth Protect Agcy, Ctr Infect, Enter Resp & Neurol Virus Lab, London NW9 5EQ, England	Health Protection Agency; Health Protection Agency	Savage, E (corresponding author), Hlth Protect Agcy, Ctr Infect, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England.	Emma.Savage@HPA.org.uk	Ramsay, Mary Elizabeth/S-8281-2016	Ramsay, Mary Elizabeth/0000-0002-7156-7640; White, Joanne/0000-0001-7786-4462				*COMM DIS SURV CTR, 2002, COMMUN DIS REP CDR W, V12; *COMM DIS SURV CTR, 1999, COMMUN DIS REP CDR W, V9, P227; *COMM DIS SURV CTR, 1999, COMMUN DIS REP CDR W, V9, P230; GAY N, 1997, COMMUNICAB DIS REP, V7, P21; Gay N J, 1994, Commun Dis Rep CDR Rev, V4, pR77; HARLING R, 2005, IN PRESS VACCINE	6	64	64	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 14	2005	330	7500					1119	1120		10.1136/bmj.330.7500.1119	http://dx.doi.org/10.1136/bmj.330.7500.1119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891227	Green Published, Bronze			2022-12-24	WOS:000229166900018
J	Shemansky, DE; Stewart, AIF; West, RA; Esposito, LW; Hallett, JT; Liu, XM				Shemansky, DE; Stewart, AIF; West, RA; Esposito, LW; Hallett, JT; Liu, XM			The Cassini UVIS stellar probe of the Titan atmosphere	SCIENCE			English	Article							PHOTOABSORPTION CROSS-SECTIONS; VACUUM ULTRAVIOLET; ABSORPTION; METHANE; TEMPERATURE; PHOTOCHEMISTRY; THERMOSPHERE; SPECTROSCOPY; ACETYLENE; SPECTRA	The Cassini Ultraviolet Imaging Spectrometer (UVIS) observed the extinction of photons from two stars by the atmosphere of Titan during the Titan flyby. Six species were identified and measured: methane, acetylene, ethylene, ethane, diacetylene, and hydrogen cyanide. The observations cover altitudes from 450 to 1600 kilometers above the surface. A mesopause is inferred from extraction of the temperature structure of methane, located at 615 km with a temperature minimum of 114 kelvin. The asymptotic kinetic temperature at the top of the atmosphere determined from this experiment is 151 kelvin. The higher order hydrocarbons and hydrogen cyanide peak sharply in abundance and are undetectable below altitudes ranging from 750 to 600 km, leaving methane as the only identifiable carbonaceous molecule in this experiment below 600 km.	Univ So Calif, Dept Aerosp Engn, Los Angeles, CA 90089 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Southern California; University of Colorado System; University of Colorado Boulder; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Shemansky, DE (corresponding author), Univ So Calif, Dept Aerosp Engn, Univ Pk, Los Angeles, CA 90089 USA.	dons@hippolyta.usc.edu	ESPOSITO, LARRY W/AAB-3673-2021	ESPOSITO, LARRY W/0000-0003-3381-2016				AU JW, 1993, CHEM PHYS, V173, P209, DOI 10.1016/0301-0104(93)80142-V; Chen FZ, 2004, J QUANT SPECTROSC RA, V85, P195, DOI 10.1016/S0022-4073(03)00225-5; COOPER G, 1995, J ELECTRON SPECTROSC, V73, P139, DOI 10.1016/0368-2048(94)02271-2; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Flasar FM, 1998, PLANET SPACE SCI, V46, P1109, DOI 10.1016/S0032-0633(97)00182-7; Flasar FM, 1998, PLANET SPACE SCI, V46, P1125, DOI 10.1016/S0032-0633(97)00223-7; FRIEDSON AJ, 1984, J GEOPHYS RES-SPACE, V89, P85, DOI 10.1029/JA089iA01p00085; LELLOUCH E, 1990, ICARUS, V83, P308, DOI 10.1016/0019-1035(90)90070-P; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; MOUNT GH, 1977, ASTROPHYS J, V214, pL47, DOI 10.1086/182440; MOUNT GH, 1978, ASTROPHYS J, V224, pL35, DOI 10.1086/182753; Muller-Wodarg ICF, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016100; NAGATA T, 1981, CHEM PHYS, V57, P45, DOI 10.1016/0301-0104(81)80019-5; NUTH JA, 1982, J QUANT SPECTROSC RA, V28, P223, DOI 10.1016/0022-4073(82)90025-5; OKABE H, 1981, J CHEM PHYS, V75, P2772, DOI 10.1063/1.442348; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; SAMSON JAR, 1989, J CHEM PHYS, V90, P6925, DOI 10.1063/1.456267; SAMSON JAR, 1974, J OPT SOC AM, V64, P47, DOI 10.1364/JOSA.64.000047; SICARDY B, 2004, 362206S AASDPS; SMITH GR, 1982, J GEOPHYS RES-SPACE, V87, P1351, DOI 10.1029/JA087iA03p01351; STROBEL DF, 1992, ICARUS, V100, P512, DOI 10.1016/0019-1035(92)90114-M; STROBEL DF, COMMUNICATION; SUN H, 1955, J CHEM PHYS, V23, P1160, DOI 10.1063/1.1742205; Vervack RJ, 2004, ICARUS, V170, P91, DOI 10.1016/j.icarus.2004.03.005; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wilson EH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002181; Wu CYR, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002180; Wu CYR, 2001, J GEOPHYS RES-PLANET, V106, P7629, DOI 10.1029/2000JE001292; YELLE R, COMMUNICATION; YELLE RV, 1997, ESA SP PUBL, V1177, P243; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	31	113	113	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					978	982		10.1126/science.1111790	http://dx.doi.org/10.1126/science.1111790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890872				2022-12-24	WOS:000229190700033
J	Schousboe, JT; Nyman, JA; Kane, RL; Ensrud, KE				Schousboe, JT; Nyman, JA; Kane, RL; Ensrud, KE			Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; VERTEBRAL FRACTURES; HIP FRACTURE; POPULATION HEALTH; ECONOMIC-EVALUATION; CLINICAL-PRACTICE; BONE-DENSITY; BACK-PAIN; OSTEOPOROSIS; RISK	Background: Treatment guidelines recommend drug treatment to prevent fractures for some postmenopausal women who have low bone mass (osteopenia) but do not have osteoporosis or a history of clinical fractures. Objective: To estimate the societal costs and health benefits of alendronate drug treatment to prevent fractures in postmenopausal women with osteopenia. Design: Markov model with 8 health states: no fracture, post-distal forearm fracture, post-clinical vertebral fracture, post-radiographic (but clinically inapparent) vertebral fracture, post-hip fracture, post-hip and vertebral fractures, post-other fracture, and death. Data Sources: Population -based studies of age-specific fracture rates and costs, prospectively measured estimates of disutility after fractures, and the Fracture Intervention Trial of alendronate versus placebo to prevent fracture. Target Population: Postmenopausal women 55 to 75 years of age with femoral neck T-scores between -1.5 and -2.4. Time Horizon: Lifetime. Perspective: Societal. Interventions: Five years of alendronate therapy or no drug treatment. Outcome Measures: Costs, quality-adjusted life-years, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: For women with no additional fracture risk factors, the cost per quality-adjusted life-year gained ranged from $70 000 to $332 000, depending on age and femoral neck bone density. Limitations: Results apply only to postmenopausal white women residing in the United States. Conclusion: Alendronate therapy for postmenopausal women with femoral neck T-scores better than -2.5 and no history of clinical fractures or other bone mineral density-independent risk factors for fracture is not cost-effective, assuming U.S. costs of alendronate and currently available estimates of alendronate efficacy in osteopenic women.	Univ Minnesota, Pk Nicollet Hlth Serv, Minneapolis, MN USA; Vet Adm Med Ctr, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Schousboe, JT (corresponding author), Pk Nicollet Clin, 3800 Pk Nocollet Blvd, Minneapolis, MN 55416 USA.	schouj@parknicollet.com		Ensrud, Kristine/0000-0002-9069-3036				American Association of Clinical Endocrinologists Osteoporosis Task Force, 2001, Endocr Pract, V7, P293; American College of Obstetricians and Gynecologists Women's Health Care Physicians, 2004, Obstet Gynecol, V103, P203; Anderson Robert N, 2002, Natl Vital Stat Rep, V50, P1; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Brecht JG, 2003, INT J CLIN PHARM RES, V23, P93; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; CHESTNUT CH, 1995, AM J MED, V99, P144, DOI 10.1016/S0002-9343(99)80134-X; *CTR MED MED SERV, 2005, NAT PHYS FEE SCH REL; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; De Laet CEDH, 1998, J BONE MINER RES, V13, P1587, DOI 10.1359/jbmr.1998.13.10.1587; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Ensrud K, 2003, J BONE MINER RES, V18, pS90; Ettinger M, 2004, ARTHRITIS RHEUM, V50, pS513; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Halpern EF, 2000, MED DECIS MAKING, V20, P314, DOI 10.1177/0272989X0002000308; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Huopio J, 2000, OSTEOPOROSIS INT, V11, P219, DOI 10.1007/s001980050284; Iglesias CP, 2002, QJM-INT J MED, V95, P305, DOI 10.1093/qjmed/95.5.305; Johannesson M, 1998, HEALTH ECON, V7, P1, DOI 10.1002/(SICI)1099-1050(199802)7:1<1::AID-HEC327>3.0.CO;2-U; Johannesson M, 1996, J INTERN MED, V240, P23, DOI 10.1046/j.1365-2796.1996.491830000.x; Johnell O, 2003, PHARMACOECONOMICS, V21, P305, DOI 10.2165/00019053-200321050-00002; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P15, DOI 10.1007/s00198-004-1688-0; Kanis JA, 2002, BONE, V31, P26, DOI 10.1016/S8756-3282(02)00813-X; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Kanis JA, 2002, J BONE MINER RES, V17, pS146; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P765, DOI 10.1007/s001980200106; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Macran S, 2003, MED CARE, V41, P218; *MED EC, 2001, 2001 DRUG TOPICS RED; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Melton LJ, 2000, J AM GERIATR SOC, V48, P338, DOI 10.1111/j.1532-5415.2000.tb02658.x; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; Meunier PJ, 1999, CLIN THER, V21, P1025, DOI 10.1016/S0149-2918(99)80022-8; Miller PD, 2004, ARCH INTERN MED, V164, P1113, DOI 10.1001/archinte.164.10.1113; National Osteoporosis Foundation, 2003, PHYS GUID PREV TREAT; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; O'Neill TW, 2004, OSTEOPOROSIS INT, V15, P760, DOI 10.1007/s00198-004-1615-4; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; OSTER G, 1994, STROKE, V25, P1149, DOI 10.1161/01.STR.25.6.1149; Rosner AJ, 1998, PHARMACOECONOMICS, V14, P559, DOI 10.2165/00019053-199814050-00007; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P1042, DOI 10.1007/s001980170015; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P849, DOI 10.1007/s001980170036; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; Wainwright SA, 2001, J BONE MINER RES, V16, pS155; Wehren LE, 2004, CURR MED RES OPIN, V20, P525, DOI 10.1185/030079904125003269; 1998, OSTEOPOROS INT S, V4, pS7	57	88	89	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					734	741		10.7326/0003-4819-142-9-200505030-00008	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922GW	15867405				2022-12-24	WOS:000228825800002
J	Wormser, GP; McKenna, D; Carlin, J; Nadelman, RB; Cavaliere, LF; Holmgren, D; Byrne, DW; Nowakowski, J				Wormser, GP; McKenna, D; Carlin, J; Nadelman, RB; Cavaliere, LF; Holmgren, D; Byrne, DW; Nowakowski, J			Brief communication: Hematogenous dissemination in early Lyme disease	ANNALS OF INTERNAL MEDICINE			English	Article							BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; GENETIC DIVERSITY; BLOOD CULTURES; ASSOCIATION; EVOLUTION; YIELD; PCR	Background: Bloodstream invasion in Lyme disease has been difficult to study because until recently blood culture methods were too insensitive to detect spirochetemia. Objective: To evaluate the clinical and laboratory features of spirochetemic patients. Design: Cross-sectional study. Setting: Lyme Disease Diagnostic Center in Valhalla, New York, 1997 to 2002. Patients: 213 untreated adults with erythema migrans. Intervention: Blood culture for Borrelia burgdorferi. Measurements: Symptom scores and selected laboratory measures. Results: Spirocheternia was found in 93 (43.7%) patients. Spirochetemic patients were more often symptomatic (89.2% vs. 74.2%; P = 0.006) and more often had multiple erythema migrans lesions (41.9% vs. 15.0%; P < 0.001) than patients without spirochetemia. However, 8 (22.9%) of the 35 asymptomatic patients with a single skin lesion nevertheless had a positive blood culture. Risk for spirochetemia was present the day the patient noticed the lesion and continued for more than 2 weeks. Limitations: Long-term outcome data were not available. Conclusions: The high rate, early onset, and prolonged duration of risk for spirochetemia explain why untreated patients with erythema migrans are at risk for dissemination of B. burgdorferi to anatomic sites beyond the lesion site. Differences in the strain of the infecting spirochete, as well as host factors, may be important determinants of hematogenous dissemination.	New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA; Vanderbilt Univ, Ctr Med, Nashville, TN 37232 USA	New York Medical College; Vanderbilt University	Wormser, GP (corresponding author), New York Med Coll, Div Infect Dis, Munger Pavil,Room 245, Valhalla, NY 10595 USA.	gary_wormser@nymc.edu			ODCDC CDC HHS [U50/CCU219613, U50/CCU219612] Funding Source: Medline	ODCDC CDC HHS		AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; Bakken JS, 2001, CLIN INFECT DIS, V32, P862, DOI 10.1086/319350; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P20; Harrel F.E., 2001, REGRESSION MODELING; Kim N, 1998, CLIN INFECT DIS, V26, P1218, DOI 10.1086/520302; Lagal V, 2003, J CLIN MICROBIOL, V41, P5059, DOI 10.1128/JCM.41.11.5059-5065.2003; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; Luft BJ, 1996, ANN INTERN MED, V124, P785, DOI 10.7326/0003-4819-124-9-199605010-00002; NADELMAN RB, 1990, AM J MED, V88, P21, DOI 10.1016/0002-9343(90)90122-T; Piesman J, 2001, J CLIN MICROBIOL, V39, P4145, DOI 10.1128/JCM.39.11.4145-4148.2001; SCHWARTZ I, 1992, J CLIN MICROBIOL, V30, P3082, DOI 10.1128/JCM.30.12.3082-3088.1992; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Wormser GP, 1998, J CLIN MICROBIOL, V36, P296, DOI 10.1128/JCM.36.1.296-298.1998; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Wormser GP, 2001, J INFECT DIS, V184, P1070, DOI 10.1086/323424	18	80	83	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					751	755		10.7326/0003-4819-142-9-200505030-00011	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922GW	15867407				2022-12-24	WOS:000228825800004
J	Batlle, E; Bacani, J; Begthel, H; Jonkeer, S; Gregorieff, A; van de Born, M; Malats, N; Sancho, E; Boon, E; Pawson, T; Gallinger, S; Pals, S; Clevers, H				Batlle, E; Bacani, J; Begthel, H; Jonkeer, S; Gregorieff, A; van de Born, M; Malats, N; Sancho, E; Boon, E; Pawson, T; Gallinger, S; Pals, S; Clevers, H			EphB receptor activity suppresses colorectal cancer progression	NATURE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; BETA-CATENIN; APC; COLON; ACTIVATION; MICE; EPITHELIUM; EXPRESSION; MUTATIONS; PATHWAY	Most sporadic colorectal cancers are initiated by activating Wnt pathway mutations(1), characterized by the stabilization of beta-catenin and constitutive transcription by the beta-catenin/T cell factor-4 (Tcf-4) complex(2,3). EphB guidance receptors are Tcf4 target genes that control intestinal epithelial architecture through repulsive interactions with Ephrin-B ligands(4,5). Here we show that, although Wnt signalling remains constitutively active, most human colorectal cancers lose expression of EphB at the adenoma-carcinoma transition. Loss of EphB expression strongly correlates with degree of malignancy. Furthermore, reduction of EphB activity accelerates tumorigenesis in the colon and rectum of Apc(Min/+) mice, and results in the formation of aggressive adenocarcinomas. Our data demonstrate that loss of EphB expression represents a critical step in colorectal cancer progression.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; Biomed Res Inst, Barcelona 08028, Spain; ICREA, Barcelona 08010, Spain; Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Inst Municipal Invest Med, E-08003 Barcelona, Spain	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Clevers, H (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	Batlle, Eduard/K-8080-2014; Pawson, Tony J/E-4578-2013; Sancho, Elena/ABH-4867-2020; Gallinger, Steven/E-4575-2013; Malats, Nuria/H-7041-2015	Batlle, Eduard/0000-0003-2422-0326; Sancho, Elena/0000-0002-8182-513X; Pals, Steven/0000-0002-1419-0939; Malats, Nuria/0000-0003-2538-3784	ICREA Funding Source: Custom	ICREA(ICREA)		Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lal G, 2001, CANCER RES, V61, P6131; Mao WG, 2004, CANCER RES, V64, P781, DOI 10.1158/0008-5472.CAN-03-1047; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Munarini N, 2002, J CELL SCI, V115, P25; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Shitoh K, 2001, GENE CHROMOSOME CANC, V30, P32, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1065>3.0.CO;2-I; Sparks AB, 1998, CANCER RES, V58, P1130; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Yamada Y, 2002, CANCER RES, V62, P6367	20	329	354	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1126	1130		10.1038/nature03626	http://dx.doi.org/10.1038/nature03626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973414				2022-12-24	WOS:000229970400055
J	van Wijk, I; Kappelle, LJ; van Gijn, J; Koudstaal, PJ; Franke, CL; Vermeulen, M; Gorter, JW; Algra, A				van Wijk, I; Kappelle, LJ; van Gijn, J; Koudstaal, PJ; Franke, CL; Vermeulen, M; Gorter, JW; Algra, A		LiLAC Study Grp	Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study	LANCET			English	Article							FOLLOW-UP; INTEROBSERVER AGREEMENT; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CEREBRAL-ISCHEMIA; RECURRENT STROKE; PROGNOSIS; MORTALITY; HANDICAP	Background Determinants of survival and of risk of vascular events after transient ischaemic attack (TIA) or minor ischaemic stroke are not well defined in the long term. We aimed to restudy these risks in a prospective cohort of patients after TIA or minor ischaemic stroke (Rankin grade <= 3), after 10 years or more. Methods We assessed the survival status and occurrence of vascular events in 2473 participants of the Dutch TIA Trial (recruitment in 1986-89; arterial cause of cerebral ischaemia). We included 24 hospitals in the Netherlands that recruited at least 50 patients. Primary outcomes were all-cause mortality and the composite event of death from all vascular causes, non-fatal stroke, and non-fatal myocardial infarction. We assessed cumulative risks by Kaplan-Meier analysis and prognostic factors with Cox univariate and multivariate analysis. Findings Follow-up was complete in 2447 (99%) patients. After a mean follow-up of 10.1 years, 1489 (60%) patients had died and 1336 (54%) had had at least one vascular event. 10-year risk of death was 42.7% (95% CI 40.8-44.7). Age and sex-adjusted hazard ratios were 3.33 (2.97-3.73) for age over 65 years, 2.10 (1.79-2.48) for diabetes, 1.77 (1.45-2.15) for claudication, 1.94 (1.42-2.65) for previous peripheral vascular surgery, and 1.50 (1.31-1.71) for pathological Q waves on baseline electrocardiogram. 10-year risk of a vascular event was 44.1% (42.0-46.1). After falling in the first 3 years, yearly risk of a vascular event increased over time. Predictive factors for risk of vascular events were similar to those for risk of death. Interpretation Long-term secondary prevention in patients with cerebral ischaemia still has room for further improvement.	Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; Rehabil Ctr Hoogstr, Utrecht, Netherlands; Erasmus MC, Dept Neurol, Rotterdam, Netherlands; Atrium Med Ctr, Dept Neurol, Heerlen, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Atrium Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Algra, A (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.	a.algra@umcutrecht.nl	Gorter, Jan Willem/AAK-8784-2021; van Gijn, Jan/A-9444-2008	Gorter, Jan Willem/0000-0002-3012-2119; 				Algra A, 1996, J NEUROL NEUROSUR PS, V60, P197, DOI 10.1136/jnnp.60.2.197; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Anderson CS, 2004, STROKE, V35, P1920, DOI 10.1161/01.STR.0000133130.20322.9f; [Anonymous], 1993, Stroke, V24, P527; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bravata DM, 2003, STROKE, V34, P699, DOI 10.1161/01.STR.0000057578.26828.78; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; BURN J, 1994, STROKE, V25, P333, DOI 10.1161/01.STR.25.2.333; Clark TG, 2003, J NEUROL NEUROSUR PS, V74, P577, DOI 10.1136/jnnp.74.5.577; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; De Schryver ELLM, 2000, CEREBROVASC DIS, V10, P147, DOI 10.1159/000016044; Eriksson SE, 2001, CEREBROVASC DIS, V12, P171, DOI 10.1159/000047700; Gresham GE, 1998, STROKE, V29, P793, DOI 10.1161/01.STR.29.4.793; HANKEY GJ, 1992, J NEUROL NEUROSUR PS, V55, P640, DOI 10.1136/jnnp.55.8.640; HANKEY GJ, 1991, J NEUROL NEUROSUR PS, V54, P793, DOI 10.1136/jnnp.54.9.793; Hankey GJ, 1998, STROKE, V29, P2491, DOI 10.1161/01.STR.29.12.2491; Hardie K, 2003, STROKE, V34, P1842, DOI 10.1161/01.STR.0000082382.42061.EE; Jorgensen HS, 1997, NEUROLOGY, V48, P891; KERNAN WN, 1991, STROKE, V22, P1108, DOI 10.1161/01.STR.22.9.1108; KERNAN WN, 1991, ANN INTERN MED, V114, P552, DOI 10.7326/0003-4819-114-7-552; Marini C, 1999, STROKE, V30, P2320, DOI 10.1161/01.STR.30.11.2320; Peltonen M, 1998, STROKE, V29, P1358, DOI 10.1161/01.STR.29.7.1358; Prencipe M, 1998, STROKE, V29, P126, DOI 10.1161/01.STR.29.1.126; Reitsma JB, 1999, HEART, V82, P52, DOI 10.1136/hrt.82.1.52; SAEKI S, 1995, STROKE, V26, P399, DOI 10.1161/01.STR.26.3.399; SANDERCOCK P, 1992, BRIT MED J, V305, P1460, DOI 10.1136/bmj.305.6867.1460; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Staaf G, 2001, STROKE, V32, P2592, DOI 10.1161/hs1101.098355; TUOMILEHTO J, 1995, STROKE, V26, P971, DOI 10.1161/01.STR.26.6.971; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vernino S, 2003, STROKE, V34, P1828, DOI 10.1161/01.STR.0000080534.98416.A0; WARLOW C, 1992, LANCET, V339, P724, DOI 10.1016/0140-6736(92)90608-6; Wilkinson PR, 1997, STROKE, V28, P507, DOI 10.1161/01.STR.28.3.507; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	36	213	213	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2005	365	9477					2098	2104		10.1016/S0140-6736(05)66734-7	http://dx.doi.org/10.1016/S0140-6736(05)66734-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936LZ	15964446				2022-12-24	WOS:000229858800026
J	Kaiser, J				Kaiser, J			Meeting - American Society of Gene Therapy - Retroviral vectors: A double-edged sword	SCIENCE			English	News Item																			0	7	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2005	308	5729					1735	1736						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961648				2022-12-24	WOS:000229926800015
J	Winn, MP; Conlon, PJ; Lynn, KL; Farrington, MK; Creazzo, T; Hawkins, AF; Daskalakis, N; Kwan, SY; Ebersviller, S; Burchette, JL; Pericak-Vance, MA; Howel, DN; Vance, JM; Rosenberg, PB				Winn, MP; Conlon, PJ; Lynn, KL; Farrington, MK; Creazzo, T; Hawkins, AF; Daskalakis, N; Kwan, SY; Ebersviller, S; Burchette, JL; Pericak-Vance, MA; Howel, DN; Vance, JM; Rosenberg, PB			A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis	SCIENCE			English	Article							NEPHROTIC SYNDROME; SLIT DIAPHRAGM; GENETIC-HETEROGENEITY; GLOMERULAR-DISEASE; PODOCIN; ALPHA-ACTININ-4; EXPRESSION; INSERTION; NEPHRIN; PROTEIN	Focal and segmental glomerulosclerosis (FSGS) is a kidney disorder of unknown etiology, and up to 20% of patients on dialysis have been diagnosed with it. Here we show that a large family with hereditary FSGS carries a missense mutation in the TRPC6 gene on chromosome 11q, encoding the ion-channel protein transient receptor potential cation channel 6 (TRPC6). The proline-to-glutamine substitution at position 112, which occurs in a highly conserved region of the protein, enhances TRPC6-mediated calcium signals in response to agonists such as angiotensin II and appears to alter the intracellular distribution of TRPC6 protein. Previous work has emphasized the importance of cytosketetal and structural proteins in proteinuric kidney diseases. Our findings suggest an alternative mechanism for the pathogenesis of glomerular disease.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Beaumont Hosp, Dept Nephrol, Dublin, Ireland; Christchurch Hosp, Dept Nephrol, Christchurch, New Zealand; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Durham VA Med Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Christchurch Hospital New Zealand; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Winn, MP (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	michelle.winn@duke.edu; jeff@chg.duhs.duke.edu; rosen029@mc.duke.edu	Ebersviller, Seth/ABA-7279-2021	Ebersviller, Seth/0000-0002-3035-5000; Vance, Jeffery/0000-0003-3815-8199; Rosenberg, Paul/0000-0002-5659-160X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074748] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK074748] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balla T, 1998, ENDOCR RES, V24, P335, DOI 10.3109/07435809809032613; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Conlon PJ, 1999, KIDNEY INT, V56, P1863, DOI 10.1046/j.1523-1755.1999.00727.x; Facemire CS, 2004, AM J PHYSIOL-RENAL, V286, pF546, DOI 10.1152/ajprenal.00338.2003; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hurtado A, 2000, CLIN NEPHROL, V53, P325; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Korbet SM, 1996, AM J KIDNEY DIS, V27, P647, DOI 10.1016/S0272-6386(96)90098-0; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Srivastava T, 1999, PEDIATR NEPHROL, V13, P13, DOI 10.1007/s004670050555; Taal MW, 2000, KIDNEY INT, V57, P1803, DOI 10.1046/j.1523-1755.2000.00031.x; Winn MP, 1999, GENOMICS, V58, P113, DOI 10.1006/geno.1999.5828; Winn MP, 1999, KIDNEY INT, V55, P1241, DOI 10.1046/j.1523-1755.1999.00384.x	23	778	851	6	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1801	1804		10.1126/science.1106215	http://dx.doi.org/10.1126/science.1106215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15879175				2022-12-24	WOS:000229926800059
J	Levin, LI; Munger, KL; Rubertone, MV; Peck, CA; Lennette, ET; Spiegelman, D; Ascherio, A				Levin, LI; Munger, KL; Rubertone, MV; Peck, CA; Lennette, ET; Spiegelman, D; Ascherio, A			Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUCLEAR ANTIGEN; INFECTION; DISEASE; MONONUCLEOSIS; EXPOSURE; EBNA-2; LEVEL; RISK	Context Infection with Epstein-Barr virus (EBV) has been associated with an increased risk of multiple sclerosis (MS), but the temporal relationship remains unclear. Objective To determine whether antibodies to EBV are elevated before the onset of MS. Design, Setting, and Participants Nested case-control study conducted among more than 3 million US military personnel with blood samples collected between 1988 and 2000 and stored in the Department of Defense Serum Repository. Cases were identified as individuals granted temporary or permanent disability because of MS. For each case (n = 83), 2 controls matched by age, sex, race/ethnicity, and dates of blood sample collection were selected. Serial samples collected before the onset of symptoms were available for 69 matched case-control sets. Main Outcome Measures Antibodies including IgA against EBV viral capsid antigen (VCA), and IgG against VCA, nuclear antigens (EBNA complex, EBNA-1, and EBNA-2), diffuse and restricted early antigens, and cytomegalovirus. Results The average time between blood collection and MS onset was 4 years (range, <1-11 years). The strongest predictors of MS were serum levels of IgG antibodies to EBNA complex or EBNA-1. Among individuals who developed MS, serum antibody titers to EBNA complex were similar to those of controls before the age of 20 years (geometric mean titers: cases=245, controls=265), but 2- to 3-fold higher at age 25 years and older (cases=684, controls=282; P<.001). The risk of MS increased with these antibody titers; the relative risk (RR) in persons with EBNA complex titers of at least 1280 compared with those with titers less than 80 was 9.4 (95% confidence interval [CI], 2.5-35.4; P for trend <.001). In longitudinal analyses, a 4-fold increase in anti-EBNA complex or anti-EBNA-1 titers during the follow-up was associated with a 3-fold increase in MS risk (EBNA complex: RR,3.0; 95% Cl, 1.3-6.5; EBNA-1: RR, 3.0; 95% Cl, 1.2-7.3). No association was found between cytomegalovirus antibodies and MS. Conclusion These results suggest an age-dependent relationship between EBV infection and development of MS.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Walter Reed Army Inst Res, Div Prevent Med, Silver Spring, MD USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; USA, Army Med Surveillance Act, Ctr Hlth Promot & Prevent Med, Washington, DC 20310 USA; USA, Phys Disabil Agcy, Washington, DC 20310 USA; Virolab Inc, Berkeley, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ascherio, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	Alberto.Ascherio@channing.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042194] Funding Source: NIH RePORTER; NINDS NIH HHS [NS42194] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alotaibi S, 2004, JAMA-J AM MED ASSOC, V291, P1875, DOI 10.1001/jama.291.15.1875; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Brex PA, 1999, NEUROLOGY, V53, P1184, DOI 10.1212/WNL.53.6.1184; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; DETHE G, 1982, HERPESVIRUSES, V1, P25; Diggle P, 1994, ANAL LONGITUDINAL DA, VXI, P253; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; HENLE W, 1971, J INFECT DIS, V124, P58, DOI 10.1093/infdis/124.1.58; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; HORWITZ CA, 1985, J INFECT DIS, V151, P1150, DOI 10.1093/infdis/151.6.1150; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Kaslow, 1997, VIRAL INFECT HUMANS, P253; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; KUSUNOKI Y, 1993, MICROBIOL IMMUNOL, V37, P461, DOI 10.1111/j.1348-0421.1993.tb03237.x; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; LENNETTE ET, 1993, EUR J CANCER, V29A, P1584, DOI 10.1016/0959-8049(93)90299-U; LENNETTE ET, 2000, CLIN VIROLOGY MANUAL, P140; MUELLER N, 1989, NEW ENGL J MED, V320, P689, DOI 10.1056/NEJM198903163201103; Ponsonby AL, 2005, JAMA-J AM MED ASSOC, V293, P463, DOI 10.1001/jama.293.4.463; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; SHIRODARIA PV, 1987, ARCH NEUROL-CHICAGO, V44, P1237, DOI 10.1001/archneur.1987.00520240019006; Sitki-Green D, 2003, J VIROL, V77, P1840, DOI 10.1128/JVI.77.3.1840-1847.2003; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820	30	291	299	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2005	293	20					2496	2500		10.1001/jama.293.20.2496	http://dx.doi.org/10.1001/jama.293.20.2496			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929BX	15914750				2022-12-24	WOS:000229318200024
J	Liu, Y; Schiff, M; Czymmek, K; Talloczy, Z; Levine, B; Dinesh-Kumar, SP				Liu, Y; Schiff, M; Czymmek, K; Talloczy, Z; Levine, B; Dinesh-Kumar, SP			Autophagy regulates programmed cell death during the plant innate immune response	CELL			English	Article							MEDIATED RESISTANCE; PROTEINS; GENE; INHIBITION; DISEASE; MACROAUTOPHAGY; TUMORIGENESIS; DISRUPTION; SENESCENCE; SURVIVAL	The plant innate immune response includes the hypersensitive response (HR), a form of programmed cell death (PCD). PCD must be restricted to infection sites to prevent the HR from playing a pathologic rather than protective role. Here we show that plant BECLIN 1, an ortholog of the yeast and mammalian autophagy gene ATG6/VPS30/beclin 1, functions to restrict HR PCD to infection sites. Initiation of HR PCD is normal in BECLIN 1-deficient plants, but remarkably, healthy uninfected tissue adjacent to HR lesions and leaves distal to the inoculated leaf undergo unrestricted PCD. In the HR PCD response, autophagy is induced in both pathogen-infected cells and distal uninfected cells; this is reduced in BECLIN 1-deficient plants. The restriction of HR PCD also requires orthologs of other autophagy-related genes including P13K/VPS34, ATG3, and ATG7. Thus, the evolutionarily conserved autophagy pathway plays an essential role in plant innate immunity and negatively regulates PCD.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Delaware, Delaware Biotechnol Inst, Dept Biol Sci, Newark, DE 19711 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX 75390 USA	Yale University; University of Delaware; Columbia University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Dinesh-Kumar, SP (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	savithramma.dinesh-kumar@yale.edu	Dinesh-Kumar, Savithramma/E-1153-2011; Liu, Yule/E-5700-2010	Liu, Yule/0000-0002-4423-6045; Czymmek, Kirk/0000-0002-5471-7395	NIAID NIH HHS [AI 51367] Funding Source: Medline; NIGMS NIH HHS [GM 62625] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI051367, R01AI051367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062625] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.arplant.46.1.189; Bourett TM, 1999, PLANTA, V208, P472, DOI 10.1007/s004250050584; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Erickson FL, 1999, PLANT J, V18, P67, DOI 10.1046/j.1365-313X.1999.00426.x; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lee CY, 2001, DEVELOPMENT, V128, P1443; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Marathe R, 2002, MOL PLANT PATHOL, V3, P167, DOI 10.1046/j.1364-3703.2002.00110.x; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Moriyasu Y, 2003, PLANT CELL PHYSIOL, V44, P795, DOI 10.1093/pcp/pcg100; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Surpin M, 2003, PLANT CELL, V15, P2885, DOI 10.1105/tpc.016121; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	48	642	700	11	129	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					567	577		10.1016/j.cell.2005.03.007	http://dx.doi.org/10.1016/j.cell.2005.03.007			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907470	Bronze			2022-12-24	WOS:000229331200013
J	English, SK				English, SK			Saying good-bye	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												shamrock25@iname.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2005	293	19					2321	2322						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926JX	15899986				2022-12-24	WOS:000229120600001
J	Piercy, J				Piercy, J			10-minute consultation - Hyperhidrosis	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Warwick, Warwick Med Sch, Div Med Educ, Coventry CV4 7AL, W Midlands, England	University of Warwick	Piercy, J (corresponding author), Univ Warwick, Warwick Med Sch, Div Med Educ, Coventry CV4 7AL, W Midlands, England.	ann.mcpherson@dphpc.ox.ac.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1127	1127		10.1136/bmj.330.7500.1127	http://dx.doi.org/10.1136/bmj.330.7500.1127			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891228	Bronze, Green Published			2022-12-24	WOS:000229166900021
J	Yuan, XL; Xiao, SH; Taylor, TN				Yuan, XL; Xiao, SH; Taylor, TN			Lichen-like symbiosis 600 million years ago	SCIENCE			English	Article							NEOPROTEROZOIC DOUSHANTUO FORMATION; FUNGI; EVOLUTION	The fossil record of fungi and lichens is scarce. Here we report the discovery of lichen-like fossils, involving filamentous hyphae closely associated with coccoidal cyanobacteria or algae, preserved in marine phosphorite of the Doushantuo Formation (between 551 and 635 million years old) at Weng'an, South China. These fossils indicate that fungi developed symbiotic partnerships with photoautotrophs before the evolution of vascular plants.	Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA; Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; University of Kansas	Xiao, SH (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA.	xiao@vt.edu	Xiao, Shuhai/A-2190-2009	Xiao, Shuhai/0000-0003-4655-2663				Alexopoulos C. J., 1996; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Berbee ML, 2001, MYCOTA, V7, P229; Butterfield NJ, 2005, PALEOBIOLOGY, V31, P165, DOI 10.1666/0094-8373(2005)031<0165:PPF>2.0.CO;2; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; DePriest PT, 2004, ANNU REV MICROBIOL, V58, P273, DOI 10.1146/annurev.micro.58.030603.123730; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; Gehrig H, 1996, J MOL EVOL, V43, P71, DOI 10.1007/BF02352301; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; KNOLL AH, 1979, PRECAMBRIAN RES, V10, P115, DOI 10.1016/0301-9268(79)90022-6; Kohlmeyer J., 1979, Marine mycology. The higher fungi.; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Peterson KJ, 2003, INTEGR COMP BIOL, V43, P127, DOI 10.1093/icb/43.1.127; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; RETALLACK GJ, 1994, PALEOBIOLOGY, V20, P523, DOI 10.1017/S0094837300012975; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; TAYLOR TN, 1995, MYCOLOGIA, V87, P560, DOI 10.2307/3760776; Taylor TN, 2004, T ROY SOC EDIN-EARTH, V94, P457, DOI 10.1017/S026359330000081X; Taylor TN, 1997, AM J BOT, V84, P992, DOI 10.2307/2446290; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; Tehler A, 2003, MYCOL RES, V107, P901, DOI 10.1017/S0953756203008128; Wedin M, 2004, NEW PHYTOL, V164, P459, DOI 10.1111/j.1469-8137.2004.01198.x; Xiao SH, 2004, AM J BOT, V91, P214, DOI 10.3732/ajb.91.2.214; ZHANG XG, 1989, LETHAIA, V22, P13, DOI 10.1111/j.1502-3931.1989.tb01164.x; ZHANG Y, 1998, PALEONTOL SOC MEM, V50, P1	26	195	240	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1017	1020		10.1126/science.1111347	http://dx.doi.org/10.1126/science.1111347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890881				2022-12-24	WOS:000229190700045
J	Kent, SC; Chen, YH; Bregoli, L; Clemmings, SM; Kenyon, NS; Ricordi, C; Hering, BJ; Hafler, DA				Kent, SC; Chen, YH; Bregoli, L; Clemmings, SM; Kenyon, NS; Ricordi, C; Hering, BJ; Hafler, DA			Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope	NATURE			English	Article							CLASS-II MOLECULES; GENE USAGE; MICE; MELLITUS; RESPONSES; ANTIGENS; DISEASE; CLONES; IDENTIFICATION; AUTOANTIGENS	In autoimmune type 1 diabetes, pathogenic T lymphocytes are associated with the specific destruction of insulin-producing beta-islet cells(1,2). Identification of the autoantigens involved in triggering this process is a central question. Here we examined T cells from pancreatic draining lymph nodes, the site of islet-cell-specific self-antigen presentation(3). We cloned single T cells in a non-biased manner from pancreatic draining lymph nodes of subjects with type 1 diabetes and from non-diabetic controls. A high degree of T-cell clonal expansion was observed in pancreatic lymph nodes from long-term diabetic patients but not from control subjects. The oligoclonally expanded T cells from diabetic subjects with DR4, a susceptibility allele for type 1 diabetes(4), recognized the insulin A 1 - 15 epitope restricted by DR4. These results identify insulin-reactive, clonally expanded T cells from the site of autoinflammatory drainage in long-term type 1 diabetics, indicating that insulin may indeed be the target antigen causing autoimmune diabetes.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Minnesota, Dept Surg, Diabet Inst Immunol & Transplantat, Minneapolis, MN 55455 USA; Univ Miami, Diabet Res Inst, Cell Transplant Ctr, Miami, FL 33136 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Miami	Hafler, DA (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	dhafler@rics.bwh.harvard.edu	RICORDI, CAMILLO/AAA-4740-2019	Ricordi, Camillo/0000-0001-8092-7153; Bregoli, Lisa/0000-0001-9376-1914				ACHAORBEA H, 1990, CURR TOP MICROBIOL, V156, P103; Akatsuka Y, 1999, TISSUE ANTIGENS, V53, P122, DOI 10.1034/j.1399-0039.1999.530202.x; Astill TP, 2003, DIABETOLOGIA, V46, P496, DOI 10.1007/s00125-003-1070-3; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; CANDEIAS S, 1991, P NATL ACAD SCI USA, V88, P6167, DOI 10.1073/pnas.88.14.6167; DAYAN CM, 1991, P NATL ACAD SCI USA, V88, P7415, DOI 10.1073/pnas.88.16.7415; Eisenbarth George S., 2002, Autoimmunity Reviews, V1, P139, DOI 10.1016/S1568-9972(02)00035-6; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Endl J, 1997, J CLIN INVEST, V99, P2405, DOI 10.1172/JCI119423; HAFLER DA, 1988, J EXP MED, V167, P1313, DOI 10.1084/jem.167.4.1313; Han M, 1999, J IMMUNOL, V163, P301; HARRISON LC, 1992, J CLIN INVEST, V89, P1161, DOI 10.1172/JCI115698; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; LONDEI M, 1989, P NATL ACAD SCI USA, V86, P636, DOI 10.1073/pnas.86.2.636; MIYAZAKI A, 1985, CLIN EXP IMMUNOL, V60, P622; Mycko MP, 2004, J IMMUNOL, V173, P1689, DOI 10.4049/jimmunol.173.3.1689; NAKANO N, 1991, J EXP MED, V173, P1091, DOI 10.1084/jem.173.5.1091; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Peakman M, 2001, DIABETES, V50, P1749, DOI 10.2337/diabetes.50.8.1749; Roep BO, 1996, DIABETES, V45, P1147, DOI 10.2337/diabetes.45.9.1147; Schloot NC, 2003, J AUTOIMMUN, V21, P365, DOI 10.1016/S0896-8411(03)00111-2; SIBLEY RK, 1985, LAB INVEST, V53, P132; THOMSON G, 1988, AM J HUM GENET, V43, P799; Tian J, 1997, J EXP MED, V186, P2039, DOI 10.1084/jem.186.12.2039; TODD JA, 1988, NATURE, V333, P710, DOI 10.1038/333710a0; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183	32	315	335	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					224	228		10.1038/nature03625	http://dx.doi.org/10.1038/nature03625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889096				2022-12-24	WOS:000229021100045
J	Sugasawa, K; Okuda, Y; Saijo, M; Nishi, R; Matsuda, N; Chu, G; Mori, T; Iwai, S; Tanaka, K; Tanaka, K; Hanaoka, F				Sugasawa, K; Okuda, Y; Saijo, M; Nishi, R; Matsuda, N; Chu, G; Mori, T; Iwai, S; Tanaka, K; Tanaka, K; Hanaoka, F			UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-C; DNA-BINDING PROTEIN; GLOBAL GENOMIC REPAIR; GROUP-E CELLS; CYCLOBUTANE PYRIMIDINE DIMERS; DAMAGED-DNA; ULTRAVIOLET-LIGHT; GENE-PRODUCT; IN-VIVO	The xeroderma pigmentosum group C (XPC) protein complex plays a key role in recognizing DNA damage throughout the genome for mammalian nucleotide excision repair (NER). Ultraviolet light (UV)-damaged DNA binding protein (UV-DDB) is another complex that appears to be involved in the recognition of NER-inducing damage, although the precise role it plays and its relationship to XPC remain to be elucidated. Here we show that XPC undergoes reversible ubiquitylation upon UV irradiation of cells and that this depends on the presence of functional UV-DDB activity. XPC and UV-DDB were demonstrated to interact physically, and both are polyubiquitylated by the recombinant UV-DDB-ubiquitin ligase complex. The polyubiquitylation altered the DNA binding properties of XPC and UV-DDB and appeared to be required for cell-free NER of UV-induced (6-4) photoproducts specifically when UV-DDB was bound to the lesion. Our results strongly suggest that ubiquitylation plays a critical role in the transfer of the UV-induced lesion from UVDDB to XPC.	RIKEN, Discovery Drug Res, Cellular Physiol Lab, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Wako, Saitama 3510198, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan; Stanford Univ, Dept Med & Biochem, Stanford, CA 94305 USA; Nara Med Univ, Radioisotope Ctr, Kashihara, Nara 6348521, Japan; Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	RIKEN; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Tokyo Metropolitan Institute of Medical Science; Stanford University; Nara Medical University; Osaka University	Sugasawa, K (corresponding author), RIKEN, Discovery Drug Res, Cellular Physiol Lab, Wako, Saitama 3510198, Japan.	sugasawa@riken.jp	Nishi, Ryotaro/AAA-3372-2019; Matsuda, Noriyuki/AAI-3156-2020	Matsuda, Noriyuki/0000-0001-8199-952X; Mori, Toshio/0000-0002-8321-0710; Nishi, Ryotaro/0000-0001-8179-5818				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200; Araujo SJ, 2000, GENE DEV, V14, P349; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; BOOTSMA D, 1997, METABOLIC BASIS INHE, P245; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fitch ME, 2003, DNA REPAIR, V2, P819, DOI 10.1016/S1568-7864(03)00066-1; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Itoh T, 2004, P NATL ACAD SCI USA, V101, P2052, DOI 10.1073/pnas.0306551101; Itoh T, 2000, J INVEST DERMATOL, V114, P1022, DOI 10.1046/j.1523-1747.2000.00952.x; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; MATSUMOTO Y, 1983, FEBS LETT, V151, P139, DOI 10.1016/0014-5793(83)80359-7; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Nichols AF, 1996, J BIOL CHEM, V271, P24317, DOI 10.1074/jbc.271.40.24317; Okuda Y, 2004, DNA REPAIR, V3, P1285, DOI 10.1016/j.dnarep.2004.06.010; Otrin VR, 1997, J CELL SCI, V110, P1159; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Rapic-Otrin V, 2003, HUM MOL GENET, V12, P1507, DOI 10.1093/hmg/ddg174; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; SHIVJI MKK, 1994, J BIOL CHEM, V269, P22749; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Wakasugi M, 2001, J BIOL CHEM, V276, P15434, DOI 10.1074/jbc.M011177200	39	441	459	3	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					387	400		10.1016/j.cell.2005.02.035	http://dx.doi.org/10.1016/j.cell.2005.02.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882621	Bronze			2022-12-24	WOS:000229031600009
J	Osterholm, MT				Osterholm, MT			Preparing for the next pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFLUENZA		Ctr Infect Dis Res & Policy, Minneapolis, MN USA; Natl Ctr Food Protect & Def, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Ctr Infect Dis Res & Policy, Minneapolis, MN USA.							Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; SANDMAN PM, 2005, PANDEMIC INFLUENZA R; Stohr K, 2005, NEW ENGL J MED, V352, P405, DOI 10.1056/NEJMe048344	5	364	407	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1839	1842		10.1056/NEJMp058068	http://dx.doi.org/10.1056/NEJMp058068			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872196	Green Submitted, Bronze			2022-12-24	WOS:000228858600001
J	Holt, BF; Belkhadir, Y; Dangl, JL				Holt, BF; Belkhadir, Y; Dangl, JL			Antagonistic control of disease resistance protein stability in the plant immune system	SCIENCE			English	Article							DOWNY MILDEW RESISTANCE; SCF UBIQUITIN-LIGASE; TOBACCO-MOSAIC-VIRUS; MOLECULAR CHAPERONE; MEDIATED RESISTANCE; ESSENTIAL COMPONENT; ARABIDOPSIS; HSP90; GENE; SGT1	Pathogen recognition by the plant immune system is governed by structurally related, polymorphic products of disease resistance (R) genes. RAR1 and/or SGT1b mediate the function of many R proteins. RAR1 controls preactivation R protein accumulation by an unknown mechanism. We demonstrate that Arabidopsis SGT1b has two distinct, genetically separable functions in the plant immune system: SGT1b antagonizes RAR1 to negatively regulate R protein accumulation before infection, and SGT1b has a RAR1-independent function that regulates programmed cell death during infection. The balanced activities of RAR1 and SGT1, in concert with cytosolic HSP90, modulate preactivation R protein accumulation and signaling competence.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, 108 Coker Hall,CB 3280, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Holt, Ben F/D-1513-2011; Belkhadir, Youssef/GXM-6743-2022	Belkhadir, Youssef/0000-0001-7149-7139				Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Belbahri L, 2001, PLANT J, V28, P419, DOI 10.1046/j.1365-313X.2001.01155.x; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Belkhadir Y, 2004, PLANT CELL, V16, P2822, DOI 10.1105/tpc.104.024117; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; FREIALDENHOVEN A, 1994, PLANT CELL, V6, P983; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Liu Y, 2002, PLANT CELL, V14, P1483, DOI 10.1105/tpc.002493; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Muskett PR, 2002, PLANT CELL, V14, P979, DOI 10.1105/tpc.001040; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Shirasu K, 2003, TRENDS PLANT SCI, V8, P252, DOI 10.1016/S1360-1385(03)00104-3; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tor M, 2002, PLANT CELL, V14, P993, DOI 10.1105/tpc.001123; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Warren RF, 1999, GENETICS, V152, P401; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang Y, 2004, PLANT J, V40, P213, DOI 10.1111/j.1365-313X.2004.02201.x	38	199	208	5	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					929	932		10.1126/science.1109977	http://dx.doi.org/10.1126/science.1109977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	15976272				2022-12-24	WOS:000231101400045
J	Allen, GS; Zavialov, A; Gursky, R; Ehrenberg, M; Frank, J				Allen, GS; Zavialov, A; Gursky, R; Ehrenberg, M; Frank, J			The cryo-EM structure of a translation initiation complex from Escherichia coli	CELL			English	Article							30S RIBOSOMAL-SUBUNITS; AMINOACYL-TRANSFER-RNA; FACTOR IF2; FACTOR-II; GUANOSINE TRIPHOSPHATE; CRYSTAL-STRUCTURE; GTPASE ACTIVITY; PROTEIN L7/L12; DENSITY MAPS; IN-VITRO	The 70S ribosome and its complement of factors required for initiation of translation in E. coli were purified separately and reassembled in vitro with GDPNP, producing a stable initiation complex (IC) stalled after 70S assembly. We have obtained a cryo-EM reconstruction of the IC showing IF2 center dot GDPNP at the intersubunit cleft of the 70S ribosome. IF2 center dot GDPNP contacts the 30S and 50S subunits as well as fMet-tRNA(fMet). IF2 here adopts a conformation radically different from that seen in the recent crystal structure of IF2. The C-terminal domain of IF2 binds to the singlestranded portion of fMet-tRNA(fmet), thereby forcing the tRNA into a novel orientation at the P site. The GTP binding domain of IF2 binds to the GTPase-associated center of the 50S subunit in a manner similar to EF-G and EF-Tu. Additionally, we present evidence for the localization of IF1, IF3, one C-terminal domain of L7/L12, and the N-terminal domain of IF2 in the initiation complex.	Hlth Res Inc, Wadsworth Ctr, Howard Hughes Med Inst, Albany, NY 12201 USA; Biomed Ctr, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Frank, J (corresponding author), Hlth Res Inc, Wadsworth Ctr, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.	joachim@wadsworth.org		Zavialov, Andrey/0000-0001-6420-0368	NIGMS NIH HHS [R01 GM55440, R37 GM29169, R01 GM055440-08, R37 GM029169-24] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055440, R37GM029169] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antoun A, 2003, EMBO J, V22, P5593, DOI 10.1093/emboj/cdg525; Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; BEAUDRY P, 1979, BIOCHEMISTRY-US, V18, P202, DOI 10.1021/bi00568a031; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; Brooijmans N, 2002, PROTEINS, V48, P645, DOI 10.1002/prot.10139; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CANONACO MA, 1986, FEBS LETT, V207, P198, DOI 10.1016/0014-5793(86)81488-0; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Chen JZ, 2003, J STRUCT BIOL, V144, P144, DOI 10.1016/j.jsb.2003.09.008; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; Dey D, 1998, J BIOL CHEM, V273, P1670, DOI 10.1074/jbc.273.3.1670; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gao HX, 2004, J STRUCT BIOL, V147, P283, DOI 10.1016/j.jsb.2004.02.008; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; GOSS DJ, 1982, J BIOL CHEM, V257, P119; GRIGORIADOU C, 2004, TRANSLATIONAL CONT A, P407; GRONER Y, 1973, J MOL BIOL, V74, P407, DOI 10.1016/0022-2836(73)90381-1; Grunberg-Manago M, 1975, J Mol Biol, V94, P461; GRUNBERGMANAGO M, 1972, FEBS LETT, V22, P217, DOI 10.1016/0014-5793(72)80049-8; GUALERZI C, 1971, BIOCHEM BIOPH RES CO, V45, P1312, DOI 10.1016/0006-291X(71)90162-8; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Guenneugues M, 2000, EMBO J, V19, P5233, DOI 10.1093/emboj/19.19.5233; HARTZ D, 1989, GENE DEV, V3, P1899, DOI 10.1101/gad.3.12a.1899; HARTZ D, 1990, GENE DEV, V4, P1790, DOI 10.1101/gad.4.10.1790; HEIMARK RL, 1976, J BIOL CHEM, V251, P7779; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; KAY AC, 1972, BIOCHIM BIOPHYS ACTA, V277, P225, DOI 10.1016/0005-2787(72)90369-3; Lee JH, 1999, P NATL ACAD SCI USA, V96, P4342, DOI 10.1073/pnas.96.8.4342; LOCKWOOD AH, 1971, P NATL ACAD SCI USA, V68, P3122, DOI 10.1073/pnas.68.12.3122; Luchin S, 1999, J BIOL CHEM, V274, P6074, DOI 10.1074/jbc.274.10.6074; Marzi S, 2003, RNA, V9, P958, DOI 10.1261/rna.2116303; Mayer C, 2003, BIOCHEMISTRY-US, V42, P4787, DOI 10.1021/bi034011r; McCutcheon JP, 1999, P NATL ACAD SCI USA, V96, P4301, DOI 10.1073/pnas.96.8.4301; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Montesano-Roditis L, 2001, J BIOL CHEM, V276, P14117, DOI 10.1074/jbc.M008430200; Moreno JMP, 1998, BIOCHEM BIOPH RES CO, V252, P465, DOI 10.1006/bbrc.1998.9664; Moreno JMP, 1999, FEBS LETT, V455, P130, DOI 10.1016/S0014-5793(99)00858-3; NYENGAARD NR, 1991, BIOCHEM BIOPH RES CO, V181, P1572, DOI 10.1016/0006-291X(91)92118-4; PETERSEN HU, 1979, BIOCHEM BIOPH RES CO, V91, P1068, DOI 10.1016/0006-291X(79)91989-2; PETERSEN HU, 1981, FEBS LETT, V128, P161, DOI 10.1016/0014-5793(81)81105-2; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; PON CL, 1986, FEBS LETT, V195, P215, DOI 10.1016/0014-5793(86)80163-6; PON CL, 1984, FEBS LETT, V175, P203, DOI 10.1016/0014-5793(84)80737-1; Rath BK, 2003, J STRUCT BIOL, V144, P95, DOI 10.1016/j.jsb.2003.09.029; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WAKAO H, 1989, J BIOL CHEM, V264, P20363; WAKAO H, 1990, BIOCHEMISTRY-US, V29, P8144, DOI 10.1021/bi00487a023; WEIEL J, 1982, J BIOL CHEM, V257, P1215; WINTERMEYER W, 1983, BIOCHEMISTRY-US, V22, P690, DOI 10.1021/bi00272a025; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; ZUCKER FH, 1986, BIOCHEMISTRY-US, V25, P3682, DOI 10.1021/bi00360a031	64	221	227	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					703	712		10.1016/j.cell.2005.03.023	http://dx.doi.org/10.1016/j.cell.2005.03.023			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935757	Bronze			2022-12-24	WOS:000229658000009
J	Boucrot, E; Henry, T; Borg, JP; Gorvel, JP; Meresse, S				Boucrot, E; Henry, T; Borg, JP; Gorvel, JP; Meresse, S			The intracellular fate of Salmonella depends on the recruitment of kinesin	SCIENCE			English	Article							TYPHIMURIUM; PROTEIN; SIFA; IDENTIFICATION; EFFECTOR; DOMAINS; COMPLEX	Salmonella enterica causes a variety of diseases, including gastroenteritis and typhoid fever. The success of this pathogen depends on its capacity to proliferate within host cells in a membrane-bound compartment. We found that the Salmonella-containing vacuole recruited the plus-end-directed motor kinesin. Bacterial effector proteins translocated into the host cell by a type III secretion system antagonistically regulated this event. Among these effectors, SifA targeted SKIP, a host protein that down-regulated the recruitment of kinesin on the bacterial. vacuole and, in turn, controlled vacuolar membrane dynamics.	Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; Inst J Paoli I Calmettes, F-13009 Marseille, France; INSERM, UMR 599, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm)	Meresse, S (corresponding author), Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, Case 906, F-13288 Marseille, France.	meresse@ciml.univ-mrs.fr	Henry, Thomas/G-3160-2013; Borg, Jean-Paul/AAX-8096-2020; Meresse, Stephane/E-2192-2012; Gorvel, Jean-Pierre/O-1332-2018	Henry, Thomas/0000-0002-0687-8565; Borg, Jean-Paul/0000-0001-8418-3382; Meresse, Stephane/0000-0001-6578-5177; Gorvel, Jean-Pierre/0000-0002-2829-9804				Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Clarke EJ, 2002, CURR BIOL, V12, pR596, DOI 10.1016/S0960-9822(02)01102-8; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Guignot J, 2004, J CELL SCI, V117, P1033, DOI 10.1242/jcs.00949; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Marsman M, 2004, MOL BIOL CELL, V15, P2954, DOI 10.1091/mbc.E03-08-0614; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x	22	190	198	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1174	1178		10.1126/science.1110225	http://dx.doi.org/10.1126/science.1110225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905402				2022-12-24	WOS:000229293400045
J	Kustikova, O; Fehse, B; Modlich, U; Yang, M; Dullmann, J; Kamino, K; von Neuhoff, N; Schlegelberger, B; Li, ZX; Baum, C				Kustikova, O; Fehse, B; Modlich, U; Yang, M; Dullmann, J; Kamino, K; von Neuhoff, N; Schlegelberger, B; Li, ZX; Baum, C			Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking	SCIENCE			English	Article							CANCER; PROLIFERATION; THERAPY; MOUSE	Gene marking with replication-defective retroviral vectors has been used for more than 20 years to track the in vivo fate of cell clones. We demonstrate that retroviral integrations themselves may trigger nonmalignant clonal expansion in murine long-term hematopoiesis. All 29 insertions recovered from clones dominating in serially transplanted recipients affected loci with an established or potential role in the self-renewal or survival of hematopoietic stem cells. Transcriptional dysregulation occurred in all 12 insertion sites analyzed. These findings have major implications for diagnostic gene marking and the discovery of genes regulating stem cell turnover.	Hannover Med Sch, Dept Hematol Hemostaseol & Oncol, D-30625 Hannover, Germany; Hannover Med Sch, Inst Cellular & Mol Pathol, D-30625 Hannover, Germany; Univ Hosp Eppendorf, Inst Anat Expt Morphol 2, D-20251 Hamburg, Germany; Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA	Hannover Medical School; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Li, ZX (corresponding author), Hannover Med Sch, Dept Hematol Hemostaseol & Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	li.zhixiong@mh-hannover.de; baum.christopher@mh-hannover.de	Fehse, Boris/A-8721-2012	Fehse, Boris/0000-0001-9780-7211; Modlich, Ute/0000-0001-8018-4118				Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314; Bonini C, 2003, NAT MED, V9, P367, DOI 10.1038/nm0403-367; Brenner MK, 2003, CYTOTHERAPY, V5, P190, DOI 10.1080/14653240310001307; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Fehse B, 2000, MOL THER, V1, P448, DOI 10.1006/mthe.2000.0068; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kohn DB, 2003, MOL THER, V8, P180, DOI 10.1016/S1525-0016(03)00212-0; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Lemischka IR, 2001, NAT IMMUNOL, V2, P11, DOI 10.1038/83115; Li Z, 2002, LEUKEMIA, V16, P1655, DOI 10.1038/sj.leu.2402619; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; Modlich U, 2005, BLOOD, V105, P4235, DOI 10.1182/blood-2004-11-4535; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Schmidt M, 2002, BLOOD, V100, P2737, DOI 10.1182/blood-2002-02-0407; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101	27	276	296	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1171	1174		10.1126/science.1105063	http://dx.doi.org/10.1126/science.1105063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905401				2022-12-24	WOS:000229293400044
J	Aluwihare, LI; Repeta, DJ; Pantoja, S; Johnson, CG				Aluwihare, LI; Repeta, DJ; Pantoja, S; Johnson, CG			Two chemically distinct pools of organic nitrogen accumulate in the ocean	SCIENCE			English	Article							PACIFIC SUBTROPICAL GYRE; MARINE-BACTERIA; AMINO-ACIDS; SEA-WATER; MATTER; PROTEIN; SAMPLES; PROTEOBACTERIA; CHROMATOGRAPHY; PARTICULATE	The chemical dynamics of marine dissolved organic nitrogen (DON), a reservoir featuring surface accumulations even in areas where nitrogen limits productivity, have yet to be resolved. We exploited differences in the acid lability of amide bonds within high-molecular-weight (HMW) DON to show that vertical DON profiles result in part from the presence of two chemically distinct pools of amide. Half of HMWDON in surface waters is present as N-acetyl amino polysaccharides. In contrast, nearly all deep-sea HMWDON, and therefore, most HMWDON, is present in amides that resist both chemical hydrolysis and biological degradation.	Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ Concepcion, Dept Oceanog, Concepcion, Chile; Univ Concepcion, FONDAP, Ctr Invest Oceanog Pacifico SurOriental, Concepcion, Chile	University of California System; University of California San Diego; Scripps Institution of Oceanography; Woods Hole Oceanographic Institution; Universidad de Concepcion; Universidad de Concepcion	Aluwihare, LI (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA.	laluwihare@ucsd.edu						Abell J, 2000, J MAR RES, V58, P203, DOI 10.1357/002224000321511142; Albert DB, 1997, MAR CHEM, V56, P27, DOI 10.1016/S0304-4203(96)00083-7; Aluwihare LI, 2002, DEEP-SEA RES PT II, V49, P4421, DOI 10.1016/S0967-0645(02)00124-8; Aluwihare LI, 1997, NATURE, V387, P166, DOI 10.1038/387166a0; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Berman T, 2003, AQUAT MICROB ECOL, V31, P279, DOI 10.3354/ame031279; Boon JJ, 1998, ORG GEOCHEM, V29, P1051, DOI 10.1016/S0146-6380(98)00121-1; BRONK DA, 2002, BIOGEOCHEMISTRY MARI, P163; Church MJ, 2002, LIMNOL OCEANOGR, V47, P1, DOI 10.4319/lo.2002.47.1.0001; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P1195, DOI 10.1128/AEM.66.3.1195-1201.2000; HADJA O, 1974, ANAL BIOCHEM, V60, P512; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HENRICHS SM, 1985, MAR CHEM, V17, P141, DOI 10.1016/0304-4203(85)90070-2; Kaiser K, 2000, ANAL CHEM, V72, P2566, DOI 10.1021/ac991407t; KEIL RG, 1994, MAR CHEM, V45, P187, DOI 10.1016/0304-4203(94)90002-7; Knicker H, 1997, NATURWISSENSCHAFTEN, V84, P231, DOI 10.1007/s001140050384; Leenheer JA, 2004, BIOGEOCHEMISTRY, V69, P125, DOI 10.1023/B:BIOG.0000031044.16410.27; Libby PS, 1997, DEEP-SEA RES PT I, V44, P345; Martinez JS, 2000, SCIENCE, V287, P1245, DOI 10.1126/science.287.5456.1245; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; Nagata Y, 1998, BBA-GEN SUBJECTS, V1379, P76, DOI 10.1016/S0304-4165(97)00084-6; Palenik B, 1997, LIMNOL OCEANOGR, V42, P1544, DOI 10.4319/lo.1997.42.7.1544; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Svitil AL, 1998, MICROBIOL-SGM, V144, P1299, DOI 10.1099/00221287-144-5-1299; TANOUE E, 1995, GEOCHIM COSMOCHIM AC, V59, P2643, DOI 10.1016/0016-7037(95)00134-4; ZHAO MX, 1995, J CHROMATOGR A, V690, P55, DOI 10.1016/0021-9673(94)00927-2	28	137	138	8	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1007	1010		10.1126/science.1108925	http://dx.doi.org/10.1126/science.1108925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890880				2022-12-24	WOS:000229190700042
J	Sobel, RK				Sobel, RK			MSL - Medicine as a second language	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sobel, RK (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							Harber RJ, 2001, J GEN INTERN MED, V16, P308, DOI 10.1046/j.1525-1497.2001.00233.x	1	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1945	1946		10.1056/NEJMp048342	http://dx.doi.org/10.1056/NEJMp048342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888692				2022-12-24	WOS:000229017100002
J	Durr, H; Korner, C; Muller, M; Hickmann, V; Hopfner, KP				Durr, H; Korner, C; Muller, M; Hickmann, V; Hopfner, KP			X-ray structures of the Sulfolobus solfataricus SWI2/SNF2 ATPase core and its complex with DNA	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; CRYSTAL-STRUCTURE; SUPERHELICAL TORSION; FUNCTIONAL-ANALYSIS; NUCLEOSOME; HELICASE; REPAIR; RAD54; RECOMBINATION; TRANSCRIPTION	SWI2/SNF2 ATPases remodel chromatin or other DNA:protein complexes by a poorly understood mechanism that involves ATP-dependent DNA translocation and generation of superhelical torsion. Crystal structures of a dsDNA-translocating SWI2/SNF2 ATPase core from Sulfolobus solfataricus reveal two helical SWI2/SNF2 specific subdomains, fused to a DExx box helicase-related ATPase core. Fully base paired duplex DNA binds along a central cleft via both minor groove strands, indicating that SWI2/SNF2 ATPases travel along the dsDNA minor groove without strand separation. A structural switch, linking DNA binding and the active site DExx motif, may account for the stimulation of ATPase activity by dsDNA. Our results suggest that torque in remodeling processes is generated by an ATP-driven screw motion of DNA along the active site cleft. The structures also redefine SWI2/SNF2 functional motifs and uncover unexpected structural correlation of mutations in Cockayne and X-linked mental retardation syndromes.	Univ Munich, Gene Ctr, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de	Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357; Hickmann, Volker/0000-0003-2625-0414				Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Asturias FJ, 2004, METHOD ENZYMOL, V376, P48; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Beerens N, 2005, J BIOL CHEM, V280, P4722, DOI 10.1074/jbc.M409147200; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Lammens A, 2004, CURR BIOL, V14, P1778, DOI 10.1016/j.cub.2004.09.044; Langst G, 2004, BBA-GENE STRUCT EXPR, V1677, P58, DOI 10.1016/j.bbaexp.2003.10.011; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Manzan A, 2004, EMBO REP, V5, P54, DOI 10.1038/sj.embor.7400037; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Owen-Hughes T, 2003, BIOCHEM SOC T, V31, P893; Peterson CL, 2002, EMBO REP, V3, P319, DOI 10.1093/embo-reports/kvf075; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Seitz EM, 2001, ADV APPL MICROBIOL, V50, P101, DOI 10.1016/S0065-2164(01)50005-2; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Smith GD, 1998, ACTA CRYSTALLOGR D, V54, P799, DOI 10.1107/S0907444997018805; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TURCK D, 1992, THESIS TECHNICAL U M; van den Boom V, 2002, BIOESSAYS, V24, P780, DOI 10.1002/bies.10150; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yu SR, 2004, DNA REPAIR, V3, P277, DOI 10.1016/j.dnarep.2003.11.004; Zofall M, 2004, MOL CELL BIOL, V24, P10047, DOI 10.1128/MCB.24.22.10047-10057.2004	56	209	213	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					363	373		10.1016/j.cell.2005.03.026	http://dx.doi.org/10.1016/j.cell.2005.03.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882619	Bronze, Green Submitted			2022-12-24	WOS:000229031600007
J	Cauley, JA; Lui, LY; Ensrud, KE; Zmuda, JM; Stone, KL; Hochberg, MC; Cummings, SR				Cauley, JA; Lui, LY; Ensrud, KE; Zmuda, JM; Stone, KL; Hochberg, MC; Cummings, SR			Bone mineral density and the risk of incident nonspinal fractures in black and white women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIP FRACTURE; OSTEOPOROTIC FRACTURES; AFRICAN-AMERICAN; VOLUMETRIC DENSITY; RACIAL-DIFFERENCES; OLDER WOMEN; MASS; AGE; PREDICTION; CURVES	Context Black women have a lower rate of fracture than white women, but whether bone mineral density (BMD) predicts fracture risk as well in black women as it does in white women is not established. Objective To examine the association between BMD and incident nonspinal fractures in older black and white women. Design, Setting, and Participants Prospective cohort study of baseline data collected from 1986 through 1990 (7334 white women aged 67-99 years) and from 1996 through 1998 (636 black women aged 65-94 years) at 4 US clinical centers in the Study of Osteoporotic Fractures; mean (SD) follow-up of 6.1 (1.5) years until October 1, 2004. Main Outcome Measures Incident nonspinal fractures were confirmed by radiograpic report. Total hip and femoral neck BMD and bone mineral content were measured by dual energy x-ray absorptiometry. Results A total of 58 black women had a combined total of 61 fractures and 1606 white women had a combined total of 1712 fractures. In age-adjusted proportional hazard models, a 1-SD decrease in femoral neck BMD was associated with a 37% increased risk of fracture in black women (relative risk [RR], 1.37; 95% confidence interval [CI], 1.08-1.74) and a 49% increase in fracture in white women (RR, 1.49; 95% Cl, 1.40-1.58). Adjustment for body weight and other risk factors for fracture weakened the association between BMD and fracture, especially among black women (multivariable adjusted RR per 1-SD decrease in femoral neck BMD for black vs white women: RR, 1.20 [95% Cl, 0.93-1.55) vs RR, 1.42 [95% Cl, 1.32-1.52]). The absolute incidence of fracture across the pooled BMD distribution was 30% to 40% lower among black women at every BMD tertile. The lower risk of fracture among black compared with white women was independent of BMD and other risk factors (RR, 0.48; 95% Cl, 0.36-0.64). Conclusions Decreased total hip and femoral neck BMD is associated with an increased risk of fracture in both older black and white women, but this relationship was largely explained by other risk factors in black women. Black women have a lower fracture risk than white women at every level of BMD. Race-specific normative data-bases may be appropriate for the densitometric definition of osteoporosis.	Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Minnesota, Vet Affairs Med Ctr, Minneapolis, MN USA; Univ Minnesota, Dept Med & Epidemiol, Minneapolis, MN USA; Univ Maryland, Dept Med, Baltimore, MD 21201 USA; Univ Maryland, Dept Epidemiol, Baltimore, MD 21201 USA; Univ Maryland, Dept Prevent Med, Baltimore, MD 21201 USA; Calif Pacific Med Ctr, San Francisco, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; California Pacific Medical Center	Cauley, JA (corresponding author), Univ Pittsburgh, Dept Epidemiol, 130 DeSoto St,Crabtree Hall A543, Pittsburgh, PA 15261 USA.	jcauley@pitt.edu	Cauley, Jane A/N-4836-2015; YAMAMOTO, MASAHIRO/F-9094-2011	Cauley, Jane A/0000-0003-0752-4408; YAMAMOTO, MASAHIRO/0000-0003-3859-0125; Ensrud, Kristine/0000-0002-9069-3036	NIAMS NIH HHS [AR44811, AR35582, AR35583, AR35584] Funding Source: Medline; NIA NIH HHS [AG05407] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035583, P60AR044811, R01AR035582, R01AR035584] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; BARON JA, 1994, EPIDEMIOLOGY, V5, P42, DOI 10.1097/00001648-199401000-00008; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; Binkley Neil C, 2002, J Clin Densitom, V5 Suppl, pS19, DOI 10.1385/JCD:5:3S:S19; BLACK DM, 1992, J BONE MINER RES, V7, P633; BLOCK G, 1992, J AM DIET ASSOC, V92, P969; Bohannon AD, 1999, AM J EPIDEMIOL, V149, P1002; Cauley JA, 1997, OSTEOPOROSIS INT, V7, P100, DOI 10.1007/BF01623683; Cauley JA, 2005, J AM GERIATR SOC, V53, P183, DOI 10.1111/j.1532-5415.2005.53101.x; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; CUMMINGS SR, 1994, OSTEOPOROSIS INT, V4, P226, DOI 10.1007/BF01623243; CUMMINGS SR, 1994, J BONE MINER RES, V9, P1429; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Duan YB, 1999, J BONE MINER RES, V14, P1796, DOI 10.1359/jbmr.1999.14.10.1796; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; Finkelstein JS, 2002, J CLIN ENDOCR METAB, V87, P3051, DOI 10.1210/jc.87.7.3051; GRISSO JA, 1994, NEW ENGL J MED, V330, P1555, DOI 10.1056/NEJM199406023302202; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; KATZMAN DK, 1991, J CLIN ENDOCR METAB, V73, P1332, DOI 10.1210/jcem-73-6-1332; KLEEREKOPER M, 1994, J BONE MINER RES, V9, P1267; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Orwoll ES, 1996, ANN INTERN MED, V124, P187, DOI 10.7326/0003-4819-124-2-199601150-00001; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Robbins J, 2004, J NATL MED ASSOC, V96, P1609; Seeman E, 2001, J BONE MINER RES, V16, P120, DOI 10.1359/jbmr.2001.16.1.120; STEIGER P, 1992, J BONE MINER RES, V7, P625; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; *US DEP HHS, 2004, BONE HLTH OST REP SU; Zmuda JM, 1999, GENET EPIDEMIOL, V16, P356, DOI 10.1002/(SICI)1098-2272(1999)16:4<356::AID-GEPI3>3.0.CO;2-I	35	194	204	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2102	2108		10.1001/jama.293.17.2102	http://dx.doi.org/10.1001/jama.293.17.2102			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870413	Green Published, Bronze			2022-12-24	WOS:000228808200019
J	Fox, RC; Scott, CS				Fox, RC; Scott, CS			First evidence of a venom delivery apparatus in extinct mammals	NATURE			English	Article								Numerous non-mammalian vertebrates have evolved lethal venoms to aid either in securing prey or as protection from predators, but modern mammals that use venoms in these ways are rare, including only the duck-billed platypus (Ornithorhynchus), the Caribbean Solenodon, and a few shrews (Soricidae) (Order Insectivora)(1). Here we report evidence of a venom delivery apparatus in extinct mammals, documented by well-preserved specimens recovered from late Palaeocene rocks in Alberta, Canada(2,3). Although classified within Eutheria, these mammals are phylogenetically remote from modern Insectivora(4) and have evolved specialized teeth as salivary venom delivery systems (VDSs) that differ markedly from one another and from those of Solenodon and shrews. Our discoveries therefore show that mammals have been much more flexible in the evolution of VDSs than previously believed, contradicting currently held notions that modern insectivorans are representative of the supposedly limited role of salivary venoms in mammalian history. Evidently, small predatory eutherians have paralleled colubroid snakes(5) in evolving salivary venoms and their delivery systems several times independently.	Univ Alberta, Dept Biol Sci, Paleontol Vertebres Lab, Edmonton, AB T6G 2E9, Canada	University of Alberta	Fox, RC (corresponding author), Univ Alberta, Dept Biol Sci, Paleontol Vertebres Lab, Edmonton, AB T6G 2E9, Canada.	richard.fox@ualberta.ca						BELLAIRS AD, 1957, REPTILES LIFE HIST E; DUFTON MJ, 1992, PHARMACOL THERAPEUT, V53, P199, DOI 10.1016/0163-7258(92)90009-O; FOX RC, 1990, DAWN AGE MAMMALS NO, P51; Gazin C. L., 1956, SMITHSONIAN MISCELLA, V131, P1; GINGERICH P D, 1983, Contributions from the Museum of Paleontology University of Michigan, V26, P227; GOIN CJ, 1972, INTRO HERPETOLOGY; Jackson K, 2003, ZOOL J LINN SOC-LOND, V137, P337, DOI 10.1046/j.1096-3642.2003.00052.x; Kita M, 2004, P NATL ACAD SCI USA, V101, P7542, DOI 10.1073/pnas.0402517101; Lake AR, 1996, S AFR J SCI, V92, P167; Lofgren Donald L., 2004, P43; MacDonald D, 1984, ENCY MAMMALS; MCDOWELL SAMUEL BOOKER, 1958, BULL AMER MUS NAT HIST, V115, P113; McKenna MC, 1997, CLASSIFICATION MAMMA; Rabb G.B., 1959, NAT HIST MISC, V170, P1; Scott C, 2004, J VERTEBR PALEONTOL, V24, p111A	15	37	39	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2005	435	7045					1091	1093		10.1038/nature03646	http://dx.doi.org/10.1038/nature03646			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973406				2022-12-24	WOS:000229970400047
J	Erwin, DH				Erwin, DH			Seeds of diversity	SCIENCE			English	Editorial Material							ECOSYSTEM ENGINEERS; ORGANISMS		Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Erwin, DH (corresponding author), Natl Museum Nat Hist, Dept Paleobiol, MRC-121,POB 37012, Washington, DC 20013 USA.	erwind@si.edu	Erwin, Douglas H/A-9668-2009	Erwin, Douglas/0000-0003-2518-5614				Dawkins R, 2004, BIOL PHILOS, V19, P377, DOI 10.1023/B:BIPH.0000036180.14904.96; Dawkins R., 1982, pi; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Lewontin R.C., 1983, P273; MAC ARTHUR ROBERT H., 1967; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; SIGNOR PW, 1994, PALEOBIOLOGY, V20, P297, DOI 10.1017/S0094837300012793; STANLEY SM, 1990, PALEOBIOLOGY, V16, P401, DOI 10.1017/S0094837300010150; Webby B.D., 2004, GREAT ORDOVICIAN BIO, DOI DOI 10.7312/WEBB12678	11	36	36	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2005	308	5729					1752	1753		10.1126/science.1113416	http://dx.doi.org/10.1126/science.1113416			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961660				2022-12-24	WOS:000229926800042
J	Hopkins, DS; Pekker, D; Goldbart, PM; Bezryadin, A				Hopkins, DS; Pekker, D; Goldbart, PM; Bezryadin, A			Quantum interference device made by DNA templating of superconducting nanowires	SCIENCE			English	Article								The application of single molecules as templates for nanodevices is a promising direction for nanotechnology. We used a pair of suspended DNA molecules as templates for superconducting two-nanowire devices. Because the resulting wires are very thin, comparable to the DNA molecules themselves, they are susceptible to thermal fluctuations typical for one-dimensional superconductors and exhibit a nonzero resistance over a broad temperature range. We observed resistance oscillations in these two-nanowire structures that are different from the usual Little-Parks oscillations. Here, we provide a quantitative explanation for the observed quantum interference phenomenon, which takes into account strong phase gradients created in the leads by the applied magnetic field.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bezryadin, A (corresponding author), Univ Illinois, Dept Phys, Urbana, IL 61801 USA.	bezryadi@uiuc.edu	Bezryadin, Alexey/H-1815-2016	Bezryadin, Alexey/0000-0002-4822-6960				Bezryadin A, 2000, NATURE, V404, P971, DOI 10.1038/35010060; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Braun E, 2004, ADV PHYS, V53, P441, DOI 10.1080/00018730412331294688; CLEM JR, 1972, B AM PHYS SOC, V43, P411; JAKLEVIC RC, 1964, PHYS REV LETT, V12, P159, DOI 10.1103/PhysRevLett.12.159; LANGER JS, 1967, PHYS REV, V164, P498, DOI 10.1103/PhysRev.164.498; LIKHAREV KK, 1973, SOV RADIOPHYS, V14, P722; LITTLE WA, 1967, PHYS REV, V156, P396, DOI 10.1103/PhysRev.156.396; Maksimova GM, 1998, PHYS SOLID STATE+, V40, P1607, DOI 10.1134/1.1130618; MCCUMBER DE, 1970, PHYS REV B-SOLID ST, V1, P1054, DOI 10.1103/PhysRevB.1.1054; Mertig M, 2002, NANO LETT, V2, P841, DOI 10.1021/nl025612r; Richter J, 2001, APPL PHYS LETT, V78, P536, DOI 10.1063/1.1338967; Richter J, 2002, APPL PHYS A-MATER, V74, P725, DOI 10.1007/s003390201289; Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C; Stan G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.097003; Tinkham M, 2002, APPL PHYS LETT, V80, P2946, DOI 10.1063/1.1473232; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd; Watanabe H, 2001, APPL PHYS LETT, V79, P2462, DOI 10.1063/1.1408604; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389	19	130	132	4	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1762	1765		10.1126/science.1111307	http://dx.doi.org/10.1126/science.1111307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961664				2022-12-24	WOS:000229926800047
J	Fre, S; Huyghe, M; Mourikis, P; Robine, S; Louvard, D; Artavanis-Tsakonas, S				Fre, S; Huyghe, M; Mourikis, P; Robine, S; Louvard, D; Artavanis-Tsakonas, S			Notch signals control the fate of immature progenitor cells in the intestine	NATURE			English	Article							VILLIN GENE; EPITHELIAL-CELLS; STEM-CELLS; EXPRESSION; DIFFERENTIATION; MICE; PROLIFERATION; NEUROGENIN3; MATH1; HES5	The Notch signalling pathway plays a crucial role in specifying cellular fates in metazoan development by regulating communication between adjacent cells(1,2). Correlative studies suggested an involvement of Notch in intestinal development. Here, by modulating Notch activity in the mouse intestine, we directly implicate Notch signals in intestinal cell lineage specification. We also show that Notch activation is capable of amplifying the intestinal progenitor pool while inhibiting cell differentiation. We conclude that Notch activity is required for the maintenance of proliferating crypt cells in the intestinal epithelium.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Canc Ctr,Dept Cell Biol, Charlestown, MA 02129 USA; Inst Curie, CNRS, F-75231 Paris, France; Univ Paris 11, Fac Sci Orsay, F-91405 Orsay, France; Coll France, F-75231 Paris, France	Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France	Artavanis-Tsakonas, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Canc Ctr,Dept Cell Biol, Charlestown, MA 02129 USA.	tsakonas@helix.mgh.harvard.edu	Mourikis, Philippos/AAM-2458-2020; Fre, Silvia/C-7540-2017	Fre, Silvia/0000-0002-7209-7636; Mourikis, Philippos/0000-0003-3164-7109; huyghe, mathilde/0000-0002-8473-2924				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FATH KR, 1990, DEVELOPMENT, V109, P449; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Go MJ, 1998, DEVELOPMENT, V125, P2031; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hofer D, 1996, HISTOCHEM CELL BIOL, V105, P405, DOI 10.1007/BF01463662; Ito T, 2000, DEVELOPMENT, V127, P3913; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; LOUVARD D, 1992, ANNU REV CELL BIOL, V8, P157, DOI 10.1146/annurev.cb.08.110192.001105; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MAUNOURY R, 1988, EMBO J, V7, P3321, DOI 10.1002/j.1460-2075.1988.tb03203.x; MAUNOURY R, 1992, DEVELOPMENT, V115, P717; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zine A, 2002, HEARING RES, V170, P22, DOI 10.1016/S0378-5955(02)00449-5	30	674	725	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					964	968		10.1038/nature03589	http://dx.doi.org/10.1038/nature03589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959516				2022-12-24	WOS:000229799700051
J	He, L; Thomson, JM; Hemann, MT; Hernando-Monge, E; Mu, D; Goodson, S; Powers, S; Cordon-Cardo, C; Lowe, SW; Hannon, GJ; Hammond, SM				He, L; Thomson, JM; Hemann, MT; Hernando-Monge, E; Mu, D; Goodson, S; Powers, S; Cordon-Cardo, C; Lowe, SW; Hannon, GJ; Hammond, SM			A microRNA polycistron as a potential human oncogene	NATURE			English	Article							CAENORHABDITIS-ELEGANS; DEVELOPMENTAL SWITCH; IN-VIVO; GENE; RNA; SUPPRESSION; EXPRESSION; LYMPHOMA; ENCODES; TARGET	To date, more than 200 microRNAs have been described in humans; however, the precise functions of these regulatory, noncoding RNAs remains largely obscure. One cluster of microRNAs, the mir-17-92 polycistron, is located in a region of DNA that is amplified in human B-cell lymphomas(1). Here we compared B-cell lymphoma samples and cell lines to normal tissues, and found that the levels of the primary or mature microRNAs derived from the mir-17-92 locus are often substantially increased in these cancers. Enforced expression of the mir-17-92 cluster acted with c-myc expression to accelerate tumour development in a mouse B-cell lymphoma model. Tumours derived from haematopoietic stem cells expressing a subset of the mir- 17 - 92 cluster and c-myc could be distinguished by an absence of apoptosis that was otherwise prevalent in c-myc-induced lymphomas. Together, these studies indicate that non-coding RNAs, specifically microRNAs, can modulate tumour formation, and implicate the mir- 17 - 92 cluster as a potential human oncogene.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA	Cold Spring Harbor Laboratory; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Memorial Sloan Kettering Cancer Center	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu; hammond@med.unc.edu	Mu, David/E-8933-2011; Hannon, Gregory/AAB-3568-2019	Mu, David/0000-0002-7762-0182; Hernando, Eva/0000-0003-1023-0312; Powers, Scott/0000-0003-2769-1932	NCI NIH HHS [P30 CA008748, P01 CA087497] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087497, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Knuutila S, 1998, AM J PATHOL, V152, P1107; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Michael MZ, 2003, MOL CANCER RES, V1, P882; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369	28	2915	3228	4	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2005	435	7043					828	833		10.1038/nature03552	http://dx.doi.org/10.1038/nature03552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944707	Green Submitted, Green Accepted			2022-12-24	WOS:000229638700053
J	Cyranoski, D				Cyranoski, D			Masking our ignorance	NATURE			English	News Item																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					408	408						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15952257				2022-12-24	WOS:000229337800018
J	Yudkin, JS; Eringa, E; Stehouwer, CDA				Yudkin, JS; Eringa, E; Stehouwer, CDA			"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease	LANCET			English	Article							EPICARDIAL ADIPOSE-TISSUE; HUMAN SKELETAL-MUSCLE; CAPILLARY RECRUITMENT; NITRIC-OXIDE; PHYSIOLOGICAL HYPERINSULINEMIA; PROTEIN; SENSITIVITY; SYNTHASE; OBESITY; ALPHA	Adipose tissue expresses cytokines that inhibit insulin signalling pathways in liver and muscle. Obesity also results in impairment of endothelium-dependent vasodilatation in response to insulin. We propose a vasoregulatory role for local deposits of fat around the origin of arterioles supplying skeletal muscle. Isolated first-order arterioles from rat cremaster muscle are under dual regulation by insulin, which activates both endothelin-1 mediated vasoconstriction and nitric-oxide-mediated vasodilatation. In obese rat arterioles, insulin-stimulated NO synthesis is impaired, resulting in unopposed vasoconstriction. We propose that this vasoconstriction is the consequence of production of the adipocytokine tumour necrosis factor alpha from the cuff of fat seen surrounding the origin of the arteriole in obese rats-a depot to which we ascribe a specialist vasoregulatory role. We suggest that this cytokine accesses the nutritive vascular tree to inhibit insulin-mediated capillary recruitment-a mechanism we term "vasocrine" signalling. We also suggest a homology between this vasoactive periarteriolar fat and both periarterial and visceral fat, which may explain relations between visceral fat, insulin resistance, and vascular disease.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Diabet & Cardiovasc Dis Acad Unit, London N19 5LW, England; Vrije Univ Amsterdam, Inst Cardiovasc Res, Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Amsterdam, Netherlands; Univ Limburg, Acad Hosp Maastricht, Maastricht, Netherlands; Univ Maastricht, Maastricht, Netherlands	University of London; University College London; UCL Medical School; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Hasselt University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Yudkin, JS (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Diabet & Cardiovasc Dis Acad Unit, Archway Campus,Holborn Union Bldg,2-10 Highgate H, London N19 5LW, England.	j.yudkin@ucl.ac.uk	Eringa, Ed/ABA-3194-2021; Yudkin, John S/C-1988-2008; Stehouwer, Coen/AAB-3435-2021	Eringa, Etto/0000-0002-9814-5149; Stehouwer, Coen/0000-0001-8752-3223				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Arner P, 2001, BIOCHEM SOC T, V29, P72, DOI 10.1042/bst0290072; BARON AD, 1995, J CLIN INVEST, V96, P786, DOI 10.1172/JCI118124; Coggins M, 2001, DIABETES, V50, P2682, DOI 10.2337/diabetes.50.12.2682; DAVDA RK, 1995, HYPERTENSION, V26, P764, DOI 10.1161/01.HYP.26.5.764; Eringa EC, 2004, AM J PHYSIOL-HEART C, V287, pH2043, DOI 10.1152/ajpheart.00067.2004; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GREENE AS, 1989, AM J PHYSIOL, V256, P126; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; MOHAMED F, 1995, ARTERIOSCL THROM VAS, V15, P52, DOI 10.1161/01.ATV.15.1.52; Newman JMB, 1997, MICROVASC RES, V54, P49, DOI 10.1006/mvre.1997.2021; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Rattigan S, 1997, DIABETES, V46, P1381, DOI 10.2337/diabetes.46.9.1381; Schechter AN, 2003, NEW ENGL J MED, V348, P1483, DOI 10.1056/NEJMcibr023045; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Serne EH, 2002, DIABETES, V51, P1515, DOI 10.2337/diabetes.51.5.1515; Wallis MG, 2002, DIABETES, V51, P3492, DOI 10.2337/diabetes.51.12.3492; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zhang L, 2004, DIABETES, V53, P447, DOI 10.2337/diabetes.53.2.447; Zhang L, 2003, AM J PHYSIOL-ENDOC M, V285, pE654, DOI 10.1152/ajpendo.00119.2003	22	411	431	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 21	2005	365	9473					1817	1820		10.1016/S0140-6736(05)66585-3	http://dx.doi.org/10.1016/S0140-6736(05)66585-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	928SI	15910955				2022-12-24	WOS:000229291600027
J	Okada, Y; Takeda, S; Tanaka, Y; Belmonte, JCI; Hirokawa, N				Okada, Y; Takeda, S; Tanaka, Y; Belmonte, JCI; Hirokawa, N			Mechanism of nodal flow: A conserved symmetry breaking event in left-right axis determination	CELL			English	Article							LEFT-RIGHT ASYMMETRY; ZEBRAFISH; MICE; MICROTUBULE; EXPRESSION; MONOCILIA; FLUID	The leftward flow in extraembryonic fluid is critical for the initial determination of the left-right axis of mouse embryos. It is unclear if this is a conserved mechanism among other vertebrates and how the directionality of the flow arises from the motion of cilia. In this paper, we show that rabbit and medakafish embryos also exhibit a leftward fluid flow in their ventral nodes. In all cases, primary monocilia present a clockwise rotational-like motion. Observations of defective ciliary dynamics in mutant mouse embryos support the idea that the posterior tilt of the cilia during rotational-like beating can explain the leftward fluid flow. Moreover, we show that this leftward flow may produce asymmetric distribution of exogenously introduced proteins, suggesting morphogen gradients as a subsequent mechanism of left-right axis determination. Finally, we experimentally and theoretically characterize under which conditions a morphogen gradient can arise from the flow.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	University of Tokyo; Salk Institute	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, 7-3-1 Hongo, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Takeda, Sen/I-8462-2012; Okada, Yasushi/N-5067-2015	Takeda, Sen/0000-0001-7090-2139; Okada, Yasushi/0000-0003-2601-3689; Tanaka, Yosuke/0000-0001-5376-5726				Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Bellomo D, 1996, DEV DYNAM, V205, P471, DOI 10.1002/(SICI)1097-0177(199604)205:4<471::AID-AJA10>3.0.CO;2-4; Bisgrove BW, 2001, AM J MED GENET, V101, P315, DOI 10.1002/ajmg.1180; BLAKE JR, 1974, BIOL REV, V49, P85, DOI 10.1111/j.1469-185X.1974.tb01299.x; BROWN NA, 1990, DEVELOPMENT, V109, P1; Cartwright JHE, 2004, P NATL ACAD SCI USA, V101, P7234, DOI 10.1073/pnas.0402001101; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Fanto M, 2004, J CELL SCI, V117, P527, DOI 10.1242/jcs.00973; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mercola M, 2001, ANNU REV CELL DEV BI, V17, P779, DOI 10.1146/annurev.cellbio.17.1.779; NAKATA T, 1993, BIOPHYS J, V65, P2504, DOI 10.1016/S0006-3495(93)81304-3; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Supp DM, 1999, DEVELOPMENT, V126, P5495; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; TAKEDA S, 1995, NEURON, V14, P1257, DOI 10.1016/0896-6273(95)90272-4; Vogan KJ, 1999, NATURE, V397, P295, DOI 10.1038/16796; Wargo MJ, 2003, P NATL ACAD SCI USA, V100, P137, DOI 10.1073/pnas.0135800100; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; YASUMASU S, 1992, DEV BIOL, V153, P250, DOI 10.1016/0012-1606(92)90110-3	25	333	344	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					633	644		10.1016/j.cell.2005.04.008	http://dx.doi.org/10.1016/j.cell.2005.04.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907475	Bronze			2022-12-24	WOS:000229331200018
J	Wang, XQ; Lu, T; Snider, RK; Liang, L				Wang, XQ; Lu, T; Snider, RK; Liang, L			Sustained firing in auditory cortex evoked by preferred stimuli	NATURE			English	Article							COMMUNICATION SOUNDS; CORTICAL-NEURONS; RESPONSES; REPRESENTATION; CAT; NOISE; ANESTHESIA; AMPLITUDE; PRIMATES; MONKEYS	It has been well documented that neurons in the auditory cortex of anaesthetized animals generally display transient responses to acoustic stimulation, and typically respond to a brief stimulus with one or fewer action potentials(1-5). The number of action potentials evoked by each stimulus usually does not increase with increasing stimulus duration(1,5-7). Such observations have long puzzled researchers across disciplines and raised serious questions regarding the role of the auditory cortex in encoding ongoing acoustic signals. Contrary to these long-held views, here we show that single neurons in both primary ( area A1) and lateral belt areas of the auditory cortex of awake marmoset monkeys ( Callithrix jacchus) are capable of firing in a sustained manner over a prolonged period of time, especially when they are driven by their preferred stimuli. In contrast, responses become more transient or phasic when auditory cortex neurons respond to non-preferred stimuli. These findings suggest that when the auditory cortex is stimulated by a sound, a particular population of neurons fire maximally throughout the duration of the sound. Responses of other, less optimally driven neurons fade away quickly after stimulus onset. This results in a selective representation of the sound across both neuronal population and time.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA	Johns Hopkins University	Wang, XQ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA.	xwang@bme.jhu.edu						AITKIN LM, 1986, J COMP NEUROL, V252, P175, DOI 10.1002/cne.902520204; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Bieser A, 1996, EXP BRAIN RES, V108, P273; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Cheung SW, 2001, HEARING RES, V156, P115, DOI 10.1016/S0378-5955(01)00272-6; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Eggermont JJ, 1997, NEUROREPORT, V8, P2709, DOI 10.1097/00001756-199708180-00014; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Heil P, 1997, J NEUROPHYSIOL, V77, P2642, DOI 10.1152/jn.1997.77.5.2642; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Lu T, 2004, J NEUROPHYSIOL, V91, P301, DOI 10.1152/jn.00022.2003; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Malone BJ, 2002, J NEUROSCI, V22, P4625, DOI 10.1523/JNEUROSCI.22-11-04625.2002; Mickey BJ, 2003, J NEUROSCI, V23, P8649; PFINGST BE, 1981, J NEUROPHYSIOL, V45, P16, DOI 10.1152/jn.1981.45.1.16; PHILLIPS DP, 1985, HEARING RES, V19, P253, DOI 10.1016/0378-5955(85)90145-5; PHILLIPS DP, 1993, ANN NY ACAD SCI, V682, P104, DOI 10.1111/j.1749-6632.1993.tb22963.x; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, HEARING RES, V150, P104, DOI 10.1016/S0378-5955(00)00194-5; RHODE WS, 1986, J NEUROPHYSIOL, V56, P261, DOI 10.1152/jn.1986.56.2.261; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SUGA N, 1989, J EXP BIOL, V146, P277; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; ZURITA P, 1994, NEUROSCI RES, V19, P303, DOI 10.1016/0168-0102(94)90043-4	30	276	280	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					341	346		10.1038/nature03565	http://dx.doi.org/10.1038/nature03565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902257				2022-12-24	WOS:000229185000045
J	Hallenbeck, J				Hallenbeck, J			Palliative care in the final days of life - "They were expecting it at any time"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ILL CANCER-PATIENTS; LAST 48 HOURS; END-OF-LIFE; TERMINALLY-ILL; CULTURAL CONSIDERATIONS; HOSPITALIZED-PATIENTS; CONTROLLED-TRIAL; UNITED-STATES; DEATH RATTLE; BAD-NEWS	Providing care to actively dying patients presents unique challenges for the clinician. Patients, in their final days require careful symptom management. Families need support and coaching as death approaches. Care does not end with the death of the patient but continues through death pronouncement, family notification of the death, discussion of autopsy, and immediate bereavement support. Skills in these and related areas are discussed in the context of one man's death, as illuminated by comments made after death by his daughter and his physician. This case also highlights the often differing perspectives of families and clinicians as they work to deal with a patient's death. A goal of mastering the palliative skills necessary to competently care for an actively dying patient is to enable a patient to die peacefully and relatively free of discomfort. Achieving such competency should also help to relieve clinician stress attendant to caring for dying patients.	Stanford Univ, Sch Med, VA Palto Alto HCS, Palo Alto, CA 94304 USA	Stanford University	Hallenbeck, J (corresponding author), Stanford Univ, Sch Med, VA Palto Alto HCS, 1002C,3801 Miranda Ave, Palo Alto, CA 94304 USA.	james.hallenbeck@med.va.gov						[Anonymous], 1999, DEATH FORETOLD PROPH; Back IN, 2001, PALLIATIVE MED, V15, P329, DOI 10.1191/026921601678320313; Baile WF, 2002, J CLIN ONCOL, V20, P2189, DOI 10.1200/JCO.2002.08.004; Breitbart W, 2002, PSYCHOSOMATICS, V43, P183, DOI 10.1176/appi.psy.43.3.183; Breitbart W, 2000, CLIN GERIATR MED, V16, P357, DOI 10.1016/S0749-0690(05)70061-6; Bruera E, 1990, J Pain Symptom Manage, V5, P341, DOI 10.1016/0885-3924(90)90027-H; Byock I., 1997, DYING WELL; BYOCK IR, 2004, 4 THINS MATTER MOST; Campbell ML, 2004, CRIT CARE CLIN, V20, P403, DOI 10.1016/j.ccc.2004.03.015; Chandler S, 1999, Am J Hosp Palliat Care, V16, P418, DOI 10.1177/104990919901600113; CHERNY NJ, 1995, CANCER-AM CANCER SOC, V76, P1283, DOI 10.1002/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0; Conill C, 1997, J PAIN SYMPTOM MANAG, V14, P328, DOI 10.1016/S0885-3924(97)00263-7; COYLE N, 1990, J PAIN SYMPTOM MANAG, V5, P83; Dalal Shalini, 2004, J Support Oncol, V2, P467; Ellershaw J, 2001, J PAIN SYMPTOM MANAG, V21, P12, DOI 10.1016/S0885-3924(00)00240-2; Ellershaw J, 2003, BRIT MED J, V326, P30, DOI 10.1136/bmj.326.7379.30; FAINSINGER R, 1991, J PALLIATIVE CARE, V7, P5; FAINSINGER RL, 1998, TOPICS PALLIATIVE CA, V4, P261; Hall P, 2002, J AM GERIATR SOC, V50, P501, DOI 10.1046/j.1532-5415.2002.50117.x; Hallenbeck J, 1996, CLIN GERIATR MED, V12, P393; Hallenbeck J, 1999, GENERATIONS, V23, P24; HALLENBECK J, 2002, PRINCIPLES PRACTICE, P661; HALLENBECK J, END OF LIFE CARE CUR; Hallenbeck J. L., 2003, PALLIATIVE CARE PERS; Herndon CM, 2001, J PAIN SYMPTOM MANAG, V22, P1027, DOI 10.1016/S0885-3924(01)00365-7; Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KOENIG BA, 1997, APPROACHING DEATH IM; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; Lichter I, 1990, J Palliat Care, V6, P7; Lo RSK, 2002, J PAIN SYMPTOM MANAG, V24, P388, DOI 10.1016/S0885-3924(02)00504-3; LYNN J, 1999, HDB MORTALS GUIDANCE; Marchand Lucille, 2004, J Palliat Med, V7, P80, DOI 10.1089/109662104322737322; Mazzocato C, 1999, ANN ONCOL, V10, P1511, DOI 10.1023/A:1008337624200; McPhee SJ, 1996, ARCH PATHOL LAB MED, V120, P743; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; MENKIN E, 2000, WRITING CONDOLENCE L; Morita T, 2004, ANN ONCOL, V15, P1551, DOI 10.1093/annonc/mdh386; Morita T, 2004, PSYCHOSOMATICS, V45, P107, DOI 10.1176/appi.psy.45.2.107; Morita T, 2002, J PAIN SYMPTOM MANAG, V24, P447, DOI 10.1016/S0885-3924(02)00499-2; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; Morita T, 1998, Am J Hosp Palliat Care, V15, P217, DOI 10.1177/104990919801500407; ONeill B, 1997, BRIT MED J, V315, P801, DOI 10.1136/bmj.315.7111.801; Penson R T, 2000, Oncologist, V5, P425; PICKETT M, 1993, CANCER NURS, V16, P102; Prigerson HG, 2001, JAMA-J AM MED ASSOC, V286, P1369, DOI 10.1001/jama.286.11.1369; Puchalski Christina M, 2002, J Palliat Med, V5, P289, DOI 10.1089/109662102753641287; QUILL TE, 1990, ARCH INTERN MED, V150, P1857, DOI 10.1001/archinte.150.9.1857; Rando T. A., 1993, TREATMENT COMPLICATE; ROUSSEAU P, 2003, J PALLIAT MED, V4, P255; SCHNEIDERMAN H, 1985, POSTGRAD MED, V77, P153, DOI 10.1080/00325481.1985.11698924; Sinard JH, 2001, EXP MOL PATHOL, V70, P333, DOI 10.1006/exmp.2001.2371; STEINHAUSER KE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI DOI 10.1001/JAMA.284.19.2476; STOREY P, 1998, PRINCIPLES PRACTICE, P741; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Vandekieft GK, 2001, AM FAM PHYSICIAN, V64, P1975; Ventafridda V, 1990, J Palliat Care, V6, P7; Wildiers H, 2002, J PAIN SYMPTOM MANAG, V23, P310, DOI 10.1016/S0885-3924(01)00421-3; Zeitlin SV, 2001, PRIMARY CARE, V28, P415, DOI 10.1016/S0095-4543(05)70031-2	60	28	29	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2265	2271		10.1001/jama.293.18.2265	http://dx.doi.org/10.1001/jama.293.18.2265			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	924LU	15886382				2022-12-24	WOS:000228981100028
J	Ye, XQ; Hama, K; Contos, JJA; Anliker, B; Inoue, A; Skinner, MK; Suzuki, H; Amano, T; Kennedy, G; Arai, H; Aoki, J; Chun, J				Ye, XQ; Hama, K; Contos, JJA; Anliker, B; Inoue, A; Skinner, MK; Suzuki, H; Amano, T; Kennedy, G; Arai, H; Aoki, J; Chun, J			LPA(3)-mediated lysophosphatidic acid signalling in embryo implantation and spacing	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; OBVIOUS PHENOTYPIC ABNORMALITY; MOUSE UTERUS; MICE LACKING; EXPRESSION; INITIATION; PREGNANCY; DEFICITS; CELLS; GENE	Every successful pregnancy requires proper embryo implantation. Low implantation rate is a major problem during infertility treatments using assisted reproductive technologies(1). Here we report a newly discovered molecular influence on implantation through the lysophosphatidic acid (LPA) receptor LPA(3) (refs 2 - 4). Targeted deletion of LPA(3) in mice resulted in significantly reduced litter size, which could be attributed to delayed implantation and altered embryo spacing. These two events led to delayed embryonic development, hypertrophic placentas shared by multiple embryos and embryonic death. An enzyme demonstrated to influence implantation, cyclooxygenase 2 (COX2) (ref. 5), was downregulated in LPA(3)-deficient uteri during preimplantation. Downregulation of COX2 led to reduced levels of prostaglandins E-2 and I-2 (PGE(2) and PGI(2)), which are critical for implantation(1). Exogenous administration of PGE(2) or carbaprostacyclin ( a stable analogue of PGI(2)) into LPA(3)-deficient female mice rescued delayed implantation but did not rescue defects in embryo spacing. These data identify LPA(3) receptor-mediated signalling as having an influence on implantation, and further indicate linkage between LPA signalling and prostaglandin biosynthesis.	Scripps Res Inst, Dept Mol Biol, Helen L Dorris Child & Adolescent Neuropsychiat D, La Jolla, CA 92037 USA; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Dev Med Technol Sankyo, Bunkyo Ku, Tokyo 1130033, Japan; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan	Scripps Research Institute; University of Tokyo; University of Tokyo; Fred Hutchinson Cancer Center; Washington State University; Obihiro University of Agriculture & Veterinary Medicine	Chun, J (corresponding author), Scripps Res Inst, Dept Mol Biol, Helen L Dorris Child & Adolescent Neuropsychiat D, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jchun@scripps.edu	Chun, Jerold/Y-4670-2019; Kennedy, Grace/GRS-1071-2022	Aoki, Junken/0000-0001-9435-1896	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001723] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH001723] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Cleary-Goldman J, 2004, OBSTET GYNECOL SURV, V59, P285, DOI 10.1097/01.OGX.0000120165.52159.04; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Daniel Y, 2000, FERTIL STERIL, V74, P683, DOI 10.1016/S0015-0282(00)01491-6; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Frenkian M, 2001, PROSTAG OTH LIPID M, V65, P11, DOI 10.1016/S0090-6980(01)00116-2; Gabardi Steven, 2004, Prog Transplant, V14, P148; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; KENNEDY TG, 1977, BIOL REPROD, V16, P286, DOI 10.1095/biolreprod16.3.286; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Kinoshita K, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P605; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Paria BC, 2001, INT J DEV BIOL, V45, P597; Reese J, 1999, MOL CELL ENDOCRINOL, V150, P23, DOI 10.1016/S0303-7207(99)00033-7; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Song H, 2002, DEVELOPMENT, V129, P2879; TOKUMURA A, 1980, ARCH INT PHARMACOD T, V245, P74; Umstad MP, 2003, MED J AUSTRALIA, V178, P613, DOI 10.5694/j.1326-5377.2003.tb05384.x; Wang HB, 2004, J BIOL CHEM, V279, P10649, DOI 10.1074/jbc.M312203200; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Yang ZM, 1997, BIOL REPROD, V56, P368, DOI 10.1095/biolreprod56.2.368	30	401	429	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					104	108		10.1038/nature03505	http://dx.doi.org/10.1038/nature03505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875025	Green Accepted			2022-12-24	WOS:000228864600047
J	de Letona, JM				de Letona, JM			Aortic aneurysm: the physician as patient	LANCET			English	Editorial Material									Univ Autonoma Madrid, Hosp Puerta de Hierro, Madrid, Spain	Autonomous University of Madrid; Hospital Puerta de Hierro-Majadahonda	de Letona, JM (corresponding author), Univ Autonoma Madrid, Hosp Puerta de Hierro, Madrid, Spain.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 30	2005	365	9470					1590	1590		10.1016/S0140-6736(05)66460-4	http://dx.doi.org/10.1016/S0140-6736(05)66460-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866313				2022-12-24	WOS:000228754800031
J	Bernhardt, ES; Palmer, MA; Allan, JD; Alexander, G; Barnas, K; Brooks, S; Carr, J; Clayton, S; Dahm, C; Follstad-Shah, J; Galat, D; Gloss, S; Goodwin, P; Hart, D; Hassett, B; Jenkinson, R; Katz, S; Kondolf, GM; Lake, PS; Lave, R; Meyer, JL; O'Donnell, TK; Pagano, L; Powell, B; Sudduth, E				Bernhardt, ES; Palmer, MA; Allan, JD; Alexander, G; Barnas, K; Brooks, S; Carr, J; Clayton, S; Dahm, C; Follstad-Shah, J; Galat, D; Gloss, S; Goodwin, P; Hart, D; Hassett, B; Jenkinson, R; Katz, S; Kondolf, GM; Lake, PS; Lave, R; Meyer, JL; O'Donnell, TK; Pagano, L; Powell, B; Sudduth, E			Ecology - Synthesizing US river restoration efforts	SCIENCE			English	Editorial Material							FRESH-WATER		Univ Maryland, College Pk, MD 20742 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; NOAA, Natl Fisheries Sci Ctr, Seattle, WA USA; Monash Univ, Clayton, Vic 3168, Australia; Natl Acad Sci, Philadelphia, PA USA; Univ Idaho, Boise, ID USA; Univ New Mexico, Albuquerque, NM 87131 USA; US Geol Survey, Cooperat Res Unit, Columbia, MO USA; Univ Missouri, Columbia, MO USA; USGS, SW Biol Sci Ctr, Tucson, AZ USA; Univ Idaho, Moscow, ID 83843 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Georgia, Athens, GA 30602 USA; USGS, Ctr Biol Informat, Denver, CO USA	University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; National Oceanic Atmospheric Admin (NOAA) - USA; Monash University; National Academies of Sciences, Engineering & Medicine; Idaho; University of Idaho; University of New Mexico; United States Department of the Interior; United States Geological Survey; University of Missouri System; University of Missouri Columbia; United States Department of the Interior; United States Geological Survey; Idaho; University of Idaho; University of California System; University of California Berkeley; University System of Georgia; University of Georgia; United States Department of the Interior; United States Geological Survey	Bernhardt, ES (corresponding author), Duke Univ, Durham, NC 27706 USA.	emily.bernhardt@duke.edu	Bernhardt, Emily/B-4541-2010; Bernhardt, Emily S/D-9940-2011; Goodwin, Peter/AAP-1649-2021	Bernhardt, Emily S/0000-0003-3031-621X; Sudduth, Elizabeth/0000-0001-8274-8159; Brooks, Shane/0000-0002-5636-1783; Lave, Rebecca/0000-0001-5335-9058				Baron JS, 2002, ECOL APPL, V12, P1247; Buijse AD, 2002, FRESHWATER BIOL, V47, P889, DOI 10.1046/j.1365-2427.2002.00915.x; Cohn JP, 2001, BIOSCIENCE, V51, P998, DOI 10.1641/0006-3568(2001)051[0998:RTDALA]2.0.CO;2; G.A.O, 2002, GAO02612; GAO (United States General Accounting Office), 2003, GAO03515; GILLILAN S, IN PRESS J APPL ECOL; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; KOEBEL JW, 1995, RESTOR ECOL, V3, P149, DOI 10.1111/j.1526-100X.1995.tb00167.x; Lavendel B., 2002, ECOL RES, V20, P173, DOI DOI 10.3368/ER.20.3.173; Malakoff D, 2004, SCIENCE, V305, P937, DOI 10.1126/science.305.5686.937; ( National Research Council) NRC, 1996, UPSTR SALM SOC PAC N; *NRC, 1999, DOWNSTR AD MAN GLEN; NRC, 1999, OUR COMM JOURN TRANS; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; PALMER MA, IN PRESS J APPL ECOL; Postel S, 2003, RIVERS LIFE MANAGING; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Sand-Jensen Kaj, 2001, P89; *US EPA, 2000, EPA PUBL; Whalen PJ, 2002, WATER SCI TECHNOL, V45, P55, DOI 10.2166/wst.2002.0379	20	1302	1340	22	616	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					636	637		10.1126/science.1109769	http://dx.doi.org/10.1126/science.1109769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860611				2022-12-24	WOS:000228810900030
J	Cirelli, C; Bushey, D; Hill, S; Huber, R; Kreber, R; Ganetzky, B; Tononi, G				Cirelli, C; Bushey, D; Hill, S; Huber, R; Kreber, R; Ganetzky, B; Tononi, G			Reduced sleep in Drosophila shaker mutants	NATURE			English	Article							POTASSIUM CHANNELS; HEALTHY INSOMNIA; NERVOUS-SYSTEM; K+ CHANNEL; MELANOGASTER; GENE; MICE; HOMEOSTASIS; REST; DEPRIVATION	Most of us sleep 7-8 h per night, and if we are deprived of sleep our performance suffers greatly; however, a few do well with just 3-4 h of sleep-a trait that seems to run in families. Determining which genes underlie this phenotype could shed light on the mechanisms and functions of sleep. To do so, we performed mutagenesis in Drosophila melanogaster, because flies also sleep for many hours and, when sleep deprived, show sleep rebound and performance impairments. By screening 9,000 mutant lines, we found minisleep (mns), a line that sleeps for one-third of the wild-type amount. We show that mns flies perform normally in a number of tasks, have preserved sleep homeostasis, but are not impaired by sleep deprivation. We then show that mns flies carry a point mutation in a conserved domain of the Shaker gene. Moreover, after crossing out genetic modifiers accumulated over many generations, other Shaker alleles also become short sleepers and fail to complement the mns phenotype. Finally, we show that short-sleeping Shaker flies have a reduced lifespan. Shaker, which encodes a voltage-dependent potassium channel controlling membrane repolarization and transmitter release, may thus regulate sleep need or efficiency.	Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	gtononi@wisc.edu	Tononi, Giulio/B-8387-2009	Hill, Sean/0000-0001-8055-860X				BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; BENINGTON JH, 1995, BRAIN RES, V692, P86, DOI 10.1016/0006-8993(95)00591-D; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2003, BIOESSAYS, V25, P940, DOI 10.1002/bies.10333; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Easton A, 2004, SLEEP, V27, P1307, DOI 10.1093/sleep/27.7.1307; Espinosa F, 2004, GENES BRAIN BEHAV, V3, P90, DOI 10.1046/j.1601-183x.2003.00054.x; HEATH AC, 1990, SLEEP, V13, P318, DOI 10.1093/sleep/13.4.318; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Horne J., 1989, WHY WE SLEEP; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; JONES HS, 1968, ELECTROEN CLIN NEURO, V24, P378, DOI 10.1016/0013-4694(68)90199-5; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kopp C, 2002, EUR J NEUROSCI, V16, P1099, DOI 10.1046/j.1460-9568.2002.02156.x; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liguori R, 2001, BRAIN, V124, P2417, DOI 10.1093/brain/124.12.2417; Linkowski P, 1999, J SLEEP RES, V8, P11; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; MEDDIS R, 1973, ELECTROEN CLIN NEURO, V35, P213, DOI 10.1016/0013-4694(73)90180-6; Naylor E, 2000, J NEUROSCI, V20, P8138; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; PARTINEN M, 1983, SLEEP, V6, P179, DOI 10.1093/sleep/6.3.179; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rogero O, 1997, J NEUROSCI, V17, P5108; Rorth P, 1998, DEVELOPMENT, V125, P1049; Schenck CH, 2001, SLEEP MED, V2, P531, DOI 10.1016/S1389-9457(01)00114-9; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Shiromani PJ, 2004, AM J PHYSIOL-REG I, V287, pR47, DOI 10.1152/ajpregu.00138.2004; Spradling AC, 1999, GENETICS, V153, P135; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; STUSS D, 1978, WAKING SLEEPING, V2, P101; SUTCLIFFE JG, 1988, TRENDS GENET, V4, P297, DOI 10.1016/0168-9525(88)90105-9; Tafti M, 2002, J APPL PHYSIOL, V92, P1339, DOI 10.1152/japplphysiol.00834.2001; Taheri S, 2002, LANCET NEUROL, V1, P242, DOI 10.1016/S1474-4422(02)00103-5; TIMPE LC, 1987, J NEUROSCI, V7, P1307; TOBLER I, 2000, PRINCIPLES PRACTICE, P72; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vyazovskiy VV, 2002, BRAIN RES, V947, P204, DOI 10.1016/S0006-8993(02)02925-6; Walcourt A, 2001, ANESTH ANALG, V92, P535, DOI 10.1213/00000539-200102000-00047; Webb W B, 1970, Int Psychiatry Clin, V7, P44; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	50	317	330	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1087	1092		10.1038/nature03486	http://dx.doi.org/10.1038/nature03486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858564				2022-12-24	WOS:000228693300032
J	Kim, TH; Barrera, LO; Zheng, M; Qu, CX; Singer, MA; Richmond, TA; Wu, YN; Green, RD; Ren, B				Kim, TH; Barrera, LO; Zheng, M; Qu, CX; Singer, MA; Richmond, TA; Wu, YN; Green, RD; Ren, B			A high-resolution map of active promoters in the human genome	NATURE			English	Article							EXPRESSED GENES; IDENTIFICATION; TRANSCRIPTOME; SEQUENCE; UPDATE; MOUSE	In eukaryotic cells, transcription of every protein-coding gene begins with the assembly of an RNA polymerase II preinitiation complex (PIC) on the promoter(1). The promoters, in conjunction with enhancers, silencers and insulators, define the combinatorial codes that specify gene expression patterns(2). Our ability to analyse the control logic encoded in the human genome is currently limited by a lack of accurate information regarding the promoters for most genes(3). Here we describe a genome-wide map of active promoters in human fibroblast cells, determined by experimentally locating the sites of PIC binding throughout the human genome. This map defines 10,567 active promoters corresponding to 6,763 known genes and at least 1,196 un-annotated transcriptional units. Features of the map suggest extensive use of multiple promoters by the human genes and widespread clustering of active promoters in the genome. In addition, examination of the genome-wide expression profile reveals four general classes of promoters that define the transcriptome of the cell. These results provide a global view of the functional relationships among transcriptional machinery, chromatin structure and gene expression in human cells.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; NimbleGen Syst Inc, Madison, WI 53711 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; Roche Holding; Roche NimbleGen	Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu		Soriaga, Leah/0000-0001-5852-741X; Kim, Tae Hoon/0000-0003-3950-7557	NCI NIH HHS [R33 CA105829, R21 CA105829, F32 CA108313] Funding Source: Medline; NHGRI NIH HHS [U01 HG003151] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA105829, R33CA105829] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003151] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; *ENCODE PROJ CONS, 2001, SCIENCE, V306, P636; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Pruitt KD, 2003, NUCLEIC ACIDS RES, V31, P34, DOI 10.1093/nar/gkg111; Reinberg D, 1998, COLD SPRING HARB SYM, V63, P83, DOI 10.1101/sqb.1998.63.83; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Suzuki Y, 2004, NUCLEIC ACIDS RES, V32, pD78, DOI 10.1093/nar/gkh076; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896	30	727	759	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					876	880		10.1038/nature03877	http://dx.doi.org/10.1038/nature03877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	15988478	Green Accepted			2022-12-24	WOS:000231116500052
J	Shakarishvili, A; Dubovskaya, LK; Zohrabyan, LS; St Lawrence, JS; Aral, SO; Dugasheva, LG; Okan, SA; Lewis, JS; Parker, KA; Ryan, CA				Shakarishvili, A; Dubovskaya, LK; Zohrabyan, LS; St Lawrence, JS; Aral, SO; Dugasheva, LG; Okan, SA; Lewis, JS; Parker, KA; Ryan, CA		LIBRA Project Investigation Team	Sex work, drug use, HIV infection, and spread of sexually transmitted infections in Moscow, Russian Federation	LANCET			English	Article								Rates of HIV-1 infection are growing rapidly, and the epidemic of sexually transmitted infections is continuing at an alarming rate, in the Russian Federation. We did a cross-sectional study of sexually transmitted infections, HIV infection, and drug use in street youth at a juvenile detention facility, adults at homeless detention centres, and women and men at a remand Centre in Moscow. 160 (79%) women at the remand Centre were sex workers. 91 (51%) homeless women had syphilis. At least one bacterial sexually transmitted infection was present in 97 (58%) female juvenile detainees, 120 (64%) women at the remand Centre, and 133 (75%) homeless women. HIV seroprevalence was high in women at the remand Centre (n=7 [4%]), adolescent male detainees (5 [3%]), and homeless women (4 [2%]). In view of the interaction between sexually transmitted infections and HIV infection, these findings of high prevalence of sexually transmitted infections show that these disenfranchised populations have the potential to make a disproportionately high contribution to the explosive growth of the HIV epidemic unless interventions targeting these groups are implemented in the Russian Federation.	US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Russian Assoc Prevent STIs Sanam, Moscow, Russia; Sechenov Moscow Med Acad, Moscow, Russia	Centers for Disease Control & Prevention - USA; Sechenov First Moscow State Medical University	Shakarishvili, A (corresponding author), US Ctr Dis Control & Prevent, Mail Stop E-04,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	afsg@cdc.gov						Aral SO, 2003, SEX TRANSM DIS, V30, P39, DOI 10.1097/00007435-200301000-00009; Field MG, 2004, NEW ENGL J MED, V351, P117, DOI 10.1056/NEJMp048066; Lowndes C. M., 2003, International Journal of Drug Policy, V14, P45, DOI 10.1016/S0955-3959(02)00208-6; *MOSC CIT HLTH COM, 2002, SAN EP SURV REP HIV; *MOSC CIT HLTH COM, 2001, SAN EP SURV REP HIV; *UN, 2004, HIV AIDS E EUR COMM	6	54	54	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					57	60		10.1016/S0140-6736(05)66828-6	http://dx.doi.org/10.1016/S0140-6736(05)66828-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	15993234				2022-12-24	WOS:000230277600035
J	Ammann, P; Sticherling, C; Kalusche, D; Eckstein, J; Bernheim, A; Schaer, B; Osswald, S				Ammann, P; Sticherling, C; Kalusche, D; Eckstein, J; Bernheim, A; Schaer, B; Osswald, S			An electrocardiogram-based algorithm to detect loss of left ventricular capture during cardiac resynchronization therapy	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC HEART-FAILURE; BUNDLE-BRANCH-BLOCK; DEFIBRILLATION; ASYNCHRONY; MORTALITY; TRIAL; SITE	Background: Loss of left ventricular capture in patients with cardiac resynchronization devices may account for worsening heart failure and can be difficult to diagnose without a programmer. Objective: To determine whether distinct morphologic changes on the surface electrocardiogram indicate loss of left ventricular capture. Design: After analysis of the R-S spike ratio in the 12-lead electrocardiogram during right ventricular and biventricular pacing in 10 patients, an algorithm to detect loss of left ventricular capture was developed. Setting: University hospital. Patients: 54 patients with a cardiac resynchronization device and underlying left bundle-branch block. Measurements: Leads V1 and I of a 12-lead electrocardiogram were assessed after biventricular pacing was confirmed and after the device was programmed to right ventricular pacing only (simulating loss of left ventricular capture). Results: The sensitivity of the algorithm to correctly identify loss of left ventricular capture was 94% (95% Cl, 88.2% to 97.7%), and the specificity was 93% (Cl, 86.3% to 95.8%). The likelihood ratio of a positive test result was 12.8 (Cl, 6.443 to 23.310), and the likelihood ratio of a negative test result was 0.06 (Cl, 0.024 to 0.137). Limitations: The algorithm was tested in patients in whom the right ventricular electrode was placed in the apex of the right ventricle only. Conclusion: Presence of biventricular capture-the prerequisite for successful cardiac resynchronization therapy-and loss of left ventricular capture can be accurately detected by an algorithm based on analysis of the R-S ratio on leads V1 and I of the surface electrocardiogram.	Univ Basel Hosp, CH-4031 Basel, Switzerland; Kantonsspital St Gallen, St Gallen, Switzerland; Herz Zentrum Bad Krozingen, Bad Krozingen, Germany	University of Basel	Ammann, P (corresponding author), Univ Basel Hosp, CH-4031 Basel, Switzerland.	peter.ammann@kssg.ch	Osswald, Stefan/A-6904-2018; Sticherling, Christian/AAY-4435-2021	Osswald, Stefan/0000-0002-9240-6731; Sticherling, Christian/0000-0001-8428-7050				Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Auricchio A, 1999, AM J CARDIOL, V83, p136D; Bradley DJ, 2003, JAMA-J AM MED ASSOC, V289, P730, DOI 10.1001/jama.289.6.730; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Bristow MR, 2000, J CARD FAIL, V6, P276, DOI 10.1054/jcaf.2000.9501; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Eriksson P, 1998, CIRCULATION, V98, P2494, DOI 10.1161/01.CIR.98.22.2494; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Garrigue S, 2001, AM J CARDIOL, V88, P1436, DOI 10.1016/S0002-9149(01)02131-2; GRINES CL, 1989, CIRCULATION, V79, P845, DOI 10.1161/01.CIR.79.4.845; Janousek J, 2004, J AM COLL CARDIOL, V44, P1927, DOI 10.1016/j.jacc.2004.08.044; Meisel E, 2001, CIRCULATION, V104, P442, DOI 10.1161/hc2901.093145; Muntwyler J, 2002, EUR HEART J, V23, P1861, DOI 10.1053/euhj.2002.3282; Pitzalis MV, 2002, J AM COLL CARDIOL, V40, P1615, DOI 10.1016/S0735-1097(02)02337-9; Ricci R, 2002, J INTERV CARD ELECTR, V6, P279, DOI 10.1023/A:1019570022647; Yee R, 2004, PACE, V27, P894, DOI 10.1111/j.1540-8159.2004.00553.x; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685	18	32	34	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2005	142	12	1				968	973		10.7326/0003-4819-142-12_Part_1-200506210-00006	http://dx.doi.org/10.7326/0003-4819-142-12_Part_1-200506210-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937IN	15968011				2022-12-24	WOS:000229917900003
J	Janke, C; Rogowski, K; Wloga, D; Regnard, C; Kajava, AV; Strub, JM; Temurak, N; van Dijk, J; Boucher, D; van Dorsselaer, A; Suryavanshi, S; Gaertig, J; Edde, B				Janke, C; Rogowski, K; Wloga, D; Regnard, C; Kajava, AV; Strub, JM; Temurak, N; van Dijk, J; Boucher, D; van Dorsselaer, A; Suryavanshi, S; Gaertig, J; Edde, B			Tubulin polyglutamylase enzymes are members of the TTL domain protein family	SCIENCE			English	Article							ALPHA-TUBULIN; TYROSINE LIGASE; CELLS; POLYGLYCYLATION; GLUTAMYLATION; TETRAHYMENA; CENTRIOLE; COMPLEX; BRAIN	Polyglutamylation of tubulin has been implicated in several functions of microtubules, but the identification of the responsible enzyme(s) has been challenging, We found that the neuronal tubulin polyglutamylase is a protein complex containing a tubulin tyrosine ligase-like (TTLL) protein, TTLL1. TTLL1 is a member of a large family of proteins with a TTL homology domain, whose members could catalyze ligations of diverse amino acids to tubulins or other substrates. In the model protist Tetrahymena thermophila, two conserved types of polyglutamylases were characterized that differ in substrate preference and subcellular localization.	Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; CNRS, Ctr Rech Biochim Macromol, F-34293 Montpellier, France; Adolf Butenandt Inst, Dept Mol Biol, D-80336 Munich, Germany; Univ Strasbourg 1, F-67087 Strasbourg, France; Univ Paris 06, CNRS, Biochim Cellulaire Lab, F-75252 Paris, France	University System of Georgia; University of Georgia; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Munich; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Gaertig, J (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	jgaertig@cb.uga.edu; bernard.edde@crbm.cnrs	Janke, Carsten/A-7279-2011; Kajava, Andrey V/E-1107-2014; Gaertig, Jacek/F-1553-2010; Włoga, Dorota/R-4078-2016	Janke, Carsten/0000-0001-7053-2000; Kajava, Andrey V/0000-0002-2342-6886; Włoga, Dorota/0000-0003-3314-7773; Strub, Jean-Marc/0000-0001-6224-3428; Regnard, Catherine/0000-0001-9915-7494; Rogowski, Krzysztof/0000-0002-0206-3289				Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Campbell PK, 2002, GENETICS, V162, P307; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Gaertig J, 2000, J EUKARYOT MICROBIOL, V47, P185, DOI 10.1111/j.1550-7408.2000.tb00037.x; Gagnon C, 1996, J CELL SCI, V109, P1545; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Hara T, 1996, BIOCHEMISTRY-US, V35, P11967, DOI 10.1021/bi9605245; *I GEN RES, TETR THERM SEQ BLAST; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Million K, 1999, J CELL SCI, V112, P4357; PRESTON SF, 1979, J MOL EVOL, V13, P233, DOI 10.1007/BF01739482; RAYBIN D, 1977, J CELL BIOL, V73, P492, DOI 10.1083/jcb.73.2.492; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Regnard C, 2003, J CELL SCI, V116, P4181, DOI 10.1242/jcs.00743; Regnard C, 1998, BIOCHEMISTRY-US, V37, P8395, DOI 10.1021/bi9804131; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Regnard C, 1999, J CELL SCI, V112, P4281; ROGOWSKI K, UNPUB; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Trichet V, 2000, GENE, V257, P109, DOI 10.1016/S0378-1119(00)00383-8	25	222	253	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1758	1762		10.1126/science.1113010	http://dx.doi.org/10.1126/science.1113010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15890843				2022-12-24	WOS:000229926800046
J	Scott, TF; Schneider, AD; Cook, WD; Bowman, CN				Scott, TF; Schneider, AD; Cook, WD; Bowman, CN			Photoinduced plasticity in cross-linked polymers	SCIENCE			English	Article							RING-OPENING POLYMERIZATION; CONTROLLED MOLECULAR-WEIGHT; CYCLIC ALLYLIC SULFIDES	Chemically cross-linked polymers are inherently limited by stresses that are introduced by post-gelation volume changes during polymerization. It is also difficult to change a cross-linked polymer's shape without a corresponding loss of material properties or substantial stress development. We demonstrate a cross-linked polymer that, upon exposure to light, exhibits stress and/or strain relaxation without any concomitant change in material properties. This result is achieved by introducing radicals via photocleavage of residual photoinitiator in the polymer matrix, which then diffuse via addition-fragmentation chain transfer of midchain functional groups. These processes lead to photoinduced plasticity, actuation, and equilibrium shape changes without residual stress. Such polymeric materials are critical to the development of microdevices, biomaterials, and polymeric coatings.	Univ Colorado, Dept Biol & Chem Engn, Boulder, CO 80309 USA; Monash Univ, Sch Phys & Mat Engn, Clayton, Vic 3800, Australia	University of Colorado System; University of Colorado Boulder; Monash University	Bowman, CN (corresponding author), Univ Colorado, Dept Biol & Chem Engn, Boulder, CO 80309 USA.	christopher.bowman@colorado.edu	Bowman, Christopher N/B-1490-2008; Cook, Wayne D/A-4787-2012	Bowman, Christopher N/0000-0001-8458-7723; 	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE010959, R01DE012998, R01DE010959] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE12998, DE10959] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adhikari B, 2000, PROG POLYM SCI, V25, P909, DOI 10.1016/S0079-6700(00)00020-4; BILLMEYER FW, 1984, TXB POLYM SCI, P436; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Cramer NB, 2001, J POLYM SCI POL CHEM, V39, P3311, DOI 10.1002/pola.1314; Evans RA, 2001, J POLYM SCI POL CHEM, V39, P202, DOI 10.1002/1099-0518(20010101)39:1<202::AID-POLA230>3.0.CO;2-6; Evans RA, 1996, MACROMOLECULES, V29, P6983, DOI 10.1021/ma960573p; EVANS RA, 1994, MACROMOLECULES, V27, P7935, DOI 10.1021/ma00104a062; Evans RA, 2000, MACROMOLECULES, V33, P6722, DOI 10.1021/ma9917646; Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9; Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398; MEIJS GF, 1991, MACROMOLECULES, V24, P3689, DOI 10.1021/ma00012a033; MEIJS GF, 1988, MACROMOLECULES, V21, P3122, DOI 10.1021/ma00188a039; Sanda F, 2001, J POLYM SCI POL CHEM, V39, P265, DOI 10.1002/1099-0518(20010115)39:2<265::AID-POLA20>3.3.CO;2-4; Sunder A, 1999, MACROMOL CHEM PHYSIC, V200, P58, DOI 10.1002/(SICI)1521-3935(19990101)200:1<58::AID-MACP58>3.0.CO;2-C	14	545	561	16	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1615	1617		10.1126/science.1110505	http://dx.doi.org/10.1126/science.1110505			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947185				2022-12-24	WOS:000229827000053
J	Nelson, R; Sawaya, MR; Balbirnie, M; Madsen, AO; Riekel, C; Grothe, R; Eisenberg, D				Nelson, R; Sawaya, MR; Balbirnie, M; Madsen, AO; Riekel, C; Grothe, R; Eisenberg, D			Structure of the cross-beta spine of amyloid-like fibrils	NATURE			English	Article							X-RAY-DIFFRACTION; MOLECULAR-BASIS; PROTEIN MODELS; CORE STRUCTURE; SHEET; PEPTIDE; TRANSTHYRETIN; CONFORMATION; CONVERSION; REVEALS	Numerous soluble proteins convert to insoluble amyloid-like fibrils that have common properties. Amyloid fibrils are associated with fatal diseases such as Alzheimer's, and amyloid-like fibrils can be formed in vitro. For the yeast protein Sup35, conversion to amyloid-like fibrils is associated with a transmissible infection akin to that caused by mammalian prions. A seven-residue peptide segment from Sup35 forms amyloid-like fibrils and closely related microcrystals, from which we have determined the atomic structure of the cross-beta spine. It is a double beta-sheet, with each sheet formed from parallel segments stacked in register. Side chains protruding from the two sheets form a dry, tightly self-complementing steric zipper, bonding the sheets. Within each sheet, every segment is bound to its two neighbouring segments through stacks of both backbone and side-chain hydrogen bonds. The structure illuminates the stability of amyloid fibrils, their self-seeding characteristic and their tendency to form polymorphic structures.	Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Univ Copenhagen, Ctr Crystallog Studies, Dept Chem, DK-2100 KBH, Denmark	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; European Synchrotron Radiation Facility (ESRF); University of Copenhagen	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Proteom, Box 951570, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Madsen, Anders Østergaard/B-4760-2015	Madsen, Anders Østergaard/0000-0001-5422-8076; Sawaya, Michael/0000-0003-0874-9043	NIGMS NIH HHS [P01 GM031299, T32 GM007185] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM031299, T32GM007185] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; COULSON CA, 1966, PROC R SOC LON SER-A, V291, P445, DOI 10.1098/rspa.1966.0105; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; DeLano WL, 2002, PYMOL USERS MANUAL; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Diaz-Avalos R, 2003, J MOL BIOL, V330, P1165, DOI 10.1016/S0022-2836(03)00659-4; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; EISENBERG D, 1989, CHEM SCRIPTA, V29A, P217; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Pickersgill RW, 2003, STRUCTURE, V11, P137, DOI 10.1016/S0969-2126(03)00009-1; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Riekel C, 2004, J SYNCHROTRON RADIAT, V11, P4, DOI 10.1107/S090904950302541X; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serag AA, 2001, BIOCHEMISTRY-US, V40, P9089, DOI 10.1021/bi010655s; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sivaraman T, 1998, J BIOL CHEM, V273, P10181, DOI 10.1074/jbc.273.17.10181; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; VARLEY P, 1993, SCIENCE, V260, P1110, DOI 10.1126/science.8493553; VRIEND G, 1993, J APPL CRYSTALLOGR, V26, P47, DOI 10.1107/S0021889892008240; Wetzel R, 2002, STRUCTURE, V10, P1031, DOI 10.1016/S0969-2126(02)00809-2; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008	50	1735	1771	4	420	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					773	778		10.1038/nature03680	http://dx.doi.org/10.1038/nature03680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944695	Green Accepted			2022-12-24	WOS:000229638700041
J	Sotin, C; Jaumann, R; Buratti, BJ; Brown, RH; Clark, RN; Soderblom, LA; Baines, KH; Bellucci, G; Bibring, JP; Capaccioni, F; Cerroni, P; Combes, M; Coradini, A; Cruikshank, DP; Drossart, P; Formisano, V; Langevin, Y; Matson, DL; McCord, TB; Nelson, RM; Nicholson, PD; Sicardy, B; LeMouelic, S; Rodriguez, S; Stephan, K; Scholz, CK				Sotin, C; Jaumann, R; Buratti, BJ; Brown, RH; Clark, RN; Soderblom, LA; Baines, KH; Bellucci, G; Bibring, JP; Capaccioni, F; Cerroni, P; Combes, M; Coradini, A; Cruikshank, DP; Drossart, P; Formisano, V; Langevin, Y; Matson, DL; McCord, TB; Nelson, RM; Nicholson, PD; Sicardy, B; LeMouelic, S; Rodriguez, S; Stephan, K; Scholz, CK			Release of volatiles from a possible cryovolcano from near-infrared imaging of Titan	NATURE			English	Article							OCEAN	Titan is the only satellite in our Solar System with a dense atmosphere. The surface pressure is 1.5 bar ( ref. 1) and, similar to the Earth, N-2 is the main component of the atmosphere. Methane is the second most important component(2), but it is photodissociated on a timescale of 10(7) years ( ref. 3). This short timescale has led to the suggestion that Titan may possess a surface or subsurface reservoir of hydrocarbons(4,5) to replenish the atmosphere. Here we report near-infrared images of Titan obtained on 26 October 2004 by the Cassini spacecraft. The images show that a widespread methane ocean does not exist; subtle albedo variations instead suggest topographical variations, as would be expected for a more solid ( perhaps icy) surface. We also find a circular structure similar to 30 km in diameter that does not resemble any features seen on other icy satellites. We propose that the structure is a dome formed by upwelling icy plumes that release methane into Titan's atmosphere.	Univ Nantes, CNRS, UMR 6112, Lab Planetol & Geodynam, F-44100 Nantes, France; DLR, Inst Planetary Explorat, D-12489 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Arizona, Stewart Observ, Tucson, AZ 85721 USA; US Geol Survey, Denver, CO 80225 USA; US Geol Survey, Flagstaff, AZ 86011 USA; CNR, Ist Fis Spazio Interplanetario, I-00133 Rome, Italy; Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; CNR, Ist Astrofis Spaziale & Fis Cosmica, I-00133 Rome, Italy; Observ Paris, F-92195 Meudon, France; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; University of Arizona; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Washington; University of Washington Seattle; Cornell University	Sotin, C (corresponding author), Univ Nantes, CNRS, UMR 6112, Lab Planetol & Geodynam, F-44100 Nantes, France.	Christophe.Sotin@univ-nantes.fr	Bellucci, Giancarlo/ABA-9201-2020; Rodriguez, Sebastien/H-5902-2016; Drossart, Pierre/H-8670-2013; Jaumann, Ralf/N-1001-2018; Stephan, Katrin/U-2524-2018	Bellucci, Giancarlo/0000-0003-0867-8679; Rodriguez, Sebastien/0000-0003-1219-0641; Jaumann, Ralf/0000-0002-9759-6597; Capaccioni, Fabrizio/0000-0003-1631-4314; Cerroni, Priscilla/0000-0003-0239-2741; Le Mouelic, Stephane/0000-0001-5260-1367				Brown RH, 2003, ICARUS, V164, P461, DOI 10.1016/S0019-1035(03)00134-9; Gibbard SG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019803; KUIPER GP, 1944, ASTORPHYS J, V100, P329; LELLOUCH E, 1990, ANN GEOPHYS-ATM HYDR, V8, P653; LUCCHITTA BK, 1980, ICARUS, V44, P481, DOI 10.1016/0019-1035(80)90039-1; LUNINE JI, 1993, REV GEOPHYS, V31, P133, DOI 10.1029/92RG02794; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; Meier R, 2000, ICARUS, V145, P462, DOI 10.1006/icar.2000.6360; Sotin C, 2004, CR PHYS, V5, P769, DOI 10.1016/j.crhy.2004.08.001; Sotin C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013844; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	11	149	152	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					786	789		10.1038/nature03596	http://dx.doi.org/10.1038/nature03596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944697	Green Submitted			2022-12-24	WOS:000229638700043
J	Choudhry, NK; Avorn, J				Choudhry, NK; Avorn, J			Over-the-counter statins	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; CONSUMER USE; PREVENTION; THERAPY; PERSISTENCE; PRAVASTATIN; LOVASTATIN; AVERAGE; EVENTS	In late 2004, the British government decided to allow a lipid-lowering agent to be sold as an over-the-counter medication. In contrast, the U.S. Food and Drug Administration recently decided not to do so. The United States and other countries will soon face similar decisions for other statins. Although statins have infrequent side effects and have been shown to be effective in moderate-risk primary prevention populations, many questions remain unanswered about their effectiveness at lower doses in over-the-counter use, the ability of patients to self-select themselves for appropriate therapy, and the social and economic implications associated with this method of distribution for preventive medications. A rational policy decision concerning over-the-counter statin use will require an effectiveness trial to provide data on how such drugs would be used in this context, as well as on the clinical outcomes that could be expected from this novel "route of administration".	Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Choudhry, NK (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St, Boston, MA 02120 USA.							Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; ALVAREZ L, 2004, NY TIMES        1015, pA10; [Anonymous], 2004, LANCET, V363, P1659; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Avorn J, 2004, POWERFUL MED BENEFIT; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Brass EP, 2004, AM J CARDIOL, V94, p22F, DOI 10.1016/j.amjcard.2004.07.051; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; *CTR DRUG EV RES, OV THE COUNT DRUG PR; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Dyer Owen, 2005, BMJ, V330, P164, DOI 10.1136/bmj.330.7484.164-d; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; JOHNSON LA, OTC STATUS SOUGHT ST; Kopjar B, 2003, AM J CARDIOL, V92, P1106, DOI 10.1016/j.amjcard.2003.07.008; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; *MED HLTH PROD REG, 2003, RECL SUMM SIMV POM P; Melin JM, 2004, AM J CARDIOL, V94, P1243, DOI 10.1016/j.amjcard.2004.08.007; Mitka M, 2004, JAMA-J AM MED ASSOC, V292, P317, DOI 10.1001/jama.292.3.317; PARKS MH, NONPR MEV 20 MG JOIN; Pearson TA, 2000, ARCH INTERN MED, V160, P459, DOI 10.1001/archinte.160.4.459; Schneeweiss S, 2004, BRIT MED J, V328, P560, DOI 10.1136/bmj.38020.698194.F6; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SHETTY D, MEVACOR DAILY 20 MG; U.S Preventive Services Task Force, 2016, ANN INTERN MED; *US FDA, CONS BEH SAF DAT NON; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	31	13	13	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2005	142	11					910	913		10.7326/0003-4819-142-11-200506070-00009	http://dx.doi.org/10.7326/0003-4819-142-11-200506070-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932LX	15941698				2022-12-24	WOS:000229556300005
J	Eisen, SA; Kang, HK; Murphy, FM; Blanchard, MS; Reda, DJ; Henderson, WG; Toomey, R; Jackson, LW; Alpem, R; Parks, BJ; Klimas, N; Hall, C; Pak, HS; Hunter, J; Karlinsky, J; Battistone, MJ; Lyons, MJ				Eisen, SA; Kang, HK; Murphy, FM; Blanchard, MS; Reda, DJ; Henderson, WG; Toomey, R; Jackson, LW; Alpem, R; Parks, BJ; Klimas, N; Hall, C; Pak, HS; Hunter, J; Karlinsky, J; Battistone, MJ; Lyons, MJ		Gulf War Study Participating Inves	Gulf war veterans' health: Medical evaluation of a US cohort	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC-FATIGUE-SYNDROME; POPULATION-BASED SURVEY; OPERATION-DESERT-STORM; AL ESKAN DISEASE; VISCERAL INFECTION; LEISHMANIA-TROPICA; ILLNESS; FIBROMYALGIA; PREVALENCE; ACTIVATION	Background: United States military personnel reported various symptoms after deployment to the Persian Gulf during the 1991 Gulf War. However, the symptoms' long-term prevalence and association with deployment remain controversial. Objective: To assess and compare the prevalence of selected medical conditions in a national cohort of deployed and nondeployed Gulf War veterans who were evaluated by direct medical and teledermatologic examinations. Design: A cross-sectional prevalence study performed 10 years after the 1991 Gulf War. Setting: Veterans were examined at 1 of 16 Veterans Affairs medical centers. Participants: Deployed (n = 1061) and nondeployed (n = 1128) veterans of the 1991 Gulf War. Measurements: Primary outcome measures included fibromyalgia, the chronic fatigue syndrome, dermatologic conditions, dyspepsia, physical health-related quality of life (Short Form-36 [SF36]), hypertension, obstructive lung disease, arthralgias, and peripheral neuropathy. Results: Of 12 conditions, only 4 conditions were more prevalent among deployed than nondeployed veterans: fibromyalgia (deployed, 2.0%; nondeployed, 1.2%; odds ratio, 2.32 [95% Cl, 1.02 to 5.27]); the chronic fatigue syndrome (deployed, 1.6%; nondeployed 0.1%; odds ratio, 40.6 [Cl, 10.2 to 161]); dermatologic conditions (deployed, 34.6%; nondeployed, 26.8%; odds ratio, 1.38 [Cl, 1.06 to 1.80]), and dyspepsia (deployed, 9.1%; nondeployed, 6.0%; odds ratio, 1.87 [Cl, 1.16 to 2.99]). The mean physical component summary score of the SF-36 for deployed and nondeployed veterans was 49.3 and 50.8, respectively. Limitations: Relatively low participation rates introduce potential participation bias, and deployment-related illnesses that resolved before the research examination could not, by design, be detected. Conclusions: Ten years after the Gulf War, the physical health of deployed and nondeployed veterans is similar. However, Gulf War deployment is associated with an increased risk for fibromyalgia, the chronic fatigue syndrome, skin conditions, dyspepsia, and a clinically insignificant decrease in the SF-36 physical component score.	Washington Univ, Sch Med, Med Affairs Med Ctr 151 JC, St Louis, MO 63103 USA; St Louis Univ, St Louis, MO 63103 USA; US Dept Vet Affairs, Vet Hlth Adm, Environm Epidemiol Serv, Washington, DC USA; Uniformed Serv Univ Hlth Sci, Washington, DC USA; Hines Vet Affairs Hosp, Cooperat Studies Program, Coodinating Ctr, Hines, IL USA; Harvard Univ, Vet Affairs Med Ctr, Brockton, MA 02401 USA; Harvard Univ, Sch Med, Massachusetts Mental Hlth Ctr,Vet Affairs Med Ctr, Harvard Inst Psychiat Epidemiol & Genet, Boston, MA 02115 USA; Boston Univ, Sch Med, Boston, MA 02215 USA; Vet Affairs Med Ctr, Miami, FL 33125 USA; Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA; Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA	Washington University (WUSTL); Saint Louis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Harvard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Antonio Military Medical Center; United States Department of Defense; United States Army; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Eisen, SA (corresponding author), Washington Univ, Sch Med, Med Affairs Med Ctr 151 JC, 915 N Grand Ave, St Louis, MO 63103 USA.	seth.eisen@med.va.gov	Lyons, Michael J./B-6119-2011	Eisen, Seth/0000-0001-7746-6624; , Domenic/0000-0003-1831-4270; Lyons, Michael/0000-0001-6516-9219				Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026; [Anonymous], 1996, FIN REP; Buchwald D, 2001, PSYCHOSOM MED, V63, P936, DOI 10.1097/00006842-200111000-00012; BUCHWALD D, 1992, ANN INTERN MED, V116, P103, DOI 10.7326/0003-4819-116-2-103; Coker WJ, 1999, BMJ-BRIT MED J, V318, P290, DOI 10.1136/bmj.318.7179.290; Cook DB, 2003, MED SCI SPORT EXER, V35, P569, DOI 10.1249/01.MSS.0000058438.25278.33; Davis LE, 2004, NEUROLOGY, V63, P1070, DOI 10.1212/01.WNL.0000138426.88460.CB; DEMITRACK MA, 1991, J CLIN ENDOCR METAB, V73, P1224, DOI 10.1210/jcem-73-6-1224; Endresen GKM, 2003, RHEUMATOL INT, V23, P211, DOI 10.1007/s00296-003-0355-7; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Hickie I B, 2001, Twin Res, V4, P94, DOI 10.1375/twin.4.2.94; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kang HK, 2001, AM J EPIDEMIOL, V154, P399, DOI 10.1093/aje/154.5.399; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Karlinsky JB, 2004, ARCH INTERN MED, V164, P2488, DOI 10.1001/archinte.164.22.2488; KELLER RH, 1994, CLIN INFECT DIS, V18, pS154, DOI 10.1093/clinids/18.Supplement_1.S154; Kennedy G, 2004, ANN EPIDEMIOL, V14, P95, DOI 10.1016/j.annepidem.2003.10.004; Khan F, 2004, CLIN SCI, V106, P183, DOI 10.1042/CS20030246; Kipen HM, 1999, ARCH ENVIRON HEALTH, V54, P313, DOI 10.1080/00039899909602493; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; KORENYIBOTH AL, 1992, MIL MED, V157, P452, DOI 10.1093/milmed/157.9.452; KorenyiBoth AL, 1997, MIL MED, V162, P1; LANDAY AL, 1991, LANCET, V338, P707, DOI 10.1016/0140-6736(91)91440-6; MAGILL AJ, 1993, NEW ENGL J MED, V328, P1383, DOI 10.1056/NEJM199305133281904; MAGILL AJ, 1994, CLIN INFECT DIS, V19, P805, DOI 10.1093/clinids/19.4.805; Murphy FM, 1999, MIL MED, V164, P327, DOI 10.1093/milmed/164.5.327; MURRAYLEISURE KA, 1994, 34 INT C ANT AG CHEM; Naschitz JE, 2001, SEMIN ARTHRITIS RHEU, V31, P199, DOI 10.1053/sarh.2001.27738; Natelson BH, 2001, JAMA-J AM MED ASSOC, V285, P2557, DOI 10.1001/jama.285.20.2557; NICHOLSON G, 1996, INT J OCCUPAT MED IM, V5, P69; OSTER CN, 1992, HOSP PRACT, V27, P145; Oumeish OY, 2002, CLIN DERMATOL, V20, P401, DOI 10.1016/S0738-081X(02)00241-9; Patarca-Montero R, 2001, Appl Neuropsychol, V8, P51, DOI 10.1207/S15324826AN0801_7; PRICE RK, 1992, PUBLIC HEALTH REP, V107, P514; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; ROBINSON A, 1995, CAN MED ASSOC J, V152, P944; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; STRAUS SE, 1993, CIBA F SYMP, V173, P132; STRAUS SE, 1993, J CLIN IMMUNOL, V13, P30, DOI 10.1007/BF00920633; STRAUS SE, 1993, CIBA FOUND S, V173, P139; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Visser J, 2001, J NEUROIMMUNOL, V119, P343, DOI 10.1016/S0165-5728(01)00400-3; Ware J., 1993, SF 36 HLTH SURVEY MA; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2; 1995, MMWR MORB MORTAL WKL, V44, P443	48	95	97	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2005	142	11					881	890		10.7326/0003-4819-142-11-200506070-00005	http://dx.doi.org/10.7326/0003-4819-142-11-200506070-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	932LX	15941694				2022-12-24	WOS:000229556300001
J	Haas, JS; Phillips, KA; Gerstenberger, EP; Seger, AC				Haas, JS; Phillips, KA; Gerstenberger, EP; Seger, AC			Potential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey, 1997-2000	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING-ENZYME-INHIBITORS; PHARMACY BENEFITS; PHYSICIAN; COMPANIES	Background: Generic substitution is one mechanism of curtailing prescription drug expenditures. Limited information is available about the potential savings associated with generic substitution. Objective: To estimate the potential savings associated with broad substitution of generic drugs. Design: Cross-sectional, nationally representative survey of noninstitutionalized adults. Setting: United States. Participants: Adults included in the Medical Expenditure Panel Survey Household Component, 1997-2000. Measurements: Use of a multisource drug (that is, a drug available in a brand-name and >= 1 generic formulation) or a generic drug and the potential cost savings associated with broad generic substitution for all multisource products. Results: Fifty-six percent of all outpatient drugs were multisource products, accounting for 41% of total outpatient drug expenditures. Of these multisource drugs, 61% were dispensed as a generic. If a generic had been substituted for all corresponding brand-name outpatient drugs in 2000, the median annual savings in drug expenditures per person would have been $45.89 (interquartile range, $10.35 to 158.06) for adults younger than 65 years of age and $78.05 (interquartile range, $19.94 to $241.72) for adults at least 65 years of age. in these age groups, the national savings would have been $5.9 billion (95% Cl, $5.5 billion to $6.2 billion) and $2.9 billion (Cl, $2.6 billion to $3.1 billion), respectively, representing approximately 11% of drug expenditures. Limitations: Specific information about an individual's formulary was not available, so the authors could not estimate how much of the potential savings would benefit an individual or his or her health plan. Conclusion: Although broad substitution of generic drugs would affect only a modest percentage of drug expenditures, it could result in substantial absolute savings.	Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Haas, JS (corresponding author), Brigham & Womens Hosp, Div Gen Med & Primary Care, 1620 Tremont St, Boston, MA 02120 USA.	jhaas@partners.org		HAAS, JENNIFER/0000-0001-7227-851X				ANDERSON GF, 2004, HLTH AFF MILLWOOD, V4, P396; Bae JP, 1997, HEALTH SERV RES, V32, P87; Banahan BF, 1997, ARCH INTERN MED, V157, P2080, DOI 10.1001/archinte.157.18.2080; Brennan TA, 2004, ANN INTERN MED, V141, P126, DOI 10.7326/0003-4819-141-2-200407200-00011; Cohen JW, 1996, INQUIRY-J HEALTH CAR, V33, P373; COHEN SB, AHCRP PUB; CRUICKSHANK JM, 1988, BRIT MED J, V297, P1597, DOI 10.1136/bmj.297.6663.1597; CUBANSKI J, 2004, HLTH AFF W, V4, P198; DeCara JM, 1998, CHEST, V113, P261, DOI 10.1378/chest.113.2.261; Dong BJ, 1997, JAMA-J AM MED ASSOC, V277, P1205, DOI 10.1001/jama.277.15.1205; Fischer MA, 2003, HEALTH SERV RES, V38, P1051, DOI 10.1111/1475-6773.00162; Gaither CA, 2001, J AM PHARM ASS, V41, P729, DOI [10.1016/S1086-5802(16)31308-0, DOI 10.1016/S1086-5802(16)31308-0]; Ganther J M, 2000, J Am Pharm Assoc (Wash), V40, P378; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; HARRIS G, 2003, NY TIMES        1005, P1; Hellerstein JK, 1998, RAND J ECON, V29, P108, DOI 10.2307/2555818; HENRY J, 2003, FAMILY FDN; *HJ KAIS FAM FDN, 2001, KAIS COMM MED UN; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; *MEDC HLTH SOL INC, ANT 1 TIM GEN 2004 2; MOELLER JF, 1996, AHRQ PUB; MOON N, 2004, BENEFICIARIES FARE N; Mott DA, 2002, MED CARE, V40, P662, DOI 10.1097/00005650-200208000-00006; Murphy JE, 1999, ARCH INTERN MED, V159, P429, DOI 10.1001/archinte.159.5.429; Nightingale SL, 1998, JAMA-J AM MED ASSOC, V279, P645, DOI 10.1001/jama.279.9.645-b; *NIH CAR MAN FDN, 2002, PRIM GEN DRUGS PAT P; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P1238, DOI 10.1001/jama.277.15.1238; Robinson AR, 2004, ARCH INTERN MED, V164, P427, DOI 10.1001/archinte.164.4.427; Schneeweiss S, 2004, MED CARE, V42, P653, DOI 10.1097/01.mlr.0000129497.10930.a2; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Suh DC, 1999, PHARM WORLD SCI, V21, P260, DOI 10.1023/A:1008781619011; *US FOOD DRUG ADM, NEW FDA IN IMPR; 2002, FORMULARY, V38, P499; 2001, PRESCRIPTION DRUG TR	34	185	192	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2005	142	11					891	897		10.7326/0003-4819-142-11-200506070-00006	http://dx.doi.org/10.7326/0003-4819-142-11-200506070-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932LX	15941695				2022-12-24	WOS:000229556300002
J	Anway, MD; Cupp, AS; Uzumcu, M; Skinner, MK				Anway, MD; Cupp, AS; Uzumcu, M; Skinner, MK			Epigenetic transgenerational actions of endocrine disruptors and mate fertility	SCIENCE			English	Article							POSTNATAL TESTIS DEVELOPMENT; ANDROGEN RECEPTOR; METHOXYCHLOR; CELLS; VINCLOZOLIN; EXPOSURE; RAT; IMMUNOLOCALIZATION; DIFFERENTIATION; INHERITANCE	Transgenerational effects of environmental toxins require either a chromosomal or epigenetic alteration in the germ line. Transient exposure of a gestating female rat during the period of gonadal sex determination to the endocrine disruptors vinclozolin (an antiandrogenic compound) or methoxychlor (an estrogenic compound) induced an adult phenotype in the F-1 generation of decreased spermatogenic capacity (cell number and viability) and increased incidence of mate infertility. These effects were transferred through the mate germ line to nearly all mates of ail subsequent generations examined (that is F-1 to F-4). The effects on reproduction correlate with altered DNA methylation patterns in the germ line. The ability of an environmental factor (for example, endocrine disruptor) to reprogram the germ line and to promote a transgenerational disease state has significant implications for evolutionary biology and disease etiology.	Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@mail.wsu.edu	Anway, Matthew D/B-1480-2008; Reis-Silva, Thiago M./E-6318-2013					Barber R, 2002, P NATL ACAD SCI USA, V99, P6877, DOI 10.1073/pnas.102015399; BUEHR M, 1993, DEVELOPMENT, V117, P273; Chapin RE, 1997, FUND APPL TOXICOL, V40, P138, DOI 10.1006/faat.1997.2381; Cummings AM, 1997, CRIT REV TOXICOL, V27, P367, DOI 10.3109/10408449709089899; Cupp AS, 2003, J ANDROL, V24, P736; DeRosa C, 1998, J TOXICOL ENV HEAL B, V1, P3, DOI 10.1080/10937409809524541; Dong H, 2004, BIOCHEMISTRY-US, V43, P15922, DOI 10.1021/bi0482194; Durcova-Hills G, 2001, DIFFERENTIATION, V68, P220, DOI 10.1046/j.1432-0436.2001.680409.x; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Foran CM, 2002, TOXICOL SCI, V68, P389, DOI 10.1093/toxsci/68.2.389; Gaido KW, 1999, ENDOCRINOLOGY, V140, P5746, DOI 10.1210/en.140.12.5746; Goyal HO, 1997, ANAT REC, V249, P54, DOI 10.1002/(SICI)1097-0185(199709)249:1<54::AID-AR7>3.0.CO;2-F; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; JOST A, 1981, HUM GENET, V58, P59, DOI 10.1007/BF00284150; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; Kelce WR, 1997, TOXICOL APPL PHARM, V142, P192, DOI 10.1006/taap.1996.7966; MAJDIC G, 1995, J ENDOCRINOL, V147, P285, DOI 10.1677/joe.0.1470285; Morris ID, 2002, INT J ANDROL, V25, P255, DOI 10.1046/j.1365-2605.2002.00372.x; Rakyan V, 2003, CURR BIOL, V13, pR6, DOI 10.1016/S0960-9822(02)01377-5; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Shi BS, 2004, MUTAT RES-FUND MOL M, V556, P1, DOI 10.1016/j.mrfmmm.2004.05.014; Tokumura A, 2004, J CELL BIOCHEM, V92, P869, DOI 10.1002/jcb.20147; Uzumcu M, 2004, REPROD TOXICOL, V18, P765, DOI 10.1016/j.reprotox.2004.05.008	24	1775	1857	4	390	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1466	1469		10.1126/science.1108190	http://dx.doi.org/10.1126/science.1108190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933200	Green Published			2022-12-24	WOS:000229619300053
J	Foster, KR				Foster, KR			Biomedicine - Hamiltonian medicine: Why the social lives of pathogens matter	SCIENCE			English	Editorial Material							PARASITE VIRULENCE; COMPETITION; BIOFILMS; BACTERIA		Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA	Rice University	Foster, KR (corresponding author), Wissensch Kolleg Berlin, Inst Adv Study, Wallotstr 19, D-14193 Berlin, Germany.	krfoster@rice.edu		Foster, Kevin/0000-0003-4687-6633				Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Ewald PW, 1994, EVOLUTION INFECT DIS; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Kreft JU, 2005, MICROBIOL-SGM, V151, P637, DOI 10.1099/mic.0.27415-0; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Massey RC, 2004, P ROY SOC B-BIOL SCI, V271, P785, DOI 10.1098/rspb.2004.2676; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; [No title captured]	12	52	52	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2005	308	5726					1269	1270		10.1126/science.1108158	http://dx.doi.org/10.1126/science.1108158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919984				2022-12-24	WOS:000229482300035
J	van Heel, DA; Ghosh, S; Butler, M; Hunt, KA; Lundberg, AMC; Ahmad, T; McGovern, DPB; Onnie, C; Negoro, K; Goldthorpe, S; Foxwell, BMJ; Mathew, CG; Forbes, A; Jewell, DP; Playford, RJ				van Heel, DA; Ghosh, S; Butler, M; Hunt, KA; Lundberg, AMC; Ahmad, T; McGovern, DPB; Onnie, C; Negoro, K; Goldthorpe, S; Foxwell, BMJ; Mathew, CG; Forbes, A; Jewell, DP; Playford, RJ			Murarnyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease	LANCET			English	Article							NOD2; SUSCEPTIBILITY	Both NOD2 (CARD15) alleles are mutated in roughly 15% of patients with Crohn's disease, but functional effects are unclear. We analysed the cytokine response of peripheral blood mononuclear cells to muramyl dipeptide (MDP), the ligand for NOD2. MDP induced little TNF alpha or interleukin 1 beta, but strong interleukin-8 secretion. MDP also substantially upregulated secretion of TNF alpha and interleukin 1 beta induced by toll-like receptor ligands. These effects were abolished by the most common Crohn's NOD2 double mutant genotypes at low nanomolar MDP concentrations, and provide the basis to develop a test of NOD2 functional deficiency. In Crohn's disease, there are defects in neutrophil recruitment driven by NOD2 and interleukin 8 and in cross talk between the NOD2 and toll-like receptor pathways, which suggests that the immune system fails to receive an early priming signal.	Univ London Imperial Coll Sci & Technol, Dept Gastroenterol, Intestinal Inflammat & Repair Grp, London W12 0NN, England; Univ London Imperial Coll Sci & Technol, Kennedy Inst Rheumatol, London W12 0NN, England; Univ London Imperial Coll Sci & Technol, St Marks Hosp, London W12 0NN, England; Univ Oxford, Radcliffe Infirm, Gibson Labs, Gastroenterol Unit, Oxford OX2 6HE, England; Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London, England; Tohoku Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Sendai, Miyagi 980, Japan	Imperial College London; Imperial College London; University of Oxford; Imperial College London; Radcliffe Infirmary; University of Oxford; University of London; King's College London; Tohoku University	van Heel, DA (corresponding author), Univ London Imperial Coll Sci & Technol, Dept Gastroenterol, Intestinal Inflammat & Repair Grp, Hammersmith Campus, London W12 0NN, England.	d.vanheel@imperial.ac.uk	Mathew, Christopher G/G-3434-2015	Mathew, Christopher G/0000-0003-4178-1838; Playford, Raymond/0000-0003-1235-8504; van Heel, David/0000-0002-0637-2265; Forbes, Alastair/0000-0001-7416-9843				Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Philpott DJ, 2004, MOL IMMUNOL, V41, P1099, DOI 10.1016/j.molimm.2004.06.012; Traub S, 2004, J BIOL CHEM, V279, P8694, DOI 10.1074/jbc.M310556200; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092	8	262	267	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 21	2005	365	9473					1794	1796		10.1016/S0140-6736(05)66582-8	http://dx.doi.org/10.1016/S0140-6736(05)66582-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	928SI	15910952				2022-12-24	WOS:000229291600024
J	Mery, F; Kawecki, TJ				Mery, F; Kawecki, TJ			A cost of long-term memory in Drosophila	SCIENCE			English	Article							CONSOLIDATED MEMORY		Univ Fribourg, Dept Biol, Sect Ecol & Evolut, CH-1700 Fribourg, Switzerland	University of Fribourg	Mery, F (corresponding author), Univ Fribourg, Dept Biol, Sect Ecol & Evolut, Chemin Musee 10, CH-1700 Fribourg, Switzerland.	frederic.mery@unifr.ch	Kawecki, Tadeusz/K-5466-2015	Kawecki, Tadeusz/0000-0002-9244-1991				Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Karan D, 1998, EVOLUTION, V52, P825, DOI [10.1111/j.1558-5646.1998.tb03706.x, 10.2307/2411276]; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Nevo E, 1998, HEREDITY, V80, P9, DOI 10.1046/j.1365-2540.1998.00274.x; Niven JE, 2003, P ROY SOC B-BIOL SCI, V270, pS58, DOI 10.1098/rsbl.2003.0010; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0	6	183	186	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1148	1148		10.1126/science.1111331	http://dx.doi.org/10.1126/science.1111331			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905396	Green Submitted			2022-12-24	WOS:000229293400037
J	Gardner, TJ; Naef, F; Naef-, F				Gardner, TJ; Naef, F; Naef-, F			Freedom and rules: The acquisition and reprogramming of a bird's learned song	SCIENCE			English	Article							CANARY SONG; ZEBRA FINCHES; SPEECH	Canary song is hierarchically structured: Short stereotyped syllables are repeated to form phrases, which in turn are arranged to form songs. This structure occurs even in the songs of young isolates, which suggests that innate rules govern canary song development. However, juveniles that had never heard normal song imitated abnormal synthetic songs with great accuracy, even when the tutor songs lacked phrasing. As the birds matured, imitated songs were reprogrammed to form typical canary phrasing. Thus, imitation and innate song constraints are separate processes that can be segregated in time: freedom in youth, rules in adulthood.	Rockefeller Univ, Lab Anim Behav, New York, NY 10021 USA; Rockefeller Univ, Phys Math Lab, New York, NY 10021 USA; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Swiss Inst Bioinformat, CH-1066 Epalinges, Switzerland	Rockefeller University; Rockefeller University; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics	Gardner, TJ (corresponding author), Rockefeller Univ, Lab Anim Behav, 1230 York Ave, New York, NY 10021 USA.	tgardner@mit.edu	Naef, Felix/C-9527-2011	Naef, Felix/0000-0001-9786-3037	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018343, R01MH018343] Funding Source: NIH RePORTER; NIMH NIH HHS [MH18343, MH63132] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson SE, 1996, J ACOUST SOC AM, V100, P1209, DOI 10.1121/1.415968; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Gardner T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208101; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GUTTINGER HR, 1981, Z TIERPSYCHOL, V56, P323; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MARLER P, 1982, DEV PSYCHOBIOL, V15, P369, DOI 10.1002/dev.420150409; MARLER P, 1970, AM SCI, V58, P669; MARLER P, 1977, J COMP PHYSIOL PSYCH, V91, P8, DOI 10.1037/h0077303; Marler Peter, 2004, P1, DOI 10.1016/B978-012473070-0/50004-9; Mundinger PC, 1995, ANIM BEHAV, V50, P1491, DOI 10.1016/0003-3472(95)80006-9; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1986, BEHAV NEURAL BIOL, V46, P445, DOI 10.1016/S0163-1047(86)90485-1; Rabiner L. R., 1993, FUNDAMENTALS SPEECH; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; THORPE W. H., 1958, IBIS, V100, P535, DOI 10.1111/j.1474-919X.1958.tb07960.x; Thorpe W. H., 1955, Ibis, V97, P247, DOI 10.1111/j.1474-919X.1955.tb01911.x; Vu ET, 1998, J NEUROSCI, V18, P9088; VU ET, 1994, J NEUROSCI, V14, P6924; WANCHUN L, IN PRESS P NATL ACAD; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	23	86	86	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1046	1049		10.1126/science.1108214	http://dx.doi.org/10.1126/science.1108214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890887				2022-12-24	WOS:000229190700054
J	Waite, JH; Niemann, H; Yelle, RV; Kasprzak, WT; Cravens, TE; Luhmann, JG; McNutt, RL; Ip, WH; Gell, D; De La Haye, V; Muller-Wordag, I; Magee, B; Borggren, N; Ledvina, S; Fletcher, G; Walter, E; Miller, R; Scherer, S; Thorpe, R; Xu, J; Block, B; Arnett, K				Waite, JH; Niemann, H; Yelle, RV; Kasprzak, WT; Cravens, TE; Luhmann, JG; McNutt, RL; Ip, WH; Gell, D; De La Haye, V; Muller-Wordag, I; Magee, B; Borggren, N; Ledvina, S; Fletcher, G; Walter, E; Miller, R; Scherer, S; Thorpe, R; Xu, J; Block, B; Arnett, K			Ion Neutral Mass Spectrometer results from the first flyby of Titan	SCIENCE			English	Article							ISOTOPIC FRACTIONATION; NITROGEN; ATMOSPHERE; ORIGIN; TEMPERATURE; C-12/C-13; CLATHRATE; HCN	The Cassini Ion Neutral Mass Spectrometer (INMS) has obtained the first in situ composition measurements of the neutral densities of molecular nitrogen, methane, molecular hydrogen, argon, and a host of stable carbon-nitrile compounds in Titan's upper atmosphere. INMS in situ mass spectrometry has also provided evidence for atmospheric waves in the upper atmosphere and the first direct measurements of isotopes of nitrogen, carbon, and argon, which reveal interesting clues about the evolution of the atmosphere. The bulk composition and thermal structure of the moon's upper atmosphere do not appear to have changed considerably since the Voyager 1 flyby.	Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; Univ London Imperial Coll Sci Technol & Med, Space & Atmospher Phys Grp, London SW7 2BW, England; SW Res Inst, San Antonio, TX 78228 USA	University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; University of Kansas; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Central University; Imperial College London; Southwest Research Institute	Waite, JH (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.		McNutt, Ralph L/E-8006-2010	McNutt, Ralph L/0000-0002-4722-9166				ATREYA SK, 1978, SCIENCE, V201, P611, DOI 10.1126/science.201.4356.611; COUSTENIS A, 1989, ICARUS, V80, P54, DOI 10.1016/0019-1035(89)90161-9; Cravens TE, 1997, PLANET SPACE SCI, V45, P889, DOI 10.1016/S0032-0633(97)00064-0; FEGLEY B, 1995, GLOBAL EARTH PHYS HD, P320, DOI DOI 10.1029/RF001P0320; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Gautier D, 2005, SPACE SCI REV, V116, P25, DOI 10.1007/s11214-005-1946-2; Gurwell MA, 2004, ASTROPHYS J, V616, pL7, DOI 10.1086/423954; Hidayat T, 1997, ICARUS, V126, P170, DOI 10.1006/icar.1996.5640; JOHNS TF, 1957, ATOMIC ENERGY RES ES; Kallenbach R, 1998, ASTROPHYS J, V507, pL185, DOI 10.1086/311702; Kasprzak W, 1996, P SOC PHOTO-OPT INS, V2803, P129, DOI 10.1117/12.253413; LODDERS K, 1999, PLANETARY SCI COMPAN; LUNINE JI, 1987, ICARUS, V70, P61, DOI 10.1016/0019-1035(87)90075-3; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; Lunine JI, 1999, PLANET SPACE SCI, V47, P1291, DOI 10.1016/S0032-0633(99)00052-5; MCKAY CP, 1988, NATURE, V332, P520, DOI 10.1038/332520a0; Mousis O, 2002, ICARUS, V156, P162, DOI 10.1006/icar.2001.6782; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; OWEN T, 1982, PLANET SPACE SCI, V30, P833, DOI 10.1016/0032-0633(82)90115-5; Owen TC, 2000, PLANET SPACE SCI, V48, P747, DOI 10.1016/S0032-0633(00)00040-4; Press W., 1986, NUMERICAL RECIPES; STROBEL DF, 1997, ESA SPECIAL PUBLICAT, P299; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x; Vervack RJ, 2004, ICARUS, V170, P91, DOI 10.1016/j.icarus.2004.03.005; Waite JH, 2004, SPACE SCI REV, V114, P113, DOI 10.1007/s11214-004-1408-2; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Yung YL, 1997, SCIENCE, V278, P1778, DOI 10.1126/science.278.5344.1778; YUNG YL, COMMUNICATION	28	348	350	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					982	986		10.1126/science.1110652	http://dx.doi.org/10.1126/science.1110652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890873				2022-12-24	WOS:000229190700034
J	Riley, JR; Greggers, U; Smith, AD; Reynolds, DR; Menzel, R				Riley, JR; Greggers, U; Smith, AD; Reynolds, DR; Menzel, R			The flight paths of honeybees recruited by the waggle dance	NATURE			English	Article							HARMONIC RADAR; BEES; TRACKING	In the 'dance language' of honeybees(1,2), the dancer generates a specific, coded message that describes the direction and distance from the hive of a new food source, and this message is displaced in both space and time from the dancer's discovery of that source. Karl von Frisch concluded that bees 'recruited' by this dance used the information encoded in it to guide them directly to the remote food source, and this Nobel Prize-winning discovery revealed the most sophisticated example of non-primate communication that we know of(3,4). In spite of some initial scepticism(5-9), almost all biologists are now convinced that von Frisch was correct(3,4,10-14), but what has hitherto been lacking is a quantitative description of how effectively recruits translate the code in the dance into flight to their destinations. Using harmonic radar(15-17) to record the actual flight paths of recruited bees, we now provide that description.	Rothamsted Res, Plant & Invertebrate Ecol Div, Harpenden AL5 2JQ, Herts, England; Free Univ Berlin, Fachbereich Biol Chem Pharm, Inst Biol Neurobiol, D-14195 Berlin, Germany; Univ Greenwich, Nat Resources Inst, Plant Anim & Human Hlth Grp, Chatham ME4 4TB, Kent, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Free University of Berlin; University of Greenwich	Riley, JR (corresponding author), Rothamsted Res, Plant & Invertebrate Ecol Div, Harpenden AL5 2JQ, Herts, England.	joe@radarent.freeserve.co.uk	Reynolds, Donald R/C-7361-2013	Reynolds, Donald/0000-0001-8749-7491				Baker TC, 1996, PHYSIOL ENTOMOL, V21, P20, DOI 10.1111/j.1365-3032.1996.tb00831.x; Carde RT, 1997, INSECT PHEROMONE RESEARCH, P275; CHITTKA L, 1995, ETHOLOGY, V99, P117, DOI 10.1111/j.1439-0310.1995.tb01093.x; Dyer F.C., 1994, ANIM BEHAV, V47, P1242; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; ESCH H, 1970, Z VERGL PHYSIOL, V68, P175, DOI 10.1007/BF00297693; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; GOULD JL, 1975, SCIENCE, V189, P685, DOI 10.1126/science.1154023; GOULD JL, 1976, Q REV BIOL, V51, P211, DOI 10.1086/409309; MAUTZ D, 1971, Z VERGL PHYSIOL, V72, P197, DOI 10.1007/BF00297822; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Reynolds D. R., 1997, P111; Riley Joseph R., 2001, Symposia of the Royal Entomological Society of London, V20, P129, DOI 10.1079/9780851994567.0129; Riley JR, 1999, NATURE, V400, P126, DOI 10.1038/22029; Riley JR, 2003, P ROY SOC B-BIOL SCI, V270, P2421, DOI 10.1098/rspb.2003.2542; Riley JR, 2002, COMPUT ELECTRON AGR, V35, P151, DOI 10.1016/S0168-1699(02)00016-9; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; Riley JR, 1998, J INSECT BEHAV, V11, P287, DOI 10.1023/A:1021004209198; SEELEY T, 1991, NATURE, V349, P114, DOI 10.1038/349114a0; SEELEY TD, 1983, BEHAV ECOL SOCIOBIOL, V12, P253, DOI 10.1007/BF00290778; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Tautz J, 2003, J COMP PHYSIOL A, V189, P293, DOI 10.1007/s00359-003-0402-6; TOWNE W F, 1988, Journal of Insect Behavior, V1, P129, DOI 10.1007/BF01052234; von Frisch K., 1967, DANCE LANGUAGE ORIEN; VONFRISCH K, 1967, SCIENCE, V158, P1072; WELLS PH, 1973, NATURE, V241, P171, DOI 10.1038/241171a0; Wenner AM, 2002, J INSECT BEHAV, V15, P859, DOI 10.1023/A:1021131725124; WENNER AM, 1991, AM ZOOL, V31, P768; Wenner AM., 1990, ANATOMY CONTROVERSY, DOI [10.7312/wenn90330, DOI 10.7312/WENN90330]	30	242	248	23	298	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					205	207		10.1038/nature03526	http://dx.doi.org/10.1038/nature03526			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889092				2022-12-24	WOS:000229021100040
J	Huang, JK; Hu, RF; Rozelle, S; Pray, C				Huang, JK; Hu, RF; Rozelle, S; Pray, C			Insect-resistant GM rice in farmers' fields: Assessing productivity and health effects in China	SCIENCE			English	Article							BIOTECHNOLOGY; PESTICIDES	Although no country to date has released a major genetically modified (GM) food grain crop, China is on the threshold of commercializing GM rice. This paper studies two of the four GM varieties that are now in farm-level pre-production trials, the last step before commercialization. Farm surveys of randomly selected farm households that are cultivating the insect-resistant GM rice varieties, without the aid of experimental station technicians, demonstrate that when compared with households cultivating non-GM rice, small and poor farm households benefit from adopting GM rice by both higher crop yields and reduced use of pesticides, which also contribute to improved health.	Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China; Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; Rutgers State Univ, Dept Agr Food & Resource Econ, New Brunswick, NJ 08901 USA	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; University of California System; University of California Davis; Rutgers State University New Brunswick	Huang, JK (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Jia 11,Datun Rd, Beijing 100101, Peoples R China.	jkhuang.ccap@igsnrr.ac.cn						ANTLE JM, 1994, AM J AGR ECON, V76, P418, DOI 10.2307/1243654; Deng CY, 2003, ACTA BOT SIN, V45, P1084; HUANG J, 2001, 2001RR3 EEPSEA IDRC; Huang JK, 2003, AGR ECON, V29, P55, DOI 10.1016/S0169-5150(03)00044-6; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Paarlberg R. L., 2003, ISSUES SCI TECHN SPR; Qaim M, 2003, SCIENCE, V299, P900, DOI 10.1126/science.1080609; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310	8	250	302	2	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					688	690		10.1126/science.1108972	http://dx.doi.org/10.1126/science.1108972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860626				2022-12-24	WOS:000228810900048
J	Messenger, S; Keller, LP; Lauretta, DS				Messenger, S; Keller, LP; Lauretta, DS			Supernova olivine from cometary dust	SCIENCE			English	Article							MOLECULAR-CLOUD MATERIAL; PRESOLAR SIC GRAINS; SOLAR-SYSTEM; ISOTOPIC COMPOSITIONS; ISO SPECTROSCOPY; SILICON-CARBIDE; MASSIVE STARS; CARBON; CONDENSATION; NITROGEN	An interplanetary dust particle contains a submicrometer crystalline silicate aggregate of probable supernova origin. The grain has a pronounced enrichment in O-18/O-16 (13 times the solar value) and depletions in O-17/O-16 (one-third solar) and Si-29/Si-28 (<0.8 times solar), indicative of formation from a type 11 supernova. The aggregate contains olivine (forsterite 83) grains <100 nanometers in size, with microstructures that are consistent with minimal thermal alteration. This unusually iron-rich olivine grain could have formed by equilibrium condensation from cooling supernova ejecta if several different nucleosynthetic zones mixed in the proper proportions. The supernova grain is also partially encased in nitrogen-15-rich organic matter that likely formed in a presolar cold molecular cloud.	NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Houston, TX 77058 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Arizona	Messenger, S (corresponding author), NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Mail Code KR, Houston, TX 77058 USA.	scott.r.messenger@nasa.gov						Alexander CMO, 1998, METEORIT PLANET SCI, V33, P603, DOI 10.1111/j.1945-5100.1998.tb01667.x; ALEXANDER CMO, 1993, GEOCHIM COSMOCHIM AC, V57, P2869, DOI 10.1016/0016-7037(93)90395-D; Amari S, 2001, ASTROPHYS J, V559, P463, DOI 10.1086/322397; Amari S, 2001, ASTROPHYS J, V546, P248, DOI 10.1086/318230; ARNARI S, 1992, ASTROPHYS J, V394, P643; ARNOULD M, 1998, AIP C P, V402, P179; BERNATOWIC TJ, 1998, AIP C P, V402; Bernstein MP, 2002, ASTROPHYS J, V576, P1115, DOI 10.1086/341863; Boothroyd AI, 1999, ASTROPHYS J, V510, P232, DOI 10.1086/306546; Bradley J. P., 1988, METEORITES EARLY SOL, P861; Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; Busso M, 2003, PUBL ASTRON SOC AUST, V20, P356, DOI 10.1071/AS03035; Charnley SB, 2002, ASTROPHYS J, V569, pL133, DOI 10.1086/340484; Choi BG, 1998, SCIENCE, V282, P1284, DOI 10.1126/science.282.5392.1284; Choi BG, 1999, ASTROPHYS J, V522, pL133, DOI 10.1086/312239; Clayton DD, 1999, SCIENCE, V283, P1290, DOI 10.1126/science.283.5406.1290; Clayton DD, 2001, ASTROPHYS J, V562, P480, DOI 10.1086/323467; CLAYTON DD, 2004, ORIGIN EVOLUTION ELE, P297; Deneault EAN, 2003, ASTROPHYS J, V594, P312, DOI 10.1086/376863; Dunne L, 2003, NATURE, V424, P285, DOI 10.1038/nature01792; Ebel DS, 2000, GEOCHIM COSMOCHIM AC, V64, P339, DOI 10.1016/S0016-7037(99)00284-7; FEDKIN AV, 2004, LUNAR PLANET SCI, V35, pA1823; Floss C, 2004, SCIENCE, V303, P1355, DOI 10.1126/science.1093283; Floss C., 2004, LUNAR PLANET SCI, VXXXV; Gibb EL, 2000, ASTROPHYS J, V536, P347, DOI 10.1086/308940; HOPPE P, 1994, ASTROPHYS J, V430, P870, DOI 10.1086/174458; Hoppe P, 1996, GEOCHIM COSMOCHIM AC, V60, P883, DOI 10.1016/0016-7037(95)00435-1; HOPPE P, 2005, LUNAR PLANET SCI, V36; Huss GR, 1997, GEOCHIM COSMOCHIM AC, V61, P5117, DOI 10.1016/S0016-7037(97)00299-8; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Kemper F, 2002, ASTRON ASTROPHYS, V394, P679, DOI 10.1051/0004-6361:20021119; KOBAYASHI S, 2005, LUNAR PLANET SCI, V36; KRESTINA H, 2002, LUNAR PLANET SCI, V33; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Li AG, 1997, ASTRON ASTROPHYS, V323, P566; MARHAS KK, 2004, LUNAR PLANET SCI, V35; Meeus G, 2001, ASTRON ASTROPHYS, V365, P476, DOI 10.1051/0004-6361:20000144; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2002, METEORIT PLANET SCI, V37, P1491, DOI 10.1111/j.1945-5100.2002.tb00806.x; MESSENGER S, 1997, AIP C P, V402, P545; MEYER BS, 1995, METEORITICS, V30, P325, DOI 10.1111/j.1945-5100.1995.tb01131.x; Mostefaoui S, 2004, ASTROPHYS J, V613, pL149, DOI 10.1086/424842; Mouri H, 2000, ASTROPHYS J, V534, pL63, DOI 10.1086/312633; Nagashima K, 2004, NATURE, V428, P921, DOI 10.1038/nature02510; Nguyen AN, 2004, SCIENCE, V303, P1496, DOI 10.1126/science.1094389; NGUYEN AN, 2005, LUNAR PLANET SCI, V36; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; Nittler LR, 1997, ASTROPHYS J, V483, P475, DOI 10.1086/304234; Pasek MA, 2005, ICARUS, V175, P1, DOI 10.1016/j.icarus.2004.10.012; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; STROUD RM, 2004, MET PLANET SCI, V39; Tachibana S, 2003, ASTROPHYS J, V588, pL41, DOI 10.1086/375362; Travaglio C, 1999, ASTROPHYS J, V510, P325, DOI 10.1086/306551; van Dishoeck EF, 2004, ANNU REV ASTRON ASTR, V42, P119, DOI 10.1146/annurev.astro.42.053102.134010; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361; WOODEN DH, 1998, AIP C P, V402, P317; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; Yada T., 2005, LUNAR PLANET SCI, VXXXVI; Zinner E, 2003, GEOCHIM COSMOCHIM AC, V67, P5083, DOI 10.1016/S0016-7037(03)00261-8; Zinner EK, 2005, TREATISE GEOCHEM, V1, P17	63	133	133	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					737	741		10.1126/science.1109602	http://dx.doi.org/10.1126/science.1109602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	15994379				2022-12-24	WOS:000230938200040
J	Decullier, E; Lheritier, V; Chapuis, F				Decullier, E; Lheritier, V; Chapuis, F			Fate of biomedical research protocols and publication bias in France: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; FOLLOW-UP; REGISTRATION; COMMITTEE	Objectives To describe the fate of protocols approved by the French research ethics committees, a national system created by the French 1988 Huriet-Serusclat Act; to assess publication bias at a national level. Design Retrospective cohort study. Setting Representative sample of 25/48 French research ethics committees in 1994. Protocols 649 research protocols approved by committees, with follow-up information. Main outcome measures Protocols' initial characteristics (design, study size, investigator) abstracted from committees' archives; follow-up information (rates of initiation, completion, and publication) obtained from mailed questionnaire to principal investigators. Results Completed questionnaires were available for 649/976 (69%) protocols. Of these, 581 (90%) studies were initiated, 501/581 (86%) were completed, and 190/501 (38%) were published. Studies with confirmatory results were more likely to be published as scientific papers than were studies with inconclusive results (adjusted odds ratio 4.59, 95% confidence interval 2.21 to 9.54). Moreover, studies with confirmatory results were published more quickly than studies with inconclusive results (hazard ratio 2.48, 1.36 to 4.55). Conclusion At a national level, too many research studies are not completed, and among those completed too many are not published. We suggest capitalising on research ethics committees to register and follow all authorised research on human participants on a systematic and prospective basis.	Hop Hotel Dieu, French Natl Confederat Res Eth Comm, F-69002 Lyon, France; Hosp Civils Lyon, DIM, Clin Res Unit, F-69424 Lyon, France; Hop Hotel Dieu, CCPPRB Lyon B, F-69002 Lyon, France	CHU Lyon; CHU Lyon; CHU Lyon	Chapuis, F (corresponding author), Hop Hotel Dieu, French Natl Confederat Res Eth Comm, F-69002 Lyon, France.	francois.chapuis@chu-lyon.fr	decullier, evelyne/AAL-5861-2021					Abbasi K, 2004, BRIT MED J, V329, P637, DOI 10.1136/bmj.329.7467.637; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; De Angelis C, 2004, MED J AUSTRALIA, V181, P293, DOI 10.5694/j.1326-5377.2004.tb06290.x; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; DICKERSIN K, 1992, CONTROL CLIN TRIALS, V13, P170, DOI 10.1016/0197-2456(92)90022-R; EASTERBROOK P, 1987, BRIT MED J, V295, P1347, DOI 10.1136/bmj.295.6609.1347-a; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; EASTERBROOK PJ, 1992, J ROY SOC MED, V85, P71; GREENWALD AG, 1975, PSYCHOL BULL, V82, P1, DOI 10.1037/h0076157; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640	13	106	107	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2005	331	7507					19	22		10.1136/bmj.38488.385995.8F	http://dx.doi.org/10.1136/bmj.38488.385995.8F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	947TD	15967761	Green Published, Bronze			2022-12-24	WOS:000230668500016
J	Chao, WL; Harteneck, BD; Liddle, JA; Anderson, EH; Attwood, DT				Chao, WL; Harteneck, BD; Liddle, JA; Anderson, EH; Attwood, DT			Soft X-ray microscopy at a spatial resolution better than 15nm	NATURE			English	Article							ELECTRON-BEAM LITHOGRAPHY; MAGNETIC NANOSTRUCTURES; TRANSMISSION MICROSCOPY; WATER; TOMOGRAPHY; DOMAINS	Analytical tools that have spatial resolution at the nanometre scale are indispensable for the life and physical sciences. It is desirable that these tools also permit elemental and chemical identification on a scale of 10 nm or less, with large penetration depths. A variety of techniques(1-7) in X-ray imaging are currently being developed that may provide these combined capabilities. Here we report the achievement of sub-15-nm spatial resolution with a soft X-ray microscope - and a clear path to below 10 nm - using an overlay technique for zone plate fabrication. The microscope covers a spectral range from a photon energy of 250 eV (similar to 5 nm wavelength) to 1.8 keV (similar to 0.7 nm), so that primary K and L atomic resonances of elements such as C, N, O, Al, Ti, Fe, Co and Ni can be probed. This X-ray microscopy technique is therefore suitable for a wide range of studies: biological imaging in the water window(8,9); studies of wet environmental samples(10,11); studies of magnetic nanostructures with both elemental and spin-orbit sensitivity(12-14); studies that require viewing through thin windows, coatings or substrates ( such as buried electronic devices in a silicon chip(15)); and three-dimensional imaging of cryogenically fixed biological cells(9,16).	Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Xray Opt, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chao, WL (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Xray Opt, 1 Cyclotron Rd,MS 2-400, Berkeley, CA 94720 USA.	wlchao@lbl.gov	Liddle, James A/A-4867-2013	Liddle, James A/0000-0002-2508-7910				Anderson EH, 2004, MICROELECTRON ENG, V73-4, P74, DOI 10.1016/j.mee.2004.02.019; Anderson EH, 2000, J VAC SCI TECHNOL B, V18, P2970, DOI 10.1116/1.1321282; Anderson EH, 1995, J VAC SCI TECHNOL B, V13, P2529, DOI 10.1116/1.588387; Attwood D., 2000, SOFT XRAYS EXTREME U; BORN M, 1999, PRINCIPLES OPTICS, P596; Chao W, 2003, J VAC SCI TECHNOL B, V21, P3108, DOI 10.1116/1.1619956; Chao WL, 2003, OPT LETT, V28, P2019, DOI 10.1364/OL.28.002019; Di Fabrizio E, 1999, NATURE, V401, P895, DOI 10.1038/44791; Eisebitt S, 2004, NATURE, V432, P885, DOI 10.1038/nature03139; Fischer P, 1996, Z PHYS B CON MAT, V101, P313, DOI 10.1007/s002570050214; Fischer P, 2002, J PHYS D APPL PHYS, V35, P2391, DOI 10.1088/0022-3727/35/19/310; Gibson EA, 2003, SCIENCE, V302, P95, DOI 10.1126/science.1088654; GOODMAN JW, 2000, STAT OPTICS, P303; Jochum E., 1995, SYNCHROTRON RAD NEWS, V8, P29; Juenger MCG, 2003, J MATER SCI LETT, V22, P1335, DOI 10.1023/A:1025731210337; Kipp L, 2001, NATURE, V414, P184, DOI 10.1038/35102526; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; Larotonda MA, 2004, IEEE J SEL TOP QUANT, V10, P1363, DOI 10.1109/JSTQE.2004.838038; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; Meyer-Ilse W, 2001, J MICROSC-OXFORD, V201, P395, DOI 10.1046/j.1365-2818.2001.00845.x; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Miao JW, 2003, P NATL ACAD SCI USA, V100, P110, DOI 10.1073/pnas.232691299; Myneni SCB, 1999, SCIENCE, V286, P1335, DOI 10.1126/science.286.5443.1335; SCHMAHL G, 1984, XRAY MICROSCOPY; Schneider G, 2002, J VAC SCI TECHNOL B, V20, P3089, DOI 10.1116/1.1523403; Schneider G, 2002, SURF REV LETT, V9, P177, DOI 10.1142/S0218625X02001914; Stoll H, 2004, APPL PHYS LETT, V84, P3328, DOI 10.1063/1.1723698; SUSINI J, 2003, XRAY MICROSCOPY, V7; Toh K. K. H., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V772, P202, DOI 10.1117/12.967051; Vogt U, 2004, APPL PHYS B-LASERS O, V78, P53, DOI 10.1007/s00340-003-1338-9; Yasin S, 2001, APPL PHYS LETT, V78, P2760, DOI 10.1063/1.1369615	31	682	740	12	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2005	435	7046					1210	1213		10.1038/nature03719	http://dx.doi.org/10.1038/nature03719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988520				2022-12-24	WOS:000230140500038
J	Lyamin, O; Pryaslova, J; Lance, V; Siegel, J				Lyamin, O; Pryaslova, J; Lance, V; Siegel, J			Continuous activity in cetaceans after birth	NATURE			English	Editorial Material							SLEEP-DEPRIVATION; STATE; DROSOPHILA		Univ Calif Los Angeles, North Hills, CA 91343 USA; VA GLAHS, North Hills, CA 91343 USA; Utrish Dolphinarium, Moscow 119071, Russia; San Diego State Univ, San Diego, CA 92182 USA	University of California System; University of California Los Angeles; California State University System; San Diego State University	Siegel, J (corresponding author), Univ Calif Los Angeles, North Hills, CA 91343 USA.	jsiegel@ucla.edu	Lyamin, Oleg/AAO-4881-2020	Lyamin, Oleg/0000-0003-2049-0943	NINDS NIH HHS [R01 NS042947] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BONNET MH, 1989, PHYSIOL BEHAV, V45, P1049, DOI 10.1016/0031-9384(89)90236-9; FLANIGAN WF, 1975, SLEEP RES, V4, P139; HOPPENBROUWERS T, 1975, EXP NEUROL, V49, P822, DOI 10.1016/0014-4886(75)90062-X; Lyamin OI, 2004, ARCH ITAL BIOL, V142, P557; Lyamin OI, 2002, BEHAV BRAIN RES, V129, P125, DOI 10.1016/S0166-4328(01)00346-1; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a	10	95	99	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1177	1177		10.1038/4351177a	http://dx.doi.org/10.1038/4351177a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988513	Green Accepted, Bronze			2022-12-24	WOS:000230140500031
J	Olsen, NJ				Olsen, NJ			Tailoring arthritis therapy in the wake of the NSAID crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas, SW Med Ctr, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olsen, NJ (corresponding author), Univ Texas, SW Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.								0	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2578	2580		10.1056/NEJMp058105	http://dx.doi.org/10.1056/NEJMp058105			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972863				2022-12-24	WOS:000229953700004
J	Viner, RM; Cole, TJ				Viner, RM; Cole, TJ			Adult socioeconomic, educational, social, and psychological outcomes of childhood obesity: a national birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; SELF-REPORTED HEIGHT; YOUNG ADULTHOOD; OVERWEIGHT; WEIGHT; HEALTH; CONSEQUENCES; ADOLESCENCE; DEPRESSION; VALIDITY	Objectives To assess adult socioeconomic, educational, social, and psychological outcomes of childhood obesity by using nationally representative data. Design 1970 British birth cohort. Participants 16 567 babies born in Great Britain 5-11 April 1970 and followed up at 5, 10, and 29-30 years. Main outcome measures Obesity at age 10 and 30 years. Self reported socioeconomic, educational, psychological, and social outcomes at 30 years. Odds ratios were calculated for the risk of each adult outcome associated with obesity in childhood only, obesity in adulthood only, and persistent child and adult obesity, compared with those obese at neither period. Results Of the 8490 participants with data on body mass index at 10 and 30 years, 4.3% were obese at 10 years and 16.3% at 30 years. Obesity in childhood only was not associated with adult social class, income, years of schooling, educational attainment, relationships, or psychological morbidity in either sex after adjustment for confounding factors. Persistent obesity was not associated with any adverse adult outcomes in men, though it was associated among women with a higher risk of never having been gainfully employed (odds ratio 1.9, 95% confidence interval 1.1 to 3.3) and not having a current partner (2.0, 1.3 to 3.3). Conclusions Obesity limited to childhood has little impact on adult outcomes. Persistent obesity in women is associated with poorer employment and relationship outcomes. Efforts to reduce the socioeconomic and psychosocial burden of obesity in adult life should focus on prevention of the persistence of obesity from childhood into adulthood.	UCL, Dept Paediat, Royal Free & Univ Coll Med Sch, London NW3 2PF, England; UCL, Ctr Paediat Edpidemiol & Biostat, Inst Child Hlth, London WC1N 1EH, England	University of London; University College London; University of London; University College London	Viner, RM (corresponding author), UCL, Dept Paediat, Royal Free & Univ Coll Med Sch, London NW3 2PF, England.	R.Viner@ich.ucl.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	MRC [G9827821] Funding Source: UKRI; Medical Research Council [G9827821, G9827821(62595)] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Butler NR, 2000, 1970 BRIT BIRTH COHO; BYNNER J, 2002, 1 CLS I ED; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; CRAWLEY HF, 1995, INT J OBESITY, V19, P579; Elliot C. D., 1983, BRIT ABILITY SCALES; Ferraro KF, 2003, J GERONTOL B-PSYCHOL, V58, pS110, DOI 10.1093/geronb/58.2.S110; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; Goodman E, 2003, J ADOLESCENT HEALTH, V33, P140, DOI 10.1016/S1054-139X(03)00247-7; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; HOFFMANS MDAF, 1988, J CLIN EPIDEMIOL, V41, P749, DOI 10.1016/0895-4356(88)90161-8; Laitinen J, 2002, INT J OBESITY, V26, P1329, DOI 10.1038/sj.ijo.0802134; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; MAXWELL SE, 1993, PSYCHOL BULL, V113, P181, DOI 10.1037/0033-2909.113.1.181; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; Power C, 2003, INT J OBESITY, V27, P1081, DOI 10.1038/sj.ijo.0802323; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rodgers B, 1999, SOC PSYCH PSYCH EPID, V34, P333, DOI 10.1007/s001270050153; SARGENT JD, 1994, ARCH PEDIAT ADOL MED, V148, P681, DOI 10.1001/archpedi.1994.02170070019003; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; Wright CM, 2001, BMJ-BRIT MED J, V323, P1280, DOI 10.1136/bmj.323.7324.1280	23	130	133	1	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 11	2005	330	7504					1354	1357		10.1136/bmj.38453.422049.E0	http://dx.doi.org/10.1136/bmj.38453.422049.E0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	936FE	15901644	Green Published, Green Submitted			2022-12-24	WOS:000229840100016
J	Lu, J; Getz, G; Miska, EA; Alvarez-Saavedra, E; Lamb, J; Peck, D; Sweet-Cordero, A; Ebet, BL; Mak, RH; Ferrando, AA; Downing, JR; Jacks, T; Horvitz, HR; Golub, TR				Lu, J; Getz, G; Miska, EA; Alvarez-Saavedra, E; Lamb, J; Peck, D; Sweet-Cordero, A; Ebet, BL; Mak, RH; Ferrando, AA; Downing, JR; Jacks, T; Horvitz, HR; Golub, TR			MicroRNA expression profiles classify human cancers	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; STEM-CELLS; SIGNATURES; RNA; DIFFERENTIATION; IDENTIFICATION; ACCUMULATION; MICROARRAYS	Recent work has revealed the existence of a class of small non-coding RNA species, known as microRNAs ( miRNAs), which have critical functions across various biological processes(1,2). Here we use a new, bead-based flow cytometric miRNA expression profiling method to present a systematic expression analysis of 217 mammalian miRNAs from 334 samples, including multiple human cancers. The miRNA profiles are surprisingly informative, reflecting the developmental lineage and differentiation state of the tumours. We observe a general downregulation of miRNAs in tumours compared with normal tissues. Furthermore, we were able to successfully classify poorly differentiated tumours using miRNA expression profiles, whereas messenger RNA profiles were highly inaccurate when applied to the same samples. These findings highlight the potential of miRNA profiling in cancer diagnosis.	MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Golub, TR (corresponding author), MIT, Broad Inst, Cambridge, MA 02141 USA.	golub@broad.mit.edu	Ferrando, Adolfo A/Q-7026-2016; Downing, James R./N-8102-2018	Mak, Raymond/0000-0002-8754-0565; Miska, Eric/0000-0002-4450-576X				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Pavlidis N, 2003, EUR J CANCER, V39, P1990, DOI 10.1016/S0959-8049(03)00547-1; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	30	7636	8287	20	1486	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2005	435	7043					834	838		10.1038/nature03702	http://dx.doi.org/10.1038/nature03702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944708				2022-12-24	WOS:000229638700054
J	Hegde, SS; Vetting, MW; Roderick, SL; Mitchenall, LA; Maxwell, A; Takiff, HE; Blanchard, JS				Hegde, SS; Vetting, MW; Roderick, SL; Mitchenall, LA; Maxwell, A; Takiff, HE; Blanchard, JS			A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA	SCIENCE			English	Article							MEDIATED QUINOLONE RESISTANCE; ESCHERICHIA-COLI; MICROCIN B17; CRYSTAL-STRUCTURE; GYRASE; PLASMID; INHIBITOR; MOXIFLOXACIN; MUTATIONS; SEQUENCE	Fluoroquinolones are gaining increasing importance in the treatment of tuberculosis. The expression of MfpA, a member of the pentapeptide repeat family of proteins from Mycobacterium tuberculosis, causes resistance to ciprofloxacin and sparfloxacin. This protein binds to DNA gyrase and inhibits its activity. Its three-dimensional structure reveals a fold, which we have named the right-handed quadrilateral beta helix, that exhibits size, shape, and electrostatic similarity to B-form DNA. This represents a form of DNA mimicry and explains both its inhibitory effect on DNA gyrase and fluoroquinolone resistance resulting from the protein's expression in vivo.	Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Mol Genet Lab, Caracas 1020A, Venezuela	Yeshiva University; Albert Einstein College of Medicine; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Venezuelan Institute Science Research	Blanchard, JS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	btanchar@aecom.yu.edu		Mitchenall, Lesley/0000-0002-0063-1991; Maxwell, Anthony/0000-0002-5756-6430	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033696, T32AI007501, R01AI060899] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: Medline; NIAID NIH HHS [AI60899, AI33696, T32 AI07501] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aubry A, 2004, ANTIMICROB AGENTS CH, V48, P1281, DOI 10.1128/AAC.48.4.1281-1288.2004; Bateman A, 1998, PROTEIN SCI, V7, P1477, DOI 10.1002/pro.5560070625; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; CAMBAU E, 1994, J INFECT DIS, V170, P479, DOI 10.1093/infdis/170.2.479; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crofton J., 1997, GUIDELINES MANAGEMEN; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; GARRIDO MD, 1988, EMBO J, V7, P1853, DOI 10.1002/j.1460-2075.1988.tb03018.x; Guillemin I, 1998, ANTIMICROB AGENTS CH, V42, P2084, DOI 10.1128/AAC.42.8.2084; Hata M, 2005, ANTIMICROB AGENTS CH, V49, P801, DOI 10.1128/AAC.49.2.801-803.2005; Heddle JG, 2001, J MOL BIOL, V307, P1223, DOI 10.1006/jmbi.2001.4562; HEGDE S, UNPUB; Jacoby GA, 2003, ANTIMICROB AGENTS CH, V47, P559, DOI 10.1128/AAC.47.2.559-562.2003; Ji BH, 1998, ANTIMICROB AGENTS CH, V42, P2066, DOI 10.1128/AAC.42.8.2066; Jonas D, 2005, ANTIMICROB AGENTS CH, V49, P773, DOI 10.1128/AAC.49.2.773-775.2005; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Montero C, 2001, ANTIMICROB AGENTS CH, V45, P3387, DOI 10.1128/AAC.45.12.3387-3392.2001; Nakanishi A, 2002, J BIOL CHEM, V277, P8949, DOI 10.1074/jbc.M111278200; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Parsons LX, 2004, PROTEINS, V54, P375, DOI 10.1002/prot.10607; Pierrat OA, 2003, J BIOL CHEM, V278, P35016, DOI 10.1074/jbc.M304516200; Romanowski MJ, 2002, PROTEINS, V47, P403, DOI 10.1002/prot.10102; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SULLIVAN EA, 1995, LANCET, V345, P1148, DOI 10.1016/S0140-6736(95)90980-X; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P118, DOI 10.1128/AAC.49.1.118-125.2005; Walkinshaw MD, 2002, MOL CELL, V9, P187, DOI 10.1016/S1097-2765(02)00435-5; WILLMOTT CJR, 1993, ANTIMICROB AGENTS CH, V37, P126, DOI 10.1128/AAC.37.1.126; Xu C, 1996, J INFECT DIS, V174, P1127, DOI 10.1093/infdis/174.5.1127	32	200	217	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1480	1483		10.1126/science.1110699	http://dx.doi.org/10.1126/science.1110699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933203				2022-12-24	WOS:000229619300057
J	Rickert, M; Wang, XQ; Boulanger, MJ; Goriatcheva, N; Garcia, KC				Rickert, M; Wang, XQ; Boulanger, MJ; Goriatcheva, N; Garcia, KC			The structure of interleukin-2 complexed with its alpha receptor	SCIENCE			English	Article							CRYSTAL-STRUCTURE; IL-2 RECEPTOR; BINDING; IDENTIFICATION; LOCALIZATION; COMPONENT; ANTIBODY; CHAIN; P55	Interleukin-2 (IL-2) is an immunoregulatory cytokine that binds sequentially to the alpha (IL-2R alpha), beta (IL-2R beta), and common gamma chain (gamma(c)) receptor subunits. Here we present the 2.8 angstrom crystal structure of a complex between human IL-2 and IL-2R alpha, which-interact in a docking mode distinct from that of other cytokine receptor complexes. IL-2R alpha is composed of strand-swapped "sushi-like" domains, unlike the classical cytokine receptor fold. As a result of this domain swap, IL-2R alpha uses a composite surface to dock into a groove on IL-2 that also serves as a binding site for antagonist drugs. With this complex, we now have representative structures for each class of hematopoietic cytokine receptor-docking modules.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, 299 Campus Dr,Fairchild D319, Stanford, CA 94305 USA.	kcgarcia@stanford.edu			NIAID NIH HHS [AI51321] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; BAMBOROUGH P, 1994, STRUCTURE, V2, P839, DOI 10.1016/S0969-2126(94)00085-9; BARON M, 1991, TRENDS BIOCHEM SCI, V16, P13, DOI 10.1016/0968-0004(91)90009-K; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BAZAN JF, 1992, SCIENCE, V257, P410, DOI 10.1126/science.1631562; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRANDHUBER BJ, 1987, SCIENCE, V238, P1707, DOI 10.1126/science.3500515; Church AC, 2003, QJM-INT J MED, V96, P91, DOI 10.1093/qjmed/hcg014; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Eklund JW, 2004, CURR OPIN ONCOL, V16, P542, DOI 10.1097/01.cco.0000142070.45097.68; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; LAMBERT G, 1989, J BIOL CHEM, V264, P12730; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; Liparoto SF, 1999, J MOL RECOGNIT, V12, P316, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<316::AID-JMR468>3.0.CO;2-1; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; ROBB RJ, 1988, P NATL ACAD SCI USA, V85, P5654, DOI 10.1073/pnas.85.15.5654; SAUVE K, 1991, P NATL ACAD SCI USA, V88, P4636, DOI 10.1073/pnas.88.11.4636; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; SHACKELFORD DA, 1986, EMBO J, V5, P3275, DOI 10.1002/j.1460-2075.1986.tb04639.x; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Theze J, 1996, IMMUNOL TODAY, V17, P481, DOI 10.1016/0167-5699(96)10057-C; Tilley JW, 1997, J AM CHEM SOC, V119, P7589, DOI 10.1021/ja970702x; Tsytsikov VN, 1996, J BIOL CHEM, V271, P23055, DOI 10.1074/jbc.271.38.23055; UCHIYAMA T, 1985, J CLIN INVEST, V76, P446, DOI 10.1172/JCI111992; Waldmann TA, 1998, CURR OPIN IMMUNOL, V10, P507, DOI 10.1016/S0952-7915(98)80215-X; WU ZN, 1995, J BIOL CHEM, V270, P16039, DOI 10.1074/jbc.270.27.16039; ZURAWSKI SM, 1990, EMBO J, V9, P3899, DOI 10.1002/j.1460-2075.1990.tb07610.x	31	162	177	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1477	1480		10.1126/science.1109745	http://dx.doi.org/10.1126/science.1109745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933202				2022-12-24	WOS:000229619300056
J	Kumar, S; Regan, F				Kumar, S; Regan, F			Management of pregnancies with RhD alloimmunisation	BRITISH MEDICAL JOURNAL			English	Review							RED-CELL ALLOIMMUNIZATION; RHESUS HEMOLYTIC-DISEASE; INTRAUTERINE TRANSFUSIONS; FETAL TRANSFUSION; LATE ANEMIA; BLOOD; ISOIMMUNIZATION; ERYTHROPOIESIS; PREDICTION; HYDROPS		Univ London Imperial Coll Sci Technol & Med, Queen Charlottes Hosp, Hammersmith Hosp NHS Trust, Ctr Fetal Care, London W12 0HS, England; Univ London Imperial Coll Sci Technol & Med, Queen Charlottes Hosp, Hammersmith Hosp NHS Trust, Dept Haematol, London W12 0HS, England	Imperial College London; Imperial College London	Kumar, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Queen Charlottes Hosp, Hammersmith Hosp NHS Trust, Ctr Fetal Care, London W12 0HS, England.	sailesh.kumar@imperial.ac.uk	Kumar, Sailesh/M-3207-2014; Kumar, Sailesh/A-9203-2011	Kumar, Sailesh/0000-0003-0832-4811; 				BERGER HM, 1990, LANCET, V335, P933, DOI 10.1016/0140-6736(90)90997-J; Bowman J M, 1988, Transfus Med Rev, V2, P129, DOI 10.1016/S0887-7963(88)70039-5; BOWMAN JM, 1986, VOX SANG, V51, P117, DOI 10.1111/j.1423-0410.1986.tb00226.x; Bullock R, 2005, ULTRASOUND OBST GYN, V25, P331, DOI 10.1002/uog.1886; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; De Groot CJM, 2000, EARLY HUM DEV, V57, P205, DOI 10.1016/S0378-3782(99)00063-8; Finning KM, 2002, TRANSFUSION, V42, P1079, DOI 10.1046/j.1537-2995.2002.00165.x; Grab D, 1999, OBSTET GYNECOL, V93, P165, DOI 10.1016/S0029-7844(98)00421-9; Hudon L, 1998, AM J OBSTET GYNECOL, V179, P858, DOI 10.1016/S0002-9378(98)70178-4; Klumper FJ, 2000, EUR J OBSTET GYN R B, V92, P91, DOI 10.1016/S0301-2115(00)00430-9; LANDSTEINER KARL, 1940, PROC SOC EXP BIOL AND MED, V43, P223; LILEY AW, 1961, AM J OBSTET GYNECOL, V82, P1359; LO YMD, 1994, ANN NY ACAD SCI, V731, P229, DOI 10.1111/j.1749-6632.1994.tb55774.x; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; MAXWELL DJ, 1991, BRIT J OBSTET GYNAEC, V98, P892, DOI 10.1111/j.1471-0528.1991.tb13511.x; MILLARD DD, 1990, J PEDIATR-US, V117, P447, DOI 10.1016/S0022-3476(05)81096-0; *NAT I CLIN EXC, 2002, GUID PREGN ROUT ANT; NICOLAIDES KH, 1992, BRIT MED J, V304, P1155, DOI 10.1136/bmj.304.6835.1155; Ovali F, 1996, PEDIATR RES, V39, P831, DOI 10.1203/00006450-199605000-00015; PATTISON NS, 1992, ULTRASOUND OBST GYN, V2, P329, DOI 10.1046/j.1469-0705.1992.02050329.x; PETEREC SM, 1995, CLIN PERINATOL, V22, P561; *ROYAL COLL OBST G, 2002, GREEN TOP GUID ANT I; SAADE GR, 1993, FETAL DIAGN THER, V8, P161, DOI 10.1159/000263816; SCARADAVOU A, 1993, J PEDIATR-US, V123, P279, DOI 10.1016/S0022-3476(05)81704-4; Schumacher B, 1996, OBSTET GYNECOL, V88, P137, DOI 10.1016/0029-7844(96)00113-5; TRONCEK DF, 2001, IMMUNOHEMATOLOGY, V17, P37; van Kamp IL, 2001, AM J OBSTET GYNECOL, V185, P668, DOI 10.1067/mob.2001.116690; Voto LS, 1997, J PERINAT MED, V25, P85, DOI 10.1515/jpme.1997.25.1.85; Whitecar PW, 2002, AM J OBSTET GYNECOL, V187, P977, DOI 10.1067/mob.2002.126960	29	44	44	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 28	2005	330	7502					1255	1258		10.1136/bmj.330.7502.1255	http://dx.doi.org/10.1136/bmj.330.7502.1255			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930WX	15920129	Green Published			2022-12-24	WOS:000229448900023
J	Ribeiro, RC; Pui, C				Ribeiro, RC; Pui, C			Saving the children - Improving childhood cancer treatment in developing countrie.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA		St Jude Childrens Res Hosp, Int Outreach Program, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Leukemia Lymphoma Div, Memphis, TN 38105 USA; Amer Canc Soc, Atlanta, GA 30329 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; American Cancer Society	Ribeiro, RC (corresponding author), St Jude Childrens Res Hosp, Int Outreach Program, 332 N Lauderdale St, Memphis, TN 38105 USA.		Pui, Ching-Hon/N-8076-2018	Pui, Ching-Hon/0000-0003-0303-5658				Howard SC, 2004, JAMA-J AM MED ASSOC, V291, P2471, DOI 10.1001/jama.291.20.2471; Kazembe P, 2003, MED PEDIATR ONCOL, V40, P23, DOI 10.1002/mpo.10190; Pui C-H, 2004, Leukemia, V18, P1043, DOI 10.1038/sj.leu.2403365; Pui CH, 2003, NEW ENGL J MED, V349, P1299; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Pui CH, 2003, INT J HEMATOL, V78, P383, DOI 10.1007/BF02983810	6	115	120	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2005	352	21					2158	2160		10.1056/NEJMp048313	http://dx.doi.org/10.1056/NEJMp048313			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929HS	15917380				2022-12-24	WOS:000229333300002
J	Webster, R; Hulse, D				Webster, R; Hulse, D			Controlling avian flu at the source	NATURE			English	Editorial Material							INFLUENZA-VIRUS; H5N1 INFLUENZA		St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webster, R (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, 332 N Lauderdale St, Memphis, TN 38105 USA.							deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746	4	34	37	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					415	416		10.1038/435415a	http://dx.doi.org/10.1038/435415a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917777	Bronze, Green Published			2022-12-24	WOS:000229337800023
J	Reijman, M; Hazes, JMW; Pols, HAP; Bernsen, RMD; Koes, BW; Bierma-Zeinstra, SMA				Reijman, M; Hazes, JMW; Pols, HAP; Bernsen, RMD; Koes, BW; Bierma-Zeinstra, SMA			Role of radiography in predicting progression of osteoarthritis of the hip: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISABILITY; DISEASE; KNEE; DETERMINANTS; JOINT	Objectives To investigate which variables identify people at high risk of progression of osteoarthritis of the hip. Design Population based cohort study. Setting Ommoord district in Rotterdam, Netherlands. Participants 1904 men and women aged 55 years and older from the Rotterdam study were selected on the basis of the presence of osteoarthritic signs on radiography at baseline, as defined by a Kellgren and Lawrence score >= grade 1. Main outcome measures Radiological progression of osteoarthritis of the hip, defined as a decrease of joint space width (>= 1.0 mm) at follow-up or the presence of a total hip replacement. Methods Potential determinants of progression of hip osteoarthritis were collected at baseline. x Ray films of the hip at baseline and follow-up (mean follow-up time 6.6 years) were evaluated. Multivariate logistic regression models were used to assess the association between potential risk factors and progression of hip osteoarthritis. Results In 13.1% (1904 subjects) of the study population (mean age 66.2 years), progression of hip osteoarthritis was evident on the radiograph. Starting with a simple model of only directly obtainable variables, the Kellgren and Lawrence score at baseline, when added to the model, was a strong predictor (odds ratio 5.8, 95% confidence interval 4.0 to 8.4), increasing to 24.3 (11.3 to 52.1) in subjects with hip pain at baseline. Conclusions The Kellgren and Lawrence score at baseline was by far the strongest predictor for progression of hip osteoarthritis, especially in patients with existing hip pain at baseline. In patients with hip pain, a radiograph has strong additional value in identifying those at high risk of progression of hip osteoarthritis.	Erasmus MC, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Reijman, M (corresponding author), Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.reijman@erasmusmc.nl	Koes, Bart w/K-4614-2016; Bierma-Zeinstra, Sita/AAF-2122-2019; Reijman, Max/AFO-6451-2022	Koes, Bart w/0000-0002-0450-9969; 				Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Altman RD, 2004, OSTEOARTHR CARTILAGE, V12, P515, DOI 10.1016/j.joca.2004.04.004; ALUNAN RD, 1996, OSTEOARTHR CARTILAGE, V4, P217; [Anonymous], 1985, TECHN REP SER WHO; Auleley GR, 2000, ANN RHEUM DIS, V59, P422, DOI 10.1136/ard.59.6.422; Bergink AP, 2003, ARTHRITIS RHEUM, V48, P1913, DOI 10.1002/art.11046; Birrell F, 2003, BRIT J GEN PRACT, V53, P26; *CENTR BUR STAT, 1985, STAND BER; Chalmers J, 1999, J HYPERTENS, V17, P151; CROFT P, 1990, AM J EPIDEMIOL, V132, P514, DOI 10.1093/oxfordjournals.aje.a115687; Dahaghin S, 2005, ANN RHEUM DIS, V64, P99, DOI 10.1136/ard.2003.017087; Dougados M, 1999, J RHEUMATOL, V26, P855; Dougados M, 1996, ANN RHEUM DIS, V55, P356, DOI 10.1136/ard.55.6.356; Dougados M, 1996, ANN RHEUM DIS, V55, P552; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kellgren JH, 1963, EPIDEMIOLOGY CHRONIC; Lievense AM, 2002, ARTHRIT RHEUM-ARTHR, V47, P556, DOI 10.1002/art.10660; Odding E, 1998, ANN RHEUM DIS, V57, P203, DOI 10.1136/ard.57.4.203; Reijman M, 2004, ANN RHEUM DIS, V63, P1427, DOI 10.1136/ard.2003.016477; Reijman M, 2004, ARTHRITIS RHEUM-US, V50, P2471, DOI 10.1002/art.20332; Weel AEAM, 1999, J CLIN ENDOCR METAB, V84, P3146, DOI 10.1210/jc.84.9.3146; Zhang YQ, 1996, J RHEUMATOL, V23, P1130	25	47	49	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2005	330	7501					1183	1185		10.1136/bmj.38442.457488.8F	http://dx.doi.org/10.1136/bmj.38442.457488.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929CU	15894555	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000229320500018
J	Mitchell, DG; Brandt, PC; Roelof, EC; Dandouras, J; Krimigis, SM; Mauk, BH				Mitchell, DG; Brandt, PC; Roelof, EC; Dandouras, J; Krimigis, SM; Mauk, BH			Energetic neutral atom emissions from Titan interaction with Saturn's magnetosphere	SCIENCE			English	Article							UPPER-ATMOSPHERE; EXOSPHERE; MIMI	The Cassini Magnetospheric Imaging Instrument (MIMI) observed the interaction of Saturn's largest moon, Titan, with Saturn's magnetosphere during two close flybys of Titan on 26 October and 13 December 2004. The MIMI Ion and Neutral Camera (INCA) continuously imaged the energetic neutral atoms (ENAs) generated by charge exchange reactions between the energetic, singly ionized trapped magnetospheric ions and the outer atmosphere, or exosphere, of Titan. The images reveal a halo of variable ENA emission about Titan's nearly collisionless outer atmosphere that fades at larger distances as the exospheric density decays exponentially. The attitude of the emissions varies, and they are not symmetrical about the moon, reflecting the complexity of the interactions between Titan's upper atmosphere and Saturn's space environment.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 21042 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Mitchell, DG (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 21042 USA.	don.mitchell@jhuapl.edu	Brandt, Pontus C/N-1218-2016; Mauk, Barry H/E-8420-2017; Mitchell, Donald G/H-4601-2016; Dandouras, Iannis/V-2709-2017; Roelof, Edmond/G-6654-2019; Krimigis, Stamatios/G-4591-2019	Brandt, Pontus C/0000-0002-4644-0306; Mauk, Barry H/0000-0001-9789-3797; Mitchell, Donald G/0000-0003-1960-2119; Dandouras, Iannis/0000-0002-7121-1118; Roelof, Edmond/0000-0002-2270-0652; Krimigis, Stamatios/0000-0003-2781-2386				Amsif A, 1997, J GEOPHYS RES-SPACE, V102, P22169, DOI 10.1029/97JA01597; Dandouras J, 1999, PLANET SPACE SCI, V47, P1355, DOI 10.1016/S0032-0633(99)00057-4; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; Vervack RJ, 2004, ICARUS, V170, P91, DOI 10.1016/j.icarus.2004.03.005; YELLE RV, 1991, ASTROPHYS J, V383, P380, DOI 10.1086/170796	6	35	36	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					989	992		10.1126/science.1109805	http://dx.doi.org/10.1126/science.1109805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890874				2022-12-24	WOS:000229190700036
J	Acar, M; Becskei, A; van Oudenaarden, A				Acar, M; Becskei, A; van Oudenaarden, A			Enhancement of cellular memory by reducing stochastic transitions	NATURE			English	Article							EUKARYOTIC GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; POSITIVE-FEEDBACK; TOGGLE SWITCH; NETWORK; NOISE; MULTISTABILITY; METABOLISM; STABILITY	On induction of cell differentiation, distinct cell phenotypes are encoded by complex genetic networks(1-3). These networks can prevent the reversion of established phenotypes even in the presence of significant fluctuations. Here we explore the key parameters that determine the stability of cellular memory by using the yeast galactose-signalling network as a model system. This network contains multiple nested feedback loops. Of the two positive feedback loops, only the loop mediated by the cytoplasmic signal transducer Gal3p is able to generate two stable expression states with a persistent memory of previous galactose consumption states. The parallel loop mediated by the galactose transporter Gal2p only increases the expression difference between the two states. A negative feedback through the inhibitor Gal80p reduces the strength of the core positive feedback. Despite this, a constitutive increase in the Gal80p concentration tunes the system from having destabilized memory to having persistent memory. A model reveals that fluctuations are trapped more efficiently at higher Gal80p concentrations. Indeed, the rate at which single cells randomly switch back and forth between expression states was reduced. These observations provide a quantitative understanding of the stability and reversibility of cellular differentiation states.	MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	Acar, Murat/AIB-8244-2022; van Oudenaarden, Alexander/AAA-1705-2019	Becskei, Attila/0000-0002-9462-0934				Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BHAT PJ, 1991, GENETICS, V128, P233; Bialek W, 2001, ADV NEUR IN, V13, P103; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mizutani A, 2003, EMBO J, V22, P2178, DOI 10.1093/emboj/cdg220; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sillje HHW, 1997, J BACTERIOL, V179, P6560, DOI 10.1128/jb.179.21.6560-6565.1997; SuzukiFujimoto T, 1996, MOL CELL BIOL, V16, P2504; Timson DJ, 2002, BIOCHEM J, V363, P515, DOI 10.1042/0264-6021:3630515; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	30	386	394	6	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					228	232		10.1038/nature03524	http://dx.doi.org/10.1038/nature03524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889097				2022-12-24	WOS:000229021100046
J	Horton, JR; Liebert, K; Hattman, S; Jeltsch, A; Cheng, XD				Horton, JR; Liebert, K; Hattman, S; Jeltsch, A; Cheng, XD			Transition from nonspecific to specific DNA interactions along the substrate-recognition pathway of Dam methyltransferase	CELL			English	Article							ADENINE METHYLASE MUTANTS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TARGET BASE; YERSINIA-PSEUDOTUBERCULOSIS; HETEROLOGOUS SEROVARS; SEQUENCE SPECIFICITY; BACTERIOPHAGE-T4 DAM; IMMUNE-RESPONSES; GENE-EXPRESSION	DNA methyltransferases methylate target bases within specific nucleotide sequences. Three structures are described for bacteriophage T4 DNA-adenine methyltransferase (T4Dam) in ternary complexes with partially and fully specific DNA and a methyl-donor analog. We also report the effects of substitutions in the related Escherichia coli DNA methyltransferase (EcoDam), altering residues corresponding to those involved in specific interaction with the canonical GATC target sequence in T4Dam. We have identified two types of protein-DNA interactions: discriminatory contacts, which stabilize the transition state and accelerate methylation of the cognate site, and antidiscriminatory contacts, which do not significantly affect methylation of the cognate site but disfavor activity at noncognate sites. These structures illustrate the transition in enzyme-DNA interaction from nonspecific to specific interaction, suggesting that there is a temporal order for formation of specific contacts.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Int Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Emory University; University of Rochester	Jeltsch, A (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	a.jeltsch@iu-bremen.de; xcheng@emory.edu	Horton, John R/ABB-4770-2020; Hu, Ruogu/B-2203-2008; Jeltsch, Albert/O-7404-2014; Horton, John/F-2375-2010	Jeltsch, Albert/0000-0001-6113-9290; Horton, John/0000-0001-9749-8068	NIGMS NIH HHS [R01 GM049245, GM 49245, GM 29227, R01 GM049245-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan BW, 1999, BIOCHEMISTRY-US, V38, P5308, DOI 10.1021/bi9900020; Beck C, 2002, BIOCHEMISTRY-US, V41, P14103, DOI 10.1021/bi025979a; BROOKS JE, 1978, J MOL BIOL, V126, P381, DOI 10.1016/0022-2836(78)90047-5; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; Chen L, 2003, MICROBIOL-SGM, V149, P2283, DOI 10.1099/mic.0.26251-0; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Dueger EL, 2003, INT J FOOD MICROBIOL, V80, P153, DOI 10.1016/S0168-1605(02)00152-6; Dueger EL, 2001, INFECT IMMUN, V69, P7950, DOI 10.1128/IAI.69.12.7950-7954.2001; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hattman S, 2004, PROG NUCLEIC ACID RE, V77, P67, DOI 10.1016/S0079-6603(04)77003-8; HATTMAN S, 1970, VIROLOGY, V42, P359, DOI 10.1016/0042-6822(70)90279-5; HATTMAN S, 1978, J MOL BIOL, V126, P367, DOI 10.1016/0022-2836(78)90046-3; Hattman S, 1999, PHARMACOL THERAPEUT, V84, P367, DOI 10.1016/S0163-7258(99)00042-X; HATTMAN S, 1985, J BACTERIOL, V164, P932, DOI 10.1128/JB.164.2.932-937.1985; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Heithoff DM, 2001, INFECT IMMUN, V69, P6725, DOI 10.1128/IAI.69.11.6725-6730.2001; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Horton NC, 2002, NAT STRUCT BIOL, V9, P42, DOI 10.1038/nsb741; Julio SM, 2002, INFECT IMMUN, V70, P1006, DOI 10.1128/IAI.70.2.1006-1009.2002; Julio SM, 2001, INFECT IMMUN, V69, P7610, DOI 10.1128/IAI.69.12.7610-7615.2001; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; KOSSYKH VG, 1995, J BIOL CHEM, V270, P14389, DOI 10.1074/jbc.270.24.14389; Krabbe M, 2000, BACTERIAL STRESS RESPONSES, P305; LACKS S, 1977, J MOL BIOL, V114, P153, DOI 10.1016/0022-2836(77)90289-3; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; LAUSTER R, 1987, FEBS LETT, V220, P167, DOI 10.1016/0014-5793(87)80897-9; Liebert K, 2004, J MOL BIOL, V341, P443, DOI 10.1016/j.jmb.2004.05.033; Lobner-Olesen A, 2003, P NATL ACAD SCI USA, V100, P4672, DOI 10.1073/pnas.0538053100; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Malygin EG, 1999, NUCLEIC ACIDS RES, V27, P1135, DOI 10.1093/nar/27.4.1135; MESSER W, 1988, CELL, V54, P735, DOI 10.1016/S0092-8674(88)90911-7; MINER Z, 1989, NUCLEIC ACIDS RES, V17, P8149, DOI 10.1093/nar/17.20.8149; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; Roth M, 2001, NUCLEIC ACIDS RES, V29, P3137, DOI 10.1093/nar/29.15.3137; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Serre L, 2002, EMBO J, V21, P2854, DOI 10.1093/emboj/cdf304; Tsutakawa SE, 1999, CELL, V99, P615, DOI 10.1016/S0092-8674(00)81550-0; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; Watson ME, 2004, MOL MICROBIOL, V53, P651, DOI 10.1111/j.1365-2958.2004.04140.x; Yang W, 2000, MUTAT RES-DNA REPAIR, V460, P245, DOI 10.1016/S0921-8777(00)00030-6; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973; Zinoviev VV, 2003, J BIOL CHEM, V278, P7829, DOI 10.1074/jbc.M210769200	53	73	74	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					349	361		10.1016/j.cell.2005.02.021	http://dx.doi.org/10.1016/j.cell.2005.02.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882618	Green Accepted, Bronze			2022-12-24	WOS:000229031600006
J	Zimov, SA				Zimov, SA			Pleistocene park: Return of the mammoth's ecosystem	SCIENCE			English	Article									Russian Acad Sci, Pacific Inst Geog, NE Sci Stn, Far E Branch, Cherskii 678830, Republic Sakha, Russia	Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences	Zimov, SA (corresponding author), Russian Acad Sci, Pacific Inst Geog, NE Sci Stn, Far E Branch, POB 18, Cherskii 678830, Republic Sakha, Russia.		Zimov, Sergey/K-3009-2018	Zimov, Sergey/0000-0002-0053-6599					0	136	145	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					796	798		10.1126/science.1113442	http://dx.doi.org/10.1126/science.1113442			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879196				2022-12-24	WOS:000228986500025
J	Min, MS; Yang, SY; Bonett, RM; Vieites, DR; Brandon, RA; Wake, DB				Min, MS; Yang, SY; Bonett, RM; Vieites, DR; Brandon, RA; Wake, DB			Discovery of the first Asian plethodontid salamander	NATURE			English	Article							LIFE-HISTORY EVOLUTION; EASTERN NORTH-AMERICA	Nearly 70% of the 535 species of salamanders in the world are members of a single family, the Plethodontidae, or lungless salamanders(1). The centre of diversity for this clade is North and Middle America, where the vast majority (99%) of species salamander, from montane woodlands in southwestern Korea. The new species superficially resembles members of North American genera, in particular the morphologically conservative genus Plethodon. However, phylogenetic analysis of the nuclear encoded gene Rag-1 shows the new taxon to be widely divergent from Plethodon. The new salamander differs osteologically from putative relatives, especially with respect to the tongue ( attached protrusible) and the derived tarsus(2-6). We place the species in a new genus on the basis of the morphological and molecular data. The distribution of the new salamander adds to the enigma of Old World plethodontids, which are otherwise restricted to the western Mediterranean region(7,8), suggesting a more extensive past distribution of the family.	Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; Seoul Natl Univ, Sch Agr Biotechnol, Conservat Genome Resource Bank Korean Wildlife, Seoul 151742, South Korea; Seoul Natl Univ, Sch Agr Biotechnol, Brain Korea 21, Seoul 151742, South Korea; Inha Univ, Dept Biol, Inchon 402751, South Korea; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA	University of California System; University of California Berkeley; Seoul National University (SNU); Seoul National University (SNU); Inha University; University of California System; University of California Berkeley; Southern Illinois University System; Southern Illinois University	Wake, DB (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	wakelab@uclink.berkeley.edu	Vieites, David/B-4481-2009	Vieites, David/0000-0001-5551-7419				BRODIE E D JR, 1970, Herpetologica, V26, P468; Chippindale PT, 2004, EVOLUTION, V58, P2809; Jenkyns HC, 2004, NATURE, V432, P888, DOI 10.1038/nature03143; Larson Allan, 2003, P31; LOMBARD RE, 1977, J MORPHOL, V153, P39; Mueller RL, 2004, P NATL ACAD SCI USA, V101, P13820, DOI 10.1073/pnas.0405785101; Rasmuseen D.L, 2003, CENOZOIC SYSTEMS ROC, P479; Shubin Neil H., 2003, Amphibian Biology, V5, P1782; TIHEN JA, 1981, J HERPETOL, V15, P35, DOI 10.2307/1563644; Wake David B., 2000, P95, DOI 10.1016/B978-012632590-4/50005-8; WAKE DAVID B., 1966, MEM S CALIF ACAD SCI, V4, P1; WAKE DB, 1978, EVOLUTION, V32, P529, DOI 10.1111/j.1558-5646.1978.tb04595.x; WAKE DB, 1983, NATURAL HIST MUSEUM, V345, P1; Wallace SC, 2004, NATURE, V431, P556, DOI 10.1038/nature02819; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Xiang QY, 1998, MOL PHYLOGENET EVOL, V10, P178, DOI 10.1006/mpev.1998.0524; Xiang QYJ, 2004, EVOLUTION, V58, P2175, DOI 10.1111/j.0014-3820.2004.tb01596.x; 2005, AMPHIBIAWEB	18	81	90	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					87	90		10.1038/nature03474	http://dx.doi.org/10.1038/nature03474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875021				2022-12-24	WOS:000228864600043
J	Fogassi, L; Ferrari, PF; Gesierich, B; Rozzi, S; Chersi, F; Rizzolatti, G				Fogassi, L; Ferrari, PF; Gesierich, B; Rozzi, S; Chersi, F; Rizzolatti, G			Parietal lobe: From action organization to intention understanding	SCIENCE			English	Article							CORTEX; NEURONS; MONKEY; REPRESENTATION; RECOGNITION; PROJECTIONS; MECHANISMS; AFFERENT; OBJECTS	Inferior parietal lobule (IPL) neurons were studied when monkeys performed motor acts embedded in different actions and when they observed similar acts done by an experimenter. Most motor IPL neurons coding a specific act (e.g., grasping) showed markedly different activations when this act was part of different actions (e.g., for eating or for placing). Many motor IPL neurons also discharged during the observation of acts done by others. Most responded differentially when the same observed act was embedded in a specific action. These neurons fired during the observation of an act, before the beginning of the subsequent acts specifying the action. Thus, these neurons not only code the observed motor act but also allow the observer to understand the agent's intentions.	Univ Parma, Dipartimento Psicol, I-43100 Parma, Italy; Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy	University of Parma; University of Parma	Fogassi, L (corresponding author), Univ Parma, Dipartimento Psicol, Borgo Carissimi 10, I-43100 Parma, Italy.	fogassi@unipr.it	Rozzi, Stefano/F-9915-2019; Ferrari, Pier Francesco/G-5547-2017; FOGASSI, Leonardo/K-3541-2018	Rozzi, Stefano/0000-0002-6147-1530; FOGASSI, Leonardo/0000-0003-3348-039X				Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; BAIZER JS, 1991, J NEUROSCI, V11, P168; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; COLBY CL, 1996, INFORMATION INTEGRAT, V14, P157; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; *EU, 2002, QLG3CT200200746 EU; FERRARI PF, 2003, SOC NEUR ABS, V919; FERRARI PF, UNPUB; FOGASSI L, 1998, SOC NEUR ABS, V257; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Jellema T., 2002, IMITATIVE MIND DEV E, P267; LUPPINO G, 2004, FENS ABSTR; Luria AR., 1973, WORKING BRAIN; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; PERRETT DI, 1989, J EXP BIOL, V146, P87; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Sakata Hideo, 1994, Current Opinion in Neurobiology, V4, P847, DOI 10.1016/0959-4388(94)90133-3; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; TANAKA M, 2004, SOC NEUR ABS, V82; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Yokochi H, 2003, SOMATOSENS MOT RES, V20, P115, DOI 10.1080/0899022031000105145	33	1302	1346	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					662	667		10.1126/science.1106138	http://dx.doi.org/10.1126/science.1106138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860620				2022-12-24	WOS:000228810900040
J	DiLuzio, WR; Turner, L; Mayer, M; Garstecki, P; Weibel, DB; Berg, HC; Whitesides, GM				DiLuzio, WR; Turner, L; Mayer, M; Garstecki, P; Weibel, DB; Berg, HC; Whitesides, GM			Escherichia coli swim on the right-hand side	NATURE			English	Article							3-DIMENSIONAL TRACKING; FLAGELLAR FILAMENTS; MOTILITY; CHEMOTAXIS; BACTERIA; SURFACE; DIFFERENTIATION; TYPHIMURIUM; MICROSCOPY; MUTANTS	The motion of peritrichously flagellated bacteria close to surfaces is relevant to understanding the early stages of biofilm formation and of pathogenic infection(1-4). This motion differs from the random-walk trajectories(5) of cells in free solution. Individual Escherichia coli cells swim in clockwise, circular trajectories near planar glass surfaces(6,7). On a semi-solid agar substrate, cells differentiate into an elongated, hyperflagellated phenotype and migrate cooperatively over the surface(8), a phenomenon called swarming. We have developed a technique for observing isolated E. coli swarmer cells(9) moving on an agar substrate and confined in shallow, oxidized poly( dimethylsiloxane) ( PDMS) microchannels. Here we show that cells in these microchannels preferentially 'drive on the right', swimming preferentially along the right wall of the microchannel ( viewed from behind the moving cell, with the agar on the bottom). We propose that when cells are confined between two interfaces - one an agar gel and the second PDMS they swim closer to the agar surface than to the PDMS surface ( and for much longer periods of time), leading to the preferential movement on the right of the microchannel. Thus, the choice of materials guides the motion of cells in microchannels.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Rowland Inst, Cambridge, MA 02142 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu	Garstecki, Piotr/ABA-9188-2020; Mayer, Michael/C-1299-2010; Mayer, Michael/AAS-1777-2020	Garstecki, Piotr/0000-0001-9101-7163; Mayer, Michael/0000-0002-6148-5756; 				ALLISON C, 1992, MOL MICROBIOL, V6, P1583; ARMSTRONG JB, 1967, J BACTERIOL, V93, P390, DOI 10.1128/JB.93.1.390-398.1967; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERG HC, 1990, BIOPHYS J, V58, P919, DOI 10.1016/S0006-3495(90)82436-X; Biondi SA, 1998, AICHE J, V44, P1923, DOI 10.1002/aic.690440822; Brandrup J., 1999, POLYM HDB, V4th; Damiano ER, 2004, J FLUID MECH, V500, P75, DOI 10.1017/S0022112003006566; Darnton N, 2004, BIOPHYS J, V86, P1863, DOI 10.1016/S0006-3495(04)74253-8; FRYMIER PD, 1995, P NATL ACAD SCI USA, V92, P6195, DOI 10.1073/pnas.92.13.6195; Frymier PD, 1997, AICHE J, V43, P1341, DOI 10.1002/aic.690430523; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; Pernodet N, 1997, ELECTROPHORESIS, V18, P55, DOI 10.1002/elps.1150180111; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; RAMIA M, 1993, BIOPHYS J, V65, P755, DOI 10.1016/S0006-3495(93)81129-9; TAYLOR G, 1952, PROC R SOC LON SER-A, V211, P225, DOI 10.1098/rspa.1952.0035; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Vigeant MAS, 1997, APPL ENVIRON MICROB, V63, P3474, DOI 10.1128/AEM.63.9.3474-3479.1997; Vigeant MAS, 2002, APPL ENVIRON MICROB, V68, P2794, DOI 10.1128/AEM.68.6.2794-2801.2002; Visick KL, 2000, J BACTERIOL, V182, P1779, DOI 10.1128/JB.182.7.1779-1787.2000; WOLFE AJ, 1987, J BACTERIOL, V169, P1878, DOI 10.1128/jb.169.5.1878-1885.1987; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G	28	327	332	5	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1271	1274		10.1038/nature03660	http://dx.doi.org/10.1038/nature03660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988531				2022-12-24	WOS:000230140500051
J	Paciorek, T; Zazimalova, E; Ruthardt, N; Petrasek, J; Stierhof, YD; Kleine-Vehn, J; Morris, DA; Emans, N; Jurgens, G; Geldner, N; Friml, J				Paciorek, T; Zazimalova, E; Ruthardt, N; Petrasek, J; Stierhof, YD; Kleine-Vehn, J; Morris, DA; Emans, N; Jurgens, G; Geldner, N; Friml, J			Auxin inhibits endocytosis and promotes its own efflux from cells	NATURE			English	Article							BREFELDIN-A; ARABIDOPSIS; TRANSPORT; LOCALIZATION; GRADIENTS; GENE; ACCUMULATION; MUTATIONS; MECHANISM; HORMONE	One of the mechanisms by which signalling molecules regulate cellular behaviour is modulating subcellular protein translocation. This mode of regulation is often based on specialized vesicle trafficking, termed constitutive cycling, which consists of repeated internalization and recycling of proteins to and from the plasma membrane(1). No such mechanism of hormone action has been shown in plants although several proteins, including the PIN auxin efflux facilitators, exhibit constitutive cycling(2,3). Here we show that a major regulator of plant development, auxin, inhibits endocytosis. This effect is specific to biologically active auxins and requires activity of the Calossin-like protein BIG. By inhibiting the internalization step of PIN constitutive cycling, auxin increases levels of PINs at the plasma membrane. Concomitantly, auxin promotes its own efflux from cells by a vesicle-trafficking-dependent mechanism. Furthermore, asymmetric auxin translocation during gravitropism is correlated with decreased PIN internalization. Our data imply a previously undescribed mode of plant hormone action: by modulating PIN protein trafficking, auxin regulates PIN abundance and activity at the cell surface, providing a mechanism for the feedback regulation of auxin transport.	Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; ASCR, Inst Expt Bot, Prague 16502 6, Czech Republic; Rhein Westfal TH Aachen, Cellome Res Grp, D-52074 Aachen, Germany; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	Eberhard Karls University of Tubingen; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; RWTH Aachen University; University of Southampton	Friml, J (corresponding author), Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany.	jiri.friml@zmbp.uni-tuebingen.de	Kleine-Vehn, Jürgen/C-8984-2014; Geldner, Niko/Y-2481-2019; Friml, Jiri/D-9511-2012; Petrasek, Jan/C-8240-2009; Eva, Zazimalova/G-7432-2014; Petrasek, Jan/AAW-1081-2021	Kleine-Vehn, Jürgen/0000-0002-4354-3756; Friml, Jiri/0000-0002-8302-7596; Petrasek, Jan/0000-0002-6719-2735; Eva, Zazimalova/0000-0002-8325-7092; Petrasek, Jan/0000-0002-6719-2735; Geldner, Niko/0000-0002-2300-9644				Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Berleth T, 2001, CURR OPIN PLANT BIOL, V4, P57, DOI 10.1016/S1369-5266(00)00136-9; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Delarue M, 1999, PHYSIOL PLANTARUM, V107, P120, DOI 10.1034/j.1399-3054.1999.100116.x; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gadow A. von, 1997, Journal of Agricultural and Food Chemistry, V45, P632, DOI 10.1021/jf960281n; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Kanyuka K, 2003, PLANT J, V35, P57, DOI 10.1046/j.1365-313X.2003.01779.x; KARLINNEUMANN GA, 1991, PLANT CELL, V3, P573, DOI 10.1105/tpc.3.6.573; Morris DA, 2000, PLANT GROWTH REGUL, V32, P161, DOI 10.1023/A:1010701527848; Petrasek J, 2003, PLANT PHYSIOL, V131, P254, DOI 10.1104/pp.012740; Petrasek J, 2002, PLANTA, V216, P302, DOI 10.1007/s00425-002-0845-y; Pimpl P, 2000, PLANT CELL, V12, P2219, DOI 10.1105/tpc.12.11.2219; Richards S, 1996, GENETICS, V142, P1215; Royle SJ, 2003, BIOESSAYS, V25, P39, DOI 10.1002/bies.10200; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	30	574	600	3	148	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1251	1256		10.1038/nature03633	http://dx.doi.org/10.1038/nature03633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988527				2022-12-24	WOS:000230140500047
J	Fairhurst, RM; Baruch, DI; Brittain, NJ; Ostera, GR; Wallach, JS; Hoang, HL; Hayton, K; Guindo, A; Makobongo, MO; Schwartz, OM; Tounkara, A; Doumbo, OK; Diallo, DA; Fujioka, H; Ho, M; Wellems, TE				Fairhurst, RM; Baruch, DI; Brittain, NJ; Ostera, GR; Wallach, JS; Hoang, HL; Hayton, K; Guindo, A; Makobongo, MO; Schwartz, OM; Tounkara, A; Doumbo, OK; Diallo, DA; Fujioka, H; Ho, M; Wellems, TE			Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria	NATURE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; RED-CELLS; SURFACE; ANTIGENS; ANTIBODIES; DISEASE; PATHOGENESIS; POPULATION; RESISTANCE	Haemoglobin C, which carries a glutamate-to-lysine mutation in the beta-globin chain, protects West African children against Plasmodium falciparum malaria(1,2). Mechanisms of protection are not established for the heterozygous (haemoglobin AC) or homozygous (haemoglobin CC) states. Here we report a marked effect of haemoglobin C on the cell-surface properties of P. falciparum-infected erythrocytes involved in pathogenesis. Relative to parasite-infected normal erythrocytes (haemoglobin AA), parasitized AC and CC erythrocytes show reduced adhesion to endothelial monolayers expressing CD36 and intercellular adhesion molecule-1 (ICAM-1). They also show impaired rosetting interactions with non-parasitized erythrocytes, and reduced agglutination in the presence of pooled sera from malaria-immune adults. Abnormal cell-surface display of the main variable cytoadherence ligand, PfEMP-1 (P. falciparum erythrocyte membrane protein-1), correlates with these findings. The abnormalities in PfEMP-1 display are associated with markers of erythrocyte senescence, and are greater in CC than in AC erythrocytes. Haemoglobin C might protect against malaria by reducing PfEMP-1-mediated adherence of parasitized erythrocytes, thereby mitigating the effects of their sequestration in the microvasculature.	NIAID, Lab Malaria & Vestor Res, NIH, Bethesda, MD 20892 USA; NIAID, Malaria Vaccine Dev Branch, NIH, Bethesda, MD 20892 USA; NIAID, Biol Imaging Facil, Res Technol Branch, NIH, Bethesda, MD 20892 USA; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Parasitol, Malaria Res & Training Ctr, Bamako, Mali; Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Hematol, Malaria Res & Training Ctr, Bamako, Mali; Minist Hlth, Ctr Natl Transfus Sanguine, Bamako, Mali; Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Calgary; University of Bamako; University of Bamako; Case Western Reserve University	Wellems, TE (corresponding author), NIAID, Lab Malaria & Vestor Res, NIH, Bethesda, MD 20892 USA.	twellems@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000483, ZIAAI000483] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; ALLISON AC, 1961, ANN NY ACAD SCI, V91, P710, DOI 10.1111/j.1749-6632.1961.tb31102.x; Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; BUNN HF, 1982, P NATL ACAD SCI-BIOL, V79, P7527, DOI 10.1073/pnas.79.23.7527; CHARACHE S, 1967, J CLIN INVEST, V46, P1795, DOI 10.1172/JCI105670; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; FRIEDMAN MJ, 1979, AM J TROP MED HYG, V28, P777, DOI 10.4269/ajtmh.1979.28.777; Gamain B, 2001, P NATL ACAD SCI USA, V98, P2664, DOI 10.1073/pnas.041602598; Giribaldi G, 2001, BRIT J HAEMATOL, V113, P492, DOI 10.1046/j.1365-2141.2001.02707.x; HUISMAN THJ, 1972, CLIN CHIM ACTA, V40, P159, DOI 10.1016/0009-8981(72)90264-1; KAUL DK, 1991, BLOOD, V78, P812; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; MACDONALD VW, 1982, BIOCHIM BIOPHYS ACTA, V701, P39, DOI 10.1016/0167-4838(82)90309-0; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; MURPHY JR, 1973, J LAB CLIN MED, V82, P334; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; WILLIAMS AR, 1980, SCAND J HAEMATOL, V24, P57; Winterbourn CC, 1985, CRC HDB METHODS OXYG, P137; Yipp BG, 2000, BLOOD, V96, P2292, DOI 10.1182/blood.V96.6.2292.h8002292_2292_2298	30	143	147	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1117	1121		10.1038/nature03631	http://dx.doi.org/10.1038/nature03631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973412	Bronze, Green Published			2022-12-24	WOS:000229970400053
J	Magnus, D; Cho, MK				Magnus, D; Cho, MK			Issues in oocyte donation for stem cell research	SCIENCE			English	Editorial Material							INFORMED-CONSENT; GUIDELINES; DONORS; EMBRYO		Stanford Univ, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA; Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Cho, MK (corresponding author), Stanford Univ, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA.	micho@stanford.edu						Abecassis M, 2000, JAMA-J AM MED ASSOC, V284, P2919; Adams PL, 2002, TRANSPLANTATION, V74, P582, DOI 10.1097/00007890-200208270-00030; *AM SOC TRANSPL SU, 2005, STAT SOL DON ORG; APPELBAUM PS, 1982, INT J LAW PSYCHIAT, V5, P319, DOI 10.1016/0160-2527(82)90026-7; Biller-Andorno N, 2001, THEOR MED BIOETH, V22, P351, DOI 10.1023/A:1011842211016; Delmonico FL, 2003, TRANSPLANTATION, V76, P1257, DOI 10.1097/01.TP.0000089674.07433.DA; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Golan A, 1989, Obstet Gynecol Surv, V44, P430, DOI 10.1097/00006254-198906000-00004; Henderson GE, 2004, MOL THER, V10, P225, DOI 10.1016/j.ymthe.2004.05.013; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Institute of Medicine and National Research Council, 2007, GUID HUM EMBR STEM C, DOI [10.17226/11870, DOI 10.17226/11153]; King NMP, 1999, HUM GENE THER, V10, P133, DOI 10.1089/10430349950019264; Lo B, 2004, FERTIL STERIL, V82, P559, DOI 10.1016/j.fertnstert.2004.01.040; Lo B, 2003, SCIENCE, V301, P921, DOI 10.1126/science.1087038; Macklin R, 2001, KENNEDY INST ETHIC J, V11, P17, DOI 10.1353/ken.2001.0005; Rimington M R, 2003, Reprod Biomed Online, V6, P277; SCHENKER JG, 1978, FERTIL STERIL, V30, P255; White MT, 1999, J LAW MED ETHICS, V27, P87, DOI 10.1111/j.1748-720X.1999.tb01440.x; Zink S, 2005, AM J BIOETHICS, V5, P6, DOI 10.1080/15265160590953085	19	78	78	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1747	1748		10.1126/science.1114454	http://dx.doi.org/10.1126/science.1114454			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15905363				2022-12-24	WOS:000229926800039
J	Litman, RS; Rosenberg, H				Litman, RS; Rosenberg, H			Malignant hyperthermia - Update on susceptibility testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTRAL CORE DISEASE; DEPENDENT CALCIUM-CHANNEL; VITRO CONTRACTURE-TEST; HYPOKALEMIC PERIODIC PARALYSIS; HYPERKALEMIC CARDIAC-ARREST; MUSCLE RYANODINE RECEPTOR; SKELETAL-MUSCLE; RYR1 GENE; SARCOPLASMIC-RETICULUM; CHROMOSOME 19Q12-13.2	Malignant hyperthermia (MH) is a pharmacogenetic clinical syndrome that manifests as a hypermetabolic crisis when a susceptible individual is exposed to an anesthetic triggering agent. Clinical signs include unexplained elevation of end-tidal carbon dioxide, muscle rigidity, acidosis, tachycardia, tachypnea, hyperthermia, and evidence of rhabdomyolysis. This process is a result of an abnormally increased release of calcium from the sarcoplasmic reticulum, which is often caused by an inherited mutation in the gene for the ryanodine receptor (RYR1) that resides in the membrane of the sarcoplasmic reticulum. The gold standard for determination of MH susceptibility is the caffeine-halothane contracture test. However, it is invasive, requiring skeletal muscle biopsy and is not widely available. Researchers have begun to map mutations within the ryanodine receptor gene (chromosome 19q13.1) responsible for conferring MH susceptibility. Ryanodine receptor mutations are found in at least 25% of known MH susceptible individuals in North America. Mutation analysis has recently become available in the United States and is expected to play an integral role in the diagnosis of MH susceptibility in the future.	Univ Penn, Dept Anesthesiol & Crit Care Med, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; St Barnabas Hosp, Dept Med Educ, Livingston, NJ USA; Mt Sinai Sch Med, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Icahn School of Medicine at Mount Sinai	Litman, RS (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care Med, Childrens Hosp Philadelphia, Sch Med, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	Lit-manr@email.chop.edu	Litman, Ron/AAK-6146-2020					Allen GC, 1998, ANESTHESIOLOGY, V88, P579, DOI 10.1097/00000542-199803000-00006; Anetseder M, 2002, LANCET, V359, P1579, DOI 10.1016/S0140-6736(02)08506-9; Bachand M, 1997, CAN J ANAESTH, V44, P696, DOI 10.1007/BF03013380; Bendahan D, 1998, ANESTHESIOLOGY, V88, P96, DOI 10.1097/00000542-199801000-00017; Bendahan D, 2001, ANESTH ANALG, V93, P683, DOI 10.1097/00000539-200109000-00030; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Davis MR, 2003, NEUROMUSCULAR DISORD, V13, P151, DOI 10.1016/S0960-8966(02)00218-3; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; DEUFEL T, 1995, AM J HUM GENET, V56, P1334; Dirksen RT, 2004, BIOPHYS J, V87, P3193, DOI 10.1529/biophysj.104.049447; Fletcher JE, 1999, ANESTHESIOLOGY, V90, P1294, DOI 10.1097/00000542-199905000-00012; FLETCHER JE, 1991, LIFE SCI, V49, P1651, DOI 10.1016/0024-3205(91)90060-O; Fortunato G, 1999, EUR J HUM GENET, V7, P415, DOI 10.1038/sj.ejhg.5200314; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; Guis S, 2004, ARCH NEUROL-CHICAGO, V61, P106, DOI 10.1001/archneur.61.1.106; ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969; Larach MG, 1997, CLIN PEDIATR, V36, P9; LEVITT RC, 1992, GENOMICS, V14, P562, DOI 10.1016/S0888-7543(05)80152-1; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; LOUIS CF, 1992, ANESTHESIOLOGY, V77, P114, DOI 10.1097/00000542-199207000-00017; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; *MAL HYP ASS US WE, MH MUSCL BIOPS TEST; Marchant CL, 2004, MUSCLE NERVE, V30, P114, DOI 10.1002/mus.20068; Mathews KD, 2004, ARCH NEUROL-CHICAGO, V61, P27, DOI 10.1001/archneur.61.1.27; McCarthy T V, 2004, Biochem J, V380, pe1, DOI 10.1042/BJ20040512; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; Mickelson JR, 1996, PHYSIOL REV, V76, P537, DOI 10.1152/physrev.1996.76.2.537; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Nathan A, 2005, ANESTH ANALG, V100, P672, DOI 10.1213/01.ANE.0000146533.21771.2F; O'Sullivan GH, 2001, BIOCHEM PHARMACOL, V61, P1479, DOI 10.1016/S0006-2952(01)00604-9; OLCKERS A, 1992, GENOMICS, V14, P829, DOI 10.1016/S0888-7543(05)80206-X; Ording H, 1997, ACTA ANAESTH SCAND, V41, P955, DOI 10.1111/j.1399-6576.1997.tb04820.x; ORDING H, 1985, ANESTH ANALG, V64, P700; Paul-Pletzer K, 2002, J BIOL CHEM, V277, P34918, DOI 10.1074/jbc.M205487200; Phillips MS, 1996, GENOMICS, V34, P24, DOI 10.1006/geno.1996.0238; POLLOCK N, 1992, ANAESTH INTENS CARE, V20, P520, DOI 10.1177/0310057X9202000427; Rajabally YA, 2002, MUSCLE NERVE, V25, P453, DOI 10.1002/mus.10069; Robinson RL, 2003, EUR J HUM GENET, V11, P342, DOI 10.1038/sj.ejhg.5200964; Robinson RL, 2002, HUM MUTAT, V20, P88, DOI 10.1002/humu.10098; Robinson RL, 1997, HUM MOL GENET, V6, P953, DOI 10.1093/hmg/6.6.953; Rosenberg H, 2002, ANESTHESIOLOGY, V96, P232, DOI 10.1097/00000542-200201000-00036; Sei Y, 2004, ANESTHESIOLOGY, V101, P824, DOI 10.1097/00000542-200410000-00005; Sei Y, 2002, ANESTHESIOLOGY, V97, P1052, DOI 10.1097/00000542-200211000-00005; Serfas KD, 1996, ANESTHESIOLOGY, V84, P322, DOI 10.1097/00000542-199602000-00009; Stewart SL, 2001, CLIN GENET, V59, P178, DOI 10.1034/j.1399-0004.2001.590306.x; Struk A, 1998, BIOPHYS J, V75, P2402, DOI 10.1016/S0006-3495(98)77684-2; SUDBRAK R, 1995, AM J HUM GENET, V56, P684; Tobin JR, 2001, JAMA-J AM MED ASSOC, V286, P168, DOI 10.1001/jama.286.2.168; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; Weiss RG, 2004, AM J PHYSIOL-CELL PH, V287, pC1094, DOI 10.1152/ajpcell.00173.2004; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200	52	106	117	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2005	293	23					2918	2924		10.1001/jama.293.23.2918	http://dx.doi.org/10.1001/jama.293.23.2918			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	935MD	15956637				2022-12-24	WOS:000229785500027
J	Spilianakis, CG; Lalioti, MD; Town, T; Lee, GR; Flavell, RA				Spilianakis, CG; Lalioti, MD; Town, T; Lee, GR; Flavell, RA			Interchromosomal associations between alternatively expressed loci	NATURE			English	Article							TH2 CYTOKINE LOCUS; HYPERSENSITIVE SITES; NUCLEAR-LOCALIZATION; HISTONE ACETYLATION; GENE; ENHANCER; HETEROCHROMATIN; TRANSCRIPTION; ORGANIZATION; MOBILITY	The T-helper- cell 1 and 2 (T(H)1 and T(H)2) pathways, defined by cytokines interferon-gamma (IFN-gamma) and interleukin-4 ( IL-4), respectively, comprise two alternative CD4(+) T-cell fates, with functional consequences for the host immune system. These cytokine genes are encoded on different chromosomes. The recently described T(H)2 locus control region (LCR) coordinately regulates the T(H)2 cytokine genes by participating in a complex between the LCR and promoters of the cytokine genes Il4, Il5 and Il13. Although they are spread over 120 kilobases, these elements are closely juxtaposed in the nucleus in a poised chromatin conformation. In addition to these intrachromosomal interactions, we now describe interchromosomal interactions between the promoter region of the IFN-gamma gene on chromosome 10 and the regulatory regions of the T(H)2 cytokine locus on chromosome 11. DNase I hypersensitive sites that comprise the T(H)2 LCR developmentally regulate these interchromosomal interactions. Furthermore, there seems to be a cell-type-specific dynamic interaction between interacting chromatin partners whereby interchromosomal interactions are apparently lost in favour of intrachromosomal ones upon gene activation. Thus, we provide an example of eukaryotic genes located on separate chromosomes associating physically in the nucleus via interactions that may have a function in coordinating gene expression.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Parada LA, 2004, EXP CELL RES, V296, P64, DOI 10.1016/j.yexcr.2004.03.013; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Schubeler D, 2000, GENE DEV, V14, P940; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5	37	535	559	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					637	645		10.1038/nature03574	http://dx.doi.org/10.1038/nature03574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15880101				2022-12-24	WOS:000229476200042
J	Smirnakis, SM; Brewer, AA; Schmid, MC; Tolias, AS; Schuz, A; Augath, M; Inhoffen, W; Wandell, BA; Logothetis, NK				Smirnakis, SM; Brewer, AA; Schmid, MC; Tolias, AS; Schuz, A; Augath, M; Inhoffen, W; Wandell, BA; Logothetis, NK			Lack of long-term cortical reorganization after macaque retinal lesions	NATURE			English	Article							PRIMARY VISUAL-CORTEX; PRIMATE STRIATE CORTEX; CROSS-MODAL PLASTICITY; RECEPTIVE-FIELD; ADULT CAT; SENSORY DEAFFERENTATION; TOPOGRAPHIC PLASTICITY; MACULAR DEGENERATION; FUNCTIONAL MRI; BLIND HUMANS	Several aspects of cortical organization are thought to remain plastic into adulthood, allowing cortical sensorimotor maps to be modified continuously by experience. This dynamic nature of cortical circuitry is important for learning, as well as for repair after injury to the nervous system. Electrophysiology studies suggest that adult macaque primary visual cortex (V1) undergoes large-scale reorganization within a few months after retinal lesioning, but this issue has not been conclusively settled. Here we applied the technique of functional magnetic resonance imaging ( fMRI) to detect changes in the cortical topography of macaque area V1 after binocular retinal lesions. fMRI allows non-invasive, in vivo, long-term monitoring of cortical activity with a wide field of view, sampling signals from multiple neurons per unit cortical area. We show that, in contrast with previous studies, adult macaque V1 does not approach normal responsivity during 7.5 months of follow-up after retinal lesions, and its topography does not change. Electrophysiology experiments corroborated the fMRI results. This indicates that adult macaque V1 has limited potential for reorganization in the months following retinal injury.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ Tubingen, Dept Ophthalmol 1, D-72076 Tubingen, Germany	Max Planck Society; Harvard University; Massachusetts General Hospital; Stanford University; Stanford University; Eberhard Karls University of Tubingen	Smirnakis, SM (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	smsmirnakis@partners.org	Schmid, Michael C./G-1867-2010; Schmid, Michael Christoph/AAH-4835-2020; Logothetis, Nikos/U-9282-2019	Schmid, Michael C./0000-0003-1424-130X; Schmid, Michael Christoph/0000-0003-1424-130X; 	NINDS NIH HHS [F30 NS044759] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS044759] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelucci A, 2002, PROG BRAIN RES, V136, P373; Angelucci A, 2002, J NEUROSCI, V22, P8633; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brewer AA, 2002, J NEUROSCI, V22, P10416; Calford MB, 1999, P ROY SOC B-BIOL SCI, V266, P499, DOI 10.1098/rspb.1999.0665; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DEANGELIS GC, 1995, P NATL ACAD SCI USA, V92, P9682, DOI 10.1073/pnas.92.21.9682; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fenrich K, 2004, CAN J NEUROL SCI, V31, P142, DOI 10.1017/S0317167100053798; FIORANI M, 1992, P NATL ACAD SCI USA, V89, P8547, DOI 10.1073/pnas.89.18.8547; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; Li W, 2001, EXP BRAIN RES, V139, P359, DOI 10.1007/s002210100757; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Murakami I, 1997, VISUAL NEUROSCI, V14, P89, DOI 10.1017/S0952523800008798; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; PONS TP, 1988, P NATL ACAD SCI USA, V85, P5279, DOI 10.1073/pnas.85.14.5279; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; ROSA MGP, 1995, J PHYSIOL-LONDON, V482, P589, DOI 10.1113/jphysiol.1995.sp020543; ROSIER AM, 1995, J COMP NEUROL, V359, P476, DOI 10.1002/cne.903590309; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; SCHMID LM, 1995, NEUROREPORT, V6, P1349, DOI 10.1097/00001756-199506090-00030; Schmid LM, 1996, CEREB CORTEX, V6, P388, DOI 10.1093/cercor/6.3.388; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; VOLCHAN E, 1995, VISION RES, V35, P1, DOI 10.1016/0042-6989(94)E0083-W; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561	47	150	157	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 19	2005	435	7040					300	307		10.1038/nature03495	http://dx.doi.org/10.1038/nature03495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902248				2022-12-24	WOS:000229185000036
J	Ito, K; Ito, M; Elliott, WM; Cosio, B; Caramori, G; Kon, OM; Barczyk, A; Hayashi, S; Adcock, IM; Hogg, JC; Barnes, PJ				Ito, K; Ito, M; Elliott, WM; Cosio, B; Caramori, G; Kon, OM; Barczyk, A; Hayashi, S; Adcock, IM; Hogg, JC; Barnes, PJ			Decreased histone deacetylase activity in chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THEOPHYLLINE; MACROPHAGES; EXPRESSION; ASTHMA	BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation that is greater in patients with advanced disease. We asked whether there is a link between the severity of disease and the reduction in histone deacetylase (HDAC) activity in the peripheral lung tissue of patients with COPD of varying severity. HDAC is a key molecule in the repression of production of proinflammatory cytokines in alveolar macrophages. METHODS: HDAC activity and histone acetyltransferase (HAT) activity were determined in nuclear extracts of specimens of surgically resected lung tissue from nonsmokers without COPD, patients with COPD of varying severity, and patients with pneumonia or cystic fibrosis. Alveolar macrophages from nonsmokers, smokers, and patients with COPD and bronchial-biopsy specimens from nonsmokers, healthy smokers, patients with COPD, and those with mild asthma were also examined. Total RNA extracted from lung tissue and macrophages was used for quantitative reverse-transcriptase-polymerase-chain-reaction assay of HDAC1 through HDAC8 and interleukin-8. Expression of HDAC2 protein was quantified with the use of Western blotting. Histone-4 acetylation at the interleukin-8 promoter was evaluated with the use of a chromatin immunoprecipitation assay. RESULTS: Specimens of lung tissue obtained from patients with increasing clinical stages of COPD had graded reductions in HDAC activity and increases in interleukin-8 messenger RNA (mRNA) and histone-4 acetylation at the interleukin-8 promoter. The mRNA expression of HDAC2, HDAC5, and HDAC8 and expression of the HDAC2 protein were also lower in patients with increasing severity of disease. HDAC activity was decreased in patients with COPD, as compared with normal subjects, in both the macrophages and biopsy specimens, with no changes in HAT activity, whereas HAT activity was increased in biopsy specimens obtained from patients with asthma. Neither HAT activity nor HDAC activity was changed in lung tissue from patients with cystic fibrosis or pneumonia. CONCLUSIONS: Patients with COPD have a progressive reduction in total HDAC activity that reflects the severity of the disease.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London SW3 6LY, England; St Marys Hosp, Chest & Allergy Clin, London, England; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; St Pauls Hosp, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Vancouver, BC V6Z 1Y6, Canada; Univ Ferrara, Dept Clin & Expt Med, Ctr Ric Asma & Broncopneumopatia Cron Ostrutt, I-44100 Ferrara, Italy; L Warynski Silesian Med Acad, Dept Pneumol, Katowice, Poland	Imperial College London; Imperial College London; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of Ferrara; Medical University Silesia	Barnes, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, Dovehouse St, London SW3 6LY, England.	p.j.barnes@imperial.ac.uk	Caramori, Gaetano/AAS-8611-2020; Adcock, Ian/L-3217-2019; Ito, Kazuhiro/AAF-5994-2019; G.Cosio, Borja/P-4963-2017; Barczyk, Adam/GYV-4487-2022	Caramori, Gaetano/0000-0002-9807-327X; G.Cosio, Borja/0000-0002-6388-8209; Adcock, Ian/0000-0003-2101-8843; Barnes, Peter/0000-0002-5122-4018; Barczyk, Adam/0000-0002-6567-9208				Barnes PJ, 2004, LANCET, V363, P731, DOI 10.1016/S0140-6736(04)15650-X; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DING L, 2004, J COPD, V1, P191; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; *GOLD, 2001, NIH PUBL; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Ito K, 2001, FASEB J, V15, pA473; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Saetta M, 2001, AM J RESP CRIT CARE, V163, P1304, DOI 10.1164/ajrccm.163.6.2009116; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323	18	706	746	1	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1967	1976		10.1056/NEJMoa041892	http://dx.doi.org/10.1056/NEJMoa041892			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888697	Bronze			2022-12-24	WOS:000229017100007
J	Moore, P				Moore, P			Amplifying the signal	NATURE			English	Article																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					236	236		10.1038/435236a	http://dx.doi.org/10.1038/435236a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889101	Bronze			2022-12-24	WOS:000229021100050
J	Rowe, SM; Miller, S; Sorscher, EJ				Rowe, SM; Miller, S; Sorscher, EJ			Mechanisms of disease: Cystic fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANSMEMBRANE CONDUCTANCE REGULATOR; VASOACTIVE-INTESTINAL-PEPTIDE; PREMATURE STOP MUTATIONS; AIRWAY EPITHELIAL-CELLS; LUNG-DISEASE; CHLORIDE CHANNEL; SUBMUCOSAL GLANDS; DRUG DISCOVERY; CFTR; GENE		Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sorscher, EJ (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, 1530 3rd Ave S,MCLM 796, Birmingham, AL 35294 USA.	sorscher@uab.edu		Sorscher, Eric J./0000-0001-9341-3354				BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; *CYST FIBR FDN, 2004, CYST FIBR FDN NAT PA; DETERDING RR, 2004, PEDIATR PULM, V38, P249; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Frangolias DD, 2003, AM J RESP CELL MOL, V29, P390, DOI 10.1165/rcmb.2002-0271OC; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; GAN KH, 1995, NEW ENGL J MED, V333, P95, DOI 10.1056/NEJM199507133330204; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gill S, 2003, ASSAY DRUG DEV TECHN, V1, P709, DOI 10.1089/154065803770381066; Grubb BR, 1999, AM J PHYSIOL-GASTR L, V277, pG167, DOI 10.1152/ajpgi.1999.277.1.G167; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Hilliard Jay B, 2002, Methods Mol Med, V70, P409; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; Keeling KM, 2002, J MOL MED-JMM, V80, P367, DOI 10.1007/s00109-001-0317-z; Keeling KM, 2001, HUM MOL GENET, V10, P291, DOI 10.1093/hmg/10.3.291; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; Koehler DR, 2004, AM J RESP CELL MOL, V31, P377, DOI 10.1165/rcmb.2004-0124TR; Konstan MW, 2002, ADV DRUG DELIVER REV, V54, P1409, DOI 10.1016/S0169-409X(02)00146-1; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240000255; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LOWE CU, 1949, AM J DIS CHILD, V78, P349, DOI 10.1001/archpedi.1949.02030050362008; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Olivier KN, 1996, AM J RESP CRIT CARE, V154, P217, DOI 10.1164/ajrccm.154.1.8680683; Puchelle E, 2001, PEDIATR PULM, P143; QUINTON PM, 1986, AM J PHYSIOL, V251, pC649, DOI 10.1152/ajpcell.1986.251.4.C649; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1437; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sagel SD, 2002, CLIN REV ALLERG IMMU, V23, P41, DOI 10.1385/CRIAI:23:1:041; Sagel SD, 2002, J PEDIATR-US, V141, P811, DOI 10.1067/mpd.2002.129847; SCHOUMACHER RA, 1987, NATURE, V330, P752, DOI 10.1038/330752a0; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Verkman AS, 2004, AM J PHYSIOL-CELL PH, V286, pC465, DOI 10.1152/ajpcell.00397.2003; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; VERKMAN AS, 2003, PEDIATR PULM, V36, P290; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; WELSH MJ, 1986, SCIENCE, V232, P1648, DOI 10.1126/science.2424085; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Wyckoff TJO, 2002, MICROBIOL-SGM, V148, P3423, DOI 10.1099/00221287-148-11-3423; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S; Zeitlin P, 2004, NEW ENGL J MED, V351, P606, DOI 10.1056/NEJMcibr041584; Zeitlin PL, 2000, KIDNEY INT, V57, P832, DOI 10.1046/j.1523-1755.2000.00922.x; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	65	1110	1166	8	254	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1992	2001		10.1056/NEJMra043184	http://dx.doi.org/10.1056/NEJMra043184			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888700				2022-12-24	WOS:000229017100010
J	Conigliaro, RL				Conigliaro, RL			Satisfaction?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												conigliarorl@upmc.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2193	2193		10.1001/jama.293.18.2193	http://dx.doi.org/10.1001/jama.293.18.2193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886362				2022-12-24	WOS:000228981100001
J	Nel, A				Nel, A			Air pollution-related illness: Effects of particles	SCIENCE			English	Editorial Material							DIESEL EXHAUST PARTICLES; OXIDATIVE STRESS; INFLAMMATION; MORTALITY; HEART		Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Nel, A (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.	anel@mednet.ucla.edu	Nel, Andre E/J-2808-2012					Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Donaldson K, 2002, INHAL TOXICOL, V14, P5, DOI 10.1080/089583701753338613; Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089; Gilliland FD, 2004, LANCET, V363, P119, DOI 10.1016/S0140-6736(03)15262-2; Gurgueira SA, 2002, ENVIRON HEALTH PERSP, V110, P749, DOI 10.1289/ehp.02110749; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Lim HB, 1998, FREE RADICAL BIO MED, V25, P635, DOI 10.1016/S0891-5849(98)00073-2; MURANAKA M, 1986, J ALLERGY CLIN IMMUN, V77, P616, DOI 10.1016/0091-6749(86)90355-6; *NAT AC SCI NAT RE, 1998, RES PRIOR AIRB PART, V1; Nel AE, 1998, J ALLERGY CLIN IMMUN, V102, P539, DOI 10.1016/S0091-6749(98)70269-6; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Oberdorster G, 2002, ENVIRON HEALTH PERSP, V110, pA440, DOI 10.1289/ehp.110-a440; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Silbajoris R, 2000, INHAL TOXICOL, V12, P453; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; 1994, ENVIRONMENT, V36, P4; 2002, HLTH EFFECTS I PERSP	19	1113	1181	9	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					804	806		10.1126/science.1108752	http://dx.doi.org/10.1126/science.1108752			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879201				2022-12-24	WOS:000228986500030
J	Tanaka, KD; Ueda, K				Tanaka, KD; Ueda, K			Horsfield's hawk-cuckoo nestlings simulate multiple gapes for begging	SCIENCE			English	Article							SIGNALS		Rikkyo Univ, Dept Life Sci, Tokyo 1718501, Japan	Rikkyo University	Tanaka, KD (corresponding author), Rikkyo Univ, Dept Life Sci, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	keita@zaf.att.ne.jp	Tanaka, Keita/A-5543-2008	Tanaka, Keita/0000-0001-9749-5094				Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kilner RM, 2004, SCIENCE, V305, P877, DOI 10.1126/science.1098487; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Tanaka K., UNPUB; TANAKA KD, IN PRESS J AVIAN BIO	7	56	58	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					653	653		10.1126/science.1109957	http://dx.doi.org/10.1126/science.1109957			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860618				2022-12-24	WOS:000228810900037
J	Kralovics, R; Passamonti, F; Buser, AS; Teo, S; Tiedt, R; Passweg, JR; Tichelli, A; Cazzola, M; Skoda, RC				Kralovics, R; Passamonti, F; Buser, AS; Teo, S; Tiedt, R; Passweg, JR; Tichelli, A; Cazzola, M; Skoda, RC			A gain-of-function mutation of JAK2 in myeloproliferative disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; ERYTHROID PROGENITORS; DIAGNOSTIC-CRITERIA; UNIPARENTAL DISOMY; IMATINIB MESYLATE; STEM-CELL; IN-VITRO; EXPRESSION; CLONALITY	BACKGROUND: Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal myeloproliferative disorders arising from a multipotent progenitor. The loss of heterozygosity (LOH) on the short arm of chromosome 9 (9pLOH) in myeloproliferative disorders suggests that 9p harbors a mutation that contributes to the cause of clonal expansion of hematopoietic cells in these diseases. METHODS: We performed microsatellite mapping of the 9pLOH region and DNA sequencing in 244 patients with myeloproliferative disorders (128 with polycythemia vera, 93 with essential thrombocythemia, and 23 with idiopathic myelofibrosis). RESULTS: Microsatellite mapping identified a 9pLOH region that included the Janus kinase 2 (JAK2) gene. In patients with 9pLOH, JAK2 had a homozygous G(rightarrow)T transversion, causing phenylalanine to be substituted for valine at position 617 of JAK2 (V617F). All 51 patients with 9pLOH had the V617F mutation. Of 193 patients without 9pLOH, 66 were heterozygous for V617F and 127 did not have the mutation. The frequency of V617F was 65 percent among patients with polycythemia vera (83 of 128), 57 percent among patients with idiopathic myelofibrosis (13 of 23), and 23 percent among patients with essential thrombocythemia (21 of 93). V617F is a somatic mutation present in hematopoietic cells. Mitotic recombination probably causes both 9pLOH and the transition from heterozygosity to homozygosity for V617F. Genetic evidence and in vitro functional studies indicate that V617F gives hematopoietic precursors proliferative and survival advantages. Patients with the V617F mutation had a significantly longer duration of disease and a higher rate of complications (fibrosis, hemorrhage, and thrombosis) and treatment with cytoreductive therapy than patients with wild-type JAK2. CONCLUSIONS: A high proportion of patients with myeloproliferative disorders carry a dominant gain-of-function mutation of JAK2.	Univ Basel Hosp, Dept Res Expt Hematol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Hematol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Lab Med, CH-4031 Basel, Switzerland; Univ Pavia, Sch Med, Div Hematol, I-27100 Pavia, Italy; Policlin San Matteo, Ist Ric & Cura Carattere Sci, I-27100 Pavia, Italy	University of Basel; University of Basel; University of Basel; University of Pavia; IRCCS Fondazione San Matteo	Skoda, RC (corresponding author), Univ Basel Hosp, Dept Res, Hebelstr 20, CH-4031 Basel, Switzerland.	radek.skoda@unibas.ch	Passamonti, Francesco/AAB-2262-2022; Buser, Andreas/AAL-8676-2020; Buser, Andreas S/A-2660-2008; Cazzola, Mario/AAQ-8854-2021; passweg, jakob/AAG-3911-2020	Passamonti, Francesco/0000-0001-8068-5289; Buser, Andreas/0000-0002-7942-6746; Buser, Andreas S/0000-0002-7942-6746; Cazzola, Mario/0000-0001-6984-8817; Passweg, Jakob R/0000-0001-7092-3351; Kralovics, Robert/0000-0002-6997-8539				Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Axelrad AA, 2000, BLOOD, V96, P3310; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; Brodmann S, 2000, ANN HEMATOL, V79, P312, DOI 10.1007/s002779900136; Chen Z, 1998, GENE CHROMOSOME CANC, V22, P321, DOI 10.1002/(SICI)1098-2264(199808)22:4<321::AID-GCC8>3.0.CO;2-X; CORREA PN, 1994, BLOOD, V83, P99; DAI CH, 1991, J CLIN INVEST, V87, P391, DOI 10.1172/JCI115009; DAI CH, 1992, BLOOD, V80, P891; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; DIEZMARTIN JL, 1991, MAYO CLIN PROC, V66, P287, DOI 10.1016/S0025-6196(12)61011-8; ElKassar N, 1997, BLOOD, V89, P128, DOI 10.1182/blood.V89.1.128.128_128_134; Ghilardi N, 1997, MOL ENDOCRINOL, V11, P393, DOI 10.1210/me.11.4.393; Hagstrom SA, 1999, P NATL ACAD SCI USA, V96, P2952, DOI 10.1073/pnas.96.6.2952; Harrison CN, 1999, BLOOD, V93, P417, DOI 10.1182/blood.V93.2.417.402a33_417_424; Horikawa Y, 1997, BLOOD, V90, P4031, DOI 10.1182/blood.V90.10.4031; Kralovics R, 2003, BLOOD, V102, P3793, DOI 10.1182/blood-2003-03-0885; Kralovics R, 2003, BLOOD, V102, P1869, DOI 10.1182/blood-2003-03-0744; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Liu E, 2003, BLOOD, V101, P3294, DOI 10.1182/blood-2002-07-2287; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; MERTENS F, 1991, LEUKEMIA, V5, P214; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Murphy S, 1999, SEMIN HEMATOL, V36, P9; Najfeld V, 2002, BRIT J HAEMATOL, V119, P558, DOI 10.1046/j.1365-2141.2002.03763.x; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; PAL N, 1990, ONCOGENE, V5, P1665; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Passamonti F, 2004, BRIT J HAEMATOL, V126, P650, DOI 10.1111/j.1365-2141.2004.05098.x; Pearson TC, 2001, SEMIN HEMATOL, V38, P21, DOI 10.1053/shem.2001.23043; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Raghavan M, 2005, CANCER RES, V65, P375; REGECAMBRIN G, 1987, CANCER GENET CYTOGEN, V25, P233, DOI 10.1016/0165-4608(87)90183-X; Roder S, 2001, EXP HEMATOL, V29, P694, DOI 10.1016/S0301-472X(01)00637-3; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Silver RT, 2003, LEUKEMIA, V17, P1186, DOI 10.1038/sj.leu.2402938; Spivak JL, 2004, BLOOD, V103, P3241, DOI 10.1182/blood-2003-12-4248; Spivak JL, 2004, SEMIN HEMATOL, V41, P1, DOI 10.1053/j.seminhematol.2004.02.011; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; WADEY RB, 1990, ONCOGENE, V5, P901; Weinberg RS, 1997, SEMIN HEMATOL, V34, P64; Westwood NB, 2000, BRIT J HAEMATOL, V110, P839, DOI 10.1046/j.1365-2141.2000.02242.x; Westwood NB, 2001, HAEMATOLOGICA, V86, P464	47	2689	2878	2	86	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1779	1790		10.1056/NEJMoa051113	http://dx.doi.org/10.1056/NEJMoa051113			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858187	Bronze			2022-12-24	WOS:000228689000008
J	Malescio, G				Malescio, G			Predicting with unpredictability	NATURE			English	Editorial Material							RANDOMNESS		Univ Messina, Dept Phys, I-98166 Messina, Italy	University of Messina	Malescio, G (corresponding author), Univ Messina, Dept Phys, I-98166 Messina, Italy.							Calude CS, 1999, NATURE, V400, P319, DOI 10.1038/22435; CHAITIN GJ, 1975, SCI AM, V232, P47, DOI 10.1038/scientificamerican0575-47; Metropolis N., 1987, LOS ALAMOS SCI, V15, P125, DOI DOI 10.1128/JCM.05092-11	3	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1073	1073		10.1038/4341073a	http://dx.doi.org/10.1038/4341073a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858553	Bronze			2022-12-24	WOS:000228693300021
